Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" ABCC3 "cMOAT2, EST90757, MLP2, MOAT-D, MRP3" ENSG00000108846 "ATP binding cassette subfamily C member 3" O15438 17 50634777-50692253 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 59.1;liver: 50.4" "Cell type enhanced" "Detected in many" "Cholangiocytes: 231.6;Distal enterocytes: 265.1;Gastric mucus-secreting cells: 271.7;Hepatocytes: 192.9;Paneth cells: 194.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 5.1;non-classical monocyte: 6.4" "Lineage enriched" "Detected in many" 5 "monocytes: 6.4" "Cell line enhanced" "Detected in many" "A549: 79.4;CAPAN-2: 60.6;HeLa: 36.9;OE19: 89.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB037136, HPA048483" Enhanced Supported "Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "CAB037136: AB_477165, HPA048483: AB_2680414" "unprognostic (1.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.65e-2)" "unprognostic (9.67e-3)" "unprognostic (6.19e-3)" "unprognostic (7.44e-3)" "unprognostic (8.20e-2)" "unprognostic (3.18e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.60e-3)" "prognostic unfavorable (4.68e-6)" "unprognostic (3.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.44e-2)" "unprognostic (1.57e-3)" 3.1 59.1 0.1 3.4 1.8 0.8 4.2 0.2 0.7 2.1 0.0 18.9 12.0 1.1 1.8 7.5 1.0 11.9 0.9 0.3 0.3 8.0 50.4 4.8 1.9 5.9 0.8 0.7 22.6 0.8 0.8 1.1 3.5 5.9 8.7 0.4 7.0 5.5 0.2 7.1 11.9 1.3 1.7 3.4 17.1 1.0 2.5 0.3 5.5 0.0 1.7 6.3 3.6 2.4 5.7 79.4 0.0 0.3 4.4 6.9 0.1 10.4 13.1 0.7 0.7 4.2 60.6 0.0 8.0 20.6 14.5 14.5 0.0 1.0 1.0 0.0 0.0 1.7 36.9 24.2 17.2 0.0 0.0 7.5 5.6 2.9 6.2 8.5 1.4 0.0 0.2 0.0 8.0 18.9 0.0 0.0 0.1 89.7 10.1 0.1 0.0 0.3 33.4 34.2 0.1 0.6 19.2 3.1 0.0 0.1 2.6 0.0 17.3 0.5 3.4 0.2 8.5 0.1 0.0 0.0 8.2 0.0 0.9 0.2 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.0 0.3 6.4 0.1 0.5 5.4 0.1 1.8 0.2 0.7 0.3 0.3 5.9 0.8 3.5 1.7 2.5 2.4 0.7 19.2 5.5 0.0 1.8 9.4 122.2 47.1 42.7 1.6 1.9 6.9 3.1 231.6 19.5 14.7 0.0 0.4 0.0 265.1 5.9 100.1 82.9 5.9 8.8 2.7 23.5 0.0 4.3 106.1 3.7 3.6 271.7 30.5 0.0 3.1 3.9 192.9 26.1 1.7 0.9 96.2 12.2 33.0 11.4 118.6 9.0 31.6 3.6 2.8 8.7 2.9 1.0 0.5 0.5 105.9 194.7 3.0 2.1 104.6 57.2 10.8 2.7 0.3 0.0 1.9 5.6 0.9 0.8 12.7 10.5 1.0 2.6 0.1 111.0 118.4 AC068631.2 ENSG00000283149 "Novel protein" 3 186581995-186597103 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA010814 Uncertain Uncertain "Endoplasmic reticulum" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "Endoplasmic reticulum" "HPA010814: AB_1078691" 9.2 10.1 5.2 11.6 5.4 9.8 7.9 5.4 15.4 6.7 4.9 18.2 12.1 5.9 13.9 8.6 5.9 7.6 13.4 5.2 5.2 14.7 32.7 9.7 4.5 5.2 5.3 6.0 22.7 7.9 8.3 6.0 5.4 8.6 5.9 8.9 9.2 4.2 4.6 6.5 9.9 3.0 4.9 13.4 10.6 8.5 5.2 6.0 18.6 0.0 5.2 7.6 6.8 5.1 36.3 28.9 35.7 42.8 29.6 12.9 9.3 71.3 16.4 25.1 16.4 102.9 15.0 21.6 82.1 46.3 40.5 24.3 31.8 25.1 22.6 18.7 0.0 23.6 52.7 102.2 22.7 46.0 11.6 14.0 8.0 32.0 50.5 21.3 13.4 10.6 12.8 81.1 10.7 83.7 23.7 2.0 9.7 93.6 0.0 14.2 37.2 26.9 12.4 69.5 0.3 0.6 30.9 62.2 18.4 35.9 40.0 57.9 7.3 17.9 21.3 13.0 62.9 31.5 88.4 66.5 26.3 33.7 35.2 7.5 6.4 8.6 10.3 8.6 7.0 7.8 6.4 8.8 9.9 4.8 4.2 8.3 1.6 10.2 7.2 15.3 8.4 7.3 5.2 5.4 5.4 15.4 5.2 5.2 5.2 5.3 5.4 4.9 5.2 5.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACADL "ACAD4, LCAD" ENSG00000115361 "Acyl-CoA dehydrogenase long chain" P28330 2 210187126-210225447 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.0;pancreas: 28.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 70.9;Early spermatids: 85.6;Late spermatids: 69.4;Leydig cells: 46.9;Peritubular cells: 46.6;Proximal tubular cells: 31.5" "Group enriched" "Detected in many" 8 "liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 2.4;RPTEC TERT1: 2.6;SuSa: 2.3;U-2 OS: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011990 Enhanced Supported NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 10: Non-specific - Unknown function" "HPA011990: AB_1844465" "unprognostic (6.29e-3)" "unprognostic (7.61e-2)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (1.33e-2)" "unprognostic (7.66e-3)" "unprognostic (3.24e-1)" "unprognostic (1.55e-1)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" "unprognostic (1.99e-1)" "prognostic favorable (1.58e-11)" "unprognostic (4.22e-3)" "unprognostic (1.18e-4)" "unprognostic (8.81e-3)" "unprognostic (1.06e-1)" 11.9 1.1 0.8 0.1 0.8 0.0 8.0 0.7 1.1 3.4 0.9 0.5 0.0 0.7 1.1 0.5 4.0 0.6 3.1 0.7 1.2 19.8 28.0 10.1 0.0 0.8 0.8 12.7 28.4 4.5 2.9 1.0 0.8 20.6 0.1 0.0 6.8 4.8 9.5 2.8 0.4 0.1 0.8 0.0 5.6 3.1 0.7 1.5 23.7 5.0 0.0 1.0 3.8 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 2.6 0.5 0.0 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.7 1.1 0.7 1.2 0.8 0.8 0.8 0.8 0.7 0.9 0.2 28.9 70.9 1.0 0.0 0.6 1.4 1.1 1.2 0.2 1.3 0.5 1.1 8.6 7.6 22.0 2.1 8.8 0.0 0.0 15.6 4.0 85.6 7.1 0.4 0.2 0.0 0.0 0.2 11.9 0.3 4.9 3.6 5.9 2.5 0.8 0.7 23.0 0.5 0.0 13.3 0.0 0.0 0.3 0.4 69.4 46.9 0.4 0.0 4.7 0.0 0.2 0.0 7.5 0.3 3.9 0.0 46.6 0.0 8.2 0.0 31.5 2.4 0.2 0.0 7.6 13.7 0.7 0.7 0.7 1.0 6.3 0.4 0.1 0.0 0.7 ACP1 "HAAP, LMW-PTP, LMWPTP" ENSG00000143727 "Acid phosphatase 1" P24666 2 264140-278283 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1061.1;Late spermatids: 2128.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016754 Approved Approved Nucleoplasm,Cytosol NA NA 2000000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Cytosol "HPA016754: AB_1844505" "unprognostic (1.15e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-2)" "unprognostic (6.25e-3)" "unprognostic (1.06e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.67e-6)" "unprognostic (2.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (9.72e-3)" "unprognostic (4.89e-2)" "unprognostic (2.71e-2)" "unprognostic (7.10e-2)" "unprognostic (2.88e-2)" "unprognostic (3.39e-2)" "unprognostic (1.92e-1)" "unprognostic (2.44e-2)" 41.2 104.0 43.1 45.5 47.6 91.9 64.7 43.9 54.0 43.4 63.9 61.4 64.0 46.6 69.3 43.3 57.9 45.4 57.3 49.4 47.1 78.1 106.4 46.8 66.2 43.4 44.2 59.2 94.1 73.9 59.2 61.7 44.3 52.1 64.7 72.7 71.1 44.2 76.6 41.3 60.7 41.5 44.9 44.7 67.1 46.1 45.3 66.2 63.7 74.9 61.9 47.5 36.4 50.2 78.3 112.5 177.4 97.4 76.1 77.1 142.2 92.6 97.7 91.9 80.8 151.7 78.5 48.8 70.7 85.1 114.6 76.5 169.4 97.0 82.3 118.7 157.9 142.3 99.0 348.5 105.7 162.5 80.4 78.7 90.5 81.9 102.3 95.5 105.8 176.9 145.1 95.1 110.9 103.1 178.5 161.3 214.1 204.7 111.7 118.2 176.1 114.5 144.2 110.5 191.6 191.3 56.0 137.6 196.3 115.0 82.1 89.8 88.9 101.3 65.2 84.0 142.6 123.8 261.2 150.4 120.0 138.9 123.7 65.4 61.6 57.2 88.8 75.2 118.1 106.6 100.4 103.2 57.3 97.2 118.1 115.2 10.9 121.5 80.2 65.3 117.6 115.0 43.1 47.6 43.9 54.0 49.4 47.1 43.4 44.2 44.3 44.9 45.3 50.2 62.5 44.8 96.7 9.1 102.6 79.2 105.3 173.4 51.8 53.1 118.8 130.0 84.9 131.5 119.6 68.0 8.4 207.1 101.3 81.9 270.1 226.7 1061.1 113.1 56.2 70.6 82.5 291.5 20.4 169.0 279.7 74.2 54.6 85.5 70.3 95.9 56.0 115.8 141.1 28.6 21.0 125.1 126.1 72.0 66.3 2128.2 94.4 74.6 81.8 16.9 117.8 92.2 152.4 19.6 26.0 174.4 109.2 92.2 106.4 187.0 174.2 306.6 128.1 56.9 92.1 42.5 87.0 122.6 137.4 87.4 91.2 187.7 86.0 124.4 143.9 148.3 ACP2 LAP ENSG00000134575 "Acid phosphatase 2, lysosomal" P11117 11 47239302-47248906 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 89.3;Hofbauer cells: 113.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "intermediate monocyte: 69.9" "Lineage enriched" "Detected in all" 5 "monocytes: 69.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 12000 "Cluster 51: Monocytes - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (5.27e-3)" "unprognostic (1.56e-1)" "unprognostic (3.86e-2)" "prognostic favorable (1.04e-4)" "unprognostic (7.90e-3)" "unprognostic (2.93e-1)" "unprognostic (6.16e-3)" "unprognostic (1.09e-1)" "unprognostic (2.63e-1)" "unprognostic (3.28e-3)" "unprognostic (2.64e-3)" "unprognostic (5.42e-2)" "unprognostic (1.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.20e-1)" "unprognostic (8.68e-3)" "unprognostic (1.57e-1)" 25.2 36.6 17.3 22.9 17.1 6.4 21.8 17.0 18.5 16.5 22.1 23.3 42.9 15.8 29.8 14.3 14.1 19.6 21.7 19.8 26.0 27.4 80.5 21.4 29.4 20.8 19.6 11.1 45.9 21.3 21.3 28.7 23.1 25.4 18.1 11.9 50.3 18.3 14.0 11.4 31.9 16.9 16.9 29.1 24.8 12.2 22.0 13.7 19.3 14.8 15.3 22.0 13.1 17.2 16.5 33.5 31.9 28.2 28.1 13.6 24.4 26.6 47.1 47.5 49.4 23.3 26.3 4.3 21.9 34.2 14.3 23.7 16.9 24.6 22.5 85.5 29.1 11.1 48.1 24.6 38.4 16.4 27.1 34.1 15.2 24.6 14.5 28.3 34.9 14.1 20.3 33.9 31.5 26.8 13.4 14.2 21.5 24.8 20.0 10.8 43.1 36.2 34.9 37.6 16.7 26.0 36.8 80.1 19.2 16.3 49.0 14.0 21.0 23.9 19.8 31.4 38.4 28.1 40.0 3.6 35.0 8.2 37.6 12.5 16.9 7.2 12.3 69.9 9.4 2.5 7.6 11.1 15.1 1.5 6.6 5.7 2.8 9.7 48.2 0.6 8.3 10.9 17.3 17.1 17.0 18.5 19.8 26.0 20.8 19.6 23.1 16.9 22.0 17.2 13.3 19.2 18.6 6.2 5.6 4.1 9.3 42.2 10.2 14.4 13.5 9.1 9.2 21.5 29.4 18.4 6.2 41.3 2.6 37.6 9.8 50.6 1.8 7.7 15.6 18.3 15.0 13.5 6.9 60.1 33.3 15.3 17.3 12.1 12.0 10.7 45.7 89.3 113.5 11.8 8.9 26.7 22.4 80.0 3.9 3.5 5.0 33.8 24.9 3.7 29.8 20.6 7.2 8.5 4.3 33.5 29.5 10.5 21.1 10.9 55.3 33.4 19.2 11.9 19.7 8.1 14.5 11.8 19.1 9.5 2.4 29.3 5.8 25.2 14.3 8.6 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621337-88632281 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 62.7" "Cancer enhanced" "Detected in all" "testis cancer: 38.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.1 12.2 6.8 10.7 7.1 17.7 6.0 6.6 6.8 6.8 7.0 8.4 5.1 7.6 9.6 9.6 7.0 12.5 7.3 6.3 11.5 9.0 13.5 10.1 12.8 8.6 7.7 8.0 20.9 4.4 22.4 6.9 7.7 12.1 8.6 1.0 8.3 8.2 15.1 7.2 9.1 10.1 8.1 15.2 13.2 9.8 9.5 10.7 10.3 3.7 11.9 11.5 5.9 7.7 14.9 64.5 39.6 34.2 17.4 20.7 83.7 51.5 46.8 39.1 47.8 53.8 28.2 63.6 16.1 28.3 35.0 20.9 148.0 42.1 32.6 15.7 58.2 34.0 26.4 89.9 42.0 28.5 32.8 25.6 36.4 48.5 39.7 14.0 33.0 20.6 54.6 35.2 48.3 34.4 35.5 24.0 96.0 30.8 36.9 45.4 28.2 46.9 16.5 31.9 31.1 28.5 20.8 23.7 40.1 90.7 19.7 32.0 29.9 39.5 55.1 16.2 70.5 67.0 48.5 54.7 36.0 31.5 79.1 0.0 2.3 0.8 6.2 3.7 12.0 10.9 10.8 8.4 5.2 10.3 11.6 10.6 0.6 3.9 4.9 3.1 19.6 9.2 6.8 7.1 6.6 6.8 6.3 11.5 8.6 7.7 7.7 8.1 9.5 7.7 6.9 6.4 8.1 4.2 21.0 18.6 25.8 6.2 12.0 1.2 21.4 15.4 3.9 8.6 12.9 1.8 0.0 4.7 8.4 5.6 3.9 11.4 23.6 22.5 5.3 7.6 9.0 11.8 20.5 7.6 16.3 9.0 11.7 17.7 2.5 12.3 2.5 6.3 4.5 1.7 16.0 9.9 26.4 4.7 26.4 62.7 4.4 7.8 14.2 3.7 14.2 3.1 9.2 9.0 2.5 11.5 6.2 2.6 26.9 27.8 2.3 5.5 5.4 0.9 13.1 12.0 11.6 10.2 18.2 10.9 28.3 6.2 14.9 6.8 9.7 25.4 AGAP5 "CTGLF2, Em:AC073389.1" ENSG00000172650 "ArfGAP with GTPase domain, ankyrin repeat and PH domain 5" A6NIR3 10 73674287-73697881 "Predicted intracellular proteins" "GTPase activation" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 79.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA042490 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA042490: AB_2678022" "unprognostic (1.84e-1)" "unprognostic (3.59e-2)" "unprognostic (1.27e-2)" "unprognostic (1.07e-1)" "unprognostic (1.61e-1)" "unprognostic (4.45e-3)" "unprognostic (1.40e-1)" "unprognostic (4.52e-1)" "unprognostic (1.41e-1)" "unprognostic (1.98e-2)" "unprognostic (4.04e-3)" "unprognostic (4.33e-3)" "unprognostic (5.83e-5)" "unprognostic (3.33e-2)" "unprognostic (2.87e-1)" "unprognostic (7.29e-2)" "unprognostic (1.17e-2)" 3.2 5.1 2.7 3.8 3.1 3.2 4.3 4.2 3.7 3.9 4.4 3.5 3.5 3.3 4.2 3.2 3.3 2.6 5.5 2.7 3.2 4.4 6.9 3.6 4.4 3.0 2.8 4.8 9.9 1.9 4.7 2.6 3.2 4.7 3.1 5.3 6.3 2.5 8.7 6.5 4.0 2.2 2.1 5.0 4.3 8.4 3.4 3.1 4.0 2.1 2.8 3.3 3.5 4.6 2.4 2.9 3.8 4.2 3.0 2.3 5.7 2.9 2.1 2.0 1.7 3.9 3.3 2.9 2.4 2.3 0.8 5.9 2.8 2.4 1.3 3.4 3.3 2.3 6.7 4.5 2.5 5.9 3.7 2.4 2.6 2.3 6.2 5.2 1.6 4.2 3.0 5.8 1.8 2.3 2.3 7.7 1.1 2.6 7.9 3.1 1.6 2.2 2.0 2.3 1.7 1.5 1.7 6.2 3.5 2.7 3.5 4.7 2.9 2.5 3.4 2.5 3.8 6.9 3.7 1.7 2.6 6.7 1.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 2.7 3.1 4.2 3.7 2.7 3.2 3.0 2.8 3.2 2.1 3.4 4.6 2.1 0.0 9.0 4.2 1.5 1.9 0.3 0.8 0.0 2.4 2.4 1.7 0.0 1.5 3.7 3.7 6.2 1.7 2.1 1.0 0.0 1.6 79.9 2.6 2.3 2.1 0.0 2.7 6.4 2.2 0.7 1.7 4.6 1.5 3.8 2.5 3.9 3.5 1.5 3.3 6.3 2.0 0.0 1.3 2.2 18.9 1.2 1.9 1.8 1.9 2.4 1.7 2.1 4.5 8.4 2.7 0.5 3.8 1.6 1.1 3.2 0.6 6.6 2.7 0.0 0.9 0.9 4.2 2.4 0.9 1.3 0.7 1.8 1.3 2.1 0.7 AHCY SAHH ENSG00000101444 Adenosylhomocysteinase P23526 20 34280268-34311802 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "One-carbon metabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 275.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041225, HPA044675" Approved Supported Cytosol NA NA 5000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA041225: AB_2677371, HPA044675: AB_2679041" "unprognostic (3.35e-1)" "unprognostic (2.17e-1)" "unprognostic (2.41e-2)" "unprognostic (1.32e-2)" "unprognostic (7.74e-2)" "unprognostic (3.15e-2)" "unprognostic (7.34e-3)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (2.61e-1)" "unprognostic (4.21e-2)" "unprognostic (1.24e-1)" "unprognostic (5.27e-2)" "unprognostic (2.06e-1)" "unprognostic (1.20e-1)" "unprognostic (1.88e-1)" "unprognostic (2.93e-3)" 44.9 56.7 38.5 34.3 41.1 59.3 71.0 41.7 40.1 69.2 45.2 61.8 72.7 55.8 65.7 140.9 75.8 31.1 67.1 38.8 42.8 155.5 187.4 41.5 45.4 42.1 42.2 116.4 161.5 65.5 45.4 39.5 43.3 83.9 58.0 24.6 57.7 49.6 109.3 50.9 54.8 43.6 42.5 39.9 75.8 82.0 42.5 51.7 95.1 63.6 55.9 59.3 66.9 44.6 270.8 345.9 143.6 254.7 163.6 174.8 164.4 108.1 153.9 235.5 186.1 942.0 226.2 417.0 188.0 139.4 152.0 301.2 340.7 606.4 150.3 55.6 207.6 503.9 157.3 612.7 175.5 238.1 158.3 364.1 271.2 146.9 233.8 125.9 162.9 152.0 250.1 102.7 126.8 285.2 313.3 224.2 185.0 343.0 332.7 231.8 364.6 294.1 212.7 188.3 247.8 164.8 216.1 252.6 364.5 112.8 380.3 217.9 104.5 203.3 215.5 104.1 207.6 151.7 239.0 252.3 150.2 144.4 111.3 9.0 32.9 1.0 8.9 60.7 15.0 20.5 13.0 11.5 48.8 19.4 13.8 16.1 2.7 11.6 40.8 55.1 16.4 28.2 38.5 41.1 41.7 40.1 38.8 42.8 42.1 42.2 43.3 42.5 42.5 44.6 13.2 41.7 23.2 5.5 35.3 36.7 88.2 106.1 68.9 11.7 77.6 82.0 47.8 44.3 43.2 27.6 0.0 109.0 31.4 36.6 58.7 73.5 76.5 30.9 110.6 27.1 21.0 60.8 9.0 82.4 165.3 35.6 83.6 42.8 21.0 42.8 19.6 70.4 115.7 11.8 8.4 73.5 30.5 52.2 32.4 187.4 42.6 34.5 26.6 2.8 26.4 42.4 5.2 5.0 16.4 60.4 41.2 40.6 66.2 95.8 51.4 275.0 17.9 15.2 13.1 27.8 34.6 43.5 45.3 100.8 39.5 91.9 19.8 84.3 117.1 82.6 AKR7A3 ENSG00000162482 "Aldo-keto reductase family 7 member A3" O95154 1 19282573-19288770 "Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 248.9;liver: 154.6;pancreas: 288.4;stomach 1: 224.4" "Group enriched" "Detected in many" 5 "Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6" "Cancer enhanced" "Detected in many" "liver cancer: 36.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 15.9;SK-BR-3: 25.0" HPA064638 Supported "Golgi apparatus,Cytosol" NA NA 1900000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "HPA064638: AB_2685307" "unprognostic (7.78e-2)" "unprognostic (5.07e-2)" "unprognostic (6.08e-2)" "unprognostic (1.61e-1)" "unprognostic (1.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.85e-3)" "unprognostic (7.70e-3)" "unprognostic (2.72e-1)" "unprognostic (2.50e-2)" "unprognostic (1.17e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.80e-7)" "unprognostic (4.53e-2)" "unprognostic (5.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.35e-1)" 1.6 4.0 2.3 2.6 2.4 0.3 4.2 2.8 3.2 2.3 16.7 29.2 248.9 1.4 0.4 1.8 1.8 38.0 0.6 3.3 2.6 71.1 154.6 1.0 0.4 2.7 2.9 2.6 288.4 0.3 2.2 0.2 2.6 1.9 17.4 1.5 3.5 0.3 0.4 2.6 144.8 1.4 2.5 1.3 224.4 2.1 2.9 0.1 1.8 0.1 0.2 1.0 1.6 2.6 0.5 0.0 0.5 0.3 0.5 0.2 1.8 0.1 0.1 0.2 0.1 0.5 1.9 0.2 0.3 0.4 0.0 0.8 0.0 0.0 0.0 0.2 0.5 0.2 0.7 0.8 0.2 0.2 0.2 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.2 0.3 0.1 0.7 0.5 1.7 0.3 15.9 0.6 0.7 0.1 1.6 0.0 0.1 0.9 1.4 0.3 25.0 0.6 0.1 4.1 0.5 0.4 0.3 0.2 0.9 0.3 1.2 0.3 0.3 0.5 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.3 2.4 2.8 3.2 3.3 2.6 2.7 2.9 2.6 2.5 2.9 2.6 0.4 0.0 0.0 7.5 3.3 0.8 0.7 0.2 0.6 1.0 13.8 9.5 0.8 140.2 0.3 29.5 0.0 0.5 0.5 133.3 119.3 3.9 3.5 0.5 0.4 0.8 20.8 11.2 4.1 31.8 0.3 0.5 348.1 0.4 4.5 0.9 4.2 119.0 0.3 0.0 3.6 87.6 4.1 3.5 0.0 4.7 0.3 4.4 0.0 1.9 0.1 3.6 0.0 2.5 1.9 18.3 125.0 0.4 0.8 1.2 1132.3 766.6 3.2 1.1 0.0 0.7 0.4 1.8 1.1 1.1 0.6 0.5 3.0 0.7 130.2 0.4 ALDH18A1 "GSAS, P5CS, PYCS, SPG9" ENSG00000059573 "Aldehyde dehydrogenase 18 family member A1" P54886 10 95605941-95656711 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" "Kinase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 120.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 80.5;Granulosa cells: 81.6;Proximal enterocytes: 79.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008333, HPA012604" Approved Enhanced Mitochondria NA NA 48000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "HPA008333: AB_1078125, HPA012604: AB_1844721" "unprognostic (5.97e-3)" "unprognostic (2.08e-2)" "unprognostic (5.75e-2)" "prognostic favorable (4.20e-4)" "unprognostic (1.60e-2)" "unprognostic (1.06e-1)" "unprognostic (8.30e-3)" "unprognostic (7.08e-2)" "unprognostic (4.06e-2)" "unprognostic (8.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.60e-9)" "unprognostic (1.02e-3)" "unprognostic (6.57e-2)" "unprognostic (1.29e-3)" "unprognostic (6.43e-2)" 15.3 16.1 12.2 21.2 12.6 16.7 20.2 12.4 13.1 33.4 21.0 51.9 89.3 18.5 30.9 21.0 21.9 25.2 11.5 12.2 13.6 17.7 24.3 10.8 22.0 12.4 14.7 16.7 61.8 33.5 28.2 26.3 13.1 24.2 49.3 11.4 120.1 24.9 4.3 22.4 73.1 26.3 12.7 12.1 40.5 11.7 14.0 17.2 37.5 5.5 26.9 25.2 14.3 13.1 66.5 61.6 57.9 152.7 76.0 72.9 62.2 75.6 112.8 75.1 93.7 124.4 51.6 223.7 68.9 119.7 36.2 85.6 117.1 77.8 84.6 64.0 92.0 71.2 40.5 177.9 49.7 125.6 76.1 77.0 46.8 61.5 119.1 124.5 79.9 82.6 67.5 46.0 57.1 95.0 114.5 80.5 68.6 109.2 60.7 105.9 66.3 76.9 88.3 49.7 57.5 56.9 60.1 47.1 56.9 66.0 70.5 57.9 66.7 31.1 49.0 80.9 88.2 52.4 41.7 135.8 60.4 142.8 40.7 0.1 2.6 0.2 27.3 5.2 28.7 23.0 24.5 28.3 9.6 16.1 20.7 23.1 0.5 26.3 8.3 5.9 25.8 15.5 12.2 12.6 12.4 13.1 12.2 13.6 12.4 14.7 13.1 12.7 14.0 13.1 4.6 6.4 9.2 7.2 12.6 11.2 8.3 8.9 14.2 6.3 15.6 12.4 4.6 11.5 14.3 20.2 0.0 43.9 6.7 80.5 1.9 13.7 1.3 12.7 18.1 8.0 19.8 17.9 15.7 21.1 31.6 16.2 18.8 16.9 8.2 81.6 5.3 27.3 11.5 10.1 13.6 41.3 8.2 3.5 3.8 1.6 9.3 3.5 16.0 11.2 2.6 7.1 8.2 17.6 12.8 11.7 56.4 12.0 30.1 18.4 79.4 8.4 15.2 3.4 0.0 10.5 10.1 8.2 9.9 17.6 8.1 30.2 9.0 10.8 38.7 9.4 ALG1 "CDG1K, HMAT1, HMT-1, Mat-1" ENSG00000033011 "ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase" Q9BT22 16 5033923-5087379 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060392 Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum" "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "Nucleoli fibrillar center" "HPA060392: AB_2684273" "unprognostic (1.66e-2)" "unprognostic (5.18e-1)" "prognostic favorable (5.79e-4)" "unprognostic (1.55e-2)" "unprognostic (2.10e-2)" "unprognostic (3.22e-2)" "unprognostic (2.84e-2)" "unprognostic (2.52e-1)" "unprognostic (1.18e-2)" "unprognostic (1.17e-1)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (5.27e-2)" "unprognostic (1.02e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.58e-3)" "unprognostic (3.86e-2)" 11.3 19.6 6.2 12.8 6.6 7.7 9.9 6.1 7.9 12.4 12.7 18.8 15.8 11.0 14.5 11.2 12.4 9.8 8.3 6.5 6.6 12.6 21.0 9.3 12.4 6.3 6.0 8.8 26.8 17.5 10.9 9.5 6.9 10.5 16.3 6.8 18.8 10.6 7.4 8.8 13.1 12.0 5.8 15.0 19.6 20.8 6.5 12.0 11.6 5.5 12.1 12.4 8.3 6.8 24.0 53.7 10.8 25.5 40.7 24.2 26.4 50.6 50.6 46.9 46.4 44.8 72.4 44.4 43.1 48.0 20.7 58.2 30.1 36.2 31.6 42.0 43.3 20.7 40.1 87.1 33.4 37.6 37.3 29.7 26.9 36.2 23.0 18.5 28.7 32.2 29.5 44.7 34.5 50.1 28.9 40.7 51.2 31.7 33.6 48.8 16.0 124.9 28.3 18.7 20.7 21.7 49.3 67.8 27.4 14.3 45.1 29.2 29.8 22.5 25.6 134.7 40.1 39.8 59.3 30.2 20.5 39.8 38.1 11.5 79.9 28.8 87.2 80.6 77.1 72.9 74.9 86.3 86.7 73.9 66.7 75.0 4.3 79.8 80.0 75.6 81.1 126.6 6.2 6.6 6.1 7.9 6.5 6.6 6.3 6.0 6.9 5.8 6.5 6.8 4.6 16.0 6.1 4.2 11.2 2.4 3.4 15.7 5.2 7.4 6.8 6.0 0.7 8.6 14.3 7.3 12.5 16.2 7.2 8.5 3.9 19.5 10.7 5.4 8.1 8.7 13.3 12.0 4.0 28.3 18.7 9.3 13.7 5.5 1.3 8.1 8.6 17.7 21.7 3.3 4.6 21.0 8.2 10.6 2.4 25.5 9.6 7.6 10.6 1.0 9.3 7.5 9.2 3.5 3.4 21.6 11.1 6.8 22.7 4.5 11.8 10.4 11.7 6.3 6.6 5.4 7.1 28.0 16.0 7.7 1.6 8.5 8.6 13.8 18.0 4.4 ALG2 "CDG1I, CDGIi, FLJ14511, hALPG2, NET38" ENSG00000119523 "ALG2 alpha-1,3/1,6-mannosyltransferase" Q9H553 9 99216425-99221942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041512, HPA041601" Approved Approved "Golgi apparatus" NA No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA041512: AB_10794380, HPA041601: AB_10794302" "unprognostic (8.86e-3)" "unprognostic (4.39e-1)" "unprognostic (2.37e-1)" "prognostic favorable (8.44e-5)" "unprognostic (9.21e-3)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.06e-2)" "unprognostic (5.94e-2)" "unprognostic (3.31e-1)" "unprognostic (3.66e-1)" "unprognostic (2.99e-2)" "unprognostic (1.08e-1)" "prognostic favorable (2.28e-7)" "unprognostic (4.16e-2)" "unprognostic (1.73e-1)" "unprognostic (3.10e-2)" "unprognostic (4.81e-1)" 17.7 38.2 13.4 19.4 14.6 23.0 27.1 16.6 18.4 35.1 19.8 24.9 21.9 23.8 74.0 15.1 29.5 26.2 13.4 14.5 15.0 34.3 47.4 24.3 20.8 14.7 16.1 30.2 42.0 37.0 21.8 29.9 15.1 32.8 27.3 15.0 37.9 34.5 15.3 17.9 20.5 24.2 14.8 17.9 25.0 19.2 14.7 16.7 42.3 13.5 27.5 31.7 10.9 16.9 22.9 28.7 22.7 34.4 82.6 52.7 42.0 46.7 75.3 45.6 39.3 34.9 31.2 24.6 18.8 54.3 60.0 85.3 37.9 49.1 45.7 35.2 16.2 14.4 23.7 54.0 99.7 28.2 26.2 61.9 65.2 37.7 72.8 45.8 52.3 15.1 23.2 56.2 44.7 47.8 12.9 29.8 27.6 75.0 39.6 14.0 43.4 38.1 65.2 31.1 22.5 19.3 33.5 63.8 61.6 33.5 24.4 23.3 38.8 31.4 27.9 40.9 28.6 45.8 28.0 10.5 58.6 20.5 16.3 38.7 35.5 22.0 33.7 28.2 49.2 30.8 32.0 33.9 45.1 26.3 27.7 27.4 9.3 38.0 28.4 79.9 38.3 36.0 13.4 14.6 16.6 18.4 14.5 15.0 14.7 16.1 15.1 14.8 14.7 16.9 12.6 12.8 22.9 6.8 22.1 23.3 26.8 56.2 10.2 11.3 22.6 16.6 6.9 32.9 35.8 23.9 2.1 50.3 30.2 20.0 21.5 36.1 28.7 16.9 30.9 19.8 12.5 12.0 8.1 35.2 34.2 30.4 15.3 26.4 7.6 14.1 21.8 55.5 28.1 10.1 8.3 26.3 38.7 25.8 45.4 20.3 26.8 23.0 21.4 10.3 64.2 15.5 15.5 9.5 9.7 31.9 16.0 25.2 47.0 37.3 18.7 36.6 33.1 8.3 6.6 17.2 18.2 22.6 24.6 15.0 23.7 89.2 16.6 25.6 20.8 31.3 ALG3 "CDGS4, D16Ertd36e, Not56, NOT56L" ENSG00000214160 "ALG3 alpha-1,3- mannosyltransferase" Q92685 3 184242301-184249548 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 211.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045103 Enhanced NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA045103: AB_10960547" "unprognostic (3.63e-2)" "unprognostic (2.60e-1)" "unprognostic (2.36e-2)" "unprognostic (1.80e-3)" "unprognostic (3.63e-1)" "unprognostic (7.93e-3)" "prognostic unfavorable (1.58e-5)" "prognostic unfavorable (8.67e-5)" "unprognostic (6.18e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-3)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (9.35e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-1)" "unprognostic (5.02e-2)" 22.0 32.6 9.3 15.0 9.3 15.7 19.7 10.8 11.1 18.1 13.9 23.8 16.9 17.5 12.5 30.5 15.1 11.6 19.6 8.8 9.7 18.7 58.0 18.1 13.0 10.6 10.1 12.7 37.1 23.1 14.6 19.6 11.2 19.8 18.3 6.0 26.8 13.7 30.2 24.9 20.4 16.4 10.0 20.8 23.1 25.7 10.7 12.2 18.4 14.8 14.1 22.5 19.8 10.3 77.2 67.6 18.0 59.5 70.2 39.4 59.3 40.6 46.0 54.9 47.3 102.8 50.9 67.6 108.4 50.8 112.0 90.8 64.1 90.0 34.5 49.0 76.7 60.8 49.3 84.7 64.3 99.5 52.4 47.0 74.7 64.8 90.9 29.4 30.0 46.0 60.7 132.6 36.1 95.8 48.5 83.1 55.9 153.3 85.8 49.9 27.5 269.7 63.2 25.7 44.3 36.7 37.6 147.0 67.5 21.8 140.2 54.8 24.3 57.2 36.0 51.2 88.4 72.3 137.8 71.3 51.5 129.2 52.9 0.6 60.9 14.6 35.8 61.1 40.5 31.6 38.3 36.8 71.4 30.8 33.9 33.2 2.0 48.9 51.3 65.3 44.6 41.7 9.3 9.3 10.8 11.1 8.8 9.7 10.6 10.1 11.2 10.0 10.7 10.3 14.2 6.4 18.1 4.6 24.5 25.0 28.3 61.0 26.2 10.4 24.1 20.8 11.7 21.5 43.0 20.2 10.4 79.2 21.0 24.9 7.9 62.3 95.7 9.1 17.7 18.7 14.5 24.4 5.6 63.1 100.4 22.3 25.0 13.5 12.7 16.3 12.5 51.7 69.8 8.4 5.9 33.3 50.8 24.9 15.5 211.5 12.5 25.8 21.4 7.5 21.2 13.7 16.5 7.1 6.3 44.6 22.0 15.1 63.8 47.2 39.4 31.8 16.7 13.0 19.7 9.0 34.6 29.7 34.3 39.4 27.0 65.8 17.6 23.1 45.6 29.1 ALG5 bA421P11.2 ENSG00000120697 "ALG5 dolichyl-phosphate beta-glucosyltransferase" Q9Y673 13 36949738-37000763 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007989 Approved Approved Cytosol No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA007989: AB_1078132" "unprognostic (1.87e-1)" "unprognostic (1.73e-2)" "unprognostic (6.07e-2)" "unprognostic (1.05e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.57e-2)" "unprognostic (5.82e-2)" "unprognostic (5.21e-2)" "unprognostic (7.46e-2)" "unprognostic (3.51e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.40e-5)" "unprognostic (7.44e-2)" "unprognostic (1.66e-1)" "unprognostic (7.14e-3)" "unprognostic (1.86e-1)" 29.1 32.3 12.1 19.6 13.3 26.9 41.6 13.4 25.7 34.2 14.9 36.0 27.1 23.5 77.9 21.7 23.3 23.2 18.5 12.4 13.7 41.2 61.9 24.5 20.7 13.5 13.1 20.6 90.1 40.2 18.7 25.4 14.0 26.5 46.4 11.2 51.9 30.9 18.5 20.9 27.6 23.4 13.6 23.6 36.6 15.2 12.6 22.7 54.9 10.5 28.9 30.5 21.6 14.8 24.3 35.0 31.5 29.4 95.1 61.8 22.5 63.9 81.1 63.7 53.7 71.0 84.1 35.2 25.9 45.7 55.0 57.5 41.9 55.0 62.6 37.4 77.7 77.2 27.5 40.1 85.1 69.6 43.7 62.7 88.8 49.4 60.6 41.5 47.7 43.9 39.8 49.7 59.9 45.6 47.4 59.8 29.1 188.2 27.5 54.3 30.4 102.5 71.5 49.8 25.2 45.5 29.2 62.8 34.2 25.4 34.4 79.1 36.1 32.7 20.4 37.2 45.8 35.8 28.8 37.4 51.2 41.9 57.1 59.1 55.7 26.2 53.4 62.3 54.4 44.1 49.1 55.6 57.1 40.2 46.4 47.2 5.8 54.7 53.0 109.0 65.7 69.2 12.1 13.3 13.4 25.7 12.4 13.7 13.5 13.1 14.0 13.6 12.6 14.8 52.0 51.3 51.9 11.1 51.5 34.7 45.9 142.9 27.3 19.8 50.2 42.5 14.2 61.5 86.0 53.3 10.4 81.4 49.4 28.9 23.5 93.5 33.7 31.5 44.1 45.5 36.1 25.9 19.5 140.2 74.4 46.0 32.1 40.1 29.2 25.9 37.9 77.3 69.7 11.8 22.4 76.3 111.9 37.1 52.1 25.8 40.0 39.4 80.0 14.0 45.2 36.6 25.7 18.1 30.6 85.9 50.9 38.4 166.6 56.4 51.4 62.7 43.8 25.2 46.0 34.4 70.7 57.6 23.7 33.6 30.3 81.3 43.0 58.5 62.2 50.7 ALG9 DIBD1 ENSG00000086848 "ALG9 alpha-1,2-mannosyltransferase" Q9H6U8 11 111782195-111871581 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 26.6;Inhibitory neurons: 31.8;Oligodendrocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038575 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 59: Non-specific - Transcription" "Endoplasmic reticulum" "HPA038575: AB_10672718" "unprognostic (1.48e-1)" "unprognostic (5.39e-2)" "unprognostic (6.22e-2)" "unprognostic (5.34e-3)" "unprognostic (8.72e-2)" "unprognostic (2.90e-1)" "unprognostic (2.43e-2)" "unprognostic (1.04e-2)" "unprognostic (7.07e-3)" "unprognostic (5.11e-2)" "unprognostic (8.75e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (7.29e-5)" "unprognostic (9.15e-2)" "unprognostic (7.76e-2)" "unprognostic (4.20e-2)" "unprognostic (1.10e-2)" 14.0 9.7 6.3 8.6 7.1 7.8 12.4 8.2 7.8 12.9 6.3 10.9 12.1 11.5 10.9 11.4 9.2 7.9 10.1 6.3 6.6 9.5 13.4 9.6 6.6 6.5 6.8 12.5 19.7 12.7 10.0 9.6 6.7 9.6 10.3 12.0 17.5 11.3 9.1 15.2 10.2 11.1 5.6 8.4 12.0 13.6 6.1 9.8 12.3 8.3 9.2 11.3 11.1 6.4 16.6 16.5 30.7 31.1 19.0 18.0 23.7 20.5 16.5 16.4 17.9 28.7 27.4 27.1 28.7 23.8 21.4 29.8 16.6 25.4 23.4 20.2 12.2 19.7 8.6 21.2 22.0 22.2 13.6 15.5 17.2 17.7 17.8 24.2 16.2 20.2 20.3 41.0 28.4 12.5 22.2 20.3 10.7 23.3 15.9 20.4 26.9 51.5 18.5 13.7 15.0 25.4 18.0 28.0 11.4 21.6 29.0 9.3 16.9 35.0 25.2 17.1 22.6 13.3 10.2 24.4 15.1 27.4 24.7 4.5 3.1 3.8 4.0 4.5 4.7 4.0 4.1 4.6 5.2 3.1 5.8 3.6 1.1 4.2 4.0 5.6 4.5 3.3 6.3 7.1 8.2 7.8 6.3 6.6 6.5 6.8 6.7 5.6 6.1 6.4 3.2 0.0 4.4 21.5 5.9 2.0 1.5 3.2 9.6 8.9 3.8 3.4 5.6 1.5 3.9 7.3 8.4 3.5 4.6 3.2 3.9 7.5 5.1 2.0 5.2 4.1 4.2 6.3 26.6 7.1 12.6 4.7 4.6 3.8 0.0 5.5 2.2 6.8 3.2 15.2 31.8 4.0 4.1 1.9 1.9 4.3 4.7 3.5 0.0 12.2 3.1 4.9 3.1 21.1 31.8 6.5 2.9 3.8 22.8 1.3 4.6 2.3 2.2 9.7 6.6 3.5 5.4 4.2 5.7 8.6 1.6 9.0 5.8 2.5 4.4 0.8 ANXA4 ANX4 ENSG00000196975 "Annexin A4" P09525 2 69644425-69827112 "Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "gallbladder: 569.9;pancreas: 356.8" "Cell type enhanced" "Detected in all" "Cholangiocytes: 2344.8;Ductal cells: 1469.8;Proximal enterocytes: 657.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 414.2;Hep G2: 456.9;RPTEC TERT1: 623.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005076, HPA007393, CAB017560" Enhanced Approved Cytosol NA NA 550000 "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 1: Pancreatic cells - Digestion" Cytosol "CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168" "prognostic unfavorable (8.55e-4)" "unprognostic (3.37e-2)" "unprognostic (4.82e-2)" "unprognostic (9.03e-2)" "unprognostic (1.62e-3)" "unprognostic (1.66e-1)" "unprognostic (3.57e-1)" "unprognostic (3.21e-1)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (7.23e-3)" "unprognostic (1.29e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (1.79e-1)" "unprognostic (8.85e-2)" "unprognostic (3.60e-2)" "unprognostic (3.97e-2)" 48.2 21.6 14.5 33.6 15.4 30.8 45.9 14.9 18.9 62.4 52.4 101.7 271.3 50.9 30.3 43.0 68.6 569.9 26.1 14.4 15.2 104.0 120.9 81.6 21.1 15.6 15.1 38.8 356.8 78.0 11.9 52.7 15.8 46.3 92.3 30.0 39.2 52.1 17.2 61.0 232.4 52.0 15.7 24.2 108.2 9.7 15.2 23.0 43.6 20.4 24.0 61.3 50.2 16.6 69.6 249.4 3.4 31.0 185.0 158.3 11.3 66.0 101.5 27.1 38.0 37.9 121.7 22.8 414.2 109.5 78.9 104.7 23.8 108.1 27.6 65.2 20.3 35.0 20.5 456.9 131.2 12.5 43.0 95.9 104.8 36.5 87.3 62.9 71.1 11.0 2.0 20.1 74.7 63.8 18.3 22.8 6.1 280.0 34.3 19.4 6.8 28.3 623.2 99.1 5.1 22.9 72.9 99.5 103.8 35.6 33.3 156.3 100.9 49.2 23.8 65.5 37.7 8.2 9.7 1.3 75.8 59.7 34.1 80.4 34.7 29.6 23.1 42.5 17.5 40.6 11.7 17.5 50.6 46.7 2.0 12.5 4.9 9.5 58.7 15.5 14.5 24.2 14.5 15.4 14.9 18.9 14.4 15.2 15.6 15.1 15.8 15.7 15.2 16.6 66.4 205.1 154.8 47.3 27.3 74.2 98.5 148.2 68.9 8.2 36.8 36.4 10.6 2344.8 139.4 84.6 6.2 86.4 27.2 315.1 221.1 1469.8 14.6 257.9 79.0 49.1 18.6 12.6 29.9 344.4 370.1 103.6 196.7 488.8 111.5 24.3 33.9 68.5 227.6 8.4 17.7 193.8 240.1 46.1 80.4 11.2 64.7 54.5 92.5 63.7 87.2 48.7 45.3 17.6 106.0 245.7 268.6 92.2 6.9 55.6 657.1 400.4 230.2 59.9 6.6 27.6 64.6 15.8 3.7 61.3 79.6 439.6 32.5 19.1 174.1 96.9 ANXA9 ANX31 ENSG00000143412 "Annexin A9" O76027 1 150982249-150995634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 61.5;Collecting duct cells: 12.9;Ductal cells: 21.2;Hepatocytes: 17.4;Proximal tubular cells: 44.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;granulocytes: 1.0;monocytes: 1.2" "Cell line enhanced" "Detected in many" "CAPAN-2: 40.6;Hep G2: 42.3;MCF7: 59.2;OE19: 47.8;T-47d: 139.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA028404, HPA028698" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear speckles, Cytosol" "HPA028404: AB_10599190, HPA028698: AB_10600227" "unprognostic (4.06e-1)" "unprognostic (1.55e-2)" "unprognostic (3.15e-3)" "unprognostic (2.08e-3)" "unprognostic (2.93e-2)" "unprognostic (4.49e-2)" "unprognostic (1.84e-2)" "unprognostic (3.39e-2)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" "unprognostic (2.10e-1)" "unprognostic (2.97e-1)" "prognostic favorable (8.74e-6)" "unprognostic (1.58e-2)" "unprognostic (1.11e-1)" "unprognostic (8.99e-2)" "unprognostic (1.72e-2)" 3.2 3.7 2.6 2.6 7.1 2.4 6.9 6.1 3.5 2.2 3.3 2.1 4.6 6.4 5.9 26.2 4.7 9.2 6.0 1.7 3.5 22.0 29.9 3.1 2.3 9.0 6.7 4.7 35.8 19.2 1.2 1.0 7.9 2.4 0.3 7.2 7.5 21.2 3.8 32.4 4.2 2.9 4.5 2.8 4.2 3.8 5.3 0.5 25.0 0.2 23.2 6.3 6.0 12.1 11.7 2.8 4.2 4.4 0.0 0.0 11.4 1.0 0.8 0.1 0.0 33.9 40.6 0.4 2.5 0.0 1.3 6.8 0.0 0.8 0.1 3.9 4.4 6.1 4.7 42.3 0.0 2.4 2.6 0.0 0.3 0.1 0.2 9.5 0.0 1.8 3.0 13.2 0.1 59.2 0.5 3.2 1.1 47.8 0.8 2.8 0.6 15.0 0.1 17.0 6.4 3.6 2.6 28.8 1.7 2.3 139.9 3.7 4.7 0.9 1.3 0.7 0.8 4.0 13.0 18.8 6.2 4.2 3.3 0.0 1.2 0.7 0.0 0.7 0.3 0.2 0.1 0.2 1.6 0.0 0.3 0.0 1.0 0.0 0.1 0.0 0.0 0.4 2.6 7.1 6.1 3.5 1.7 3.5 9.0 6.7 7.9 4.5 5.3 12.1 0.1 0.0 1.1 0.3 0.2 0.1 0.4 0.8 0.0 0.0 4.5 2.5 0.4 61.5 4.5 12.9 0.0 2.0 0.1 0.0 3.9 21.2 1.5 1.3 0.8 0.1 0.0 0.0 0.2 7.5 0.3 0.6 0.0 1.6 1.3 0.0 0.0 17.4 2.2 0.0 0.2 0.0 0.0 0.6 0.4 0.9 1.5 1.4 1.8 0.0 0.2 0.0 0.0 1.0 0.5 2.9 0.1 1.2 0.0 0.3 0.3 44.6 2.5 0.0 0.0 0.1 0.3 4.9 0.2 0.3 0.0 1.5 0.2 0.0 0.3 5.4 ARCN1 COPD ENSG00000095139 "Archain 1" P48444 11 118572390-118603033 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037573, HPA044874" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA 140000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "Golgi apparatus, Cytosol" "HPA037573: AB_10696938, HPA044874: AB_2679126" "unprognostic (1.46e-2)" "unprognostic (4.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.20e-1)" "unprognostic (9.99e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (2.97e-5)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.31e-1)" "unprognostic (1.67e-3)" "unprognostic (9.39e-2)" "unprognostic (3.56e-2)" "unprognostic (7.99e-2)" "unprognostic (9.20e-2)" "unprognostic (4.14e-3)" "unprognostic (5.56e-3)" 75.4 67.7 47.5 53.8 51.0 30.4 67.5 52.0 60.5 78.0 61.2 65.0 59.2 69.2 111.1 72.5 60.5 51.6 75.6 46.8 50.9 58.3 91.6 62.6 53.2 51.2 51.3 65.5 119.7 61.9 88.7 54.7 51.1 68.8 67.1 39.2 79.6 64.5 51.1 60.9 64.9 71.0 50.0 57.9 71.8 46.2 50.5 58.8 65.2 55.0 62.2 66.4 60.9 57.2 90.9 72.6 135.3 98.9 174.0 172.7 66.6 244.8 208.5 102.4 120.7 239.4 116.6 96.4 199.7 275.7 148.0 123.7 160.5 139.5 151.5 128.0 66.3 211.6 56.7 151.4 197.1 140.4 121.8 157.8 117.6 175.0 168.7 149.3 162.2 95.0 106.8 139.2 201.3 157.0 123.2 130.8 85.3 207.7 92.4 107.9 134.2 147.4 137.3 107.0 88.3 86.6 130.2 129.0 70.1 132.5 155.9 111.4 144.0 129.4 65.1 118.4 109.5 79.9 78.5 147.6 74.3 122.6 161.4 118.1 49.8 50.7 52.7 59.8 69.0 39.5 51.7 51.3 54.0 35.4 48.0 44.7 41.5 64.5 64.5 44.9 53.9 55.8 47.5 51.0 52.0 60.5 46.8 50.9 51.2 51.3 51.1 50.0 50.5 57.2 43.6 35.3 47.9 12.4 32.2 31.6 38.5 31.5 23.9 22.4 39.4 27.9 46.5 24.3 41.9 31.3 4.2 17.2 45.6 68.4 9.8 34.3 11.1 38.4 72.2 43.1 40.2 14.9 15.4 37.8 36.1 44.9 39.3 50.4 39.3 31.9 31.4 55.7 30.3 18.5 17.7 80.2 22.4 36.0 37.6 8.5 48.1 35.3 23.2 11.2 49.0 17.3 26.8 17.1 20.2 46.9 35.8 41.3 68.3 51.5 56.2 30.5 46.2 13.6 19.7 52.7 45.7 44.8 47.6 30.4 34.7 30.2 38.4 43.9 42.6 51.6 ARF4 ARF2 ENSG00000168374 "ADP ribosylation factor 4" P18085 3 57571363-57598220 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 3100000 "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.75e-1)" "unprognostic (2.11e-2)" "unprognostic (8.22e-2)" "unprognostic (1.17e-1)" "unprognostic (2.32e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.29e-7)" "unprognostic (4.78e-1)" "unprognostic (1.14e-1)" "unprognostic (1.24e-2)" "unprognostic (1.76e-2)" "unprognostic (2.47e-2)" "unprognostic (4.22e-2)" "unprognostic (3.56e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.30e-4)" "unprognostic (4.98e-3)" 128.5 162.7 53.5 107.4 56.5 72.6 138.4 56.5 73.3 208.7 75.3 158.9 123.5 121.7 226.7 108.9 96.1 154.8 116.5 56.8 64.5 114.4 172.6 126.3 73.9 57.4 62.3 113.5 151.2 101.5 105.8 181.8 59.6 138.5 197.2 54.0 182.1 132.8 64.8 67.3 109.2 169.2 61.6 66.5 130.9 100.8 58.6 74.9 143.9 69.5 97.3 203.6 91.4 63.6 251.8 90.4 218.5 182.1 516.7 533.3 212.8 617.9 585.5 382.0 483.4 264.4 235.0 89.2 110.3 774.3 334.8 95.4 234.0 353.1 491.3 111.7 76.9 183.4 196.6 351.3 647.1 115.7 127.8 517.3 308.8 355.4 423.8 482.6 480.1 86.8 134.5 173.8 672.8 123.1 69.7 146.8 263.8 333.5 306.5 40.7 173.3 170.5 459.6 175.8 67.5 164.1 252.9 240.1 325.0 298.5 167.9 193.4 369.8 299.8 174.9 447.9 360.6 126.3 116.3 124.0 331.4 220.8 378.3 249.4 85.3 95.4 41.1 72.8 72.2 53.2 58.3 53.5 72.3 48.1 71.4 55.5 102.8 58.2 65.9 109.2 59.9 90.8 53.5 56.5 56.5 73.3 56.8 64.5 57.4 62.3 59.6 61.6 58.6 63.6 172.5 76.9 90.8 18.3 150.2 350.1 505.9 429.6 195.8 32.2 249.8 204.7 48.4 91.5 259.6 97.5 6.2 322.3 146.7 226.5 191.7 287.1 179.1 195.5 197.2 146.5 164.5 232.4 25.2 232.6 448.2 298.4 200.3 301.4 101.7 121.8 101.7 161.0 197.2 18.5 26.9 403.7 248.2 90.1 264.9 72.6 177.0 139.4 241.9 15.9 112.8 156.2 35.0 30.2 30.2 396.8 238.1 185.8 346.8 399.6 180.8 178.5 201.2 27.2 78.9 115.1 345.5 132.4 80.7 188.2 321.9 698.2 133.0 230.4 272.3 599.7 ARFGAP3 ARFGAP1 ENSG00000242247 "ADP ribosylation factor GTPase activating protein 3" Q9NP61 22 42796502-42858106 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000638 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "Golgi apparatus" "HPA000638: AB_1078188" "unprognostic (3.29e-2)" "unprognostic (6.08e-2)" "unprognostic (3.22e-1)" "prognostic favorable (8.97e-6)" "unprognostic (5.83e-2)" "unprognostic (8.85e-3)" "unprognostic (5.00e-3)" "unprognostic (1.00e-1)" "unprognostic (2.05e-1)" "unprognostic (1.31e-1)" "unprognostic (9.06e-3)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (2.52e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (2.65e-4)" "unprognostic (1.73e-1)" 30.1 88.9 16.5 34.1 17.4 47.8 30.9 19.5 20.4 56.1 23.2 26.9 36.5 32.2 53.3 22.1 22.9 36.6 23.6 17.9 20.6 53.2 49.2 32.3 28.1 20.5 18.7 20.7 85.8 38.0 38.1 34.8 20.3 64.7 30.6 35.5 68.5 40.2 31.3 20.7 51.1 30.8 19.0 26.0 43.2 49.5 19.6 25.9 61.3 21.8 32.6 45.2 23.4 21.0 59.6 19.3 41.1 24.7 57.2 94.1 17.3 111.8 76.4 50.5 60.9 23.5 32.8 30.1 24.5 102.9 41.8 14.4 18.7 33.0 54.7 18.5 25.4 35.7 27.6 37.4 79.6 31.9 53.2 42.0 57.6 42.6 75.9 71.9 52.4 27.4 16.1 132.0 89.6 15.7 49.4 17.5 6.7 32.7 23.2 31.1 92.3 38.3 80.7 27.5 14.6 9.0 54.3 21.5 46.0 30.6 22.7 24.4 67.0 58.7 42.5 52.1 30.7 94.7 48.2 33.1 41.9 34.0 46.7 86.2 33.2 36.8 45.1 44.4 58.8 27.1 29.7 39.8 32.5 26.1 19.2 27.2 50.8 49.4 50.9 53.1 28.8 30.1 16.5 17.4 19.5 20.4 17.9 20.6 20.5 18.7 20.3 19.0 19.6 21.0 40.8 38.5 54.8 27.4 41.7 26.6 86.9 43.0 19.9 42.8 43.1 29.5 26.5 37.1 62.1 57.0 18.8 18.8 67.3 36.4 66.5 65.9 19.1 60.5 89.9 42.4 49.1 17.5 26.1 64.3 23.7 58.1 30.1 96.3 65.9 28.4 30.4 37.3 28.7 33.7 28.8 53.0 46.8 21.7 89.3 15.0 48.1 68.2 69.4 35.6 33.7 40.5 38.1 43.7 40.0 83.0 15.6 45.5 110.0 121.5 70.9 62.9 65.5 33.7 39.5 80.0 65.5 178.7 67.6 14.6 26.7 59.9 49.6 39.0 22.7 86.7 ARHGEF38 FLJ20184 ENSG00000236699 "Rho guanine nucleotide exchange factor 38" Q9NXL2 4 105552620-105708093 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 7.8;pancreas: 6.5" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036510, HPA045484" Uncertain Approved Nucleoplasm,Centrosome NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Centrosome "HPA036510: AB_10672357, HPA045484: AB_2679345" "unprognostic (1.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (6.19e-3)" "unprognostic (2.09e-2)" "unprognostic (2.24e-3)" "unprognostic (1.85e-1)" "unprognostic (5.47e-3)" "unprognostic (2.79e-1)" "unprognostic (6.14e-5)" "unprognostic (1.17e-1)" "unprognostic (3.53e-3)" "unprognostic (3.16e-8)" "unprognostic (2.33e-3)" "unprognostic (6.16e-2)" "unprognostic (3.19e-3)" "unprognostic (6.45e-3)" 0.0 0.0 0.0 0.3 0.0 0.0 7.8 0.0 0.0 2.5 0.0 2.6 1.9 0.2 5.5 0.1 0.6 3.2 0.0 0.0 0.0 3.9 0.1 3.6 0.0 0.0 0.0 0.0 6.5 0.0 2.0 0.0 0.0 5.7 4.2 0.0 4.9 0.4 0.3 0.5 2.6 0.0 0.0 0.0 3.1 0.0 0.0 0.0 1.4 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.1 14.3 0.0 0.0 0.0 0.0 8.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 48.5 0.0 0.2 0.0 1.1 1.1 0.0 0.0 17.9 6.1 1.8 4.3 12.6 12.9 0.0 0.2 0.2 9.8 9.8 6.8 1.9 12.6 0.5 0.3 8.4 0.0 0.3 5.8 0.1 0.3 9.2 7.8 0.0 0.0 0.0 0.1 0.1 0.0 0.3 14.8 10.2 0.0 0.2 0.4 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.1 2.4 6.4 0.0 0.1 9.4 4.8 0.5 31.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 11.4 0.8 ARMCX3 "ALEX3, GASP6" ENSG00000102401 "Armadillo repeat containing X-linked 3" Q9UH62 X 101622797-101627843 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "thyroid cancer: 88.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000325, HPA000967, HPA001530" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "Golgi apparatus, Cytosol" "HPA000325: AB_1078206, HPA000967: AB_1078208, HPA001530: AB_2666349" "unprognostic (1.67e-1)" "unprognostic (2.14e-1)" "unprognostic (5.23e-2)" "unprognostic (8.69e-3)" "unprognostic (1.73e-2)" "unprognostic (1.47e-2)" "unprognostic (9.72e-3)" "unprognostic (2.19e-2)" "unprognostic (4.77e-2)" "unprognostic (6.80e-2)" "unprognostic (3.38e-3)" "unprognostic (2.12e-2)" "prognostic favorable (1.55e-5)" "unprognostic (3.29e-2)" "unprognostic (3.13e-1)" "unprognostic (1.07e-2)" "unprognostic (1.55e-2)" 34.9 58.9 30.8 24.4 33.0 14.7 32.2 35.4 35.7 45.0 27.6 31.5 20.2 40.9 105.3 18.1 27.7 34.0 51.0 34.1 38.7 37.2 24.6 29.5 21.8 34.5 33.7 38.3 57.4 103.6 47.7 45.4 34.8 44.5 21.8 19.0 59.6 46.7 30.7 11.9 21.5 36.3 35.4 41.3 29.7 12.9 35.5 20.1 49.9 63.6 21.5 31.9 22.5 37.7 26.4 18.8 48.8 23.9 109.4 118.3 10.0 56.5 54.3 23.2 68.3 20.7 21.5 9.5 31.7 64.7 50.8 5.0 34.9 20.2 28.7 21.6 23.2 18.7 64.9 30.2 85.2 18.2 41.5 67.0 27.4 30.9 30.3 65.1 47.6 11.6 15.2 78.9 67.4 10.9 15.0 0.8 24.4 49.5 4.3 19.1 62.2 8.9 36.0 10.1 22.1 18.9 28.3 1.5 63.9 67.7 19.2 19.0 67.5 29.8 18.9 70.8 11.2 69.7 20.9 0.1 50.4 14.5 25.5 43.6 15.3 13.6 14.6 15.8 18.3 15.0 14.0 12.4 15.8 9.8 15.2 10.6 5.6 13.7 16.8 25.8 9.0 14.4 30.8 33.0 35.4 35.7 34.1 38.7 34.5 33.7 34.8 35.4 35.5 37.7 67.4 44.8 36.1 16.3 61.1 37.9 81.2 40.6 42.7 63.1 70.9 42.3 114.6 50.1 48.4 75.4 58.4 55.3 61.1 20.4 37.2 53.9 0.6 42.2 80.9 69.2 82.4 25.6 35.9 30.6 27.4 85.8 33.1 78.8 79.1 45.5 58.2 48.6 50.7 62.2 41.8 67.6 40.7 52.5 84.9 2.8 64.7 72.3 97.8 18.7 27.2 86.6 34.0 28.6 31.0 30.6 22.1 72.6 122.6 75.2 20.1 43.1 25.1 13.3 32.9 57.1 73.2 2.5 0.4 24.6 21.5 114.9 58.0 70.2 32.1 81.2 ARSD ENSG00000006756 "Arylsulfatase D" P51689 X 2903972-2929349 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 109.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.2;EFO-21: 24.5" "HPA004694, HPA063835" Approved Approved "Vesicles,Lipid droplets" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Vesicles, Lipid droplets" "HPA004694: AB_1078221, HPA063835: AB_2685132" "unprognostic (3.92e-1)" "unprognostic (7.50e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.21e-4)" "unprognostic (5.90e-3)" "unprognostic (6.32e-3)" "unprognostic (1.73e-1)" "unprognostic (1.34e-1)" "unprognostic (2.44e-1)" "unprognostic (4.09e-3)" "unprognostic (7.18e-2)" "unprognostic (3.93e-1)" "prognostic favorable (1.97e-5)" "unprognostic (1.37e-1)" "unprognostic (3.93e-2)" "unprognostic (4.99e-2)" "unprognostic (2.11e-3)" 8.4 7.8 4.3 6.1 4.1 4.9 23.6 4.2 4.5 23.9 10.7 20.5 21.0 11.2 15.9 10.0 28.0 11.4 4.8 4.1 5.1 38.9 40.0 16.8 3.6 6.3 5.7 18.7 32.4 12.7 4.2 8.6 5.4 19.3 14.8 1.7 17.5 13.3 1.7 7.3 15.4 7.6 5.6 7.2 30.4 3.8 4.6 2.8 21.1 3.2 4.2 11.7 8.4 5.0 6.9 12.0 3.2 15.4 13.6 7.7 0.1 3.9 7.1 1.7 1.1 0.7 23.2 0.0 24.5 7.9 18.1 0.0 0.6 2.0 1.6 0.2 0.0 0.0 0.0 4.0 7.5 0.0 9.1 12.3 6.3 3.4 3.6 11.1 11.5 0.0 0.0 0.1 7.6 16.9 0.1 1.7 2.7 21.3 5.0 2.9 0.0 0.2 12.3 0.1 0.0 8.5 5.4 6.3 4.1 8.5 17.1 13.1 10.6 0.0 0.5 1.2 1.8 0.1 0.0 0.0 11.1 8.2 8.8 1.5 5.8 4.1 1.7 5.0 0.6 1.3 0.8 1.4 4.4 0.8 0.2 0.9 1.0 2.0 2.0 3.0 0.3 2.5 4.3 4.1 4.2 4.5 4.1 5.1 6.3 5.7 5.4 5.6 4.6 5.0 13.4 19.2 36.4 9.8 4.5 5.0 13.9 11.3 10.8 4.9 45.0 30.9 5.6 74.4 23.1 44.1 0.0 19.1 8.6 44.3 19.6 35.1 0.7 68.6 19.6 13.8 67.9 3.4 0.9 53.9 25.0 7.9 31.6 67.8 16.5 66.8 11.7 109.9 18.5 0.0 1.7 56.2 10.2 17.8 6.4 1.4 6.2 16.1 14.2 6.5 23.1 5.8 11.3 3.5 1.5 47.4 47.9 6.8 1.6 18.1 53.1 23.4 25.8 0.9 6.6 15.1 10.7 1.3 3.9 16.2 7.2 26.0 4.3 38.3 60.9 16.4 ARSL "ARSE, CDPX, CDPX1" ENSG00000157399 "Arylsulfatase L" P51690 X 2934521-2968475 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 36.6;liver: 86.3;pancreas: 105.2" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "liver cancer: 34.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6" "Low region specificity" "Detected in all" "HPA060518, HPA070651" Approved Supported "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA060518: AB_2684301, HPA070651: AB_2732160" "unprognostic (2.07e-1)" "unprognostic (6.60e-3)" "prognostic favorable (8.95e-4)" "unprognostic (8.74e-3)" "unprognostic (1.14e-3)" "unprognostic (3.48e-2)" "unprognostic (2.38e-1)" "unprognostic (8.27e-2)" "unprognostic (5.45e-2)" "unprognostic (2.25e-1)" "unprognostic (2.27e-1)" "unprognostic (2.37e-1)" "unprognostic (1.05e-1)" "unprognostic (1.49e-1)" "unprognostic (1.28e-1)" "unprognostic (5.94e-2)" "unprognostic (4.76e-2)" 0.4 0.7 2.6 2.2 2.7 0.3 1.1 2.1 2.8 1.7 4.5 20.8 17.9 3.2 2.2 0.4 4.1 8.2 1.0 2.8 2.6 36.6 86.3 2.7 0.1 2.8 2.8 7.1 105.2 0.0 0.7 0.7 2.9 0.5 16.7 0.3 1.3 2.9 0.2 0.2 13.6 1.9 2.4 0.0 2.9 0.4 2.6 0.0 0.2 0.3 0.1 0.5 1.6 2.3 4.5 68.9 8.2 0.0 3.3 4.0 1.3 3.9 6.4 4.0 4.0 42.7 0.0 0.0 13.7 0.1 30.8 0.0 0.0 0.9 2.3 0.0 4.5 0.0 0.0 64.1 1.8 0.0 0.1 9.6 0.0 3.8 0.0 7.3 3.8 0.0 0.0 0.1 10.5 0.1 0.0 0.0 33.6 2.4 0.2 2.8 1.1 0.3 7.1 0.0 0.1 0.2 0.0 0.0 2.6 13.7 0.0 0.2 5.0 0.1 0.2 0.0 7.4 0.0 0.0 0.1 9.1 0.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.7 2.1 2.8 2.8 2.6 2.8 2.8 2.9 2.4 2.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 ATF6 ATF6A ENSG00000118217 "Activating transcription factor 6" P18850 1 161766298-161977574 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005935 Approved NA NA 46000000 "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" "HPA005935: AB_2667472" "unprognostic (1.31e-1)" "unprognostic (5.15e-3)" "unprognostic (3.18e-2)" "unprognostic (8.43e-3)" "unprognostic (1.59e-1)" "unprognostic (5.58e-3)" "unprognostic (1.24e-1)" "unprognostic (5.32e-2)" "unprognostic (3.37e-2)" "unprognostic (3.24e-1)" "unprognostic (6.09e-3)" "unprognostic (3.38e-1)" "unprognostic (7.55e-2)" "unprognostic (2.03e-1)" "unprognostic (2.43e-1)" "unprognostic (1.56e-2)" "unprognostic (7.57e-3)" 13.6 10.1 7.2 13.9 8.4 12.6 11.5 8.3 7.5 8.4 13.6 9.9 9.9 10.6 18.9 11.0 8.9 11.3 9.4 7.2 9.9 14.6 22.0 11.4 10.6 10.2 9.4 9.0 34.4 18.9 7.1 18.0 10.5 10.7 11.2 16.7 13.3 10.3 8.9 11.2 9.4 12.8 10.0 11.3 11.2 10.1 8.0 8.4 15.1 9.5 11.1 13.7 7.9 11.9 23.3 17.9 15.1 22.4 18.6 17.7 26.7 27.8 25.3 17.7 19.2 11.6 38.2 16.9 39.6 34.6 19.9 34.0 15.1 18.6 17.6 23.2 12.9 15.9 22.6 12.7 40.3 29.7 40.6 18.3 29.0 18.2 53.3 23.8 40.3 22.7 37.9 19.2 19.3 23.0 15.9 17.3 12.2 24.5 23.1 13.7 21.4 39.2 19.3 11.1 9.1 13.8 33.3 19.8 41.0 32.9 24.5 39.2 54.4 23.2 21.9 8.7 31.5 28.0 29.2 20.4 28.2 5.1 29.0 9.7 17.8 12.0 9.2 18.3 9.0 8.7 8.3 7.7 12.8 9.5 9.5 9.7 33.2 7.4 24.4 5.7 9.6 10.6 7.2 8.4 8.3 7.5 7.2 9.9 10.2 9.4 10.5 10.0 8.0 11.9 40.5 102.5 85.1 41.8 31.4 34.8 45.4 28.4 18.2 38.6 38.0 25.4 21.6 25.8 67.0 51.5 50.1 49.2 23.2 30.5 7.9 45.9 13.0 27.1 25.3 49.8 37.1 17.9 79.9 37.6 43.1 46.2 23.9 40.2 54.3 24.0 37.5 53.5 50.3 26.9 69.7 28.2 30.5 59.5 59.4 10.8 23.0 66.6 26.6 103.0 62.0 34.1 21.6 60.3 105.8 35.9 15.6 24.5 53.9 43.3 22.3 18.8 61.7 29.9 6.6 61.3 31.8 43.1 30.5 22.7 47.7 103.0 29.0 22.1 22.9 44.1 AZGP1 "ZA2G, ZAG" ENSG00000160862 "Alpha-2-glycoprotein 1, zinc-binding" P25311 7 99966720-99976042 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 2809.6;salivary gland: 3847.3" "Cell type enhanced" "Detected in many" "Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2" "Group enriched" "Detected in many" 12 "breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012582, HPA012876, CAB016087, CAB032276" Enhanced Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 55200000000 74000000000 "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 35: Glandular cells - Unknown function" Vesicles Nucleoplasm "CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: " "unprognostic (8.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.41e-1)" "unprognostic (5.42e-3)" "unprognostic (4.98e-2)" "unprognostic (5.74e-3)" "prognostic favorable (2.90e-4)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (1.79e-1)" "prognostic favorable (1.53e-4)" "unprognostic (2.18e-1)" "unprognostic (2.08e-2)" "unprognostic (9.80e-2)" "unprognostic (3.51e-3)" 128.6 3.9 17.1 2.7 28.8 0.4 1061.4 23.1 18.8 3.4 16.0 6.7 30.9 1.5 2.5 22.0 3.0 38.7 114.7 14.9 22.2 326.8 2809.6 14.8 0.4 20.2 23.3 6.0 752.1 0.1 1.3 0.5 27.1 1051.4 4.2 3.6 3847.3 40.2 1.7 206.8 28.6 0.3 14.0 1.4 315.2 25.9 21.4 0.8 1.9 2.3 1.5 5.8 7.5 24.5 0.2 0.0 0.0 0.0 11.3 0.0 5.5 0.0 0.0 0.0 0.0 0.1 4.0 14.2 0.7 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.1 0.3 0.1 56.6 4.9 1.5 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.3 29.9 0.0 0.0 0.0 5.1 0.2 158.9 0.0 0.0 1.7 130.4 0.0 0.0 0.0 2.0 1.0 25.4 13.0 0.0 41.8 0.0 0.0 0.5 0.1 1.8 0.9 1.9 0.8 0.4 0.0 0.5 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 28.8 23.1 18.8 14.9 22.2 20.2 23.3 27.1 14.0 21.4 24.5 9.9 22.4 276.8 0.0 14.7 4.2 422.1 25.3 0.0 0.0 1315.5 704.8 115.9 451.8 63.0 5.5 2.1 0.0 10.4 5.5 46.9 11.7 1.9 1.4 1.2 14.2 12.4 85.5 0.1 254.2 0.0 7.7 94.8 5.5 3.8 1.2 65.3 4270.8 0.0 0.0 0.1 13.1 901.3 93.1 0.7 4.2 0.9 14.8 62.2 1.0 2.0 23.7 0.0 7.5 7.3 221.5 6.4 0.0 0.3 1691.9 15.3 596.1 6.3 0.3 0.0 0.0 11.9 7.4 0.4 9.9 9.7 0.0 12.3 0.1 12.6 674.2 B4GALT1 "beta4Gal-T1, GGTB2" ENSG00000086062 "Beta-1,4-galactosyltransferase 1" P15291 9 33104082-33167356 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 333.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 215.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 346.6;SiHa: 635.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010806, HPA010807" Enhanced Enhanced "Golgi apparatus" "Intracellular and membrane" NA NA 97000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "HPA010806: AB_1078255, HPA010807: AB_1078254" "unprognostic (7.57e-2)" "unprognostic (1.24e-2)" "unprognostic (2.09e-1)" "prognostic favorable (6.85e-7)" "unprognostic (1.83e-2)" "unprognostic (9.94e-2)" "unprognostic (3.08e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (1.07e-1)" "unprognostic (5.45e-2)" "unprognostic (1.68e-3)" "unprognostic (2.78e-1)" "unprognostic (7.93e-3)" "unprognostic (4.98e-2)" "unprognostic (3.91e-2)" "unprognostic (7.07e-2)" "unprognostic (3.46e-2)" 52.4 39.2 5.6 43.9 5.1 80.2 91.1 7.3 6.4 64.9 17.9 38.0 21.9 35.7 35.7 49.7 49.3 47.8 55.4 5.4 6.8 42.1 89.4 50.1 33.3 8.6 6.4 77.4 43.9 77.1 21.2 52.9 7.7 38.8 34.3 26.2 70.3 34.0 30.9 35.8 28.1 55.2 8.1 39.7 52.1 38.3 8.3 26.8 60.8 16.7 41.2 79.4 44.9 9.4 99.1 71.8 13.1 18.1 64.9 113.7 235.9 100.6 125.7 59.5 58.8 44.0 112.1 37.8 62.4 147.3 77.2 51.9 13.7 124.5 59.4 346.6 13.6 21.6 277.6 34.1 127.4 17.9 35.0 128.0 218.1 68.0 82.2 127.6 64.0 11.5 24.9 45.5 57.0 86.1 16.3 35.4 8.1 54.1 21.8 21.0 12.2 25.1 177.0 84.6 9.8 12.7 635.5 122.2 25.8 40.4 154.8 32.3 59.9 42.2 49.4 137.2 39.8 7.6 17.9 23.3 131.0 24.2 15.8 30.6 33.2 20.3 45.2 30.5 59.2 87.1 30.4 40.7 23.3 69.9 17.9 23.3 96.5 72.4 24.8 215.3 22.0 24.0 5.6 5.1 7.3 6.4 5.4 6.8 8.6 6.4 7.7 8.1 8.3 9.4 104.4 86.6 71.9 3.3 112.0 141.9 53.0 59.2 75.7 3.8 215.8 66.7 37.2 88.6 59.5 167.3 20.9 94.9 206.2 146.1 15.6 78.2 21.9 108.6 39.7 60.6 8.4 12.8 4.1 125.9 155.8 99.9 80.0 163.7 36.8 19.6 91.1 195.4 53.9 0.0 4.5 64.0 24.4 82.3 333.3 11.1 50.7 129.0 96.0 33.7 31.3 7.7 39.1 3.0 1.0 157.8 57.4 44.4 116.4 89.0 23.9 57.7 33.8 40.1 52.6 80.0 50.8 6.4 13.8 86.1 108.4 173.9 92.7 33.9 41.6 93.2 BAIAP2L1 IRTKS ENSG00000006453 "BAR/IMD domain containing adaptor protein 2 like 1" Q9UHR4 7 98291650-98401090 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "stomach 1: 58.8" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 108.1;Prostatic glandular cells: 114.7;Urothelial cells: 147.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SK-BR-3: 72.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA019484, HPA021257, HPA023874, HPA029503" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane" Cytosol "HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330" "unprognostic (1.75e-1)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.42e-2)" "unprognostic (1.00e-1)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" "unprognostic (8.31e-3)" "unprognostic (4.56e-2)" "unprognostic (1.34e-2)" "unprognostic (9.09e-2)" "unprognostic (2.79e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" 5.8 20.7 1.5 6.2 1.5 0.4 7.8 1.3 1.7 10.1 3.1 23.0 28.6 2.8 1.4 29.2 11.6 15.5 5.2 1.4 2.1 13.9 33.4 14.0 1.4 1.7 1.7 1.3 31.2 13.1 13.0 10.2 1.8 26.2 21.4 0.6 23.6 2.6 2.8 19.9 25.4 2.6 1.5 1.9 58.8 9.8 1.8 2.1 14.9 1.6 4.6 16.8 17.1 1.8 43.2 33.6 0.9 0.7 0.0 1.5 55.0 10.9 7.1 5.6 4.1 47.0 62.9 1.8 15.9 4.1 47.4 37.3 15.6 46.1 5.0 0.2 20.3 0.0 14.3 27.0 6.7 0.0 14.7 1.5 61.0 3.2 44.4 12.3 0.2 0.1 26.4 0.1 4.8 36.1 0.1 0.1 26.3 61.8 18.5 0.1 0.5 7.0 35.2 37.2 23.5 4.6 25.3 72.2 12.8 35.3 20.2 1.0 1.4 8.3 39.6 1.6 5.1 0.9 13.1 21.8 0.9 5.4 13.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.5 1.5 1.3 1.7 1.4 2.1 1.7 1.7 1.8 1.5 1.8 1.8 16.9 12.8 22.9 23.5 0.8 16.7 64.8 31.5 14.2 0.6 17.4 7.6 2.3 30.0 36.3 22.0 4.2 11.8 5.5 100.3 9.8 60.8 33.1 25.2 3.0 11.2 32.2 2.7 23.1 77.6 78.4 2.2 108.1 33.4 0.0 4.5 0.7 16.6 2.4 1.7 26.1 53.6 18.3 0.3 1.7 52.5 0.9 1.0 8.8 37.5 2.6 1.2 0.0 26.7 31.4 102.6 84.7 0.7 0.6 114.7 35.3 2.4 58.6 0.8 0.0 1.9 6.7 50.0 56.3 22.4 19.5 12.2 1.9 0.2 44.7 147.8 BET1 hbet1 ENSG00000105829 "Bet1 golgi vesicular membrane trafficking protein" O15155 7 93962762-94004382 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 171.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (6.85e-3)" "unprognostic (1.58e-2)" "unprognostic (3.52e-2)" "unprognostic (2.88e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.60e-2)" "unprognostic (4.19e-2)" "unprognostic (1.51e-2)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.28e-1)" "unprognostic (3.36e-1)" "prognostic unfavorable (1.32e-4)" "unprognostic (2.10e-2)" "unprognostic (2.16e-1)" "unprognostic (2.69e-1)" "unprognostic (7.24e-3)" 18.2 28.1 10.5 16.3 11.2 4.9 23.3 11.2 15.6 22.9 14.7 15.8 21.9 18.7 34.3 12.2 18.5 13.3 14.2 10.4 12.7 24.3 31.8 13.9 24.3 11.4 11.5 24.3 22.7 19.4 18.0 36.5 11.2 20.8 17.0 13.3 26.2 21.1 9.7 13.8 23.4 15.2 11.5 16.7 20.0 13.9 12.2 19.7 22.2 10.4 21.0 17.6 11.5 13.5 26.1 22.2 34.3 31.6 58.6 66.1 23.7 42.6 55.1 35.8 47.0 12.1 28.7 42.5 82.4 23.5 69.8 13.8 18.9 31.7 60.9 25.2 26.4 16.5 21.1 30.2 61.4 30.7 16.9 27.9 56.7 32.6 88.9 52.7 50.5 31.3 37.2 57.4 48.7 22.6 41.1 43.3 34.0 38.2 33.6 26.6 22.5 58.2 74.2 16.0 15.5 28.0 32.2 45.0 85.7 46.3 28.4 30.7 35.3 46.8 24.4 96.4 29.0 37.9 50.3 59.0 67.3 41.2 35.6 62.8 18.0 19.9 20.2 19.0 25.7 40.7 22.8 20.8 17.1 37.4 26.5 22.3 5.5 24.4 22.8 40.3 20.9 19.5 10.5 11.2 11.2 15.6 10.4 12.7 11.4 11.5 11.2 11.5 12.2 13.5 26.3 12.8 21.4 14.4 39.3 19.5 25.2 69.2 15.9 10.4 34.6 29.8 11.1 27.1 40.2 42.3 4.2 64.7 27.6 16.2 101.8 52.6 19.1 24.8 24.8 33.3 15.6 26.1 17.1 34.7 171.5 34.9 15.3 32.6 11.4 21.2 35.0 53.5 35.6 10.1 21.1 28.7 69.2 23.1 21.1 9.3 36.4 34.6 26.6 15.0 53.7 19.7 23.7 16.6 25.3 35.5 26.6 22.2 49.7 52.6 45.7 90.9 47.8 10.7 26.3 15.5 33.5 72.7 41.1 22.7 25.4 128.3 21.7 31.8 20.7 40.7 BET1L "GOLIM3, GS15" ENSG00000177951 "Bet1 golgi vesicular membrane trafficking protein like" Q9NYM9 11 167784-207428 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039819 Approved Supported "Nucleoplasm,Golgi apparatus" No No "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" Nucleoplasm "HPA039819: AB_10673020" "unprognostic (1.68e-1)" "unprognostic (2.07e-1)" "unprognostic (2.14e-3)" "unprognostic (2.56e-3)" "prognostic unfavorable (9.80e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.82e-1)" "unprognostic (1.52e-1)" "unprognostic (3.08e-2)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.03e-1)" "unprognostic (9.10e-2)" "unprognostic (1.69e-1)" "unprognostic (3.75e-2)" "unprognostic (8.49e-2)" 36.2 38.2 26.8 29.4 28.2 18.0 35.5 26.5 27.6 43.2 33.2 37.0 29.1 37.0 37.3 30.1 38.8 27.5 34.3 25.6 27.1 40.4 53.5 35.4 32.9 31.0 28.5 53.6 79.9 39.9 56.0 29.8 28.0 43.4 29.8 17.1 52.9 41.6 22.5 36.1 39.4 31.3 27.5 39.4 43.1 33.0 27.5 28.2 37.5 23.4 35.7 37.4 33.2 30.1 46.2 37.6 22.0 27.3 66.5 58.3 31.8 48.1 62.8 50.6 51.5 47.3 43.4 40.5 22.9 87.7 36.4 42.1 25.6 44.0 38.3 31.6 27.7 37.5 21.5 48.2 61.4 43.2 70.2 66.2 58.1 29.8 79.6 58.7 34.7 28.2 55.7 41.3 32.7 25.0 31.7 27.3 33.6 66.8 42.3 32.6 32.6 27.7 41.8 20.3 23.9 29.0 42.9 68.5 47.7 31.5 35.2 33.6 38.6 39.0 18.0 16.0 24.0 72.2 35.9 35.6 52.7 35.6 36.4 58.5 19.0 66.0 28.4 27.5 34.1 31.9 32.5 29.1 19.0 25.0 37.4 29.6 43.5 27.9 25.8 22.1 27.4 32.5 26.8 28.2 26.5 27.6 25.6 27.1 31.0 28.5 28.0 27.5 27.5 30.1 9.8 12.8 17.0 3.9 23.0 9.3 16.8 12.8 16.5 6.8 21.3 19.0 14.5 15.7 10.7 14.7 8.4 15.8 16.9 24.4 21.5 12.8 58.8 8.6 13.2 10.6 7.8 12.0 3.6 23.4 28.2 19.4 20.9 10.1 38.0 10.2 18.2 39.3 22.7 3.3 4.4 23.1 14.2 16.4 12.7 142.9 22.1 18.4 7.2 2.8 14.8 9.1 10.3 4.0 4.7 18.6 26.1 18.8 68.3 29.2 39.2 28.7 12.6 10.4 6.6 12.8 15.9 47.2 21.8 11.9 11.6 26.3 19.4 8.9 17.1 29.3 BSDC1 "FLJ10276, RP4-811H24.7" ENSG00000160058 "BSD domain containing 1" Q9NW68 1 32364633-32394731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 37.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031358, HPA031360" Approved Supported "Golgi apparatus,Plasma membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "Plasma membrane" "HPA031358: AB_2673841, HPA031360: AB_10601120" "unprognostic (1.42e-1)" "unprognostic (8.97e-2)" "unprognostic (2.91e-2)" "unprognostic (3.86e-2)" "unprognostic (2.48e-1)" "prognostic favorable (8.82e-5)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.56e-3)" "unprognostic (5.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.92e-3)" "unprognostic (2.68e-1)" "unprognostic (2.37e-1)" "unprognostic (2.07e-1)" 36.8 63.0 28.0 17.4 29.4 77.1 37.8 31.7 30.6 38.7 27.3 35.9 25.4 35.3 24.9 36.7 35.3 23.3 35.9 28.9 27.2 38.7 73.2 33.7 22.4 32.5 27.8 54.5 56.0 42.3 46.5 22.1 28.8 41.0 22.5 21.7 45.0 24.3 36.7 47.5 34.8 20.7 28.1 35.8 41.0 51.3 28.4 19.5 37.9 16.3 21.8 33.2 36.5 35.9 24.3 16.2 32.8 25.2 38.6 29.6 25.6 23.0 43.9 39.8 41.0 18.1 19.9 17.8 27.0 41.3 22.6 26.1 23.4 21.6 25.6 33.4 33.3 14.2 35.5 22.1 33.2 17.6 24.7 35.5 46.4 30.7 23.2 47.8 24.8 28.0 36.4 30.8 22.3 10.7 18.7 10.3 20.8 14.1 19.0 18.8 18.8 24.7 22.6 19.5 34.6 25.0 22.1 22.7 25.2 37.7 21.4 13.9 30.1 22.1 19.8 28.3 22.6 42.2 41.6 15.9 25.8 22.3 13.5 37.4 5.1 18.3 6.2 5.9 6.1 7.0 5.5 5.2 4.9 8.3 6.0 5.6 8.4 6.1 5.0 6.5 7.3 6.2 28.0 29.4 31.7 30.6 28.9 27.2 32.5 27.8 28.8 28.1 28.4 35.9 24.6 32.1 18.6 23.5 42.8 28.4 56.6 31.5 25.6 53.6 38.9 26.7 19.4 55.8 21.9 25.8 83.4 51.1 38.8 59.3 19.6 37.8 88.9 23.7 26.3 35.2 40.1 76.0 25.6 44.1 31.0 32.7 27.0 34.4 21.0 36.1 50.0 56.7 20.0 85.8 31.6 47.8 28.5 25.8 13.1 100.7 54.7 20.1 32.0 25.3 28.0 30.3 57.7 29.1 35.0 45.6 40.0 47.4 32.1 58.4 63.9 28.0 18.4 69.8 39.5 33.1 38.1 42.9 45.9 21.2 25.9 96.5 34.6 60.5 39.3 57.2 BTD ENSG00000169814 Biotinidase P43251 3 15601341-15722311 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052275 Uncertain "Secreted to blood" NA NA 2800000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA052275: AB_2681782" "unprognostic (6.04e-2)" "unprognostic (2.42e-1)" "unprognostic (9.37e-3)" "unprognostic (5.84e-2)" "unprognostic (2.13e-1)" "unprognostic (1.95e-2)" "unprognostic (6.37e-3)" "unprognostic (4.26e-2)" "unprognostic (3.29e-2)" "unprognostic (1.23e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "prognostic favorable (2.60e-9)" "unprognostic (2.44e-2)" "unprognostic (4.90e-2)" "unprognostic (1.67e-3)" "unprognostic (3.73e-2)" 25.3 16.7 10.7 8.0 12.7 13.1 16.4 20.2 12.6 13.7 11.0 15.9 46.1 13.2 62.4 9.9 18.3 19.9 10.2 11.5 10.3 37.6 95.9 15.9 9.6 12.0 10.0 25.3 44.1 27.7 5.9 17.0 12.6 19.5 17.0 35.2 16.0 21.1 7.8 9.5 30.7 14.1 10.3 11.3 24.4 18.2 9.9 10.6 26.8 11.4 10.4 14.3 7.5 19.1 9.2 22.0 7.8 7.3 51.7 15.3 39.6 15.4 18.4 16.2 28.3 10.1 21.5 4.1 16.3 31.6 7.1 9.7 5.3 16.7 18.7 7.6 11.7 12.9 28.8 24.8 12.7 8.8 14.7 18.3 16.9 42.9 5.1 39.7 30.5 5.9 8.7 32.3 44.7 11.1 4.5 8.2 8.5 16.9 13.0 5.9 18.4 27.9 16.5 17.7 5.3 11.8 17.9 5.2 24.4 15.1 19.9 11.3 24.3 20.5 13.6 19.1 10.1 8.9 11.4 4.1 21.4 7.7 14.4 74.1 20.7 44.9 22.9 19.6 21.0 14.7 23.3 19.2 21.4 13.1 19.7 15.4 19.8 15.0 15.8 24.9 28.8 16.5 10.7 12.7 20.2 12.6 11.5 10.3 12.0 10.0 12.6 10.3 9.9 19.1 14.9 6.4 11.0 11.8 11.7 5.9 12.4 25.0 6.2 13.5 9.1 7.9 6.0 45.8 16.7 18.4 18.8 25.3 19.7 9.9 5.9 21.1 31.0 9.5 6.0 9.1 7.2 4.0 6.6 28.5 22.4 14.5 9.7 5.7 5.1 8.9 20.3 63.3 14.9 5.0 12.2 8.5 16.2 8.2 5.9 17.9 32.3 9.2 10.6 5.6 8.7 19.2 6.2 27.2 23.9 12.0 17.9 18.0 16.6 6.3 52.1 32.0 19.8 54.1 13.1 8.5 8.6 45.3 7.5 7.7 5.5 23.1 13.6 17.4 8.9 9.5 C4orf19 FLJ11017 ENSG00000154274 "Chromosome 4 open reading frame 19" Q8IY42 4 37453925-37623495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.0" "Cell type enhanced" "Detected in many" "Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 8.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.6" "Group enriched" "Detected in some" 5 "OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043458, HPA052894" Enhanced Supported "Cell Junctions" No No "Cluster 1: Neutrophils - Mixed function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cell Junctions" "HPA043458: AB_10960696, HPA052894: AB_2681982" "unprognostic (8.83e-2)" "unprognostic (7.86e-2)" "unprognostic (3.00e-3)" "unprognostic (2.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.59e-3)" "unprognostic (5.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.66e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.49e-11)" "unprognostic (1.33e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (8.19e-3)" 3.4 0.3 2.7 3.0 2.9 3.8 3.8 5.3 4.3 10.2 5.9 25.5 17.7 6.7 0.2 2.1 2.8 9.2 0.4 3.5 4.2 12.4 36.0 3.7 0.5 4.9 4.9 0.2 24.9 16.0 1.2 7.6 4.2 1.7 23.7 4.6 28.2 6.8 0.2 1.6 19.6 4.0 4.5 0.3 20.7 1.4 4.9 0.2 1.5 0.4 4.3 8.8 2.9 4.1 0.1 0.2 3.2 0.3 0.0 0.0 4.2 0.7 0.0 0.0 0.0 12.6 5.2 0.1 3.0 0.0 0.1 0.4 0.2 0.8 0.1 0.0 0.4 0.0 8.3 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.1 14.3 0.2 0.2 0.5 64.6 1.7 0.1 7.8 0.2 12.7 81.0 0.9 0.3 0.5 32.6 1.0 4.0 113.1 0.7 0.6 0.4 4.5 0.2 1.6 0.2 0.1 0.5 0.0 6.9 5.6 0.9 1.4 2.1 0.6 0.2 0.4 0.2 0.3 0.4 0.2 0.5 0.5 0.8 8.6 0.8 0.1 1.6 0.7 0.3 2.7 2.9 5.3 4.3 3.5 4.2 4.9 4.9 4.2 4.5 4.9 4.1 0.3 0.0 12.6 45.4 0.7 0.3 7.8 4.9 0.0 0.6 7.1 3.9 0.2 27.1 10.1 11.0 0.0 6.7 0.2 61.3 11.7 25.2 1.2 9.5 0.4 0.9 9.6 0.0 2.3 51.8 4.7 0.3 33.6 5.5 0.0 0.0 0.0 13.1 0.7 0.0 2.4 28.0 4.1 0.0 0.3 2.4 0.0 0.2 3.6 22.5 0.6 5.3 0.0 46.8 1.8 53.6 67.2 0.0 0.0 7.8 52.3 9.2 12.3 1.0 0.0 0.2 0.9 0.3 0.2 0.5 0.0 47.5 0.4 0.1 31.8 19.1 CALR "cC1qR, CRT, FLJ26680, RO, SSA" ENSG00000179218 Calreticulin P27797 19 12938578-12944489 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1717.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001513, HPA002242, CAB019952, CAB079775" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 210000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" "CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (8.46e-2)" "unprognostic (4.25e-2)" "unprognostic (9.44e-3)" "unprognostic (6.93e-2)" "unprognostic (2.47e-2)" "unprognostic (4.60e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.10e-4)" "unprognostic (2.07e-1)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (2.37e-1)" "unprognostic (1.96e-1)" "unprognostic (1.37e-1)" "unprognostic (5.27e-2)" 295.5 257.6 201.7 352.9 213.4 554.9 218.9 238.0 213.5 256.3 324.0 304.6 287.3 275.8 647.7 338.2 266.7 164.1 303.2 203.5 239.7 296.9 782.3 308.9 230.0 260.4 230.1 272.2 319.7 292.2 284.5 403.3 254.5 277.9 336.7 96.2 299.3 247.2 119.8 189.3 277.2 349.7 237.7 277.3 300.6 165.2 267.3 245.3 702.9 104.7 319.4 252.2 236.6 274.2 1681.4 673.6 832.5 1984.9 1110.8 861.5 724.6 2075.3 1160.8 839.6 1280.4 1044.2 1353.5 1087.2 1960.0 2528.4 1064.5 672.1 906.1 1476.5 800.7 730.0 588.1 894.3 689.0 1619.6 2667.5 3638.5 1171.8 946.8 638.7 1222.3 957.7 1472.5 1507.8 743.1 814.5 536.3 911.7 1222.3 1040.0 2511.9 808.7 952.0 970.1 777.0 770.8 1329.9 1138.3 846.9 312.4 668.4 1438.7 769.8 472.6 789.9 1014.4 1558.9 1460.6 1113.2 666.2 1533.6 938.3 644.3 569.7 985.8 1567.6 1616.3 1258.1 67.5 72.8 39.7 172.8 147.8 119.3 90.0 99.7 130.0 76.3 77.5 73.0 134.4 23.8 103.1 122.7 215.6 83.4 75.8 201.7 213.4 238.0 213.5 203.5 239.7 260.4 230.1 254.5 237.7 267.3 274.2 385.2 147.4 160.7 34.6 385.7 261.7 336.3 217.3 221.4 76.8 214.9 140.8 43.7 163.0 175.4 222.5 127.2 652.9 515.5 524.4 64.6 582.7 27.8 206.3 364.2 305.6 353.6 266.1 14.2 285.5 1717.5 422.5 289.5 348.2 207.4 341.6 312.7 612.4 789.3 35.3 23.8 595.1 93.6 208.8 433.2 30.6 318.7 378.4 213.5 31.9 229.9 316.5 360.5 28.6 31.1 410.2 462.8 311.1 1059.6 426.1 377.8 182.8 147.5 167.7 203.8 224.2 328.9 276.1 306.6 245.5 213.5 964.4 345.8 399.4 471.4 329.6 CANX "CNX, IP90, P90" ENSG00000127022 Calnexin P27824 5 179678628-179731641 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 817.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 528.3;SK-MEL-30: 790.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004738, HPA009433, HPA009696" Enhanced Enhanced "Endoplasmic reticulum" NA NA 13000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379" "unprognostic (6.56e-2)" "unprognostic (9.34e-3)" "prognostic favorable (1.38e-4)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" "unprognostic (1.41e-2)" "unprognostic (4.66e-3)" "unprognostic (8.57e-2)" "unprognostic (4.34e-2)" "unprognostic (1.25e-2)" "unprognostic (2.17e-3)" "unprognostic (4.48e-2)" "unprognostic (2.28e-1)" "unprognostic (1.87e-1)" "unprognostic (7.12e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (2.15e-1)" 128.3 112.8 15.0 36.3 17.6 76.0 110.6 18.8 31.1 121.4 25.1 108.7 45.0 137.7 171.7 106.7 109.8 6.2 137.5 13.8 24.1 121.4 193.2 112.7 18.4 24.7 24.1 129.6 209.7 9.6 96.5 75.0 20.2 96.0 62.6 68.0 123.3 17.8 111.6 83.5 97.4 85.0 19.2 73.2 115.2 75.0 17.9 9.0 159.2 53.6 16.6 112.0 95.6 22.6 13.0 91.5 89.5 53.0 295.4 229.3 37.9 261.4 342.8 341.2 298.2 148.2 49.6 309.3 351.0 127.8 121.4 18.7 120.2 121.1 405.9 64.6 6.3 63.0 247.8 22.9 399.9 82.9 50.0 39.1 313.5 118.6 528.3 56.1 93.9 23.9 43.2 99.9 39.9 51.2 40.9 15.1 9.4 11.7 6.4 43.2 71.3 24.9 252.1 82.8 24.4 8.0 62.7 16.7 790.3 182.7 267.3 16.3 234.7 49.9 56.5 36.1 200.2 19.7 87.2 46.1 53.3 50.4 46.5 51.8 61.8 17.4 29.9 38.9 34.4 14.4 21.2 25.0 47.6 10.0 15.3 15.6 9.6 32.1 30.1 38.7 16.4 74.1 15.0 17.6 18.8 31.1 13.8 24.1 24.7 24.1 20.2 19.2 17.9 22.6 187.0 198.7 296.6 53.5 109.4 148.5 115.4 181.3 152.0 117.4 245.8 153.5 537.0 185.8 247.0 182.1 158.4 162.5 148.6 174.3 49.0 173.6 225.5 160.9 253.9 204.0 178.0 133.3 45.5 153.5 245.8 202.8 156.5 255.5 197.9 137.7 157.5 438.7 227.7 159.9 77.0 250.0 134.3 206.4 215.6 817.5 159.1 218.3 176.1 44.0 181.1 213.8 84.5 63.3 79.4 153.1 125.1 191.1 327.3 249.5 188.2 196.4 294.3 160.9 92.1 114.6 211.2 158.4 72.7 182.3 161.8 244.8 105.8 183.1 251.0 157.8 CBWD1 ENSG00000172785 "COBW domain containing 1" Q9BRT8 9 121038-179147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 185.1" "HPA042759, HPA042813" Approved Approved "Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (3.75e-2)" "unprognostic (3.47e-2)" "unprognostic (5.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.39e-1)" "unprognostic (2.67e-2)" "unprognostic (3.91e-2)" "unprognostic (3.72e-1)" "unprognostic (4.15e-2)" "unprognostic (2.07e-3)" "unprognostic (1.82e-1)" "unprognostic (4.68e-2)" "unprognostic (5.80e-7)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (8.94e-2)" "unprognostic (4.98e-3)" 18.6 34.4 8.7 15.3 9.2 13.0 19.9 10.6 11.1 14.3 13.0 16.9 13.3 13.7 20.8 26.8 14.6 10.6 20.7 9.0 10.2 40.1 26.8 16.1 13.4 9.0 9.0 15.4 30.0 38.3 19.4 22.2 9.2 19.9 15.2 27.5 23.7 12.2 21.8 22.3 14.1 12.2 9.0 16.9 19.1 16.4 9.1 13.2 25.4 17.6 20.1 23.4 17.1 9.9 43.3 16.1 22.7 12.2 29.1 26.2 50.3 22.2 14.6 30.4 23.0 23.4 16.1 39.4 28.3 8.2 18.4 7.3 11.3 21.1 32.4 67.8 38.9 0.4 39.1 72.6 31.5 115.1 17.2 23.5 9.9 7.3 59.0 19.5 32.9 19.7 13.6 84.3 25.2 52.1 25.1 185.1 22.9 37.6 34.6 47.7 34.6 75.8 39.4 120.7 40.8 24.8 45.8 16.8 17.8 55.5 35.6 109.2 34.4 16.0 22.9 20.8 19.7 10.1 14.6 44.6 39.6 60.6 19.2 3.6 65.7 19.3 10.3 75.6 16.9 21.1 18.6 16.8 74.1 15.7 16.2 17.7 10.2 12.8 60.8 19.6 18.1 48.3 8.7 9.2 10.6 11.1 9.0 10.2 9.0 9.0 9.2 9.0 9.1 9.9 19.5 54.5 50.1 8.1 41.2 47.7 29.9 47.6 97.9 50.8 49.4 37.6 51.8 30.0 49.8 35.0 108.4 96.3 17.7 20.4 35.2 79.9 51.7 14.9 10.1 23.0 31.2 44.6 17.0 118.5 41.2 23.0 34.7 11.9 32.8 26.7 20.7 19.0 32.0 38.7 17.1 39.0 50.8 25.1 38.0 16.4 18.0 37.9 32.0 18.7 81.5 32.2 18.6 5.5 16.7 66.9 38.2 13.2 90.0 32.0 49.5 73.6 31.0 63.5 32.9 20.2 27.8 48.6 28.1 83.8 50.6 124.8 23.5 24.1 62.3 24.9 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300035 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "HPA042759: AB_2678149, HPA042813: AB_2678181" "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 12.2 19.4 7.5 18.8 7.5 13.5 17.3 9.8 9.5 9.8 5.3 14.0 13.0 9.9 7.3 17.2 9.7 6.6 13.0 8.1 8.9 21.2 28.4 10.2 16.9 8.4 7.7 12.0 27.2 8.6 18.4 15.6 8.8 10.5 9.8 18.0 13.5 10.2 17.5 13.1 20.6 8.9 4.4 12.7 17.5 12.3 6.9 12.7 14.3 13.3 13.0 18.8 12.2 10.6 73.0 52.6 25.1 41.2 18.9 6.7 34.3 35.6 14.1 15.2 17.4 15.0 69.4 84.1 33.9 26.1 67.5 86.7 48.0 70.5 39.8 128.2 31.0 31.9 137.8 73.6 24.8 60.9 38.3 15.6 21.3 27.0 35.3 30.5 35.6 93.1 60.4 66.1 22.3 47.4 71.8 81.9 38.5 86.4 88.7 32.6 78.7 94.0 17.3 32.8 40.3 25.7 58.0 36.2 46.3 46.6 26.7 71.5 16.6 22.6 58.1 38.4 70.1 38.3 165.4 102.3 68.8 92.3 41.6 29.8 86.1 66.2 27.8 71.5 24.0 52.5 25.2 28.7 62.0 52.3 27.6 25.5 86.5 16.1 52.0 46.5 37.9 59.8 7.5 7.5 9.8 9.5 8.1 8.9 8.4 7.7 8.8 4.4 6.9 10.6 4.3 25.6 30.0 2.0 15.9 14.5 16.2 6.0 12.0 25.2 14.5 9.7 28.7 7.2 21.0 11.0 29.2 13.2 5.6 9.7 1.9 7.1 4.7 4.0 2.4 9.0 4.2 5.2 10.8 11.6 7.9 8.9 8.6 3.8 12.6 12.4 6.1 8.2 5.0 11.8 8.9 9.1 2.0 11.0 10.1 2.4 5.0 6.8 5.4 6.5 19.7 5.9 8.2 10.1 5.6 8.8 17.4 3.0 20.3 12.6 28.9 7.1 24.1 36.2 6.6 5.3 6.3 16.7 7.8 7.3 21.5 15.5 10.6 7.6 10.7 12.9 CCDC125 KENAE ENSG00000183323 "Coiled-coil domain containing 125" Q86Z20 5 69280175-69332809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 15.0;neutrophil: 11.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "T-47d: 27.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041878 Approved Uncertain "Nucleoplasm,Nuclear membrane,Intermediate filaments" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear membrane, Intermediate filaments" Nucleoplasm "HPA041878: AB_10796787" "prognostic unfavorable (8.06e-4)" "unprognostic (1.01e-1)" "unprognostic (2.35e-2)" "prognostic favorable (4.40e-4)" "unprognostic (1.05e-1)" "unprognostic (1.91e-2)" "unprognostic (8.21e-2)" "unprognostic (3.08e-2)" "unprognostic (4.06e-2)" "unprognostic (5.07e-2)" "unprognostic (2.52e-2)" "unprognostic (1.91e-2)" "unprognostic (2.05e-2)" "unprognostic (5.40e-2)" "unprognostic (4.68e-2)" "unprognostic (2.52e-2)" "prognostic favorable (2.51e-4)" 3.3 3.9 2.3 2.9 2.4 10.9 7.0 2.6 2.8 2.8 2.7 4.8 4.9 2.7 2.6 4.5 3.6 3.3 2.1 2.1 2.5 3.8 12.9 3.3 2.9 2.7 2.7 3.0 5.1 3.2 4.3 3.9 3.2 6.9 5.6 3.2 6.6 1.9 2.0 3.8 5.4 1.3 2.0 3.5 5.9 1.4 2.5 2.4 2.9 1.1 2.4 3.2 2.9 3.5 3.1 5.0 0.9 14.0 1.6 0.9 17.9 1.8 2.6 1.2 0.7 4.4 15.3 5.5 10.4 2.1 1.1 3.9 10.3 5.3 1.1 19.4 8.1 3.5 7.5 8.6 4.2 3.9 1.9 5.5 2.6 5.7 1.7 2.8 2.0 6.6 10.6 2.3 1.1 12.5 4.9 6.1 0.2 3.9 3.2 7.2 0.0 7.4 6.7 3.5 5.8 3.6 3.7 8.2 2.8 0.2 27.0 3.9 2.3 1.1 2.0 3.4 2.9 10.8 17.8 2.0 3.5 20.5 0.5 6.9 1.0 15.0 1.1 1.0 0.9 1.1 0.9 0.8 1.7 0.8 0.8 0.5 11.4 1.1 2.8 1.3 0.7 0.9 2.3 2.4 2.6 2.8 2.1 2.5 2.7 2.7 3.2 2.0 2.5 3.5 4.7 25.6 20.4 21.9 5.7 1.0 4.0 8.5 7.4 4.7 13.4 10.3 5.9 7.2 16.8 1.8 2.1 34.2 4.4 11.0 5.9 13.7 0.9 31.6 5.6 3.4 1.2 9.2 17.2 12.2 8.5 5.5 28.5 15.1 15.8 9.9 1.8 17.9 6.1 3.3 16.7 14.1 10.2 4.1 2.7 1.9 2.1 8.7 1.8 17.8 7.8 4.5 5.2 16.1 13.4 8.6 17.1 2.2 6.9 5.5 9.6 8.9 60.7 7.4 0.0 5.3 4.7 1.8 3.1 8.5 1.0 12.4 5.2 14.1 7.9 4.8 CCNC CycC ENSG00000112237 "Cyclin C" P24863 6 99542387-99568825 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Cyclin, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010499, HPA069322" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "CAB010499: AB_2244021, HPA069322: AB_2686120" "unprognostic (1.48e-2)" "unprognostic (1.21e-2)" "unprognostic (1.85e-3)" "unprognostic (6.34e-2)" "unprognostic (1.92e-2)" "unprognostic (1.95e-3)" "unprognostic (2.09e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-1)" "unprognostic (1.64e-2)" "unprognostic (1.92e-1)" "unprognostic (7.10e-2)" "prognostic favorable (8.12e-4)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (3.83e-2)" 31.3 32.5 15.9 27.4 17.0 33.0 47.4 26.1 19.3 29.8 26.8 30.9 42.8 21.9 58.7 41.3 18.9 42.1 23.6 17.3 17.9 54.3 74.6 25.1 39.6 17.0 16.9 16.7 62.6 47.3 22.2 35.7 17.0 34.6 30.3 27.0 70.4 23.2 22.1 32.5 35.0 21.9 17.0 24.1 41.6 17.1 18.1 32.1 60.6 17.7 43.3 34.6 19.7 18.0 86.9 29.8 45.8 99.2 39.3 53.7 126.9 61.4 78.3 75.9 97.9 118.2 53.2 177.2 69.1 51.5 69.8 60.5 72.2 91.1 109.7 45.1 91.2 101.6 44.4 97.7 67.6 118.6 35.3 51.5 55.4 55.9 67.3 52.0 82.2 102.3 151.6 62.9 68.3 53.8 43.7 98.5 64.1 53.5 47.4 75.8 76.7 71.2 105.3 101.2 72.5 43.8 35.6 67.1 69.5 65.5 46.5 117.8 60.6 38.4 51.2 47.0 92.8 42.9 69.7 134.1 69.0 87.9 55.8 40.9 20.7 16.2 21.2 22.1 39.8 29.7 25.5 20.9 23.4 25.3 27.4 21.7 3.3 28.2 16.7 23.0 29.6 30.7 15.9 17.0 26.1 19.3 17.3 17.9 17.0 16.9 17.0 17.0 18.1 18.0 37.1 44.8 32.8 25.5 58.3 75.1 99.3 58.0 50.7 42.8 60.0 31.0 16.1 81.5 57.5 23.9 22.9 110.3 45.0 32.2 84.1 127.2 45.1 36.7 27.3 46.3 43.6 23.3 64.2 186.9 93.3 33.2 38.2 43.1 32.4 31.1 36.4 53.0 41.1 25.2 56.6 38.2 67.1 37.0 52.8 45.5 22.4 32.8 58.7 24.4 41.2 64.6 40.2 52.8 40.5 133.7 27.1 25.2 120.5 158.8 37.8 128.4 37.4 42.2 19.7 26.9 40.2 62.3 21.4 60.0 67.5 176.4 38.7 42.8 46.3 147.0 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 279.2;neutrophil: 296.6" "Group enriched" "Detected in all" 7 "granulocytes: 296.6;monocytes: 84.2" "Cell line enhanced" "Detected in many" "HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: AB_2668242, HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavorable (5.07e-4)" "prognostic unfavorable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 38.9 37.8 24.0 23.7 27.7 63.8 34.1 23.1 28.4 61.1 36.8 33.3 24.3 26.7 36.1 20.1 22.0 53.8 56.2 24.7 26.9 51.5 66.9 39.3 22.2 18.4 17.3 22.9 84.8 73.3 32.3 27.4 17.7 41.0 33.2 48.2 77.1 42.3 53.0 13.5 25.6 33.5 17.2 28.7 47.5 29.6 27.3 12.2 84.4 35.3 24.2 29.9 9.7 22.9 13.9 47.7 10.9 24.4 173.6 59.3 15.5 30.0 56.4 17.2 26.1 14.4 23.5 20.8 99.5 97.5 33.6 18.7 9.5 25.1 14.4 55.5 14.2 28.1 58.4 12.8 223.9 39.6 84.2 49.5 59.8 35.6 34.4 143.3 65.2 0.8 47.7 337.4 55.1 17.9 0.2 19.3 6.5 54.4 11.8 6.2 17.4 84.8 36.1 10.1 14.0 21.5 35.3 19.5 151.4 35.0 31.0 85.1 65.7 50.8 11.1 38.9 20.4 65.2 259.6 13.0 95.6 77.2 41.0 220.8 59.4 279.2 26.8 50.7 22.5 18.1 16.6 20.7 27.6 13.4 13.9 20.0 296.6 25.7 84.2 4.7 23.0 32.9 24.0 27.7 23.1 28.4 24.7 26.9 18.4 17.3 17.7 17.2 27.3 22.9 92.3 115.4 118.1 0.0 44.6 15.4 30.3 99.2 13.6 68.7 40.2 40.1 14.4 50.1 136.5 88.3 93.8 29.3 42.9 43.7 5.9 60.9 136.2 49.6 41.0 60.1 16.7 25.2 0.0 145.3 23.2 78.6 33.1 62.3 39.1 30.0 76.1 96.1 51.0 85.8 0.0 28.8 114.0 55.9 25.2 216.1 56.5 71.7 48.0 0.0 89.8 72.6 38.1 0.0 0.0 67.6 45.1 116.6 180.8 42.6 29.5 36.7 123.8 128.0 52.6 80.2 48.1 43.3 41.1 11.8 16.6 24.6 41.8 70.0 16.2 21.8 CHAD SLRR4A ENSG00000136457 Chondroadherin O15335 17 50464496-50468906 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 36.2;pancreas: 32.6" "Cell type enhanced" "Detected in some" "Breast glandular cells: 4.6;Breast myoepithelial cells: 2.4;Distal enterocytes: 3.3;Gastric mucus-secreting cells: 4.6;Hepatocytes: 2.4;Intestinal goblet cells: 4.3;Oligodendrocyte precursor cells: 5.5;Paneth cells: 2.5;Proximal enterocytes: 2.6" "Group enriched" "Detected in many" 5 "breast cancer: 23.7;liver cancer: 10.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 53 "memory B-cell: 21.5;naive B-cell: 8.0" "Lineage enriched" "Detected in single" 76 "B-cells: 21.5" "Cell line enhanced" "Detected in some" "RT4: 4.0;SCLC-21H: 8.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA018241 Enhanced "Secreted to extracellular matrix" NA NA 22000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA018241: AB_1846612" "prognostic favorable (7.68e-4)" "unprognostic (4.34e-2)" "unprognostic (1.24e-1)" "unprognostic (9.67e-3)" "unprognostic (1.92e-1)" "unprognostic (3.06e-3)" "prognostic favorable (1.59e-4)" "unprognostic (1.51e-2)" "unprognostic (4.75e-2)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (1.39e-1)" "unprognostic (1.92e-1)" "unprognostic (2.52e-1)" "unprognostic (1.84e-2)" "unprognostic (1.51e-3)" "unprognostic (1.41e-3)" 2.1 14.1 6.2 0.7 7.9 0.3 9.6 17.4 7.3 21.8 3.9 6.7 7.6 0.5 0.1 1.8 0.8 1.5 1.7 5.5 6.3 2.4 36.2 1.6 0.6 5.6 4.9 3.1 32.6 0.0 1.3 0.5 5.7 1.9 4.0 0.5 21.3 0.2 14.5 8.5 10.3 0.1 5.1 1.1 10.8 1.2 5.8 0.2 4.2 0.9 0.2 1.2 1.6 5.4 1.0 0.8 0.7 0.6 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.5 0.8 0.1 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.6 0.7 1.2 0.7 1.5 0.0 0.4 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.1 0.3 0.0 0.5 0.0 0.7 0.1 0.1 0.7 0.9 0.1 1.5 0.0 4.0 8.5 0.2 0.1 0.3 0.0 0.3 0.3 0.2 0.9 2.1 0.4 0.1 0.0 1.4 0.0 0.1 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.6 6.2 7.9 17.4 7.3 5.5 6.3 5.6 4.9 5.7 5.1 5.8 5.4 0.0 0.0 0.0 1.3 1.0 0.3 0.2 0.3 0.0 0.0 4.6 2.4 0.2 1.5 0.2 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 2.4 0.0 0.0 0.2 4.3 0.0 0.3 0.4 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 5.5 0.1 0.0 2.5 0.0 1.1 0.2 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.4 CHID1 "FLJ42707, MGC3234, SI-CLP" ENSG00000177830 "Chitinase domain containing 1" Q9BWS9 11 867859-915058 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 404.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039374 Uncertain Uncertain "Nucleoplasm,Intermediate filaments" "Intracellular and membrane" No No 1500000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Intermediate filaments" "HPA039374: AB_10673609" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (8.96e-2)" "prognostic favorable (6.76e-4)" "unprognostic (4.82e-2)" "unprognostic (3.22e-1)" "unprognostic (1.97e-2)" "unprognostic (3.62e-2)" "unprognostic (7.88e-2)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" "unprognostic (5.21e-2)" "unprognostic (1.74e-3)" "unprognostic (1.15e-1)" "unprognostic (7.53e-2)" "unprognostic (3.29e-2)" "unprognostic (2.89e-2)" 43.9 63.3 43.1 22.7 44.1 46.2 40.2 41.0 51.7 44.5 60.0 34.2 30.9 38.0 89.5 34.8 63.5 41.3 54.4 44.1 47.2 52.5 85.8 30.9 27.2 42.9 42.9 58.0 149.9 46.1 62.8 42.7 42.5 42.3 29.7 25.2 82.2 41.3 37.0 34.9 27.7 35.7 42.6 71.6 47.1 74.1 45.7 20.1 47.3 31.1 20.2 34.3 35.3 47.0 75.6 71.7 53.2 131.6 203.3 107.5 90.1 83.2 97.0 78.8 76.7 78.7 214.6 61.1 75.1 121.7 78.4 145.2 53.1 95.9 57.3 53.7 131.9 44.1 25.9 75.1 92.6 102.9 37.4 104.1 59.2 53.9 77.2 130.3 67.2 76.6 81.2 152.6 55.8 52.9 58.4 134.0 47.2 141.6 107.3 49.0 50.9 111.8 57.5 21.5 101.8 84.5 90.3 124.0 78.4 53.0 50.4 156.8 66.6 89.6 38.9 25.3 68.3 88.9 81.4 36.0 100.2 88.6 71.7 21.1 50.4 19.2 34.7 45.0 37.1 45.7 33.2 36.8 74.0 32.1 34.9 35.3 6.2 43.4 45.6 69.6 32.4 46.0 43.1 44.1 41.0 51.7 44.1 47.2 42.9 42.9 42.5 42.6 45.7 47.0 33.0 41.7 36.7 4.2 28.6 22.8 62.2 78.9 22.2 38.5 69.9 75.7 25.6 51.5 49.0 53.3 18.8 121.3 34.4 25.2 72.4 62.3 120.9 44.0 44.4 31.5 53.3 56.4 7.8 58.3 79.7 69.6 20.9 36.8 29.2 107.6 50.0 91.2 81.1 30.3 7.8 42.8 57.0 66.6 24.7 404.8 62.7 34.0 55.2 1.9 35.2 60.6 20.6 6.0 6.8 38.0 43.2 58.3 123.7 86.5 71.5 85.1 45.7 53.2 52.6 45.9 41.7 208.3 139.9 37.2 23.3 91.5 19.2 85.4 59.9 62.6 CHPF "CHSY2, CSS2" ENSG00000123989 "Chondroitin polymerizing factor" Q8IZ52 2 219538948-219543809 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 163.7;Extravillous trophoblasts: 182.7;Syncytiotrophoblasts: 310.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035123 Approved Supported Vesicles,Centrosome,Cytosol "Intracellular and membrane" NA NA 570000 "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Vesicles, Centrosome" "HPA035123: AB_10602799" "unprognostic (1.13e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.65e-3)" "unprognostic (2.55e-3)" "unprognostic (1.86e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.37e-1)" "unprognostic (6.59e-3)" "unprognostic (7.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (6.79e-2)" "unprognostic (1.64e-1)" "unprognostic (6.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.96e-4)" 29.9 45.7 26.9 12.5 24.9 1.7 22.3 25.8 34.2 59.1 36.7 21.9 26.7 55.9 13.7 27.3 30.2 24.2 134.8 38.4 31.2 41.1 97.8 42.8 6.5 34.0 30.4 127.4 138.9 24.6 128.3 40.6 32.1 58.6 4.7 8.5 56.1 25.6 16.3 26.2 23.2 12.6 27.4 16.6 40.9 97.5 33.2 3.6 52.8 3.9 4.5 34.3 30.0 34.0 67.5 13.0 9.6 81.0 36.0 55.8 109.7 66.4 55.4 18.5 16.8 36.8 57.5 20.7 139.0 64.6 63.3 84.1 6.3 40.3 2.9 32.3 22.5 7.4 18.0 161.9 49.8 6.6 42.1 75.0 69.2 18.8 17.9 66.7 0.1 7.1 47.2 49.6 17.7 105.5 1.0 17.6 39.8 22.8 50.6 0.1 30.4 41.6 22.4 29.7 23.4 36.0 32.1 30.7 94.3 17.9 10.5 22.6 1.6 67.9 37.1 81.9 35.2 58.9 19.9 9.7 62.1 6.7 70.4 1.7 0.0 6.5 1.9 0.1 2.4 1.0 1.5 1.3 0.0 0.1 1.7 0.6 0.0 1.9 0.0 9.5 1.2 0.7 26.9 24.9 25.8 34.2 38.4 31.2 34.0 30.4 32.1 27.4 33.2 34.0 2.1 0.0 15.2 16.0 16.5 14.5 23.2 52.8 17.1 14.6 40.0 29.6 30.5 22.8 31.2 75.4 10.4 163.7 21.7 15.9 9.8 58.1 4.1 14.0 22.2 2.9 43.0 3.2 4.3 80.4 182.7 56.0 25.5 42.4 10.2 27.4 4.2 64.0 18.5 43.7 9.2 57.8 36.7 2.4 9.1 7.1 24.8 2.3 67.6 5.6 1.8 56.8 9.2 5.5 3.7 65.6 32.7 63.2 123.6 42.3 60.7 20.6 14.6 11.5 26.3 19.3 27.1 11.9 6.3 14.2 11.1 310.3 9.7 46.3 14.3 33.0 CLCC1 MCLC ENSG00000121940 "Chloride channel CLIC like 1" Q96S66 1 108927361-108963504 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009087, HPA013210" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Endoplasmic reticulum" "HPA009087: AB_1078532, HPA013210: AB_1846895" "unprognostic (2.95e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.33e-5)" "unprognostic (4.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-1)" "unprognostic (2.40e-2)" "unprognostic (1.45e-1)" "unprognostic (5.30e-2)" "unprognostic (9.23e-2)" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (7.50e-2)" "unprognostic (1.74e-1)" "unprognostic (2.04e-1)" "unprognostic (4.68e-3)" "unprognostic (9.65e-2)" 14.6 16.5 10.1 11.4 14.3 6.1 16.3 10.6 11.7 17.0 7.8 15.4 13.2 17.0 24.3 9.9 15.1 14.0 18.3 10.7 11.5 11.0 22.2 13.0 10.5 12.8 10.9 18.6 24.8 21.3 18.3 17.7 12.1 20.2 13.2 11.8 22.3 20.0 27.2 10.3 12.7 14.9 11.0 11.5 16.1 7.6 11.8 5.2 21.9 24.8 10.8 15.2 13.4 16.0 44.2 22.3 25.1 45.8 36.7 33.9 35.6 43.8 34.2 30.1 34.2 22.6 21.0 10.8 43.7 33.3 18.5 17.1 23.9 16.1 39.4 38.0 23.2 30.4 24.7 23.5 28.9 28.7 28.2 25.2 21.9 33.2 25.7 28.3 27.1 12.1 38.6 47.7 22.1 18.9 2.3 10.1 21.5 16.6 19.8 24.5 13.1 31.2 24.3 30.5 15.9 22.7 46.9 49.6 38.9 18.9 15.9 19.7 26.7 38.3 27.7 35.1 38.4 32.1 33.3 17.1 44.7 21.8 82.5 4.1 5.6 6.1 5.6 8.4 6.1 6.1 4.5 4.4 5.6 3.2 4.9 4.5 1.4 4.7 12.4 6.4 6.8 4.4 10.1 14.3 10.6 11.7 10.7 11.5 12.8 10.9 12.1 11.0 11.8 16.0 13.3 25.6 20.9 26.8 11.8 3.7 14.0 11.7 1.8 12.3 11.8 9.1 5.9 20.0 18.0 11.0 29.2 28.7 9.0 7.1 0.0 18.6 6.7 8.1 21.3 10.9 3.6 5.9 25.0 21.1 12.8 19.5 10.7 13.5 12.0 16.3 9.7 22.3 13.1 21.9 30.3 9.0 16.2 6.7 5.1 2.8 19.9 9.3 8.8 14.0 12.0 11.4 3.1 35.7 39.3 17.7 3.8 18.8 17.7 17.7 7.2 5.0 14.9 18.9 19.7 18.6 10.7 5.5 5.4 6.4 6.3 18.5 8.4 12.5 9.8 9.9 CLPTM1L "CRR9, FLJ14400" ENSG00000049656 "CLPTM1 like" Q96KA5 5 1317752-1345099 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 474.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014791 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: U-266 - Nucleosome" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA014791: AB_1847250" "unprognostic (2.92e-2)" "unprognostic (1.34e-1)" "unprognostic (9.53e-2)" "unprognostic (8.43e-2)" "unprognostic (5.16e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (3.75e-4)" "unprognostic (3.42e-2)" "unprognostic (1.41e-1)" "unprognostic (5.47e-3)" "unprognostic (9.14e-3)" "unprognostic (1.06e-1)" "unprognostic (5.77e-3)" "unprognostic (8.57e-2)" "unprognostic (4.92e-2)" "unprognostic (4.54e-2)" "unprognostic (4.17e-2)" 37.7 37.2 23.1 28.9 23.5 28.9 35.6 23.1 26.6 28.5 34.0 41.5 45.4 32.1 15.2 36.0 29.2 18.0 33.4 24.3 24.9 58.4 133.9 49.7 37.4 24.8 31.5 24.8 74.1 22.3 36.2 20.1 23.7 33.4 20.1 5.3 65.0 21.5 23.8 36.6 43.4 17.2 24.8 59.3 67.7 43.1 26.4 41.4 48.7 10.0 29.6 35.7 27.9 24.5 71.1 117.6 39.5 106.8 63.0 26.9 103.9 71.0 46.9 62.9 61.8 129.3 109.8 67.2 212.7 67.2 138.3 60.8 53.7 59.4 28.6 275.4 147.8 35.7 261.5 86.2 70.5 93.6 87.0 43.4 66.6 57.6 53.9 46.1 51.6 149.7 81.7 222.9 48.0 116.5 104.2 121.7 72.9 77.2 126.2 86.6 64.1 207.5 49.0 66.8 41.4 82.0 123.5 106.0 56.6 32.8 177.7 138.7 38.5 74.2 211.0 51.9 103.4 399.4 474.2 109.0 55.4 139.9 86.7 5.1 4.9 10.1 5.6 4.8 6.6 7.6 5.9 5.6 4.6 10.3 5.6 6.6 3.9 10.1 8.1 9.3 7.7 4.0 23.1 23.5 23.1 26.6 24.3 24.9 24.8 31.5 23.7 24.8 26.4 24.5 33.4 57.7 64.7 7.2 50.2 22.3 23.3 24.3 8.0 10.1 40.4 36.4 12.7 51.5 30.4 29.5 14.6 11.2 35.1 49.0 5.9 17.9 2.8 32.1 27.5 25.4 44.5 17.0 13.7 32.3 26.6 23.2 27.5 35.0 24.7 40.4 26.0 113.8 23.7 21.9 10.7 52.2 14.2 39.5 16.0 6.2 17.4 27.9 16.0 7.5 22.4 28.7 27.8 12.1 12.7 45.6 29.0 19.2 95.6 48.3 46.1 66.2 31.0 11.5 13.1 19.4 21.3 28.9 40.3 14.4 23.4 10.9 24.4 60.3 39.8 33.3 CMTM6 "CKLFSF6, FLJ20396" ENSG00000091317 "CKLF like MARVEL transmembrane domain containing 6" Q9NX76 3 32481312-32502852 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 815.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026980, HPA063491" Enhanced Approved Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 41: Macrophages - Immune response" Vesicles "HPA026980: AB_10602801, HPA063491: " "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.34e-2)" "unprognostic (1.81e-2)" "unprognostic (7.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.99e-1)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (1.04e-3)" "unprognostic (6.79e-2)" "unprognostic (2.27e-1)" "unprognostic (7.23e-2)" "unprognostic (6.58e-2)" "unprognostic (3.74e-2)" "unprognostic (1.55e-3)" 40.3 26.2 11.6 69.0 11.4 97.3 54.4 11.7 13.5 50.4 24.8 47.7 26.7 46.3 41.0 40.3 176.6 50.3 18.5 10.8 13.4 40.0 132.4 54.3 53.9 14.5 12.5 18.6 23.5 41.6 9.2 70.1 14.3 48.6 58.4 13.0 33.2 39.9 5.0 49.4 29.5 41.6 14.5 55.4 46.9 40.4 13.5 47.8 61.7 13.6 78.3 79.0 18.9 14.7 107.4 34.2 66.5 50.1 112.1 111.0 292.4 77.5 110.4 79.7 91.5 36.6 174.4 63.5 86.1 104.6 53.8 67.6 47.0 128.9 108.2 285.4 57.3 80.4 22.8 54.5 79.6 135.3 153.0 110.5 81.3 92.0 68.6 128.2 130.3 60.9 39.8 116.0 103.0 33.4 81.9 70.0 59.3 88.6 50.0 68.6 51.7 49.9 111.1 147.9 15.3 44.3 70.5 39.5 76.1 66.9 58.3 133.5 117.8 88.0 57.9 86.7 94.1 59.6 63.9 58.6 61.4 116.8 112.1 176.8 84.4 208.0 29.1 133.4 32.8 54.4 38.1 28.3 72.7 42.2 22.0 24.7 313.4 65.1 210.2 38.6 46.3 108.6 11.6 11.4 11.7 13.5 10.8 13.4 14.5 12.5 14.3 14.5 13.5 14.7 57.0 35.3 49.9 12.4 243.7 96.0 82.4 159.3 55.2 13.9 233.0 57.5 5.8 60.1 112.0 95.6 12.5 253.6 122.5 88.0 33.2 113.8 12.3 129.1 68.3 70.7 132.1 41.2 14.2 83.0 101.7 74.9 63.2 180.9 126.8 186.5 124.9 305.2 156.5 50.5 19.2 117.6 118.0 310.1 815.8 8.4 39.4 326.0 81.8 30.0 425.8 130.1 71.1 18.1 9.4 136.7 46.1 42.9 104.7 147.1 23.8 63.4 183.0 17.3 39.5 32.9 74.3 36.1 20.2 89.7 126.6 261.7 120.9 50.3 64.6 110.3 CMTM8 CKLFSF8 ENSG00000170293 "CKLF like MARVEL transmembrane domain containing 8" Q8IZV2 3 32238679-32370321 "Predicted membrane proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 47.7" "Cell type enhanced" "Detected in many" "Adipocytes: 94.7;Cytotrophoblasts: 107.6;Granulosa cells: 129.9;Syncytiotrophoblasts: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "BEWO: 208.4;SK-BR-3: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055077, HPA073258" Approved Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA055077: AB_2682691, HPA073258: AB_2686591" "unprognostic (9.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.32e-1)" "unprognostic (3.83e-1)" "unprognostic (1.14e-1)" "unprognostic (3.33e-2)" "unprognostic (9.46e-2)" "unprognostic (5.67e-2)" "unprognostic (8.85e-2)" "unprognostic (1.29e-1)" "unprognostic (7.59e-2)" "unprognostic (2.56e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.78e-2)" "unprognostic (2.14e-1)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" 14.8 12.9 6.0 3.3 5.8 1.2 15.5 4.9 6.7 5.9 5.9 7.0 7.3 4.4 17.4 3.5 8.4 3.4 13.6 5.5 5.0 10.2 41.2 17.9 3.9 6.2 5.4 1.4 47.7 12.0 3.6 17.4 6.3 11.7 7.4 1.1 19.7 6.0 4.7 9.2 6.2 2.5 5.5 1.3 14.9 1.0 7.0 9.5 13.6 5.1 4.1 4.8 3.7 4.9 10.6 10.8 2.1 13.5 9.5 14.7 208.4 0.1 0.3 1.1 1.2 15.0 14.9 0.0 21.8 0.0 0.0 5.8 17.2 3.5 0.9 0.0 31.5 6.8 2.1 25.2 0.6 2.8 5.3 28.8 10.8 1.5 10.4 5.2 8.4 11.2 0.1 0.0 10.7 7.8 8.9 1.0 4.4 16.4 9.9 12.4 2.5 2.1 13.1 12.1 3.7 3.0 1.7 59.3 5.8 2.5 17.0 1.4 7.6 0.0 15.5 0.0 3.2 0.5 0.4 0.1 0.0 4.8 3.7 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.9 0.2 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.1 6.0 5.8 4.9 6.7 5.5 5.0 6.2 5.4 6.3 5.5 7.0 4.9 94.7 38.5 36.3 1.0 2.8 11.6 35.2 4.6 18.8 0.1 75.4 45.6 2.2 17.2 16.1 0.0 0.0 107.6 2.3 13.7 11.7 18.1 13.0 22.1 5.6 51.9 22.2 5.7 2.2 37.0 67.5 17.7 32.1 29.2 0.0 129.9 54.7 79.5 9.8 0.0 41.6 40.7 16.2 5.3 15.0 2.4 2.5 3.6 5.4 36.5 1.2 35.6 0.0 17.6 1.0 25.8 17.7 1.2 1.4 64.9 21.3 24.3 9.9 2.7 0.0 2.2 12.3 3.5 3.7 12.1 6.5 116.2 18.6 10.9 21.0 49.7 CNPY2 "HP10390, TMEM4, ZSIG9" ENSG00000257727 "Canopy FGF signaling regulator 2" Q9Y2B0 12 56309842-56316119 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 475.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA038465, HPA038466" Supported Supported Cytosol "Intracellular and membrane" NA NA 220000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 43: THP-1 - Innate immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "HPA038465: AB_10967609, HPA038466: AB_10672646" "unprognostic (3.83e-2)" "unprognostic (5.62e-2)" "unprognostic (2.49e-1)" "unprognostic (2.46e-2)" "unprognostic (4.33e-2)" "unprognostic (2.20e-1)" "unprognostic (1.17e-3)" "unprognostic (1.46e-1)" "unprognostic (7.68e-2)" "unprognostic (2.04e-3)" "prognostic favorable (8.37e-4)" "unprognostic (5.89e-2)" "prognostic unfavorable (2.32e-8)" "unprognostic (1.91e-1)" "unprognostic (1.16e-1)" "unprognostic (2.67e-2)" "unprognostic (5.06e-2)" 36.7 52.5 28.4 25.8 30.3 24.7 41.8 30.0 30.7 43.3 38.1 36.6 30.9 35.6 74.4 34.1 38.1 25.4 28.4 27.7 31.8 37.8 75.7 30.5 22.0 31.1 29.0 42.7 58.9 47.3 66.8 40.8 28.9 35.3 38.5 18.8 53.1 36.4 21.2 23.5 34.6 24.9 30.5 35.1 42.1 20.0 29.8 27.0 44.7 18.6 26.6 32.9 31.1 32.2 50.6 75.5 76.0 62.8 186.0 64.0 120.7 51.0 117.4 108.7 76.5 116.0 87.9 51.2 95.0 132.4 53.2 72.4 92.3 62.8 68.7 51.3 57.5 49.9 106.1 121.8 83.6 94.9 60.4 76.5 80.5 89.9 106.6 165.5 91.1 59.0 73.8 113.5 81.3 76.2 58.2 105.3 72.6 107.5 109.5 65.1 58.3 84.9 90.1 47.6 67.9 41.7 85.1 86.8 93.6 92.7 78.0 176.8 41.2 42.7 33.6 52.2 74.7 58.4 88.2 41.5 90.2 88.2 70.9 56.8 66.5 36.8 65.8 56.9 77.8 73.2 70.7 71.7 69.5 66.2 70.4 67.0 9.8 70.9 34.6 71.3 68.4 76.4 28.4 30.3 30.0 30.7 27.7 31.8 31.1 29.0 28.9 30.5 29.8 32.2 76.2 48.1 93.7 17.3 79.2 54.8 75.2 129.9 17.1 80.5 178.6 191.6 9.8 140.2 95.2 101.2 64.6 248.3 74.0 80.2 52.8 191.8 40.2 54.7 59.9 72.6 141.9 34.3 31.8 168.7 475.0 77.5 31.1 53.1 91.3 60.7 98.9 185.8 147.4 58.9 32.4 187.2 103.7 59.2 55.8 17.7 103.8 47.8 122.7 13.1 99.7 88.6 125.7 40.2 45.6 162.4 114.1 100.1 68.2 107.4 176.6 145.5 74.1 92.2 26.3 59.1 82.8 72.4 44.0 20.0 53.8 236.4 60.5 78.2 177.8 71.0 COG3 SEC34 ENSG00000136152 "Component of oligomeric golgi complex 3" Q96JB2 13 45464898-45536701 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040353, HPA054470" Approved Supported "Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus, Plasma membrane" "Nucleoplasm, Cytosol" "HPA040353: AB_10794027, HPA054470: AB_2732585" "unprognostic (1.75e-1)" "unprognostic (3.03e-3)" "unprognostic (1.75e-1)" "unprognostic (4.04e-3)" "unprognostic (9.69e-2)" "unprognostic (2.86e-2)" "unprognostic (2.18e-2)" "unprognostic (4.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (5.82e-2)" "unprognostic (1.21e-2)" "unprognostic (4.49e-2)" "unprognostic (7.06e-3)" "unprognostic (1.13e-1)" "unprognostic (8.25e-2)" "unprognostic (1.71e-1)" 11.2 15.0 7.5 9.3 7.7 11.8 15.6 10.5 9.3 15.2 10.5 16.2 12.6 13.0 16.8 12.4 12.2 9.5 11.8 7.4 7.2 12.3 29.5 10.4 10.7 7.0 7.0 15.1 20.8 12.3 14.9 13.0 7.0 18.7 18.9 10.0 18.0 12.4 11.4 13.2 13.2 12.1 6.8 12.4 14.7 9.7 7.5 12.2 17.0 9.7 10.9 12.7 13.1 9.4 8.3 7.4 13.9 12.6 17.9 20.4 13.2 13.5 19.1 15.4 12.8 10.8 14.9 11.3 5.9 16.2 11.4 17.7 11.6 13.7 23.3 8.9 9.3 12.7 9.2 19.2 22.1 18.8 11.7 15.4 20.3 10.3 36.1 18.6 15.2 11.0 8.3 6.8 18.7 12.9 10.5 17.6 11.4 41.5 8.7 12.1 8.1 10.6 14.4 13.4 6.9 12.5 8.7 17.1 18.2 13.1 11.7 19.3 14.4 7.4 5.7 13.9 8.7 9.4 5.4 11.7 14.2 9.4 13.5 3.5 1.9 3.6 3.4 2.2 3.6 2.2 2.6 2.9 1.4 2.3 2.9 2.7 1.7 2.5 1.3 3.4 3.0 1.7 7.5 7.7 10.5 9.3 7.4 7.2 7.0 7.0 7.0 6.8 7.5 9.4 15.8 9.6 31.4 23.2 18.9 15.8 15.2 13.1 14.2 9.7 22.0 17.9 19.7 24.3 19.8 12.9 14.6 14.2 35.5 32.5 15.6 11.6 24.1 15.0 20.1 16.7 22.2 11.4 39.3 37.9 18.8 14.3 26.0 30.8 17.1 22.4 18.9 72.8 10.8 10.1 34.7 54.5 6.1 20.9 9.0 9.0 14.0 13.3 10.6 22.5 13.2 7.6 15.5 34.2 36.9 22.7 32.8 13.5 31.3 26.6 29.4 17.3 11.7 11.2 6.6 12.8 11.7 12.7 8.9 17.7 16.1 32.8 21.2 21.7 24.4 37.3 COG5 "GOLTC1, GTC90" ENSG00000164597 "Component of oligomeric golgi complex 5" Q9UP83 7 107201372-107564261 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020300, HPA041583" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA020300: AB_2081406, HPA041583: AB_2677564" "unprognostic (3.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (3.40e-3)" "unprognostic (1.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.91e-3)" "unprognostic (8.73e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (1.15e-1)" 11.4 12.1 6.7 9.5 7.7 14.2 10.8 7.7 8.5 20.4 8.1 12.0 9.3 17.1 10.0 12.8 9.0 12.9 19.7 7.1 7.5 9.7 6.8 10.2 9.5 7.0 7.5 12.4 14.7 19.4 10.2 10.5 7.6 17.8 12.4 11.8 22.8 11.0 14.0 12.9 10.1 14.4 6.3 9.0 11.7 8.6 7.5 6.2 20.3 15.4 10.4 10.5 16.7 9.4 39.3 14.9 16.1 15.1 14.7 16.2 12.6 27.0 28.2 11.7 20.5 12.0 17.5 7.9 14.9 27.0 26.5 15.5 10.7 16.0 18.2 23.5 9.6 8.7 9.9 15.1 17.4 18.8 19.0 15.4 15.3 20.4 24.0 32.1 31.7 17.1 16.6 25.1 21.5 18.5 19.2 17.8 5.9 30.0 19.1 6.8 13.6 18.6 13.6 17.9 7.6 21.8 16.6 27.2 31.2 23.8 6.2 12.2 36.6 12.6 16.0 39.7 17.2 16.3 16.9 17.3 24.2 21.0 33.9 9.4 6.6 7.5 6.1 7.6 8.4 6.0 7.7 6.9 5.4 5.8 6.4 6.4 3.4 5.1 9.3 3.7 6.5 5.9 6.7 7.7 7.7 8.5 7.1 7.5 7.0 7.5 7.6 6.3 7.5 9.4 14.8 3.2 15.5 124.4 21.7 12.2 15.0 11.1 24.5 23.2 10.0 7.7 27.6 7.2 16.5 14.7 33.3 10.2 16.5 15.8 1.9 10.5 22.6 11.8 21.8 11.0 10.3 5.9 147.0 10.9 8.5 14.4 14.8 19.8 3.8 12.3 9.7 5.8 11.3 11.8 196.1 36.2 18.3 14.8 12.3 22.1 11.8 15.3 12.4 147.1 15.7 9.0 11.3 136.7 183.2 10.8 10.1 12.4 20.7 20.6 14.5 6.5 16.3 17.4 26.3 15.4 10.2 18.2 14.0 19.0 13.4 10.5 18.9 7.5 14.9 16.1 COG6 "COD2, KIAA1134" ENSG00000133103 "Component of oligomeric golgi complex 6" Q9Y2V7 13 39655627-39791665 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 123.1;Inhibitory neurons: 99.9;Oligodendrocyte precursor cells: 82.9;Oligodendrocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040410, HPA040441" Uncertain Approved "Nuclear speckles,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles, Golgi apparatus" "HPA040410: AB_10793964, HPA040441: AB_10794030" "unprognostic (2.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.85e-2)" "unprognostic (1.05e-2)" "unprognostic (4.81e-2)" "unprognostic (4.99e-2)" "unprognostic (6.81e-2)" "unprognostic (9.59e-2)" "unprognostic (3.66e-2)" "unprognostic (1.14e-1)" "unprognostic (9.07e-2)" "unprognostic (1.62e-1)" "unprognostic (6.60e-3)" "prognostic favorable (2.81e-4)" "unprognostic (4.87e-2)" "unprognostic (2.14e-1)" "unprognostic (2.24e-1)" 8.7 10.5 2.1 7.9 3.8 2.1 9.7 5.3 5.8 12.0 5.0 9.3 10.5 9.2 4.4 10.6 9.9 10.5 15.8 5.5 2.6 9.8 8.9 6.8 8.3 2.1 2.3 14.2 19.0 18.3 13.3 13.7 3.2 13.0 8.4 7.2 13.0 8.8 6.4 10.1 9.7 7.7 1.7 8.0 12.5 16.4 2.1 8.8 14.0 8.5 7.7 10.2 6.4 6.1 10.8 7.0 10.8 7.7 21.0 26.5 20.6 17.0 24.1 14.2 17.4 8.6 16.8 18.2 9.6 24.7 16.7 13.5 11.5 12.9 15.1 21.5 16.1 17.7 7.0 12.5 12.0 17.9 18.1 11.2 15.9 8.9 10.0 17.8 13.9 16.5 7.5 6.8 23.1 11.0 13.4 16.5 10.6 30.2 8.9 12.8 29.3 8.8 10.0 13.6 6.3 8.2 15.4 12.8 13.0 14.8 14.9 11.2 20.7 7.9 9.3 17.6 8.5 5.3 5.5 13.6 23.4 9.5 23.6 3.0 3.2 4.0 3.8 5.0 6.6 4.7 4.9 5.3 4.5 4.4 4.1 5.4 0.7 7.1 3.1 2.5 6.4 4.2 2.1 3.8 5.3 5.8 5.5 2.6 2.1 2.3 3.2 1.7 2.1 6.1 8.7 19.2 7.8 46.0 12.6 9.7 5.9 9.5 8.0 15.2 11.0 8.4 22.0 2.8 10.2 12.9 10.4 15.6 9.5 9.9 5.9 7.7 23.4 13.9 14.8 8.5 9.1 9.5 123.1 10.0 29.6 12.3 10.7 13.0 10.1 9.7 12.1 9.6 8.6 5.0 99.9 19.8 8.2 6.7 3.9 12.6 13.4 7.6 1.8 37.5 5.9 15.5 7.2 82.9 89.4 8.7 10.8 12.8 17.7 5.0 10.2 12.4 13.2 12.5 6.6 12.2 9.7 39.0 27.4 11.9 13.4 16.0 10.3 12.6 10.3 5.7 COMMD10 PTD002 ENSG00000145781 "COMM domain containing 10" Q9Y6G5 5 116085016-116412762 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 184.6;Oligodendrocyte precursor cells: 142.7;Oligodendrocytes: 236.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045441, HPA054156" Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA045441: AB_10961905, HPA054156: " "unprognostic (1.14e-1)" "unprognostic (2.15e-2)" "unprognostic (5.38e-2)" "unprognostic (5.72e-2)" "unprognostic (1.79e-1)" "unprognostic (5.72e-3)" "unprognostic (2.12e-2)" "unprognostic (1.51e-1)" "unprognostic (3.02e-2)" "unprognostic (2.64e-1)" "unprognostic (2.07e-1)" "unprognostic (3.14e-1)" "unprognostic (1.84e-3)" "prognostic unfavorable (2.99e-4)" "unprognostic (9.47e-2)" "prognostic unfavorable (6.93e-4)" "unprognostic (1.59e-1)" 19.4 24.1 12.5 14.2 12.4 14.9 23.1 12.8 15.9 19.2 14.4 17.0 13.0 16.7 32.2 15.6 12.9 17.3 31.3 11.7 13.3 35.4 24.6 13.9 22.1 12.8 13.2 13.9 24.1 25.4 14.3 19.6 13.4 20.7 20.1 17.1 30.7 17.0 14.3 9.6 13.8 19.6 13.5 18.6 16.3 8.1 13.2 16.3 27.4 17.5 20.3 18.0 13.6 14.7 34.7 36.7 37.5 20.0 27.3 37.1 40.2 26.5 30.0 37.5 31.0 29.2 43.7 17.9 29.0 37.9 75.0 18.6 20.8 42.6 56.9 49.3 14.6 22.1 10.7 22.9 30.8 17.5 37.1 23.7 28.7 22.4 29.2 31.1 37.9 25.2 13.6 12.1 50.2 24.2 32.9 41.9 32.7 26.8 16.9 30.9 40.1 51.2 54.7 21.8 20.2 26.0 31.3 30.5 39.7 28.1 34.6 64.1 20.9 31.5 38.5 15.3 46.0 11.9 16.3 45.8 32.1 63.2 36.5 13.6 24.6 18.3 9.9 29.7 13.7 16.2 12.9 12.8 32.7 11.3 12.5 13.0 4.7 22.7 31.0 24.9 15.3 18.9 12.5 12.4 12.8 15.9 11.7 13.3 12.8 13.2 13.4 13.5 13.2 14.7 25.7 9.6 20.0 97.3 36.7 22.2 30.4 54.0 17.6 15.7 28.1 18.3 48.9 11.5 29.5 23.9 6.2 44.9 16.9 11.5 92.0 26.2 1.9 15.8 22.2 24.0 10.7 18.5 84.8 15.1 53.4 25.0 27.0 22.8 46.3 22.5 26.4 15.1 48.7 16.8 90.5 25.1 46.8 28.7 38.4 3.7 21.1 33.1 32.0 184.6 27.1 30.2 15.5 142.7 236.7 17.1 17.2 20.3 30.6 33.1 17.3 101.3 10.4 20.9 0.0 13.4 22.4 8.7 15.6 20.5 25.1 49.5 28.4 36.3 25.5 32.0 COMTD1 FLJ23841 ENSG00000165644 "Catechol-O-methyltransferase domain containing 1" Q86VU5 10 75233641-75236030 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 128.6" "Cell type enhanced" "Detected in many" "Distal enterocytes: 334.8;Exocrine glandular cells: 249.5;Paneth cells: 272.5;Proximal enterocytes: 435.9;Squamous epithelial cells: 285.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 30.2;PC-3: 38.3;RPMI-8226: 24.5;U-266/70: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042165 Approved Approved "Golgi apparatus,Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "Plasma membrane, Cytosol" "HPA042165: AB_10794042" "unprognostic (2.53e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (9.07e-2)" "unprognostic (2.44e-1)" "unprognostic (1.36e-1)" "unprognostic (1.03e-1)" "unprognostic (1.90e-1)" "unprognostic (3.23e-2)" "unprognostic (8.08e-3)" "unprognostic (9.35e-2)" "unprognostic (6.74e-2)" "prognostic favorable (1.88e-4)" "unprognostic (1.33e-1)" "unprognostic (1.73e-1)" "unprognostic (1.12e-1)" "unprognostic (2.35e-1)" 11.0 17.9 1.1 1.0 1.5 1.5 9.8 1.2 1.8 18.3 5.8 23.3 7.4 7.5 0.4 70.6 7.2 0.4 33.5 1.3 1.7 29.1 37.5 11.7 0.6 1.7 2.0 8.0 128.6 3.4 17.1 0.9 1.7 11.8 1.0 1.1 23.9 1.0 28.2 25.3 25.2 0.5 1.1 12.4 27.8 3.4 1.6 0.5 18.5 0.7 0.7 8.3 29.0 0.9 6.9 2.2 0.5 1.3 0.1 0.7 19.0 2.1 1.0 0.3 0.6 1.6 6.0 20.0 3.5 0.4 1.1 9.0 0.9 1.9 0.1 3.2 30.2 0.8 4.8 3.3 1.1 3.5 3.3 0.6 3.2 0.1 2.9 1.3 0.3 3.6 7.8 4.7 0.1 6.2 5.3 11.0 1.2 5.1 38.3 10.6 1.3 24.5 1.8 0.6 8.4 2.3 2.4 16.0 4.8 0.5 8.9 0.5 1.4 0.6 5.9 1.2 2.1 21.5 4.5 9.8 0.7 3.4 0.6 0.0 7.1 3.9 10.6 10.0 11.6 7.1 10.6 11.0 8.5 5.6 3.5 6.1 1.4 7.3 9.4 15.3 8.9 6.8 1.1 1.5 1.2 1.8 1.3 1.7 1.7 2.0 1.7 1.1 1.6 0.9 23.6 19.2 11.5 1.6 18.2 29.4 40.5 54.1 133.1 6.0 29.3 37.1 31.1 57.2 33.8 53.3 10.4 33.4 30.8 334.8 144.8 162.8 1.6 10.5 7.7 13.5 40.2 16.0 3.4 249.5 79.1 13.4 148.8 33.4 12.7 10.3 25.4 84.0 35.1 1.7 3.9 206.0 42.7 24.2 21.3 3.5 9.6 21.8 37.4 6.5 31.8 10.7 24.7 1.5 0.5 109.2 272.5 7.2 50.8 38.7 435.9 140.3 11.3 34.5 32.9 6.2 25.6 2.6 3.4 285.3 38.2 30.4 29.2 10.7 143.8 56.7 COPB1 COPB ENSG00000129083 "COPI coat complex subunit beta 1" P53618 11 14443440-14500027 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012338, HPA043954, HPA064403" Supported Enhanced "Golgi apparatus,Vesicles,Cytosol" NA NA 330000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles, Cytosol" "CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258" "unprognostic (2.35e-1)" "unprognostic (1.02e-3)" "unprognostic (1.36e-2)" "unprognostic (4.76e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (6.91e-4)" "prognostic unfavorable (5.63e-7)" "unprognostic (4.69e-3)" "unprognostic (3.42e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (8.94e-2)" "unprognostic (1.78e-2)" "unprognostic (3.02e-2)" "unprognostic (8.00e-2)" "unprognostic (3.87e-1)" "unprognostic (1.69e-2)" 48.1 47.1 19.9 55.0 21.8 79.8 62.6 26.2 25.3 64.9 44.7 59.8 57.7 52.6 69.3 46.7 49.2 54.9 43.7 20.1 23.6 65.3 73.6 49.9 59.1 24.2 21.8 49.1 59.2 67.6 48.4 69.2 23.7 66.9 67.1 39.3 67.5 53.8 33.1 36.6 58.8 61.1 23.5 46.3 59.7 46.8 23.0 68.1 81.0 38.1 64.5 60.4 40.0 27.6 134.9 113.6 118.6 89.4 193.1 221.3 95.9 199.2 206.5 173.1 202.0 89.1 203.5 130.1 87.1 252.9 164.6 144.7 134.6 133.3 212.1 122.7 114.0 138.3 74.3 135.8 171.3 128.9 134.4 156.3 172.4 116.0 217.8 158.9 183.7 71.6 104.5 103.8 221.1 101.6 117.2 78.7 61.7 163.3 123.1 94.9 163.1 89.0 156.1 123.3 75.6 81.2 154.2 123.2 104.8 135.5 112.3 110.1 189.5 166.2 85.4 181.3 110.1 55.2 100.5 143.8 125.1 79.2 158.6 52.8 38.7 43.5 45.7 47.8 55.7 38.4 38.1 47.6 52.3 32.0 37.8 39.8 31.2 44.6 49.8 31.1 44.8 43.2 19.9 21.8 26.2 25.3 20.1 23.6 24.2 21.8 23.7 23.5 23.0 27.6 55.6 109.0 63.2 29.0 64.3 38.9 59.7 82.6 52.3 28.4 43.0 27.9 31.3 35.8 107.8 44.1 27.1 65.4 71.2 55.9 41.1 77.1 17.2 72.6 81.4 55.5 43.8 50.9 36.9 81.7 69.6 70.5 63.2 72.5 65.2 50.7 51.4 58.1 60.9 18.5 39.1 87.5 61.1 50.7 43.5 10.7 51.0 61.5 21.4 35.6 70.1 34.0 44.3 32.6 49.6 93.6 37.5 55.3 107.4 54.3 60.6 57.3 131.9 29.5 52.6 60.8 78.7 87.5 64.3 48.7 35.8 117.0 77.0 49.3 51.5 60.7 COPB2 "beta'-COP, betaprime-COP" ENSG00000184432 "COPI coat complex subunit beta 2" P35606 3 139353946-139389736 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036867, HPA058180" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA 63000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "Golgi apparatus" "HPA036867: AB_10672271, HPA058180: AB_2683630" "unprognostic (3.37e-2)" "unprognostic (2.04e-1)" "unprognostic (9.38e-2)" "unprognostic (6.93e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.41e-7)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (8.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.44e-2)" "unprognostic (1.14e-1)" "unprognostic (6.05e-2)" "unprognostic (4.95e-2)" 46.7 58.2 17.9 50.5 19.7 22.3 60.4 20.4 21.0 76.5 35.9 62.5 57.4 48.5 62.5 55.0 47.5 48.4 47.9 17.4 21.8 52.9 71.1 44.3 44.8 20.5 18.9 38.9 89.7 68.2 60.0 68.9 20.4 72.2 71.7 37.0 71.1 57.0 33.5 37.4 53.4 63.5 20.8 42.8 60.7 35.0 20.2 54.4 64.3 31.2 61.5 56.2 42.2 25.0 192.1 84.0 111.2 99.0 247.2 214.9 96.8 223.9 235.9 158.2 204.7 143.4 83.5 90.2 203.0 287.1 145.1 110.9 136.2 141.0 210.6 139.0 85.2 138.2 114.9 152.3 152.7 121.9 139.7 160.1 114.7 132.2 138.5 178.6 161.6 76.5 86.7 105.7 199.4 138.6 59.4 59.7 102.2 215.0 99.5 75.8 93.6 149.5 141.2 133.4 85.2 61.7 254.6 212.0 147.2 168.6 193.2 123.2 185.1 90.3 66.4 122.8 83.7 148.0 80.8 129.7 115.2 61.0 138.0 74.4 49.8 52.0 36.0 56.3 35.8 35.3 31.0 37.6 57.7 23.8 24.2 31.1 45.0 44.1 57.2 30.2 38.1 44.2 17.9 19.7 20.4 21.0 17.4 21.8 20.5 18.9 20.4 20.8 20.2 25.0 36.6 57.7 46.6 18.3 45.8 19.6 39.5 61.2 29.6 38.0 41.3 29.3 58.5 32.9 74.5 20.2 31.3 83.3 34.9 52.4 41.1 83.4 40.8 64.9 62.9 45.2 63.9 51.1 25.1 82.1 76.1 66.6 75.4 54.8 45.0 50.4 36.4 48.5 52.7 42.1 25.5 86.7 46.8 34.6 21.3 8.6 54.7 42.8 21.4 13.1 60.1 62.0 29.9 20.1 30.8 79.7 34.8 50.0 118.6 46.6 46.9 42.4 108.6 51.1 19.7 47.3 69.6 83.1 45.6 36.5 14.9 133.1 37.5 74.4 44.7 52.9 COPG1 COPG ENSG00000181789 "COPI coat complex subunit gamma 1" Q9Y678 3 129249606-129277773 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037866, HPA037867, HPA045712" Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" No No 57000 "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: AB_2679428" "unprognostic (8.86e-2)" "unprognostic (2.22e-2)" "unprognostic (4.22e-3)" "unprognostic (1.15e-1)" "unprognostic (1.81e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (1.22e-6)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (5.64e-2)" "unprognostic (8.90e-3)" "unprognostic (3.29e-1)" "unprognostic (1.23e-3)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (2.99e-1)" "unprognostic (1.60e-1)" 84.7 111.0 66.6 59.0 68.2 59.4 79.8 69.5 80.7 100.4 93.0 107.6 86.7 75.5 157.4 86.8 70.0 53.8 95.5 70.3 73.7 82.7 149.5 84.4 54.8 74.3 71.5 77.9 162.4 96.3 139.0 81.9 77.4 107.7 109.8 33.4 130.7 72.7 75.7 74.4 86.7 72.2 66.4 81.9 114.0 46.5 73.2 53.5 83.3 43.2 67.1 67.2 72.2 73.2 167.8 83.2 119.1 104.0 272.8 219.0 126.9 266.3 251.8 179.5 225.2 153.9 101.2 91.1 150.8 380.7 145.6 98.4 99.5 157.2 193.6 112.0 41.4 151.9 103.2 252.6 247.9 116.4 156.4 230.9 135.6 143.8 235.0 196.1 164.3 68.9 54.2 213.6 219.2 253.4 68.7 117.7 71.3 243.6 100.9 73.3 111.8 178.3 227.3 136.7 74.1 86.1 204.2 150.3 255.9 129.8 167.1 167.6 223.9 96.9 91.7 207.2 104.2 165.7 86.1 158.9 236.4 86.9 190.0 79.1 49.9 37.2 44.1 59.2 53.6 24.9 39.8 43.9 57.0 26.9 30.0 36.2 37.2 57.0 57.3 52.2 43.8 56.2 66.6 68.2 69.5 80.7 70.3 73.7 74.3 71.5 77.4 66.4 73.2 73.2 16.6 16.0 31.5 7.8 19.2 8.8 16.9 35.4 12.0 9.2 18.9 8.6 23.3 17.2 34.6 27.6 4.2 55.6 19.7 77.0 43.0 44.5 10.4 26.2 27.7 22.8 38.6 22.9 14.1 46.5 63.1 32.5 53.0 36.9 15.2 28.6 28.9 56.5 39.0 5.0 14.8 75.1 22.4 31.2 14.8 4.7 41.0 21.6 23.2 7.5 36.5 12.7 18.6 4.5 11.8 40.8 44.6 31.2 68.4 24.4 64.5 39.5 32.6 7.1 19.7 20.2 33.3 24.3 17.0 16.4 10.2 72.2 19.4 27.7 44.6 20.6 COPZ1 "CGI-120, COPZ" ENSG00000111481 "COPI coat complex subunit zeta 1" P61923 12 54301202-54351846 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 70000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "prognostic unfavorable (7.84e-4)" "unprognostic (2.79e-1)" "unprognostic (4.51e-1)" "unprognostic (7.54e-3)" "unprognostic (1.46e-1)" "unprognostic (2.80e-2)" "prognostic unfavorable (6.40e-5)" "unprognostic (1.02e-2)" "unprognostic (3.56e-2)" "unprognostic (7.44e-3)" "unprognostic (1.18e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (7.45e-5)" "unprognostic (2.16e-1)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (3.41e-2)" 75.1 101.1 70.7 51.0 71.9 58.2 95.3 70.8 86.4 85.8 84.6 83.7 74.1 73.1 125.3 107.0 90.2 55.8 104.0 70.8 71.9 105.1 115.4 74.0 68.4 69.6 70.8 73.0 151.3 106.5 105.7 83.5 69.9 76.1 102.6 104.2 104.9 68.7 104.4 76.0 68.5 79.2 70.9 74.9 89.4 35.9 72.0 96.2 115.3 90.3 93.8 73.2 68.7 73.8 135.4 212.1 149.8 133.2 179.8 234.7 96.5 109.3 166.9 149.9 110.6 122.9 185.5 103.1 180.6 165.9 96.3 102.0 265.0 183.7 181.1 137.0 153.5 99.8 181.8 190.6 183.9 133.3 89.9 172.8 250.0 183.2 294.8 257.5 206.8 103.2 221.7 202.1 199.7 177.3 158.7 141.5 109.2 204.2 160.0 121.8 96.4 145.8 225.7 123.5 140.3 112.5 113.2 197.7 147.2 139.6 274.7 210.0 131.7 92.0 96.8 90.7 108.0 82.6 112.1 100.7 172.5 110.4 164.9 97.5 127.3 95.0 93.6 117.7 100.3 86.4 86.2 84.8 128.0 86.2 69.9 75.2 42.9 114.7 134.6 151.6 116.7 134.7 70.7 71.9 70.8 86.4 70.8 71.9 69.6 70.8 69.9 70.9 72.0 73.8 54.3 57.7 73.3 15.3 64.4 28.7 71.9 137.9 47.8 51.0 91.6 72.0 77.2 68.6 105.7 68.0 22.9 175.3 73.3 62.5 273.9 152.2 19.8 66.8 73.6 58.1 66.9 58.5 13.5 115.6 273.9 73.8 63.7 74.5 87.5 100.9 50.7 95.1 173.1 48.8 15.4 141.4 85.5 64.3 42.6 25.4 62.7 78.8 53.4 7.5 150.5 86.3 76.2 14.6 13.7 113.9 74.0 57.2 132.5 100.9 118.0 208.0 92.8 75.4 19.7 35.8 57.1 64.2 60.2 66.6 35.9 202.2 62.0 99.8 87.5 95.3 CRB3 MGC17303 ENSG00000130545 "Crumbs cell polarity complex component 3" Q9BUF7 19 6463777-6467221 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 54.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 160.9;Pancreatic endocrine cells: 149.9;Paneth cells: 177.3;Suprabasal keratinocytes: 139.5;Urothelial cells: 243.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 9.2" "Group enriched" "Detected in many" 20 "B-cells: 3.1;T-cells: 9.2" "Cell line enhanced" "Detected in some" "A-431: 57.9;BEWO: 35.1;CACO-2: 38.1;HaCaT: 36.9;hTCEpi: 27.8;OE19: 33.1;SK-BR-3: 29.5;T-47d: 25.8" "Low region specificity" "Detected in many" HPA013835 Enhanced Supported "Cell Junctions" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cell Junctions" "HPA013835: AB_1847214" "unprognostic (3.25e-1)" "unprognostic (4.41e-2)" "unprognostic (9.69e-2)" "prognostic favorable (4.54e-4)" "unprognostic (1.24e-1)" "unprognostic (1.95e-2)" "unprognostic (2.81e-1)" "unprognostic (1.03e-2)" "unprognostic (1.86e-1)" "unprognostic (2.57e-2)" "unprognostic (4.98e-2)" "unprognostic (1.11e-1)" "prognostic favorable (0.00e+0)" "unprognostic (8.42e-3)" "unprognostic (1.96e-1)" "unprognostic (1.12e-2)" "prognostic favorable (8.06e-5)" 0.8 0.4 0.3 4.0 0.7 0.3 5.1 1.2 0.5 9.3 6.1 26.9 36.9 2.2 4.6 54.5 8.2 8.2 0.3 0.3 0.2 34.1 32.5 19.0 0.9 0.4 0.2 0.4 44.0 20.7 15.9 3.5 0.5 9.1 10.5 0.4 24.8 8.9 0.1 41.9 30.6 0.5 0.1 0.8 31.1 0.4 0.2 0.8 16.2 0.0 5.4 6.4 17.6 0.5 57.9 7.0 0.0 0.2 0.0 0.1 35.1 0.0 0.0 0.0 0.0 38.1 23.8 0.3 22.1 0.0 0.3 36.9 0.4 12.5 0.0 0.0 0.4 0.1 0.2 21.5 0.0 0.1 0.1 0.0 27.8 0.0 0.0 0.0 0.1 0.5 0.1 0.5 0.0 15.1 0.2 0.4 1.3 33.1 0.0 0.0 0.0 0.7 16.5 24.0 0.0 0.1 0.2 29.5 0.1 1.7 25.8 0.2 0.0 0.1 0.4 0.2 0.1 0.7 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.3 3.1 4.6 2.2 0.0 1.0 9.2 3.6 0.3 0.0 0.0 0.0 3.4 1.9 0.3 0.7 1.2 0.5 0.3 0.2 0.4 0.2 0.5 0.1 0.2 0.5 0.2 35.3 38.0 0.0 2.2 72.1 64.6 81.3 21.1 0.0 43.6 19.9 0.3 71.4 64.0 31.3 0.0 28.1 0.9 160.9 46.9 113.0 0.0 43.8 4.0 1.8 16.8 3.2 0.1 101.5 9.8 2.0 34.7 58.3 1.3 0.1 0.4 31.8 2.5 0.0 0.0 60.2 63.1 1.0 6.2 0.0 0.0 1.3 7.2 0.0 2.7 0.9 0.0 0.0 0.1 149.9 177.3 0.0 3.1 94.4 86.8 44.5 36.3 0.5 0.0 0.0 4.2 1.1 0.4 45.0 139.5 56.2 3.2 0.2 52.0 243.6 CRELD2 MGC11256 ENSG00000184164 "Cysteine rich with EGF like domains 2" Q6UXH1 22 49918167-49927540 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 349.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000603, CAB025604" Approved "Intracellular and membrane" NA NA 480000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" "CAB025604: , HPA000603: AB_1078565" "unprognostic (1.12e-1)" "unprognostic (7.35e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.42e-7)" "unprognostic (5.04e-2)" "unprognostic (5.43e-2)" "unprognostic (3.21e-3)" "unprognostic (2.71e-1)" "unprognostic (3.60e-1)" "unprognostic (1.24e-1)" "unprognostic (2.57e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (1.34e-9)" "unprognostic (6.13e-2)" "unprognostic (3.01e-1)" "unprognostic (7.30e-2)" "unprognostic (4.02e-1)" 29.0 28.5 17.7 25.8 20.6 18.1 24.1 19.3 20.1 25.4 19.2 29.6 26.4 31.5 41.8 26.6 28.2 13.6 33.0 18.3 21.4 26.7 97.8 31.5 19.1 22.1 19.9 23.5 123.3 13.0 65.5 14.4 21.5 27.3 16.4 7.7 39.5 17.1 15.8 17.0 26.8 15.8 19.0 40.3 46.0 43.2 24.9 15.4 67.4 7.6 15.2 27.1 21.3 21.9 37.5 25.5 29.3 96.6 30.6 34.6 39.1 76.4 46.0 41.9 35.5 44.7 44.0 20.4 59.6 66.2 42.3 36.4 37.1 38.3 18.0 11.0 60.1 11.2 37.3 55.8 126.1 44.1 41.4 31.8 33.6 36.4 30.6 29.5 42.9 21.8 16.5 79.5 31.8 119.3 17.2 46.2 21.1 73.9 54.7 41.1 51.9 46.4 20.3 33.6 19.0 53.5 64.9 75.2 32.0 19.3 30.8 51.8 32.7 35.5 59.2 33.1 23.9 65.4 16.9 17.9 52.6 32.5 57.3 33.5 12.4 17.2 17.2 14.9 17.7 29.2 14.9 23.2 13.7 28.1 12.4 10.2 6.4 35.4 8.9 52.2 11.3 12.9 17.7 20.6 19.3 20.1 18.3 21.4 22.1 19.9 21.5 19.0 24.9 21.9 42.4 6.4 16.1 12.7 82.6 32.8 34.4 49.0 10.2 34.7 35.3 34.2 17.7 31.5 39.6 9.2 25.0 32.4 65.6 45.6 7.9 41.2 112.5 28.4 41.5 32.2 39.9 12.4 9.7 63.2 120.5 56.8 50.4 37.0 36.2 27.0 47.2 63.9 74.6 25.2 10.9 136.3 26.4 25.7 47.0 25.8 44.1 33.8 96.0 6.5 27.8 41.7 80.3 9.5 16.2 51.2 35.1 41.3 349.6 82.4 28.2 16.6 37.4 32.0 13.1 25.7 39.7 143.5 104.8 21.6 30.7 55.1 53.0 41.0 55.7 43.8 CTBS CTB ENSG00000117151 Chitobiase Q01459 1 84549611-84574480 "Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Low region specificity" "Detected in all" "Region enriched" "Detected in some" 7 "basal ganglia: 7.4" "CAB017043, HPA023594, HPA048810" Approved Uncertain Cytosol "Intracellular and membrane" NA NA 370000000 "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol "CAB017043: , HPA023594: AB_1847311, HPA048810: " "unprognostic (7.76e-2)" "unprognostic (1.28e-2)" "unprognostic (1.11e-1)" "unprognostic (1.36e-1)" "unprognostic (9.36e-2)" "unprognostic (3.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.76e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (9.23e-2)" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.08e-2)" "unprognostic (4.89e-2)" "unprognostic (3.12e-1)" "unprognostic (4.04e-2)" 1.5 1.4 0.4 1.4 0.8 3.3 1.6 1.0 0.6 1.2 2.1 1.2 0.9 1.5 3.1 1.0 1.1 1.2 1.0 0.2 0.6 1.7 3.7 1.4 1.6 1.3 0.9 0.8 1.7 1.6 0.5 1.2 1.5 2.2 1.4 1.4 3.3 0.8 0.8 2.4 1.2 1.1 0.5 2.5 1.4 0.5 0.8 1.0 1.3 0.9 1.0 1.0 0.5 1.3 0.9 0.3 0.2 0.2 2.7 3.2 0.6 0.6 2.2 0.3 0.8 0.1 1.1 1.2 0.2 1.4 0.3 0.4 0.0 0.9 0.9 1.1 0.3 0.8 0.1 0.1 1.6 0.8 0.4 2.4 1.6 0.8 1.2 1.9 0.9 0.5 0.7 2.2 0.6 0.0 0.5 0.9 0.2 0.2 0.3 0.2 0.3 0.8 1.9 0.4 0.1 0.4 0.2 0.9 1.1 0.5 0.5 0.9 1.5 1.1 0.1 1.5 0.7 0.6 0.2 0.3 0.8 1.1 0.8 0.5 0.1 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.1 0.3 0.1 0.0 0.0 0.4 0.8 1.0 0.6 0.2 0.6 1.3 0.9 1.5 0.5 0.8 1.3 43.6 9.6 23.4 10.4 37.4 30.3 30.2 28.0 34.1 5.9 33.1 15.6 5.8 31.5 25.5 23.9 41.7 26.8 25.4 30.2 43.0 20.2 3.3 24.1 24.4 29.9 23.0 14.1 6.2 19.2 24.2 28.1 25.0 19.4 43.8 9.7 49.6 70.8 48.2 3.3 4.3 18.9 16.2 75.5 27.9 3.7 21.1 58.8 7.2 20.6 56.5 21.8 18.6 5.5 9.0 19.1 25.2 24.5 59.8 36.7 30.0 44.4 38.2 41.9 13.1 20.2 16.6 10.4 12.8 27.3 24.7 25.6 26.8 25.3 18.4 29.9 CTPS1 "CTPS, GATD5" ENSG00000171793 "CTP synthase 1" P17812 1 40979688-41012565 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 73.4" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017111, HPA051322" Enhanced Approved "Actin filaments,Cytosol" NA Yes 150000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Cytosol "Actin filaments" "CAB017111: , HPA051322: AB_2681441" "unprognostic (6.60e-2)" "unprognostic (4.44e-2)" "unprognostic (3.21e-2)" "unprognostic (2.00e-3)" "unprognostic (2.14e-1)" "unprognostic (8.37e-2)" "unprognostic (1.42e-2)" "unprognostic (9.72e-3)" "unprognostic (1.94e-3)" "unprognostic (1.01e-1)" "unprognostic (2.04e-2)" "unprognostic (8.93e-3)" "unprognostic (1.09e-1)" "unprognostic (8.21e-3)" "unprognostic (1.34e-1)" "unprognostic (4.49e-1)" "unprognostic (1.89e-2)" 9.1 8.1 4.8 11.1 4.7 6.8 6.7 4.0 5.8 9.3 7.9 8.7 4.4 23.6 5.7 14.9 11.1 10.6 5.3 4.9 5.3 12.4 73.4 7.6 12.4 4.6 4.9 3.4 4.7 47.6 0.0 7.8 5.8 13.5 12.0 2.4 50.6 24.8 7.7 4.6 8.4 51.9 4.7 5.0 4.1 14.7 4.9 17.3 4.8 7.6 17.8 17.7 0.3 5.0 77.8 68.5 95.3 60.5 22.9 30.9 138.5 138.8 57.0 141.2 92.0 131.5 66.6 149.8 55.6 61.7 39.4 38.6 91.5 97.0 139.5 66.5 78.0 87.3 72.3 43.3 87.8 128.0 56.8 34.0 49.2 148.5 103.0 23.0 64.1 102.2 84.7 51.5 99.4 42.9 125.0 38.1 126.8 66.4 81.3 100.9 120.0 93.7 71.4 69.4 118.4 61.7 79.2 77.7 33.9 90.8 30.1 152.9 53.5 78.2 119.6 61.7 167.2 36.8 50.8 134.5 59.8 84.5 97.4 0.0 3.5 0.0 3.6 6.5 5.7 5.2 4.1 4.3 11.0 4.0 3.7 6.1 0.0 6.9 5.9 11.9 6.3 3.4 4.8 4.7 4.0 5.8 4.9 5.3 4.6 4.9 5.8 4.7 4.9 5.0 5.4 6.4 18.4 4.9 10.9 8.0 14.3 9.1 9.6 12.5 4.6 4.7 5.7 21.5 7.0 5.5 6.2 15.4 26.4 2.2 1.9 19.2 32.4 4.7 10.8 8.5 3.0 22.5 14.1 17.2 26.4 8.7 7.1 7.3 1.3 15.8 2.2 29.0 11.0 11.8 18.7 3.4 6.1 2.8 6.2 27.9 10.8 6.8 1.8 7.5 8.7 5.4 7.2 7.1 10.3 19.3 1.1 24.8 15.1 19.3 25.2 12.8 2.8 4.3 39.5 9.3 17.5 11.1 40.6 11.8 7.4 5.6 9.9 20.7 5.8 7.3 CYB561D2 "101F6, TSP10" ENSG00000114395 "Cytochrome b561 family member D2" O14569 3 50350845-50358460 "Enzymes, Predicted membrane proteins" "Electron transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071862 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA071862: " "unprognostic (4.89e-2)" "unprognostic (3.25e-1)" "unprognostic (2.02e-1)" "unprognostic (6.98e-2)" "unprognostic (5.15e-2)" "unprognostic (2.72e-2)" "unprognostic (2.28e-3)" "unprognostic (2.47e-2)" "unprognostic (1.76e-1)" "unprognostic (5.41e-2)" "prognostic favorable (1.86e-4)" "unprognostic (3.26e-1)" "prognostic favorable (6.16e-5)" "unprognostic (4.33e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-1)" "unprognostic (7.57e-2)" 13.3 20.7 8.1 16.7 9.8 22.0 13.9 9.7 9.2 10.6 10.5 19.7 22.0 7.6 25.8 14.6 9.7 14.6 10.1 8.3 8.6 19.8 34.3 14.1 22.2 9.8 9.6 7.0 19.5 18.2 13.8 11.1 9.8 16.3 18.0 3.1 20.3 11.5 10.0 9.8 22.7 7.1 9.6 24.7 21.7 10.5 9.2 13.2 20.3 3.5 15.3 12.3 9.3 11.3 16.2 33.5 8.4 15.8 17.2 14.7 19.2 27.4 20.4 24.5 28.0 24.1 25.3 25.3 29.3 33.8 29.8 16.5 12.8 25.2 10.7 38.5 31.9 23.7 40.7 22.5 24.2 26.3 52.3 23.0 11.3 29.3 13.5 12.4 21.1 19.1 10.5 32.3 19.7 30.3 17.0 22.9 13.4 24.6 52.1 11.6 5.8 50.2 26.3 27.0 8.4 23.7 13.7 56.1 17.5 8.4 19.8 30.9 23.1 22.5 18.9 37.6 35.8 24.6 26.2 16.8 30.2 32.1 24.4 145.8 113.9 176.1 144.3 140.1 95.6 88.4 96.1 115.7 86.3 79.3 67.1 99.6 110.8 109.3 136.2 89.0 114.7 112.4 8.1 9.8 9.7 9.2 8.3 8.6 9.8 9.6 9.8 9.6 9.2 11.3 13.3 6.4 21.7 5.5 24.4 5.0 12.0 37.4 8.6 6.8 26.5 12.3 0.0 0.0 30.9 25.8 6.2 35.0 40.2 47.1 11.7 44.9 19.9 19.7 14.7 9.1 31.8 6.7 6.7 68.1 46.0 13.0 31.1 18.4 21.5 8.4 0.0 0.0 57.3 8.4 5.8 47.0 46.8 0.0 12.3 9.1 8.7 29.1 19.6 6.5 36.2 22.2 45.3 6.0 13.3 43.3 49.4 7.9 36.7 17.9 55.6 22.3 38.4 8.2 13.1 8.0 15.6 6.1 14.1 14.0 7.4 55.1 32.9 15.9 28.1 18.4 CYSTM1 "C5orf32, ORF1-FL49" ENSG00000120306 "Cysteine rich transmembrane module containing 1" Q9H1C7 5 140175156-140282052 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 1317.5" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2568.9;Gastric mucus-secreting cells: 2148.3;Late spermatids: 1327.7;Pancreatic endocrine cells: 1331.5;Proximal tubular cells: 1301.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 7 "neutrophil: 425.2" "Lineage enriched" "Detected in all" 7 "granulocytes: 425.2" "Cell line enhanced" "Detected in all" "OE19: 773.7;RPTEC TERT1: 364.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050930 Enhanced NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA050930: AB_2681278" "unprognostic (7.39e-2)" "unprognostic (3.68e-2)" "unprognostic (4.46e-2)" "prognostic favorable (1.31e-4)" "unprognostic (5.38e-2)" "unprognostic (1.63e-3)" "prognostic unfavorable (1.71e-4)" "unprognostic (2.26e-1)" "unprognostic (1.12e-1)" "unprognostic (2.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "prognostic favorable (9.69e-5)" "unprognostic (7.63e-2)" "unprognostic (2.23e-1)" "unprognostic (4.67e-2)" "unprognostic (1.14e-2)" 86.3 187.3 111.3 53.7 112.6 161.2 61.1 114.2 131.5 48.5 148.6 184.3 320.5 36.6 53.9 28.3 139.6 150.8 114.6 110.2 121.1 264.8 74.4 96.6 23.4 117.9 117.4 29.1 141.3 128.6 53.9 64.6 119.3 31.3 166.2 35.2 81.7 41.7 293.5 23.8 168.0 60.0 112.7 33.4 1317.5 35.7 116.4 31.7 87.2 360.0 20.9 158.1 21.9 112.5 68.5 118.8 10.1 65.8 152.5 118.2 51.0 26.7 77.1 34.5 67.8 142.0 115.1 28.4 92.2 44.8 180.1 42.8 55.7 70.8 27.5 54.3 74.6 2.7 50.4 92.3 119.1 9.1 63.5 31.4 92.2 42.2 77.0 62.7 67.5 91.1 48.7 68.4 8.2 66.2 31.4 16.6 16.4 773.7 44.5 7.0 12.4 51.4 364.9 284.0 25.4 16.6 45.8 28.8 280.6 33.3 96.9 27.0 16.0 17.0 17.1 12.8 31.8 62.5 48.6 26.4 87.9 8.9 32.8 15.6 32.4 22.4 4.3 37.3 8.1 18.2 11.5 7.2 41.3 14.4 3.1 4.8 425.2 4.5 39.1 64.0 17.2 16.4 111.3 112.6 114.2 131.5 110.2 121.1 117.9 117.4 119.3 112.7 116.4 112.5 259.9 317.3 115.2 34.6 52.8 169.5 525.6 252.8 51.2 5.6 85.5 77.8 107.2 424.7 186.1 573.8 2.1 422.8 42.8 1024.7 2568.9 674.9 444.3 469.0 60.8 147.8 435.8 47.4 10.6 846.6 53.6 174.0 2148.3 218.9 119.2 9.4 120.0 88.5 205.2 11.8 12.5 285.8 205.4 45.3 150.0 1327.7 101.5 77.1 394.8 13.1 105.5 153.3 3.1 4.5 11.1 1331.5 1148.5 116.6 37.4 365.1 727.1 1301.6 576.5 18.8 144.7 115.6 190.6 208.6 81.4 28.4 113.7 393.1 53.9 30.2 429.3 736.7 DAP ENSG00000112977 "Death associated protein" P51397 5 10679230-10761234 "Predicted intracellular proteins" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA029456 Uncertain Approved Nucleoplasm,Vesicles,Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 30: Mammary glandular cells - Lactation" "Vesicles, Mitochondria" Nucleoplasm "HPA029456: AB_10601262" "unprognostic (2.70e-2)" "unprognostic (3.48e-1)" "unprognostic (2.25e-1)" "unprognostic (1.88e-2)" "unprognostic (1.95e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (4.05e-2)" "unprognostic (1.19e-1)" "unprognostic (1.52e-3)" "unprognostic (3.50e-1)" "unprognostic (1.91e-2)" "unprognostic (3.03e-3)" "unprognostic (2.11e-1)" "unprognostic (2.39e-1)" "unprognostic (8.58e-3)" "unprognostic (2.04e-2)" 54.5 103.7 34.8 47.0 33.6 44.5 69.0 30.6 38.8 75.1 91.0 65.8 93.8 59.0 68.6 39.0 63.1 83.3 60.9 35.4 32.9 99.0 161.8 64.9 45.6 39.9 37.1 75.0 241.4 82.9 80.9 64.1 33.1 76.7 69.1 13.8 129.4 92.2 9.4 46.9 87.0 63.6 34.7 46.3 106.3 27.3 36.6 41.2 92.9 14.7 50.8 87.9 49.0 32.5 107.3 76.3 92.6 86.3 169.6 203.6 102.8 255.3 394.4 189.5 217.8 54.7 88.9 46.3 163.8 318.4 119.6 20.6 58.3 151.7 205.1 245.3 42.5 62.2 137.9 136.0 159.7 117.7 44.6 105.4 51.9 124.5 223.3 109.1 358.4 51.1 73.5 152.5 188.2 85.0 63.1 74.9 33.7 143.9 172.9 86.0 40.9 76.8 250.1 195.2 62.7 84.3 261.2 105.2 69.6 70.6 83.4 170.4 177.4 116.8 125.9 78.1 137.6 85.1 118.6 68.3 115.4 225.3 179.3 40.7 78.0 45.0 32.7 70.7 38.5 39.8 33.6 29.0 76.8 25.9 24.4 24.4 63.4 33.1 72.1 62.3 39.3 62.2 34.8 33.6 30.6 38.8 35.4 32.9 39.9 37.1 33.1 34.7 36.6 32.5 29.0 16.0 44.7 8.5 36.7 19.2 62.6 14.1 19.9 8.9 90.4 39.2 12.3 72.9 27.3 53.3 6.2 66.2 42.3 75.6 133.1 97.3 13.3 45.0 31.7 38.4 44.3 23.4 5.5 193.0 98.5 45.1 61.7 58.1 35.0 68.9 41.0 109.1 52.3 5.0 7.8 115.3 10.2 49.9 34.2 33.4 29.8 56.5 28.4 35.6 44.2 29.8 32.0 22.6 6.2 124.8 69.0 34.3 74.8 78.6 133.5 100.5 15.1 8.1 0.0 18.6 41.8 30.7 7.1 15.7 18.2 101.0 24.1 43.0 70.4 108.8 DAPK1 "DAPK, ROCO3" ENSG00000196730 "Death associated protein kinase 1" P53355 9 87497228-87708634 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Translation regulation" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 139.1;Excitatory neurons: 120.2;Inhibitory neurons: 155.9;Kupffer cells: 85.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 6.7;eosinophil: 8.7;intermediate monocyte: 14.0;myeloid DC: 4.8;non-classical monocyte: 15.2;plasmacytoid DC: 6.2" "Group enriched" "Detected in many" 56 "dendritic cells: 6.2;granulocytes: 8.7;monocytes: 15.2" "Cell line enhanced" "Detected in many" "HMC-1: 97.6;HUVEC TERT2: 56.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037302, HPA040472, HPA048436" Approved Approved Centrosome NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Centrosome "CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390" "unprognostic (2.55e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.75e-1)" "unprognostic (1.88e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-2)" "unprognostic (2.77e-3)" "unprognostic (8.31e-3)" "unprognostic (8.76e-2)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (1.09e-3)" 22.9 5.9 12.1 11.8 16.4 5.4 5.9 2.2 20.5 9.6 12.6 27.1 10.1 7.9 18.8 5.5 15.2 28.0 5.2 22.8 7.6 22.0 27.6 37.5 12.5 7.6 7.6 46.0 29.2 6.7 23.4 27.3 13.8 5.2 9.2 11.5 13.7 8.5 1.8 5.0 14.4 9.4 7.8 22.8 19.5 8.1 8.6 41.8 9.8 2.3 6.8 14.5 3.8 7.5 0.0 47.5 22.5 15.8 0.7 0.3 35.4 3.1 4.4 18.3 20.4 6.8 0.3 0.4 4.7 1.0 0.2 43.9 13.9 1.0 7.9 0.4 11.4 23.4 6.6 23.7 19.5 0.0 97.6 1.4 7.5 3.5 1.4 28.5 56.3 6.5 17.8 9.6 15.4 1.5 7.0 0.0 25.4 44.4 0.0 2.0 19.8 0.1 50.6 47.6 10.2 11.3 0.0 4.6 20.1 32.7 0.0 15.2 0.4 0.1 0.3 0.1 0.1 36.9 8.1 0.0 0.2 6.4 3.0 1.7 6.7 8.7 0.0 14.0 0.0 0.1 0.0 0.0 4.8 0.0 0.0 0.1 2.0 0.1 15.2 6.2 0.0 3.0 12.1 16.4 2.2 20.5 22.8 7.6 7.6 7.6 13.8 7.8 8.6 7.5 8.8 51.3 72.2 139.1 2.7 3.6 0.8 1.2 0.6 19.4 1.3 2.3 2.4 31.5 24.3 22.0 2.1 6.8 9.5 1.1 1.9 33.8 1.8 30.2 7.9 17.3 0.0 12.8 120.2 23.0 19.0 12.3 26.5 58.6 24.1 22.1 68.9 20.8 22.7 18.5 155.9 9.3 0.0 85.7 18.3 3.1 14.9 57.1 12.4 18.7 41.2 14.6 2.1 6.6 4.7 35.8 1.9 13.5 6.2 3.2 9.6 7.0 10.2 2.9 0.0 1.5 3.9 3.4 7.2 1.6 3.1 14.2 2.8 3.4 3.7 14.9 DCLRE1A "hSNM1, KIAA0086, PSO2, SNM1" ENSG00000198924 "DNA cross-link repair 1A" Q6PJP8 10 113834725-113854383 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036907 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm "Nucleoli fibrillar center" "HPA036907: AB_10673626" "unprognostic (1.22e-1)" "unprognostic (7.55e-2)" "unprognostic (4.84e-2)" "unprognostic (3.82e-2)" "unprognostic (1.09e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.74e-5)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-2)" "unprognostic (4.05e-2)" "unprognostic (2.85e-1)" "unprognostic (3.07e-1)" "unprognostic (6.34e-2)" 2.1 3.8 3.9 3.9 4.2 4.6 5.2 4.2 5.5 4.0 4.1 4.3 4.1 2.9 5.5 3.3 4.1 2.8 4.4 4.2 4.3 6.0 9.8 3.6 5.3 3.8 3.9 5.3 7.4 8.4 2.9 4.2 4.0 5.9 5.2 8.0 5.0 4.0 3.6 3.7 4.0 3.2 3.8 4.0 5.2 4.7 4.1 5.0 5.1 3.3 5.3 3.2 1.9 4.1 15.8 13.0 19.3 19.7 2.5 4.2 11.0 9.4 9.5 12.5 14.3 10.2 21.1 12.2 10.4 4.8 9.7 12.9 18.6 8.2 16.1 24.2 16.0 20.7 8.0 13.1 8.2 21.9 18.8 2.8 9.8 10.5 18.5 8.3 7.7 16.3 24.1 12.9 7.1 9.4 10.6 8.8 9.4 12.5 6.9 6.1 23.0 8.0 8.3 7.3 8.4 13.9 5.4 9.2 13.8 13.2 11.0 10.5 6.8 7.2 14.1 9.8 15.6 14.9 18.2 18.6 10.7 31.5 10.5 1.3 0.3 0.7 2.8 0.2 1.8 0.6 1.2 1.9 1.1 0.3 0.8 1.4 0.1 1.0 0.5 0.4 3.2 1.2 3.9 4.2 4.2 5.5 4.2 4.3 3.8 3.9 4.0 3.8 4.1 4.1 0.9 6.4 4.1 4.9 1.3 0.6 0.6 2.8 0.6 4.2 2.9 1.9 9.6 5.7 3.6 1.8 0.0 3.0 2.0 2.2 7.9 1.9 0.7 2.9 1.8 1.6 3.5 6.5 4.9 1.1 1.8 2.5 1.5 2.0 1.3 3.6 1.8 7.7 3.2 6.7 4.7 2.5 4.1 3.8 0.6 0.5 1.5 10.3 0.0 2.8 3.6 3.9 2.1 8.0 4.1 1.6 2.3 1.5 3.0 1.3 1.6 3.7 5.1 3.9 0.0 1.7 1.2 6.0 5.4 2.5 0.6 0.7 3.1 2.4 3.4 0.7 DDOST "GATD6, KIAA0115, OST, OST48, WBP1" ENSG00000244038 "Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit" P39656 1 20651767-20661544 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009746, HPA046841, HPA052867" Supported Supported "Endoplasmic reticulum" NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977" "unprognostic (8.57e-3)" "unprognostic (1.35e-2)" "unprognostic (1.57e-2)" "prognostic favorable (5.99e-4)" "unprognostic (1.62e-1)" "prognostic unfavorable (4.88e-4)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.33e-1)" "unprognostic (5.51e-3)" "unprognostic (2.70e-2)" "unprognostic (3.59e-2)" "unprognostic (3.72e-1)" "prognostic unfavorable (9.05e-7)" "unprognostic (1.07e-1)" "unprognostic (2.98e-1)" "unprognostic (1.69e-2)" "unprognostic (1.07e-1)" 98.1 132.7 44.6 108.5 46.4 191.4 111.9 44.9 46.3 130.7 64.1 161.4 119.4 115.8 224.5 113.2 137.4 98.2 123.4 47.2 53.7 100.6 137.2 104.4 104.6 48.1 45.3 139.5 259.8 112.7 119.1 183.3 46.9 99.8 165.7 42.1 151.7 130.4 80.0 87.3 108.4 122.8 46.1 113.1 139.0 83.4 52.4 84.0 185.6 66.4 121.6 119.3 92.8 51.4 366.0 206.7 178.8 533.9 347.4 359.8 376.6 286.1 545.9 435.5 445.3 278.9 678.8 275.8 501.8 447.0 238.7 292.7 250.4 334.3 321.3 257.0 256.3 235.7 138.5 375.0 513.2 377.5 618.8 371.6 370.2 365.2 439.5 522.8 504.1 180.5 116.3 445.0 266.5 251.1 179.6 308.2 196.5 529.8 214.2 164.5 238.6 492.2 358.7 150.4 133.0 238.3 294.0 299.1 413.5 257.1 237.8 566.8 260.2 249.7 279.6 435.1 274.6 586.1 677.5 195.6 409.4 489.4 342.0 272.0 268.3 257.3 255.6 284.2 270.3 230.4 218.1 239.9 389.7 207.8 203.1 209.6 63.8 266.1 251.4 320.1 256.0 490.6 44.6 46.4 44.9 46.3 47.2 53.7 48.1 45.3 46.9 46.1 52.4 51.4 62.0 35.3 72.3 7.5 93.6 50.2 95.8 200.6 47.3 18.3 70.0 62.5 22.1 77.2 120.0 35.0 29.2 350.7 92.9 52.5 39.2 162.5 29.9 44.7 71.9 65.2 71.8 49.6 10.9 148.3 270.0 102.8 74.5 71.6 79.1 113.2 55.3 74.4 140.8 16.8 9.4 152.6 79.3 66.8 78.8 13.9 74.6 74.5 85.4 6.5 96.4 54.1 87.6 15.6 10.7 93.5 89.7 60.9 320.5 68.9 69.1 54.3 78.9 24.6 46.0 42.5 103.3 136.0 171.3 55.1 53.6 349.7 78.5 122.9 133.7 84.3 DERL2 "CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa" ENSG00000072849 "Derlin 2" Q9GZP9 17 5471254-5486811 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 259.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037287, HPA048957, HPA056551" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Endoplasmic reticulum" "CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171" "unprognostic (2.54e-1)" "unprognostic (5.30e-2)" "unprognostic (5.83e-2)" "prognostic favorable (7.26e-4)" "unprognostic (1.51e-2)" "unprognostic (4.70e-2)" "unprognostic (1.36e-1)" "unprognostic (2.63e-1)" "unprognostic (2.17e-1)" "unprognostic (1.12e-3)" "unprognostic (1.73e-3)" "unprognostic (5.23e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (1.91e-1)" "unprognostic (1.82e-1)" "unprognostic (3.73e-1)" "unprognostic (2.91e-2)" 14.5 18.8 5.7 16.4 6.0 33.9 12.9 6.3 7.6 13.1 7.0 12.9 14.9 12.8 29.6 15.3 14.0 17.3 10.2 5.4 6.2 14.0 28.0 11.3 18.2 6.4 6.4 12.8 28.5 14.7 12.1 13.4 6.6 14.0 12.3 8.1 28.3 11.4 10.6 10.1 17.5 12.4 6.2 15.1 15.5 24.4 6.1 10.8 24.6 4.9 15.4 14.9 11.1 7.6 32.0 40.4 18.8 31.7 31.5 23.6 24.0 44.5 36.1 30.0 36.4 27.8 27.9 22.0 39.2 28.5 33.6 35.0 13.2 25.7 29.9 29.3 27.6 10.8 25.8 30.0 43.4 8.1 25.2 22.0 21.0 40.6 34.9 26.4 31.4 22.4 12.0 37.5 40.9 16.5 17.3 12.3 18.2 20.7 16.0 20.8 26.6 16.3 32.5 16.2 7.9 23.2 27.1 18.5 47.6 20.6 24.8 11.8 23.9 35.4 23.9 21.8 43.3 26.0 31.4 20.0 37.0 20.1 28.4 71.9 62.6 77.0 64.6 70.4 67.2 66.5 61.2 68.7 48.2 65.5 48.3 59.3 59.9 60.4 56.4 69.2 81.0 117.5 5.7 6.0 6.3 7.6 5.4 6.2 6.4 6.4 6.6 6.2 6.1 7.6 36.1 12.8 23.9 12.4 46.4 34.3 50.5 157.7 27.9 17.7 48.4 48.5 31.3 35.8 82.7 44.1 22.9 70.6 70.5 28.1 15.6 79.9 259.2 32.5 41.7 35.7 18.5 35.3 8.1 89.7 103.6 51.3 22.4 41.6 49.4 38.8 30.4 57.5 74.5 11.8 9.0 37.2 89.5 33.6 44.8 63.4 43.8 37.8 46.2 6.5 64.7 35.1 48.4 6.6 16.2 86.7 25.2 35.3 119.9 68.7 37.1 50.4 55.6 24.8 59.2 33.9 54.3 126.4 45.4 26.2 31.1 96.2 47.7 45.8 30.4 62.8 DHRS12 "FLJ13639, SDR40C1" ENSG00000102796 "Dehydrogenase/reductase 12" A0PJE2 13 51767993-51804162 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "pancreas: 66.8" "Cell type enhanced" "Detected in many" "Late spermatids: 69.1;Proximal tubular cells: 83.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB034238, HPA057028, HPA058315" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "Golgi apparatus, Vesicles" "CAB034238: AB_2091845, HPA057028: AB_2683314, HPA058315: AB_2683678" "prognostic favorable (1.41e-4)" "unprognostic (1.98e-2)" "unprognostic (2.98e-1)" "unprognostic (7.57e-2)" "unprognostic (2.98e-1)" "unprognostic (1.42e-1)" "unprognostic (8.47e-3)" "unprognostic (1.70e-1)" "unprognostic (3.51e-1)" "unprognostic (3.99e-2)" "unprognostic (1.21e-2)" "unprognostic (3.98e-1)" "prognostic favorable (2.22e-16)" "unprognostic (2.85e-3)" "unprognostic (1.01e-1)" "unprognostic (2.03e-2)" "unprognostic (3.44e-1)" 22.7 10.6 7.8 2.9 7.3 4.5 20.5 8.9 7.8 13.9 6.5 14.0 5.5 13.1 5.0 10.3 14.5 6.1 14.3 7.3 6.7 24.6 28.9 11.7 5.3 7.2 6.6 18.4 66.8 6.6 18.7 3.6 7.0 15.4 3.7 5.9 15.0 5.9 16.0 14.1 12.5 4.0 7.6 15.7 15.0 8.2 7.0 2.3 18.8 4.1 3.5 13.2 11.2 8.3 1.1 2.5 3.8 5.6 1.2 2.6 4.4 1.6 4.1 1.8 1.3 4.5 8.6 4.2 1.2 2.5 2.5 2.0 0.0 0.3 0.3 4.2 3.4 0.6 1.1 3.2 6.6 0.4 0.7 2.7 3.9 0.6 2.4 4.5 5.2 4.0 2.0 3.0 1.3 5.5 1.0 3.5 6.1 4.2 0.6 0.5 0.8 5.8 5.6 3.2 3.4 6.9 2.9 2.5 7.1 5.0 2.8 2.8 3.7 1.3 1.5 0.1 1.7 1.4 1.8 1.9 2.3 1.4 3.7 6.6 16.6 0.5 14.0 14.2 24.1 13.7 19.7 16.9 9.0 13.4 16.4 12.9 31.4 3.8 16.5 10.6 19.8 13.5 7.8 7.3 8.9 7.8 7.3 6.7 7.2 6.6 7.0 7.6 7.0 8.3 14.1 12.8 14.8 11.1 11.4 11.3 12.1 22.2 10.8 11.9 23.5 22.9 15.7 18.6 13.3 16.5 8.4 24.9 8.0 7.8 52.8 12.5 26.1 5.6 7.7 10.1 10.3 2.1 4.9 16.7 17.5 17.1 7.1 6.4 12.0 6.8 8.6 30.7 17.1 3.3 5.4 12.4 22.4 11.2 11.6 69.1 11.1 10.1 14.2 3.7 10.5 32.4 8.2 24.6 12.9 12.6 21.9 9.8 4.8 12.2 25.5 83.5 19.5 18.5 0.0 14.2 11.4 1.4 8.2 10.5 14.9 23.8 13.7 13.4 11.0 12.2 DHRSX "DHRS5X, DHRS5Y, DHRSXY, DHRSY, SDR46C1, SDR7C6" ENSG00000169084 "Dehydrogenase/reductase X-linked" Q8N5I4 X 2219506-2502805 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA003035, HPA075955" Approved Uncertain "Mitotic spindle,Cytosol" "Secreted to blood" Yes NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 1: Pancreatic cells - Digestion" Cytosol "Mitotic spindle" "HPA003035: AB_1080631, HPA075955: " "unprognostic (7.77e-2)" "unprognostic (1.06e-1)" "unprognostic (3.95e-2)" "unprognostic (4.65e-3)" "unprognostic (8.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (4.59e-3)" "unprognostic (1.08e-1)" "unprognostic (1.21e-1)" "unprognostic (1.08e-2)" "unprognostic (1.17e-1)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (1.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.69e-2)" 13.1 16.2 7.0 4.8 8.2 5.2 12.2 6.7 7.7 13.3 11.9 12.7 6.5 13.0 8.0 6.0 11.0 8.8 19.9 6.1 6.8 14.7 30.6 10.3 5.6 11.5 10.1 12.6 21.9 11.5 10.6 8.2 8.4 13.2 8.3 2.2 14.7 7.0 12.4 9.0 10.8 6.9 8.5 10.1 16.5 6.4 10.9 6.1 13.3 7.0 3.9 11.2 9.3 8.2 8.1 35.7 23.9 11.0 28.8 18.0 18.5 17.8 29.9 13.3 17.9 26.9 16.8 12.6 22.6 21.5 31.4 3.9 16.4 14.3 9.4 24.1 26.1 12.2 17.9 21.2 33.8 6.6 9.5 22.3 17.7 11.6 11.4 22.7 10.9 13.9 14.0 6.1 21.7 9.2 28.5 9.7 6.9 10.6 9.9 10.4 12.4 3.5 14.5 19.3 24.3 22.9 17.0 20.3 14.2 14.8 8.7 10.8 15.6 14.5 3.6 8.4 10.6 7.1 0.1 33.2 9.7 8.7 6.7 14.9 38.3 34.6 15.1 30.6 16.0 25.0 13.5 12.7 35.1 20.1 12.3 10.6 56.4 17.7 19.5 28.3 18.2 21.0 7.0 8.2 6.7 7.7 6.1 6.8 11.5 10.1 8.4 8.5 10.9 8.2 8.7 19.2 9.3 64.3 19.2 10.6 22.9 58.0 20.5 9.5 19.3 16.9 23.4 25.8 24.4 25.8 10.4 42.9 17.0 32.9 13.7 52.3 0.6 16.1 15.9 14.8 19.2 13.7 41.2 81.2 43.5 26.9 21.4 14.4 17.8 27.1 15.0 50.6 38.4 3.3 42.7 21.4 32.6 20.8 30.7 3.0 24.2 26.3 12.4 61.8 35.9 9.4 14.4 46.3 31.9 71.0 28.8 25.2 29.1 65.3 49.2 43.7 14.8 6.2 19.7 12.0 18.3 12.0 21.2 11.3 6.5 107.3 14.0 14.6 24.1 29.2 DNAJB11 "EDJ, ERdj3, HEDJ" ENSG00000090520 "DnaJ heat shock protein family (Hsp40) member B11" Q9UBS4 3 186567403-186585800 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010814, HPA017051" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 100000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA010814: AB_1078691, HPA017051: AB_1847792" "unprognostic (4.29e-1)" "unprognostic (1.07e-1)" "unprognostic (2.98e-2)" "unprognostic (2.24e-2)" "unprognostic (8.53e-2)" "unprognostic (1.07e-3)" "unprognostic (3.86e-2)" "unprognostic (6.52e-2)" "unprognostic (7.95e-2)" "unprognostic (2.14e-3)" "unprognostic (2.58e-2)" "unprognostic (1.05e-3)" "prognostic unfavorable (3.44e-9)" "unprognostic (1.27e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (1.82e-1)" 36.1 26.3 17.3 51.5 18.8 50.1 28.2 20.1 19.8 30.3 21.0 38.9 35.2 31.5 36.7 33.2 28.7 28.1 42.9 17.9 20.1 33.0 81.8 35.8 34.5 21.1 19.8 20.5 62.3 31.7 27.0 46.2 20.2 23.3 37.2 16.1 34.3 23.1 22.9 23.9 38.4 30.9 19.3 41.7 37.8 27.1 20.0 30.7 53.2 15.8 36.5 40.6 26.1 21.6 154.5 60.5 87.5 150.5 69.6 53.1 142.4 166.5 98.5 138.6 145.9 187.0 100.5 109.4 326.7 113.3 199.6 139.1 96.0 88.0 135.6 123.7 81.7 97.8 57.0 128.8 150.8 116.8 149.0 46.6 85.5 78.0 130.6 76.4 116.7 59.0 55.8 263.9 93.6 117.4 77.6 85.7 83.1 211.8 76.3 78.1 96.8 187.8 87.7 66.4 73.3 101.3 108.2 181.4 123.2 103.2 209.3 177.6 89.5 76.6 97.1 100.7 244.5 202.9 159.0 175.8 102.3 141.6 169.8 37.4 37.3 39.8 44.0 45.9 37.2 37.2 22.9 36.5 46.2 21.8 21.8 29.2 17.2 50.2 35.4 84.8 33.9 38.4 17.3 18.8 20.1 19.8 17.9 20.1 21.1 19.8 20.2 19.3 20.0 21.6 42.2 19.2 20.9 12.1 78.1 145.3 212.5 104.3 48.9 22.9 38.3 22.7 152.0 67.2 61.4 14.7 18.8 88.7 75.0 93.5 3.9 109.2 41.5 58.2 44.9 63.6 142.1 37.6 10.8 85.7 173.0 63.3 41.3 77.5 54.7 29.4 61.1 105.0 149.4 23.5 11.6 122.8 67.1 65.3 130.3 10.8 31.4 59.4 103.2 14.0 33.3 48.5 63.8 12.1 24.5 86.9 88.2 25.9 251.1 136.6 74.6 18.9 47.3 28.4 65.7 63.7 61.3 190.6 100.7 51.1 112.2 195.1 61.7 28.4 106.8 155.8 DNAJB9 MDG1 ENSG00000128590 "DnaJ heat shock protein family (Hsp40) member B9" Q9UBS3 7 108569867-108574850 "Predicted intracellular proteins" "Unfolded protein response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 350.9;Plasma cells: 409.3;Syncytiotrophoblasts: 569.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 116.5;Karpas-707: 109.3;U-266/70: 191.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040967, HPA041553" Supported Approved "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum, Cytosol" "HPA040967: AB_10794430, HPA041553: AB_10794300" "unprognostic (1.08e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (4.75e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (5.37e-2)" "unprognostic (5.13e-2)" "unprognostic (3.16e-2)" "unprognostic (1.89e-1)" "unprognostic (1.76e-1)" "unprognostic (1.05e-1)" "unprognostic (2.68e-3)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (8.76e-2)" 21.9 58.4 16.2 21.5 17.1 40.8 29.9 18.0 22.5 34.8 27.0 20.6 23.4 23.9 62.8 13.3 19.4 22.3 45.3 16.8 23.5 63.2 103.8 21.4 21.1 18.8 21.3 27.9 71.6 21.4 43.5 41.6 20.8 28.4 19.4 23.1 41.7 44.6 34.8 10.9 20.7 21.9 19.6 17.6 25.7 33.7 18.5 15.9 77.8 26.3 31.1 28.9 11.5 20.0 9.4 10.6 14.2 16.3 38.6 27.6 31.2 33.6 40.8 18.2 21.8 10.7 17.5 12.4 36.6 10.7 56.6 11.2 16.0 8.3 18.7 13.2 8.7 6.6 7.2 33.0 116.5 9.8 12.3 19.5 63.2 10.8 58.6 41.1 19.3 7.0 9.7 109.3 29.0 14.0 9.3 11.5 14.2 11.0 5.9 6.0 14.3 65.8 15.1 6.1 9.8 20.5 12.4 55.7 65.2 39.4 10.4 13.6 22.4 19.1 9.0 24.0 11.8 191.8 66.0 14.0 16.8 12.7 17.6 75.9 19.3 9.4 34.1 15.0 59.0 24.5 36.2 34.2 14.3 21.2 20.2 23.5 5.3 26.0 17.0 78.1 22.6 30.3 16.2 17.1 18.0 22.5 16.8 23.5 18.8 21.3 20.8 19.6 18.5 20.0 65.7 3.2 28.8 10.1 110.3 185.6 102.4 123.1 71.7 40.3 129.4 58.9 65.6 44.3 75.1 53.3 8.4 106.7 95.0 28.0 49.0 47.5 350.9 46.1 38.1 55.3 66.6 44.9 14.5 45.7 123.0 121.2 51.0 92.5 92.1 16.2 33.5 185.9 40.1 20.2 15.6 76.8 69.2 37.8 190.5 211.4 38.2 60.2 339.7 11.2 16.0 90.4 23.7 8.5 11.2 33.0 32.3 46.3 409.3 144.7 31.3 155.6 35.4 33.3 39.5 49.4 129.0 157.0 89.9 39.4 158.7 569.4 115.1 18.6 28.8 79.5 DNAJC1 "DNAJL1, ERdj1, MTJ1" ENSG00000136770 "DnaJ heat shock protein family (Hsp40) member C1" Q96KC8 10 21756548-22003769 "Predicted membrane proteins, Transcription factors" "Chaperone, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013432 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum" "HPA013432: AB_1847797" "unprognostic (7.00e-2)" "unprognostic (9.81e-2)" "unprognostic (3.61e-1)" "unprognostic (5.12e-2)" "unprognostic (5.51e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (1.96e-5)" "unprognostic (3.81e-2)" "unprognostic (1.21e-1)" "unprognostic (3.46e-2)" "unprognostic (1.09e-1)" "unprognostic (9.36e-2)" "prognostic favorable (2.33e-4)" "unprognostic (4.44e-3)" "unprognostic (4.88e-2)" "unprognostic (1.45e-2)" "unprognostic (2.22e-2)" 17.6 16.9 9.9 16.3 11.2 18.3 20.0 10.6 13.1 17.8 15.0 20.6 28.3 15.5 13.4 16.3 14.2 17.7 15.8 9.0 12.9 23.0 36.9 24.0 15.6 12.1 11.1 14.0 38.5 45.6 19.6 19.9 12.4 23.7 18.7 7.1 40.7 16.3 12.7 14.3 22.4 15.8 11.5 15.2 28.6 9.4 11.3 13.1 29.0 11.2 13.0 26.5 15.2 12.7 38.5 24.5 53.9 20.1 49.3 34.9 23.4 50.9 22.1 20.8 32.7 33.8 33.1 16.9 21.9 31.2 31.2 36.1 12.3 25.7 11.5 88.6 41.1 40.3 18.8 20.3 119.5 3.0 16.5 35.8 46.5 24.7 28.3 30.4 27.8 16.4 42.7 93.6 23.8 39.2 9.6 12.9 7.1 33.2 20.3 13.8 18.8 62.3 29.1 9.1 11.3 17.1 37.7 62.2 38.1 58.7 19.8 42.8 42.7 20.3 43.5 34.4 29.3 29.8 10.0 11.7 30.3 126.1 12.3 11.8 16.6 7.0 36.2 16.6 36.5 8.4 20.2 29.1 15.3 12.3 12.9 16.5 9.3 34.2 30.9 39.6 15.8 15.0 9.9 11.2 10.6 13.1 9.0 12.9 12.1 11.1 12.4 11.5 11.3 12.7 56.4 35.3 26.9 73.4 46.7 38.7 64.8 26.6 30.1 27.9 67.9 76.1 16.9 57.2 31.0 31.3 45.9 16.7 92.9 52.4 27.4 73.6 47.6 40.9 74.6 54.7 38.3 49.0 134.4 74.2 92.6 67.4 59.7 58.3 41.8 14.3 52.8 84.5 55.0 38.7 77.1 75.8 28.5 43.7 52.5 19.6 94.8 44.2 67.6 112.4 46.9 37.4 99.9 91.5 137.7 80.6 49.2 67.0 202.7 71.2 57.9 80.1 23.9 149.1 59.2 49.3 56.7 232.2 109.5 45.3 44.2 35.3 81.5 41.0 55.8 71.9 DNAJC3 "ERdj6, HP58, P58, p58(IPK), P58IPK, PRKRI" ENSG00000102580 "DnaJ heat shock protein family (Hsp40) member C3" Q13217 13 95677139-95794988 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Antiviral defense, Stress response, Translation regulation, Unfolded protein response" "Chaperone, Repressor" "Deafness, Diabetes mellitus, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039336, HPA041326" Uncertain Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 4900000 "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA039336: AB_2676451, HPA041326: AB_2677412" "unprognostic (1.44e-2)" "unprognostic (8.08e-2)" "unprognostic (2.12e-2)" "prognostic favorable (3.47e-5)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (1.09e-1)" "unprognostic (2.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (9.69e-2)" "unprognostic (7.19e-2)" "unprognostic (3.37e-2)" "unprognostic (8.30e-3)" "unprognostic (8.18e-2)" 21.0 20.0 10.7 22.5 13.0 45.6 21.3 13.0 11.4 35.1 22.3 25.2 23.8 20.4 38.9 15.9 20.4 22.0 16.6 10.0 14.1 25.5 41.8 22.9 15.0 15.1 12.5 15.8 36.0 24.4 16.2 24.7 15.5 34.5 26.4 9.9 36.3 26.0 9.3 10.9 24.0 22.3 13.4 19.8 28.8 12.7 14.6 11.3 52.8 11.2 17.8 22.1 11.9 16.4 32.4 18.0 14.2 40.7 57.7 28.6 42.6 44.6 40.3 20.2 18.4 22.7 66.5 29.5 41.5 45.0 28.5 32.3 18.7 34.1 30.7 28.8 8.4 40.7 24.6 36.5 79.1 49.8 51.6 34.3 35.7 29.7 68.2 36.9 44.4 13.2 13.9 0.3 34.4 13.1 17.0 17.8 10.6 75.2 13.9 17.1 24.8 22.9 44.9 39.5 8.2 15.6 31.6 74.9 22.5 32.4 37.3 54.6 50.8 39.0 13.3 26.2 23.3 60.6 28.4 13.4 65.6 29.6 54.9 64.7 25.5 86.2 23.9 32.1 25.3 11.2 19.6 20.1 17.2 9.0 13.7 18.7 77.1 22.8 36.0 45.9 13.4 15.7 10.7 13.0 13.0 11.4 10.0 14.1 15.1 12.5 15.5 13.4 14.6 16.4 81.7 80.1 71.3 47.3 61.1 94.1 88.5 81.1 33.6 25.7 65.2 35.9 58.2 81.5 83.4 47.8 27.1 57.1 109.6 69.0 21.5 98.8 160.5 58.0 87.5 64.8 41.9 33.7 30.1 118.7 135.5 99.6 56.6 94.5 67.8 34.4 68.6 140.7 78.8 25.2 37.3 84.9 69.2 70.5 130.2 33.6 71.7 82.0 119.2 47.8 63.1 38.7 51.5 53.3 58.9 97.6 52.4 75.6 214.3 151.2 58.1 71.1 96.7 19.6 92.1 80.8 104.5 47.1 79.9 38.1 92.9 189.8 67.0 53.3 63.8 124.4 DNASE2 "DNL, DNL2" ENSG00000105612 "Deoxyribonuclease 2, lysosomal" O00115 19 12875209-12881466 "Enzymes, Predicted intracellular proteins" Apoptosis "Developmental protein, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hofbauer cells: 226.7;Paneth cells: 125.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066185 Enhanced "Intracellular and membrane" NA NA 560000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" "HPA066185: AB_2685632" "unprognostic (9.62e-2)" "unprognostic (2.19e-3)" "unprognostic (8.97e-2)" "unprognostic (7.45e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (5.42e-2)" "unprognostic (4.85e-2)" "unprognostic (1.40e-1)" "unprognostic (5.12e-2)" "unprognostic (4.37e-2)" "unprognostic (2.58e-2)" "unprognostic (4.69e-2)" "unprognostic (3.57e-1)" "unprognostic (1.98e-1)" 27.0 26.7 17.1 24.0 17.5 9.6 23.3 17.2 19.1 22.7 19.7 24.7 23.7 25.1 29.5 18.9 25.3 25.3 22.7 16.5 17.6 19.2 36.0 37.7 42.2 18.7 18.2 26.1 41.7 43.1 23.8 20.6 19.4 27.7 19.2 5.6 33.0 26.1 19.7 29.2 22.7 22.0 19.3 26.2 30.0 5.9 17.8 20.8 38.7 13.1 26.5 24.3 19.9 23.0 63.7 36.3 2.9 80.8 86.8 46.2 55.0 34.4 87.2 33.2 79.6 3.8 43.6 27.9 97.3 54.9 73.0 71.8 30.7 33.2 16.2 89.8 41.0 13.1 36.8 17.5 68.3 26.5 119.8 46.5 74.5 24.8 36.7 80.2 50.2 42.4 14.0 112.1 20.3 82.7 27.3 14.1 6.1 66.3 60.8 17.1 14.2 64.3 32.9 29.7 17.3 28.6 46.1 65.8 123.5 11.8 98.5 23.4 32.5 67.8 21.4 70.3 31.1 139.9 153.6 35.7 112.9 24.6 34.4 73.5 71.0 10.9 64.5 95.8 53.5 31.1 56.1 68.8 14.0 35.6 49.0 53.7 40.6 70.9 114.2 28.3 85.8 66.4 17.1 17.5 17.2 19.1 16.5 17.6 18.7 18.2 19.4 19.3 17.8 23.0 18.7 25.6 22.4 7.5 25.5 14.5 23.6 56.9 14.2 6.7 22.7 18.5 10.6 28.6 31.0 36.8 4.2 60.0 23.5 17.3 3.9 67.1 0.5 24.1 15.1 21.4 16.4 5.7 1.3 58.3 96.2 27.9 13.7 25.4 22.2 23.8 28.9 26.4 226.7 5.0 1.7 15.0 83.4 87.5 6.8 2.5 32.0 55.5 46.2 2.8 28.4 32.2 33.0 3.0 1.7 39.5 125.0 33.4 36.6 15.1 10.8 6.8 29.9 3.3 13.1 16.5 16.9 0.6 4.8 12.4 12.4 48.0 23.9 23.0 26.2 18.5 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947603 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 9.6 14.3 6.6 6.3 6.3 1.5 7.8 6.7 6.7 7.4 8.6 7.5 7.6 9.3 13.5 8.6 8.9 7.9 10.5 6.5 7.1 9.1 10.5 9.1 6.8 6.9 7.6 6.7 14.5 16.8 5.9 9.3 7.3 10.0 6.6 4.4 12.0 10.0 6.7 9.9 7.5 9.4 6.5 8.0 10.6 14.5 7.6 5.1 7.8 7.1 6.6 8.6 5.9 6.8 11.7 42.5 14.8 22.0 42.6 22.2 20.0 23.7 38.1 28.5 21.0 33.7 17.9 6.4 12.3 34.6 40.3 80.3 20.3 29.6 14.7 10.7 17.8 8.0 27.4 24.5 43.0 8.8 13.5 31.1 27.0 30.8 16.8 16.7 28.1 9.1 19.7 10.0 31.3 56.9 7.3 7.3 19.0 33.0 26.0 7.2 19.5 25.1 25.7 17.3 13.5 15.1 31.4 25.6 14.1 13.7 44.8 11.4 23.6 25.6 9.2 32.5 19.8 9.4 25.0 6.4 24.2 8.0 19.9 2.7 15.4 6.9 11.2 15.3 10.1 11.8 9.9 12.3 16.6 12.5 12.8 13.2 2.2 13.0 21.2 9.3 16.8 10.5 6.6 6.3 6.7 6.7 6.5 7.1 6.9 7.6 7.3 6.5 7.6 6.8 8.5 6.4 4.1 2.9 2.6 1.8 3.6 13.9 4.6 9.1 4.4 4.3 3.5 10.0 10.9 7.3 8.4 25.6 3.5 5.2 0.0 15.7 15.1 5.9 7.2 9.2 1.2 3.6 1.2 14.2 16.4 8.1 5.1 3.6 1.3 7.5 16.1 9.2 13.5 5.0 2.2 3.5 12.2 5.2 2.7 3.7 12.2 2.9 3.6 1.9 2.8 10.7 5.2 2.5 1.7 11.1 7.5 6.0 1.5 4.4 7.5 9.0 11.4 7.1 0.0 7.0 15.7 33.8 15.1 3.3 1.3 18.2 2.3 15.8 5.7 2.1 DPAGT1 "ALG7, CDG-Ij, D11S366, DGPT, DPAGT, DPAGT2, GPT" ENSG00000172269 "Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1" Q9H3H5 11 119096503-119108331 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053878 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" "HPA053878: AB_2682288" "unprognostic (1.66e-2)" "unprognostic (3.14e-3)" "unprognostic (1.76e-1)" "unprognostic (7.83e-3)" "unprognostic (6.50e-2)" "unprognostic (8.53e-3)" "prognostic unfavorable (2.03e-5)" "unprognostic (2.52e-1)" "unprognostic (3.95e-1)" "unprognostic (9.05e-2)" "unprognostic (2.08e-2)" "unprognostic (7.12e-2)" "unprognostic (2.19e-3)" "unprognostic (1.87e-3)" "unprognostic (1.08e-2)" "unprognostic (2.52e-2)" "unprognostic (4.57e-2)" 11.3 14.1 13.0 13.7 13.3 9.1 14.8 13.9 22.4 16.1 17.6 17.7 16.8 10.2 21.8 12.4 17.3 14.5 8.6 13.5 14.1 12.8 21.2 11.4 11.5 14.2 14.4 9.0 27.1 18.6 4.4 15.8 14.2 14.3 20.0 7.4 27.8 16.3 5.6 9.0 14.9 17.7 13.4 9.8 14.4 4.8 14.6 8.2 15.5 8.5 14.3 16.8 6.2 14.9 22.0 39.2 22.2 55.7 60.0 37.0 24.6 33.7 38.3 25.7 32.2 43.4 88.3 41.5 62.8 45.4 57.7 77.1 42.0 60.7 31.1 29.4 23.8 83.5 14.1 51.6 50.7 53.9 47.4 40.3 48.7 62.4 85.3 29.9 53.3 25.2 51.7 84.1 50.9 67.7 19.5 39.9 22.5 148.3 49.4 26.2 26.6 61.3 60.3 44.7 23.0 30.1 30.7 99.3 17.1 32.3 116.8 19.4 29.1 57.3 24.5 30.3 23.7 19.6 32.2 13.9 14.3 68.3 48.9 28.4 35.7 4.4 25.2 35.5 28.4 24.5 20.1 24.8 43.3 25.6 16.6 15.8 3.0 20.7 32.7 37.5 19.6 20.2 13.0 13.3 13.9 22.4 13.5 14.1 14.2 14.4 14.2 13.4 14.6 14.9 11.5 6.4 8.1 7.2 10.7 13.3 15.2 34.4 13.1 6.1 18.4 12.1 5.0 14.3 22.8 14.7 14.6 34.2 9.6 10.3 3.9 32.9 0.9 15.6 12.3 16.0 10.2 8.6 7.3 13.3 44.4 11.0 14.3 11.2 12.7 12.7 15.7 23.1 28.8 3.3 5.7 19.8 32.6 13.0 11.4 1.9 14.0 14.1 8.8 5.6 20.9 6.2 13.4 7.5 5.4 13.9 11.1 8.2 33.2 14.5 19.3 11.3 37.2 4.6 0.0 6.0 10.7 6.8 10.3 14.1 12.5 23.5 10.0 15.9 20.7 12.9 DPEP1 ENSG00000015413 "Dipeptidase 1" P16444 16 89613308-89638456 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Lipid metabolism" "Dipeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "intestine: 377.4;kidney: 255.9;pancreas: 440.7" "Cell type enhanced" "Detected in many" "Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6" "Cancer enriched" "Detected in many" 8 "colorectal cancer: 107.4" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009426, HPA012783" Enhanced Approved "Nucleoplasm,Cell Junctions" "Intracellular and membrane" NA NA 370000 "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Cell Junctions" "HPA009426: AB_1847842, HPA012783: AB_1847843" "unprognostic (3.31e-2)" "unprognostic (3.86e-1)" "unprognostic (1.37e-1)" "unprognostic (1.95e-2)" "unprognostic (1.91e-2)" "unprognostic (4.93e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-1)" "unprognostic (3.45e-2)" "unprognostic (5.18e-1)" "unprognostic (8.68e-2)" "unprognostic (1.27e-1)" "prognostic favorable (6.84e-4)" "unprognostic (6.12e-3)" "unprognostic (1.92e-1)" "unprognostic (5.23e-2)" "unprognostic (3.93e-2)" 0.6 2.3 0.0 1.8 0.0 0.4 0.5 0.0 0.2 4.1 0.0 1.7 85.5 0.6 0.9 0.3 0.6 3.9 0.3 0.0 0.3 255.9 0.5 0.9 2.8 0.2 1.1 0.8 440.7 0.0 0.5 0.8 0.6 0.5 0.5 0.3 1.2 1.0 0.0 2.2 377.4 0.3 0.3 4.5 1.6 46.5 0.9 0.9 0.8 0.0 0.9 2.2 0.9 0.0 0.0 0.9 0.2 0.0 1.7 0.2 4.4 0.0 0.0 0.0 0.0 8.5 0.2 0.0 3.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.6 0.0 0.0 33.1 13.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.3 1.1 1.1 3.4 0.0 0.0 0.0 3.0 0.0 0.1 0.9 0.8 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 1.4 0.0 0.0 0.2 0.1 0.0 46.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 1.1 0.6 0.3 0.9 0.0 0.1 3.2 1.8 0.0 9.2 0.5 0.0 0.0 0.0 5.8 1.7 0.0 0.3 0.0 0.6 23.9 0.0 0.2 0.0 2.0 56.7 0.5 13.2 0.2 0.2 7.0 8.9 0.0 0.3 192.1 0.8 8.9 1.1 0.1 1.3 0.7 1.1 0.0 0.5 0.0 0.3 142.3 0.0 0.3 0.3 45.2 289.8 4.8 5.4 0.0 1.0 0.1 0.0 0.0 0.1 27.4 187.4 1217.5 61.2 0.0 4683.5 829.6 0.0 0.2 6.6 0.0 0.7 17.3 2.8 0.0 0.3 0.4 2.5 0.2 151.7 0.0 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 91.7;Oligodendrocytes: 101.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 8.6 7.5 3.7 4.9 4.7 5.4 10.8 4.6 5.0 6.8 3.6 6.7 6.1 7.9 10.7 9.6 8.1 6.0 10.2 3.6 4.7 10.4 8.1 5.3 5.3 4.6 4.4 9.7 14.3 8.7 5.9 8.1 4.8 5.8 7.0 8.9 6.7 6.1 10.8 9.7 6.6 6.4 4.3 6.3 6.8 5.9 3.9 7.0 10.8 6.9 7.4 8.0 7.1 5.7 16.9 8.9 14.7 12.5 2.6 11.7 14.3 6.2 10.8 14.7 7.6 11.9 15.5 5.2 14.8 5.7 17.9 19.0 17.2 17.9 17.5 4.1 10.7 19.6 9.9 18.9 15.3 10.6 12.1 9.9 22.2 5.9 28.5 9.0 14.4 11.0 21.8 20.6 13.6 6.6 13.0 9.8 13.0 25.4 8.1 16.0 13.7 7.2 12.9 21.0 10.7 10.4 11.6 12.8 10.7 8.5 44.6 14.4 4.4 14.2 13.8 14.4 10.0 18.2 31.3 13.4 12.3 17.7 13.9 0.0 6.7 0.3 6.0 6.7 7.7 8.9 8.1 8.4 6.7 6.3 10.3 9.3 0.3 14.7 6.2 5.8 5.8 4.5 3.7 4.7 4.6 5.0 3.6 4.7 4.6 4.4 4.8 4.3 3.9 5.7 15.9 16.0 7.5 91.7 18.7 31.0 20.0 19.8 24.5 29.2 12.0 16.6 15.8 18.6 17.2 9.2 39.6 26.7 9.3 7.5 13.7 16.3 2.2 10.7 13.7 10.0 5.4 16.8 28.0 24.1 23.5 12.0 21.4 13.3 3.8 21.1 5.7 7.4 17.5 18.5 47.0 7.4 14.2 10.3 12.9 3.3 14.0 9.8 16.0 44.0 14.3 15.0 11.3 71.9 101.5 18.7 7.1 6.8 6.9 8.9 13.4 19.9 7.6 24.2 0.0 18.9 14.0 9.8 14.0 21.2 23.2 22.6 9.9 21.9 10.5 13.4 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49621037-49656232 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles" Yes No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Vesicles" "HPA042214: AB_2677903" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.6 11.8 7.7 13.0 10.1 5.4 18.2 8.2 9.1 27.4 6.5 21.1 7.4 22.6 16.8 13.3 21.1 23.0 11.0 9.0 8.9 11.0 11.5 10.9 12.9 5.7 6.9 22.7 33.3 11.5 9.2 12.8 6.0 15.7 11.9 8.8 21.5 14.7 10.3 12.2 9.1 20.5 6.4 9.0 14.9 9.5 9.9 11.7 17.6 21.1 10.0 20.4 15.9 9.8 10.0 11.9 21.2 11.5 41.3 84.1 16.6 29.3 28.6 36.8 27.5 4.2 8.3 16.7 20.3 38.7 16.8 17.8 15.6 15.8 37.7 10.8 11.2 13.8 23.5 14.5 29.1 18.0 11.1 38.8 20.4 24.3 29.7 32.9 15.5 19.3 26.3 17.3 41.7 23.3 12.3 15.1 12.4 22.6 15.7 17.4 44.7 64.9 12.3 7.1 18.6 14.4 34.7 11.5 27.3 22.1 12.1 25.4 10.7 43.6 17.3 25.6 32.3 13.2 22.2 10.0 37.5 53.9 28.3 8.7 9.7 5.2 6.8 11.7 9.8 9.7 10.3 11.6 12.8 10.1 12.0 11.5 2.6 13.9 15.3 25.3 8.9 6.0 7.7 10.1 8.2 9.1 9.0 8.9 5.7 6.9 6.0 6.4 9.9 9.8 39.9 19.2 15.0 36.6 16.6 19.2 15.4 31.9 18.2 41.8 23.0 34.0 18.8 12.8 22.1 35.0 31.3 23.4 27.1 4.7 31.3 20.1 21.0 27.8 88.1 23.6 15.5 20.8 57.2 21.0 27.7 49.9 20.4 14.1 7.0 29.3 25.4 14.9 19.5 18.5 55.2 19.2 40.7 16.4 14.9 11.2 37.9 16.7 16.0 18.7 10.4 20.3 18.6 33.7 66.1 20.8 10.3 28.2 27.0 21.5 9.5 22.0 37.9 40.0 6.6 35.5 46.7 51.2 44.3 19.6 19.0 9.7 16.2 35.4 17.1 12.7 ECE1 ECE ENSG00000117298 "Endothelin converting enzyme 1" P42892 1 21217247-21345572 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 164.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 29.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 673.8;TIME: 588.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001490, HPA013616" Enhanced NA NA 1300000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA001490: AB_1078718, HPA013616: AB_1847963" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (1.48e-1)" "unprognostic (1.99e-2)" "unprognostic (1.49e-2)" "unprognostic (1.46e-1)" "unprognostic (5.24e-2)" "unprognostic (1.23e-1)" "unprognostic (6.20e-2)" "unprognostic (1.92e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (7.70e-2)" "unprognostic (3.55e-2)" "unprognostic (9.10e-2)" "unprognostic (1.97e-2)" "unprognostic (1.97e-2)" 87.3 123.2 26.5 47.7 29.4 48.1 79.4 23.0 30.1 61.4 12.6 71.0 30.1 42.4 10.0 26.7 46.9 36.8 70.9 21.3 33.7 38.1 54.0 72.1 35.7 34.4 25.7 71.0 91.8 125.0 47.4 66.5 30.4 53.1 34.7 14.7 33.6 25.1 19.8 34.3 46.1 42.3 21.2 48.5 43.3 22.7 28.1 21.1 51.4 33.2 34.9 58.8 43.8 27.5 93.0 60.1 77.9 38.3 111.0 116.4 44.1 135.4 236.8 72.9 66.6 44.1 275.8 34.0 323.6 138.8 157.7 38.4 32.6 64.9 63.5 83.0 27.2 48.7 89.9 34.8 144.3 7.1 11.8 61.6 74.3 112.6 55.8 199.2 673.8 27.6 10.0 17.7 62.9 19.4 14.6 11.4 23.2 26.3 46.5 17.5 45.0 49.2 114.0 17.0 26.4 63.1 134.3 79.2 57.4 42.5 55.9 20.2 588.7 160.7 77.9 73.3 79.9 26.4 49.0 39.1 332.6 16.5 196.6 0.2 8.4 3.3 2.9 10.0 4.2 6.1 6.1 4.6 0.7 4.1 4.0 2.7 29.8 1.5 7.8 2.8 8.6 7.2 26.5 29.4 23.0 30.1 21.3 33.7 34.4 25.7 30.4 21.2 28.1 27.5 164.0 19.2 7.5 46.4 25.1 20.3 19.7 81.6 18.8 5.0 71.3 44.7 18.9 10.0 54.7 23.9 0.0 6.0 12.4 105.8 5.9 25.8 1.5 19.6 35.2 106.1 25.2 20.2 19.2 56.7 35.0 51.8 20.9 51.8 18.4 35.4 97.1 36.0 3.3 0.0 14.8 13.0 57.0 9.6 14.3 4.2 43.5 17.3 7.2 31.9 25.5 50.4 8.2 13.6 22.5 100.4 106.5 55.3 29.4 34.9 45.7 7.5 24.2 4.4 39.5 72.7 47.5 1.3 5.9 8.5 16.1 10.5 17.9 80.6 21.6 40.8 EDEM2 "bA4204.1, C20orf31, C20orf49, FLJ10783" ENSG00000088298 "ER degradation enhancing alpha-mannosidase like protein 2" Q9BV94 20 35115364-35147336 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 137.9;Plasma cells: 89.0;Syncytiotrophoblasts: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037238, HPA048353" Approved "Intracellular and membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB037238: AB_1840826, HPA048353: AB_2680369" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.05e-2)" "unprognostic (2.19e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (9.87e-2)" "unprognostic (1.46e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (4.53e-2)" "unprognostic (1.31e-1)" "unprognostic (3.50e-3)" "unprognostic (2.29e-2)" 21.1 26.9 10.3 16.2 11.4 27.7 17.9 16.0 12.8 18.5 13.6 19.5 20.0 11.6 44.9 14.5 16.2 14.7 15.0 9.8 10.7 19.1 38.9 26.7 20.1 13.4 11.4 10.4 32.4 13.2 24.5 28.1 12.9 16.0 21.8 10.7 19.1 15.5 7.5 13.9 19.4 15.4 11.0 32.5 16.4 6.6 14.8 16.8 15.3 5.9 21.7 16.4 12.2 12.5 18.6 54.4 8.6 34.0 98.0 33.9 49.2 20.8 70.5 24.4 34.4 61.3 47.7 16.0 61.3 40.9 77.0 37.6 31.5 43.3 19.6 12.3 8.8 31.6 11.8 58.7 54.1 23.2 117.6 41.3 59.4 23.5 58.2 60.2 91.9 30.3 14.9 66.5 33.9 20.6 18.6 28.9 9.7 52.8 35.0 15.5 29.5 33.6 54.6 16.0 7.1 11.1 21.8 55.8 53.9 36.3 26.2 38.5 41.0 36.9 22.0 21.9 25.6 34.5 23.2 9.7 64.7 29.2 31.4 35.9 96.9 75.3 39.9 72.4 78.4 42.3 36.4 39.6 101.4 42.0 26.0 32.9 67.2 42.9 72.9 59.1 47.7 79.9 10.3 11.4 16.0 12.8 9.8 10.7 13.4 11.4 12.9 11.0 14.8 12.5 16.7 16.0 17.4 6.8 27.5 4.0 14.6 34.7 6.2 3.7 12.0 9.3 4.6 24.3 18.9 12.9 2.1 72.9 27.4 14.7 11.7 35.5 2.5 11.4 13.8 16.4 4.8 13.3 5.2 29.1 137.9 14.1 7.7 16.6 55.1 13.6 13.9 23.3 72.2 0.0 6.5 13.8 32.6 21.3 7.9 1.2 7.8 28.3 12.4 9.4 26.8 7.9 14.4 1.5 6.9 28.9 16.1 5.3 89.0 12.8 43.6 18.9 15.3 6.5 13.1 7.9 19.0 8.7 11.2 8.9 4.7 94.7 18.7 15.7 17.3 12.7 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 7 "RH-30: 152.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 7.5 6.2 2.5 3.6 2.3 2.6 9.2 4.1 2.7 10.5 2.6 5.6 3.9 9.3 9.6 5.6 8.4 5.4 3.7 2.4 1.8 11.6 6.5 5.3 3.6 2.6 2.4 11.4 21.7 6.4 3.7 4.6 2.7 8.2 4.6 3.7 19.4 8.7 2.9 7.3 3.8 7.6 2.1 4.0 7.2 4.2 2.4 1.9 10.1 3.1 3.1 6.3 7.3 3.1 5.4 11.0 4.6 5.9 12.8 12.0 4.0 5.8 10.9 8.9 9.0 5.6 9.5 3.1 7.4 7.6 7.2 5.2 3.7 3.3 9.3 4.0 5.6 14.9 6.6 9.2 11.3 3.7 6.6 12.6 8.7 9.3 9.8 15.2 9.7 13.2 8.9 22.6 5.4 3.8 4.7 11.0 3.4 4.3 8.0 8.5 152.1 10.0 6.0 5.3 4.4 6.0 10.0 7.5 6.2 4.1 11.9 10.0 9.5 13.7 7.7 5.8 6.4 5.7 2.3 3.8 11.3 15.4 10.0 0.4 3.0 0.1 1.8 1.1 7.8 0.5 3.5 2.2 3.1 0.4 1.7 1.4 0.7 1.5 4.6 1.5 2.2 2.3 2.5 2.3 4.1 2.7 2.4 1.8 2.6 2.4 2.7 2.1 2.4 3.1 3.9 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 7.6 0.0 0.0 1.8 1.8 0.0 3.4 1.3 0.0 5.9 5.5 0.0 2.0 6.0 1.9 0.0 0.0 0.0 12.7 4.9 3.4 0.0 2.5 2.5 5.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 8.8 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 16.4 1.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.6 0.5 4.7 0.0 0.0 ELL2 MRCCAT1 ENSG00000118985 "Elongation factor for RNA polymerase II 2" O00472 5 95885098-95961851 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 382.9;Plasma cells: 430.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 322.3;HDLM-2: 291.4;U-266/84: 216.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013569 Supported Nucleoplasm No No "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm "HPA013569: AB_2668853" "unprognostic (1.18e-2)" "unprognostic (1.88e-2)" "unprognostic (3.41e-2)" "unprognostic (2.94e-2)" "unprognostic (1.93e-1)" "unprognostic (5.82e-2)" "unprognostic (9.14e-2)" "unprognostic (3.21e-2)" "unprognostic (1.29e-1)" "unprognostic (8.05e-2)" "unprognostic (9.16e-2)" "unprognostic (1.70e-1)" "prognostic unfavorable (1.31e-4)" "prognostic unfavorable (1.61e-4)" "unprognostic (6.27e-2)" "unprognostic (1.37e-2)" "unprognostic (1.74e-2)" 49.0 19.5 13.5 28.6 32.3 48.3 37.3 22.9 26.8 24.0 6.8 13.5 14.5 9.1 5.7 61.2 16.0 35.6 39.9 18.4 32.0 16.5 86.8 35.8 14.6 51.1 28.5 24.8 94.3 15.6 25.1 25.3 33.7 39.1 13.1 3.7 96.5 23.0 33.5 58.9 14.5 11.4 21.3 18.0 44.3 15.2 41.4 8.1 17.1 10.7 21.8 33.2 35.7 55.8 31.7 12.3 3.8 0.5 45.0 56.1 4.6 322.3 56.2 105.4 89.7 23.7 7.2 1.4 6.7 173.7 24.6 40.0 10.0 103.5 129.3 291.4 7.6 20.5 53.5 52.3 29.0 4.5 33.3 55.1 70.1 64.0 191.4 63.2 17.0 3.8 11.5 120.3 100.6 3.3 0.1 5.6 4.9 5.0 16.8 3.1 19.2 25.3 20.3 30.0 6.4 2.1 118.6 6.2 7.3 15.1 3.6 3.7 35.5 137.6 27.4 32.0 59.4 84.0 216.0 1.5 71.9 2.1 9.4 7.0 0.8 5.7 0.6 1.0 1.0 3.5 0.8 0.9 0.4 1.7 0.6 0.5 1.8 1.6 0.8 0.3 1.1 0.6 13.5 32.3 22.9 26.8 18.4 32.0 51.1 28.5 33.7 21.3 41.4 55.8 30.9 28.9 94.9 28.1 93.2 183.2 137.3 47.1 134.9 0.6 56.0 37.6 31.6 14.3 61.5 18.4 0.0 2.0 98.6 19.4 5.9 24.6 2.5 46.2 32.4 33.4 107.8 25.7 138.6 91.9 14.8 64.4 85.6 88.6 172.4 11.2 18.5 141.1 36.7 0.0 87.5 18.1 12.2 64.4 52.0 4.3 7.8 126.5 46.2 83.4 25.3 1.2 2.1 49.8 382.9 70.8 14.7 7.2 430.1 134.7 12.7 15.8 35.2 0.5 13.1 213.2 76.8 17.2 9.2 185.8 171.5 25.9 72.4 2.4 14.3 88.8 ELMO3 "CED-12, CED12, ELMO-3, FLJ13824" ENSG00000102890 "Engulfment and cell motility 3" Q96BJ8 16 67199111-67204029 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 63.9;Paneth cells: 50.3;Proximal enterocytes: 100.3;Undifferentiated cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 33.1;CAPAN-2: 49.3;HaCaT: 46.9;T-47d: 45.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA021484 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cell Junctions" "HPA021484: AB_1848129" "unprognostic (4.49e-3)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (8.08e-2)" "unprognostic (1.39e-1)" "unprognostic (6.16e-3)" "unprognostic (3.14e-1)" "unprognostic (8.17e-3)" "unprognostic (1.73e-1)" "unprognostic (8.06e-2)" "unprognostic (3.40e-2)" "unprognostic (6.95e-3)" "prognostic favorable (2.77e-5)" "unprognostic (3.47e-1)" "unprognostic (2.66e-1)" "unprognostic (1.84e-1)" "unprognostic (1.97e-2)" 2.8 1.8 1.5 4.3 1.4 5.6 8.8 2.4 2.6 6.4 0.3 24.3 33.1 2.0 4.1 25.8 8.5 8.6 1.9 1.1 1.7 21.4 8.1 8.3 2.9 2.1 1.0 1.8 41.0 8.5 29.8 7.1 2.8 19.3 9.1 0.7 20.3 9.6 1.2 33.5 26.3 0.8 0.4 5.6 26.0 13.0 1.3 2.1 19.3 0.3 2.6 8.5 13.2 1.5 22.1 2.5 2.4 3.0 0.4 0.6 33.1 1.3 0.7 1.6 1.4 14.2 49.3 3.0 1.5 0.7 0.7 46.9 2.2 21.6 0.3 1.4 2.9 3.2 4.8 4.7 1.0 1.9 7.5 0.5 15.6 1.2 1.1 1.6 1.7 2.6 3.1 1.5 0.9 18.4 2.0 9.3 3.2 20.7 1.9 4.6 2.3 4.9 2.0 2.9 16.2 3.6 3.2 14.4 1.5 1.3 45.8 3.4 2.8 3.7 4.5 2.3 2.3 4.9 1.7 5.8 1.9 4.4 1.8 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.1 0.1 0.0 1.5 1.4 2.4 2.6 1.1 1.7 2.1 1.0 2.8 0.4 1.3 1.5 1.8 0.0 13.1 0.0 2.0 8.8 11.9 21.9 13.1 0.9 20.6 16.3 1.2 15.7 12.6 20.2 0.0 33.8 1.0 63.9 17.6 20.1 22.9 8.8 1.7 1.6 13.1 6.9 0.4 24.0 15.0 1.7 47.4 12.2 4.5 1.3 1.4 3.6 3.6 0.0 0.3 33.8 22.4 1.6 3.1 36.3 0.9 2.6 3.6 1.9 2.8 0.4 0.0 0.0 1.0 24.8 50.3 0.7 1.4 7.9 100.3 28.6 12.3 1.5 0.0 0.4 1.6 14.5 5.9 14.4 13.5 16.8 2.3 5.0 52.3 13.0 ELP2 "FLJ10879, STATIP1, StIP" ENSG00000134759 "Elongator acetyltransferase complex subunit 2" Q6IA86 18 36129444-36180557 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002996, CAB020835" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" Cytosol Nucleoplasm "CAB020835: , HPA002996: AB_1857552" "unprognostic (5.51e-2)" "unprognostic (1.29e-1)" "prognostic favorable (5.41e-4)" "unprognostic (6.66e-3)" "unprognostic (4.33e-2)" "unprognostic (4.54e-1)" "unprognostic (2.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.92e-1)" "unprognostic (6.74e-3)" "unprognostic (7.31e-3)" "unprognostic (7.07e-2)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (3.05e-2)" "unprognostic (1.14e-1)" "unprognostic (8.97e-2)" 17.7 20.7 12.1 12.3 13.2 13.2 35.3 12.4 11.9 23.5 12.3 19.1 15.2 27.3 31.0 15.9 28.8 20.3 23.6 11.4 14.2 18.9 46.2 16.6 19.9 12.1 12.1 48.6 24.4 24.8 20.7 20.8 12.6 29.4 16.2 21.2 19.1 26.3 32.4 21.5 14.0 22.5 12.2 16.7 16.5 22.2 13.4 23.6 21.8 32.3 23.3 22.5 16.9 16.0 23.7 16.7 30.8 27.8 42.7 63.9 33.9 47.9 69.3 39.6 52.5 17.6 21.5 49.6 32.6 40.4 26.5 32.9 39.7 35.8 55.8 22.6 21.1 19.2 27.4 31.0 46.6 63.0 19.6 52.3 40.2 39.4 63.6 59.5 45.0 33.8 32.9 25.4 42.4 28.4 30.6 27.0 36.7 18.2 12.6 48.7 37.0 34.9 35.7 54.4 24.2 46.3 45.1 17.6 73.0 44.0 22.5 31.2 26.8 35.6 20.5 13.2 24.8 30.4 25.6 46.2 30.0 33.2 31.3 22.0 12.1 10.0 12.6 17.6 17.9 20.0 17.0 15.0 17.6 16.3 21.5 18.9 2.2 22.2 24.8 17.5 18.4 14.0 12.1 13.2 12.4 11.9 11.4 14.2 12.1 12.1 12.6 12.2 13.4 16.0 25.0 48.1 28.8 34.3 46.3 32.9 49.4 33.8 39.9 50.1 42.1 28.6 48.5 22.8 29.2 35.0 43.8 39.5 45.9 10.9 29.4 26.4 55.0 29.9 33.1 29.4 24.7 21.7 61.7 22.2 42.3 39.2 17.3 29.5 36.7 39.9 24.7 75.3 22.8 33.7 60.7 20.3 20.3 28.0 24.8 90.4 43.5 20.8 23.2 34.7 39.1 26.9 41.2 52.3 77.4 18.7 12.1 36.5 34.2 60.9 24.3 19.0 36.5 45.4 6.6 40.8 30.6 40.0 33.2 25.0 36.7 39.8 39.7 28.0 26.9 50.7 ENPP1 "M6S1, NPPS, PC-1, PCA1, PDNP1" ENSG00000197594 "Ectonucleotide pyrophosphatase/phosphodiesterase 1" P22413 6 131808016-131895155 "CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins" Biomineralization Hydrolase "Diabetes mellitus, Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in single" "NK-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032904, HPA062066" Enhanced "Secreted - unknown location" NA NA 4400000 "Cluster 48: NK-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "CAB032904: AB_2099635, HPA062066: AB_2684674" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.60e-3)" "unprognostic (2.40e-1)" "unprognostic (1.11e-1)" "unprognostic (2.00e-1)" "unprognostic (1.60e-2)" "unprognostic (7.22e-3)" "unprognostic (8.96e-2)" "unprognostic (1.95e-1)" "unprognostic (3.00e-1)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" "unprognostic (1.96e-1)" "unprognostic (1.84e-1)" "unprognostic (3.28e-3)" 8.4 3.1 0.4 1.4 0.5 0.1 7.1 0.7 0.4 7.1 0.4 2.3 1.8 22.1 7.4 2.3 6.9 1.2 1.6 0.4 0.7 4.2 31.9 0.8 1.4 1.2 1.4 8.3 28.5 27.8 10.9 44.0 0.9 3.4 2.0 0.5 4.2 5.8 2.7 1.7 1.3 10.2 0.8 1.9 1.7 1.6 1.0 2.2 20.1 3.2 0.8 2.7 4.9 0.8 0.0 1.3 1.2 0.1 34.1 5.3 0.0 9.2 9.4 3.5 9.5 4.1 1.1 0.0 0.8 5.9 7.2 0.0 1.3 0.2 14.8 0.3 1.8 0.0 1.1 12.0 1.0 0.0 4.2 8.8 0.4 9.6 0.4 4.1 4.3 0.7 0.0 1.8 21.1 2.6 0.0 0.0 7.9 1.6 1.3 0.0 10.2 0.3 0.2 0.4 3.4 0.0 0.2 1.3 4.2 5.7 3.9 0.0 2.9 27.6 1.0 1.9 9.1 3.4 0.0 0.0 12.6 0.0 3.5 0.6 0.0 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.7 0.2 0.0 0.0 0.3 1.6 0.1 0.1 0.0 0.0 0.4 0.5 0.7 0.4 0.4 0.7 1.2 1.4 0.9 0.8 1.0 0.8 2.6 0.0 1.7 0.3 1.5 1.5 9.9 0.0 0.6 4.5 28.7 19.9 6.4 5.7 0.1 1.8 0.0 3.0 1.2 16.7 5.9 0.3 4.8 3.9 80.2 4.1 0.0 8.0 3.5 10.6 2.1 56.9 6.1 3.2 0.0 9.4 3.3 111.6 4.6 1.7 10.5 12.7 0.0 2.9 5.9 6.7 25.1 3.9 1.8 12.2 0.2 3.6 0.0 21.6 1.6 5.2 3.9 70.0 0.4 2.3 6.7 25.2 0.1 0.5 13.1 12.6 18.8 4.1 2.2 0.1 1.3 6.2 2.6 1.9 2.5 1.7 EPB41L4B "EHM2, LULU2" ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171974-109321059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 88.9;pancreas: 149.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 134.8;Excitatory neurons: 79.7;Hepatocytes: 125.2;Proximal enterocytes: 79.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 31.7;hTCEpi: 49.8;OE19: 62.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavorable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 21.0 9.7 6.0 4.5 8.7 0.0 15.3 2.0 12.2 4.1 11.8 57.6 47.6 1.2 17.9 1.5 10.8 4.2 8.8 10.7 6.4 6.4 88.9 6.3 0.2 2.7 5.3 13.8 149.1 11.1 1.6 2.5 3.7 7.6 56.7 3.0 26.9 9.1 6.1 15.5 51.9 1.9 7.2 0.1 30.6 7.5 10.9 0.6 44.7 0.7 1.6 2.2 3.4 4.3 8.7 10.8 0.7 0.8 0.8 0.0 31.7 1.1 0.4 3.7 1.9 18.5 8.5 0.0 2.3 1.0 8.9 13.9 21.5 11.5 3.9 9.2 5.1 0.0 3.4 26.5 2.2 0.4 0.0 0.3 49.8 1.5 17.0 1.1 0.2 8.0 0.3 0.0 5.2 22.3 0.4 0.2 13.8 62.8 15.7 0.0 0.0 0.6 12.9 13.1 13.1 1.4 3.4 22.2 0.0 6.3 5.2 0.1 0.5 7.5 7.6 2.5 3.1 0.1 0.1 0.0 5.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 8.7 2.0 12.2 10.7 6.4 2.7 5.3 3.7 7.2 10.9 4.3 0.2 6.4 5.1 2.6 0.4 11.5 5.4 6.0 1.2 7.5 22.7 10.4 18.5 20.0 9.6 7.3 0.0 4.1 0.0 134.8 0.0 3.5 11.7 23.8 2.3 0.8 51.6 0.0 79.7 20.8 2.1 2.5 26.0 20.7 0.0 6.2 5.0 125.2 0.6 38.7 58.9 51.4 12.2 1.6 1.5 1.9 13.4 0.4 1.8 3.7 0.0 1.9 0.0 12.1 3.8 10.2 54.4 2.6 0.0 7.2 79.2 0.8 39.2 1.1 0.0 0.8 1.0 1.4 17.2 0.9 24.0 1.9 0.5 6.8 46.5 6.5 ERGIC2 "Erv41, PTX1" ENSG00000087502 "ERGIC and golgi 2" Q96RQ1 12 29337352-29381189 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 383.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049695 Approved Supported "Nucleoli rim,Golgi apparatus,Vesicles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "Nucleoli rim" "HPA049695: AB_2680855" "unprognostic (1.62e-2)" "unprognostic (3.50e-2)" "unprognostic (5.53e-2)" "unprognostic (3.56e-1)" "unprognostic (1.45e-1)" "unprognostic (5.19e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (3.70e-2)" "unprognostic (2.32e-2)" "prognostic favorable (8.18e-4)" "prognostic unfavorable (7.02e-6)" "unprognostic (2.67e-1)" "prognostic unfavorable (3.76e-6)" "unprognostic (6.02e-2)" "unprognostic (2.08e-1)" "unprognostic (3.19e-2)" "unprognostic (2.64e-1)" 38.5 32.5 22.7 37.8 24.6 10.5 46.0 25.1 29.0 34.4 20.8 37.1 34.4 34.4 50.1 46.0 24.2 33.1 52.4 22.6 25.9 30.6 47.6 26.3 33.8 24.9 23.9 26.9 40.2 47.2 20.7 53.1 24.3 39.5 33.7 29.4 49.2 34.5 33.8 19.2 34.9 39.3 25.4 26.7 32.6 57.8 24.4 35.0 45.1 47.0 43.6 50.1 22.1 34.4 96.7 87.0 69.1 46.8 94.8 111.5 170.1 153.1 123.4 92.7 98.3 115.7 157.6 51.3 149.1 120.7 168.7 98.7 66.0 98.3 146.4 112.6 69.4 84.0 114.6 68.3 55.7 121.2 70.0 79.1 75.9 115.8 116.7 169.3 71.8 69.8 70.5 144.6 122.6 52.3 60.3 126.2 98.9 101.3 235.0 54.9 189.9 107.6 75.5 140.1 26.5 43.2 77.2 86.5 91.5 145.9 168.0 96.7 81.8 124.1 108.1 169.1 167.6 106.4 145.5 106.0 103.7 87.3 105.3 92.3 50.2 70.6 84.7 79.9 102.9 83.2 107.6 101.2 55.1 71.0 106.6 90.3 181.1 72.1 101.1 120.9 130.8 90.1 22.7 24.6 25.1 29.0 22.6 25.9 24.9 23.9 24.3 25.4 24.4 34.4 54.6 28.9 28.6 20.9 74.3 57.9 68.9 144.1 39.9 54.8 57.2 55.1 61.7 38.6 99.0 53.3 54.2 119.2 60.8 19.4 49.0 72.7 383.0 48.7 66.5 43.7 41.8 44.8 39.2 62.8 120.6 73.0 25.5 54.6 55.8 44.2 34.6 50.2 56.4 48.8 37.8 33.5 87.5 25.5 40.2 51.9 52.5 37.1 62.2 14.0 41.6 69.5 52.5 32.2 48.3 58.1 20.5 59.8 154.0 85.7 32.4 49.5 64.6 60.0 32.9 58.5 105.7 75.0 36.3 49.4 66.3 156.2 68.0 54.0 34.7 78.8 ERLEC1 "C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB" ENSG00000068912 "Endoplasmic reticulum lectin 1" Q96DZ1 2 53787044-53818819 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 394.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031501, HPA031502, HPA031503" Enhanced "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425" "unprognostic (1.27e-2)" "unprognostic (3.36e-3)" "unprognostic (3.17e-1)" "unprognostic (1.97e-3)" "unprognostic (1.08e-2)" "unprognostic (1.86e-1)" "unprognostic (3.27e-3)" "unprognostic (3.79e-1)" "unprognostic (1.29e-1)" "unprognostic (2.95e-2)" "unprognostic (1.82e-1)" "unprognostic (1.92e-1)" "unprognostic (4.71e-2)" "unprognostic (1.47e-1)" "unprognostic (8.13e-2)" "unprognostic (2.33e-2)" "unprognostic (3.92e-2)" 38.4 51.0 30.2 31.3 32.1 33.8 48.7 29.3 41.9 66.4 39.3 45.8 37.7 40.9 93.9 26.1 36.2 41.0 45.2 32.9 39.2 38.1 43.4 44.1 32.4 28.7 31.1 38.0 67.1 57.3 59.4 56.6 31.5 72.8 50.2 54.5 54.0 55.9 32.1 20.1 34.0 38.5 30.1 33.1 55.3 42.4 31.5 28.1 72.5 39.5 41.2 44.7 27.2 34.4 42.1 47.3 44.4 27.4 123.3 111.3 65.5 100.5 109.1 49.0 51.4 31.3 55.7 29.4 94.5 106.3 86.3 29.7 29.2 42.3 62.1 67.0 38.7 36.1 29.1 93.8 84.4 60.2 63.9 70.5 69.4 51.6 83.3 99.4 58.1 28.6 39.0 115.8 73.6 35.3 27.7 48.0 34.1 67.1 30.4 24.9 53.1 82.7 57.7 39.3 26.5 46.3 36.6 79.0 64.6 50.3 38.0 45.9 63.3 53.9 47.2 44.0 60.3 170.1 120.3 16.5 88.2 35.8 64.5 77.0 25.1 30.7 41.4 27.8 45.8 36.8 36.3 39.9 28.0 28.6 33.9 39.0 9.6 45.4 33.3 40.1 36.6 41.5 30.2 32.1 29.3 41.9 32.9 39.2 28.7 31.1 31.5 30.1 31.5 34.4 57.2 89.8 116.7 22.2 86.3 25.1 42.5 88.0 34.1 77.0 76.3 54.6 83.5 52.9 93.5 66.2 31.3 100.2 60.9 43.4 33.2 76.1 168.4 67.7 77.5 63.8 55.1 23.1 24.0 115.7 105.8 99.7 54.6 101.7 74.1 36.6 68.6 81.8 60.1 95.9 28.5 169.7 107.8 39.7 31.5 117.9 88.3 41.7 80.0 17.8 61.7 79.7 72.1 20.6 25.3 90.2 42.8 84.2 394.0 113.4 32.3 51.4 118.2 68.6 52.6 55.6 109.5 146.1 65.3 40.3 33.4 183.6 57.0 48.3 57.1 67.5 ERMAP "BTN5, RD, SC" ENSG00000164010 "Erythroblast membrane associated protein (Scianna blood group)" Q96PL5 1 42817122-42844991 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 38.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA042573, HPA054672" Uncertain Approved "Golgi apparatus,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 6: Erythroid cells - Oxygen transport" "Golgi apparatus" Cytosol "HPA042573: AB_10794282, HPA054672: " "unprognostic (9.46e-2)" "unprognostic (4.47e-2)" "unprognostic (2.56e-3)" "unprognostic (1.15e-1)" "unprognostic (6.09e-2)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (7.48e-2)" "unprognostic (2.71e-3)" "unprognostic (6.46e-2)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (8.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.48e-1)" "unprognostic (9.48e-2)" 8.0 9.2 3.9 4.7 4.2 30.5 8.3 3.8 4.6 8.6 4.8 7.3 6.5 6.0 15.8 7.2 10.1 7.5 4.3 3.8 5.0 7.1 13.2 7.2 4.9 5.0 4.5 5.5 9.5 8.4 5.8 5.9 4.4 7.8 8.1 4.3 8.6 6.2 2.3 9.3 6.1 6.3 4.4 5.2 7.8 4.1 4.8 5.3 13.0 3.6 5.4 5.5 3.9 5.0 5.2 7.1 2.1 7.0 7.7 22.4 2.0 10.5 17.8 9.3 9.3 2.9 9.6 4.6 3.5 11.2 4.4 6.5 2.4 3.2 8.3 7.8 8.2 38.3 5.2 2.3 9.5 5.2 18.8 13.7 11.8 4.3 9.9 16.8 6.1 5.6 26.4 4.7 8.6 3.6 2.3 1.6 5.1 3.3 3.8 2.6 2.8 4.3 8.0 8.1 4.7 3.2 9.0 3.3 4.0 3.7 6.6 19.6 9.6 6.9 3.9 5.9 4.8 1.8 4.4 2.0 5.6 5.8 4.4 0.0 4.3 2.1 1.2 4.5 0.6 1.3 1.2 0.9 5.1 0.7 1.0 1.0 1.3 2.2 3.0 1.0 3.2 1.9 3.9 4.2 3.8 4.6 3.8 5.0 5.0 4.5 4.4 4.4 4.8 5.0 2.4 12.8 10.9 9.8 2.9 3.8 2.9 3.2 6.2 1.8 6.6 6.3 2.2 4.3 6.2 3.7 22.9 3.1 4.4 4.8 1.9 3.6 4.3 4.7 6.2 3.3 5.4 81.7 5.5 7.2 1.6 3.6 6.1 5.6 2.5 10.4 3.6 12.9 7.8 11.8 2.2 4.4 0.0 11.7 2.9 25.7 2.8 7.4 5.4 14.0 7.1 4.8 1.0 9.5 10.6 4.8 3.9 4.1 2.1 2.9 3.5 4.0 6.5 4.5 0.0 4.7 2.6 0.1 0.7 5.7 3.8 2.9 2.3 7.4 5.5 2.3 ERN1 "IRE1, IRE1P" ENSG00000178607 "Endoplasmic reticulum to nucleus signaling 1" O75460 17 64039080-64130819 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Transcription, Transcription regulation, Unfolded protein response" "Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 53.0;pancreas: 66.7" "Cell type enhanced" "Detected in many" "Plasma cells: 325.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 17.9" "Group enriched" "Detected in many" 5 "dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0" "Cell line enhanced" "Detected in many" "Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009495, HPA027730" Supported NA Yes "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "CAB009495: AB_2098712, HPA027730: AB_10602494" "unprognostic (2.52e-1)" "unprognostic (1.16e-2)" "unprognostic (1.89e-1)" "unprognostic (4.05e-3)" "unprognostic (3.63e-2)" "unprognostic (2.81e-2)" "unprognostic (9.14e-2)" "unprognostic (2.72e-2)" "unprognostic (4.55e-1)" "unprognostic (6.17e-2)" "unprognostic (2.95e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.65e-1)" "unprognostic (1.89e-1)" "unprognostic (1.36e-2)" "unprognostic (3.11e-2)" 9.5 53.0 1.5 5.4 1.7 13.4 7.5 2.6 3.2 22.6 2.1 7.7 6.3 10.1 6.4 9.5 14.3 6.2 6.1 1.6 2.4 5.6 23.5 16.5 5.8 1.7 1.0 16.9 66.7 4.3 19.5 5.6 1.3 9.9 4.5 8.8 15.7 7.1 6.8 11.3 10.6 5.6 1.0 15.8 16.2 2.8 1.6 6.8 10.2 2.4 6.6 8.3 11.7 1.7 4.0 4.0 2.2 4.8 4.8 4.4 9.8 4.1 9.7 2.8 1.3 2.5 2.3 6.6 3.2 2.8 3.5 3.6 1.9 4.5 6.1 1.6 1.5 6.0 3.2 2.4 19.6 3.2 2.1 3.8 8.1 6.4 21.5 3.5 5.0 4.7 4.2 74.6 2.8 3.9 4.5 1.0 0.6 3.6 3.2 4.2 4.2 40.2 1.1 5.5 7.1 3.5 4.3 6.1 5.7 3.5 3.8 5.9 5.9 2.5 4.1 6.4 2.7 77.4 23.9 4.8 4.0 2.1 4.2 17.9 0.9 0.4 4.9 0.4 9.0 0.2 3.3 4.1 0.4 0.3 0.9 0.9 4.9 2.5 0.3 7.7 0.8 1.0 1.5 1.7 2.6 3.2 1.6 2.4 1.7 1.0 1.3 1.0 1.6 1.7 31.9 0.0 36.1 7.2 27.8 22.0 54.3 8.3 15.4 4.0 35.0 29.7 8.6 11.5 8.6 12.9 6.2 8.1 106.4 10.0 1.9 12.6 2.3 26.1 49.1 18.3 79.7 11.2 8.6 27.3 8.8 42.2 52.0 79.4 8.2 11.8 13.9 26.8 8.0 3.3 6.1 8.2 8.2 15.7 71.3 1.7 4.7 60.4 74.7 12.2 10.2 3.5 28.8 6.0 4.6 17.9 7.3 6.0 325.8 44.7 7.9 4.4 6.1 26.5 0.0 19.0 25.7 4.0 4.1 27.7 45.0 54.9 88.2 12.0 9.6 60.1 ERP29 "C12orf8, ERp28, ERp31, PDI-DB, PDIA9" ENSG00000089248 "Endoplasmic reticulum protein 29" P30040 12 112013348-112023449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039363, HPA039456" Enhanced Uncertain Nucleoplasm,Microtubules "Intracellular and membrane" NA NA 900000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Microtubules Nucleoplasm "HPA039363: AB_10673422, HPA039456: AB_10672963" "unprognostic (2.70e-2)" "unprognostic (1.16e-1)" "unprognostic (1.96e-1)" "prognostic favorable (7.43e-5)" "unprognostic (1.13e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.02e-4)" "unprognostic (1.04e-2)" "unprognostic (2.00e-1)" "unprognostic (1.21e-1)" "unprognostic (5.10e-3)" "unprognostic (2.58e-1)" "unprognostic (3.21e-1)" "unprognostic (2.74e-3)" "unprognostic (3.34e-1)" "unprognostic (1.76e-1)" "unprognostic (6.26e-2)" 62.7 100.9 56.9 77.9 58.0 202.3 84.0 65.1 62.0 78.4 91.1 94.5 100.7 60.5 109.8 91.5 74.8 64.1 59.0 56.0 68.7 93.0 179.9 78.8 123.8 61.1 62.6 78.9 174.6 123.6 99.1 73.0 64.2 93.4 91.3 68.3 122.7 87.4 34.3 113.3 96.1 47.1 57.8 118.3 131.4 57.6 60.8 107.6 90.4 34.3 111.2 75.9 71.0 61.6 145.4 137.2 98.8 194.2 367.4 143.7 211.3 139.2 163.7 108.5 139.3 215.2 164.4 152.7 106.4 244.5 117.8 175.4 187.8 181.2 89.3 133.7 104.2 174.3 150.1 239.2 246.8 432.1 164.0 207.5 227.6 178.4 201.6 287.4 156.1 157.9 203.2 277.3 84.7 166.6 140.9 765.7 161.5 513.1 102.5 114.2 120.9 501.2 229.8 213.5 88.6 119.8 173.6 140.1 426.1 187.4 177.1 575.7 116.5 92.6 142.7 88.8 103.3 303.4 379.8 128.0 157.8 268.5 73.2 96.2 241.4 346.2 131.6 178.8 140.4 259.1 170.7 164.1 229.7 264.1 186.5 154.9 47.5 86.5 170.9 455.8 179.6 307.4 56.9 58.0 65.1 62.0 56.0 68.7 61.1 62.6 64.2 57.8 60.8 61.6 102.6 83.3 183.4 13.7 324.8 141.4 205.5 249.3 132.6 125.3 207.8 199.9 91.6 198.8 178.0 185.8 110.5 497.7 396.6 210.1 93.9 239.5 7.7 142.1 84.9 114.9 197.9 134.4 14.4 211.8 405.3 118.3 131.5 149.9 88.8 164.4 146.3 346.6 373.1 80.8 20.6 280.6 343.8 306.9 192.6 16.6 128.9 230.4 168.9 12.2 269.0 152.8 160.6 11.6 22.8 128.7 288.0 106.8 350.1 195.4 355.5 274.6 187.0 164.9 52.6 79.2 112.2 100.3 195.3 143.1 161.0 441.6 221.7 252.4 285.2 219.8 ERP44 "KIAA0573, PDIA10, TXNDC4" ENSG00000023318 "Endoplasmic reticulum protein 44" Q9BS26 9 99979185-100099000 "Plasma proteins, Predicted intracellular proteins" "Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001318 Supported "Intracellular and membrane" NA NA 5300000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "HPA001318: AB_1080427" "unprognostic (8.28e-2)" "unprognostic (1.32e-1)" "unprognostic (5.56e-2)" "unprognostic (5.97e-3)" "unprognostic (1.55e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (1.29e-1)" "unprognostic (3.88e-2)" "unprognostic (2.58e-1)" "unprognostic (2.00e-2)" "unprognostic (5.38e-2)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "unprognostic (1.66e-1)" "unprognostic (3.90e-1)" "unprognostic (2.31e-1)" 18.4 17.3 8.1 17.7 8.5 21.3 16.2 12.9 10.5 19.5 10.1 22.0 22.4 15.2 39.3 17.8 13.7 16.7 15.9 8.2 9.1 18.0 34.2 18.6 17.9 8.0 8.7 12.4 27.4 18.7 13.3 32.6 8.5 18.9 23.6 15.8 20.8 18.3 11.6 12.9 23.8 16.8 8.4 18.4 24.1 10.6 8.6 14.6 27.1 11.6 18.6 19.3 14.1 9.0 18.5 14.7 20.7 23.6 73.5 34.9 37.6 39.9 54.2 27.6 36.3 31.2 52.4 47.3 25.7 45.5 41.1 65.9 25.7 28.1 24.9 24.5 14.4 17.8 14.3 22.8 64.3 32.2 27.0 39.4 41.5 24.2 34.7 26.2 34.2 15.7 34.7 35.7 22.7 28.8 22.1 22.6 21.5 72.0 18.9 19.2 34.7 32.9 35.9 20.9 16.2 18.9 32.8 40.2 28.9 30.5 15.0 32.8 23.8 20.5 19.2 27.4 17.7 20.5 19.3 15.8 31.3 21.0 28.3 32.8 45.7 42.7 20.2 49.2 19.5 28.1 19.9 22.1 37.4 26.5 15.1 17.6 41.5 27.4 62.3 23.4 23.5 37.7 8.1 8.5 12.9 10.5 8.2 9.1 8.0 8.7 8.5 8.4 8.6 9.0 72.3 54.5 41.8 38.8 77.5 43.3 80.3 146.6 29.0 34.3 33.9 25.3 34.7 54.3 84.6 33.1 18.8 141.4 72.5 90.0 17.6 104.4 8.4 42.2 61.4 62.5 53.1 38.3 69.4 111.8 150.5 72.0 57.1 62.3 71.0 54.2 64.6 73.3 165.7 30.3 70.0 118.1 73.2 79.5 101.9 7.7 61.2 102.2 64.0 85.3 128.5 32.7 61.8 45.8 68.9 92.8 90.0 67.7 97.9 75.9 111.2 51.4 60.2 30.6 72.3 48.9 95.9 83.3 41.4 40.0 49.6 229.3 60.3 87.5 88.9 84.2 ERRFI1 "GENE-33, MIG-6, RALT" ENSG00000116285 "ERBB receptor feedback inhibitor 1" Q9UJM3 1 8004404-8026309 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 743.8;pancreas: 678.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 1242.3;Basal prostatic cells: 1428.1;Hepatocytes: 722.3;Suprabasal keratinocytes: 732.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "non-classical monocyte: 2.0" "Lineage enriched" "Detected in single" 5 "monocytes: 2.0" "Cell line enhanced" "Detected in many" "HHSteC: 558.4;LHCN-M2: 442.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076543 Supported Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA076543: " "unprognostic (2.13e-3)" "unprognostic (1.01e-2)" "unprognostic (2.34e-1)" "unprognostic (1.71e-2)" "unprognostic (2.50e-3)" "unprognostic (1.66e-3)" "unprognostic (2.27e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (1.47e-1)" "unprognostic (4.50e-2)" "unprognostic (2.10e-1)" "unprognostic (1.19e-3)" "unprognostic (1.11e-3)" "unprognostic (1.18e-1)" "unprognostic (2.34e-1)" "unprognostic (8.03e-3)" 143.6 41.7 13.8 31.0 15.3 1.8 127.6 33.0 20.5 87.0 42.2 61.5 33.3 78.1 18.3 51.2 75.8 131.1 53.3 16.7 20.3 157.3 743.8 82.8 17.6 31.9 16.7 148.5 678.8 88.0 112.1 125.6 17.4 53.1 23.4 36.3 76.1 26.0 225.9 124.6 47.2 88.5 28.6 9.5 125.0 16.5 18.7 18.4 113.4 30.2 12.5 86.9 75.5 20.9 86.1 49.7 20.8 28.2 192.6 143.0 215.7 81.9 23.8 15.0 17.5 22.2 218.9 1.4 47.9 27.6 102.5 18.2 5.8 144.7 68.2 2.6 16.1 1.3 15.1 260.1 558.4 0.9 3.3 195.8 142.7 49.4 118.7 208.4 38.3 3.6 6.1 0.7 442.5 36.8 0.3 5.5 50.0 66.3 121.7 7.4 233.8 1.4 69.3 27.0 14.3 8.5 16.2 36.5 26.0 145.6 25.4 2.0 54.4 57.7 33.9 49.0 116.6 1.3 1.1 1.5 222.0 3.8 54.4 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.4 0.4 0.0 0.1 0.3 0.4 0.0 0.0 2.0 0.1 0.2 0.0 13.8 15.3 33.0 20.5 16.7 20.3 31.9 16.7 17.4 28.6 18.7 20.9 93.0 221.2 108.7 22.5 9.2 1242.3 1428.1 228.6 249.8 9.8 186.3 115.9 52.1 177.3 198.7 27.6 14.6 87.6 25.7 161.9 31.3 99.1 24.0 209.6 74.4 29.8 109.5 21.5 18.4 111.2 51.0 130.1 56.6 336.3 14.5 3.9 32.5 722.3 10.0 3.3 16.5 70.2 59.0 11.7 95.0 63.9 51.9 17.9 71.2 8.4 0.6 40.0 3.1 13.0 30.9 144.9 127.2 38.4 6.6 382.2 78.1 131.1 86.3 9.9 6.6 113.9 93.3 21.1 21.8 152.6 732.9 259.0 33.5 4.9 82.7 543.4 FAAH2 "AMDD, FAAH-2, FLJ31204, RP11-479E16.1" ENSG00000165591 "Fatty acid amide hydrolase 2" Q6GMR7 X 57286706-57489193 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 75.7;Excitatory neurons: 110.2;Inhibitory neurons: 131.2;Oligodendrocyte precursor cells: 110.6;Oligodendrocytes: 105.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 16.7" "Lineage enriched" "Detected in many" 9 "T-cells: 16.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.0;HDLM-2: 13.0;RPMI-8226: 26.6;U-266/70: 20.9;U-266/84: 11.4" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 58: T-cells - T-cell receptor" "unprognostic (1.37e-1)" "unprognostic (1.78e-2)" "unprognostic (7.68e-2)" "unprognostic (2.29e-2)" "unprognostic (1.02e-1)" "unprognostic (4.51e-2)" "unprognostic (7.93e-3)" "unprognostic (4.47e-2)" "unprognostic (1.94e-1)" "prognostic favorable (5.99e-4)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" "prognostic favorable (2.47e-13)" "unprognostic (9.16e-3)" "unprognostic (2.27e-1)" "prognostic favorable (2.66e-4)" "prognostic favorable (6.83e-5)" 0.8 1.6 1.1 1.6 0.8 0.4 6.8 3.3 1.0 3.6 0.9 3.2 3.0 1.3 4.4 4.9 6.1 1.7 0.3 0.7 2.6 7.2 10.5 3.2 2.6 1.2 1.3 0.4 15.1 13.4 6.7 0.8 1.2 7.3 4.0 7.0 7.1 4.1 0.1 9.6 3.0 0.3 0.5 0.7 4.6 0.1 2.2 7.3 4.8 0.2 7.0 3.4 3.4 0.9 3.4 0.3 0.1 0.2 0.1 0.1 3.1 0.0 0.1 0.0 0.0 2.4 14.0 0.1 4.0 0.0 0.0 0.6 1.1 2.5 0.0 13.0 6.9 0.4 3.1 1.0 0.0 1.5 0.0 0.0 4.2 0.0 0.0 0.1 0.0 1.4 1.6 6.3 0.0 1.4 0.8 0.0 2.4 2.9 0.0 0.0 2.4 26.6 8.1 4.5 2.4 0.1 0.2 3.9 0.0 5.7 3.9 0.1 0.0 0.0 0.3 0.0 0.2 20.9 11.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.7 0.0 5.0 1.8 8.0 3.4 0.0 0.5 7.7 0.9 0.3 0.9 0.0 1.2 16.7 1.6 1.1 0.8 3.3 1.0 0.7 2.6 1.2 1.3 1.2 0.5 2.2 0.9 0.2 3.2 7.8 75.7 4.0 2.7 12.1 19.0 15.4 4.4 6.0 4.2 0.3 4.3 14.9 5.5 18.8 5.5 0.2 4.2 9.8 11.9 0.0 12.6 1.1 0.4 13.2 0.0 110.2 14.1 2.5 1.1 15.8 12.2 0.0 0.9 1.1 11.3 0.7 1.7 131.2 5.4 26.4 0.0 0.3 0.0 0.6 0.6 3.6 45.0 0.6 1.2 0.0 110.6 105.3 11.9 3.8 0.4 14.4 7.4 4.8 5.6 25.1 11.8 0.0 0.5 1.0 0.0 0.0 7.1 6.7 5.6 16.7 0.3 4.0 9.2 FAM136A FLJ14668 ENSG00000035141 "Family with sequence similarity 136 member A" Q96C01 2 70295975-70302090 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030103, HPA030104" Enhanced Approved Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" Mitochondria "HPA030103: AB_10600194, HPA030104: AB_10600534" "unprognostic (2.81e-1)" "unprognostic (5.76e-2)" "unprognostic (9.16e-2)" "unprognostic (3.69e-2)" "unprognostic (5.53e-2)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (1.14e-1)" "unprognostic (1.12e-2)" "unprognostic (1.28e-2)" "unprognostic (5.91e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (1.33e-6)" "unprognostic (4.95e-3)" "unprognostic (3.03e-1)" "unprognostic (4.03e-1)" "unprognostic (2.00e-3)" 10.7 12.2 16.0 17.8 16.4 20.4 16.8 16.4 19.4 15.2 16.1 25.9 26.1 10.0 14.6 19.2 14.3 9.7 21.5 16.0 17.8 20.1 32.5 10.5 17.5 17.0 17.0 10.6 31.4 20.6 10.3 18.0 17.9 15.8 27.1 16.4 27.1 14.1 24.5 14.7 21.6 14.0 15.8 13.6 19.6 8.9 17.9 17.7 20.6 22.2 21.4 17.8 10.5 15.5 94.8 83.4 51.5 72.4 26.5 39.1 78.4 50.2 47.7 67.8 46.8 222.0 53.3 64.9 44.5 43.6 58.9 42.5 106.8 40.0 69.2 67.1 121.3 99.7 62.1 138.8 38.1 166.5 62.7 27.0 27.3 63.9 54.0 36.3 73.8 93.0 161.1 51.0 51.0 138.0 107.6 143.9 129.2 127.7 88.7 71.2 96.2 107.1 104.9 65.4 119.7 52.3 37.7 90.6 76.1 47.3 37.6 47.9 44.9 28.9 85.1 44.7 96.2 42.3 70.0 75.2 72.0 93.2 50.1 35.8 27.9 21.0 21.3 39.8 31.9 37.0 23.6 25.9 37.8 33.2 27.3 27.6 2.6 53.4 27.9 24.8 20.5 29.6 16.0 16.4 16.4 19.4 16.0 17.8 17.0 17.0 17.9 15.8 17.9 15.5 16.7 41.7 31.6 8.8 49.5 28.0 35.4 41.3 35.3 26.3 46.6 46.1 54.7 11.5 38.9 33.1 25.0 89.5 46.0 52.3 70.5 71.8 1.3 39.3 28.3 20.1 32.9 50.5 8.6 99.1 107.5 31.9 40.8 47.1 27.9 46.1 18.9 59.3 69.8 8.4 9.4 61.2 44.7 22.4 29.2 3.6 13.4 31.9 28.4 3.7 42.0 29.1 49.4 6.0 3.6 95.0 58.1 18.4 88.6 54.8 69.7 73.5 31.8 26.7 13.1 19.8 32.5 14.0 53.8 49.8 41.9 29.6 36.8 49.2 66.7 45.7 FBXO4 FBX4 ENSG00000151876 "F-box protein 4" Q9UKT5 5 41925254-41941743 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003362 Approved Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA003362: AB_2666918" "unprognostic (1.43e-1)" "unprognostic (2.10e-2)" "unprognostic (9.25e-3)" "unprognostic (2.65e-2)" "unprognostic (2.50e-1)" "unprognostic (7.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.48e-2)" "unprognostic (1.62e-3)" "unprognostic (5.42e-3)" "unprognostic (1.69e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (1.28e-4)" "unprognostic (8.57e-2)" "unprognostic (1.51e-1)" "unprognostic (5.39e-2)" "unprognostic (8.27e-2)" 10.0 7.5 2.3 6.8 2.8 8.4 12.4 3.0 3.6 8.8 2.2 6.8 7.9 6.2 15.8 6.3 8.3 6.6 5.3 2.4 2.9 7.4 11.2 6.6 11.6 2.5 2.5 7.3 11.8 7.0 4.4 6.0 2.8 8.3 8.0 4.9 7.3 8.1 4.1 7.0 7.0 5.9 2.8 9.3 8.0 8.3 2.5 11.1 12.7 4.9 12.5 6.3 5.5 3.3 9.0 6.5 1.2 16.4 8.5 13.9 9.6 7.4 13.9 12.3 16.8 3.2 23.9 22.6 9.7 10.5 2.8 2.3 3.9 2.5 10.3 8.0 1.5 11.5 22.8 8.2 16.6 19.4 7.4 8.4 5.4 6.3 23.6 4.6 9.4 10.2 10.8 7.1 14.4 3.6 12.6 3.9 0.5 12.9 5.4 2.3 2.5 5.9 8.5 8.7 2.5 4.8 29.0 2.3 11.2 0.6 14.6 22.2 6.8 13.9 3.8 9.3 5.9 10.7 9.8 1.6 13.9 21.7 7.2 2.9 5.4 1.3 8.9 8.7 10.2 12.5 9.7 9.4 10.6 12.0 9.8 9.2 0.4 9.4 20.1 9.4 8.4 7.3 2.3 2.8 3.0 3.6 2.4 2.9 2.5 2.5 2.8 2.8 2.5 3.3 12.3 9.6 11.9 12.1 18.5 12.6 13.3 20.1 13.6 6.1 14.8 10.7 3.7 15.7 9.6 11.0 0.0 26.4 11.4 2.9 11.7 13.7 0.7 12.9 12.0 10.2 1.8 20.4 14.7 16.0 27.9 13.1 9.7 13.7 5.1 12.9 16.1 17.6 16.3 3.3 15.6 10.8 12.2 6.5 12.3 1.5 10.5 10.0 19.6 5.6 5.8 8.7 8.2 25.1 26.7 9.8 6.8 10.5 17.4 5.1 9.7 24.8 14.7 8.7 6.6 11.4 18.9 24.9 23.8 15.8 14.2 12.4 12.7 16.5 10.5 9.4 FNDC3A "bA203I16.5, FNDC3, KIAA0970" ENSG00000102531 "Fibronectin type III domain containing 3A" Q9Y2H6 13 48975912-49209779 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008927, HPA012555, HPA012825" Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Golgi apparatus, Centrosome" Cytosol "HPA008927: AB_1078899, HPA012555: , HPA012825: AB_1848985" "unprognostic (1.54e-1)" "unprognostic (1.34e-3)" "unprognostic (8.83e-2)" "unprognostic (1.04e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-1)" "unprognostic (2.91e-2)" "unprognostic (5.71e-2)" "unprognostic (6.17e-2)" "unprognostic (3.16e-2)" "unprognostic (1.87e-2)" "unprognostic (4.03e-2)" "prognostic favorable (4.25e-4)" "unprognostic (8.93e-3)" "unprognostic (1.03e-1)" "unprognostic (9.60e-2)" "unprognostic (6.14e-2)" 17.8 39.9 15.2 18.7 18.6 17.0 26.3 12.7 16.4 35.2 13.6 23.3 27.5 32.1 38.8 13.1 26.5 26.8 14.0 15.3 39.4 29.7 66.9 21.6 16.7 16.7 19.6 35.4 43.1 27.7 30.8 44.1 17.4 22.1 24.0 21.9 36.8 33.9 10.1 11.4 23.8 26.0 15.5 22.6 28.8 30.4 31.9 21.3 51.2 13.1 18.9 25.6 14.1 17.9 11.6 13.1 47.1 12.4 58.3 73.0 9.2 53.3 70.8 50.2 36.3 17.9 27.7 8.8 9.7 40.5 21.8 12.4 28.4 18.1 72.6 22.1 21.9 14.3 36.9 33.2 35.3 13.4 2.3 37.7 24.8 44.7 51.4 47.1 52.6 11.9 18.0 21.0 55.4 4.7 13.3 26.7 23.2 25.0 11.0 12.6 18.8 16.4 42.4 21.2 17.8 29.4 20.1 17.8 38.8 29.8 9.6 26.0 41.7 26.1 17.9 24.3 38.3 25.4 14.4 8.1 19.6 16.9 27.4 1.9 3.0 1.9 2.5 2.0 3.6 3.3 2.9 2.2 1.9 2.2 3.7 3.3 4.5 2.1 4.0 4.0 2.6 1.7 15.2 18.6 12.7 16.4 15.3 39.4 16.7 19.6 17.4 15.5 31.9 17.9 46.7 54.5 49.0 88.2 36.2 18.4 37.4 17.5 44.3 52.0 33.4 25.5 27.1 27.1 28.9 36.8 37.5 13.2 36.4 21.6 13.7 30.6 45.9 42.1 74.3 42.4 43.5 17.9 159.5 36.2 38.2 58.0 57.6 56.4 31.6 38.8 32.9 74.2 25.4 35.3 170.8 37.4 18.3 31.8 24.4 13.1 33.8 45.5 37.4 112.4 27.0 52.7 24.7 177.9 178.2 25.5 29.0 39.5 165.9 44.2 37.8 48.0 35.6 42.5 6.6 48.0 50.8 89.8 33.7 20.3 11.9 32.3 30.9 46.4 24.7 26.4 FNDC3B "DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421" ENSG00000075420 "Fibronectin type III domain containing 3B" Q53EP0 3 172039578-172401669 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 283.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 4 "cerebral cortex: 29.4;hypothalamus: 8.2;pons: 9.4;thalamus: 14.4" "Immune cell enhanced" "Detected in many" "neutrophil: 37.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 37.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007859 Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA007859: AB_1078900" "unprognostic (7.18e-2)" "prognostic unfavorable (2.41e-5)" "unprognostic (6.03e-2)" "unprognostic (6.38e-2)" "prognostic unfavorable (6.94e-4)" "unprognostic (3.25e-2)" "prognostic unfavorable (9.85e-4)" "unprognostic (2.17e-3)" "unprognostic (1.98e-1)" "unprognostic (2.46e-2)" "prognostic unfavorable (9.06e-5)" "unprognostic (3.50e-2)" "prognostic unfavorable (5.65e-7)" "unprognostic (4.35e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-2)" "unprognostic (3.00e-2)" 34.4 25.5 1.1 26.3 1.1 37.0 16.6 0.6 29.4 26.0 11.9 19.8 13.0 21.9 18.2 9.2 12.5 19.4 24.4 3.5 8.2 17.5 28.5 21.8 8.9 3.3 3.4 22.8 28.3 15.0 8.5 52.7 9.4 12.9 19.6 4.4 21.3 15.6 21.2 7.0 11.4 25.4 0.7 14.7 20.6 9.3 14.4 6.8 32.4 18.5 11.0 38.6 9.5 1.9 47.4 55.9 36.0 43.5 107.6 73.6 87.6 68.3 73.1 43.3 58.3 30.5 100.5 4.2 178.9 99.0 85.6 27.4 12.4 53.2 74.9 27.5 9.2 6.0 34.8 78.6 109.2 62.1 100.1 75.5 24.9 80.8 75.9 102.8 116.7 8.1 10.9 32.6 44.3 14.8 2.4 24.9 20.8 18.0 22.0 5.4 37.5 21.9 44.8 42.1 2.2 10.8 62.2 30.6 53.9 49.3 31.1 28.5 182.6 60.5 28.5 78.9 52.2 67.3 84.0 9.3 63.5 32.7 61.0 13.5 8.3 20.4 4.2 5.3 1.8 1.1 1.3 2.3 4.7 0.1 1.4 2.5 37.5 4.6 2.7 0.7 1.2 3.4 1.1 1.1 0.6 29.4 3.5 8.2 3.3 3.4 9.4 0.7 14.4 1.9 54.8 86.6 49.0 115.2 19.2 63.9 51.4 61.1 39.3 7.5 27.4 31.9 51.0 41.5 47.9 46.0 12.5 41.4 29.2 53.1 15.6 69.8 16.2 73.7 73.4 61.5 16.8 16.4 37.9 45.6 99.6 103.7 32.6 179.5 15.2 95.2 58.2 68.9 47.1 0.0 43.9 30.7 12.2 59.2 53.3 9.3 57.5 65.1 69.4 155.5 52.2 17.4 39.1 115.6 31.4 78.5 44.8 54.5 283.6 67.8 16.1 35.7 33.6 11.5 52.6 89.4 69.1 2.3 3.2 18.6 33.5 34.8 23.1 26.0 26.2 88.4 FOXA2 HNF3B ENSG00000125798 "Forkhead box A2" Q9Y261 20 22580998-22585455 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 36.2;pancreas: 26.6;stomach 1: 31.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "midbrain: 2.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 9 "midbrain: 3.9" "CAB001388, HPA066846" Enhanced Supported "Nucleoplasm,Cell Junctions" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Cell Junctions" "CAB001388: AB_2262810, HPA066846: AB_2685736" "unprognostic (1.19e-1)" "unprognostic (1.99e-1)" "prognostic favorable (7.57e-6)" "unprognostic (6.82e-2)" "unprognostic (1.50e-6)" "unprognostic (1.38e-1)" "unprognostic (8.17e-2)" "prognostic favorable (6.28e-4)" "prognostic favorable (2.34e-4)" "unprognostic (3.18e-1)" "unprognostic (2.55e-15)" "unprognostic (2.50e-2)" "unprognostic (1.68e-1)" "unprognostic (7.12e-2)" "unprognostic (3.93e-3)" 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 14.2 0.0 7.3 3.7 2.1 0.0 0.1 4.3 4.0 0.0 0.0 0.0 0.2 36.2 13.7 0.0 0.0 2.5 0.0 26.6 0.0 0.0 0.0 0.0 0.3 9.5 0.0 0.0 0.0 0.0 0.0 2.8 0.1 0.0 0.0 31.1 0.4 0.5 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 19.3 0.0 0.0 1.2 0.0 0.0 28.8 0.0 0.0 0.0 0.0 10.3 0.0 12.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 22.7 24.7 0.0 0.0 0.0 0.8 0.0 42.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.5 0.0 0.0 96.1 78.0 0.0 0.1 0.0 0.8 0.5 0.0 0.0 0.1 0.3 0.3 47.1 12.5 0.0 0.0 0.0 0.0 21.7 0.0 25.6 0.1 30.8 2.6 0.1 28.1 0.0 0.0 37.0 0.0 0.3 37.8 27.1 4.5 0.0 0.7 63.7 0.0 0.0 0.0 87.2 6.1 1.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 24.4 6.8 0.0 0.2 1.0 1.0 0.0 10.0 0.0 0.0 0.0 0.2 4.1 0.2 0.0 0.0 0.0 1.0 0.0 28.7 0.1 FOXA3 HNF3G ENSG00000170608 "Forkhead box A3" P55318 19 45863989-45873797 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "intestine: 17.5;liver: 64.6;pancreas: 48.2;stomach 1: 36.8" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB015154, HPA054034" Uncertain Approved Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm "CAB015154: AB_647545, HPA054034: AB_2682349" "unprognostic (2.88e-1)" "unprognostic (6.95e-2)" "unprognostic (2.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.07e-1)" "unprognostic (2.27e-1)" "unprognostic (2.39e-2)" "unprognostic (1.42e-1)" "unprognostic (6.87e-3)" "unprognostic (1.55e-1)" "unprognostic (6.42e-2)" "unprognostic (1.17e-2)" "unprognostic (2.57e-2)" "unprognostic (1.91e-2)" "unprognostic (3.55e-1)" "unprognostic (3.75e-1)" "unprognostic (2.11e-1)" 0.1 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.1 1.4 0.0 17.5 10.6 0.1 0.0 0.1 0.0 2.3 0.0 0.0 0.0 2.8 64.6 0.3 0.1 0.0 0.0 0.0 48.2 1.1 0.0 0.0 0.0 0.5 17.1 0.0 2.1 0.4 0.0 0.0 12.8 0.7 0.0 0.0 36.8 1.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.6 4.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 12.5 1.1 0.2 0.0 29.1 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.7 23.5 0.0 0.0 0.3 0.1 0.0 11.2 101.2 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.5 0.0 0.3 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 2.5 0.3 0.9 0.3 1.3 0.7 0.0 0.0 2.6 1.5 0.5 15.7 2.5 1.8 0.0 0.0 0.6 40.2 0.0 12.5 0.2 0.1 0.1 0.9 83.3 10.7 0.1 24.5 0.0 0.5 152.9 0.4 4.5 0.1 1.4 29.9 0.0 0.0 0.1 230.1 0.0 2.2 0.7 0.5 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.5 0.1 26.0 74.7 0.0 0.6 6.6 17.8 0.4 0.3 0.0 0.0 0.0 1.1 2.7 5.6 0.2 0.3 0.0 0.4 0.1 46.2 1.7 GALNT2 GalNAc-T2 ENSG00000143641 "Polypeptide N-acetylgalactosaminyltransferase 2" Q10471 1 230057990-230282122 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 133.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 429.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011222 Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA 13000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA011222: AB_1849446" "unprognostic (1.26e-1)" "prognostic unfavorable (1.22e-6)" "unprognostic (1.15e-2)" "unprognostic (1.35e-2)" "unprognostic (8.70e-3)" "unprognostic (7.77e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.48e-8)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (1.70e-2)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.79e-13)" "unprognostic (3.79e-3)" "unprognostic (1.49e-1)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" 32.9 49.6 17.0 34.8 19.9 13.9 21.9 15.2 16.7 24.7 22.0 28.9 19.5 27.1 6.9 21.0 22.4 21.2 27.4 15.8 18.6 18.5 100.1 27.1 14.0 23.0 19.5 39.2 68.1 9.9 13.6 27.6 18.3 21.4 12.4 19.8 22.1 14.3 67.4 14.7 23.6 25.0 15.3 17.4 33.1 19.7 25.1 42.8 19.0 27.4 11.2 33.4 19.5 15.5 79.5 103.7 59.9 71.4 112.4 95.3 122.8 146.3 90.0 58.4 55.6 45.2 146.5 20.0 106.2 77.7 135.9 150.7 39.9 123.0 48.6 200.1 52.0 60.7 217.2 50.9 60.9 23.4 114.8 136.9 59.8 78.0 30.9 127.3 69.2 110.1 77.0 29.6 65.6 21.8 122.3 23.9 82.1 52.8 97.7 134.3 85.5 61.7 57.4 92.9 18.9 70.1 148.4 7.9 91.0 31.7 46.5 43.5 165.3 56.7 107.9 129.5 118.0 97.9 60.3 44.4 146.1 46.3 429.7 1.5 10.7 3.6 4.4 9.3 3.2 3.4 2.6 4.5 7.8 5.8 2.5 5.0 3.2 2.8 10.2 13.2 3.3 7.7 17.0 19.9 15.2 16.7 15.8 18.6 23.0 19.5 18.3 15.3 25.1 15.5 18.6 16.0 21.3 71.5 32.1 15.3 20.0 52.8 20.5 30.8 13.8 10.7 13.6 18.6 30.1 23.9 33.3 7.3 21.7 24.1 5.9 49.7 47.2 18.7 15.4 17.9 16.8 27.6 67.3 133.0 123.4 36.1 21.4 24.5 13.3 20.5 19.6 98.8 24.9 28.6 82.0 18.9 4.1 42.4 9.7 24.6 35.8 28.9 24.9 106.8 44.0 10.9 18.6 72.9 44.6 88.5 21.6 29.3 109.0 23.5 17.9 19.2 23.5 73.5 13.1 33.1 25.4 3.4 14.0 16.6 8.0 16.6 21.2 32.8 17.6 29.9 GANAB "G2AN, GIIA, GluII, KIAA0088" ENSG00000089597 "Glucosidase II alpha subunit" Q14697 11 62624826-62646726 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026874, HPA061426" Enhanced Approved "Endoplasmic reticulum" "Intracellular and membrane" NA NA 23000000 "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA026874: AB_1849745, HPA061426: AB_2684516" "unprognostic (2.12e-1)" "unprognostic (5.95e-3)" "unprognostic (4.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.20e-2)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (5.80e-3)" "unprognostic (1.09e-1)" "unprognostic (1.79e-1)" "unprognostic (1.68e-3)" "unprognostic (5.91e-2)" "unprognostic (1.01e-3)" "unprognostic (3.81e-2)" "unprognostic (1.82e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.54e-4)" 93.9 73.7 31.8 88.2 34.5 83.7 92.8 36.6 36.7 112.6 51.6 104.7 95.6 102.1 151.7 66.4 106.9 75.3 67.9 31.7 41.2 98.5 171.7 86.8 81.7 38.5 34.9 115.5 88.1 130.6 21.8 141.8 38.1 97.5 116.8 79.4 101.8 111.1 39.4 74.7 90.5 126.0 36.5 86.7 85.2 66.1 39.8 105.2 132.6 53.0 94.8 90.7 34.2 43.4 298.2 245.9 318.2 552.0 464.1 389.0 332.9 312.4 480.4 436.2 362.1 222.2 515.9 201.2 616.0 572.5 337.8 376.4 375.2 376.7 443.8 155.8 191.3 202.9 317.8 125.6 389.0 325.7 248.7 397.2 248.4 433.6 475.3 533.0 422.3 199.6 278.5 352.9 398.2 313.6 167.6 193.4 262.3 236.6 237.7 209.5 368.7 513.1 285.7 230.3 168.6 221.2 451.1 308.2 370.8 321.6 380.9 304.8 311.6 430.0 272.2 342.9 309.9 360.8 423.8 152.2 473.9 173.1 421.7 23.9 19.3 19.1 23.8 23.4 23.1 15.9 17.2 20.0 20.8 14.9 20.9 21.3 8.9 29.8 22.2 18.4 17.3 22.6 31.8 34.5 36.6 36.7 31.7 41.2 38.5 34.9 38.1 36.5 39.8 43.4 42.7 12.8 20.7 17.3 29.8 28.3 29.4 45.8 13.6 31.4 57.4 53.8 7.8 52.9 24.2 68.0 60.5 81.7 33.4 40.1 5.9 47.0 18.5 31.4 59.1 42.2 31.8 25.0 12.6 42.6 137.3 45.9 27.5 46.5 11.4 72.8 48.2 98.0 57.9 35.3 16.0 48.9 34.6 45.8 25.1 16.4 58.4 32.7 35.6 15.9 38.9 36.5 38.1 11.1 16.5 39.5 29.3 68.1 50.4 34.0 47.8 27.0 26.3 41.4 32.9 36.4 34.7 25.3 47.4 21.2 31.3 80.2 25.2 63.1 56.3 32.4 GATA4 ENSG00000136574 "GATA binding protein 4" P43694 8 11676959-11760002 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 88.6;ovary: 95.4;pancreas: 53.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 41.4;Exocrine glandular cells: 33.7;Gastric mucus-secreting cells: 61.2;Granulosa cells: 158.4;Hepatic stellate cells: 57.8;Late spermatids: 37.0;Leydig cells: 41.3;Peritubular cells: 41.3;Theca cells: 80.1" "Cancer enhanced" "Detected in many" "stomach cancer: 21.8;testis cancer: 12.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 19.7;HHSteC: 20.9;OE19: 6.2;SH-SY5Y: 20.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB013125, HPA073899" Uncertain Supported "Nuclear bodies" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear bodies" "CAB013125: AB_2533804, HPA073899: AB_2686641" "unprognostic (2.99e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (8.68e-4)" "unprognostic (2.66e-3)" "unprognostic (1.71e-1)" "unprognostic (8.55e-3)" "unprognostic (1.02e-2)" "unprognostic (5.47e-2)" "unprognostic (2.55e-1)" "unprognostic (2.78e-2)" "unprognostic (2.49e-1)" "unprognostic (1.67e-8)" "unprognostic (1.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.29e-2)" 0.2 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 20.2 0.2 0.0 0.0 2.3 4.0 88.6 0.0 0.0 0.0 36.6 0.2 0.0 0.0 0.0 95.4 53.5 0.0 0.1 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.1 35.2 32.4 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 1.2 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 19.7 20.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.2 0.0 0.0 0.2 1.3 0.0 0.0 1.5 20.5 0.0 0.0 0.1 3.9 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.4 1.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 16.1 0.0 0.1 6.1 0.0 0.0 0.1 33.7 0.2 12.0 61.2 0.0 0.0 158.4 57.8 12.1 0.6 0.0 0.1 0.8 0.0 2.8 0.0 37.0 41.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.0 41.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 5.3 2.4 2.2 0.0 0.0 0.8 0.1 80.1 0.9 0.0 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "kidney: 2099.3;liver: 2804.2;pancreas: 2935.3" "Group enriched" "Detected in many" 8 "Hepatocytes: 1495.2;Proximal tubular cells: 3703.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 11.0;dendritic cells: 6.8" "Group enriched" "Detected in many" 4 "RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria NA NA 600000 "Cluster 43: B-cells - Humoral immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 14.4 21.4 133.9 12.4 138.4 1.8 25.4 152.5 216.5 9.9 94.3 19.6 175.5 8.4 10.5 25.1 11.6 47.7 57.2 131.1 140.9 2099.3 2804.2 7.3 18.4 148.0 135.4 165.2 2935.3 2.7 8.3 74.7 153.4 12.4 11.5 7.5 57.5 15.1 142.5 137.6 110.2 14.5 149.2 33.6 99.2 78.2 140.4 12.6 63.0 46.9 29.7 18.0 15.5 181.2 12.9 6.5 4.4 0.6 0.1 0.2 0.8 0.1 0.1 0.0 0.2 1.4 21.4 34.4 1.0 0.0 5.7 2.2 17.0 0.6 0.4 1.9 0.3 2.8 0.4 0.3 0.8 20.7 2.6 0.8 0.7 0.0 0.4 0.0 0.3 7.8 0.4 0.7 0.2 0.6 2.2 0.6 11.2 31.3 0.0 0.5 210.1 1.5 3.5 55.8 23.5 4.1 6.9 0.4 1.2 2.1 2.9 23.7 0.0 0.0 0.5 0.2 6.3 126.3 165.5 0.8 1.6 0.3 1.0 0.0 1.1 0.3 0.2 1.6 0.0 11.0 0.0 0.2 6.6 5.4 0.0 1.4 0.0 0.1 0.6 6.8 0.0 1.0 133.9 138.4 152.5 216.5 131.1 140.9 148.0 135.4 153.4 149.2 140.4 181.2 2.4 3.2 1.1 67.3 42.3 54.3 14.9 5.2 5.7 8.1 16.9 9.5 35.5 228.8 5.4 71.7 0.0 1.0 0.8 3.1 295.4 58.2 8.8 1.3 0.4 7.3 0.0 29.3 6.8 290.0 1.2 19.8 69.8 2.7 3.8 219.5 23.9 1495.2 89.6 8.4 3.3 3.1 2.0 80.3 80.3 18.3 4.4 50.6 23.2 20.6 3.1 19.1 2.1 57.3 196.3 97.3 3.9 3.4 7.2 6.4 98.4 3703.0 1.9 3.8 6.6 38.4 16.8 22.0 9.7 16.0 133.7 1.8 17.6 4.1 3.4 20.4 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984193-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 183.7;Early spermatids: 168.7;Proximal enterocytes: 371.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Secreted to blood" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: AB_2685038" "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favorable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 17.7 21.2 19.6 13.8 19.0 18.2 17.8 21.6 23.1 14.2 17.9 32.8 42.7 16.6 6.6 17.5 16.0 13.5 29.8 19.0 19.7 21.9 45.9 15.3 20.9 21.5 21.1 11.3 53.7 29.6 18.1 12.2 20.9 19.6 25.4 7.7 28.8 13.1 40.9 14.5 45.2 10.9 18.8 21.9 24.7 38.5 20.6 10.5 15.9 30.4 16.9 19.4 12.8 20.6 27.2 44.1 35.6 29.2 14.7 28.9 43.5 28.6 31.2 44.2 35.6 63.7 46.1 15.2 39.7 24.2 25.7 39.8 27.3 42.4 27.9 44.7 46.6 20.9 44.3 73.4 26.6 32.1 37.9 18.9 32.5 38.8 34.6 27.8 21.1 32.7 33.0 51.3 32.6 66.1 34.9 33.9 54.9 23.9 39.7 74.5 26.8 50.7 45.5 21.9 30.5 28.9 39.3 91.2 34.5 18.2 43.4 33.6 19.1 42.8 45.0 24.0 54.3 79.1 48.3 45.7 14.2 21.5 36.7 3.8 16.2 13.4 11.2 13.9 11.4 23.5 14.9 18.5 11.6 17.8 13.6 9.5 1.4 10.7 17.4 5.1 24.9 10.6 19.6 19.0 21.6 23.1 19.0 19.7 21.5 21.1 20.9 18.8 20.6 20.6 18.0 3.2 6.7 2.3 32.5 15.9 19.9 21.1 17.6 10.8 32.7 27.6 17.4 27.1 16.6 9.2 0.0 43.4 23.0 183.7 35.2 44.0 168.7 24.0 11.4 17.9 27.2 17.0 3.4 80.8 57.8 17.7 16.8 18.7 12.7 22.8 20.7 59.1 45.9 8.4 3.2 60.3 26.4 39.3 24.8 123.7 17.4 24.7 23.2 1.0 39.6 12.6 39.1 1.5 3.3 57.3 100.3 12.4 39.6 21.7 371.7 84.6 33.3 11.5 13.1 15.8 18.5 41.9 26.7 17.3 14.8 37.5 27.4 26.7 68.7 26.0 GFUS "FX, P35B, SDR4E1, TSTA3" ENSG00000104522 "GDP-L-fucose synthase" Q13630 8 143612618-143618048 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Multifunctional enzyme, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 32.1;Cytotrophoblasts: 82.1;Extravillous trophoblasts: 156.4;Hofbauer cells: 69.9;Syncytiotrophoblasts: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023361 Approved Approved Nucleoplasm,Cytosol Yes No 850000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" Cytosol Nucleoplasm "HPA023361: AB_1858420" "unprognostic (1.37e-2)" "unprognostic (5.35e-2)" "unprognostic (8.62e-3)" "unprognostic (3.55e-2)" "unprognostic (2.90e-1)" "unprognostic (5.82e-2)" "unprognostic (2.48e-2)" "unprognostic (1.98e-1)" "unprognostic (8.62e-2)" "prognostic favorable (2.41e-4)" "unprognostic (6.62e-3)" "unprognostic (6.89e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (4.23e-2)" "unprognostic (2.78e-2)" "unprognostic (1.87e-2)" "unprognostic (3.27e-2)" 36.3 37.2 21.6 27.7 21.1 52.3 34.0 21.4 25.9 28.6 21.7 45.9 69.2 24.8 19.2 88.7 24.0 29.3 32.1 20.7 21.3 37.5 86.6 28.4 29.1 23.5 21.9 19.0 99.5 22.8 44.0 24.4 22.8 45.0 37.6 6.5 70.9 24.2 30.2 81.5 52.4 19.4 20.2 35.7 111.4 49.4 21.0 26.6 32.1 18.4 27.1 31.0 36.0 22.5 85.6 67.1 29.2 99.7 28.6 26.1 54.1 70.3 73.0 50.2 38.1 78.5 94.3 37.5 64.6 52.5 21.2 60.6 47.8 100.8 23.2 101.7 53.8 58.7 103.0 93.4 57.2 42.2 67.1 30.3 47.4 31.7 127.3 42.2 84.3 61.9 66.4 57.0 41.2 267.5 39.8 53.2 45.8 267.7 87.1 47.1 26.3 122.3 106.1 94.8 67.3 45.9 53.3 100.2 73.0 23.0 133.5 58.8 75.5 34.8 132.0 35.1 67.6 34.1 30.2 29.0 52.8 91.6 54.7 34.9 27.4 42.9 40.3 38.5 43.0 35.2 43.1 46.8 30.1 40.1 31.5 38.5 31.0 63.6 33.8 54.5 57.5 45.7 21.6 21.1 21.4 25.9 20.7 21.3 23.5 21.9 22.8 20.2 21.0 22.5 32.1 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 82.1 11.2 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 156.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 69.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 87.7 1.7 0.0 0.0 0.0 GLB1 "EBP, ELNR1" ENSG00000170266 "Galactosidase beta 1" P16278 3 32996609-33097202 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 857.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008382, HPA040610, HPA069503" Enhanced Supported "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 2700000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 4: Macrophages - Innate immune response" Vesicles "Golgi apparatus" "CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142" "unprognostic (1.51e-2)" "unprognostic (3.66e-2)" "unprognostic (5.02e-3)" "unprognostic (9.66e-3)" "unprognostic (9.61e-3)" "unprognostic (1.04e-1)" "unprognostic (2.31e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (2.06e-1)" "unprognostic (2.08e-1)" "prognostic favorable (1.14e-5)" "unprognostic (3.05e-1)" "unprognostic (2.33e-1)" "unprognostic (2.20e-1)" "unprognostic (5.85e-2)" 22.0 36.1 12.1 27.8 13.0 21.9 20.5 12.5 14.8 33.4 16.0 43.5 43.0 21.9 103.6 15.4 28.2 32.0 15.5 12.5 14.8 46.0 48.2 42.7 25.8 14.3 12.9 21.4 30.8 59.4 18.5 53.8 15.4 23.2 45.6 14.9 25.3 29.3 7.7 15.8 31.0 30.6 12.4 24.4 35.5 13.5 13.5 17.5 52.8 10.8 23.0 31.8 16.2 15.1 37.4 63.6 39.8 48.3 241.9 123.7 857.2 59.1 157.6 73.7 95.1 91.3 86.5 17.9 50.9 120.9 53.9 35.1 38.1 75.5 53.7 104.9 33.0 69.9 35.3 47.4 124.3 50.5 69.9 144.9 70.2 67.0 39.2 144.1 116.5 24.7 64.3 67.0 81.8 44.6 29.6 31.6 26.4 78.0 27.0 24.7 26.4 86.6 78.4 54.4 12.0 40.3 75.0 120.2 74.4 69.3 80.3 130.2 67.7 46.8 32.2 65.2 50.1 53.2 87.9 5.9 99.6 71.2 36.7 43.9 146.2 86.4 29.2 125.8 40.4 37.9 34.3 31.8 166.5 35.6 17.9 21.8 56.6 26.0 92.1 35.1 77.1 91.9 12.1 13.0 12.5 14.8 12.5 14.8 14.3 12.9 15.4 12.4 13.5 15.1 8.7 19.2 25.3 39.2 18.6 6.0 13.6 60.1 10.8 11.3 11.5 7.5 9.1 34.3 43.3 27.6 6.2 100.1 14.1 41.9 27.4 53.5 24.8 18.7 16.0 17.4 16.9 20.6 46.7 35.4 55.3 29.2 26.0 27.1 26.6 20.6 19.6 39.7 79.5 5.0 46.0 23.5 40.7 43.9 13.9 5.0 15.2 41.7 14.2 23.4 64.6 16.5 10.3 27.2 24.2 28.1 43.4 21.1 19.8 9.9 36.2 33.1 31.0 16.2 13.1 12.9 16.3 1.0 6.6 10.1 3.4 49.1 18.7 51.0 32.0 12.1 GMPPA ENSG00000144591 "GDP-mannose pyrophosphorylase A" Q96IJ6 2 219498884-219506989 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 79.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035512, HPA035513" Approved Approved Nucleoplasm NA NA 51000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA035512: AB_2674660, HPA035513: AB_10671934" "unprognostic (3.43e-1)" "unprognostic (3.95e-2)" "unprognostic (7.75e-3)" "unprognostic (1.40e-3)" "unprognostic (4.87e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (5.57e-1)" "unprognostic (2.39e-1)" "unprognostic (2.25e-1)" "unprognostic (1.17e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.90e-10)" "prognostic favorable (5.24e-4)" "unprognostic (1.28e-1)" "unprognostic (2.01e-1)" "unprognostic (2.28e-1)" 22.6 25.8 19.3 23.9 20.1 19.0 21.6 20.1 22.6 32.1 22.4 29.7 28.8 26.4 68.7 25.5 24.6 19.7 27.1 20.1 20.5 25.7 68.5 20.9 20.7 20.5 19.8 20.1 60.3 24.7 48.5 21.2 20.0 37.3 32.3 8.0 40.1 23.4 22.8 17.8 30.0 26.2 19.6 35.2 32.5 9.6 21.3 13.2 28.6 12.6 23.8 25.2 23.1 19.8 43.4 36.0 21.2 37.8 79.5 70.6 56.4 73.8 98.6 85.2 105.2 66.8 40.5 23.4 51.1 107.7 54.3 40.1 39.7 63.9 73.3 45.3 35.0 45.5 35.7 119.3 72.0 24.1 51.7 54.3 50.7 79.9 89.9 43.9 52.8 29.7 82.3 66.3 66.8 55.5 23.8 45.3 21.7 52.8 38.5 18.6 22.9 42.4 48.6 30.1 27.4 24.0 31.0 46.3 52.1 44.4 31.5 38.8 30.9 49.2 33.6 89.4 40.9 45.4 19.4 28.9 100.4 26.7 55.8 76.0 52.6 37.3 30.1 56.0 35.0 32.1 23.4 31.9 43.5 24.1 17.3 15.7 11.8 36.4 59.3 43.9 34.8 35.2 19.3 20.1 20.1 22.6 20.1 20.5 20.5 19.8 20.0 19.6 21.3 19.8 12.5 16.0 14.4 5.5 18.8 5.6 12.8 25.2 6.2 6.1 20.9 13.5 13.2 10.0 20.1 16.5 6.2 37.6 16.6 37.7 35.2 24.3 1.3 8.5 15.8 9.5 10.8 19.1 3.1 30.0 79.8 19.2 38.7 14.4 19.0 13.3 11.0 36.3 33.7 1.7 3.6 61.6 10.2 17.6 10.0 3.4 18.3 16.5 12.4 1.9 15.9 11.1 12.3 1.0 4.9 19.0 37.6 13.5 50.3 15.1 45.9 36.8 11.6 4.7 13.1 7.9 27.1 4.4 6.5 9.9 8.5 47.2 13.5 10.7 29.1 15.1 GMPPB KIAA1851 ENSG00000173540 "GDP-mannose pyrophosphorylase B" Q9Y5P6 3 49716844-49723973 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 130.2;Syncytiotrophoblasts: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014657 Uncertain NA NA 38000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "HPA014657: AB_1849852" "unprognostic (3.48e-2)" "unprognostic (9.84e-2)" "unprognostic (2.77e-2)" "prognostic favorable (6.19e-6)" "unprognostic (1.01e-2)" "unprognostic (5.11e-3)" "unprognostic (1.54e-2)" "unprognostic (4.01e-3)" "unprognostic (1.04e-1)" "unprognostic (1.99e-2)" "unprognostic (5.01e-3)" "unprognostic (5.73e-2)" "prognostic favorable (3.17e-4)" "unprognostic (1.60e-1)" "unprognostic (1.79e-1)" "unprognostic (1.67e-1)" "unprognostic (1.22e-1)" 14.5 30.1 6.1 16.1 6.0 11.8 15.3 5.7 6.6 20.8 9.2 23.1 14.5 18.6 14.5 26.3 19.5 9.5 18.2 6.0 6.3 17.5 44.2 21.4 13.0 6.7 6.5 14.0 57.4 10.1 39.4 7.5 6.1 27.9 12.2 4.1 35.4 14.7 13.4 14.9 21.8 9.4 6.1 27.9 26.2 9.6 6.8 9.3 26.3 5.7 13.0 15.9 16.8 5.9 31.8 27.0 21.0 12.3 15.6 10.8 21.7 36.1 17.1 29.0 26.1 18.7 21.5 17.6 15.8 18.1 22.2 16.7 18.6 29.0 10.6 17.2 14.5 13.5 27.2 21.5 31.1 19.0 19.6 8.2 15.1 40.0 34.8 11.3 24.8 20.2 10.4 32.0 16.3 20.3 27.3 11.7 12.2 22.5 34.3 9.2 12.5 30.4 16.3 24.0 13.8 16.0 15.7 36.5 12.5 10.6 20.6 13.9 21.9 25.7 25.0 33.4 38.8 33.7 11.1 13.6 25.4 14.7 28.6 22.1 15.6 6.7 18.3 21.3 18.6 22.7 15.9 19.3 14.7 22.5 11.8 14.6 4.0 11.3 21.8 61.8 12.0 14.8 6.1 6.0 5.7 6.6 6.0 6.3 6.7 6.5 6.1 6.1 6.8 5.9 7.3 9.6 17.2 1.6 35.4 0.8 22.8 0.7 2.8 3.7 34.1 14.1 4.5 15.7 3.8 18.4 2.1 28.5 28.5 43.6 29.4 39.8 10.0 18.3 14.3 10.7 16.7 9.9 0.8 50.6 67.2 15.5 34.7 17.8 0.0 11.2 9.3 28.4 39.0 6.7 0.8 55.9 0.0 10.7 1.7 10.0 15.5 13.7 1.8 1.0 40.9 5.8 19.6 1.0 0.4 31.9 27.1 7.5 130.2 40.9 29.2 25.7 14.4 6.2 0.0 5.3 12.2 22.9 12.6 14.7 1.7 79.5 14.7 13.1 32.8 37.1 GOLGA5 "golgin-84, GOLIM5, ret-II, rfg5" ENSG00000066455 "Golgin A5" Q8TBA6 14 92794305-92839947 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000992, HPA063876" Enhanced Supported Supported "Golgi apparatus" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA000992: AB_1079009, HPA063876: AB_2685140" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (2.77e-2)" "unprognostic (1.68e-1)" "unprognostic (3.15e-1)" "unprognostic (1.78e-1)" "unprognostic (5.02e-2)" "unprognostic (1.15e-2)" "unprognostic (2.83e-2)" "unprognostic (7.67e-2)" "unprognostic (6.44e-2)" "unprognostic (1.76e-1)" "unprognostic (1.06e-2)" "unprognostic (2.49e-2)" 26.0 23.3 21.4 18.2 23.7 10.4 33.1 22.4 26.4 32.2 23.9 26.4 23.3 21.9 54.2 25.0 19.2 24.0 21.5 20.8 22.3 25.5 54.3 22.4 18.8 22.6 22.4 20.6 32.2 33.6 23.5 28.2 23.1 31.2 32.5 15.8 32.4 25.8 26.9 23.3 22.9 26.0 22.6 19.1 32.9 34.3 22.1 16.9 33.2 20.0 23.3 24.1 19.6 25.9 32.4 29.4 25.9 23.7 53.1 71.4 44.3 43.9 80.4 41.9 49.2 21.8 43.4 21.0 35.1 70.2 29.2 33.4 23.1 35.9 56.6 25.8 11.2 19.9 14.0 29.3 61.5 23.3 31.8 55.1 63.7 29.5 60.6 46.2 42.0 21.8 17.7 27.3 46.5 60.1 18.1 19.6 16.1 70.2 31.0 13.9 37.9 21.1 42.8 38.9 18.4 26.0 40.0 29.6 45.7 35.7 51.0 25.6 35.0 23.9 15.6 31.3 22.2 33.3 27.6 18.2 54.9 18.2 40.8 10.4 10.0 23.6 10.3 13.0 11.8 9.5 10.4 10.6 9.9 9.5 9.2 8.1 8.8 8.7 11.9 9.1 12.9 6.7 21.4 23.7 22.4 26.4 20.8 22.3 22.6 22.4 23.1 22.6 22.1 25.9 18.7 28.9 26.3 8.8 15.7 7.8 11.2 17.9 16.5 7.5 16.2 11.9 26.8 8.6 19.6 14.7 12.5 23.7 17.2 23.8 29.4 25.3 31.6 17.6 24.6 16.7 22.3 15.8 17.6 32.7 32.0 21.7 33.1 25.7 9.5 29.7 13.9 33.5 15.4 25.2 15.6 31.6 4.1 14.7 10.3 18.5 23.0 14.6 12.4 15.0 18.2 15.6 16.5 14.6 21.9 28.9 12.0 25.2 29.2 19.4 19.9 24.2 18.7 10.7 26.3 18.0 19.3 34.1 37.0 16.5 11.4 50.3 15.9 15.6 16.5 16.5 GORAB "FLJ11752, GO, NTKL-BP1, SCYL1BP1" ENSG00000120370 "Golgin, RAB6 interacting" Q5T7V8 1 170532131-170553834 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027250, HPA027746" Approved Supported "Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "Nucleoplasm, Nucleoli, Cytosol" "HPA027250: AB_10611253, HPA027746: " "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (4.75e-3)" "prognostic favorable (1.39e-4)" "prognostic unfavorable (5.26e-4)" "unprognostic (8.48e-3)" "unprognostic (2.94e-2)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.77e-2)" "prognostic unfavorable (7.83e-12)" "unprognostic (2.52e-2)" "unprognostic (2.83e-1)" "unprognostic (7.71e-2)" "unprognostic (1.70e-1)" 3.1 5.2 1.6 1.9 1.6 0.6 2.8 1.6 3.1 3.8 1.9 3.6 1.4 3.2 3.5 2.3 2.1 2.1 3.1 1.5 2.3 2.5 4.3 2.5 3.6 1.6 1.8 4.3 3.7 1.9 3.0 3.1 1.7 2.8 3.3 1.3 3.3 2.6 1.1 1.9 2.7 2.0 1.7 3.1 2.1 2.0 2.0 2.8 3.0 2.1 3.0 3.1 3.3 1.8 3.4 3.8 4.5 2.0 9.0 5.8 2.9 4.8 7.5 3.6 4.6 1.9 4.9 5.1 6.1 4.3 2.4 4.0 6.4 2.8 6.0 4.8 1.6 2.5 4.0 2.8 4.9 4.4 3.1 4.4 2.5 4.2 3.9 5.5 3.5 2.3 4.4 2.3 5.3 0.6 5.8 4.0 4.7 6.2 4.0 3.9 3.8 6.0 4.2 1.9 1.4 3.0 3.6 4.8 11.5 3.1 2.7 8.4 4.4 6.8 3.1 2.9 7.2 3.5 4.4 3.8 5.2 4.0 5.4 0.7 3.9 0.0 2.3 4.2 3.9 2.8 4.1 3.5 4.3 2.8 3.6 3.0 0.5 3.8 3.1 2.7 5.3 2.6 1.6 1.6 1.6 3.1 1.5 2.3 1.6 1.8 1.7 1.7 2.0 1.8 8.1 0.0 11.4 8.8 8.9 2.8 4.0 6.5 8.6 4.7 5.2 7.1 9.4 10.0 7.1 5.5 2.1 6.0 6.2 12.8 3.9 12.3 2.3 5.5 10.4 8.3 0.0 3.4 9.3 6.0 7.3 10.5 9.2 6.7 13.9 5.2 5.3 6.6 7.1 5.0 7.7 9.4 8.2 6.9 4.6 3.2 14.0 5.6 3.6 3.7 10.1 4.3 3.1 9.0 7.3 5.7 9.8 6.4 10.3 4.9 4.3 6.0 2.4 7.1 6.6 8.2 9.3 13.1 8.1 5.4 1.6 5.6 6.3 5.1 6.4 3.0 GORASP2 "GOLPH6, GRASP55, GRS2" ENSG00000115806 "Golgi reassembly stacking protein 2" Q9H8Y8 2 170928464-170967130 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 380.7;Syncytiotrophoblasts: 229.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035274, HPA035275, CAB075758" Enhanced Enhanced "Golgi apparatus" NA NA 830000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600" "unprognostic (2.04e-2)" "unprognostic (4.37e-3)" "unprognostic (4.61e-1)" "unprognostic (1.64e-1)" "unprognostic (9.94e-2)" "prognostic unfavorable (7.32e-4)" "unprognostic (3.13e-2)" "unprognostic (3.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.58e-1)" "unprognostic (4.56e-3)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.38e-8)" "unprognostic (1.26e-1)" "unprognostic (2.13e-1)" "unprognostic (6.56e-2)" "unprognostic (3.13e-1)" 32.1 43.1 32.6 32.0 34.6 33.7 40.5 35.8 36.7 62.6 34.1 43.5 38.3 43.2 60.4 46.8 34.3 37.2 57.6 32.5 35.9 33.6 45.6 34.3 39.9 34.2 34.5 37.3 67.1 47.3 40.0 55.5 34.8 40.7 43.6 37.0 68.4 52.6 39.7 38.6 36.7 46.1 34.6 31.1 42.0 32.0 34.4 41.8 50.8 38.1 44.2 53.3 24.0 37.0 66.1 51.7 72.2 54.9 137.5 103.2 83.0 101.5 113.9 89.6 113.8 132.8 84.2 97.0 59.7 143.2 61.0 75.9 82.3 96.0 102.2 57.8 81.2 107.5 41.2 198.8 138.4 90.2 62.9 79.2 102.9 90.0 148.3 95.7 98.9 64.5 92.4 72.4 80.3 103.2 85.5 87.0 74.3 109.9 49.3 68.4 64.5 115.0 112.9 91.8 59.3 54.3 58.4 91.6 95.9 59.0 60.8 73.6 93.5 82.8 56.2 79.5 55.7 81.1 56.2 112.4 86.6 58.3 95.6 48.3 38.3 27.0 53.0 40.6 81.7 44.8 59.1 63.4 48.3 40.7 58.0 48.5 9.6 64.5 46.8 63.9 57.0 62.8 32.6 34.6 35.8 36.7 32.5 35.9 34.2 34.5 34.8 34.6 34.4 37.0 28.7 41.7 36.6 15.0 46.7 37.2 39.6 83.4 38.1 30.6 33.0 22.5 40.9 27.1 64.2 20.2 31.3 114.4 49.3 39.2 56.7 69.1 196.6 16.2 34.4 32.1 31.3 35.1 20.1 78.1 112.1 48.4 48.4 32.7 20.3 25.7 38.9 45.0 46.4 42.1 23.0 63.9 48.8 22.7 29.7 380.7 58.7 23.9 48.0 22.5 46.3 39.3 35.0 27.2 31.7 69.7 41.9 49.7 171.9 62.1 31.7 43.7 23.1 34.8 59.2 27.5 40.3 39.6 39.6 47.1 36.1 229.7 43.4 44.9 48.2 67.7 GPR108 LUSTR2 ENSG00000125734 "G protein-coupled receptor 108" Q9NPR9 19 6729914-6737603 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041924, HPA041951, HPA063863" Uncertain Approved "Golgi apparatus,Vesicles" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" Vesicles "HPA041924: AB_10804122, HPA041951: AB_10795385, HPA063863: AB_2685135" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.07e-1)" "prognostic favorable (1.04e-7)" "unprognostic (1.58e-1)" "unprognostic (5.29e-2)" "unprognostic (1.53e-1)" "unprognostic (1.11e-2)" "unprognostic (4.23e-2)" "unprognostic (3.01e-2)" "unprognostic (7.89e-2)" "unprognostic (3.57e-2)" "prognostic favorable (1.29e-9)" "unprognostic (8.68e-3)" "unprognostic (2.95e-2)" "unprognostic (4.96e-3)" "unprognostic (4.13e-3)" 29.9 45.2 26.9 18.8 29.3 26.2 32.7 29.7 27.2 36.8 29.9 39.9 32.9 31.6 31.6 39.6 40.1 32.2 22.5 24.2 29.4 42.1 34.4 32.4 23.2 28.9 28.1 34.5 46.7 49.0 23.2 22.2 27.5 34.4 28.1 27.8 57.5 40.2 18.4 31.2 36.6 26.3 27.7 33.3 35.8 25.5 29.1 23.5 41.3 20.5 27.8 31.0 32.9 27.8 33.5 35.9 21.7 42.6 83.0 44.8 24.4 25.6 77.0 34.7 36.7 22.2 37.5 15.8 46.4 52.4 41.6 28.1 24.7 53.3 17.8 64.1 28.4 25.7 37.7 29.6 81.3 16.7 33.7 48.7 100.2 33.5 67.2 45.9 41.3 37.9 26.4 102.7 35.6 23.3 29.5 24.0 15.6 60.2 31.5 23.7 24.7 61.0 72.7 32.6 0.2 23.4 25.9 41.8 38.7 18.4 39.9 40.0 34.4 19.7 12.5 63.2 27.6 66.2 39.3 11.4 68.0 52.9 21.7 79.3 116.1 123.0 82.6 109.7 75.2 48.2 65.2 70.4 84.6 49.9 45.9 52.8 178.4 80.9 130.5 30.0 81.2 132.7 26.9 29.3 29.7 27.2 24.2 29.4 28.9 28.1 27.5 27.7 29.1 27.8 40.8 9.6 14.5 12.7 26.3 26.5 43.7 107.4 21.1 28.3 42.7 33.0 8.0 45.8 59.7 36.8 22.9 58.7 31.1 76.4 37.2 87.7 38.0 30.8 23.6 32.7 21.7 6.9 5.4 110.1 37.2 27.4 39.3 44.1 26.0 15.0 40.7 26.7 57.1 21.9 6.0 57.6 81.4 30.3 46.7 94.9 23.6 42.4 30.2 5.6 50.3 46.0 42.2 7.5 9.6 83.3 83.7 18.4 27.8 29.1 121.2 55.0 39.8 43.0 39.5 22.2 26.4 34.3 19.9 27.2 31.8 58.6 38.9 28.3 47.1 36.1 GPRC5C RAIG-3 ENSG00000170412 "G protein-coupled receptor class C group 5 member C" Q9NQ84 17 74424851-74451653 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 192.7;stomach 1: 230.3" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 211.3;Gastric mucus-secreting cells: 143.2;Hepatocytes: 183.6;Paneth cells: 153.8;Sertoli cells: 144.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 7.9" "Group enriched" "Detected in many" 9 "dendritic cells: 7.9;monocytes: 3.7" "Cell line enhanced" "Detected in many" "Hep G2: 82.4;HMC-1: 146.7;PC-3: 80.8;RPTEC TERT1: 172.1;RT4: 89.9;T-47d: 108.0" "Region enriched" "Detected in all" 9 "cerebellum: 42.5" "Low region specificity" "Detected in all" HPA029776 Enhanced Uncertain "Nucleoplasm,Centriolar satellite,Cytosol" NA Yes 15000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 15: Hepatocytes - Hemostasis" "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA029776: AB_10602324" "unprognostic (1.48e-1)" "unprognostic (3.35e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-3)" "unprognostic (1.80e-2)" "unprognostic (1.09e-2)" "unprognostic (4.40e-2)" "unprognostic (1.57e-1)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "unprognostic (9.61e-3)" "unprognostic (1.05e-1)" "prognostic favorable (1.58e-5)" "unprognostic (7.58e-2)" "unprognostic (3.70e-2)" "unprognostic (2.75e-2)" "unprognostic (1.54e-3)" 16.1 19.3 17.4 3.1 18.4 0.4 20.1 48.9 18.1 42.0 28.0 38.7 25.0 17.1 10.2 12.2 30.0 21.3 33.7 14.8 16.9 135.7 192.7 23.0 2.1 18.1 18.7 38.2 136.1 28.2 14.8 11.9 18.6 45.6 14.6 1.5 37.4 24.3 110.1 43.9 30.3 4.0 16.6 22.3 230.3 4.0 17.0 4.4 74.8 33.9 3.0 30.8 20.9 15.7 17.3 61.6 3.8 5.5 0.0 0.0 0.2 0.3 0.0 0.0 0.0 66.4 73.0 0.0 45.0 0.3 18.5 52.9 7.7 1.0 0.1 0.2 10.7 0.0 4.0 82.4 15.8 0.0 146.7 1.3 26.7 0.0 0.0 69.2 0.0 0.1 4.8 1.2 0.0 18.0 0.7 17.2 9.2 79.5 80.8 0.2 0.1 2.8 172.1 89.9 27.5 2.5 3.7 5.9 0.1 33.1 108.0 4.6 0.0 0.0 5.5 0.1 0.1 0.1 0.4 0.2 6.5 2.5 0.4 0.0 1.1 0.1 0.0 2.5 0.0 0.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 3.7 7.9 0.0 0.3 17.4 18.4 48.9 18.1 14.8 16.9 18.1 18.7 18.6 16.6 17.0 15.7 11.2 3.2 57.7 13.4 1.4 13.6 39.2 79.6 26.7 0.8 27.3 19.4 211.3 67.2 76.2 136.1 0.0 0.8 11.8 74.9 29.4 65.5 0.1 62.5 6.6 20.9 45.5 5.3 0.1 68.1 20.3 11.3 143.2 74.9 10.2 0.1 48.2 183.6 12.3 5.0 0.5 50.8 69.2 16.3 4.6 1.7 18.0 6.3 3.6 2.8 4.1 15.9 0.0 5.0 0.2 41.2 153.8 22.2 1.2 44.6 61.0 73.5 45.4 1.5 144.7 4.7 64.0 0.5 5.0 14.8 11.2 25.3 2.4 1.5 48.5 63.1 GUSB ENSG00000169919 "Glucuronidase beta" P08236 7 65960684-65982215 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Cancer-related genes, Disease variant, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 213.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036322, HPA036323" Approved Supported Vesicles "Intracellular and membrane" NA NA 330000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 4: Macrophages - Innate immune response" Vesicles "HPA036322: AB_10670796, HPA036323: AB_2675059" "unprognostic (1.54e-2)" "unprognostic (6.49e-2)" "unprognostic (1.18e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.89e-1)" "unprognostic (1.56e-3)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (7.00e-3)" "unprognostic (1.91e-1)" "unprognostic (3.34e-2)" "unprognostic (8.83e-3)" "unprognostic (1.98e-1)" "unprognostic (5.06e-1)" "unprognostic (1.45e-1)" 28.4 18.2 11.0 22.3 12.3 84.2 80.9 12.0 16.1 26.7 14.3 38.2 36.1 26.2 41.8 16.4 24.6 27.6 19.6 10.7 11.5 25.1 104.0 35.7 25.6 13.2 12.2 19.9 33.6 30.3 12.6 48.2 13.2 20.2 41.9 9.7 32.9 21.2 10.9 18.8 29.8 19.1 11.9 34.0 38.1 19.5 13.0 22.7 27.7 14.4 24.0 27.3 15.4 13.5 67.0 26.5 25.2 56.3 80.9 49.1 35.3 21.3 56.8 45.0 42.1 37.0 67.8 30.9 32.3 26.8 24.1 27.5 16.5 25.1 26.8 27.3 34.1 41.5 40.9 27.3 39.7 89.6 67.1 33.4 26.7 26.3 33.3 54.5 39.3 18.0 63.2 213.5 30.5 50.3 34.2 92.0 17.9 103.0 21.0 34.4 55.9 172.4 29.4 42.8 36.2 32.7 55.6 129.1 72.3 29.9 71.1 88.8 28.5 55.3 49.3 21.8 53.6 119.6 151.9 50.0 41.0 116.3 68.3 26.0 80.1 65.7 32.0 103.0 28.4 27.7 24.7 28.4 80.5 22.6 16.8 19.5 13.2 46.6 93.5 34.2 34.5 51.4 11.0 12.3 12.0 16.1 10.7 11.5 13.2 12.2 13.2 11.9 13.0 13.5 53.1 51.3 58.7 10.1 33.0 18.0 32.0 51.9 29.0 12.2 26.1 19.9 12.2 48.6 48.9 29.5 8.4 81.9 32.6 52.2 5.9 41.1 59.1 28.9 26.5 39.7 43.0 47.1 12.3 30.3 61.2 49.5 49.5 49.4 36.8 38.3 37.9 72.7 126.4 16.8 10.6 51.6 30.5 88.1 33.2 46.7 43.2 78.0 39.2 14.0 44.8 28.0 20.6 8.5 14.2 29.4 49.5 28.6 87.5 25.3 50.6 26.8 43.2 20.1 26.3 27.1 26.0 49.6 31.0 16.0 14.8 66.9 32.2 24.4 44.3 29.6 HECTD3 FLJ21156 ENSG00000126107 "HECT domain E3 ubiquitin protein ligase 3" Q5T447 1 45002540-45011324 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 33.7;Proximal enterocytes: 44.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027467 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 45: Enterocytes - Digestion" "HPA027467: AB_10600710" "unprognostic (1.86e-1)" "unprognostic (1.19e-2)" "unprognostic (2.39e-1)" "unprognostic (1.58e-1)" "unprognostic (1.18e-1)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.14e-5)" "unprognostic (1.74e-2)" "unprognostic (2.92e-2)" "unprognostic (7.42e-2)" "unprognostic (2.47e-1)" "unprognostic (8.39e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.35e-1)" "prognostic favorable (1.85e-6)" "unprognostic (3.19e-1)" 22.8 24.5 19.7 12.3 21.2 15.0 20.0 20.9 20.6 17.1 18.7 33.2 47.2 18.1 16.0 26.4 13.8 12.3 17.0 20.4 20.7 19.6 30.5 14.0 16.5 22.2 20.5 19.5 37.0 26.7 11.9 14.2 22.3 14.8 26.2 7.4 34.1 15.6 39.9 27.9 40.4 14.8 19.8 20.1 22.6 13.6 20.9 12.7 17.0 24.0 14.4 20.4 18.9 22.6 22.1 19.8 12.4 20.1 42.5 26.5 24.3 20.6 31.2 22.3 25.2 28.7 6.8 10.3 17.1 34.1 50.0 20.2 29.7 21.5 20.0 19.3 22.8 16.6 28.4 24.9 37.2 13.0 26.8 28.6 36.5 38.4 14.8 23.2 50.4 17.8 38.0 11.3 28.9 18.8 16.6 10.6 17.1 24.9 29.6 19.5 22.7 15.0 33.2 25.7 29.7 12.4 27.9 47.8 25.5 31.1 15.5 12.0 38.0 25.7 20.4 32.2 23.9 14.4 18.3 5.8 41.3 14.0 12.9 10.7 8.0 8.0 7.3 10.9 6.3 6.0 6.1 6.5 7.3 3.3 5.0 6.1 2.8 4.0 6.3 5.5 6.7 6.5 19.7 21.2 20.9 20.6 20.4 20.7 22.2 20.5 22.3 19.8 20.9 22.6 6.9 3.2 8.2 7.2 5.6 3.8 2.2 3.1 8.6 5.2 8.5 6.2 6.0 8.6 5.8 5.5 6.2 7.1 9.2 33.7 1.9 10.3 1.2 4.0 7.5 7.0 2.4 20.6 5.4 15.5 14.2 7.0 21.4 8.1 6.3 6.4 6.4 14.1 13.6 6.7 5.0 15.1 0.0 15.3 2.9 2.3 14.6 7.8 3.6 4.7 10.2 3.1 5.2 2.0 4.7 13.2 28.1 9.8 9.1 2.8 44.8 6.9 1.4 6.2 6.6 4.5 6.7 4.5 7.4 9.7 6.1 6.0 7.1 13.5 14.9 2.3 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932142-56944864 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 2680.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 497.6;U-266/70: 533.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 75.3 108.4 68.4 102.0 70.6 113.6 128.9 73.7 92.6 127.1 99.0 149.5 98.2 65.7 220.2 53.2 86.5 77.8 92.0 67.9 77.9 193.1 193.0 92.0 114.1 77.3 72.8 188.8 377.0 206.9 78.8 97.1 75.2 213.0 141.8 39.7 170.0 102.0 102.9 58.7 84.9 77.8 78.4 114.8 144.1 25.0 74.6 58.0 213.6 120.9 246.6 94.5 45.0 82.8 28.6 30.9 29.8 61.8 66.9 86.9 105.2 65.9 104.6 83.5 64.9 43.1 63.5 115.0 82.7 64.6 84.6 47.9 51.0 23.3 82.4 67.1 30.8 9.9 48.3 156.3 364.6 21.1 49.5 106.0 219.2 38.0 119.6 100.4 64.4 125.9 15.9 159.6 236.3 24.1 39.8 42.7 19.1 164.8 68.9 27.0 74.9 497.6 179.8 31.8 32.7 37.5 57.5 278.8 308.2 41.9 31.3 77.4 40.0 34.8 34.4 30.8 26.8 533.9 191.0 182.6 49.3 28.7 46.4 224.0 291.2 139.5 113.2 238.1 124.0 383.2 120.1 149.7 230.6 340.4 77.2 117.8 215.9 179.6 175.0 915.5 263.8 417.7 68.4 70.6 73.7 92.6 67.9 77.9 77.3 72.8 75.2 78.4 74.6 82.8 316.4 70.5 105.9 16.6 964.5 364.0 561.8 316.3 203.7 134.6 191.3 185.2 221.5 91.5 193.4 71.7 281.5 131.9 577.3 369.1 170.2 192.7 73.3 162.5 121.3 199.8 434.4 40.8 29.9 197.7 182.4 223.8 251.8 260.5 151.8 108.8 134.2 164.0 194.7 47.1 32.2 569.7 290.9 241.6 395.9 251.6 104.1 507.7 948.0 88.1 197.0 94.3 81.4 21.1 30.7 144.8 336.5 95.5 2680.7 447.4 156.1 209.0 95.6 117.1 98.6 178.8 215.6 54.7 10.6 146.6 255.3 693.8 342.6 137.4 311.4 456.8 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340924-72376420 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 234.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018082, HPA054583" Supported Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 20000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" Vesicles Cytosol "HPA018082: , HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favorable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 49.8 56.1 18.3 37.6 21.1 110.0 58.5 20.4 21.6 73.8 28.5 55.1 49.8 42.6 164.6 24.8 47.8 76.7 54.3 19.9 20.1 90.1 79.4 84.2 54.2 23.0 21.3 39.3 30.6 54.0 26.3 102.0 24.6 45.3 67.0 32.1 45.0 53.3 22.1 21.8 41.2 59.5 21.7 54.7 45.1 35.6 27.0 38.1 76.5 33.2 42.4 71.6 19.7 29.9 39.8 66.4 27.8 53.8 223.6 253.1 39.7 54.8 274.1 115.3 182.8 34.6 282.7 32.9 50.9 110.0 59.9 77.1 74.5 34.6 72.5 26.5 30.0 41.4 60.4 60.9 172.9 99.9 113.1 216.7 101.3 50.4 89.3 210.3 107.4 48.4 65.1 197.6 156.0 33.9 21.7 50.0 16.0 128.9 0.3 22.3 60.6 75.3 129.1 61.6 23.8 26.4 136.5 126.6 307.3 56.1 23.4 123.9 54.1 171.9 70.7 160.1 59.3 104.7 151.8 33.4 62.1 130.4 85.3 24.2 84.6 60.1 43.8 35.7 38.7 41.1 28.8 38.9 98.0 38.0 22.5 33.2 8.1 51.3 13.3 37.3 28.2 63.0 18.3 21.1 20.4 21.6 19.9 20.1 23.0 21.3 24.6 21.7 27.0 29.9 68.9 64.1 62.4 19.9 46.3 22.2 33.3 94.3 19.4 42.4 28.6 30.4 26.9 30.0 68.0 66.2 106.3 150.2 54.2 36.6 60.7 88.3 20.6 27.2 30.2 50.8 47.2 19.1 22.7 38.0 68.0 78.7 42.8 40.6 29.9 49.9 43.5 42.9 234.3 26.9 24.7 46.3 81.4 92.8 75.0 13.7 74.3 118.1 94.3 24.4 60.3 38.4 82.4 20.6 26.7 39.1 74.6 44.8 37.7 33.0 68.5 66.7 37.5 56.9 46.0 24.5 31.7 24.3 32.3 13.5 15.6 157.6 36.7 45.2 50.6 27.5 HEXB ENSG00000049860 "Hexosaminidase subunit beta" P07686 5 74640023-74722647 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 746.0;GAMG: 646.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055409, HPA056010" Enhanced "Intracellular and membrane" NA NA 40000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA055409: AB_2682808, HPA056010: AB_2683008" "unprognostic (3.45e-1)" "unprognostic (5.84e-2)" "unprognostic (1.85e-2)" "unprognostic (8.72e-2)" "unprognostic (1.12e-2)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (2.21e-1)" "unprognostic (5.01e-2)" "unprognostic (1.58e-3)" "unprognostic (6.45e-2)" "unprognostic (2.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (1.31e-2)" "unprognostic (9.67e-2)" "unprognostic (1.64e-2)" 92.2 72.0 22.1 59.7 25.3 59.9 83.0 22.3 32.5 97.6 39.4 105.0 99.0 71.5 321.4 38.5 66.7 99.0 84.3 23.1 26.2 81.6 137.5 111.3 47.0 23.8 22.9 62.4 103.6 94.2 46.6 319.4 24.7 98.7 116.9 33.6 123.4 54.0 43.3 54.3 75.4 76.1 23.2 64.7 88.4 19.6 28.2 29.1 89.6 38.4 40.4 94.6 64.1 30.4 147.3 111.0 39.4 131.8 746.0 232.3 122.3 173.5 590.4 175.0 375.2 130.6 194.5 0.0 133.0 152.2 646.3 115.2 43.2 185.2 228.7 79.2 72.6 19.1 101.4 101.5 216.5 16.2 152.3 206.7 108.0 180.7 121.3 275.9 204.5 47.3 54.3 236.9 194.9 145.7 19.8 36.6 36.8 142.7 47.8 43.9 56.2 191.8 119.8 130.4 24.5 30.4 134.2 92.6 180.0 68.8 99.1 108.6 118.5 112.1 26.6 207.8 165.6 102.6 191.3 0.9 257.9 143.6 209.8 86.2 343.2 99.1 69.3 129.9 80.7 45.2 56.1 64.0 310.8 28.1 52.6 51.3 125.2 42.4 82.5 93.4 73.2 269.0 22.1 25.3 22.3 32.5 23.1 26.2 23.8 22.9 24.7 23.2 28.2 30.4 49.6 41.7 38.4 5.9 31.5 44.0 82.8 103.2 21.6 10.2 26.3 27.6 19.8 82.9 63.8 29.5 8.4 466.5 32.8 68.2 19.6 151.3 1.3 21.0 21.4 56.2 22.8 23.1 32.2 125.6 175.4 107.2 33.6 26.9 69.8 19.8 74.3 70.1 340.2 10.1 24.3 56.7 107.8 127.3 134.3 3.4 85.1 168.8 72.9 17.8 114.2 35.4 29.9 22.6 13.3 65.8 54.8 72.2 71.5 74.2 99.5 79.6 36.3 16.3 46.0 32.6 49.5 0.3 1.4 23.8 32.5 493.6 35.3 31.4 81.8 71.0 HFE "HFE1, HLA-H" ENSG00000010704 "Homeostatic iron regulator" Q30201 6 26087281-26098343 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Kupffer cells: 25.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 39.2;T-47d: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" No No "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: AB_2682163" "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 9.6 7.9 1.3 5.3 2.1 0.6 7.8 1.4 1.9 6.7 9.3 5.8 5.9 4.9 12.4 4.8 4.5 8.1 3.7 1.5 1.5 6.7 15.4 7.5 3.6 2.4 1.7 7.3 6.3 15.4 1.2 6.1 2.2 6.8 6.9 1.3 6.9 9.6 2.3 2.8 5.0 6.0 1.7 8.6 8.3 1.7 1.9 1.7 9.9 3.0 3.1 7.4 3.2 2.8 17.2 39.2 0.7 18.6 27.3 21.1 0.1 12.2 28.5 15.1 23.6 3.3 34.3 1.8 32.4 20.2 22.9 10.7 0.0 14.2 19.1 4.6 0.2 0.5 8.1 2.6 5.6 0.0 0.7 21.6 4.0 16.7 1.4 13.2 10.4 0.0 0.7 0.4 13.0 7.2 0.1 0.2 0.9 8.1 0.0 2.3 0.0 0.3 12.5 11.5 0.1 0.1 7.3 0.0 10.2 0.3 54.0 1.9 8.2 10.6 1.1 10.7 10.6 0.2 0.4 0.2 15.9 0.2 23.5 1.3 10.7 0.0 1.5 10.4 1.2 3.3 1.6 2.1 4.7 1.3 0.4 1.0 1.9 0.2 9.2 0.3 0.3 3.8 1.3 2.1 1.4 1.9 1.5 1.5 2.4 1.7 2.2 1.7 1.9 2.8 3.9 3.2 5.1 1.0 1.7 1.7 2.6 3.7 6.2 1.0 3.7 2.2 3.2 2.8 6.7 5.5 2.1 1.7 0.5 3.8 0.0 4.1 0.1 1.8 2.3 3.4 1.8 2.7 0.1 3.4 0.8 4.6 8.2 1.5 2.5 3.0 6.8 12.2 11.1 0.0 0.1 4.0 4.1 25.4 7.6 0.2 3.7 7.4 0.0 2.8 3.8 2.9 2.1 0.0 3.3 2.4 0.9 6.0 0.3 2.6 2.9 2.7 5.9 1.7 0.0 5.7 2.4 0.2 1.1 3.4 3.4 1.8 1.0 2.8 3.3 1.9 HM13 "dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1" ENSG00000101294 "Histocompatibility minor 13" Q8TCT9 20 31514410-31577923 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 324.9;Plasma cells: 400.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045089, HPA056062" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA045089: AB_10962054, HPA056062: AB_2683022" "unprognostic (8.03e-2)" "unprognostic (2.11e-2)" "unprognostic (5.03e-2)" "unprognostic (1.59e-1)" "unprognostic (2.82e-1)" "unprognostic (5.87e-3)" "prognostic unfavorable (1.95e-5)" "unprognostic (2.66e-2)" "unprognostic (2.14e-2)" "unprognostic (2.55e-1)" "unprognostic (2.30e-1)" "unprognostic (8.10e-2)" "prognostic unfavorable (4.64e-12)" "unprognostic (3.77e-2)" "unprognostic (1.57e-1)" "unprognostic (1.85e-1)" "unprognostic (8.17e-2)" 78.6 102.9 10.5 60.9 13.5 61.7 63.4 13.6 15.7 100.0 42.4 54.5 52.6 72.9 111.4 128.6 70.4 46.7 55.9 12.5 17.1 61.4 136.1 83.7 40.7 17.8 17.9 59.2 241.1 68.8 90.0 64.6 17.4 66.0 44.4 20.8 217.7 80.3 44.6 51.6 52.1 49.1 14.2 70.2 92.5 21.9 23.9 30.5 74.7 14.1 54.2 64.9 72.2 20.9 143.8 147.6 56.6 87.7 260.2 163.5 197.6 239.0 221.3 159.7 162.8 287.3 166.8 90.4 312.8 262.7 209.7 253.8 74.9 162.0 97.7 46.2 112.0 201.3 99.7 179.3 287.0 118.1 78.1 152.5 103.5 133.7 182.7 159.0 124.5 56.0 90.2 364.0 148.8 170.3 100.0 84.0 67.8 234.9 248.5 63.6 272.6 436.5 154.4 75.6 76.3 90.4 243.5 234.9 199.2 56.4 182.0 109.5 153.3 243.1 129.8 246.3 136.2 225.5 145.5 71.7 328.7 413.0 219.4 117.7 380.9 190.8 116.7 372.6 159.7 91.9 108.0 112.9 260.8 74.4 70.6 84.1 282.8 117.5 363.7 271.9 104.1 374.1 10.5 13.5 13.6 15.7 12.5 17.1 17.8 17.9 17.4 14.2 23.9 20.9 67.4 51.3 55.4 23.8 78.2 33.4 59.0 127.8 31.3 45.4 65.6 49.1 13.6 71.4 102.2 53.3 123.0 154.0 70.7 115.2 13.7 145.6 15.5 55.0 111.5 60.9 61.5 38.9 40.5 169.7 139.0 93.2 80.0 128.4 42.4 55.5 53.2 86.4 324.9 43.7 39.2 134.5 63.1 81.2 83.1 15.9 60.6 106.1 65.8 28.1 77.4 52.2 53.5 33.7 23.8 144.3 81.2 43.6 400.6 92.4 54.8 51.0 49.3 44.8 32.9 49.2 79.2 26.1 26.4 60.0 35.4 213.6 60.1 97.2 70.8 69.3 HSD17B8 "D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1" ENSG00000204228 "Hydroxysteroid 17-beta dehydrogenase 8" Q92506 6 33204655-33206831 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 125.2;Proximal tubular cells: 137.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 79.5;T-47d: 62.0;U-266/70: 65.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042132 Enhanced NA NA 97000 "Cluster 35: T-regs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA042132: AB_10793978" "prognostic favorable (9.99e-4)" "unprognostic (4.24e-1)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (2.10e-1)" "unprognostic (8.11e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.50e-3)" "unprognostic (3.12e-1)" "unprognostic (1.34e-2)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "prognostic favorable (2.18e-12)" "unprognostic (2.82e-2)" "unprognostic (5.57e-1)" "unprognostic (3.09e-1)" "unprognostic (3.23e-2)" 9.6 24.6 10.1 6.5 10.5 9.7 17.0 9.9 11.3 13.7 10.9 18.0 19.7 7.2 29.4 25.5 23.6 7.9 20.3 9.6 10.8 30.7 67.4 11.2 10.5 11.3 11.9 8.6 55.3 42.2 14.1 5.6 12.3 11.3 16.2 11.8 25.1 16.5 20.8 25.9 18.8 7.3 11.4 12.1 15.1 5.9 10.8 13.3 32.9 25.0 15.1 9.8 12.8 11.3 7.0 15.0 6.8 9.3 2.3 4.4 1.3 0.8 4.7 0.1 0.1 5.8 17.5 45.4 11.2 1.2 2.2 29.1 7.2 11.7 1.0 8.6 0.0 2.6 14.0 27.1 20.0 0.0 3.8 5.0 28.9 0.2 49.4 0.4 2.1 13.6 0.3 46.2 4.1 9.4 31.2 1.3 2.1 23.3 2.9 11.0 1.2 79.5 27.8 1.3 12.1 7.6 2.9 34.3 7.6 4.6 62.0 1.8 1.3 0.7 7.3 0.6 0.4 65.5 42.4 16.6 3.1 1.0 1.7 0.1 5.8 2.0 18.7 13.4 30.0 16.6 24.0 29.2 11.6 13.1 26.4 28.5 0.7 16.8 14.6 20.8 21.8 26.7 10.1 10.5 9.9 11.3 9.6 10.8 11.3 11.9 12.3 11.4 10.8 11.3 12.5 19.2 21.6 3.3 18.6 29.7 28.3 55.0 21.6 12.4 31.3 34.8 31.8 48.6 25.9 22.0 6.2 29.9 9.7 21.2 125.2 27.9 6.3 20.0 6.0 10.1 18.0 12.8 0.3 32.4 12.9 9.1 16.3 13.7 7.0 9.8 10.0 83.2 17.4 1.7 0.5 26.6 20.3 10.3 16.4 18.1 7.5 7.9 49.8 1.0 8.1 32.6 6.2 1.0 0.7 21.9 21.1 6.0 47.6 15.4 74.8 137.2 33.3 14.8 0.0 11.3 9.8 8.1 8.5 40.0 37.2 17.4 18.0 29.8 44.4 31.5 HSP90B1 "GP96, GRP94, TRA1" ENSG00000166598 "Heat shock protein 90 beta family member 1" P14625 12 103930107-103953931 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Plasma cells: 4874.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003901, CAB005224, HPA008424, CAB078151" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 330000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 12: NES - Nervous system development" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184" "unprognostic (1.03e-1)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (5.70e-2)" "unprognostic (1.17e-2)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (7.22e-2)" "unprognostic (8.77e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (1.03e-10)" "unprognostic (2.95e-1)" "unprognostic (2.39e-1)" "unprognostic (1.24e-1)" "unprognostic (1.28e-2)" 330.4 340.6 166.0 423.5 183.7 438.9 341.8 185.3 234.2 363.2 225.6 340.5 261.4 302.2 1032.5 157.5 305.5 218.9 309.5 164.4 206.2 317.1 736.4 271.1 245.9 205.0 191.3 302.6 397.1 336.0 247.2 521.1 201.6 360.2 387.5 185.6 254.9 382.8 87.5 120.0 269.5 385.7 188.8 322.4 297.6 180.7 196.5 228.2 1411.8 91.2 328.0 356.6 164.6 237.3 856.5 459.9 926.2 940.0 960.1 897.5 1229.9 1449.4 1133.4 776.0 1038.1 839.1 805.3 243.8 1102.2 1579.2 995.1 583.2 934.6 1578.9 1063.2 607.3 307.4 684.5 447.6 861.0 1457.4 702.1 514.6 519.6 690.9 920.0 1342.8 2643.7 1513.9 293.8 560.0 914.8 1039.9 314.7 409.2 768.3 756.9 925.5 544.5 372.2 597.1 1079.2 1064.3 527.1 271.5 645.7 889.2 912.0 932.7 1468.4 743.9 1016.2 854.4 566.1 476.0 462.8 607.9 945.5 949.0 455.6 1106.9 494.7 904.5 113.8 81.3 30.3 199.7 88.6 244.9 108.5 118.5 187.8 111.8 71.1 75.9 133.8 18.7 199.3 83.3 322.7 81.1 188.5 166.0 183.7 185.3 234.2 164.4 206.2 205.0 191.3 201.6 188.8 196.5 237.3 507.5 237.2 373.8 28.7 646.0 309.3 905.1 743.6 196.9 50.3 261.4 334.0 687.8 235.9 475.3 257.5 156.4 568.4 480.6 424.0 56.7 471.2 89.6 570.8 751.1 439.6 406.6 213.5 34.0 250.4 1081.0 714.0 390.9 690.9 405.3 500.6 446.9 891.9 553.1 77.4 41.9 631.5 238.0 300.1 309.8 47.0 563.2 378.4 421.6 52.5 240.5 141.0 199.8 30.2 61.3 321.8 419.1 337.7 4874.6 760.6 246.1 271.4 404.2 111.6 216.9 325.7 569.3 489.0 154.4 196.3 260.7 921.0 316.0 542.6 494.6 620.0 HSPA5 "BiP, GRP78" ENSG00000044574 "Heat shock protein family A (Hsp70) member 5" P11021 9 125234853-125241382 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction" "Chaperone, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1327.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005221, HPA038845, HPA038846" Enhanced Approved Cytosol "Intracellular and membrane" NA NA 790000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478" "unprognostic (3.98e-2)" "unprognostic (2.50e-3)" "unprognostic (6.64e-2)" "unprognostic (9.60e-3)" "unprognostic (1.54e-3)" "unprognostic (6.02e-3)" "unprognostic (9.08e-3)" "unprognostic (9.11e-3)" "unprognostic (4.50e-2)" "unprognostic (7.45e-3)" "unprognostic (1.49e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.03e-1)" "unprognostic (1.34e-1)" "unprognostic (7.28e-2)" "unprognostic (3.66e-2)" 211.2 170.2 83.7 276.1 91.7 856.2 147.2 101.8 107.3 202.9 112.0 181.6 166.5 183.6 379.1 150.7 177.9 130.6 284.0 90.2 126.8 168.7 327.8 182.8 145.4 105.8 107.0 142.1 260.7 223.3 182.7 311.3 120.2 192.8 183.7 105.1 211.0 167.5 87.6 143.2 175.8 205.2 111.4 129.8 177.9 173.5 101.7 116.2 692.8 85.2 180.0 197.7 105.1 163.9 593.4 380.3 480.2 631.3 505.6 592.0 1152.8 1047.6 728.2 675.9 778.5 558.4 1093.4 649.5 644.7 682.4 1564.0 732.5 403.3 839.4 684.7 403.7 213.8 396.7 392.9 945.1 2692.4 547.4 730.2 363.6 1515.2 551.3 2309.4 728.1 1065.6 129.0 291.9 870.3 482.2 382.6 249.7 297.8 559.1 1327.5 362.2 233.2 492.4 1061.2 608.4 352.7 248.5 448.0 648.1 653.4 1079.3 715.5 694.3 378.0 791.8 439.5 433.0 462.7 484.2 939.0 994.7 551.2 1070.4 435.9 689.0 455.5 366.3 305.3 384.7 361.8 390.0 209.0 276.7 360.1 322.0 173.9 224.6 277.2 280.9 362.9 252.5 349.5 213.6 758.2 83.7 91.7 101.8 107.3 90.2 126.8 105.8 107.0 120.2 111.4 101.7 163.9 227.1 185.9 273.5 38.5 254.0 292.9 1225.2 573.2 192.9 97.3 193.7 166.2 803.4 97.2 416.9 112.2 352.3 505.9 408.7 426.5 45.0 415.0 86.2 372.1 402.2 247.9 508.8 82.3 19.7 258.4 955.2 455.5 258.4 467.4 334.2 304.6 147.4 379.4 449.4 63.9 34.6 508.2 195.3 133.4 271.0 50.3 175.2 261.6 181.5 30.0 135.0 134.6 80.3 29.7 41.1 313.7 408.3 174.5 1041.5 360.8 196.9 121.2 267.6 176.6 118.3 245.9 673.8 435.7 204.3 167.4 236.4 1327.5 323.8 243.0 376.4 795.4 HUNK ENSG00000142149 "Hormonally up-regulated Neu-associated kinase" P57058 21 31873020-32044633 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 9.8" "Cell type enriched" "Detected in many" 5 "Inhibitory neurons: 109.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 13.2;BEWO: 16.3;RH-30: 18.1;SCLC-21H: 14.8;SiHa: 13.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA027295, HPA027372" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Plasma membrane" "HPA027295: AB_2672203, HPA027372: AB_2672239" "unprognostic (9.09e-3)" "unprognostic (7.29e-2)" "unprognostic (1.42e-1)" "unprognostic (5.95e-3)" "unprognostic (1.99e-1)" "unprognostic (2.12e-4)" "unprognostic (4.00e-2)" "unprognostic (6.90e-2)" "unprognostic (5.07e-1)" "unprognostic (2.27e-1)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.48e-5)" "unprognostic (8.84e-2)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.69e-2)" 0.7 1.0 0.8 1.3 1.3 0.2 1.2 0.4 4.7 0.4 0.0 3.6 1.4 4.1 1.9 0.4 1.9 0.5 0.4 4.2 2.6 3.7 0.5 0.9 0.4 0.4 0.1 0.6 9.8 0.1 1.1 4.6 0.1 0.9 3.7 3.0 0.6 2.1 0.3 3.0 2.7 2.4 0.0 0.1 1.3 0.9 0.2 0.7 0.6 0.2 0.6 1.5 0.7 1.6 0.0 3.9 13.2 0.1 0.0 0.0 16.3 1.3 0.0 0.2 0.0 5.3 0.1 0.0 0.5 6.2 0.2 0.0 7.7 0.0 0.1 0.1 3.9 0.0 3.7 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 1.1 0.2 1.1 10.2 0.1 0.1 0.1 18.1 0.1 1.3 0.0 14.8 9.8 13.2 1.0 0.5 9.3 5.5 1.4 0.0 0.1 9.3 0.1 0.0 0.1 0.0 1.8 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.3 0.4 4.7 4.2 2.6 0.4 0.1 0.1 0.0 0.2 1.6 0.2 6.4 9.1 7.5 0.0 5.1 2.6 0.2 0.6 8.1 0.5 2.8 3.5 14.3 3.0 7.3 2.1 9.2 0.0 4.6 0.0 5.3 0.2 1.2 1.3 0.8 4.9 0.0 19.0 3.3 13.9 7.9 0.5 3.4 0.0 4.3 0.4 1.0 2.7 3.3 109.6 5.1 0.0 0.0 4.2 0.1 0.3 0.4 3.6 1.0 0.1 8.1 0.0 10.1 1.5 1.6 4.4 0.0 0.0 2.1 1.8 1.9 0.8 1.2 0.0 6.3 2.2 0.7 1.1 0.7 5.8 6.2 0.5 0.0 10.6 0.9 HYOU1 "Grp170, HSP12A, ORP150" ENSG00000149428 "Hypoxia up-regulated 1" Q9Y4L1 11 119044188-119057227 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Stress response" Chaperone "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 201.9" "Cell type enhanced" "Detected in all" "Plasma cells: 118.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 35.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 418.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049296 Approved "Intracellular and membrane" NA NA 130000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 65: Plasmacytoid DCs - Unknown function" "HPA049296: AB_2680702" "unprognostic (2.97e-2)" "unprognostic (2.48e-2)" "unprognostic (8.46e-2)" "prognostic favorable (2.58e-4)" "unprognostic (2.19e-1)" "unprognostic (1.35e-2)" "unprognostic (1.61e-3)" "unprognostic (1.81e-1)" "unprognostic (8.98e-2)" "unprognostic (7.93e-2)" "unprognostic (2.01e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (5.10e-5)" "unprognostic (3.86e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.38e-2)" 38.2 48.5 30.7 27.1 32.2 18.6 31.0 28.3 34.1 37.2 25.5 40.9 18.1 44.6 51.2 47.4 40.8 14.0 56.5 32.9 41.0 63.0 201.9 47.7 17.4 32.6 34.5 36.1 165.9 18.8 100.1 19.9 34.2 47.9 21.3 11.9 46.3 20.7 19.1 25.0 39.0 19.0 28.5 47.6 60.3 85.7 35.2 21.7 87.2 8.4 20.9 39.9 31.7 32.9 40.5 34.5 77.2 224.4 41.2 19.7 107.7 56.1 38.0 63.1 47.2 105.0 103.0 85.3 418.9 40.7 122.1 59.5 71.5 69.3 53.8 92.8 26.1 151.8 32.6 76.7 187.7 88.6 73.5 23.9 91.1 55.2 185.3 57.9 100.2 57.2 53.5 136.8 33.9 97.8 59.4 49.6 55.5 83.2 33.6 63.1 55.9 144.3 48.6 67.8 45.7 70.0 80.4 103.8 53.3 65.5 78.8 82.9 75.0 59.9 46.4 27.2 77.5 88.1 64.0 61.2 53.8 76.2 135.6 4.4 4.5 2.2 11.7 6.1 12.6 5.4 6.4 8.7 5.0 4.0 4.0 6.1 1.3 7.6 4.4 35.9 5.5 4.7 30.7 32.2 28.3 34.1 32.9 41.0 32.6 34.5 34.2 28.5 35.2 32.9 16.4 9.6 14.1 6.2 22.7 17.8 18.5 17.5 14.2 11.5 28.5 21.1 12.4 15.7 16.8 25.8 43.8 11.2 36.6 35.3 9.8 20.7 74.0 20.4 29.1 20.0 35.8 17.0 12.0 18.8 26.6 21.0 39.8 38.1 15.8 43.1 13.9 49.9 22.2 25.2 13.7 52.1 18.3 8.2 21.6 38.8 13.1 17.8 23.2 5.6 15.5 8.7 17.5 4.5 9.3 31.4 24.2 13.5 118.7 44.4 14.9 17.6 16.7 14.5 13.1 16.4 15.6 27.8 29.1 16.2 19.9 19.3 20.8 14.8 27.3 24.7 IFT20 ENSG00000109083 "Intraflagellar transport 20" Q8IY31 17 28328325-28335489 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 245.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021376 Approved Approved Microtubules NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" Microtubules "HPA021376: AB_1851460" "unprognostic (1.29e-1)" "unprognostic (2.35e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (8.65e-4)" "unprognostic (1.13e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (8.02e-2)" "unprognostic (4.86e-3)" "unprognostic (2.42e-1)" "unprognostic (2.48e-2)" "unprognostic (6.19e-3)" "prognostic unfavorable (5.09e-7)" "unprognostic (1.67e-1)" "unprognostic (2.29e-1)" "unprognostic (2.59e-2)" "unprognostic (4.71e-3)" 24.9 32.9 26.6 14.7 26.9 77.0 26.8 27.0 46.1 23.4 29.1 37.0 28.8 20.9 39.2 18.8 22.6 22.2 19.7 26.9 28.3 33.5 41.4 22.3 20.7 27.7 27.6 21.6 116.1 25.5 45.2 24.1 27.0 29.9 20.0 26.7 41.2 20.5 9.5 17.6 28.0 20.0 27.5 24.9 42.4 50.1 27.0 22.8 29.2 7.5 19.9 27.9 19.6 27.9 27.3 39.0 25.2 20.7 74.2 75.2 24.2 47.2 58.0 28.9 45.5 59.6 12.7 13.4 24.8 59.8 17.5 29.1 16.9 35.1 41.8 55.0 72.5 8.0 39.7 26.7 72.7 34.1 16.0 57.6 46.4 24.8 39.9 48.2 46.1 26.6 24.2 32.8 23.0 38.2 30.7 26.8 16.9 82.4 21.8 14.4 32.6 35.4 46.2 26.7 31.7 46.2 31.3 64.3 74.8 43.6 41.0 38.2 51.3 16.9 25.8 25.3 25.9 49.6 44.8 17.1 61.6 24.6 25.1 53.7 67.7 52.6 38.6 50.6 44.8 43.2 39.2 38.6 78.1 51.6 39.8 34.7 71.1 36.8 49.0 56.1 45.8 53.7 26.6 26.9 27.0 46.1 26.9 28.3 27.7 27.6 27.0 27.5 27.0 27.9 42.1 38.5 55.8 17.9 36.7 37.0 38.0 63.0 34.7 63.3 74.6 68.3 6.1 47.1 51.5 51.5 60.5 73.0 47.4 30.7 140.8 60.8 245.4 79.8 40.3 47.3 62.6 25.7 31.3 113.2 82.6 47.4 32.1 39.5 23.5 34.2 38.2 48.6 54.2 57.2 36.5 69.5 40.7 47.8 69.4 53.4 60.3 49.6 32.0 7.5 72.8 37.4 42.2 24.6 30.7 68.0 29.9 57.6 57.8 45.9 127.8 98.0 102.6 78.3 78.9 33.5 67.0 164.8 53.0 25.7 42.8 81.4 35.9 59.6 43.1 49.5 IGFBP2 IBP2 ENSG00000115457 "Insulin like growth factor binding protein 2" P18065 2 216632828-216664436 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth regulation" "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 956.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 1379.1;Granulosa cells: 1649.7;Hepatocytes: 658.6;Theca cells: 2199.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 2139.8;HMC-1: 5110.0;NB-4: 1106.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077723 Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 303000000 810000000 "Cluster 48: NK-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 40: Granulosa cells - Unknown function" "Endoplasmic reticulum" "HPA077723: AB_2686853" "unprognostic (2.58e-1)" "unprognostic (5.95e-2)" "unprognostic (1.94e-1)" "unprognostic (3.32e-3)" "unprognostic (9.50e-3)" "unprognostic (2.36e-2)" "unprognostic (2.06e-1)" "unprognostic (9.11e-3)" "prognostic unfavorable (2.43e-4)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (1.82e-1)" "prognostic unfavorable (2.22e-5)" "unprognostic (5.04e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (1.22e-1)" 219.5 58.8 15.9 28.3 14.8 21.4 90.5 15.6 30.2 86.9 123.3 85.5 76.8 232.5 59.9 145.6 157.0 26.9 169.2 15.6 16.3 187.3 607.7 71.0 8.8 15.3 21.7 281.7 956.0 12.4 66.9 81.0 19.3 217.3 35.0 2.4 76.4 196.2 23.3 30.8 44.6 49.7 13.2 398.9 492.2 58.0 16.0 33.6 57.8 21.9 14.5 132.6 97.4 13.2 0.1 52.3 402.1 396.3 2139.8 652.9 8.5 125.2 61.9 6.1 0.6 1.2 1.5 0.1 171.7 0.8 15.2 11.5 145.4 156.9 0.6 0.8 84.9 91.3 0.2 26.3 53.3 38.6 5110.0 219.3 15.8 2.5 7.1 12.5 0.2 184.7 3.9 11.7 2.8 103.1 162.8 1106.5 437.4 98.2 4.8 139.2 9.1 2.0 2.0 117.1 84.1 443.4 0.3 3.4 2.6 362.2 332.4 67.3 0.5 1.6 2.4 1.6 6.2 6.2 0.9 9.7 6.0 177.4 478.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 15.9 14.8 15.6 30.2 15.6 16.3 15.3 21.7 19.3 13.2 16.0 13.2 354.3 3.2 0.6 2.0 3.3 13.8 534.0 238.2 19.4 0.2 79.0 498.0 12.5 11.5 40.1 264.8 2.1 1.8 5.4 86.4 29.4 3.0 1.0 153.2 1379.1 149.2 321.0 31.1 4.5 128.4 7.7 296.7 411.8 176.0 4.5 1649.7 92.1 658.6 5.3 0.0 0.8 191.6 54.9 24.1 5.0 4.9 5.6 21.8 3.6 13.1 1.3 3.6 3.1 1.0 1.0 60.7 51.3 79.4 0.4 255.7 4.2 1.2 195.9 1.7 105.2 17.9 435.7 6.0 35.8 103.3 5.5 2.2 16.0 2199.1 133.8 304.0 JAGN1 "FLJ14602, GL009" ENSG00000171135 "Jagunal homolog 1" Q8N5M9 3 9890574-9894349 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067610 Approved Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Vesicles "HPA067610: " "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-3)" "unprognostic (1.97e-2)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (2.37e-2)" "unprognostic (6.36e-3)" "unprognostic (9.93e-3)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.65e-2)" "unprognostic (2.49e-1)" 29.6 43.5 21.3 15.7 22.3 12.1 26.6 23.8 28.9 21.9 24.6 26.3 27.0 23.4 39.7 19.4 25.7 16.4 22.9 21.6 23.1 30.1 62.6 17.4 19.2 22.5 22.3 25.5 40.2 31.5 17.8 20.6 22.5 20.9 30.2 19.9 24.0 20.8 36.1 27.6 26.4 20.5 22.9 17.6 30.8 14.1 22.7 24.0 17.8 30.1 23.6 23.0 21.0 23.6 32.7 54.0 39.8 23.9 116.9 121.5 128.3 43.8 65.2 49.4 49.6 40.6 43.1 51.4 19.6 44.2 54.0 28.1 63.1 59.5 48.9 38.4 65.7 62.4 55.7 73.7 99.4 45.6 37.3 115.3 89.4 63.6 73.2 51.0 47.0 45.8 65.0 34.5 59.2 99.0 37.8 80.5 50.1 65.3 74.3 31.0 32.5 64.4 73.3 45.9 25.0 46.4 29.6 31.8 58.1 35.8 50.4 56.8 39.9 26.2 28.1 29.3 35.4 60.2 94.5 60.7 33.1 55.7 44.9 100.9 61.8 31.1 48.1 48.6 50.5 52.5 46.8 45.9 57.4 53.3 50.9 48.0 24.9 51.9 37.9 58.1 54.7 67.9 21.3 22.3 23.8 28.9 21.6 23.1 22.5 22.3 22.5 22.9 22.7 23.6 28.7 32.1 17.5 5.2 38.6 27.5 47.8 84.1 30.7 27.3 53.0 58.8 14.1 55.8 43.5 38.6 10.4 74.7 30.8 49.5 21.5 80.6 3.2 33.0 33.5 36.3 25.8 30.9 4.8 98.1 80.1 37.9 30.1 22.9 8.2 36.5 42.8 52.4 55.8 23.5 5.7 55.2 59.0 40.7 22.5 6.8 39.4 29.8 37.4 4.7 75.3 52.3 50.4 8.0 8.0 73.5 55.7 38.7 35.3 66.2 114.2 55.9 40.6 23.3 46.0 31.6 31.7 66.0 51.2 35.8 36.8 52.9 31.3 48.8 58.3 39.2 JMJD8 C16orf20 ENSG00000161999 "Jumonji domain containing 8" Q96S16 16 681670-684528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.32e-2)" "unprognostic (1.38e-2)" "unprognostic (1.13e-1)" "unprognostic (1.54e-2)" "unprognostic (8.38e-2)" "unprognostic (1.03e-2)" "unprognostic (2.87e-1)" "unprognostic (4.79e-2)" "unprognostic (1.46e-1)" "unprognostic (1.50e-2)" "unprognostic (4.33e-2)" "unprognostic (1.63e-2)" "unprognostic (4.96e-3)" "unprognostic (5.53e-2)" "unprognostic (1.86e-1)" "unprognostic (3.29e-1)" "unprognostic (7.04e-2)" 24.5 25.9 19.9 14.5 19.8 17.4 17.3 18.9 23.7 25.9 31.4 21.0 17.5 24.9 30.5 24.7 29.6 21.3 37.2 20.1 20.0 23.0 23.1 19.2 15.6 22.4 19.9 23.7 41.0 31.5 14.0 15.4 19.9 23.8 10.9 7.5 40.5 32.6 13.1 22.4 15.3 21.9 20.2 15.7 19.3 15.7 21.8 15.1 32.2 14.5 10.8 22.3 15.5 19.6 21.5 59.5 14.6 63.0 59.8 22.9 8.5 26.3 49.0 26.9 30.6 33.7 49.8 7.4 28.2 38.1 0.3 36.8 17.4 34.2 10.2 28.6 27.5 15.5 32.5 4.3 26.4 35.7 27.3 27.3 22.8 18.0 20.9 20.1 41.4 14.9 20.0 40.8 16.1 52.8 18.8 28.1 34.9 35.5 25.3 22.6 3.8 76.3 54.0 13.4 26.1 28.3 38.1 43.0 9.3 8.4 44.3 33.3 21.8 1.9 21.5 12.8 15.6 23.7 14.5 9.5 7.1 16.6 22.5 0.2 6.3 0.1 5.0 5.2 6.5 3.9 5.7 5.0 7.3 4.6 4.8 4.8 0.2 3.4 4.8 4.9 6.7 3.0 19.9 19.8 18.9 23.7 20.1 20.0 22.4 19.9 19.9 20.2 21.8 19.6 33.8 9.6 21.3 5.5 14.0 13.8 21.1 7.2 14.2 15.2 34.5 37.6 11.5 21.5 11.3 23.9 14.6 35.8 19.8 26.2 29.4 46.4 21.2 22.5 23.9 19.8 21.6 9.2 4.3 42.0 40.7 29.1 15.8 18.8 2.5 29.9 15.4 26.8 20.5 16.8 5.0 17.0 8.2 16.1 17.3 50.1 23.3 13.9 17.8 1.9 15.5 31.8 17.5 3.5 4.4 31.0 10.7 29.3 19.9 23.3 15.4 30.6 11.0 21.2 0.0 16.3 32.0 22.4 13.0 18.8 19.5 30.4 14.2 39.2 23.5 18.3 KCNQ1 "JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1" ENSG00000053918 "Potassium voltage-gated channel subfamily Q member 1" P51787 11 2444684-2849105 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 197.1;stomach 1: 98.9" "Cell type enhanced" "Detected in many" "Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8" "Cancer enhanced" "Detected in all" "colorectal cancer: 42.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB018656, HPA048553, HPA071107" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "Plasma membrane" "CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: " "unprognostic (6.02e-2)" "unprognostic (2.48e-1)" "unprognostic (6.39e-3)" "unprognostic (4.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.83e-1)" "unprognostic (3.46e-2)" "unprognostic (7.36e-2)" "unprognostic (8.07e-2)" "unprognostic (8.81e-2)" "unprognostic (1.58e-1)" "unprognostic (5.39e-2)" "unprognostic (2.46e-3)" "prognostic favorable (9.85e-4)" "unprognostic (3.99e-2)" "unprognostic (4.19e-2)" "unprognostic (5.27e-2)" 5.4 197.1 2.1 9.0 2.4 14.2 3.0 2.4 2.6 16.5 5.7 22.6 47.8 2.9 14.1 2.9 8.9 19.5 28.4 2.6 2.6 25.3 1.8 15.9 5.0 4.1 3.1 1.4 61.2 21.4 5.5 7.6 3.9 6.1 15.2 0.7 20.0 50.2 1.0 1.2 39.7 3.1 4.0 8.2 98.9 1.6 4.2 3.6 71.6 1.6 2.9 14.7 1.6 4.4 0.0 0.1 0.0 5.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 2.6 1.9 5.2 0.0 0.4 0.1 0.7 0.0 0.0 0.4 1.3 0.0 3.7 0.4 0.3 0.0 33.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.7 1.3 41.4 0.2 0.1 0.0 23.2 8.0 2.7 0.7 5.6 0.7 0.0 0.0 0.5 0.2 10.3 0.0 0.0 0.3 0.2 0.0 11.5 0.0 0.0 0.0 13.4 0.0 0.7 3.1 3.1 0.0 1.8 0.0 0.8 0.4 0.1 3.8 0.3 1.0 1.2 3.3 0.0 2.8 1.3 0.3 1.0 2.1 2.4 2.4 2.6 2.6 2.6 4.1 3.1 3.9 4.0 4.2 4.4 7.1 3.2 12.9 0.3 8.4 0.6 8.0 4.2 0.0 1.7 6.1 1.8 18.6 14.3 7.1 29.5 0.0 1.1 0.3 34.0 15.6 23.2 2.0 3.3 0.4 6.3 6.6 0.4 13.7 21.7 1.4 1.0 23.4 4.9 19.7 47.6 9.3 1.1 17.3 0.0 20.0 26.1 8.2 25.4 15.9 0.9 0.3 19.6 1.8 71.2 11.0 0.5 1.0 43.7 34.9 15.3 20.2 0.0 6.4 5.2 30.9 2.0 4.4 0.5 6.6 0.4 1.7 0.2 0.2 0.1 1.0 2.1 4.0 16.6 57.8 20.4 KCTD14 MGC2376 ENSG00000151364 "Potassium channel tetramerization domain containing 14" Q9BQ13 11 78015715-78046191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Breast glandular cells: 13.7;Breast myoepithelial cells: 12.8;Exocrine glandular cells: 17.1;Gastric mucus-secreting cells: 14.3;Intestinal goblet cells: 20.8;Prostatic glandular cells: 14.3;Proximal tubular cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 26.1;Hep G2: 29.0;RPTEC TERT1: 45.9;U-2 OS: 20.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041118, HPA042181" Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm "Vesicles, Cytosol" "HPA041118: AB_10963117, HPA042181: AB_10968059" "unprognostic (7.37e-3)" "unprognostic (4.27e-2)" "unprognostic (7.03e-2)" "unprognostic (6.93e-2)" "unprognostic (1.59e-2)" "unprognostic (2.28e-2)" "unprognostic (2.04e-3)" "unprognostic (3.26e-1)" "prognostic unfavorable (3.96e-5)" "prognostic favorable (8.01e-4)" "prognostic unfavorable (1.05e-4)" "unprognostic (3.19e-1)" "prognostic favorable (6.92e-5)" "unprognostic (2.42e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.93e-4)" "unprognostic (1.63e-1)" 3.4 23.1 2.0 1.6 2.0 0.1 20.4 5.1 2.9 10.4 3.2 8.1 4.9 3.4 14.3 1.5 11.7 6.7 0.6 2.1 2.1 11.5 10.3 8.2 0.3 1.9 2.3 0.8 27.2 8.3 2.5 1.3 2.2 7.0 11.9 1.6 28.7 19.1 0.2 1.9 5.2 2.1 1.6 0.6 20.8 0.6 2.5 1.3 15.9 0.6 0.5 2.3 1.4 1.7 0.0 3.5 0.6 0.5 1.3 0.8 3.5 1.8 1.6 3.4 8.4 13.5 8.8 0.1 9.3 1.1 0.4 1.0 0.6 26.1 8.9 0.5 13.2 0.0 3.0 29.0 4.9 0.2 0.1 4.0 0.7 13.9 11.0 2.5 1.0 0.2 0.3 0.1 1.4 0.2 0.3 0.8 6.5 0.5 0.5 0.4 0.0 0.0 45.9 3.5 2.3 0.2 0.0 0.2 4.5 0.8 1.4 1.1 0.8 0.2 20.2 0.7 0.4 0.3 0.2 0.2 0.2 0.2 3.7 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.3 0.0 0.2 0.2 0.2 0.0 0.0 2.0 2.0 5.1 2.9 2.1 2.1 1.9 2.3 2.2 1.6 2.5 1.7 0.6 3.2 10.8 0.0 0.2 0.4 12.2 2.0 2.8 0.4 13.7 12.8 0.0 1.5 4.1 5.5 0.0 0.6 0.3 5.2 3.9 2.6 0.3 2.7 2.0 0.9 4.8 0.0 0.0 17.1 1.3 1.1 14.3 3.7 1.3 0.5 0.0 4.8 0.2 0.0 0.0 20.8 0.0 0.0 0.0 0.0 3.4 0.4 1.8 0.0 0.1 2.1 0.0 0.0 0.0 10.5 6.6 5.3 0.0 14.3 2.2 15.1 0.1 0.0 0.0 0.0 1.8 0.2 0.3 0.7 0.1 0.7 0.3 0.7 8.5 7.4 KLF11 "MODY7, TIEG2, Tieg3" ENSG00000172059 "Kruppel like factor 11" O14901 2 10042849-10054836 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 135.0;Suprabasal keratinocytes: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 47.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058276 Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites,Cytosol" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Nuclear bodies, Focal adhesion sites, Cytosol" "HPA058276: AB_2683664" "unprognostic (9.66e-3)" "unprognostic (1.87e-1)" "unprognostic (1.59e-1)" "unprognostic (1.06e-2)" "unprognostic (3.02e-3)" "unprognostic (2.63e-3)" "unprognostic (6.34e-2)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-1)" "unprognostic (3.17e-3)" "unprognostic (3.08e-2)" "unprognostic (2.48e-3)" "unprognostic (8.96e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-2)" "unprognostic (9.24e-2)" 27.7 15.6 4.0 7.6 3.2 27.8 22.3 8.3 3.9 13.5 4.1 17.9 7.5 20.0 9.7 13.2 13.7 18.1 19.1 2.9 3.9 15.7 35.2 22.4 9.3 3.7 3.3 23.9 54.2 18.3 2.5 19.5 3.4 10.1 9.3 3.0 15.9 14.8 12.1 26.9 8.7 16.8 3.2 18.8 12.4 30.0 3.5 4.0 16.5 27.3 5.5 12.6 13.1 5.1 6.9 3.3 7.8 0.7 5.3 9.4 18.8 7.9 7.9 4.4 4.6 7.8 15.8 0.0 13.9 9.6 17.9 1.6 6.8 6.1 2.9 47.6 5.2 3.5 9.7 1.6 5.2 14.6 22.1 14.7 22.3 8.4 2.3 11.4 3.9 1.3 9.7 30.8 4.6 8.2 0.0 2.7 12.5 5.6 6.7 7.8 0.2 13.6 10.8 8.5 10.0 6.2 12.0 24.5 23.4 12.2 5.7 19.6 11.2 19.3 15.9 14.7 2.6 27.9 36.0 18.7 5.0 3.8 10.4 0.0 8.2 2.0 2.6 12.3 0.8 3.2 1.8 1.9 7.3 2.9 0.5 1.1 0.2 6.6 14.8 0.3 3.0 5.4 4.0 3.2 8.3 3.9 2.9 3.9 3.7 3.3 3.4 3.2 3.5 5.1 58.8 6.4 4.6 0.3 12.5 60.5 17.7 5.5 25.6 6.2 14.3 13.2 3.5 10.0 6.1 7.3 6.2 3.2 10.1 2.5 29.4 8.2 135.0 9.1 21.5 33.3 7.1 4.6 1.7 8.5 4.2 17.5 9.7 26.6 8.2 15.5 37.5 38.1 12.5 3.3 1.4 7.0 16.2 32.4 42.4 25.9 14.6 22.0 30.2 1.0 16.6 2.2 3.1 0.5 0.3 8.9 1.5 16.6 5.3 15.0 6.1 8.4 4.3 5.8 32.9 10.4 35.7 13.8 39.0 13.1 86.2 8.2 10.8 11.2 7.8 11.7 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952906 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 3698.8;Ductal cells: 6583.8;Exocrine glandular cells: 4826.1;Extravillous trophoblasts: 5496.7;Pancreatic endocrine cells: 6071.5;Syncytiotrophoblasts: 7643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "basophil: 76.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in many" "A549: 5639.4;BEWO: 3818.0;CACO-2: 6249.4;CAPAN-2: 4576.4;MCF7: 8470.0;SK-BR-3: 4583.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 12.1" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 170.3 29.0 2.6 77.5 1.4 1.5 209.8 5.3 1.6 243.5 34.8 424.1 324.3 27.8 226.0 118.4 193.5 180.6 38.3 2.2 6.9 247.2 519.5 177.8 8.6 26.1 4.3 16.4 570.2 79.5 251.9 474.5 30.3 183.3 492.3 0.6 323.4 129.5 2.1 44.5 370.7 23.4 2.5 28.5 289.9 8.3 13.9 10.3 244.1 1.4 27.8 199.7 62.2 2.5 2065.1 5639.4 1.1 7.9 0.7 1.1 3818.0 313.3 349.5 368.4 104.6 6249.4 4576.4 1.4 839.8 318.4 196.5 487.2 79.1 2228.5 217.9 2.6 138.2 19.4 865.7 1743.9 942.1 0.6 1.3 13.6 202.9 323.8 437.1 1046.9 399.0 3.4 511.4 0.2 0.3 8470.0 3.8 37.3 471.0 2740.1 457.9 3.0 0.3 236.1 1803.3 1144.9 65.6 3.7 512.7 4583.8 18.8 2696.0 2446.8 6.6 137.9 5.0 441.8 6.9 68.3 1.1 7.3 4.3 0.9 1.2 36.4 76.7 0.3 2.4 0.6 0.2 2.2 4.6 4.5 1.2 2.2 7.4 11.1 4.1 3.2 2.5 0.0 0.1 0.4 2.9 2.6 1.4 5.3 1.6 2.2 6.9 26.1 4.3 30.3 2.5 13.9 2.5 14.4 862.2 286.4 0.3 29.8 14.8 1605.7 912.1 447.3 0.1 814.6 615.6 5.3 1252.5 877.3 623.5 0.0 3698.8 14.2 1942.9 275.9 6583.8 1.0 462.3 60.3 77.8 642.3 15.4 0.0 4826.1 5496.7 203.5 971.5 742.4 48.9 51.2 57.1 610.9 308.3 1.7 0.0 2492.6 1969.3 9.8 13.8 3.8 10.5 28.3 208.1 1.0 41.5 6.2 0.0 0.0 0.0 6071.5 2164.1 0.0 13.7 1205.1 1912.3 718.5 500.8 0.6 0.0 0.6 298.6 2.7 26.0 395.7 6.7 7643.5 38.1 45.0 1635.0 1512.1 KRTCAP3 KCP3 ENSG00000157992 "Keratinocyte associated protein 3" Q53RY4 2 27442366-27446481 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 182.0;Proximal enterocytes: 168.7;Undifferentiated cells: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "MAIT T-cell: 6.8;memory B-cell: 4.5;memory CD4 T-cell: 5.6;memory CD8 T-cell: 2.6;naive B-cell: 6.4;naive CD4 T-cell: 6.6;naive CD8 T-cell: 2.7;T-reg: 4.4" "Group enriched" "Detected in many" 13 "B-cells: 6.4;T-cells: 6.8" "Cell line enhanced" "Detected in many" "A-431: 84.6;CAPAN-2: 122.5;OE19: 46.6;SCLC-21H: 60.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA047136, HPA060203" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "HPA047136: AB_2679949, HPA060203: AB_2684221" "prognostic favorable (2.67e-5)" "unprognostic (5.93e-2)" "unprognostic (5.03e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (1.44e-2)" "unprognostic (4.63e-2)" "unprognostic (1.04e-1)" "unprognostic (3.73e-3)" "unprognostic (3.79e-2)" "unprognostic (8.21e-2)" "unprognostic (9.42e-3)" 2.2 2.7 3.0 6.3 3.5 3.0 16.0 5.3 5.6 11.8 3.7 39.6 44.3 5.8 1.8 18.3 24.9 9.5 0.7 2.9 3.5 7.9 9.8 11.3 3.3 3.9 3.5 2.4 44.6 18.6 14.1 2.9 3.7 20.9 27.8 7.3 38.5 12.7 3.2 14.1 45.5 1.7 3.0 3.1 42.4 2.2 3.3 3.7 11.5 0.0 5.2 10.0 11.2 4.6 84.6 1.2 6.1 2.7 0.3 0.6 17.4 0.9 0.3 1.0 0.9 32.7 122.5 1.0 1.1 0.2 0.5 28.4 0.9 25.0 0.3 1.0 0.6 2.2 1.9 2.7 0.0 0.3 3.9 1.1 2.7 0.6 1.5 1.2 1.0 2.8 1.8 1.5 0.9 27.2 0.9 7.8 27.7 46.6 1.1 0.8 1.8 2.5 1.7 2.4 60.2 2.2 2.3 25.4 3.6 2.0 2.5 1.4 2.4 3.4 5.4 1.2 1.1 7.0 5.9 1.1 2.3 1.1 0.8 0.0 0.0 0.0 0.6 0.0 6.8 4.5 5.6 2.6 0.0 6.4 6.6 2.7 0.0 0.5 0.0 0.0 4.4 1.5 3.0 3.5 5.3 5.6 2.9 3.5 3.9 3.5 3.7 3.0 3.3 4.6 1.1 22.4 27.9 2.6 2.9 23.3 125.1 135.4 71.7 4.9 100.9 105.2 0.5 88.6 92.5 42.3 8.4 17.0 1.9 74.2 5.9 105.4 6.4 50.9 3.8 2.7 62.0 3.6 1.2 182.0 27.6 3.4 68.3 47.9 4.5 0.9 1.4 15.2 2.1 1.7 1.1 123.6 105.8 1.0 2.5 4.7 0.3 2.0 7.2 1.9 2.9 1.9 2.1 1.5 1.3 108.7 112.9 0.0 0.7 123.7 168.7 7.7 85.2 5.9 0.0 0.9 6.9 3.8 29.4 48.0 15.5 7.9 3.0 0.7 190.2 144.2 LENG9 ENSG00000275183 "Leukocyte receptor cluster member 9" 19 54461732-54463778 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 28.9" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 29.6;Intestinal goblet cells: 33.8;Proximal enterocytes: 48.2;Rod photoreceptor cells: 34.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 5.0;HEK 293: 4.5;Karpas-707: 4.1;RPMI-8226: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051671, HPA053556" Enhanced Approved "Nucleoli fibrillar center" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 45: Enterocytes - Digestion" "Nucleoli fibrillar center" "HPA051671: AB_2681568, HPA053556: AB_2682187" "unprognostic (8.38e-2)" "unprognostic (8.60e-2)" "unprognostic (1.18e-1)" "prognostic favorable (9.99e-5)" "unprognostic (2.43e-2)" "unprognostic (2.21e-3)" "unprognostic (1.09e-1)" "unprognostic (4.88e-2)" "unprognostic (5.73e-2)" "unprognostic (1.94e-1)" "unprognostic (7.40e-2)" "unprognostic (2.04e-1)" "unprognostic (1.10e-3)" "unprognostic (1.63e-3)" "unprognostic (2.96e-1)" "unprognostic (9.12e-2)" "unprognostic (2.76e-2)" 4.6 5.0 0.1 0.9 0.2 0.1 3.8 0.3 0.3 4.3 0.0 6.8 2.4 2.9 0.0 7.6 4.2 0.0 3.3 0.2 0.1 5.4 8.2 4.1 0.2 0.6 0.2 3.3 28.9 0.0 1.7 0.2 0.7 9.0 0.2 0.1 7.1 0.2 2.5 3.6 6.1 0.0 0.1 5.7 7.2 2.2 0.2 0.0 2.3 0.0 0.0 5.4 4.4 0.6 2.7 0.4 0.2 0.0 0.0 0.0 0.0 1.3 0.6 0.0 0.0 1.3 2.7 0.0 1.3 0.5 0.0 5.0 0.0 0.5 0.0 3.2 4.5 0.6 0.7 0.2 0.0 0.3 0.7 0.8 1.1 0.0 0.0 0.2 0.0 0.5 0.0 4.1 0.0 0.0 1.0 0.8 1.1 0.8 1.1 2.1 0.2 5.2 0.3 0.5 0.1 0.3 0.8 2.4 1.3 0.1 0.9 0.8 1.6 0.0 0.1 0.2 1.0 0.8 0.0 0.2 0.3 1.7 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.2 0.7 0.1 0.2 0.6 11.7 0.0 1.1 0.7 5.0 0.9 11.5 2.6 7.4 3.8 5.7 4.2 0.3 4.3 2.8 1.8 2.1 0.3 10.9 20.2 0.0 2.8 1.1 8.6 7.9 5.5 5.4 2.1 2.1 4.3 2.7 5.7 29.6 17.1 0.0 4.4 6.1 2.8 3.5 5.0 1.8 33.8 2.0 10.6 1.9 0.2 6.5 5.2 1.8 3.7 2.9 8.5 7.2 2.5 4.1 2.7 20.9 1.9 7.0 12.9 48.2 3.7 3.5 34.1 0.0 6.3 8.7 0.4 3.6 5.0 3.1 0.4 5.2 11.2 27.0 15.2 LGALS2 HL14 ENSG00000100079 "Galectin 2" P05162 22 37570248-37582616 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 335.5;intestine: 198.0;kidney: 153.0;pancreas: 211.5" "Cell type enhanced" "Detected in many" "Cholangiocytes: 779.2;Distal enterocytes: 695.4;Langerhans cells: 982.8;Proximal enterocytes: 2724.7;Proximal tubular cells: 1764.8;Undifferentiated cells: 749.3" "Cancer enhanced" "Detected in all" "renal cancer: 54.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 27 "classical monocyte: 1464.7;intermediate monocyte: 553.8;myeloid DC: 1207.2" "Group enriched" "Detected in all" 50 "dendritic cells: 1207.2;monocytes: 1464.7" "Group enriched" "Detected in many" 4 "CACO-2: 109.4;Hep G2: 62.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA003536, CAB025198" Enhanced Approved Nucleoplasm,Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria Nucleoplasm "CAB025198: , HPA003536: AB_1078936" "unprognostic (1.37e-3)" "unprognostic (4.11e-3)" "unprognostic (1.32e-3)" "unprognostic (4.32e-2)" "unprognostic (1.74e-1)" "unprognostic (2.91e-3)" "unprognostic (3.19e-1)" "unprognostic (9.92e-2)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (6.15e-2)" "unprognostic (5.19e-1)" "unprognostic (2.33e-3)" "unprognostic (1.80e-1)" "unprognostic (6.70e-2)" "unprognostic (5.01e-3)" "unprognostic (1.21e-1)" 7.5 1.4 0.6 23.5 1.4 19.2 5.4 0.2 1.1 1.8 0.2 55.0 41.2 3.6 1.0 5.2 4.4 335.5 1.6 0.5 1.0 153.0 5.0 8.6 60.7 1.6 1.2 0.9 211.5 0.2 0.1 1.7 1.4 2.2 81.1 0.1 2.1 0.7 1.9 9.9 198.0 5.2 0.4 59.2 10.7 0.6 1.1 41.3 1.0 0.7 64.0 8.2 0.5 3.4 2.8 1.5 0.9 1.0 0.0 0.0 1.1 1.7 0.0 0.0 0.0 109.4 0.1 0.4 0.3 0.0 0.3 1.7 0.0 0.0 0.0 0.2 1.1 0.0 0.0 62.5 0.3 0.0 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.0 0.5 0.0 0.0 2.8 0.0 1.0 0.4 21.2 0.3 0.0 0.9 1.3 0.0 0.0 0.0 0.3 1.7 1.9 2.4 0.5 1.6 1.7 6.4 2.0 1.0 4.3 0.8 0.0 0.2 0.3 2.7 0.2 1.3 7.7 1464.7 8.7 1.8 553.8 3.3 9.9 1.8 2.1 1207.2 2.3 2.3 1.9 26.8 2.3 39.7 9.6 3.0 981.5 0.6 1.4 0.2 1.1 0.5 1.0 1.6 1.2 1.4 0.4 1.1 3.4 1.6 6.4 3.9 0.0 16.4 17.1 0.1 0.5 0.0 0.0 13.2 7.5 0.3 779.2 1.4 29.5 0.0 0.2 7.0 695.4 127.2 26.3 0.1 0.1 0.3 2.3 73.7 4.8 0.1 206.7 0.3 3.2 5.6 0.2 2.5 0.0 0.7 1.9 26.4 0.0 0.1 413.0 0.0 100.8 982.8 0.3 0.6 150.8 24.9 0.0 164.8 0.0 4.1 0.0 0.1 291.6 331.6 0.0 0.9 0.3 2724.7 1764.8 2.1 0.0 0.0 0.3 2.3 0.0 0.4 0.1 12.4 0.3 8.6 0.0 749.3 0.3 LGR4 GPR48 ENSG00000205213 "Leucine rich repeat containing G protein-coupled receptor 4" Q9BXB1 11 27365961-27472790 "Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, Immunity, Innate immunity, Spermatogenesis, Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 204.4;Distal enterocytes: 123.3;Glandular and luminal cells: 137.7;Syncytiotrophoblasts: 128.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 83.5;RPTEC TERT1: 100.4;U-2197: 82.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030267, HPA054350" Uncertain Approved "Centriolar satellite" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 44: Endometrium - Transcription" "Centriolar satellite" "HPA030267: AB_10610004, HPA054350: " "unprognostic (5.27e-3)" "unprognostic (5.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.59e-1)" "unprognostic (4.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "unprognostic (2.00e-2)" "unprognostic (4.63e-2)" "unprognostic (5.84e-3)" "unprognostic (2.10e-1)" "prognostic favorable (2.00e-7)" "unprognostic (5.01e-1)" "unprognostic (3.59e-1)" "unprognostic (3.54e-2)" "unprognostic (1.76e-1)" 16.4 16.8 10.2 8.1 10.2 2.4 16.1 13.0 9.2 7.5 10.2 36.8 22.6 10.2 13.3 13.7 10.2 9.0 19.4 7.8 10.5 51.5 55.7 3.2 1.5 14.1 10.4 22.9 59.7 6.4 6.8 34.4 12.8 15.4 36.8 44.4 18.1 16.1 14.4 18.3 24.7 13.2 13.4 11.7 31.0 13.9 10.1 4.4 15.2 8.2 3.0 10.1 11.7 18.0 28.3 50.7 49.5 5.7 4.5 3.1 56.0 15.7 14.8 13.8 11.8 7.6 0.5 0.1 10.1 21.2 23.2 45.8 83.5 31.1 23.5 0.2 37.0 15.3 28.4 36.1 1.4 1.6 0.1 4.1 19.5 9.5 21.0 57.0 7.0 0.0 4.5 0.1 5.7 9.0 0.1 2.7 47.9 76.3 20.4 0.2 33.8 3.3 100.4 12.1 0.7 6.0 7.7 45.7 4.6 37.6 15.1 23.4 22.6 10.2 8.2 82.6 14.6 18.9 15.2 0.0 17.3 0.0 6.4 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 10.2 13.0 9.2 7.8 10.5 14.1 10.4 12.8 13.4 10.1 18.0 1.7 3.2 0.5 204.4 1.4 30.3 13.5 33.1 38.7 18.6 17.2 14.1 26.6 24.3 15.4 44.1 25.0 55.1 0.4 123.3 3.9 21.4 7.1 75.4 11.5 3.9 16.8 3.4 35.6 50.7 29.2 14.5 43.3 137.7 0.0 78.6 3.6 60.7 8.1 25.2 51.6 47.1 20.3 5.3 5.7 2.2 5.0 1.6 7.2 15.0 2.1 109.8 0.0 36.7 62.1 31.4 48.8 17.0 0.6 11.7 37.9 19.4 14.5 14.8 6.6 6.9 13.0 1.3 1.4 36.8 21.9 128.6 1.8 6.3 55.5 19.7 LLGL2 "HGL, Hugl-2" ENSG00000073350 "LLGL scribble cell polarity complex component 2" Q6P1M3 17 75525080-75575209 "Predicted intracellular proteins" "Cell cycle, Cell division, Exocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 297.5;Pancreatic endocrine cells: 249.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "gdT-cell: 3.1" "Group enriched" "Detected in many" 6 "dendritic cells: 1.1;NK-cells: 2.1;T-cells: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 92.6;CAPAN-2: 134.2;MCF7: 132.1;OE19: 101.6;RT4: 92.9;SK-BR-3: 127.5;T-47d: 96.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA022913 Uncertain Supported Vesicles,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Vesicles "HPA022913: AB_1852930" "unprognostic (1.18e-1)" "unprognostic (4.18e-2)" "unprognostic (2.89e-2)" "unprognostic (1.34e-1)" "unprognostic (3.43e-1)" "prognostic favorable (9.25e-4)" "unprognostic (2.60e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (3.49e-1)" "prognostic favorable (6.00e-5)" "unprognostic (6.22e-3)" "prognostic favorable (6.14e-9)" "unprognostic (1.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.15e-3)" "unprognostic (1.56e-2)" 3.9 7.8 2.7 14.2 6.0 4.6 9.0 6.2 3.6 16.3 9.5 64.5 54.5 4.1 24.0 55.5 14.9 21.3 3.4 2.1 4.1 56.7 26.9 27.6 5.1 6.0 5.9 4.9 74.5 17.3 11.2 6.3 6.2 14.7 28.4 10.4 43.4 12.5 1.3 34.1 55.4 1.9 4.0 24.5 64.2 6.9 4.5 2.3 17.8 0.9 5.7 9.6 25.9 9.8 60.1 54.7 0.3 10.4 0.0 0.0 22.7 0.4 0.6 1.1 0.6 92.6 134.2 4.0 13.6 0.2 5.0 73.7 10.1 10.1 0.2 5.1 18.1 4.0 16.1 35.1 0.6 0.6 8.5 0.0 13.6 0.2 2.1 1.3 2.0 5.8 7.9 5.4 0.0 132.1 3.5 7.1 7.4 101.6 21.2 6.9 0.2 14.9 28.4 92.9 22.1 4.5 11.8 127.5 4.0 12.2 96.6 9.4 0.5 0.2 0.6 0.2 1.0 6.4 9.3 1.8 0.4 0.3 2.7 0.0 0.1 0.1 3.1 0.3 0.7 0.3 0.7 2.1 0.1 0.3 0.1 1.2 0.1 2.1 0.1 1.1 0.5 0.4 2.7 6.0 6.2 3.6 2.1 4.1 6.0 5.9 6.2 4.0 4.5 9.8 7.7 89.8 51.6 3.6 9.0 10.6 34.7 17.3 12.0 15.5 28.8 20.1 3.8 74.4 40.5 90.1 166.8 3.7 44.7 297.5 31.3 84.1 0.6 88.7 7.2 9.0 95.1 0.8 1.1 138.9 8.5 3.5 158.5 87.7 22.2 7.2 4.6 25.0 6.0 8.4 0.8 113.0 32.6 3.8 6.0 1.0 4.7 4.7 3.6 5.6 5.5 28.1 50.4 0.5 49.9 249.4 159.8 4.1 16.1 37.6 84.5 47.0 53.9 117.5 6.6 1.3 6.4 1.5 18.9 27.5 21.7 4.4 21.8 7.5 136.1 89.7 LMAN1 "ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60" ENSG00000074695 "Lectin, mannose binding 1" P49257 18 59327823-59359265 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 502.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002320, CAB037163" Supported Supported "Endoplasmic reticulum,Vesicles" NA NA 18000000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "Endoplasmic reticulum" "CAB037163: AB_532237, HPA002320: AB_1079256" "unprognostic (5.64e-2)" "unprognostic (8.96e-3)" "unprognostic (4.20e-3)" "unprognostic (1.61e-1)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (1.65e-1)" "unprognostic (5.40e-3)" "unprognostic (1.16e-1)" "unprognostic (2.03e-1)" "unprognostic (2.40e-2)" "unprognostic (1.06e-1)" "unprognostic (5.79e-2)" "unprognostic (4.28e-2)" "unprognostic (5.37e-3)" "unprognostic (7.05e-2)" "unprognostic (3.71e-3)" 36.0 43.3 14.8 39.4 16.4 21.7 43.8 16.9 19.4 66.0 20.1 34.1 45.7 46.1 52.9 31.1 48.8 31.9 42.6 13.8 19.4 64.5 181.1 33.6 28.4 17.1 16.0 43.3 53.1 74.3 32.7 54.8 17.4 58.4 39.3 40.0 69.0 43.7 33.3 20.3 49.1 37.7 16.2 27.4 59.3 21.2 16.0 32.1 86.5 41.1 34.8 40.1 21.2 20.4 90.6 52.7 55.1 46.4 125.6 215.6 110.7 159.6 227.9 105.7 140.5 52.7 85.2 16.0 110.7 191.0 75.7 108.1 79.0 90.5 191.0 61.7 50.4 52.5 65.4 109.5 148.9 183.6 77.0 144.7 106.8 102.5 208.1 198.1 108.1 54.3 89.7 173.6 104.2 24.5 53.5 37.9 37.8 45.8 64.5 60.0 100.1 176.0 58.9 67.6 37.5 40.9 80.6 78.0 91.6 76.8 57.8 70.8 89.8 170.5 59.9 55.2 94.0 131.6 71.3 76.2 179.1 96.0 142.6 6.0 2.5 0.7 7.3 3.7 10.0 7.1 7.9 7.7 3.5 5.1 7.5 7.7 0.3 10.0 2.1 8.8 9.6 4.0 14.8 16.4 16.9 19.4 13.8 19.4 17.1 16.0 17.4 16.2 16.0 20.4 120.0 102.5 97.1 15.0 104.0 69.8 120.3 213.5 84.8 39.2 104.5 97.2 134.6 71.4 171.2 80.9 106.3 149.3 86.7 32.8 21.5 130.6 28.1 117.5 203.7 97.7 51.6 49.6 17.2 84.6 304.8 162.4 106.0 200.7 33.6 96.9 75.0 394.0 80.2 58.9 22.1 181.4 107.8 41.9 40.1 10.3 110.6 52.5 67.6 22.5 53.5 76.8 54.6 20.1 33.5 71.6 45.5 85.4 502.1 214.1 95.5 75.6 164.7 66.7 65.7 95.4 142.3 47.2 65.1 80.7 57.0 231.2 69.5 149.6 89.7 129.5 LMAN2 "C5orf8, GP36B, VIP36" ENSG00000169223 "Lectin, mannose binding 2" Q12907 5 177331567-177351668 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 530.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003927 Approved NA NA 88000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA003927: AB_1079257" "unprognostic (5.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.87e-2)" "unprognostic (1.85e-3)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (2.88e-3)" "unprognostic (2.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.51e-3)" "unprognostic (4.56e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (4.43e-2)" "unprognostic (6.13e-2)" "unprognostic (1.45e-2)" "unprognostic (2.32e-1)" 72.0 79.5 40.1 63.2 43.5 77.6 65.3 42.4 49.3 76.7 62.6 77.0 91.4 74.0 136.1 147.1 70.3 57.0 74.7 44.5 43.0 85.5 207.8 78.8 66.2 45.2 41.5 69.6 155.9 49.9 60.8 72.6 43.1 64.7 40.1 14.7 117.9 48.7 50.6 64.6 81.2 36.2 41.7 86.9 82.4 93.5 46.4 54.8 97.2 29.2 42.7 67.0 73.1 43.6 108.6 196.4 57.3 317.9 201.5 76.2 298.0 122.1 120.8 105.6 132.9 326.2 254.0 115.9 286.2 162.7 196.3 163.9 69.6 242.9 39.6 556.7 166.6 73.9 136.7 196.5 196.2 155.4 210.7 140.5 94.2 106.0 94.8 118.3 142.3 100.3 90.8 452.0 79.3 318.5 115.8 268.3 82.7 159.7 174.8 132.4 97.6 404.9 99.5 122.6 94.9 105.4 113.3 191.9 205.0 51.9 150.4 349.5 145.5 168.2 108.0 89.2 182.7 252.0 200.8 114.8 234.5 217.8 186.6 569.9 411.8 476.9 408.9 379.2 349.7 252.1 295.6 342.9 358.8 256.6 241.0 280.7 552.6 364.8 346.1 500.9 350.2 828.4 40.1 43.5 42.4 49.3 44.5 43.0 45.2 41.5 43.1 41.7 46.4 43.6 82.7 57.7 74.5 12.1 114.8 57.0 147.9 384.3 47.8 33.2 100.9 74.4 44.6 124.4 229.9 108.5 16.7 312.7 147.4 168.3 52.8 233.2 103.8 87.2 99.5 99.5 58.9 71.8 7.0 237.3 444.4 120.4 70.8 131.2 77.4 97.2 81.8 223.4 240.4 55.5 8.3 190.0 266.5 105.0 85.3 28.2 88.0 107.4 120.9 13.1 116.4 89.0 162.7 13.0 9.7 226.1 130.9 63.9 388.4 146.1 186.1 111.9 151.9 46.5 65.7 70.8 108.9 275.8 192.0 134.1 69.9 530.3 112.5 111.8 160.6 165.6 LMF2 "TMEM112B, TMEM153" ENSG00000100258 "Lipase maturation factor 2" Q9BU23 22 50502949-50507702 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 180.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062626 Approved Approved Centrosome NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" Centrosome "HPA062626: AB_2684812" "unprognostic (2.69e-1)" "prognostic favorable (3.47e-4)" "unprognostic (8.67e-2)" "unprognostic (2.25e-2)" "unprognostic (1.68e-2)" "unprognostic (5.13e-2)" "unprognostic (1.21e-2)" "unprognostic (2.70e-2)" "unprognostic (5.11e-2)" "unprognostic (2.90e-1)" "unprognostic (2.97e-2)" "unprognostic (3.12e-3)" "unprognostic (8.49e-2)" "unprognostic (1.47e-1)" "unprognostic (2.08e-1)" "unprognostic (2.54e-2)" "unprognostic (8.75e-2)" 50.8 43.9 21.2 20.6 21.6 33.6 46.4 21.4 30.0 49.7 33.6 40.4 25.9 43.9 8.3 48.0 42.0 15.2 37.5 21.6 23.9 48.7 56.6 46.8 22.4 25.7 21.6 47.8 180.8 12.9 63.4 18.0 23.6 51.2 5.6 3.7 49.5 20.0 23.7 36.6 51.4 9.3 21.9 60.6 38.0 42.0 21.7 13.1 56.7 7.6 9.4 45.2 44.5 23.9 48.9 36.0 20.1 38.4 28.6 24.4 46.8 85.4 44.5 53.7 60.0 35.9 24.8 21.4 22.6 45.2 23.9 57.3 6.8 27.0 7.4 17.1 74.7 12.0 69.3 38.4 35.8 22.4 45.1 36.0 24.6 36.7 9.0 23.1 30.1 16.5 14.4 70.0 23.7 35.1 15.9 26.4 12.0 12.4 44.4 35.7 32.3 58.9 22.0 26.1 18.0 26.5 58.2 49.8 40.1 9.7 28.6 15.6 44.3 75.3 42.8 54.6 4.3 26.9 9.4 13.1 54.8 13.6 62.9 16.3 17.9 22.4 26.1 23.5 19.6 13.4 21.6 24.4 18.6 8.6 12.3 13.2 16.5 16.7 20.5 33.8 21.2 18.6 21.2 21.6 21.4 30.0 21.6 23.9 25.7 21.6 23.6 21.9 21.7 23.9 42.0 12.8 10.8 13.4 26.4 18.6 17.1 37.5 19.9 15.7 23.1 18.7 11.4 28.6 24.5 14.7 22.9 64.4 43.1 55.6 3.9 37.1 9.4 7.6 21.7 25.7 15.0 22.9 14.9 74.9 106.4 39.9 27.5 17.3 15.8 32.7 27.8 33.6 43.1 11.8 11.6 29.4 18.3 21.6 26.7 20.5 29.2 26.1 24.9 13.1 21.5 23.3 40.2 12.5 10.1 30.8 55.7 25.6 49.9 10.8 74.4 19.3 9.4 16.0 19.7 17.9 29.6 12.6 20.1 29.9 17.3 28.5 34.8 32.0 34.2 15.0 LNX2 "MGC46315, PDZRN1" ENSG00000139517 "Ligand of numb-protein X 2" Q8N448 13 27545913-27620529 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 59.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040698 Approved Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 15: Hepatocytes - Hemostasis" Vesicles "Plasma membrane, Cytosol" "HPA040698: AB_10673138" "unprognostic (4.97e-2)" "unprognostic (1.97e-2)" "unprognostic (3.29e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-1)" "unprognostic (2.65e-2)" "unprognostic (1.12e-1)" "unprognostic (8.38e-2)" "unprognostic (1.16e-1)" "unprognostic (9.27e-3)" "unprognostic (4.21e-2)" "unprognostic (8.79e-2)" "prognostic favorable (7.09e-13)" "unprognostic (4.18e-3)" "unprognostic (1.67e-1)" "unprognostic (2.21e-1)" "unprognostic (2.84e-2)" 3.2 6.7 2.0 3.7 2.3 3.8 6.9 5.1 3.0 4.0 6.5 10.7 14.2 3.0 4.8 10.6 4.6 7.9 8.7 2.4 2.8 7.9 20.5 11.5 4.0 1.7 1.8 4.3 19.6 7.1 3.2 3.7 1.7 6.4 10.5 8.0 9.4 4.8 5.9 6.6 13.4 3.8 1.9 3.1 9.9 12.3 2.4 7.8 9.9 5.9 5.1 6.2 6.7 1.9 6.4 3.5 6.5 7.2 6.7 3.1 6.8 5.6 4.9 5.4 4.9 12.7 12.5 9.6 4.7 4.9 9.8 12.0 11.8 15.0 7.0 6.0 4.9 12.3 7.2 9.3 10.5 6.6 7.6 2.6 22.8 3.8 14.7 15.4 9.9 9.9 3.8 3.6 7.9 7.9 10.0 4.4 7.2 29.0 3.9 9.2 12.7 5.0 11.9 11.1 16.7 3.5 7.6 15.4 10.1 8.0 10.7 5.2 12.6 3.1 4.3 3.1 4.6 3.5 6.3 9.9 2.0 6.3 4.4 2.0 0.3 0.9 0.5 0.1 0.7 0.5 0.6 0.7 0.3 0.5 0.6 0.6 0.3 1.1 0.2 0.1 1.0 0.2 2.0 2.3 5.1 3.0 2.4 2.8 1.7 1.8 1.7 1.9 2.4 1.9 4.5 32.1 27.6 9.8 5.6 25.4 27.7 15.8 23.9 8.9 13.3 7.6 11.4 25.8 11.4 20.2 2.1 1.5 5.5 27.8 3.9 10.2 16.4 11.0 2.7 7.2 10.2 18.9 23.2 14.2 8.1 3.2 11.7 14.7 1.3 10.8 9.3 59.2 2.3 5.0 8.0 17.0 8.2 5.0 7.7 7.3 2.8 2.8 10.6 21.5 2.3 4.4 5.2 3.0 6.7 11.0 23.5 3.4 5.4 16.8 17.8 7.8 15.9 16.3 0.0 3.1 3.5 15.6 17.5 14.8 22.0 3.0 5.5 11.1 11.9 20.9 LRMDA "C10orf11, CDA017, OCA7" ENSG00000148655 "Leucine rich melanocyte differentiation associated" Q9H2I8 10 75431624-76560168 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Differentiation Albinism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 61.5;epididymis: 59.5" "Cell type enhanced" "Detected in many" "Adipocytes: 42.4;Distal tubular cells: 33.2;Endometrial ciliated cells: 27.8;Hofbauer cells: 56.9;Proximal tubular cells: 113.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 57.6;eosinophil: 22.1;intermediate monocyte: 28.8;myeloid DC: 67.5;non-classical monocyte: 17.1" "Group enriched" "Detected in many" 7 "dendritic cells: 67.5;granulocytes: 22.1;monocytes: 57.6" "Cell line enhanced" "Detected in many" "Hep G2: 46.3;HMC-1: 34.0;NB-4: 65.6;SK-MEL-30: 93.0;THP-1: 48.7;U-937: 43.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047446, HPA050419" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA047446: AB_2680050, HPA050419: AB_2756316" "unprognostic (1.04e-1)" "unprognostic (8.03e-2)" "unprognostic (2.40e-1)" "unprognostic (7.97e-2)" "unprognostic (2.03e-1)" "unprognostic (1.58e-2)" "unprognostic (1.31e-1)" "unprognostic (8.57e-3)" "unprognostic (5.86e-2)" "unprognostic (6.80e-2)" "unprognostic (8.34e-2)" "unprognostic (1.26e-1)" "unprognostic (7.34e-3)" "unprognostic (7.26e-2)" "unprognostic (6.50e-2)" "unprognostic (4.98e-3)" "unprognostic (3.64e-2)" 16.1 61.5 8.0 5.4 8.6 27.5 10.3 7.7 7.7 12.0 4.7 8.1 5.8 6.4 59.5 7.5 9.7 10.2 13.3 7.8 8.4 20.6 35.8 12.8 5.2 11.5 9.6 13.0 24.9 20.6 10.1 12.7 11.8 10.7 7.2 2.4 9.2 10.0 2.7 3.1 4.5 9.0 10.2 10.5 16.8 3.7 10.9 4.1 18.6 4.8 5.1 11.4 4.5 11.5 0.3 5.7 0.2 0.1 2.9 3.5 0.1 0.7 0.0 0.3 0.5 7.6 13.4 0.0 25.8 0.0 0.1 0.3 0.0 0.0 0.1 0.5 1.6 1.6 2.9 46.3 1.1 9.4 34.0 1.4 1.0 0.6 0.1 5.5 0.8 0.1 0.0 1.4 0.1 1.0 0.1 65.6 0.3 3.9 2.2 0.1 0.2 0.1 0.6 8.3 0.3 0.4 8.1 0.0 93.0 0.2 0.5 48.7 0.9 0.3 3.1 2.4 5.3 0.4 0.2 0.2 22.6 43.6 11.3 6.4 57.6 22.1 0.1 28.8 0.3 0.1 0.0 0.0 67.5 0.1 0.1 0.1 3.2 7.1 17.1 0.5 0.2 18.9 8.0 8.6 7.7 7.7 7.8 8.4 11.5 9.6 11.8 10.2 10.9 11.5 42.4 22.4 19.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.1 5.7 0.0 0.0 3.7 12.9 0.0 1.1 0.8 0.0 33.2 16.6 0.0 27.8 2.5 13.2 0.0 0.0 0.0 15.8 0.8 4.5 0.0 10.0 7.6 16.1 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 6.7 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.1 0.0 0.0 113.4 6.6 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 1.2 0.6 25.7 0.0 0.0 LRRC59 "FLJ21675, PRO1855" ENSG00000108829 "Leucine rich repeat containing 59" Q96AG4 17 50375059-50397523 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 272.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030827, HPA030829" Enhanced Enhanced "Endoplasmic reticulum" NA NA 740000 "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA030827: AB_10602704, HPA030829: AB_10670045" "unprognostic (4.73e-2)" "unprognostic (2.15e-2)" "prognostic favorable (2.60e-4)" "unprognostic (5.63e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (1.00e-5)" "prognostic unfavorable (3.12e-6)" "unprognostic (1.88e-3)" "unprognostic (9.95e-2)" "unprognostic (5.62e-3)" "prognostic unfavorable (6.87e-4)" "unprognostic (3.68e-2)" "prognostic unfavorable (1.19e-6)" "unprognostic (2.77e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-3)" "prognostic unfavorable (1.90e-5)" 49.6 82.6 18.5 54.1 20.5 79.3 34.1 18.4 21.7 60.4 19.0 72.1 46.8 32.2 55.5 47.9 29.4 32.2 33.0 19.1 18.6 41.1 75.0 45.8 30.9 18.2 19.3 21.7 119.4 34.8 21.8 51.7 18.6 35.3 72.0 21.7 56.2 35.7 32.6 24.3 46.0 52.3 18.3 33.0 73.8 29.2 22.0 29.3 36.0 17.0 42.8 56.6 30.1 19.9 390.5 289.9 81.8 123.6 135.3 158.7 146.2 310.7 172.3 284.5 249.4 668.8 109.0 168.8 207.8 356.4 174.3 138.1 205.2 265.2 336.3 90.4 298.6 295.9 154.8 361.8 283.7 294.1 134.8 140.8 211.3 305.2 351.7 82.6 213.3 95.7 278.9 155.6 189.4 264.3 209.0 139.0 92.5 364.2 419.1 175.9 261.9 323.6 156.0 194.9 199.1 165.4 107.5 119.3 161.9 120.4 201.1 157.9 229.6 327.4 135.5 306.2 410.4 232.3 205.1 213.6 222.2 195.9 210.8 22.8 21.9 19.8 9.4 26.9 11.7 11.0 9.5 11.5 20.3 8.5 6.1 7.9 10.9 8.6 27.8 16.5 10.3 13.0 18.5 20.5 18.4 21.7 19.1 18.6 18.2 19.3 18.6 18.3 22.0 19.9 33.1 22.4 23.7 5.2 61.2 139.4 102.1 54.7 43.9 20.4 55.0 30.9 4.1 40.0 50.0 20.2 2.1 90.8 38.4 101.6 29.4 165.0 67.1 53.6 53.8 45.6 38.3 36.6 5.5 187.0 272.2 64.5 104.5 96.3 30.4 28.9 27.1 69.1 103.3 21.9 5.5 178.3 26.4 29.0 111.1 18.7 35.4 45.1 65.8 3.7 45.6 26.5 30.9 2.0 6.8 187.7 75.7 29.0 211.3 164.8 63.5 48.0 26.5 15.5 13.1 59.1 92.8 61.3 27.7 66.1 132.7 236.0 33.2 38.3 127.1 146.7 LSR "ILDR3, LISCH7" ENSG00000105699 "Lipolysis stimulated lipoprotein receptor" Q86X29 19 35248330-35267964 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 144.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 335.6;Ductal cells: 260.5;Exocrine glandular cells: 278.9;Pancreatic endocrine cells: 336.0;Paneth cells: 273.6;Syncytiotrophoblasts: 248.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 500.5;CACO-2: 215.6;CAPAN-2: 225.3;HaCaT: 203.9;OE19: 300.4;RT4: 198.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007270, HPA075309" Approved Supported "Plasma membrane" NA NA 3500000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "HPA007270: AB_1079253, HPA075309: " "unprognostic (3.90e-1)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (2.67e-3)" "unprognostic (2.28e-2)" "unprognostic (6.07e-3)" "unprognostic (1.55e-1)" "unprognostic (9.84e-2)" "unprognostic (2.17e-1)" "unprognostic (2.70e-2)" "unprognostic (2.23e-2)" "unprognostic (3.42e-2)" "prognostic favorable (8.09e-4)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.99e-2)" "unprognostic (1.54e-2)" 15.7 31.3 15.7 17.8 13.6 3.6 25.4 13.2 14.7 20.4 39.0 96.9 85.0 14.4 13.9 60.0 29.7 36.4 7.7 12.5 13.2 28.9 144.8 30.0 14.4 17.1 14.8 6.4 114.2 16.8 27.3 46.9 15.5 25.6 43.7 8.6 69.4 18.5 4.4 51.9 75.0 5.3 12.9 17.9 133.1 27.2 17.7 6.6 32.9 2.7 14.1 29.9 29.3 14.8 500.5 8.1 0.7 1.0 1.4 0.5 86.8 1.2 1.9 2.2 1.6 215.6 225.3 19.6 73.0 1.3 7.2 203.9 44.3 75.0 0.3 30.1 82.6 0.2 6.5 96.1 1.7 0.3 0.9 1.0 81.2 2.0 24.2 1.0 0.8 0.6 80.2 17.2 1.1 177.4 0.9 1.1 69.0 300.4 3.2 3.8 0.8 54.6 46.2 198.2 37.7 1.4 40.9 130.5 35.8 21.7 112.5 2.6 0.4 3.9 44.7 3.1 2.2 27.2 52.5 45.7 3.4 0.8 12.4 6.4 0.2 0.1 2.5 0.0 2.6 4.3 5.8 5.4 0.1 3.0 4.2 4.9 0.0 5.6 0.0 0.2 4.1 2.9 15.7 13.6 13.2 14.7 12.5 13.2 17.1 14.8 15.5 12.9 17.7 14.8 38.2 16.0 21.7 0.3 26.3 51.7 123.4 90.7 50.1 2.1 60.9 49.7 5.6 78.6 71.2 36.8 16.7 210.3 4.7 335.6 11.7 260.5 9.4 41.7 27.4 44.6 56.4 3.2 0.8 278.9 93.0 11.9 214.1 61.5 31.1 30.3 20.3 89.7 21.7 0.0 0.9 145.5 73.2 2.2 14.3 2.9 6.5 4.6 14.2 22.5 7.2 11.5 3.1 1.5 0.8 336.0 273.6 3.4 41.1 113.6 117.8 24.6 43.8 12.3 0.0 4.1 24.4 7.9 19.1 57.2 51.7 248.0 24.3 3.4 124.2 206.3 MAGOHB "FLJ10292, MGN2" ENSG00000111196 "Mago homolog B, exon junction complex subunit" Q96A72 12 10604193-10613609 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 119.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043036, HPA047754" Uncertain NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" "HPA043036: AB_2678279, HPA047754: AB_2680148" "unprognostic (1.16e-2)" "unprognostic (4.94e-2)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-1)" "unprognostic (2.50e-2)" "unprognostic (3.42e-2)" "unprognostic (6.27e-2)" "unprognostic (8.57e-2)" "prognostic favorable (5.56e-6)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.04e-8)" "prognostic favorable (6.50e-4)" "unprognostic (1.61e-1)" "unprognostic (3.33e-1)" "unprognostic (6.03e-2)" 7.7 8.2 7.1 7.1 7.3 7.2 9.2 7.8 11.1 7.5 7.3 8.9 5.3 6.5 11.7 8.0 4.3 4.7 7.7 6.7 6.9 11.2 14.4 5.0 9.4 6.9 6.8 4.0 5.9 7.1 7.3 7.4 6.8 6.8 8.8 4.0 5.1 6.2 3.2 5.6 6.2 7.7 6.9 7.1 6.0 3.4 6.9 11.1 6.4 2.4 12.1 7.0 4.5 7.5 39.4 53.0 55.7 38.7 13.0 17.7 55.0 56.0 16.7 46.0 33.3 69.4 37.4 64.5 8.7 38.1 42.0 21.3 50.2 33.1 59.2 39.4 70.0 53.6 54.4 47.4 16.9 110.0 29.2 12.6 12.5 36.7 22.7 12.9 28.9 76.5 52.7 9.9 42.0 56.9 71.9 72.2 113.7 40.8 47.2 63.1 92.6 39.4 36.7 46.5 15.2 31.3 38.9 43.0 40.6 106.7 20.9 95.8 16.5 26.1 88.3 38.2 82.0 14.2 42.5 128.1 61.3 56.9 72.0 0.5 7.8 3.0 14.2 13.6 15.3 12.1 13.6 15.9 11.6 12.7 15.3 18.7 1.4 20.1 13.1 32.9 13.4 8.3 7.1 7.3 7.8 11.1 6.7 6.9 6.9 6.8 6.8 6.9 6.9 7.5 21.8 19.2 18.8 4.2 27.1 14.1 27.8 61.4 14.8 12.2 22.3 26.8 25.5 17.2 32.7 22.0 8.4 67.5 34.8 13.3 70.5 43.8 9.9 21.1 29.8 24.4 22.7 36.4 7.6 34.3 119.6 30.4 19.4 31.4 24.1 33.6 19.2 38.5 49.6 0.0 7.9 32.7 40.7 14.5 14.1 6.5 18.0 18.5 30.2 5.6 30.8 18.4 30.9 14.1 10.3 25.3 11.3 15.4 26.4 33.5 16.2 48.3 22.3 15.1 26.3 19.7 49.1 24.7 54.3 21.6 13.2 46.8 24.1 17.8 25.5 26.4 MAGT1 "DKFZp564K142, IAP, MRX95, OST3B, SLC58A1" ENSG00000102158 "Magnesium transporter 1" Q9H0U3 X 77825747-77895593 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 145.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049851 Approved "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA049851: AB_2680913" "prognostic unfavorable (1.30e-4)" "unprognostic (3.32e-1)" "unprognostic (6.47e-2)" "unprognostic (1.16e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (8.98e-4)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.60e-2)" "unprognostic (5.56e-3)" "unprognostic (1.14e-1)" "unprognostic (6.25e-3)" "unprognostic (1.66e-1)" 25.3 22.6 12.9 24.2 19.4 20.8 36.5 17.2 17.4 39.4 14.4 28.3 25.7 27.5 53.7 25.6 25.9 25.1 37.5 13.0 16.4 41.9 71.2 26.8 22.5 20.9 18.5 23.6 31.9 38.4 18.5 36.4 21.9 33.5 27.0 5.2 34.6 28.0 17.1 18.3 26.2 24.3 16.6 23.5 29.4 11.3 17.9 21.0 78.0 21.9 23.5 29.1 18.2 27.0 62.5 34.1 41.7 48.8 75.0 49.3 64.8 66.9 67.4 51.7 56.5 45.6 99.5 45.6 90.9 71.7 53.3 56.4 88.4 50.8 80.0 32.3 55.4 30.6 46.2 42.5 66.6 64.9 31.1 45.3 43.5 64.6 56.7 55.1 74.0 31.2 36.5 123.2 64.7 40.4 36.2 23.9 56.1 64.6 41.3 43.3 72.5 84.7 61.9 45.8 14.1 26.3 91.6 64.8 58.0 43.6 43.8 35.3 75.2 45.6 51.1 71.7 33.2 44.8 103.1 58.1 49.7 60.5 61.0 15.3 12.9 13.7 17.2 19.7 18.4 12.5 15.6 16.6 11.1 10.7 14.9 17.7 11.0 18.6 21.0 22.2 12.8 15.7 12.9 19.4 17.2 17.4 13.0 16.4 20.9 18.5 21.9 16.6 17.9 27.0 50.2 41.7 53.6 9.8 37.3 33.0 55.3 51.6 24.5 5.2 39.1 25.1 53.4 42.9 51.6 40.5 4.2 33.3 43.4 44.8 3.9 35.3 2.2 23.7 38.9 40.7 22.7 33.0 6.1 34.9 59.3 43.7 33.1 58.0 30.4 24.5 43.2 145.6 42.3 1.7 6.3 39.6 32.6 49.8 46.1 2.5 30.7 45.1 33.8 15.9 33.9 17.1 18.6 13.6 28.0 36.2 37.2 27.1 87.4 65.4 31.2 32.0 20.7 5.2 19.7 38.7 31.2 6.6 16.7 36.5 45.6 81.3 36.0 31.2 26.0 69.4 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" NA NA 2000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: AB_2683419" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favorable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 15.6 11.7 6.7 13.0 12.0 6.3 12.9 8.8 11.6 17.5 7.7 12.5 11.1 16.4 13.7 15.2 14.2 12.3 11.0 7.2 8.5 15.3 21.1 10.8 14.1 1.6 5.0 14.3 36.2 32.9 6.7 21.7 1.6 14.4 12.5 18.2 14.0 13.1 8.4 10.3 11.6 18.0 1.0 12.2 14.2 10.8 6.2 14.7 25.4 10.1 13.8 17.8 7.7 9.8 32.4 13.8 23.2 20.1 29.8 35.7 74.2 26.3 40.9 11.6 10.9 10.7 18.2 24.2 47.4 33.9 10.8 18.7 11.0 22.3 26.0 30.3 16.4 14.4 18.5 11.8 18.1 22.7 31.6 24.2 23.5 17.8 15.5 21.3 35.0 16.7 23.5 36.1 24.5 62.6 14.0 7.2 11.9 16.4 14.4 12.5 50.5 16.7 15.9 43.3 12.6 18.4 26.2 27.6 21.1 30.1 13.8 14.2 33.6 26.0 21.4 18.6 27.2 24.4 18.0 15.9 34.4 17.8 63.1 0.9 1.5 2.6 3.0 1.2 3.6 1.9 2.4 2.5 1.4 1.9 2.0 2.9 1.2 3.8 1.1 2.7 6.3 1.5 6.7 12.0 8.8 11.6 7.2 8.5 1.6 5.0 1.6 1.0 6.2 9.8 40.3 38.5 33.4 71.5 45.1 31.0 34.8 26.7 39.3 63.5 43.3 46.0 101.8 35.8 39.1 44.1 22.9 55.1 52.6 24.7 17.6 32.3 33.1 43.2 52.0 40.6 21.7 43.8 188.5 60.4 236.1 50.7 28.5 54.7 16.4 32.3 42.1 88.7 29.4 43.7 238.0 37.1 20.3 36.2 22.0 22.5 53.7 37.2 40.9 101.2 39.2 51.3 55.6 136.7 149.1 37.5 25.1 65.5 120.2 43.0 28.6 22.1 40.9 42.2 39.5 69.1 53.5 72.9 56.2 53.0 34.5 380.5 45.8 68.3 30.8 47.3 MAN2B2 KIAA0935 ENSG00000013288 "Mannosidase alpha class 2B member 2" Q9Y2E5 4 6575189-6623362 "Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 15000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 44: Endometrium - Transcription" "unprognostic (1.30e-1)" "unprognostic (3.32e-1)" "unprognostic (1.28e-1)" "prognostic favorable (7.59e-4)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (1.31e-1)" "unprognostic (1.57e-1)" "unprognostic (5.78e-2)" "unprognostic (3.02e-1)" "unprognostic (2.38e-2)" "unprognostic (2.72e-1)" "unprognostic (6.53e-2)" "unprognostic (2.55e-1)" "unprognostic (1.13e-1)" "unprognostic (2.66e-3)" "unprognostic (2.18e-1)" 20.0 13.6 12.9 13.8 18.2 14.8 16.4 7.7 14.3 17.6 26.0 14.5 13.4 18.6 14.1 11.3 17.7 15.9 22.6 13.2 15.6 15.1 23.7 18.2 13.5 13.0 13.2 26.6 22.0 9.2 17.9 12.9 11.8 18.0 7.9 5.2 16.7 11.5 4.7 13.6 15.8 10.3 10.6 17.7 20.1 4.4 15.0 9.0 23.2 4.7 8.5 19.3 15.9 11.9 17.5 15.6 2.9 21.0 44.7 30.9 19.7 35.0 40.5 16.8 22.9 9.0 32.3 8.7 16.5 38.2 39.2 17.4 1.0 11.1 9.2 10.4 8.8 11.7 10.9 10.2 19.5 22.0 51.8 41.0 10.9 13.4 3.6 30.3 19.7 10.8 5.1 21.9 22.1 10.8 10.9 13.9 3.8 21.8 11.9 10.7 14.4 10.4 8.8 17.4 5.0 5.5 23.4 13.9 8.9 10.0 27.7 29.1 36.3 30.3 9.1 38.2 22.5 9.0 8.4 4.2 35.4 25.5 26.7 15.4 9.0 14.3 11.7 13.2 8.9 4.2 7.0 10.7 8.6 4.4 6.3 8.2 11.0 6.8 17.5 3.3 10.7 11.0 12.9 18.2 7.7 14.3 13.2 15.6 13.0 13.2 11.8 10.6 15.0 11.9 9.8 16.0 18.9 7.8 11.6 5.0 5.5 4.9 11.4 8.9 8.2 5.6 17.0 20.0 11.1 11.0 6.2 13.5 12.9 18.3 1.9 9.7 0.6 18.7 15.8 8.2 7.8 5.7 9.4 10.7 10.2 18.4 11.7 36.8 10.8 11.1 17.5 44.1 20.9 10.1 8.3 11.0 2.0 30.2 8.2 1.1 19.6 18.0 3.6 8.4 11.2 13.0 5.2 6.0 8.9 10.1 9.0 24.5 15.1 7.1 11.7 4.2 9.5 7.4 13.1 7.5 8.5 1.1 0.6 8.0 3.8 8.5 15.6 4.4 8.9 4.6 MANF "ARMET, ARP" ENSG00000145050 "Mesencephalic astrocyte derived neurotrophic factor" P55145 3 51385291-51389397 "Plasma proteins, Predicted secreted proteins" "Stress response, Unfolded protein response" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 426.1;Syncytiotrophoblasts: 459.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 109.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011175 Approved Supported "Endoplasmic reticulum" "Secreted to blood" NA NA 7500000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA011175: AB_1845039" "unprognostic (2.90e-2)" "unprognostic (5.24e-2)" "unprognostic (1.11e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "prognostic unfavorable (9.58e-6)" "prognostic unfavorable (7.48e-4)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.12e-3)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.21e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" "unprognostic (5.10e-2)" 39.4 36.7 34.4 70.9 34.5 35.3 41.8 37.8 50.5 59.4 44.2 55.4 42.5 48.2 169.3 53.2 42.8 32.1 51.1 34.8 42.7 48.6 109.2 44.3 50.5 38.4 35.7 28.7 81.1 38.8 56.4 59.9 37.2 51.3 58.8 17.7 51.0 50.5 12.4 36.6 39.5 47.2 36.2 56.1 59.5 43.2 37.9 47.7 117.8 20.8 76.1 67.8 35.5 38.1 128.6 61.2 164.7 207.7 107.8 139.4 173.8 200.2 160.6 194.0 184.5 99.6 292.6 271.6 162.6 121.9 449.8 77.7 201.4 200.0 187.3 128.9 92.2 220.2 93.5 230.3 349.8 108.2 137.1 60.6 168.5 201.3 271.7 189.9 252.7 112.3 48.3 299.5 181.6 75.5 184.8 215.6 144.6 298.0 237.6 76.4 105.3 288.7 162.8 86.9 64.4 201.6 165.3 104.2 130.3 175.8 83.7 141.2 129.3 117.4 112.1 140.4 222.6 247.9 105.0 186.5 195.4 217.5 221.2 73.2 15.3 9.4 28.8 13.0 35.5 17.4 20.2 27.5 16.0 12.1 14.9 16.0 8.5 26.0 8.3 109.8 13.4 16.9 34.4 34.5 37.8 50.5 34.8 42.7 38.4 35.7 37.2 36.2 37.9 38.1 55.9 32.1 21.5 5.2 134.1 163.1 223.7 232.5 31.3 15.1 50.5 40.5 69.3 61.5 104.0 55.2 6.2 188.1 142.8 75.7 43.0 172.6 99.0 73.3 101.9 88.3 116.6 26.1 5.8 124.6 387.0 101.2 71.9 99.4 62.9 77.9 79.6 156.1 179.5 11.8 8.5 235.9 118.0 36.1 170.6 123.3 60.0 63.0 181.5 7.5 79.1 39.6 117.4 5.0 9.5 167.8 90.5 51.6 426.1 245.0 47.7 78.9 71.1 19.1 65.7 59.7 194.2 176.8 91.1 42.8 160.5 459.0 94.8 40.6 120.9 202.0 MAP3K21 "KIAA1804, MLK4" ENSG00000143674 "Mitogen-activated protein kinase kinase kinase 21" Q5TCX8 1 233327724-233385148 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 20.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 35.3;Alveolar cells type 2: 10.0;Collecting duct cells: 14.7;Ductal cells: 11.9;Exocrine glandular cells: 9.8;Glandular and luminal cells: 11.7;Proximal tubular cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "NK-cell: 1.5" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.5" "Cell line enhanced" "Detected in many" "HEK 293: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA007636 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane, Cytosol" "HPA007636: AB_1079392" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.42e-3)" "unprognostic (4.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.82e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (8.21e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (1.71e-1)" "unprognostic (9.22e-2)" "unprognostic (4.84e-2)" 0.7 3.8 1.8 1.3 1.6 2.1 2.5 5.2 2.4 1.0 0.7 6.3 11.7 1.2 3.3 2.5 4.6 1.7 0.4 1.4 1.4 13.5 5.4 4.5 0.9 1.5 0.3 0.7 20.3 4.3 2.1 0.3 1.7 1.3 6.9 1.0 3.8 2.7 0.0 3.3 10.1 0.6 0.2 0.5 12.4 9.4 1.8 0.4 2.3 0.0 1.3 1.2 1.8 1.3 11.6 19.4 0.4 0.0 0.0 0.0 9.6 0.3 0.0 0.4 0.8 10.8 9.8 1.1 7.7 0.2 3.6 6.0 14.4 5.9 1.2 21.6 27.4 0.1 11.4 0.0 0.7 19.0 4.3 0.2 7.8 0.3 10.9 2.2 0.7 8.7 0.2 3.7 0.0 2.6 6.1 6.8 13.6 13.4 8.4 0.0 0.0 20.7 13.1 4.8 13.9 3.7 6.6 0.3 0.0 1.5 5.6 6.0 0.0 0.0 1.8 0.1 11.5 3.4 4.6 0.0 1.8 5.1 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.8 1.6 5.2 2.4 1.4 1.4 1.5 0.3 1.7 0.2 1.8 1.3 0.9 35.3 10.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 7.0 6.5 0.0 0.0 0.6 14.7 0.0 0.0 0.4 0.0 3.9 11.9 0.0 5.7 1.0 0.3 0.0 0.0 0.0 9.8 0.0 0.5 0.0 11.7 0.0 2.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.7 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 MCEE "GLOD2, MCE" ENSG00000124370 "Methylmalonyl-CoA epimerase" Q96PE7 2 71109684-71130239 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 92.0;Proximal tubular cells: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035196 Approved Nucleoli "Intracellular and membrane" No No 29000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 30: Mammary glandular cells - Lactation" Nucleoli "HPA035196: AB_10601871" "unprognostic (7.65e-2)" "unprognostic (8.20e-2)" "unprognostic (3.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.35e-1)" "prognostic favorable (4.76e-4)" "prognostic favorable (5.78e-4)" "unprognostic (4.86e-3)" "unprognostic (6.48e-2)" "unprognostic (1.08e-1)" "unprognostic (7.43e-3)" "unprognostic (8.59e-2)" "unprognostic (9.40e-3)" "unprognostic (4.90e-2)" "unprognostic (3.55e-1)" "unprognostic (6.51e-2)" "unprognostic (5.38e-2)" 17.8 30.0 8.9 12.3 9.7 9.1 32.7 10.5 12.5 22.1 15.4 20.1 20.1 13.1 30.5 26.3 14.8 14.2 35.9 8.9 9.4 33.7 69.8 13.7 14.7 9.5 9.1 18.5 36.1 35.6 24.1 17.6 9.9 23.9 23.9 12.3 42.8 17.8 36.5 28.4 16.9 12.2 9.7 16.0 23.5 6.0 9.4 13.3 14.1 61.7 15.5 16.5 21.9 11.7 12.1 5.2 10.6 7.6 34.3 46.6 30.2 18.5 23.3 9.2 13.9 14.7 14.8 18.7 5.5 18.5 7.0 12.5 12.4 9.6 9.5 17.1 10.7 12.7 16.3 42.5 19.5 14.5 10.3 31.3 13.5 6.2 12.3 20.5 10.6 14.6 17.1 31.9 9.1 15.5 10.9 16.9 9.6 33.1 14.6 12.8 12.3 35.2 14.8 10.4 11.9 8.8 6.9 40.1 18.1 12.1 31.7 13.4 13.7 10.6 8.3 10.9 7.5 30.7 13.1 20.0 17.5 23.7 9.9 20.3 23.2 27.6 15.4 25.6 21.9 21.6 19.3 15.5 19.9 16.7 17.6 15.0 6.1 16.5 25.3 23.9 35.3 14.6 8.9 9.7 10.5 12.5 8.9 9.4 9.5 9.1 9.9 9.7 9.4 11.7 11.1 25.6 13.4 13.7 12.8 8.5 10.5 18.4 21.6 2.6 37.5 27.3 75.2 25.8 18.2 5.5 2.1 36.2 11.2 14.0 92.0 13.3 1.1 17.2 16.2 9.0 9.0 12.0 13.3 18.4 36.8 23.3 17.3 20.2 0.0 5.2 12.8 73.0 15.1 5.0 14.5 32.5 18.3 10.4 8.7 1.0 29.2 9.4 14.2 14.0 9.1 7.3 5.2 16.1 20.8 9.6 16.2 17.7 42.0 11.0 35.0 77.1 19.4 8.6 26.3 12.7 17.9 3.7 5.1 25.6 20.9 11.4 10.1 16.9 23.0 11.9 MCFD2 "F5F8D, LMAN1IP, SDNSF" ENSG00000180398 "Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit" Q8NI22 2 46901870-46941855 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Muller glia cells: 253.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022410, HPA034593" Supported "Intracellular and membrane" NA NA 1200000 "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 5: Muller glia cells - Visual perception" "CAB022410: , HPA034593: AB_2674239" "unprognostic (1.16e-2)" "unprognostic (5.71e-3)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (2.50e-1)" "unprognostic (2.87e-2)" "unprognostic (3.98e-2)" "unprognostic (3.10e-2)" "unprognostic (3.93e-2)" "unprognostic (8.32e-2)" "unprognostic (1.56e-3)" "unprognostic (1.82e-2)" "unprognostic (1.19e-1)" "unprognostic (2.42e-2)" "unprognostic (1.03e-1)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.64e-4)" 52.0 155.5 41.3 35.6 43.1 34.7 55.1 38.1 40.3 50.4 69.5 32.2 32.5 54.5 42.1 45.9 41.9 44.9 42.3 41.3 46.8 59.4 111.8 45.0 32.1 33.5 41.3 79.2 104.1 52.5 38.7 70.1 41.6 54.0 26.9 83.3 149.7 82.9 83.3 26.0 33.4 52.5 28.0 44.6 33.9 30.9 48.6 30.8 121.0 84.6 34.2 41.2 29.2 34.7 147.7 86.9 74.7 59.7 151.5 215.1 115.4 248.4 254.1 129.4 116.8 116.9 109.4 96.4 297.7 294.7 154.3 81.8 67.0 127.0 207.7 64.5 67.2 101.9 87.1 182.5 236.5 94.8 158.6 163.2 77.8 206.7 178.7 247.9 210.8 28.0 199.3 56.0 266.8 48.7 56.9 67.6 63.9 102.3 84.1 68.3 133.2 106.7 80.3 59.3 23.9 62.2 93.1 46.9 116.0 86.3 33.1 80.6 341.1 298.3 130.5 97.0 164.2 42.0 43.8 76.4 320.2 88.0 100.8 27.2 21.4 29.7 9.6 23.3 12.2 12.5 10.9 10.2 18.4 12.8 14.3 9.8 12.0 9.9 18.3 16.9 9.7 14.0 41.3 43.1 38.1 40.3 41.3 46.8 33.5 41.3 41.6 28.0 48.6 34.7 50.8 105.8 89.1 16.6 29.6 48.2 56.5 65.3 36.5 69.3 64.4 48.5 70.3 38.6 68.8 47.8 39.6 75.5 25.4 26.6 21.5 88.6 144.3 76.4 60.2 64.7 26.8 28.2 19.6 178.5 64.5 70.1 20.4 69.9 50.5 44.1 53.9 155.1 54.5 38.7 23.8 28.5 18.3 40.5 31.3 113.7 62.7 39.2 12.4 7.5 33.8 253.2 12.3 16.1 16.2 152.7 23.1 59.5 43.8 82.4 42.2 41.3 69.6 51.3 65.7 63.9 55.4 48.9 32.6 39.6 44.9 102.1 23.4 74.3 22.8 75.8 MESD "BOCA, KIAA0081, MESDC2" ENSG00000117899 "Mesoderm development LRP chaperone" Q14696 15 80946289-80989828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" Chaperone "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039414, HPA041721" Approved Supported "Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 1600000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "Nuclear bodies, Cytosol" "HPA039414: AB_10674981, HPA041721: AB_2756310" "unprognostic (9.21e-2)" "unprognostic (4.50e-2)" "unprognostic (8.02e-2)" "prognostic favorable (2.31e-4)" "unprognostic (4.93e-3)" "unprognostic (2.32e-3)" "unprognostic (3.47e-2)" "unprognostic (3.09e-3)" "unprognostic (4.04e-1)" "prognostic favorable (1.12e-4)" "unprognostic (7.93e-2)" "unprognostic (3.05e-2)" "unprognostic (3.42e-2)" "unprognostic (1.68e-1)" "unprognostic (4.32e-2)" "unprognostic (3.83e-1)" "unprognostic (1.88e-1)" 14.4 17.4 11.9 13.7 13.6 5.4 13.9 13.7 13.0 17.8 14.6 14.6 12.8 11.3 42.7 14.6 12.4 11.5 12.8 11.7 14.2 14.4 20.6 14.1 14.0 13.4 13.1 17.4 19.2 14.0 17.8 26.9 13.8 18.2 14.5 10.4 18.4 14.3 7.7 10.9 12.7 11.1 13.4 13.8 15.3 9.8 13.8 14.2 33.7 10.6 13.2 15.4 14.4 15.0 26.8 40.2 34.6 22.3 57.1 32.4 54.0 40.0 47.4 42.7 51.6 36.0 72.9 22.4 45.4 32.3 45.1 43.8 54.1 41.1 40.3 50.2 35.5 28.3 33.0 61.9 43.7 33.8 30.0 33.9 46.6 36.1 42.4 35.7 41.1 27.0 34.7 55.5 36.7 34.0 20.9 28.3 41.9 39.3 16.4 31.7 21.3 59.7 35.6 36.3 29.9 17.6 43.9 29.3 70.0 62.4 34.0 26.8 32.4 40.9 39.1 22.1 52.2 35.0 48.0 30.2 38.5 59.7 43.8 39.4 26.1 19.1 35.6 24.9 41.8 34.5 37.2 35.4 27.2 35.4 34.6 34.7 8.1 44.8 22.5 45.2 42.5 31.1 11.9 13.6 13.7 13.0 11.7 14.2 13.4 13.1 13.8 13.4 13.8 15.0 59.7 80.1 59.6 0.0 20.6 0.0 0.0 0.0 0.0 0.0 51.0 44.2 0.0 0.0 27.9 58.8 0.0 341.4 41.6 0.0 13.7 100.9 0.0 41.4 79.4 36.9 0.0 0.0 0.0 111.9 279.3 48.4 0.0 69.8 36.6 56.4 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 86.3 0.0 0.0 0.0 0.0 82.5 0.0 0.0 18.8 0.0 0.0 48.8 43.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 436.0 25.8 63.6 0.0 0.0 METTL1 "C12orf1, TRM8, TRMT8" ENSG00000037897 "Methyltransferase like 1" Q9UBP6 12 57768471-57772119 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 60.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "RH-30: 293.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020914, HPA050450" Uncertain Supported Nucleoplasm NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA020914: AB_1853830, HPA050450: AB_2681130" "unprognostic (5.24e-2)" "unprognostic (2.60e-1)" "unprognostic (9.43e-2)" "unprognostic (3.46e-1)" "unprognostic (9.01e-2)" "unprognostic (1.41e-2)" "prognostic unfavorable (4.25e-6)" "unprognostic (5.67e-2)" "unprognostic (6.19e-2)" "unprognostic (1.14e-3)" "unprognostic (1.78e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (3.55e-6)" "unprognostic (7.75e-2)" "unprognostic (1.96e-1)" "unprognostic (5.01e-2)" "unprognostic (2.22e-1)" 13.6 23.2 8.9 9.8 9.2 11.0 12.8 8.7 11.9 9.8 9.9 8.4 4.0 10.8 20.8 13.1 10.2 5.5 10.3 9.2 9.4 22.0 17.5 9.3 8.1 9.2 9.3 11.3 28.0 9.1 12.7 8.7 9.0 13.4 10.8 3.7 10.6 7.1 15.5 11.7 6.9 12.3 8.9 9.0 9.8 9.9 9.6 4.8 14.3 6.9 9.3 16.5 9.4 9.0 24.7 44.1 17.7 14.9 22.6 15.7 23.4 24.8 23.1 41.9 24.7 32.0 32.6 28.8 45.7 33.0 23.1 27.9 27.4 39.8 38.0 17.2 32.6 34.9 17.4 35.0 17.9 39.0 17.4 14.7 32.7 47.8 33.5 18.9 22.2 17.8 34.1 28.2 23.1 47.0 26.1 39.6 40.6 29.1 41.5 23.0 293.1 43.1 33.6 29.8 18.7 16.2 26.9 29.6 22.9 16.0 38.5 32.0 17.1 17.4 18.0 29.6 34.0 13.2 9.3 32.6 24.4 25.3 34.5 0.0 7.1 0.0 8.0 10.8 27.4 6.9 10.0 9.6 16.3 10.5 13.4 13.2 1.1 12.9 1.8 19.3 5.1 7.5 8.9 9.2 8.7 11.9 9.2 9.4 9.2 9.3 9.0 8.9 9.6 9.0 6.3 9.6 3.3 0.7 8.3 10.5 17.1 14.8 13.6 3.7 12.2 12.4 4.3 10.0 14.1 5.5 0.0 18.7 3.1 6.3 25.4 16.8 12.1 5.3 13.2 8.2 6.6 6.3 0.8 24.1 25.3 11.3 10.2 8.9 12.7 8.7 3.3 7.9 22.7 3.3 0.6 8.4 12.2 2.2 9.8 10.9 11.1 6.4 7.2 0.0 16.7 2.6 3.1 3.5 1.1 12.3 2.3 4.9 14.9 15.4 1.1 60.4 2.6 5.4 0.0 9.7 13.0 8.0 17.7 12.1 10.4 9.7 4.1 14.0 10.7 11.3 MFSD9 MGC11332 ENSG00000135953 "Major facilitator superfamily domain containing 9" Q8NBP5 2 102714630-102736888 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055293, HPA061859" Approved Approved "Nucleoli,Nucleoli rim" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 15: RT4 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli, Nucleoli rim" "HPA055293: AB_2682775, HPA061859: AB_2684627" "unprognostic (1.27e-2)" "unprognostic (5.07e-2)" "unprognostic (5.00e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-1)" "unprognostic (2.60e-2)" "unprognostic (2.98e-1)" "unprognostic (1.06e-1)" "unprognostic (8.42e-2)" "unprognostic (6.88e-3)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (3.33e-1)" "unprognostic (2.28e-2)" 2.8 2.2 1.4 2.9 1.4 4.1 2.6 4.3 2.0 3.6 1.8 6.4 8.7 1.8 2.8 4.5 1.8 2.3 1.4 1.9 1.7 4.6 10.5 2.2 3.2 1.4 1.6 2.4 9.2 4.1 3.4 2.4 1.5 2.6 5.8 2.4 4.9 3.1 1.3 2.9 7.2 1.9 1.3 2.7 4.7 1.2 1.7 4.5 2.9 1.2 3.6 3.3 2.2 1.2 3.1 2.4 3.0 5.2 3.6 1.6 6.1 1.9 1.9 2.8 2.8 8.6 4.1 2.7 3.1 1.2 4.3 4.7 4.8 1.8 1.8 11.5 4.4 4.5 3.1 10.9 3.0 3.6 6.2 1.6 6.1 1.7 0.9 2.9 1.8 8.8 2.7 1.3 1.4 2.9 3.7 7.2 2.3 7.4 3.1 2.8 4.9 2.8 5.9 9.4 5.8 4.1 1.7 6.1 6.9 3.2 2.3 5.7 1.3 1.9 4.0 3.2 2.7 3.6 2.9 1.8 2.1 8.4 2.6 1.3 0.3 1.5 1.2 0.6 0.9 0.8 0.9 0.8 0.6 0.6 0.9 1.1 1.0 1.0 0.5 1.2 0.7 0.7 1.4 1.4 4.3 2.0 1.9 1.7 1.4 1.6 1.5 1.3 1.7 1.2 1.6 0.0 1.5 1.0 4.1 3.3 3.2 3.7 2.8 1.5 4.1 1.3 3.1 1.5 5.4 7.3 4.2 8.2 4.3 15.9 0.0 5.8 12.8 3.3 2.0 1.6 3.0 1.7 5.4 8.6 9.1 3.3 7.1 5.3 3.8 3.0 1.4 11.5 4.8 0.0 12.2 8.7 10.2 2.9 1.4 4.5 0.9 2.6 0.0 1.9 4.3 1.4 7.2 4.0 1.3 11.4 8.0 1.2 8.9 4.2 10.4 3.6 3.9 2.8 6.6 2.1 2.4 1.0 5.3 4.3 4.4 11.5 5.1 3.1 7.2 8.2 MIA3 "FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077" ENSG00000154305 "MIA SH3 domain ER export factor 3" Q5JRA6 1 222618097-222668007 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA055922, HPA056816" Supported Enhanced Vesicles NA NA 1400000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Vesicles "HPA055922: AB_2682971, HPA056816: AB_2683243" "unprognostic (1.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.43e-1)" "unprognostic (6.60e-2)" "unprognostic (1.86e-2)" "unprognostic (8.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (5.65e-2)" "unprognostic (6.73e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.57e-2)" "unprognostic (1.83e-1)" "unprognostic (8.62e-3)" "unprognostic (3.26e-1)" 25.6 22.0 11.0 23.4 13.1 33.2 21.4 12.9 14.9 23.9 13.2 24.3 23.9 23.7 29.2 13.7 16.0 20.6 20.6 10.9 13.6 21.1 74.5 21.5 26.9 10.8 12.3 25.4 38.7 30.1 15.2 23.1 11.7 39.3 29.5 24.4 33.2 22.1 23.7 17.4 25.9 23.8 10.7 27.3 45.0 36.5 11.5 25.7 31.7 20.5 26.2 21.0 14.1 12.8 24.8 18.8 26.5 42.5 92.8 47.1 46.5 34.8 49.4 36.2 43.1 16.6 26.2 24.0 33.0 41.8 20.5 39.9 28.5 31.3 37.8 38.1 21.6 27.7 21.5 31.5 88.6 50.7 34.7 45.2 35.0 35.9 60.8 44.8 41.4 28.9 34.8 44.4 30.7 15.9 34.3 33.8 33.2 76.8 27.5 24.4 70.8 47.8 23.1 22.8 30.4 31.3 38.6 36.2 30.4 36.2 38.2 37.5 31.7 27.5 17.9 44.5 41.3 48.4 30.9 23.8 36.7 25.4 37.5 26.8 15.6 36.5 17.6 22.4 17.7 20.7 14.7 17.5 11.7 18.6 16.4 17.8 27.1 22.5 26.0 13.2 19.2 13.5 11.0 13.1 12.9 14.9 10.9 13.6 10.8 12.3 11.7 10.7 11.5 12.8 48.5 70.5 49.6 31.3 46.9 18.7 26.8 20.4 29.0 60.9 24.3 35.3 65.0 25.8 47.1 5.5 31.3 28.6 73.8 35.2 0.0 25.1 37.0 34.9 72.5 36.4 60.4 26.3 51.4 34.8 17.0 53.0 79.5 42.0 17.7 44.2 25.4 63.3 20.4 45.4 58.0 95.3 32.6 22.0 14.0 24.9 37.0 32.9 19.6 35.6 32.1 31.8 44.3 41.2 29.1 26.4 25.8 48.9 54.4 39.0 41.3 19.4 44.7 41.5 19.7 57.9 46.6 55.7 42.1 21.9 16.1 35.8 47.8 70.2 24.6 29.4 MINPP1 MIPP ENSG00000107789 "Multiple inositol-polyphosphate phosphatase 1" Q9UNW1 10 87504875-87553461 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 288.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026859 Approved "Intracellular and membrane" NA NA 370000000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA026859: AB_1853961" "unprognostic (9.15e-2)" "unprognostic (8.76e-3)" "unprognostic (2.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (5.20e-3)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (4.55e-1)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.01e-2)" 8.5 21.3 6.6 7.2 6.7 31.1 9.4 6.9 9.1 8.8 9.4 12.6 17.6 7.0 10.0 3.6 8.5 8.4 5.8 6.8 8.0 17.5 29.1 8.3 7.7 6.4 6.8 8.8 11.9 9.0 8.1 18.9 6.4 11.7 12.9 11.9 6.9 7.6 4.9 9.1 13.6 7.6 6.9 6.9 8.5 7.9 7.7 8.1 11.6 5.7 7.0 8.6 5.7 7.4 18.6 28.1 28.1 40.9 46.4 38.1 23.2 29.5 51.1 28.8 38.3 15.0 35.5 16.4 27.0 35.9 19.4 28.2 29.9 27.1 33.2 37.1 35.7 41.1 10.4 55.7 34.6 18.0 36.0 33.7 34.7 32.6 19.5 52.5 37.0 14.3 24.5 75.9 34.4 13.8 11.9 25.6 20.0 14.2 20.2 0.0 15.8 11.0 38.5 10.4 10.2 31.5 28.1 5.9 51.5 31.5 16.7 14.7 32.4 18.3 21.9 22.1 28.7 24.5 27.1 4.2 29.3 26.8 13.7 10.5 10.8 4.9 11.5 13.8 10.1 8.7 10.8 13.0 14.3 8.2 10.2 11.4 0.7 11.7 12.5 8.2 17.3 10.5 6.6 6.7 6.9 9.1 6.8 8.0 6.4 6.8 6.4 6.9 7.7 7.4 11.7 6.4 12.8 9.1 8.1 2.8 8.3 25.5 8.0 14.4 9.0 4.3 4.9 15.7 16.2 7.3 2.1 20.4 4.9 14.0 5.9 17.2 15.9 7.1 13.4 10.5 13.1 288.9 18.3 16.7 19.2 17.9 7.1 6.7 24.7 17.8 16.4 58.3 12.9 10.1 20.8 25.5 20.3 16.0 5.8 4.0 9.3 8.7 10.6 7.5 11.7 11.1 10.3 25.6 19.1 10.5 17.2 8.2 18.6 6.8 17.1 26.0 19.0 14.8 0.0 4.8 11.1 10.6 12.1 4.0 3.4 8.1 8.2 13.7 11.6 4.4 MKRN2OS "C3orf83, MKRN2-AS1" ENSG00000225526 "MKRN2 opposite strand" H3BPM6 3 12514934-12561059 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 9.2;intestine: 8.0" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 6.6;Proximal enterocytes: 7.5;Respiratory ciliated cells: 4.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "cerebellum: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.9;CAPAN-2: 13.8;HBEC3-KT: 3.4;MCF7: 3.2;RT4: 5.7;T-47d: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065586, HPA065753" Uncertain Approved "Golgi apparatus" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA065586: AB_2685514, HPA065753: AB_2685553" "unprognostic (2.53e-2)" "unprognostic (1.01e-2)" "unprognostic (3.89e-3)" "unprognostic (2.03e-3)" "unprognostic (3.81e-1)" "unprognostic (8.45e-2)" "unprognostic (2.24e-1)" "unprognostic (2.29e-1)" "unprognostic (5.26e-2)" "unprognostic (3.86e-2)" "unprognostic (1.58e-2)" "unprognostic (4.29e-3)" "unprognostic (2.53e-5)" "unprognostic (1.02e-1)" "unprognostic (2.48e-1)" "unprognostic (8.50e-3)" "unprognostic (3.17e-3)" 0.1 0.0 0.1 0.4 0.4 0.0 1.3 4.4 0.8 1.8 0.0 4.3 8.0 0.2 9.2 4.6 1.9 2.2 2.0 0.2 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.2 4.1 1.0 1.6 0.4 0.2 0.9 5.0 1.3 7.0 1.9 0.4 2.5 7.6 0.0 0.0 0.0 5.1 0.1 0.1 0.2 0.6 0.0 0.9 0.9 1.1 0.1 2.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 13.8 0.0 0.3 0.0 0.0 0.6 0.0 3.4 0.0 0.0 0.9 0.0 0.6 0.2 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.2 2.0 5.7 0.2 0.0 0.0 0.8 0.0 0.0 3.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 4.4 0.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 1.1 0.3 0.5 0.0 0.7 0.0 1.8 0.7 2.9 1.3 0.7 2.8 0.6 3.7 0.0 2.7 0.0 1.9 0.0 1.7 1.5 3.0 0.5 0.2 0.0 0.0 2.3 2.2 0.6 0.0 6.6 2.8 0.0 0.2 0.0 0.0 0.2 0.0 2.6 2.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.0 0.8 2.1 2.2 0.0 0.2 0.4 7.5 1.1 4.4 1.0 0.0 0.1 0.1 0.2 0.1 3.4 0.0 0.3 0.0 0.1 2.1 0.9 MLPH "exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a" ENSG00000115648 Melanophilin Q9BV36 2 237485428-237555322 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 135.9;salivary gland: 122.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 125.0;Alveolar cells type 2: 389.7;Gastric mucus-secreting cells: 251.8;granulocytes: 187.3;Intestinal goblet cells: 189.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 142.9;MCF7: 255.4;SK-BR-3: 234.5;SK-MEL-30: 182.2;U-87 MG: 236.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA014685 Enhanced NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA014685: AB_1853997" "unprognostic (3.32e-3)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "prognostic favorable (5.14e-6)" "unprognostic (2.26e-4)" "unprognostic (1.36e-2)" "unprognostic (5.44e-2)" "unprognostic (2.66e-1)" "unprognostic (3.74e-3)" "unprognostic (8.16e-2)" "unprognostic (5.73e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.34e-1)" "unprognostic (9.37e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-3)" 13.2 1.4 0.6 2.4 0.7 0.1 56.9 0.7 1.6 69.3 1.3 20.4 8.8 18.1 8.9 6.4 18.0 31.0 69.2 1.1 0.7 4.3 39.0 62.7 0.6 1.1 1.0 11.8 16.1 9.0 2.1 1.9 0.8 135.9 21.7 0.3 122.0 13.0 6.6 11.6 15.2 2.8 0.6 0.2 98.1 2.5 0.8 0.9 39.9 2.5 1.2 22.1 21.9 0.9 0.3 133.7 0.3 0.3 58.5 39.5 0.4 26.8 31.5 14.7 18.5 1.1 101.1 0.2 0.1 49.6 51.0 0.3 0.1 0.9 13.0 0.1 0.3 0.1 0.1 0.0 23.3 0.1 0.7 48.1 14.7 43.4 56.2 75.6 0.1 0.0 0.1 0.3 142.9 255.4 0.4 0.6 0.4 105.4 77.1 0.5 0.1 0.2 0.5 3.2 1.5 0.2 0.1 234.5 182.2 0.7 61.5 1.7 26.8 80.1 2.3 0.9 38.0 0.2 0.2 0.2 236.0 0.1 63.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.7 1.6 1.1 0.7 1.1 1.0 0.8 0.6 0.8 0.9 12.3 125.0 389.7 0.0 0.8 4.1 17.3 6.0 0.0 0.0 95.6 59.7 63.2 52.9 64.2 12.9 0.0 0.4 0.7 34.9 1.9 12.0 0.2 9.5 10.1 10.1 14.4 0.0 0.2 41.3 0.3 4.5 251.8 17.5 187.3 0.2 1.4 28.8 1.2 0.0 0.1 189.0 32.6 0.8 2.9 0.7 8.4 7.4 30.2 5.6 0.6 0.0 0.0 0.0 0.0 58.1 22.4 3.0 0.8 54.4 9.1 0.6 48.5 0.0 0.0 3.1 3.7 0.3 0.6 1.2 2.4 0.7 6.1 0.4 30.5 38.6 MOGS "CWH41, DER7, GCS1" ENSG00000115275 "Mannosyl-oligosaccharide glucosidase" Q13724 2 74461057-74465410 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 222.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011322, HPA011969" Approved Supported "Endoplasmic reticulum" NA NA 1500000 "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA011322: AB_2668483, HPA011969: AB_1849579" "unprognostic (5.66e-2)" "unprognostic (1.98e-2)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.91e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (2.34e-6)" "unprognostic (1.48e-2)" "unprognostic (2.66e-2)" "unprognostic (3.32e-2)" "unprognostic (6.21e-2)" "unprognostic (4.36e-1)" "prognostic unfavorable (2.79e-8)" "unprognostic (1.40e-2)" "unprognostic (3.06e-2)" "unprognostic (2.66e-1)" "unprognostic (7.59e-3)" 18.4 18.3 8.1 20.2 9.1 8.5 18.6 9.0 13.3 19.2 9.2 22.8 41.7 18.3 5.5 22.5 20.0 14.4 16.9 8.3 9.0 20.9 34.3 24.9 21.6 9.4 8.7 18.6 42.3 21.5 21.7 34.5 9.9 23.3 13.4 9.6 31.1 14.6 21.3 24.9 29.7 11.4 9.3 31.7 35.5 19.0 8.9 19.8 21.9 16.2 18.1 20.1 19.1 9.8 53.1 46.2 23.5 29.6 55.3 38.9 90.1 38.7 58.3 59.8 58.2 81.9 58.7 45.2 34.9 36.3 46.7 50.6 40.2 43.3 32.5 46.7 39.9 20.3 14.4 68.6 54.9 49.8 46.6 25.6 77.1 41.9 39.0 62.2 68.4 27.8 39.6 51.6 28.5 58.8 32.3 62.0 42.6 64.1 22.5 35.5 57.4 74.1 38.0 19.5 19.7 29.2 15.5 84.8 62.7 21.8 38.7 34.3 40.1 26.5 49.7 36.3 56.5 66.5 36.5 22.7 46.9 49.3 39.0 6.7 2.4 1.9 2.6 1.5 3.3 1.2 2.3 2.5 2.1 1.9 1.4 1.6 0.4 8.4 3.3 2.1 3.3 1.7 8.1 9.1 9.0 13.3 8.3 9.0 9.4 8.7 9.9 9.3 8.9 9.8 13.9 6.4 15.9 16.3 22.0 15.8 21.8 20.8 18.2 14.9 18.9 12.8 8.6 24.3 21.3 23.9 18.8 39.5 34.6 18.7 5.9 21.9 65.6 12.4 12.2 13.3 13.9 16.4 13.9 26.1 50.5 12.3 40.8 17.4 4.5 20.9 17.9 25.6 19.9 6.7 12.1 25.7 20.3 12.9 14.8 222.0 15.2 17.9 10.6 12.2 25.5 7.0 30.9 11.1 10.7 22.3 19.7 7.2 43.6 22.7 37.7 7.4 17.7 14.1 13.1 9.4 12.7 13.0 5.1 15.2 17.3 52.0 21.2 16.5 23.3 19.6 MON2 KIAA1040 ENSG00000061987 "MON2 homolog, regulator of endosome-to-Golgi trafficking" Q7Z3U7 12 62466817-62600476 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 197.9;Inhibitory neurons: 172.7;Oligodendrocyte precursor cells: 177.9;Oligodendrocytes: 271.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038697, HPA057607" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nucleoli fibrillar center" "HPA038697: AB_10697396, HPA057607: AB_2683482" "unprognostic (1.09e-1)" "unprognostic (1.98e-1)" "unprognostic (9.91e-2)" "unprognostic (1.94e-1)" "unprognostic (1.71e-2)" "prognostic favorable (2.03e-4)" "unprognostic (7.69e-2)" "unprognostic (5.99e-2)" "unprognostic (2.24e-2)" "unprognostic (6.20e-2)" "unprognostic (5.57e-2)" "unprognostic (1.58e-2)" "unprognostic (1.93e-1)" "unprognostic (1.77e-1)" "unprognostic (2.91e-1)" "unprognostic (1.80e-3)" "unprognostic (4.36e-2)" 9.9 8.7 4.8 9.1 11.2 9.1 9.5 9.4 7.3 11.7 10.4 9.0 8.3 10.7 8.6 9.0 8.3 8.7 6.3 5.6 6.0 10.3 14.2 8.7 9.5 9.5 7.5 12.8 13.7 15.5 7.1 10.4 10.5 9.9 10.5 17.5 12.4 8.0 6.4 9.1 7.8 9.2 7.0 9.4 10.7 7.0 7.4 12.6 13.0 7.5 9.8 8.9 6.8 20.9 13.5 20.3 15.0 7.9 19.0 17.8 13.6 14.2 12.0 12.9 12.7 9.2 5.3 9.6 10.8 13.8 10.0 12.6 15.0 10.4 17.4 12.2 11.7 15.0 15.2 9.6 8.1 13.1 10.2 12.0 7.8 14.0 17.1 17.1 12.6 8.6 14.3 22.2 11.4 15.4 11.6 6.2 8.9 8.3 11.1 10.6 13.4 13.3 7.1 17.9 6.4 7.0 24.0 12.9 9.8 15.3 28.0 9.5 17.7 12.4 9.0 15.9 9.3 12.3 12.1 10.7 13.2 8.1 14.2 1.1 3.0 3.2 2.4 3.1 3.2 2.5 2.0 3.4 2.7 2.8 2.8 3.2 4.4 1.9 2.3 1.5 2.6 1.8 4.8 11.2 9.4 7.3 5.6 6.0 9.5 7.5 10.5 7.0 7.4 20.9 29.4 35.3 22.9 113.9 31.5 16.8 13.9 11.7 29.0 36.2 21.5 14.4 16.9 15.7 22.5 27.6 58.4 14.1 29.9 21.9 0.0 7.2 2.7 20.7 38.1 22.6 14.4 18.5 197.9 11.0 7.0 26.9 47.4 28.7 17.1 49.8 23.2 34.8 10.7 21.9 172.7 23.0 12.2 21.4 13.4 2.6 21.8 27.3 8.8 99.3 21.0 11.9 15.5 177.9 271.5 10.9 18.4 18.0 48.7 17.6 17.0 6.7 22.4 55.8 26.3 38.7 24.3 8.0 9.5 26.7 19.6 20.4 28.0 21.1 16.7 18.1 MPV17L "FLJ39599, MLPH1, MLPH2, MPV17L1" ENSG00000156968 "MPV17 mitochondrial inner membrane protein like" Q2QL34 16 15395754-15413271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 14.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 29.5;SK-BR-3: 8.2" "Low region specificity" "Detected in all" HPA041180 Approved Supported Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA041180: AB_10794266" "unprognostic (9.65e-2)" "unprognostic (8.74e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (2.73e-1)" "unprognostic (4.38e-3)" "unprognostic (8.41e-2)" "unprognostic (8.99e-3)" "unprognostic (8.70e-2)" "unprognostic (6.36e-3)" "prognostic favorable (1.48e-11)" "unprognostic (2.84e-1)" "unprognostic (7.60e-2)" "unprognostic (6.61e-3)" "unprognostic (3.87e-2)" 1.8 2.5 1.2 1.8 0.1 4.4 6.4 1.9 2.2 2.8 0.0 2.3 3.4 2.0 0.3 1.0 1.8 2.4 1.6 0.1 0.0 3.3 9.1 0.9 2.3 0.1 0.0 2.1 14.1 2.4 3.2 0.6 0.3 2.0 1.0 4.4 7.1 1.8 8.0 4.5 2.3 0.8 0.0 1.8 1.8 1.0 0.5 0.2 2.2 2.4 0.6 1.9 1.3 0.4 1.0 1.9 0.8 0.8 0.2 0.1 1.2 0.5 0.0 0.0 0.0 1.9 3.4 1.5 1.3 0.6 0.5 1.5 3.0 0.0 0.0 1.2 0.8 5.9 4.6 3.9 0.3 3.6 29.5 0.3 0.4 0.1 0.2 0.5 0.0 1.6 2.3 3.3 0.1 1.9 1.4 2.3 1.7 0.3 0.1 2.0 0.6 1.6 0.5 0.8 4.8 1.6 2.7 8.2 0.2 0.9 1.8 2.6 2.6 1.3 0.8 1.1 1.1 1.4 0.6 1.7 0.7 1.7 0.5 1.7 1.2 0.2 0.8 0.9 0.6 0.8 0.5 0.8 0.4 1.2 0.4 0.8 1.8 1.1 0.4 0.7 0.4 0.6 1.2 0.1 1.9 2.2 0.1 0.0 0.1 0.0 0.3 0.0 0.5 0.4 2.5 6.4 8.8 3.9 2.0 7.9 14.4 8.2 0.0 12.8 11.4 6.0 6.0 14.3 13.1 0.0 10.4 0.5 4.1 2.7 15.6 7.5 4.6 5.4 9.2 6.6 1.2 2.1 5.6 12.9 0.5 8.1 2.0 10.7 6.3 7.6 4.2 29.1 1.0 8.4 5.9 8.7 2.0 13.6 20.6 0.8 7.2 6.0 21.4 2.8 0.7 6.2 0.0 7.5 3.2 5.9 15.3 14.3 1.4 9.6 9.3 19.9 21.0 16.6 0.0 23.5 6.7 9.0 2.0 0.6 11.5 0.5 9.9 4.4 12.1 10.1 MTMR12 "3-PAP, 3PAP, FLJ20476, KIAA1682, PIP3AP" ENSG00000150712 "Myotubularin related protein 12" Q9C0I1 5 32226994-32312987 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051333 Supported NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA051333: AB_2681445" "unprognostic (3.18e-3)" "unprognostic (6.29e-2)" "unprognostic (3.65e-2)" "unprognostic (1.50e-1)" "unprognostic (2.26e-1)" "unprognostic (9.39e-3)" "unprognostic (6.15e-2)" "unprognostic (1.39e-3)" "unprognostic (3.15e-1)" "unprognostic (1.09e-1)" "unprognostic (7.46e-3)" "unprognostic (8.77e-2)" "prognostic favorable (1.29e-7)" "unprognostic (2.30e-2)" "unprognostic (3.22e-1)" "unprognostic (9.95e-2)" "unprognostic (2.09e-1)" 18.4 7.6 7.9 10.8 11.2 13.4 17.4 6.3 10.6 9.2 4.8 12.1 9.6 16.0 8.8 13.8 21.0 13.3 9.1 10.5 3.6 15.8 16.7 15.7 17.5 3.0 3.8 17.8 24.7 21.5 7.4 11.9 3.1 14.2 8.5 7.5 17.0 12.2 6.0 13.3 8.2 16.6 3.6 11.3 14.9 19.1 4.5 12.4 14.6 6.7 16.1 10.1 8.3 7.9 18.7 16.7 17.6 34.3 19.8 11.5 24.6 17.0 13.6 21.0 13.1 16.3 13.1 68.4 21.0 17.5 35.8 12.4 30.2 16.5 25.3 24.0 14.9 22.6 32.4 27.2 13.9 16.1 16.1 10.3 15.3 21.0 21.9 15.2 25.3 14.5 16.9 24.6 14.1 13.7 17.3 12.4 22.8 20.2 17.5 17.5 25.3 8.8 16.8 16.8 6.2 11.6 46.8 28.1 20.6 18.3 23.2 16.6 21.3 16.2 22.4 16.2 23.8 21.4 36.1 37.9 16.5 26.6 20.1 7.5 1.8 3.1 3.1 4.7 2.5 2.8 1.4 2.1 2.4 1.8 1.2 1.4 3.0 2.3 2.2 2.9 1.8 2.5 7.9 11.2 6.3 10.6 10.5 3.6 3.0 3.8 3.1 3.6 4.5 7.9 31.1 32.1 37.8 30.7 16.0 7.0 7.2 7.2 9.6 0.0 28.1 23.4 13.8 15.7 16.4 14.7 0.0 7.5 30.5 8.6 7.9 31.1 1.7 43.1 16.2 21.9 12.0 20.4 71.6 23.6 7.7 12.6 19.4 29.8 15.2 9.3 23.6 26.7 10.1 0.0 47.2 7.5 10.2 16.1 14.8 4.0 6.5 13.9 3.6 15.9 10.2 0.0 12.3 32.2 30.7 18.2 8.2 7.2 19.0 12.2 8.2 16.4 28.2 0.0 6.6 13.1 12.8 20.8 22.3 14.1 8.4 7.5 14.1 7.2 7.7 7.1 MYDGF "C19orf10, IL-25, IL-27, IL25, IL27, IL27w, R33729_1, SF20" ENSG00000074842 "Myeloid derived growth factor" Q969H8 19 4641374-4670362 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Apoptosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 768.1;Plasma cells: 857.6;Syncytiotrophoblasts: 581.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 1043.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041872, HPA046744" Approved "Secreted to blood" NA NA 285000 2100000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA041872: AB_2677718, HPA046744: AB_2679783" "unprognostic (3.14e-1)" "unprognostic (1.32e-2)" "unprognostic (1.73e-1)" "prognostic favorable (6.50e-7)" "unprognostic (4.14e-1)" "unprognostic (1.35e-1)" "unprognostic (1.08e-2)" "unprognostic (1.71e-1)" "unprognostic (5.11e-2)" "unprognostic (4.56e-2)" "unprognostic (8.19e-2)" "unprognostic (4.54e-2)" "prognostic unfavorable (4.99e-12)" "unprognostic (4.42e-1)" "unprognostic (3.24e-1)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" 84.7 94.2 42.5 83.8 43.5 92.0 73.2 44.4 48.7 79.1 47.6 81.4 75.7 75.1 114.6 67.5 71.0 44.1 66.3 43.1 48.1 70.8 259.5 91.7 61.9 45.7 44.0 72.1 210.0 41.7 126.1 76.1 45.8 84.2 65.5 13.0 135.6 52.8 24.7 59.3 71.1 52.9 45.5 123.0 94.5 54.5 45.0 30.8 75.4 15.1 45.5 74.3 63.3 50.2 250.5 118.7 74.6 189.8 228.0 190.2 133.0 449.6 378.1 210.8 263.8 194.9 155.8 145.0 206.5 455.4 171.9 122.7 88.6 157.7 121.8 137.7 152.0 87.6 212.7 250.0 353.9 310.9 201.6 159.0 187.8 154.6 292.3 263.0 233.0 78.8 155.4 1043.7 194.9 134.4 83.9 174.1 94.5 235.3 417.1 80.0 126.3 701.0 169.1 114.2 114.1 117.0 151.0 189.1 227.5 64.2 111.4 366.6 268.9 162.8 135.1 449.2 325.9 505.8 229.6 122.2 401.8 405.8 260.1 156.8 216.6 82.6 148.7 232.2 151.6 123.6 118.7 121.1 264.0 101.0 99.8 107.0 13.8 151.5 209.0 426.0 96.3 225.2 42.5 43.5 44.4 48.7 43.1 48.1 45.7 44.0 45.8 45.5 45.0 50.2 134.4 44.8 68.1 4.6 185.1 0.0 160.1 0.0 46.1 31.0 153.8 133.9 6.6 110.1 18.6 77.3 4.2 284.0 135.6 39.8 43.0 355.9 8.7 65.9 168.2 131.9 31.5 55.3 7.3 351.1 768.1 177.0 92.8 158.8 16.4 135.8 126.7 207.3 415.6 26.9 9.6 96.2 0.0 118.8 0.0 12.8 140.5 155.4 0.0 9.4 250.8 51.3 116.4 8.0 10.6 401.8 71.3 91.0 857.6 342.0 182.9 86.8 9.5 32.7 92.1 92.7 157.1 183.2 125.1 64.4 0.0 581.6 84.9 145.5 101.0 260.7 NAGLU NAG ENSG00000108784 N-acetyl-alpha-glucosaminidase P54802 17 42536241-42544449 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Charcot-Marie-Tooth disease, Disease variant, Mucopolysaccharidosis, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038815 Supported "Intracellular and membrane" NA NA 270000000 "Cluster 37: B-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA038815: AB_10697398" "unprognostic (1.53e-1)" "unprognostic (1.19e-1)" "unprognostic (6.48e-2)" "prognostic favorable (4.17e-4)" "prognostic unfavorable (6.59e-4)" "unprognostic (1.46e-1)" "unprognostic (1.75e-3)" "unprognostic (3.09e-2)" "unprognostic (2.20e-1)" "unprognostic (6.68e-2)" "prognostic favorable (6.90e-4)" "unprognostic (8.07e-2)" "prognostic favorable (2.58e-6)" "unprognostic (2.25e-1)" "unprognostic (8.74e-3)" "unprognostic (2.15e-2)" "unprognostic (1.62e-1)" 41.6 37.9 12.5 14.8 21.6 20.3 35.3 16.6 16.7 31.1 28.7 25.1 24.3 34.7 12.8 19.5 27.6 27.4 20.1 12.0 15.0 39.3 59.3 30.8 24.0 18.0 19.2 35.2 63.8 21.3 22.5 26.1 20.1 28.3 16.4 3.1 37.7 18.4 16.0 25.1 30.9 13.8 14.2 40.7 35.1 8.7 19.5 17.1 37.6 9.7 13.4 28.9 23.9 30.0 16.0 55.3 10.8 24.6 106.6 34.5 36.4 24.0 56.9 24.9 31.7 14.9 40.4 20.3 23.7 37.4 54.7 38.3 9.7 11.7 5.5 15.8 20.2 11.2 31.3 31.8 35.3 13.3 27.7 41.4 17.8 13.6 16.9 27.3 32.8 3.6 16.6 39.3 27.9 38.9 2.2 23.0 12.6 34.6 7.0 8.7 23.6 47.2 33.1 36.1 16.2 24.4 12.9 17.6 20.4 15.6 82.1 14.1 25.8 59.3 9.7 23.8 15.7 52.6 25.8 17.6 35.9 14.4 43.1 1.1 2.4 1.9 2.5 1.8 2.4 2.4 1.0 1.3 2.1 1.8 1.8 1.4 1.1 2.1 2.9 2.8 0.2 1.1 12.5 21.6 16.6 16.7 12.0 15.0 18.0 19.2 20.1 14.2 19.5 30.0 14.1 12.8 7.8 17.3 9.0 2.8 6.1 3.9 2.2 15.5 14.2 8.9 3.8 18.6 4.9 18.4 4.2 23.8 11.4 21.1 3.9 18.4 0.3 5.8 14.5 12.2 6.7 4.4 2.3 33.2 14.5 26.4 27.0 12.1 2.5 40.1 24.3 43.7 37.6 15.2 3.1 17.6 0.0 26.0 3.5 2.4 19.9 19.0 16.0 10.3 5.9 13.2 8.2 6.0 19.2 15.8 5.4 12.8 12.9 10.7 23.0 31.8 3.7 6.7 6.6 18.0 12.8 0.4 6.0 6.1 3.4 18.5 6.0 74.6 15.0 6.0 NBPF11 NBPF24 ENSG00000263956 "NBPF member 11" Q86T75 1 148102046-148152322 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 30.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 59: Non-specific - Transcription" Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " "unprognostic (2.27e-1)" "unprognostic (6.10e-2)" "unprognostic (8.01e-2)" "unprognostic (8.20e-2)" "unprognostic (3.70e-1)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "prognostic favorable (6.87e-4)" "unprognostic (8.93e-2)" "unprognostic (6.48e-2)" "unprognostic (1.72e-3)" "unprognostic (4.78e-2)" "unprognostic (6.67e-6)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.68e-1)" "prognostic favorable (3.20e-5)" 9.5 7.6 4.0 5.7 5.0 7.6 9.5 4.1 5.4 11.7 4.6 8.5 4.2 9.5 17.0 6.5 10.3 3.8 5.6 3.9 4.0 7.3 18.1 7.0 7.5 6.1 4.6 11.6 12.1 7.7 7.8 4.6 6.0 9.8 5.7 7.2 8.8 7.0 3.3 12.3 10.6 6.5 4.8 12.6 12.0 6.6 5.1 6.1 9.8 1.5 7.7 9.0 8.5 7.1 5.4 4.4 8.6 8.3 5.8 4.7 5.8 4.7 4.5 3.9 4.2 3.4 5.4 9.3 3.7 5.8 3.7 7.1 5.4 1.8 4.8 5.1 5.8 4.2 15.6 3.8 4.1 5.9 14.4 4.1 5.0 5.1 9.8 6.0 3.0 7.9 6.8 0.4 4.0 11.0 6.9 11.0 7.5 12.6 5.6 9.1 4.8 3.6 4.0 10.8 3.4 8.9 7.8 5.3 8.0 11.2 7.7 10.1 7.3 5.0 4.3 7.8 6.1 5.3 4.7 6.3 4.9 3.7 2.9 3.7 0.9 3.0 1.8 0.6 1.3 1.6 1.6 1.1 0.9 2.2 1.6 1.3 0.1 0.5 1.9 1.9 0.6 0.6 4.0 5.0 4.1 5.4 3.9 4.0 6.1 4.6 6.0 4.8 5.1 7.1 6.0 12.8 12.0 19.9 11.9 1.1 2.3 0.3 9.6 4.5 7.8 6.2 6.9 5.7 5.2 3.7 10.4 4.9 9.1 5.5 0.0 3.4 9.7 4.3 4.5 6.9 3.5 8.8 28.1 3.3 4.2 7.0 11.2 7.5 13.9 6.6 7.5 19.1 3.3 5.0 16.8 8.0 0.0 9.6 3.4 1.4 5.3 6.6 7.2 24.4 15.9 3.8 6.2 30.7 29.9 4.1 16.0 2.6 6.9 1.5 4.9 2.7 3.8 6.8 6.6 4.4 5.5 6.9 3.9 8.6 1.4 2.9 8.1 3.3 8.4 1.1 NEDD4L "KIAA0439, NEDD4-2, RSP5" ENSG00000049759 "NEDD4 like E3 ubiquitin protein ligase" Q96PU5 18 58044226-58401540 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 253.2;Excitatory neurons: 280.9" "Cancer enhanced" "Detected in all" "prostate cancer: 29.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "T-reg: 5.1" "Lineage enriched" "Detected in many" 4 "T-cells: 5.1" "Cell line enhanced" "Detected in many" "SK-MEL-30: 146.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024618 Approved "Intracellular and membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA024618: AB_1854362" "unprognostic (2.56e-1)" "unprognostic (2.41e-2)" "unprognostic (1.58e-2)" "unprognostic (3.14e-1)" "unprognostic (3.90e-2)" "unprognostic (1.50e-1)" "unprognostic (2.11e-3)" "unprognostic (2.26e-2)" "unprognostic (9.24e-3)" "unprognostic (4.39e-2)" "unprognostic (1.24e-1)" "unprognostic (1.27e-1)" "prognostic favorable (6.55e-15)" "unprognostic (2.42e-1)" "unprognostic (8.26e-2)" "unprognostic (8.49e-3)" "unprognostic (4.75e-2)" 11.2 16.8 20.9 6.7 34.4 27.0 25.8 25.1 31.3 7.6 0.7 38.8 18.7 5.3 10.0 12.0 9.1 9.5 26.9 32.3 16.2 53.4 36.5 47.9 4.1 10.9 18.4 6.4 60.5 13.6 28.4 12.0 10.4 64.2 42.8 20.5 27.5 20.4 34.0 11.2 33.8 6.2 8.6 7.9 51.5 7.8 16.7 4.5 17.4 13.1 7.9 19.4 5.9 16.3 70.7 24.5 14.6 20.9 5.1 2.1 49.8 19.2 88.2 48.6 74.6 28.6 37.1 15.1 57.7 7.4 51.3 50.3 19.5 86.1 100.8 34.9 15.5 10.6 14.3 111.3 2.4 0.5 6.0 13.0 54.6 66.4 78.8 39.1 4.0 13.2 18.7 6.3 20.0 16.2 1.0 1.0 12.2 26.7 33.3 14.3 20.1 17.6 47.0 88.7 17.5 5.0 16.1 5.1 146.1 28.3 29.4 5.6 28.8 131.5 38.5 7.5 83.4 8.3 15.3 9.5 27.6 10.8 10.8 0.7 0.3 1.2 0.2 0.3 0.5 0.8 0.6 0.1 0.1 0.3 0.3 0.2 0.2 0.3 0.1 0.1 5.1 0.3 20.9 34.4 25.1 31.3 32.3 16.2 10.9 18.4 10.4 8.6 16.7 16.3 6.0 253.2 144.8 110.4 5.1 112.8 161.2 34.0 86.6 18.1 99.5 65.9 47.8 64.3 112.8 62.5 173.0 13.0 3.6 144.5 49.0 35.7 22.6 64.0 7.3 14.7 45.2 57.9 280.9 49.2 4.7 9.5 114.7 75.0 3.8 4.7 17.5 41.3 7.3 62.2 173.3 201.5 101.7 8.4 8.2 6.6 3.4 13.3 14.2 88.1 7.3 45.2 2.1 11.1 105.0 49.9 145.3 17.7 12.7 126.9 127.3 91.6 72.7 10.0 0.0 34.3 6.0 1.1 12.5 62.3 53.0 80.0 6.6 8.2 72.9 155.5 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128730-35142304 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 7.3 7.4 5.0 5.8 5.0 6.2 8.8 5.1 5.3 7.4 3.4 5.6 4.0 6.8 2.9 8.4 7.4 3.1 4.2 5.0 4.5 6.5 7.3 4.6 6.8 4.7 4.0 12.0 23.7 3.9 4.2 4.9 4.0 6.0 4.0 2.5 7.6 4.6 8.0 6.8 5.1 4.1 3.5 6.2 7.6 4.4 5.0 6.6 5.1 3.5 5.4 7.4 5.8 4.6 15.9 36.8 12.5 22.7 6.9 11.4 19.6 14.0 12.7 24.4 19.3 26.1 14.8 34.9 18.6 12.0 18.0 21.0 26.8 35.6 15.1 5.6 44.2 14.9 18.2 33.2 10.3 29.9 12.0 12.9 19.0 25.6 38.3 10.7 15.5 33.9 42.4 12.7 14.6 22.1 47.1 25.5 23.6 13.5 16.6 37.6 20.9 38.5 14.3 14.8 25.6 14.8 13.1 13.4 17.1 11.1 32.4 22.4 14.5 13.3 18.3 13.0 47.4 9.8 7.8 29.1 9.3 24.9 25.8 0.1 2.2 0.0 4.0 2.4 6.2 3.4 3.8 4.2 3.4 4.6 5.2 3.5 0.3 1.8 1.2 0.8 2.1 2.2 5.0 5.0 5.1 5.3 5.0 4.5 4.7 4.0 4.0 3.5 5.0 4.6 4.7 3.2 1.1 0.3 8.6 8.7 8.6 7.4 9.6 4.7 12.3 14.0 2.6 10.0 3.7 3.7 2.1 12.1 2.4 3.9 0.0 8.9 1.0 2.1 5.4 5.0 4.9 8.8 1.3 15.4 20.9 7.4 6.6 2.8 3.8 9.4 5.3 6.6 7.6 1.7 1.5 8.1 2.0 4.6 2.6 5.4 4.1 2.8 1.8 1.0 3.8 1.9 2.1 1.0 0.7 8.5 3.6 4.9 5.1 8.6 3.4 7.1 2.8 3.1 0.0 6.5 7.2 4.2 6.5 12.5 10.1 4.9 4.1 9.2 13.4 5.5 NR5A2 "B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1" ENSG00000116833 "Nuclear receptor subfamily 5 group A member 2" O00482 1 200027614-200177420 "Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 17.8;liver: 38.6;pancreas: 61.1" "Cell type enriched" "Detected in many" 5 "Granulosa cells: 276.2" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.2;neutrophil: 1.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected" "Not detected" "HPA005455, HPA017067" Approved Uncertain "Nuclear speckles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "HPA005455: AB_1078140, HPA017067: AB_1844767" "unprognostic (7.47e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (1.19e-2)" "unprognostic (6.63e-3)" "unprognostic (4.46e-2)" "unprognostic (3.78e-2)" "unprognostic (3.34e-1)" "unprognostic (8.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.44e-1)" "unprognostic (1.00e-7)" "unprognostic (5.48e-2)" "unprognostic (5.07e-2)" "unprognostic (9.23e-2)" "unprognostic (1.37e-1)" 5.4 0.4 0.5 2.6 0.2 0.9 3.7 0.5 0.3 3.4 0.2 11.9 17.4 3.3 1.4 0.9 2.2 8.0 1.0 0.3 2.8 0.7 38.6 2.7 2.1 0.7 0.6 1.0 61.1 0.4 0.1 0.4 0.8 1.6 13.1 0.2 0.5 0.8 1.1 1.1 17.8 4.3 0.4 0.2 1.3 0.8 0.8 0.5 0.9 0.7 1.4 1.8 1.2 0.7 0.0 25.0 0.0 0.1 0.0 0.2 0.6 0.0 0.4 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.7 0.7 14.9 0.0 0.0 3.3 1.1 0.0 0.3 2.7 0.5 0.1 6.4 0.1 0.0 0.0 0.1 0.0 20.4 0.1 0.0 0.3 0.0 0.6 0.0 0.4 0.9 0.0 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.7 4.7 0.3 0.1 1.0 0.2 0.1 0.2 3.4 2.3 2.6 0.3 0.2 0.1 3.2 0.4 0.4 0.2 0.2 0.2 0.3 0.3 0.3 0.1 0.4 0.4 0.3 1.5 0.5 0.2 0.5 0.4 0.1 0.5 0.2 0.5 0.3 0.3 2.8 0.7 0.6 0.8 0.4 0.8 0.7 23.7 0.0 1.7 0.3 0.2 1.9 0.1 0.0 0.0 0.2 0.2 0.0 9.9 32.9 0.0 0.0 0.0 0.0 0.3 37.5 0.0 38.2 0.4 0.3 0.3 32.4 4.9 2.7 0.4 54.5 0.0 0.8 0.0 0.2 13.3 276.2 38.6 38.5 0.1 0.0 0.6 13.8 0.0 4.9 1.5 0.3 0.6 0.6 0.0 0.0 3.1 0.0 0.0 1.0 0.3 22.0 21.8 0.0 1.2 0.3 49.9 0.0 0.8 0.3 0.0 0.5 6.1 0.1 0.1 0.0 1.4 0.0 0.3 0.1 32.3 0.2 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" P80303 11 17208153-17349980 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "DNA-binding, Guanine-nucleotide releasing factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 758.3;salivary gland: 771.4" "Cell type enhanced" "Detected in all" "Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 1867.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 690000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 56.2 75.7 23.9 62.1 27.8 619.9 141.1 28.8 32.1 137.2 58.0 68.3 57.3 60.8 458.2 146.3 107.2 60.8 95.7 22.8 34.7 43.2 102.2 49.8 60.2 25.7 28.2 56.0 758.3 479.1 113.0 90.9 26.8 70.9 68.4 64.5 771.4 190.9 38.5 21.1 40.7 78.5 26.2 42.2 92.9 119.2 28.4 334.2 153.9 30.4 78.5 61.8 44.9 26.6 119.9 49.0 53.7 163.4 118.9 162.3 65.0 260.5 381.0 115.1 203.0 48.7 26.8 182.9 63.5 250.7 107.1 50.1 34.4 66.8 178.7 126.7 76.3 135.8 57.8 85.2 340.5 1867.0 238.6 71.1 86.8 82.9 200.9 284.9 143.3 672.1 120.1 361.1 114.9 105.9 656.2 670.3 12.9 194.0 50.5 239.8 130.4 15.1 51.9 37.5 63.5 35.4 114.6 114.2 61.4 78.0 93.5 498.1 128.1 120.9 110.9 369.1 112.1 70.3 41.3 101.1 140.5 646.1 106.4 210.5 43.5 168.2 94.1 30.5 122.9 22.7 88.5 173.7 40.6 14.5 246.7 271.2 39.3 277.9 25.6 426.0 42.7 119.8 23.9 27.8 28.8 32.1 22.8 34.7 25.7 28.2 26.8 26.2 28.4 26.6 118.7 44.8 70.4 16.3 54.8 27.5 60.2 156.3 14.8 71.0 152.8 87.0 193.8 55.8 176.5 42.3 54.2 127.1 136.5 17.6 27.4 91.1 690.6 112.4 92.9 94.7 42.4 137.8 21.9 132.6 319.1 148.8 40.2 97.0 67.6 80.0 108.5 141.8 70.7 35.3 23.5 189.0 189.2 29.4 40.0 508.5 149.8 37.6 69.4 18.7 24.1 111.2 95.8 13.6 10.8 75.2 13.2 114.3 256.5 108.7 3.9 28.5 618.8 99.3 46.0 50.8 75.4 174.9 61.3 87.7 30.1 1158.2 92.3 88.3 45.3 61.2 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422573-87459455 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 160.7" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" NA NA 9900 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885" "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favorable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favorable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 23.6 36.1 20.8 16.2 21.4 6.7 19.7 25.5 38.5 27.6 39.1 27.0 42.6 24.8 32.2 19.6 24.9 16.2 28.8 21.9 24.7 40.4 46.6 23.0 13.7 21.0 20.5 26.7 67.6 55.3 29.1 19.9 21.9 30.4 27.1 20.1 28.1 23.8 42.1 16.6 40.3 23.8 19.6 14.7 22.3 22.5 22.1 13.4 28.8 45.0 14.8 22.4 24.3 26.0 30.8 25.6 34.0 19.8 67.6 39.6 26.0 59.8 35.6 21.3 21.1 17.1 53.1 47.6 58.9 47.6 41.0 21.1 32.1 38.1 33.2 34.5 24.0 13.4 34.5 31.8 42.4 25.6 21.2 41.5 52.4 25.6 22.6 45.5 41.6 13.7 40.3 30.0 38.7 33.4 39.1 23.2 29.1 68.5 12.0 45.0 31.8 27.0 160.7 24.2 41.3 28.7 37.6 63.0 30.8 44.5 36.8 38.2 43.7 34.7 34.3 25.8 27.8 21.5 18.7 37.9 51.3 21.9 48.2 1.6 17.9 5.9 19.1 21.2 18.2 22.2 18.5 19.5 21.4 18.8 22.5 26.0 1.8 15.6 24.0 20.6 19.0 16.0 20.8 21.4 25.5 38.5 21.9 24.7 21.0 20.5 21.9 19.6 22.1 26.0 32.6 67.3 44.8 20.2 14.9 9.9 40.4 45.0 9.6 15.3 11.3 13.1 40.9 30.0 55.0 23.9 27.1 33.2 13.1 21.0 41.1 44.7 28.6 26.0 26.2 25.8 16.8 6.7 21.7 36.5 32.5 29.4 8.6 27.0 20.8 23.3 18.2 47.5 33.2 6.7 24.0 18.0 40.7 12.7 11.0 11.5 25.4 14.7 10.6 20.6 16.4 26.8 8.2 18.6 24.8 29.4 37.0 26.7 15.8 32.9 55.7 56.2 41.0 18.6 26.3 36.9 23.7 44.5 23.6 15.7 9.5 37.6 12.1 29.8 24.9 27.3 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675469-117710727 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 17.8 20.0 12.1 22.2 13.0 19.4 22.2 11.4 15.5 60.3 16.1 19.8 16.5 20.6 28.4 15.7 18.4 16.1 11.7 12.9 13.8 28.4 31.6 18.2 21.4 10.8 12.5 16.5 20.4 29.8 11.9 21.6 11.9 20.6 20.3 12.5 30.5 17.6 10.0 11.1 17.6 18.7 11.7 17.8 24.2 12.6 13.5 18.5 35.4 12.6 20.6 23.5 11.7 12.4 27.1 19.5 41.3 46.4 40.7 52.9 101.0 48.3 50.1 39.5 45.1 44.6 29.5 63.4 51.1 44.7 50.0 24.0 62.1 47.2 73.0 47.9 57.0 72.8 31.5 80.2 62.6 92.8 41.2 46.6 52.5 43.3 87.7 40.3 41.3 46.5 88.4 54.9 59.7 30.5 43.9 58.8 48.0 36.9 35.3 41.7 29.7 45.7 79.0 26.6 48.7 38.5 29.1 37.4 36.9 45.6 23.8 95.9 36.4 24.3 30.1 39.2 70.5 75.6 60.8 66.8 57.6 70.0 49.7 1.9 1.3 0.8 1.3 1.4 1.9 1.1 1.6 1.8 1.5 1.0 1.3 1.7 0.1 1.9 2.5 3.8 1.7 1.0 12.1 13.0 11.4 15.5 12.9 13.8 10.8 12.5 11.9 11.7 13.5 12.4 18.7 0.0 22.3 30.3 28.5 60.5 41.9 32.6 19.4 15.3 26.6 13.7 6.3 15.7 24.0 25.8 10.4 26.8 38.1 26.4 27.4 23.4 16.0 15.7 28.9 24.3 13.1 19.1 33.4 30.2 63.6 22.8 38.2 21.4 31.1 15.8 28.2 39.7 35.3 15.2 37.1 29.3 20.3 37.0 42.2 14.0 18.0 30.2 32.0 20.6 28.4 8.3 24.7 35.7 36.5 37.4 22.7 20.3 57.5 73.1 18.6 33.6 23.1 9.6 6.6 21.3 25.9 24.9 25.4 25.7 56.1 57.9 26.2 14.5 26.1 77.5 OCLN PPP1R115 ENSG00000197822 Occludin Q16625 5 69492292-69558104 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 31.4" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 109.0;Glandular and luminal cells: 119.7;Urothelial cells: 224.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 2.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "A-431: 23.3;CAPAN-2: 39.8;HaCaT: 33.4;RPTEC TERT1: 25.7;SK-BR-3: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005933, CAB013075, CAB068212, CAB068213, CAB068214" Enhanced Supported "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cell Junctions" "CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520" "unprognostic (2.28e-1)" "unprognostic (1.88e-1)" "unprognostic (2.50e-2)" "unprognostic (9.94e-2)" "unprognostic (3.65e-1)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.08e-2)" "unprognostic (8.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.58e-2)" "unprognostic (3.48e-1)" "prognostic favorable (6.59e-11)" "unprognostic (2.83e-1)" "unprognostic (4.01e-1)" "unprognostic (1.33e-1)" "unprognostic (3.35e-1)" 1.2 0.7 6.2 1.6 6.5 1.8 7.8 7.2 6.7 6.8 22.2 11.0 10.3 2.1 4.0 11.6 7.5 8.5 1.5 5.9 5.4 11.0 18.8 15.1 0.6 9.3 7.7 2.3 20.2 8.3 3.4 3.9 8.3 3.5 11.2 2.3 6.7 4.6 0.6 11.3 10.0 0.6 5.4 2.1 15.2 2.4 6.5 0.9 31.4 0.6 2.8 5.0 7.9 7.4 23.3 4.5 0.6 0.9 0.6 0.9 15.1 0.3 1.6 2.5 3.3 20.7 39.8 0.5 5.9 1.1 8.3 33.4 7.2 4.3 7.8 0.3 12.2 2.4 1.1 9.8 0.3 1.2 2.5 0.1 6.4 4.1 1.0 1.6 1.4 3.1 0.1 0.4 0.1 22.4 1.5 1.2 3.1 8.0 2.1 0.2 6.0 1.1 25.7 22.2 2.7 2.8 0.3 27.2 0.9 5.0 14.7 4.0 1.2 0.4 7.7 1.8 2.7 0.5 0.4 0.3 0.3 0.3 0.6 1.0 0.2 0.5 0.2 0.1 0.2 0.3 0.2 0.1 0.1 0.4 0.2 0.2 2.7 0.5 0.1 0.4 0.1 0.1 6.2 6.5 7.2 6.7 5.9 5.4 9.3 7.7 8.3 5.4 6.5 7.4 4.8 109.0 67.3 1.6 3.2 3.7 60.8 7.6 1.8 5.7 49.7 16.9 1.4 64.3 51.0 25.8 14.6 30.3 3.6 94.1 9.8 65.6 1.9 78.5 12.1 10.7 26.3 2.5 1.3 61.6 2.5 5.8 46.4 119.7 2.5 6.5 18.2 48.3 3.0 6.7 1.1 45.1 16.2 12.9 1.2 1.6 3.1 2.4 1.8 16.9 3.9 2.8 1.0 0.5 1.5 64.6 61.8 1.5 1.1 101.5 42.3 10.5 63.0 6.3 13.1 3.3 4.4 4.7 8.2 29.5 15.5 16.4 4.3 0.7 47.9 224.0 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 14.4 7.5 7.2 9.2 15.0 14.0 10.4 10.1 13.3 8.4 10.8 13.4 9.4 17.2 7.8 8.8 10.6 10.0 7.6 8.2 16.7 21.8 9.5 6.7 8.9 8.6 10.3 29.1 32.4 12.4 14.2 9.2 16.6 12.7 15.2 21.7 12.2 9.0 10.3 13.6 8.8 8.7 8.5 13.1 8.3 8.2 6.4 19.9 9.5 7.1 11.5 8.2 11.9 12.6 13.9 15.1 12.1 17.5 16.3 28.8 19.9 12.2 12.7 12.8 28.2 29.7 8.7 23.5 9.9 11.6 32.3 11.4 10.9 12.5 7.1 10.9 8.2 17.7 15.9 16.4 13.8 9.6 12.5 21.3 15.4 24.1 13.2 13.8 9.0 32.1 17.3 15.3 13.5 9.7 14.3 21.6 46.0 5.0 11.2 10.5 25.0 26.1 12.9 11.0 17.2 15.1 33.0 24.5 26.9 29.1 12.4 13.2 18.1 11.5 12.2 18.9 20.2 13.3 13.3 9.8 7.4 16.7 1.4 9.0 2.5 3.0 8.9 4.5 3.6 3.8 4.2 7.6 2.3 4.7 3.6 3.9 10.0 11.4 4.8 5.7 3.9 7.5 9.2 10.4 10.1 7.6 8.2 8.9 8.6 9.2 8.7 8.2 11.9 28.1 28.9 37.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 18.8 16.5 0.0 0.0 29.7 25.8 0.0 22.0 12.6 0.0 9.8 22.8 0.0 26.8 27.0 9.8 0.0 0.0 0.0 25.4 25.7 12.3 0.0 38.6 12.6 26.4 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 6.7 0.0 0.0 0.0 0.0 24.7 0.0 0.0 4.0 0.0 0.0 10.7 15.3 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 28.0 6.9 29.0 0.0 0.0 ONECUT1 "HNF-6, HNF6, HNF6A" ENSG00000169856 "One cut homeobox 1" Q9UBC0 15 52755053-52791078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 6.0;liver: 12.9;pancreas: 13.6;retina: 4.6" "Cell type enriched" "Detected in some" 16 "Horizontal cells: 647.8" "Group enriched" "Detected in some" 7 "liver cancer: 2.9;pancreatic cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;Hep G2: 1.4;MCF7: 1.3;NTERA-2: 1.8;SuSa: 1.9;WM-115: 1.2" "Region enhanced" "Detected in single" "hypothalamus: 1.0" "Low region specificity" "Detected in many" HPA003457 Enhanced NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 12: NES - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA003457: AB_1079525" "unprognostic (5.12e-2)" "unprognostic (2.45e-2)" "unprognostic (2.64e-2)" "unprognostic (4.82e-2)" "unprognostic (9.19e-2)" "unprognostic (7.05e-2)" "unprognostic (5.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.70e-7)" "unprognostic (9.76e-3)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" 0.0 0.0 0.7 0.0 0.7 0.5 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.4 2.0 0.0 12.9 0.0 0.0 1.8 2.1 0.0 13.6 0.0 0.0 0.0 1.7 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 1.8 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.0 1.8 0.1 0.1 0.3 0.0 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.2 1.9 0.3 0.0 0.0 0.6 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.4 0.3 0.4 2.0 1.8 2.1 1.7 0.6 0.4 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.3 40.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 21.1 1.4 0.1 0.0 0.3 0.0 0.0 0.4 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 647.8 0.2 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 15.6 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.2 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OS9 "ERLEC2, OS-9" ENSG00000135506 "OS9 endoplasmic reticulum lectin" Q13438 12 57693955-57721557 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "RH-30: 3551.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011518, HPA013694" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 10000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB011518: AB_776918, HPA013694: AB_1854812" "unprognostic (1.67e-2)" "unprognostic (4.20e-1)" "unprognostic (3.93e-2)" "unprognostic (1.50e-1)" "unprognostic (9.79e-3)" "unprognostic (1.32e-3)" "unprognostic (4.78e-2)" "unprognostic (8.54e-2)" "unprognostic (2.67e-1)" "unprognostic (1.64e-1)" "unprognostic (5.67e-3)" "unprognostic (2.23e-1)" "unprognostic (1.83e-2)" "unprognostic (2.78e-1)" "unprognostic (1.67e-2)" "unprognostic (4.81e-2)" "unprognostic (2.21e-2)" 151.0 93.0 61.1 118.6 59.3 149.0 113.4 60.7 60.8 135.6 94.3 158.1 149.9 101.2 141.4 105.2 109.6 106.2 111.0 58.4 71.5 114.8 264.5 130.0 89.7 64.5 62.8 124.6 270.0 171.6 71.5 141.3 63.5 116.4 132.6 75.5 189.0 102.1 59.6 119.8 143.2 110.2 60.8 106.0 137.2 38.9 66.7 72.6 129.4 65.5 94.2 119.7 103.5 63.7 86.8 170.8 86.2 214.4 440.4 295.6 190.5 211.9 268.4 153.4 154.6 180.2 274.5 110.0 345.3 255.2 118.5 152.9 81.3 137.5 121.2 142.0 97.6 124.0 115.3 164.8 287.1 196.9 307.3 273.7 217.6 150.7 152.6 529.4 258.6 71.7 96.0 427.9 162.2 149.5 53.7 239.7 97.7 172.0 121.2 69.8 3551.9 281.5 116.5 210.6 88.4 116.4 300.3 205.5 176.6 158.1 245.4 381.0 238.9 206.0 122.3 140.4 136.4 253.4 234.6 112.9 173.8 141.6 290.4 175.7 241.2 274.6 72.9 213.0 68.5 50.5 61.1 65.0 172.6 54.3 46.8 54.1 246.4 58.8 182.4 149.0 74.4 218.9 61.1 59.3 60.7 60.8 58.4 71.5 64.5 62.8 63.5 60.8 66.7 63.7 83.3 86.6 116.7 22.2 65.8 57.7 85.4 103.3 43.9 44.1 61.2 46.6 14.1 80.1 111.8 73.5 77.2 142.4 64.5 153.0 9.8 144.8 6.7 34.0 73.3 90.2 103.6 53.4 19.5 110.1 124.6 113.6 65.7 60.0 91.1 61.6 81.4 161.1 144.8 50.5 27.0 167.3 107.8 121.1 99.1 10.7 113.4 106.1 119.2 29.0 125.0 87.2 53.5 23.6 24.4 94.7 155.4 79.0 141.1 56.5 154.0 53.9 74.0 50.9 92.1 68.3 66.9 38.1 46.4 51.3 51.6 197.7 59.5 64.9 102.4 65.0 OSTC DC2 ENSG00000198856 "Oligosaccharyltransferase complex non-catalytic subunit" Q9NRP0 4 108650585-108667820 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 628.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.26e-1)" "unprognostic (1.00e-1)" "unprognostic (2.10e-2)" "prognostic favorable (1.44e-4)" "unprognostic (6.05e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (2.77e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (6.46e-2)" "unprognostic (4.55e-2)" "unprognostic (3.13e-3)" "unprognostic (9.16e-3)" "prognostic unfavorable (2.31e-8)" "unprognostic (2.06e-1)" "unprognostic (1.68e-1)" "unprognostic (4.06e-2)" "unprognostic (1.55e-2)" 72.6 74.1 22.8 84.2 23.7 98.9 99.8 24.1 29.8 118.6 35.0 85.1 96.2 87.1 180.0 77.5 72.7 82.4 51.6 22.3 26.5 74.6 193.9 64.6 87.8 25.9 24.1 69.7 132.9 51.1 82.8 105.4 24.7 64.6 98.4 22.6 83.5 59.6 24.3 47.8 89.1 82.7 25.1 70.1 87.1 39.2 26.4 91.6 106.2 30.6 80.9 92.5 60.4 26.8 123.2 75.5 200.2 138.2 419.3 556.1 158.0 328.3 316.8 166.9 203.0 161.6 274.7 258.5 236.0 388.7 101.2 81.6 159.8 133.5 192.8 108.8 117.4 133.0 99.7 357.0 336.8 304.0 124.1 362.8 253.7 137.4 280.2 349.9 379.6 160.1 255.0 295.1 329.5 152.2 213.1 264.7 137.2 332.2 95.7 216.2 217.5 284.6 292.1 85.9 99.9 123.4 111.8 265.0 262.9 245.2 122.4 246.5 298.5 175.4 185.3 132.2 135.9 168.0 183.1 254.0 225.1 183.9 195.7 146.4 136.2 76.4 130.4 145.5 202.4 120.2 138.0 143.0 204.0 91.5 128.3 139.2 18.6 152.7 125.9 375.9 105.5 227.2 22.8 23.7 24.1 29.8 22.3 26.5 25.9 24.1 24.7 25.1 26.4 26.8 123.1 38.5 48.5 11.8 128.4 97.3 114.1 413.8 86.6 15.1 178.3 197.1 34.2 124.4 235.4 84.6 16.7 276.9 199.9 54.6 88.0 221.7 9.4 105.4 337.0 120.0 58.0 105.5 9.4 159.5 628.6 200.2 120.8 180.5 122.4 169.5 111.4 187.1 256.1 11.8 13.3 274.2 209.5 139.9 196.7 10.1 164.1 138.5 161.9 6.5 140.0 50.2 140.1 12.1 17.5 160.3 90.4 109.1 424.4 183.7 166.5 173.9 126.9 17.3 72.3 108.8 175.3 74.5 72.4 134.9 117.9 365.4 117.2 197.4 178.5 145.2 P3H4 "LEPREL4, NO55, SC65" ENSG00000141696 "Prolyl 3-hydroxylase family member 4 (inactive)" Q92791 17 41801947-41812604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 3.9;MAIT T-cell: 5.0;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.7;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.9;NK-cell: 8.5" "Group enriched" "Detected in many" 10 "NK-cells: 8.5;T-cells: 5.0" "Cell line enriched" "Detected in many" 13 "OE19: 1032.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022520 Supported "Endoplasmic reticulum,Vesicles" "Intracellular and membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum, Vesicles" "HPA022520: " "unprognostic (9.11e-2)" "unprognostic (3.72e-3)" "unprognostic (3.66e-2)" "unprognostic (3.72e-2)" "unprognostic (8.69e-3)" "unprognostic (4.32e-2)" "unprognostic (2.16e-3)" "unprognostic (1.94e-1)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (4.48e-6)" "unprognostic (1.47e-1)" "unprognostic (1.23e-1)" "unprognostic (8.96e-2)" "unprognostic (1.96e-3)" 5.1 11.6 5.4 5.5 5.6 0.5 4.9 7.3 6.6 10.0 7.5 6.2 7.6 10.7 4.9 2.8 7.7 6.8 8.8 4.6 6.8 7.8 2.3 6.0 2.7 5.2 4.9 7.9 12.9 11.5 10.5 12.1 4.9 7.3 4.2 1.3 10.4 7.2 4.8 7.4 6.5 10.1 4.5 3.3 5.2 2.3 6.6 1.3 12.2 2.0 1.6 7.2 6.4 4.5 9.2 45.0 27.4 70.8 29.1 28.1 26.9 75.5 33.6 25.6 35.0 22.3 12.4 1.4 30.6 58.7 19.5 16.4 23.6 32.3 10.1 21.0 35.5 11.4 44.1 30.3 35.4 2.3 3.6 29.5 9.5 22.3 20.3 61.0 32.6 3.2 2.2 11.6 16.7 31.6 0.6 6.8 17.1 1032.2 25.2 25.3 30.1 31.4 16.5 2.7 13.2 29.0 13.3 81.2 28.9 18.1 46.8 7.4 34.3 24.5 35.7 46.2 34.1 10.7 2.6 0.2 37.7 11.1 38.5 0.0 0.2 0.0 3.9 0.0 5.0 0.6 2.5 2.7 0.2 0.6 3.0 3.9 0.0 8.5 0.0 0.0 0.7 1.5 5.4 5.6 7.3 6.6 4.6 6.8 5.2 4.9 4.9 4.5 6.6 4.5 7.3 0.0 7.8 12.1 1.5 0.0 5.4 0.0 6.2 3.6 11.6 10.8 10.7 11.5 1.8 5.5 8.4 10.8 3.6 7.2 7.9 21.6 0.5 2.7 25.3 11.0 2.4 7.0 6.4 6.5 27.3 26.6 16.8 7.7 1.3 17.7 11.0 1.9 2.8 26.9 4.4 13.0 0.0 1.2 0.0 0.8 21.1 1.0 0.0 4.7 1.2 9.6 13.4 6.0 1.5 7.1 9.5 20.7 2.8 9.6 26.8 5.9 0.7 2.7 19.7 13.1 16.7 2.7 10.0 1.9 0.0 5.3 3.2 19.1 9.8 2.0 P4HB "DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB" ENSG00000185624 "Prolyl 4-hydroxylase subunit beta" P07237 17 81843159-81860856 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Chaperone, Isomerase" "Craniosynostosis, Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 1856.8;pancreas: 2446.9" "Cell type enhanced" "Detected in all" "Exocrine glandular cells: 1077.9;Extravillous trophoblasts: 1349.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012463, HPA018884" Enhanced Supported "Endoplasmic reticulum" "Intracellular and membrane" No No 110000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 43: THP-1 - Innate immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB012463: , HPA018884: AB_1854896" "unprognostic (9.47e-3)" "unprognostic (1.09e-2)" "unprognostic (2.99e-2)" "unprognostic (7.14e-3)" "unprognostic (7.75e-3)" "unprognostic (1.05e-2)" "unprognostic (1.30e-1)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (4.73e-3)" "unprognostic (1.43e-1)" "unprognostic (3.93e-2)" "prognostic unfavorable (2.30e-11)" "unprognostic (1.18e-1)" "unprognostic (1.04e-2)" "unprognostic (4.99e-3)" "unprognostic (3.19e-3)" 266.5 507.8 34.6 209.8 35.7 517.1 225.5 39.1 35.7 272.0 59.6 258.4 640.2 206.5 133.0 618.7 183.4 202.0 318.4 31.7 50.2 270.7 1856.8 301.3 104.0 48.9 37.1 187.8 2446.9 144.3 330.0 334.3 40.8 335.8 173.6 23.3 948.1 184.2 328.5 370.4 554.7 179.8 39.8 428.6 539.2 68.8 58.7 89.3 244.8 150.8 137.9 233.7 322.9 43.7 690.3 580.7 236.8 687.5 813.4 726.7 593.6 1038.5 1081.1 741.9 934.5 550.4 576.9 264.4 501.8 1120.2 407.5 464.1 248.8 647.4 254.1 145.8 320.5 355.2 362.9 953.6 1010.8 1146.4 613.4 618.8 494.8 478.2 596.7 843.0 1250.1 182.1 273.6 978.2 559.5 566.4 260.5 723.2 157.7 791.0 463.8 261.8 342.5 614.0 453.2 492.8 248.7 301.1 586.1 1693.1 808.1 289.6 855.3 1601.2 644.1 980.5 503.1 574.3 586.6 743.5 407.9 204.8 1372.0 591.3 825.4 198.3 268.1 163.0 202.6 154.4 209.8 83.9 138.9 165.7 174.7 68.1 74.9 114.6 72.9 157.0 115.3 311.5 105.6 372.4 34.6 35.7 39.1 35.7 31.7 50.2 48.9 37.1 40.8 39.8 58.7 43.7 122.3 102.5 162.1 23.2 151.4 120.1 163.6 371.0 140.6 59.2 283.0 170.8 24.1 247.4 211.7 112.2 33.3 790.2 208.9 420.7 41.1 671.9 43.5 78.4 196.8 153.9 199.9 140.9 15.3 1077.9 1349.1 272.5 388.9 209.1 99.1 210.4 190.2 840.7 435.9 62.2 16.2 610.9 189.2 186.9 125.5 64.9 141.4 180.3 136.9 20.6 263.3 122.7 230.7 13.6 19.6 575.2 465.6 112.1 664.3 310.6 914.2 105.0 91.3 54.3 157.8 103.4 226.7 83.4 94.1 302.3 144.6 1001.2 138.8 378.4 475.4 220.8 PAFAH2 HSD-PLA2 ENSG00000158006 "Platelet activating factor acetylhydrolase 2" Q99487 1 25959767-25998117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 48.7" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018157 Approved NA Yes "Cluster 2: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA018157: AB_1854928" "unprognostic (9.89e-2)" "unprognostic (2.60e-1)" "unprognostic (3.63e-3)" "prognostic favorable (3.28e-6)" "unprognostic (5.19e-2)" "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "unprognostic (1.78e-1)" "unprognostic (2.43e-1)" "unprognostic (1.04e-1)" "unprognostic (4.46e-2)" "unprognostic (2.62e-1)" "prognostic favorable (0.00e+0)" "unprognostic (8.15e-2)" "unprognostic (8.17e-2)" "unprognostic (1.59e-2)" "unprognostic (7.27e-2)" 4.6 7.3 4.7 6.5 6.5 6.8 9.2 6.3 6.0 8.8 6.7 16.3 17.4 4.9 9.9 7.8 8.3 10.4 9.7 4.5 5.8 19.3 18.3 8.6 8.4 6.4 6.5 4.7 31.2 22.9 5.9 9.2 6.5 8.8 16.6 14.1 10.0 6.3 18.0 11.4 19.0 6.9 5.5 7.6 15.6 7.7 6.5 48.7 16.4 10.7 7.4 7.0 5.5 8.2 8.6 10.7 6.7 7.6 13.9 10.9 13.7 9.6 5.0 8.6 5.7 4.4 18.1 3.8 11.7 5.7 8.1 7.5 10.1 9.3 11.0 7.8 6.1 6.3 4.6 8.8 8.4 3.3 52.5 7.2 21.2 13.2 8.7 4.7 8.3 8.9 8.9 7.1 11.7 3.8 10.3 3.3 13.4 29.9 5.9 8.4 6.3 8.7 13.9 3.0 8.0 6.8 5.7 7.7 18.2 11.0 12.7 6.0 7.8 5.9 7.4 12.5 7.7 13.0 18.1 4.8 12.5 13.2 20.0 36.2 6.7 60.2 23.7 6.4 15.3 3.5 8.3 15.4 5.0 4.4 10.6 14.9 5.8 17.4 2.4 39.0 9.0 8.7 4.7 6.5 6.3 6.0 4.5 5.8 6.4 6.5 6.5 5.5 6.5 8.2 4.6 16.0 12.8 9.8 3.2 1.5 2.1 5.3 1.8 9.5 9.4 4.8 6.8 11.5 11.9 18.4 27.1 11.2 37.7 34.9 3.9 11.1 1.1 8.6 4.5 5.6 7.8 3.2 4.0 7.3 9.5 3.5 12.2 13.2 27.8 7.3 5.7 21.4 11.2 5.0 3.6 18.2 4.1 11.6 1.6 1.0 2.5 7.1 8.8 5.6 7.3 6.3 23.7 4.0 10.0 10.6 15.8 2.6 6.5 4.2 43.1 18.3 8.9 8.8 6.6 5.3 4.1 19.9 8.9 4.5 3.8 10.0 9.0 4.4 19.4 4.9 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199610-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Bipolar cells: 4.9;Endometrial stromal cells: 3.5;Fibroblasts: 4.8;Peritubular cells: 3.4;Sertoli cells: 6.6;Skeletal myocytes: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.6;EFO-21: 8.9;U-2 OS: 3.0" HPA045042 Uncertain Approved "Plasma membrane" NA NA "Cluster 11: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "HPA045042: AB_2679194" "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 1.3 0.6 0.2 0.5 0.5 0.2 0.9 0.9 1.2 1.2 0.0 1.0 0.2 1.5 0.5 0.7 0.9 0.9 0.8 0.5 0.0 0.7 0.2 0.8 0.1 0.3 0.3 1.6 2.6 2.6 0.7 0.6 0.1 0.9 0.3 0.6 0.8 1.0 0.4 0.8 0.4 1.2 0.4 0.6 0.6 0.4 0.0 0.3 0.6 0.6 0.1 0.9 0.6 0.4 0.0 0.1 1.8 5.6 0.1 0.1 1.1 0.1 0.5 0.0 0.0 0.0 0.1 0.0 8.9 0.5 0.5 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.8 0.0 0.1 0.0 1.4 0.3 0.1 0.0 0.1 0.2 0.0 0.3 0.0 2.2 0.0 0.0 0.2 2.2 0.3 1.3 0.1 0.7 0.3 1.3 0.0 0.3 0.1 3.0 2.4 0.0 0.1 0.0 0.0 1.4 0.1 1.5 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.5 0.2 0.0 0.1 0.0 0.0 0.2 0.5 0.9 1.2 0.5 0.0 0.3 0.3 0.1 0.4 0.0 0.4 1.9 3.2 0.5 0.0 0.0 0.0 0.7 0.0 0.0 4.9 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.7 3.5 1.9 2.4 0.0 0.0 1.8 0.0 4.8 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 0.1 1.8 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 3.4 0.1 0.9 0.0 0.9 0.0 0.2 6.6 4.1 1.7 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.7 PCDHB13 PCDH-BETA13 ENSG00000187372 "Protocadherin beta 13" Q9Y5F0 5 141213919-141218979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.7;Exocrine glandular cells: 3.1;Horizontal cells: 3.3;Ionocytes: 4.1;Melanocytes: 3.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in single" "neutrophil: 2.9" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "EFO-21: 7.3;T-47d: 14.4;U-2197: 11.6" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (9.91e-3)" "unprognostic (3.34e-2)" "unprognostic (8.89e-2)" "unprognostic (2.06e-3)" "unprognostic (2.06e-1)" "unprognostic (1.29e-1)" "unprognostic (9.59e-2)" "unprognostic (3.55e-2)" "unprognostic (6.06e-2)" "unprognostic (2.61e-3)" "unprognostic (3.07e-1)" "unprognostic (1.13e-1)" "unprognostic (4.49e-2)" "unprognostic (2.80e-2)" "unprognostic (3.99e-2)" "unprognostic (8.19e-2)" "unprognostic (6.93e-3)" 1.1 1.3 0.2 0.5 0.6 0.2 1.1 0.5 1.2 1.4 0.0 1.0 0.2 1.6 1.2 0.7 1.1 1.6 1.4 0.7 0.0 0.8 0.6 0.9 0.3 0.1 0.2 1.4 1.9 0.7 1.5 1.3 0.0 1.2 0.6 1.2 1.5 1.1 0.5 1.8 0.4 1.3 0.1 0.8 0.8 1.0 0.1 0.1 0.9 0.7 0.2 0.8 0.9 0.5 0.0 0.1 1.8 1.4 4.6 4.9 0.4 0.3 2.4 0.7 1.4 0.0 2.0 0.0 7.3 1.8 2.5 0.5 1.7 0.0 0.4 0.0 0.1 0.0 0.9 0.3 0.1 0.0 0.9 0.4 1.2 0.1 0.1 2.1 0.7 0.2 0.3 1.8 2.3 0.3 0.2 0.1 0.4 0.0 0.2 5.6 0.8 0.0 0.1 0.1 1.7 0.6 2.4 0.2 0.7 0.5 14.4 0.1 2.2 0.5 1.3 11.6 0.0 0.0 0.1 0.0 3.2 0.1 3.6 0.9 0.2 0.8 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.5 0.2 0.2 2.9 0.1 0.1 0.2 0.1 0.0 0.2 0.6 0.5 1.2 0.7 0.0 0.1 0.2 0.0 0.1 0.1 0.5 2.1 0.0 0.0 0.0 0.0 0.8 0.2 1.5 1.8 3.7 0.4 0.4 1.5 2.8 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 1.0 0.5 2.1 1.6 0.0 0.0 0.0 3.1 0.0 1.2 0.0 0.6 0.0 0.5 1.1 0.7 0.1 3.3 0.0 0.2 4.1 0.0 0.0 0.0 0.9 0.1 3.6 0.0 0.0 2.2 0.0 0.0 0.0 0.8 0.2 1.2 0.1 0.2 0.0 0.8 0.1 0.3 0.0 2.1 0.8 0.4 0.2 0.9 0.9 0.0 0.0 0.1 0.1 0.6 PDCD4 H731 ENSG00000150593 "Programmed cell death 4" Q53EL6 10 110871795-110900006 "Predicted intracellular proteins" Apoptosis RNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 505.4" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 786.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 295.6;U-266/70: 320.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001032, HPA027214, CAB037024" Enhanced Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB037024: AB_1841089, HPA001032: AB_1079586, HPA027214: AB_1855107" "unprognostic (4.22e-3)" "unprognostic (1.23e-1)" "unprognostic (5.39e-2)" "unprognostic (1.00e-2)" "unprognostic (2.49e-1)" "unprognostic (1.78e-1)" "unprognostic (6.37e-2)" "unprognostic (3.79e-2)" "unprognostic (1.64e-2)" "unprognostic (1.64e-2)" "unprognostic (1.41e-1)" "unprognostic (9.40e-2)" "unprognostic (1.56e-2)" "unprognostic (1.62e-1)" "unprognostic (1.69e-1)" "unprognostic (2.07e-2)" "unprognostic (4.25e-1)" 45.7 30.7 15.0 53.2 15.7 74.0 146.6 18.1 16.9 49.3 24.7 157.6 90.7 67.0 36.2 151.3 57.7 43.4 22.4 13.7 17.2 26.2 36.2 32.8 60.7 15.7 18.5 133.6 505.4 283.9 40.3 97.0 15.4 55.3 130.4 50.4 255.0 60.4 11.8 104.2 100.2 51.3 15.5 67.6 102.3 29.9 16.6 73.9 154.5 18.7 95.4 42.2 61.8 17.3 26.5 25.4 40.6 43.7 61.6 110.7 23.8 29.9 89.7 14.7 25.7 16.0 65.0 252.3 81.7 43.5 11.4 118.8 26.1 79.4 32.4 219.7 50.6 127.5 146.9 27.9 26.9 65.2 135.8 88.0 247.4 15.7 84.0 67.6 28.2 40.1 35.3 119.6 37.6 69.7 24.2 76.4 10.6 19.0 46.3 10.4 71.6 138.7 24.8 36.8 17.8 73.6 58.7 31.6 109.1 44.6 295.6 121.3 71.8 22.6 16.8 17.1 11.0 320.1 163.8 143.6 22.2 87.4 24.5 186.1 19.5 52.4 54.0 27.0 96.0 54.1 49.7 59.8 23.0 39.5 43.0 53.2 38.3 84.7 29.6 38.5 29.0 40.4 15.0 15.7 18.1 16.9 13.7 17.2 15.7 18.5 15.4 15.5 16.6 17.3 85.3 19.2 50.0 16.3 132.0 133.1 88.1 104.6 113.3 61.8 148.1 113.9 16.8 42.9 90.3 25.8 31.3 229.5 246.1 348.0 35.2 70.8 20.2 66.7 132.5 79.1 33.6 94.2 26.2 101.4 78.4 72.1 82.0 59.4 132.9 111.7 97.1 23.6 56.5 21.9 44.4 150.6 81.4 84.1 49.7 11.0 145.1 66.1 291.7 46.9 57.4 40.9 75.2 36.7 70.6 45.0 244.3 222.7 134.7 51.3 292.1 28.1 47.8 206.1 39.5 69.4 48.6 63.3 72.2 200.8 165.2 786.0 229.2 176.8 190.3 73.3 PDIA3 "ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC" ENSG00000167004 "Protein disulfide isomerase family A member 3" P30101 15 43746410-43773278 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1048.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002645, HPA003230, CAB011199, CAB015181, CAB075744" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 200000000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030" "unprognostic (9.20e-2)" "unprognostic (1.21e-3)" "unprognostic (1.34e-1)" "prognostic favorable (2.05e-4)" "unprognostic (2.40e-2)" "prognostic unfavorable (8.95e-5)" "unprognostic (1.67e-1)" "unprognostic (8.60e-2)" "unprognostic (2.65e-1)" "unprognostic (2.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.82e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (6.63e-2)" 17.0 16.6 7.5 16.5 8.0 27.1 15.6 9.2 7.6 24.7 13.9 20.6 23.6 16.4 44.7 18.9 15.4 13.5 17.3 7.7 9.8 15.3 34.5 16.8 18.7 9.3 8.2 16.5 36.0 22.6 16.2 23.8 9.1 25.2 22.5 8.4 21.6 19.1 7.6 17.3 21.4 17.0 9.0 12.5 20.4 10.8 9.3 9.6 56.0 4.1 12.3 15.6 15.2 9.8 29.4 11.9 24.6 55.1 48.9 51.9 70.8 58.6 62.1 46.0 56.7 33.6 32.1 33.8 37.4 72.9 30.8 47.8 31.8 61.5 39.7 24.3 44.7 47.2 17.6 30.9 80.1 26.0 33.8 33.6 49.8 35.0 58.5 54.0 81.3 11.1 27.7 17.4 45.5 11.1 9.1 30.4 24.4 48.5 44.0 17.9 36.7 26.2 39.3 26.0 22.9 25.4 48.7 49.0 19.4 25.0 33.1 28.1 50.9 37.7 18.9 29.7 29.1 7.1 8.6 33.9 48.1 41.2 28.8 11.6 8.8 13.3 12.1 9.2 12.8 5.4 6.8 9.5 8.3 6.1 6.0 7.1 2.4 12.7 9.9 17.6 5.8 15.8 7.5 8.0 9.2 7.6 7.7 9.8 9.3 8.2 9.1 9.0 9.3 9.8 224.9 192.3 183.9 31.6 177.8 192.2 313.7 665.2 114.4 56.5 137.9 95.5 58.3 124.4 427.7 167.3 41.7 655.2 319.6 228.7 70.5 401.2 24.3 178.8 300.3 223.7 186.1 95.3 29.2 390.4 807.8 350.7 261.0 328.5 261.6 255.1 233.1 342.2 426.0 70.7 38.3 523.1 231.9 157.3 292.2 26.7 253.5 246.5 243.7 36.5 258.0 128.3 279.1 29.7 38.8 279.9 196.8 276.8 341.1 286.5 234.3 129.1 245.6 61.9 124.9 138.4 389.7 186.4 147.6 138.9 148.5 1048.8 237.8 390.8 335.4 291.7 PDIA4 "ERP70, ERP72" ENSG00000155660 "Protein disulfide isomerase family A member 4" P13667 7 149003062-149028662 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 386.7;Hepatocytes: 595.4;Plasma cells: 556.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006139, HPA006140, CAB017368" Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 15000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257" "unprognostic (1.98e-1)" "unprognostic (1.62e-2)" "unprognostic (1.77e-1)" "unprognostic (1.87e-2)" "prognostic unfavorable (9.69e-4)" "unprognostic (1.97e-2)" "unprognostic (1.81e-1)" "unprognostic (2.11e-2)" "unprognostic (5.11e-2)" "unprognostic (3.24e-3)" "unprognostic (6.08e-3)" "unprognostic (3.20e-2)" "prognostic unfavorable (5.20e-9)" "unprognostic (1.03e-1)" "unprognostic (1.53e-1)" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" 50.3 30.0 22.8 91.5 27.5 35.7 38.2 31.1 24.1 92.8 33.6 84.8 74.1 58.6 163.5 38.9 81.6 53.5 40.4 22.1 31.2 49.5 241.7 48.5 59.0 35.3 29.3 47.3 112.6 26.4 44.6 92.0 34.2 69.3 85.5 8.4 56.1 47.4 9.3 30.0 66.3 71.9 29.6 63.6 95.6 30.8 33.8 46.7 234.1 10.1 72.4 65.6 33.3 49.8 251.3 236.0 249.8 703.3 223.2 158.2 358.2 343.5 230.5 194.8 314.5 196.6 661.5 179.4 748.2 287.0 532.2 160.1 170.6 329.1 168.9 129.0 99.0 86.6 62.7 436.6 298.4 198.5 233.9 156.4 145.1 213.6 169.8 251.7 401.0 90.6 143.6 476.1 173.4 276.4 190.9 226.0 371.1 510.9 134.0 123.6 192.5 440.5 228.2 194.9 79.1 207.6 313.0 223.7 124.1 295.7 127.4 151.9 220.6 152.1 84.5 372.0 247.5 357.5 173.7 125.5 354.2 231.1 528.9 74.4 80.5 51.0 130.4 85.6 135.4 99.1 83.7 100.8 77.6 58.2 77.4 82.7 11.0 91.9 91.4 251.8 68.7 160.6 22.8 27.5 31.1 24.1 22.1 31.2 35.3 29.3 34.2 29.6 33.8 49.8 43.3 28.9 36.2 6.8 87.9 34.7 88.0 142.5 29.0 4.2 50.8 31.5 31.0 95.8 92.4 42.3 4.2 177.8 86.9 135.4 15.6 129.0 3.1 91.1 93.1 57.0 61.6 41.2 3.2 91.0 386.7 102.8 119.8 107.1 57.8 72.0 81.4 595.4 147.9 0.0 5.7 282.9 61.1 84.7 49.6 5.5 59.0 55.3 87.2 9.4 51.8 15.6 68.0 4.5 11.9 94.5 88.6 42.9 556.7 108.1 71.3 66.3 114.8 6.7 32.9 35.2 66.0 47.6 86.1 29.2 28.6 230.4 46.7 52.4 155.6 72.4 PDIA6 "ERp5, P5, TXNDC7" ENSG00000143870 "Protein disulfide isomerase family A member 6" Q15084 2 10783391-10837977 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Isomerase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 1202.1;Plasma cells: 883.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034347, HPA034652, HPA034653" Enhanced Supported "Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 15000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum, Cytosol" "CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982" "unprognostic (8.16e-2)" "prognostic unfavorable (1.80e-4)" "unprognostic (1.03e-1)" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.20e-4)" "prognostic unfavorable (3.63e-5)" "unprognostic (3.17e-2)" "unprognostic (1.02e-2)" "unprognostic (5.25e-3)" "unprognostic (6.03e-3)" "unprognostic (1.68e-1)" "prognostic unfavorable (2.51e-6)" "unprognostic (6.59e-2)" "unprognostic (2.34e-1)" "unprognostic (1.38e-2)" "unprognostic (3.69e-3)" 118.3 112.3 54.5 155.8 64.6 140.8 124.9 57.1 66.7 178.8 71.2 156.0 122.4 131.6 418.5 98.2 133.5 96.7 113.4 55.9 60.8 130.3 260.5 103.8 118.1 61.1 55.4 99.8 252.1 149.7 74.0 171.3 60.7 127.4 171.6 48.0 184.1 135.5 59.3 64.3 121.5 155.5 60.9 107.4 155.4 55.1 62.6 86.6 363.3 59.4 153.7 130.9 75.7 66.4 287.0 304.6 425.7 672.6 535.6 459.4 753.4 677.8 625.9 348.3 465.1 435.1 548.5 460.9 464.7 668.9 674.1 228.0 324.1 568.3 371.1 363.2 253.4 374.2 228.4 713.2 577.5 387.9 268.9 334.2 428.4 338.1 603.3 642.1 798.0 171.8 328.0 963.6 348.7 338.8 150.5 400.8 356.6 923.4 236.4 355.7 433.0 846.4 498.3 339.9 272.0 543.2 267.6 387.0 396.2 547.8 136.8 648.5 395.0 324.4 409.8 296.3 399.1 900.0 596.6 297.1 438.5 479.6 464.8 276.1 200.0 95.5 198.4 210.9 219.0 197.6 154.2 187.6 215.0 161.0 74.3 125.1 35.0 241.6 161.4 268.9 174.4 319.2 54.5 64.6 57.1 66.7 55.9 60.8 61.1 55.4 60.7 60.9 62.6 66.4 217.1 57.7 124.2 17.6 193.9 103.0 294.2 552.8 61.5 69.1 121.1 91.7 35.9 148.7 264.6 196.8 29.2 456.3 164.6 125.8 43.0 338.6 8.2 146.5 382.9 176.2 157.7 89.2 47.4 240.6 1202.1 228.2 138.1 255.0 131.3 210.6 211.3 355.6 413.1 42.1 30.5 276.3 170.9 155.7 149.8 16.2 121.2 145.9 199.3 15.0 132.1 106.5 142.2 32.6 25.3 175.4 131.2 135.1 883.2 385.4 99.9 149.6 145.8 60.1 85.5 96.9 225.3 98.5 117.9 95.4 102.6 554.1 125.7 254.3 248.3 265.3 PEX7 "PTS2R, RD" ENSG00000112357 "Peroxisomal biogenesis factor 7" O00628 6 136822564-136913934 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049202 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Vesicles" "HPA049202: AB_2680674" "unprognostic (1.36e-2)" "unprognostic (2.07e-2)" "prognostic favorable (1.61e-4)" "unprognostic (4.01e-3)" "unprognostic (2.50e-2)" "unprognostic (6.38e-2)" "unprognostic (1.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.87e-2)" "unprognostic (1.23e-1)" "unprognostic (2.49e-1)" "unprognostic (6.88e-2)" "prognostic favorable (1.85e-10)" "unprognostic (3.57e-1)" "unprognostic (1.44e-1)" "unprognostic (2.52e-2)" "unprognostic (2.65e-1)" 5.2 14.8 4.6 2.0 4.8 3.8 11.9 6.0 5.2 6.8 5.1 7.9 5.3 4.2 17.2 7.3 8.7 4.5 11.7 4.2 4.2 15.6 9.1 4.9 3.2 4.3 4.4 5.0 26.9 17.1 6.0 4.1 4.5 10.4 8.4 6.9 10.6 6.4 10.7 11.2 4.7 3.3 4.4 3.3 15.6 10.0 4.7 3.7 11.0 9.8 3.3 5.4 6.7 5.5 4.4 4.3 4.4 6.2 6.6 9.8 2.4 6.1 8.9 7.5 7.4 4.9 6.0 1.5 11.3 8.3 8.5 5.3 3.3 13.8 9.8 5.7 7.5 6.4 4.3 0.9 13.9 8.1 5.3 9.6 13.1 5.4 7.9 8.7 5.4 12.0 13.0 5.2 10.6 13.4 3.5 7.9 5.0 13.9 8.3 4.8 3.4 5.7 17.4 6.4 8.3 10.6 6.5 9.0 8.4 4.9 5.8 7.7 2.5 4.8 1.7 7.3 5.3 6.9 5.1 0.0 4.2 6.4 4.9 2.9 1.3 2.2 0.7 1.0 0.7 1.5 1.3 1.6 2.3 1.0 2.4 1.5 0.9 1.6 1.9 1.8 2.3 0.9 4.6 4.8 6.0 5.2 4.2 4.2 4.3 4.4 4.5 4.4 4.7 5.5 4.9 3.2 9.4 10.7 6.3 12.1 14.9 16.5 9.1 9.1 19.5 13.8 18.7 11.5 14.7 11.0 8.4 19.6 2.3 11.6 60.7 16.5 12.5 18.7 6.4 5.6 10.3 15.8 12.4 22.7 21.0 6.8 10.2 11.1 14.0 7.9 6.1 7.0 12.4 0.0 14.7 21.8 30.5 5.7 6.2 10.2 9.0 6.4 14.2 5.6 11.9 20.8 4.1 17.6 19.9 16.7 13.2 9.8 3.7 16.0 15.0 38.3 16.1 9.9 6.6 5.7 8.2 30.6 16.7 15.4 18.2 17.1 6.6 24.3 17.2 17.4 PGAP6 "M83, TMEM6, TMEM8, TMEM8A" ENSG00000129925 "Post-glycosylphosphatidylinositol attachment to proteins 6" Q9HCN3 16 370788-387113 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 36.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 129.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051281, HPA064673" Approved Supported "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "Cytokinetic bridge" "HPA051281: AB_2681418, HPA064673: AB_2685317" "unprognostic (5.84e-2)" "unprognostic (6.13e-2)" "unprognostic (3.85e-2)" "unprognostic (3.21e-2)" "unprognostic (5.77e-2)" "unprognostic (3.19e-2)" "unprognostic (1.13e-3)" "unprognostic (1.56e-2)" "unprognostic (8.89e-2)" "unprognostic (7.73e-2)" "unprognostic (3.43e-1)" "unprognostic (1.38e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.20e-3)" "unprognostic (3.19e-2)" "unprognostic (4.93e-2)" "unprognostic (2.48e-1)" 23.5 25.5 13.5 18.0 15.1 30.0 20.1 11.8 17.7 17.7 14.5 39.6 31.4 19.2 24.8 31.9 17.7 16.4 37.7 12.8 11.0 59.4 57.6 36.2 17.0 14.6 12.6 12.2 102.8 19.3 28.8 34.8 13.5 30.3 10.3 5.6 40.8 12.5 36.1 11.3 38.5 8.8 11.9 36.0 53.9 63.3 16.0 11.7 28.0 10.1 7.9 23.4 14.3 14.6 12.7 32.8 18.4 33.9 24.7 22.1 36.7 35.5 36.6 17.7 25.3 129.2 57.9 13.4 47.1 34.5 27.3 17.8 8.4 39.2 4.9 38.5 31.1 22.1 23.1 74.8 56.9 16.9 40.4 25.7 11.6 27.4 7.9 18.0 41.4 14.8 36.2 20.1 22.6 78.2 23.9 33.2 29.2 20.1 12.9 51.0 21.0 31.2 28.8 32.0 21.9 25.2 19.8 19.7 106.3 9.6 35.7 33.4 61.1 50.2 53.6 35.2 19.2 40.3 21.6 27.0 25.5 17.8 32.5 7.1 7.6 10.1 10.7 8.6 8.3 2.5 8.1 8.3 3.9 2.6 10.7 8.0 36.0 1.5 6.1 4.2 6.6 5.7 13.5 15.1 11.8 17.7 12.8 11.0 14.6 12.6 13.5 11.9 16.0 14.6 11.7 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 0.0 0.0 63.7 8.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 7.4 2.9 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 100.2 1.4 0.0 0.0 0.0 PGM3 "AGM1, DKFZP434B187, PAGM" ENSG00000013375 "Phosphoglucomutase 3" O95394 6 83161150-83193936 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004998, HPA029759, HPA029760" Enhanced Approved Nucleoplasm,Cytosol NA NA 220000 "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Cytosol" "CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109" "prognostic unfavorable (8.78e-4)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.45e-2)" "unprognostic (3.03e-2)" "unprognostic (1.51e-2)" "unprognostic (4.04e-2)" "unprognostic (1.09e-3)" "unprognostic (6.72e-3)" "unprognostic (3.11e-1)" "prognostic favorable (9.96e-4)" "unprognostic (4.00e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.39e-7)" "unprognostic (2.21e-1)" "unprognostic (7.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.22e-3)" 23.6 21.0 12.0 18.1 12.9 9.3 18.0 20.2 15.2 24.4 19.6 18.0 15.8 17.1 34.5 12.3 13.4 24.6 14.3 9.7 10.5 13.6 38.3 16.8 11.2 10.9 10.2 22.7 46.1 13.3 28.2 47.5 13.1 51.0 23.4 26.8 35.8 20.3 6.7 10.9 18.2 18.5 6.6 11.5 24.9 32.3 11.1 8.2 25.6 8.6 15.2 19.0 12.3 15.9 35.1 23.4 41.8 51.0 68.9 72.9 48.9 118.1 82.9 55.2 83.3 60.1 16.1 18.3 24.7 112.3 53.0 20.1 38.4 49.5 104.6 14.6 37.8 22.7 41.9 105.0 77.6 22.6 11.2 46.2 40.1 96.6 120.0 55.5 64.6 12.1 74.9 19.6 61.0 39.1 3.7 14.7 18.8 31.8 31.6 16.2 92.5 11.3 42.0 36.0 16.9 26.3 34.8 28.5 20.9 61.8 27.0 25.5 94.2 38.3 21.2 74.9 60.5 36.5 16.1 13.0 29.7 17.7 58.4 10.8 4.1 2.7 2.6 3.5 3.9 4.6 2.8 3.4 3.6 2.5 4.5 4.7 1.8 3.5 4.5 4.2 2.1 2.3 12.0 12.9 20.2 15.2 9.7 10.5 10.9 10.2 13.1 6.6 11.1 15.9 14.3 28.9 27.7 14.4 13.0 15.8 29.2 28.5 5.7 16.4 19.9 15.0 6.8 15.7 36.1 11.0 10.4 32.4 12.7 15.9 7.9 31.7 67.7 17.0 35.1 13.8 16.1 6.9 25.1 49.6 71.1 46.1 23.9 36.4 5.1 25.4 14.3 32.6 17.6 8.4 29.4 35.5 18.3 6.0 8.7 20.9 33.5 8.6 10.6 15.9 10.1 25.9 2.1 41.2 36.8 37.9 19.7 18.4 44.1 56.5 16.1 23.2 22.2 21.1 6.6 22.1 26.6 75.5 34.2 11.6 15.6 64.4 10.1 12.2 17.6 25.6 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 6.4 4.8 2.3 5.8 2.6 9.1 9.0 2.8 2.6 5.5 3.1 7.0 7.5 6.4 11.0 5.7 7.8 6.3 2.8 2.5 3.3 10.3 9.4 6.3 8.2 2.8 2.7 4.7 5.7 10.6 3.9 4.8 2.6 7.7 7.8 7.9 4.3 6.8 1.5 6.1 5.8 5.6 2.7 6.1 7.6 6.5 2.7 6.3 13.3 1.8 8.6 7.5 3.7 3.1 10.5 12.2 5.8 4.1 6.6 13.2 7.8 9.0 19.9 10.4 17.8 5.1 10.3 10.9 10.4 12.9 15.6 18.3 3.3 9.5 8.6 10.4 6.4 10.9 13.6 6.7 11.9 30.8 8.7 12.5 11.4 7.9 10.7 13.8 13.6 9.2 12.2 6.9 15.0 9.1 3.4 12.8 3.1 7.9 4.8 4.9 5.6 24.1 18.4 12.4 2.5 6.2 8.1 12.2 17.3 5.4 11.7 22.2 9.5 13.6 4.3 3.7 18.6 8.1 15.9 8.6 12.4 34.5 10.2 13.6 7.7 3.3 6.2 9.7 7.0 6.0 6.1 6.9 7.0 3.9 4.8 5.5 14.5 5.3 11.4 5.4 6.5 5.5 2.3 2.6 2.8 2.6 2.5 3.3 2.8 2.7 2.6 2.7 2.7 3.1 3.5 9.6 9.5 17.6 27.5 4.6 9.5 14.9 4.6 3.3 5.6 4.2 3.4 1.5 14.9 0.0 12.5 12.4 11.2 4.8 1.9 7.4 26.8 4.3 3.2 4.7 6.6 8.2 18.3 10.9 12.0 6.0 6.1 6.4 8.2 4.6 6.8 4.4 8.6 1.7 17.7 4.1 4.1 7.5 6.7 5.1 1.5 8.8 3.6 12.2 8.4 2.7 11.3 17.1 14.6 6.9 4.0 1.5 3.8 3.4 6.4 9.7 7.9 9.4 6.6 4.8 4.2 5.9 3.8 5.7 4.0 6.6 12.5 4.2 4.0 7.4 PIGP "DCRC, DSCR5, DSRC" ENSG00000185808 "Phosphatidylinositol glycan anchor biosynthesis class P" P57054 21 37062846-37073170 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 350.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026921 Uncertain Approved Vesicles Yes No "Cluster 30: Non-specific - Translation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Vesicles "HPA026921: AB_1847874" "unprognostic (4.47e-3)" "unprognostic (9.45e-2)" "unprognostic (3.03e-1)" "unprognostic (2.40e-1)" "unprognostic (2.85e-2)" "unprognostic (1.92e-2)" "unprognostic (1.92e-2)" "unprognostic (5.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.22e-2)" "unprognostic (4.21e-3)" "unprognostic (1.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.93e-1)" "unprognostic (5.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.55e-2)" 33.9 41.3 18.7 12.5 20.2 9.1 35.4 22.4 24.7 22.9 24.8 24.2 19.0 18.3 107.2 16.8 25.7 22.5 40.1 18.1 22.8 35.9 54.7 21.6 16.6 22.8 21.6 27.9 41.4 51.9 38.0 20.9 22.6 33.7 27.4 28.6 32.2 26.7 44.0 12.4 15.5 17.1 22.1 14.9 22.8 36.5 20.0 22.0 36.3 42.8 19.7 26.2 13.2 25.4 25.9 11.5 23.7 14.8 41.5 28.6 16.9 21.9 38.7 18.6 21.1 15.4 53.7 37.1 45.7 32.0 81.4 19.4 22.7 25.5 18.5 37.4 36.1 86.2 13.8 21.3 26.3 26.9 16.6 26.5 47.2 33.4 43.0 42.2 35.1 80.5 50.7 61.8 38.5 16.5 32.9 25.5 19.6 76.8 27.9 31.0 12.1 37.0 48.2 13.3 49.2 29.8 61.4 43.0 81.8 33.6 35.2 53.2 18.3 12.9 6.6 14.8 19.3 81.1 96.5 42.0 38.1 30.5 43.4 0.4 13.5 3.7 19.6 20.3 24.8 34.2 25.1 21.6 20.9 28.1 33.3 29.0 1.9 16.8 22.6 30.9 20.6 15.6 18.7 20.2 22.4 24.7 18.1 22.8 22.8 21.6 22.6 22.1 20.0 25.4 37.4 28.9 41.8 9.8 37.0 33.0 58.9 88.9 35.3 21.2 74.1 86.4 82.4 42.9 65.1 44.1 10.4 60.7 29.4 21.6 90.1 61.8 79.3 67.0 35.9 31.3 44.9 25.7 6.9 71.3 52.4 48.9 30.1 49.3 15.9 32.2 35.3 79.8 66.7 16.8 8.7 63.9 65.1 57.6 39.9 75.6 69.0 44.1 37.4 2.8 50.2 37.0 23.7 7.5 18.2 57.7 50.3 35.0 54.3 45.6 52.3 97.1 86.9 33.6 65.7 32.7 44.6 350.8 177.5 44.2 26.3 52.3 31.7 62.6 53.1 63.7 PIK3C2G ENSG00000139144 "Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma" O75747 12 18242961-18648416 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Chemotaxis "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 16.7;stomach 1: 21.7" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 44.9;Breast glandular cells: 30.4;Breast myoepithelial cells: 37.6;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 140.6" "Cancer enhanced" "Detected in some" "stomach cancer: 2.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 1.2;HaCaT: 2.1;hTERT-HME1: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (1.29e-1)" "unprognostic (1.61e-1)" "unprognostic (6.21e-2)" "unprognostic (1.47e-2)" "unprognostic (9.46e-2)" "unprognostic (8.27e-2)" "unprognostic (2.85e-1)" "unprognostic (6.52e-2)" "unprognostic (1.81e-3)" "prognostic unfavorable (3.50e-4)" "unprognostic (6.05e-2)" "unprognostic (1.81e-1)" "unprognostic (2.74e-1)" "unprognostic (1.98e-1)" "unprognostic (2.37e-2)" 0.0 0.6 0.4 0.0 0.1 0.1 9.7 0.3 0.4 0.2 0.1 0.1 0.5 0.1 16.7 2.4 1.2 6.3 0.0 0.1 0.7 4.6 12.0 0.3 0.1 0.1 0.2 0.0 1.4 4.8 0.0 0.0 0.1 0.9 0.2 0.1 3.7 9.4 0.0 9.7 3.3 0.0 0.3 0.1 21.7 0.4 0.4 0.1 0.0 0.1 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.4 0.1 0.7 0.1 0.2 0.1 0.3 0.4 0.3 1.1 0.0 0.0 1.3 0.7 17.5 8.5 0.3 44.9 0.0 30.4 37.6 0.3 27.1 0.8 40.5 0.0 1.2 0.4 0.2 1.9 2.0 9.0 4.5 1.5 1.2 0.0 2.7 2.9 0.0 4.8 0.4 140.6 10.1 0.0 0.0 0.7 27.4 0.2 0.0 1.8 2.3 0.0 0.8 1.1 1.8 0.0 0.5 1.8 7.5 0.0 0.0 0.0 1.5 1.4 0.8 5.1 0.0 1.3 0.8 18.4 1.3 0.1 0.0 0.0 0.1 0.5 2.4 3.0 27.3 21.5 0.8 1.0 0.0 3.0 1.6 PLPP6 "FLJ46512, FLJ90191, PDP1, PPAPDC2" ENSG00000205808 "Phospholipid phosphatase 6" Q8IY26 9 4662294-4665258 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 82.2;Late spermatids: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "HDLM-2: 99.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018096 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 29: Non-specific - Vesicular transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" Cytosol "HPA018096: AB_1855609" "unprognostic (2.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.03e-1)" "unprognostic (4.36e-3)" "unprognostic (1.17e-1)" "unprognostic (4.38e-2)" "unprognostic (6.95e-3)" "unprognostic (1.33e-1)" "unprognostic (5.26e-2)" "unprognostic (9.06e-2)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.99e-4)" "unprognostic (2.56e-1)" "unprognostic (2.28e-2)" "unprognostic (2.87e-2)" "unprognostic (5.88e-2)" 3.6 6.6 3.8 6.2 4.0 1.5 7.3 7.0 5.0 5.0 8.7 9.3 10.5 4.0 12.7 7.4 3.3 4.6 2.8 4.3 3.3 5.4 18.9 3.4 8.2 3.4 3.6 4.0 17.2 7.7 4.7 7.1 3.6 16.4 9.9 5.1 7.7 4.8 1.9 8.2 11.4 3.4 3.3 6.0 11.3 5.9 3.3 6.1 7.1 1.5 8.4 5.2 5.1 3.5 8.2 8.3 8.8 10.9 6.9 7.7 8.8 5.5 7.1 4.4 5.0 2.2 5.3 7.9 2.2 5.5 10.9 10.0 6.2 7.8 4.6 99.2 5.9 15.7 8.7 11.3 6.3 5.7 11.4 8.5 6.2 3.4 7.5 5.8 6.6 8.8 2.7 8.1 5.6 8.8 5.4 15.0 8.1 8.2 2.9 5.3 0.0 6.1 7.6 9.3 22.0 11.1 6.5 5.8 3.5 10.8 8.2 12.7 7.8 3.9 3.3 5.3 3.6 1.7 6.4 2.0 6.1 4.1 3.7 6.8 4.1 3.5 3.1 3.7 3.6 2.6 5.6 4.8 4.2 3.3 9.6 6.9 1.8 4.2 4.4 3.2 8.6 4.1 3.8 4.0 7.0 5.0 4.3 3.3 3.4 3.6 3.6 3.3 3.3 3.5 2.8 6.4 2.7 0.0 2.6 0.0 2.5 0.0 2.8 7.5 4.2 2.7 0.0 5.7 1.3 1.8 2.1 18.6 2.9 9.7 1.9 11.0 82.2 2.1 3.4 3.0 10.9 2.1 0.0 13.9 2.9 2.3 7.1 5.3 0.0 4.1 4.2 15.3 6.5 3.3 0.0 7.3 0.0 4.7 0.0 46.3 2.8 1.7 0.0 0.0 3.0 4.6 3.1 0.0 0.0 10.8 6.5 4.9 1.5 7.5 13.4 2.8 0.0 4.9 0.0 1.7 1.8 0.5 1.1 4.6 0.0 10.4 3.4 3.5 5.1 3.1 PMM2 "CDG1, CDG1a, CDGS, PMI, PMI1" ENSG00000140650 "Phosphomannomutase 2" O15305 16 8788823-8849325 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 8 "basophil: 210.5" "Lineage enriched" "Detected in all" 13 "granulocytes: 210.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040852, HPA063649" Approved Approved Nucleoplasm,Cytosol NA NA 21000 "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Cytosol "HPA040852: AB_10794069, HPA063649: AB_2685074" "unprognostic (8.62e-3)" "unprognostic (8.00e-3)" "prognostic favorable (1.04e-4)" "unprognostic (3.58e-2)" "unprognostic (1.79e-1)" "unprognostic (1.98e-2)" "unprognostic (6.09e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (2.09e-1)" "unprognostic (5.14e-3)" "unprognostic (2.62e-1)" "prognostic unfavorable (8.97e-6)" "unprognostic (1.22e-1)" "unprognostic (2.50e-2)" "unprognostic (6.89e-2)" "unprognostic (5.02e-2)" 18.5 18.3 3.3 15.1 4.6 6.4 16.7 3.3 4.2 13.7 8.4 26.0 25.0 10.6 11.9 29.0 10.7 10.6 13.2 3.8 3.5 16.7 51.8 13.8 13.7 3.6 3.7 7.5 36.5 10.2 12.1 15.5 3.5 14.2 26.0 1.5 22.6 7.4 9.7 16.2 21.3 12.5 3.5 14.0 19.6 4.5 3.9 9.6 11.3 5.9 14.2 21.7 15.7 3.6 26.1 56.5 12.3 32.7 21.8 33.7 27.4 39.8 47.3 38.8 41.6 42.5 31.5 41.0 16.3 69.4 20.2 35.1 25.3 48.5 39.2 30.7 29.0 13.6 33.0 73.8 40.4 36.9 31.6 50.4 33.7 41.1 37.9 18.1 40.1 24.5 18.9 39.6 26.0 68.3 37.9 33.9 52.8 60.0 35.8 47.2 27.4 82.8 43.5 45.0 23.5 43.7 32.7 71.4 23.9 19.5 46.4 31.7 47.7 27.8 31.5 76.6 39.5 48.2 43.3 51.5 23.4 45.5 38.0 210.5 16.5 3.2 7.9 13.0 11.7 9.5 7.0 10.2 12.1 7.8 7.7 7.5 26.5 6.2 8.4 10.9 5.7 10.9 3.3 4.6 3.3 4.2 3.8 3.5 3.6 3.7 3.5 3.5 3.9 3.6 16.5 16.0 24.1 12.7 18.4 3.8 11.6 7.7 14.8 4.7 10.6 9.5 3.1 4.3 28.8 0.0 14.6 8.9 11.9 11.2 9.8 16.3 0.9 15.9 32.0 11.7 7.7 9.0 29.3 28.5 11.9 16.6 23.9 38.5 22.8 12.9 2.5 12.8 5.5 1.7 26.1 21.2 2.0 4.7 1.7 0.9 6.2 10.4 1.8 21.5 9.6 2.5 9.2 22.6 21.6 23.3 9.7 2.2 49.5 12.6 12.3 17.4 16.8 9.0 0.0 13.5 9.8 2.0 4.2 27.0 4.1 10.7 16.0 13.1 12.6 14.9 PPIB "B, CYP-S1, CYPB, OI9, PPIase, SCYLP" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155740-64163134 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Isomerase, Rotamase" "Disease variant, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" No No 33000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 375.5 377.5 230.7 449.5 240.3 571.9 361.9 247.9 259.2 611.5 257.2 401.0 365.0 383.9 899.0 298.8 401.5 379.2 262.0 229.7 256.9 312.3 737.4 351.1 344.5 258.1 241.4 386.2 644.2 345.4 416.8 515.2 255.1 375.7 411.3 72.3 513.1 488.6 62.2 205.5 334.3 482.4 247.0 360.5 375.0 110.0 254.9 315.6 672.8 91.1 346.4 510.9 295.6 262.6 675.6 847.9 736.7 1666.7 2577.0 1492.3 641.9 1570.3 2108.3 1248.7 1472.3 1242.6 1223.1 653.6 1227.4 2513.0 1235.3 1067.7 1384.6 1080.4 641.1 406.2 491.0 914.5 915.3 1643.7 2682.9 915.0 778.1 1374.2 1149.4 725.9 1751.3 1516.7 1539.2 301.1 645.9 2174.7 966.0 1102.6 280.6 1404.9 625.1 1879.0 529.5 520.6 784.1 3347.9 1312.7 1062.6 410.5 647.7 726.0 1224.5 1194.2 1086.0 727.6 2767.0 927.6 1213.7 975.8 679.2 1079.4 1152.5 1269.5 693.4 1129.0 1478.0 1238.2 716.7 712.5 491.7 929.6 547.3 931.8 827.8 645.0 762.4 930.9 541.4 411.3 558.0 347.5 668.1 369.3 2643.5 569.3 1512.3 230.7 240.3 247.9 259.2 229.7 256.9 258.1 241.4 255.1 247.0 254.9 262.6 389.3 125.0 209.0 16.6 375.3 160.2 426.2 614.6 234.5 34.5 264.3 303.8 0.8 270.2 328.7 272.2 31.3 625.9 560.0 271.0 90.1 665.1 19.0 295.8 910.1 285.0 297.0 172.6 10.2 566.4 1473.7 627.8 441.4 494.2 181.2 540.4 322.7 473.2 630.1 45.4 15.8 603.9 205.4 216.9 333.4 29.5 456.3 316.6 281.1 19.7 299.1 149.1 368.7 35.2 37.0 435.1 338.9 393.1 2242.6 569.3 338.6 287.4 168.2 43.7 230.1 204.3 445.6 38.4 76.6 337.0 144.8 1118.9 352.3 674.0 477.2 422.3 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303799-177306949 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 89.1 106.5 63.6 89.2 63.5 90.7 78.9 64.0 70.5 69.9 64.6 121.8 109.3 69.3 37.5 146.9 61.4 37.1 70.6 63.8 65.2 140.1 182.3 76.0 79.0 64.3 65.8 64.0 262.3 48.1 67.4 58.6 66.2 74.9 85.8 24.4 95.7 29.8 32.2 108.3 121.8 47.2 66.6 117.4 103.2 43.0 69.0 30.9 65.9 13.7 87.4 81.5 78.7 62.8 221.4 193.8 116.1 307.1 103.3 111.0 400.6 154.5 106.6 214.6 206.1 443.2 232.5 181.4 181.6 143.7 236.0 118.1 212.5 400.0 145.8 826.0 291.9 154.9 195.7 291.1 109.6 243.6 215.1 102.7 142.2 170.6 144.9 89.1 269.0 129.2 181.4 247.7 210.5 556.7 160.5 362.5 242.1 251.6 319.7 52.7 232.1 324.5 140.0 171.5 186.3 237.7 136.8 266.9 267.5 144.4 172.5 293.4 148.5 189.3 174.9 157.4 365.5 155.4 270.9 267.4 162.2 328.0 200.4 411.1 764.6 1198.6 248.0 988.0 238.5 276.0 202.6 245.4 775.1 238.7 175.7 195.7 553.7 327.4 989.8 281.9 246.6 614.3 63.6 63.5 64.0 70.5 63.8 65.2 64.3 65.8 66.2 66.6 69.0 62.8 174.4 22.4 23.4 8.1 198.3 348.3 297.0 331.8 152.5 60.8 339.3 415.4 0.4 168.7 159.0 104.8 22.9 756.9 231.4 572.7 303.3 382.9 6.6 114.1 111.2 171.5 157.5 128.9 9.7 563.3 552.7 134.0 110.6 129.9 108.1 145.9 120.3 247.5 352.2 60.6 10.0 311.3 219.7 271.0 337.1 24.6 114.0 293.8 256.1 7.5 410.1 117.1 325.4 4.0 12.2 752.9 664.0 109.1 393.9 612.4 853.7 567.0 60.5 68.9 46.0 126.6 177.3 81.5 218.6 246.7 420.8 883.6 169.7 221.0 433.6 480.2 PRPSAP1 PAP39 ENSG00000161542 "Phosphoribosyl pyrophosphate synthetase associated protein 1" Q14558 17 76309478-76384521 "Predicted intracellular proteins" "Nucleotide biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062396 Approved Cytosol NA NA 24000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 5: Muller glia cells - Visual perception" Cytosol "HPA062396: AB_2684750" "unprognostic (1.12e-1)" "unprognostic (3.37e-2)" "prognostic favorable (1.39e-5)" "unprognostic (3.31e-2)" "unprognostic (3.11e-2)" "unprognostic (8.45e-3)" "unprognostic (1.09e-1)" "unprognostic (7.19e-2)" "unprognostic (2.66e-2)" "unprognostic (2.37e-2)" "unprognostic (6.51e-2)" "unprognostic (4.10e-3)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (8.20e-2)" "unprognostic (5.37e-2)" 26.4 26.2 24.2 13.7 24.3 22.2 27.6 25.1 29.3 29.1 24.0 22.7 16.6 22.6 28.0 34.9 21.8 18.9 21.5 22.4 26.6 26.4 69.9 27.5 18.5 29.2 26.2 21.1 25.1 43.9 21.9 20.9 29.9 20.7 25.5 29.4 65.8 19.0 16.6 24.7 19.4 23.1 23.5 15.9 23.2 35.6 27.3 18.1 49.3 13.9 26.0 19.0 27.2 26.3 38.6 46.4 54.7 26.9 36.3 32.2 21.5 33.9 46.9 55.7 45.9 33.8 32.4 44.2 18.2 50.9 44.4 22.3 49.8 40.5 55.3 17.4 44.7 32.6 36.0 149.2 45.0 28.0 24.8 35.3 32.4 40.1 34.9 54.1 110.4 44.2 40.1 40.3 37.2 41.2 50.9 25.8 13.8 65.7 41.2 41.0 70.9 32.8 42.7 43.8 31.1 51.0 37.4 37.4 77.8 60.9 61.3 32.5 42.3 63.9 46.8 38.2 42.4 27.0 18.2 31.2 28.4 25.5 27.7 18.3 16.4 22.1 16.4 14.5 17.3 17.2 16.4 15.7 14.2 13.6 13.8 13.4 5.3 19.1 14.1 14.1 24.6 13.4 24.2 24.3 25.1 29.3 22.4 26.6 29.2 26.2 29.9 23.5 27.3 26.3 37.7 0.0 14.2 25.5 18.2 13.0 33.3 42.6 16.5 33.9 34.7 40.6 17.3 38.6 25.0 14.7 35.5 49.4 23.5 21.2 49.0 60.6 32.3 26.2 25.8 43.6 15.7 13.2 29.5 29.6 65.0 21.3 23.9 40.9 20.3 70.3 20.7 38.5 29.9 60.6 52.9 26.0 44.7 18.9 21.3 27.5 29.2 21.9 32.0 15.9 64.2 129.4 18.6 24.6 27.7 38.8 18.7 46.3 16.8 25.1 26.3 27.9 32.5 40.4 59.2 25.7 30.8 118.0 97.7 24.8 14.6 30.6 24.2 19.2 34.3 22.3 PRR15L "ATAD4, MGC11242" ENSG00000167183 "Proline rich 15 like" Q9BU68 17 47951967-47957883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 178.4;pancreas: 103.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "OE19: 205.6" "Not detected" "Not detected" HPA022918 Approved Approved Cytosol No NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" Cytosol "HPA022918: AB_2060743" "unprognostic (9.91e-2)" "unprognostic (4.77e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-3)" "unprognostic (1.83e-1)" "unprognostic (2.31e-2)" "unprognostic (2.48e-1)" "unprognostic (5.22e-2)" "unprognostic (2.86e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" "unprognostic (8.32e-2)" "prognostic favorable (6.29e-13)" "prognostic favorable (1.69e-5)" "unprognostic (1.36e-1)" "unprognostic (8.26e-2)" "unprognostic (3.34e-2)" 2.2 0.1 0.0 7.9 0.1 0.1 38.8 0.2 0.2 13.4 9.5 111.2 178.4 1.4 18.3 12.9 26.5 22.0 0.4 0.8 0.0 28.0 1.9 21.7 0.2 0.1 0.0 0.3 103.9 0.8 8.5 0.0 0.0 17.7 124.3 0.0 51.8 15.8 0.1 10.0 128.5 3.3 0.0 0.0 84.4 2.5 0.0 0.4 67.8 0.0 2.0 2.7 6.7 0.1 3.8 0.6 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 8.6 5.8 0.2 0.3 0.0 0.0 20.5 0.0 0.1 0.0 0.4 0.7 0.2 0.0 2.6 0.0 0.4 0.4 0.0 4.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 19.7 0.4 0.4 0.0 205.6 0.7 0.3 0.0 1.4 1.1 2.6 11.7 0.5 0.0 35.7 0.0 0.0 24.1 0.0 0.1 0.3 0.0 0.7 0.1 0.1 0.1 0.3 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 22.4 19.8 0.3 0.1 0.0 2.6 2.4 0.0 0.0 16.7 8.9 0.1 80.1 19.8 16.5 0.0 0.0 0.1 203.0 170.2 35.6 5.5 9.8 0.3 0.2 31.6 0.0 0.1 36.1 0.0 0.4 55.5 3.9 0.0 0.0 0.0 0.8 0.1 0.0 0.1 127.8 24.4 0.0 0.0 9.0 1.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 11.6 226.4 0.4 0.2 15.6 263.7 30.0 19.2 0.0 0.0 0.0 1.0 11.1 0.1 7.3 0.0 0.0 0.6 0.0 100.9 9.9 PRRC1 FLJ32875 ENSG00000164244 "Proline rich coiled-coil 1" Q96M27 5 127517640-127555085 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039212 Supported Approved Vesicles NA NA 170000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA039212: AB_10794634" "prognostic unfavorable (9.35e-5)" "unprognostic (9.01e-2)" "unprognostic (5.26e-3)" "unprognostic (6.36e-2)" "unprognostic (2.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" "unprognostic (6.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-3)" "unprognostic (5.53e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (2.19e-1)" 17.3 18.7 7.0 18.1 8.1 21.2 24.2 8.3 9.3 27.5 12.4 23.5 25.3 22.0 23.4 20.2 15.9 17.1 14.5 6.5 7.6 21.4 26.7 18.2 17.9 7.9 8.0 22.3 32.1 30.4 19.1 27.0 8.6 21.1 27.2 11.5 25.6 18.0 12.9 19.2 24.4 22.4 7.8 16.2 24.0 13.2 7.5 19.5 26.6 10.2 20.9 19.4 17.3 9.9 30.3 30.5 44.5 34.0 58.8 75.1 51.9 52.3 58.4 45.7 71.8 52.4 34.6 33.6 53.2 83.6 34.4 26.9 35.0 64.8 70.6 46.7 24.4 29.3 29.1 45.6 33.8 27.4 36.9 51.5 46.7 48.5 56.3 41.9 49.4 31.6 25.5 40.2 53.4 34.2 53.9 29.4 25.5 43.5 39.5 20.5 58.9 43.8 36.4 37.6 32.4 25.0 41.0 44.1 40.1 40.6 47.2 35.3 58.9 41.8 31.2 49.3 37.2 33.5 26.8 43.6 49.3 42.9 42.0 18.7 11.7 9.4 18.6 13.5 22.6 15.4 15.1 16.0 15.6 11.2 16.5 14.9 3.6 12.7 13.5 10.4 13.0 12.3 7.0 8.1 8.3 9.3 6.5 7.6 7.9 8.0 8.6 7.8 7.5 9.9 16.3 35.3 25.5 9.8 17.8 14.7 14.0 37.2 22.8 12.8 24.1 15.0 12.5 27.1 40.6 27.6 14.6 25.5 14.0 38.2 13.7 30.5 3.8 16.2 33.6 22.8 15.6 12.4 13.5 30.9 42.2 30.8 28.5 23.2 15.8 28.7 26.0 37.3 21.7 8.4 13.5 50.2 28.5 20.2 7.6 4.8 34.5 14.7 19.6 15.9 17.8 10.7 22.6 18.6 25.1 31.8 25.1 30.1 38.0 26.6 34.1 28.0 30.0 12.7 13.1 18.8 26.4 13.6 21.2 18.2 18.6 31.6 19.3 21.7 33.6 26.0 PRRT1B "DSPD2, IFITMD8" ENSG00000283526 "Proline rich transmembrane protein 1B" A0A1B0GWB2 9 131545514-131558620 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 6.4;lung: 4.1;pancreas: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 14.7;BEWO: 9.6;MCF7: 3.9;T-47d: 7.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" 0.0 0.0 0.2 0.0 0.9 0.0 0.2 0.6 0.5 0.5 0.1 1.4 0.4 0.2 0.0 0.0 6.4 0.7 0.0 0.1 0.1 0.5 2.9 4.1 0.0 0.2 0.2 0.0 4.2 1.5 0.1 0.0 0.1 2.5 1.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.7 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.5 0.1 0.1 0.2 0.2 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRSS8 ENSG00000052344 "Serine protease 8" Q16651 16 31131433-31135727 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "salivary gland: 245.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 403.5;Extravillous trophoblasts: 648.4;Paneth cells: 262.6;Proximal enterocytes: 358.0;Syncytiotrophoblasts: 450.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 2.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 243.7;CACO-2: 165.9;CAPAN-2: 111.9;hTCEpi: 157.8;OE19: 79.6;SK-BR-3: 186.3" "Region enriched" "Detected in single" 8 "hippocampal formation: 1.4" "Low region specificity" "Detected in single" HPA030436 Uncertain "Secreted - unknown location" NA NA 4400000 "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA030436: AB_10602291" "unprognostic (1.88e-1)" "unprognostic (2.97e-1)" "unprognostic (9.34e-2)" "unprognostic (4.08e-1)" "unprognostic (6.83e-2)" "unprognostic (5.07e-3)" "unprognostic (5.78e-2)" "unprognostic (2.05e-1)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "unprognostic (8.74e-3)" "unprognostic (1.58e-1)" "prognostic favorable (2.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.31e-1)" "unprognostic (3.63e-3)" 0.8 0.4 0.3 15.0 0.4 0.2 25.5 2.1 0.6 31.1 6.7 129.4 155.7 9.9 113.0 136.2 15.4 47.7 0.4 0.6 0.2 90.6 28.0 54.1 0.3 0.3 0.2 0.6 139.4 56.0 8.4 51.0 0.4 49.0 72.6 0.0 245.4 8.5 0.3 115.3 151.8 3.5 0.1 0.2 156.2 0.5 0.2 15.4 50.8 0.0 11.8 4.9 56.0 0.2 63.4 0.2 0.1 0.2 0.0 0.0 243.7 0.0 0.0 0.0 0.0 165.9 111.9 0.0 1.3 0.0 0.0 73.5 0.1 69.7 0.0 0.3 0.4 0.1 0.3 6.5 0.0 0.0 0.3 0.0 157.8 0.0 2.4 0.0 0.0 0.1 1.9 0.1 0.0 68.1 0.6 1.4 20.5 79.6 0.1 0.5 0.0 1.2 7.5 13.1 0.9 0.7 0.0 186.3 0.1 18.8 42.8 0.8 0.0 0.1 1.9 0.6 0.4 0.3 0.5 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 2.1 0.6 0.6 0.2 0.3 0.2 0.4 0.1 0.2 0.2 0.4 99.3 60.1 0.0 1.0 37.9 82.7 108.9 76.2 0.5 74.4 39.2 0.3 62.9 107.4 42.3 0.0 168.8 0.8 403.5 29.4 192.4 0.0 35.2 11.4 2.6 9.6 2.7 0.1 224.4 648.4 3.5 82.6 109.5 7.0 0.0 0.0 18.2 22.8 0.0 0.2 132.1 87.5 0.3 2.7 0.0 0.6 1.9 3.6 0.0 4.2 0.3 0.0 0.0 0.0 240.7 262.6 0.0 0.1 66.0 358.0 28.6 21.2 0.1 0.0 0.1 4.7 0.0 0.2 81.9 54.0 450.7 2.2 0.0 150.8 91.0 PSKH1 ENSG00000159792 "Protein serine kinase H1" P11801 16 67893254-67929676 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053927, HPA062763" Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles, Cytosol" "HPA053927: AB_2682312, HPA062763: " "unprognostic (2.57e-2)" "unprognostic (8.91e-3)" "unprognostic (1.88e-1)" "unprognostic (5.79e-2)" "unprognostic (3.26e-1)" "unprognostic (3.89e-1)" "unprognostic (1.64e-1)" "unprognostic (1.29e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-2)" "unprognostic (9.85e-3)" "unprognostic (8.32e-2)" "prognostic favorable (4.28e-10)" "unprognostic (1.46e-1)" "unprognostic (1.99e-1)" "unprognostic (4.15e-2)" "unprognostic (3.90e-3)" 14.3 18.6 12.8 9.6 14.5 5.2 14.0 12.2 13.5 13.5 19.5 18.2 13.7 19.3 10.0 16.9 18.7 10.1 17.6 11.2 11.5 20.5 16.5 12.7 10.6 15.0 14.9 19.4 26.3 32.9 13.2 7.6 13.4 15.1 10.8 4.0 18.1 12.7 15.3 13.8 15.7 15.7 13.2 12.8 21.4 21.8 13.6 12.0 15.0 13.5 8.5 16.5 9.5 14.9 13.0 22.7 25.2 28.1 38.4 19.3 16.3 15.2 23.0 15.8 14.0 17.2 18.2 12.2 22.7 25.7 12.7 19.2 14.7 15.6 5.3 4.8 16.4 13.9 16.8 22.0 26.3 13.4 8.0 35.7 26.7 18.8 19.6 21.3 23.3 22.5 21.6 5.1 16.7 28.7 18.3 8.6 24.2 14.0 13.9 27.7 9.7 25.3 18.6 16.0 21.8 26.0 47.3 12.8 15.8 9.9 23.5 23.9 20.8 17.7 6.2 15.0 7.7 15.3 8.7 26.2 21.4 8.8 19.9 0.0 2.0 1.9 2.0 2.2 1.4 1.5 1.5 2.0 2.1 1.2 1.2 1.7 1.0 2.1 1.5 1.5 0.8 1.7 12.8 14.5 12.2 13.5 11.2 11.5 15.0 14.9 13.4 13.2 13.6 14.9 5.5 0.0 3.6 4.6 2.9 1.1 3.1 5.2 2.2 11.1 5.3 4.6 2.3 7.2 3.8 5.5 6.2 6.2 3.0 11.5 11.7 6.0 14.4 5.8 6.5 5.2 10.8 3.0 4.6 7.4 4.8 5.4 5.1 4.8 6.3 13.0 5.3 10.3 4.8 6.7 6.1 6.2 10.2 6.3 1.6 22.1 4.7 2.9 5.4 3.7 4.8 11.0 3.1 5.5 9.2 7.6 4.5 7.9 3.0 3.6 10.0 8.1 4.9 6.9 13.1 6.3 6.1 6.7 6.1 5.4 1.6 5.9 3.8 10.7 7.4 2.2 QTRT1 TGT ENSG00000213339 "Queuine tRNA-ribosyltransferase catalytic subunit 1" Q9BXR0 19 10701430-10713437 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 260.9;Paneth cells: 224.5;Proximal enterocytes: 261.8;Undifferentiated cells: 280.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042695, HPA048651, HPA049440" Approved Approved Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA042695: AB_2678119, HPA048651: AB_2680477, HPA049440: AB_2680767" "unprognostic (6.19e-2)" "prognostic favorable (7.63e-5)" "unprognostic (2.90e-2)" "unprognostic (3.05e-1)" "unprognostic (4.90e-2)" "prognostic favorable (4.90e-4)" "unprognostic (2.52e-1)" "unprognostic (8.76e-3)" "unprognostic (3.88e-1)" "unprognostic (4.81e-3)" "prognostic favorable (2.13e-4)" "unprognostic (1.14e-2)" "prognostic unfavorable (1.13e-6)" "unprognostic (2.04e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" 17.2 27.1 11.2 11.8 11.4 13.4 18.1 10.0 15.9 18.4 9.4 20.0 10.3 22.7 2.7 20.5 20.9 7.3 21.4 11.8 11.3 18.3 30.2 12.5 12.2 10.8 10.6 24.4 51.9 9.6 17.6 7.7 11.1 16.9 5.0 6.1 22.3 9.2 20.5 18.3 15.2 6.1 10.8 14.8 20.7 6.4 11.3 7.0 20.7 10.2 5.1 17.6 16.4 11.6 41.5 32.3 14.6 44.1 15.3 18.2 19.7 20.8 18.3 23.8 22.9 25.6 15.0 47.1 50.1 11.5 14.4 26.6 13.8 24.9 7.7 28.1 20.8 30.4 13.3 55.7 26.6 46.4 25.7 27.8 20.3 15.3 22.1 10.5 24.2 25.5 35.0 50.2 11.8 64.2 39.7 56.5 40.3 25.3 53.5 41.2 19.9 72.2 18.8 26.1 48.4 21.6 33.0 33.4 27.8 6.2 21.5 19.0 19.5 35.0 20.3 58.2 49.7 56.7 48.3 23.3 19.3 55.0 44.4 1.9 16.6 0.4 29.6 31.4 37.4 42.0 31.7 26.4 34.0 40.8 33.3 27.5 1.3 43.9 16.6 39.8 37.9 21.3 11.2 11.4 10.0 15.9 11.8 11.3 10.8 10.6 11.1 10.8 11.3 11.6 23.2 0.0 4.5 47.3 36.6 63.7 63.5 59.0 65.4 36.7 42.6 48.6 7.3 30.0 24.5 57.0 50.1 47.8 27.3 157.0 64.6 25.8 1.6 19.8 28.8 24.7 192.5 30.3 32.8 27.6 39.7 33.5 23.9 18.8 16.5 43.7 18.2 33.9 28.8 90.9 31.4 260.9 42.7 15.8 30.9 2.6 50.7 12.8 49.8 8.4 10.5 22.0 7.2 21.6 30.0 13.9 224.5 37.6 53.2 43.6 261.8 80.3 22.6 57.9 19.7 40.7 31.1 12.9 24.6 36.9 41.9 28.0 27.0 67.4 280.7 37.2 RAB1A "RAB1, YPT1" ENSG00000138069 "RAB1A, member RAS oncogene family" P62820 2 65070696-65130331 "Plasma proteins, Predicted intracellular proteins" "Autophagy, ER-Golgi transport, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 911.4;Syncytiotrophoblasts: 703.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005331, HPA056141" Approved Supported "Endoplasmic reticulum,Cytosol" NA NA 3000000 "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum, Cytosol" "CAB005331: AB_632290, HPA056141: AB_2683051" "unprognostic (4.78e-3)" "unprognostic (1.36e-3)" "unprognostic (4.68e-3)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (4.19e-4)" "unprognostic (1.55e-3)" "unprognostic (2.61e-1)" "unprognostic (1.06e-1)" "unprognostic (1.35e-1)" "unprognostic (4.30e-3)" "unprognostic (2.79e-1)" "unprognostic (4.81e-2)" "unprognostic (2.77e-1)" "unprognostic (7.80e-2)" "unprognostic (1.83e-2)" "unprognostic (8.63e-2)" 142.5 142.9 84.2 90.6 86.8 232.4 119.1 85.2 105.2 122.6 103.7 128.1 133.6 109.7 179.9 155.0 103.5 100.1 127.3 89.0 91.9 194.1 194.9 141.9 70.5 86.0 88.4 94.4 133.9 113.1 117.2 148.3 91.3 96.6 126.8 89.4 131.8 93.8 100.3 101.3 127.6 117.4 87.7 88.6 135.9 86.2 90.4 59.0 129.6 80.4 91.1 119.2 120.5 91.3 211.3 150.7 186.2 110.5 445.5 261.2 287.5 299.9 212.3 134.8 142.8 270.1 137.5 85.8 167.9 311.2 221.4 130.6 173.7 277.6 214.1 96.3 100.6 108.3 119.2 403.8 281.9 115.4 93.7 232.0 279.6 176.9 158.5 213.3 271.2 67.7 157.2 96.6 271.1 190.6 67.3 138.6 148.6 329.1 134.6 68.3 177.3 137.3 266.1 236.0 133.9 118.5 139.2 230.6 282.4 218.7 143.3 106.9 253.4 172.5 214.6 183.2 171.8 147.6 95.3 205.6 230.2 173.9 170.4 96.8 84.6 78.7 41.9 86.3 46.7 42.6 45.4 45.8 76.0 29.3 43.2 45.1 102.1 56.4 80.9 63.1 59.0 54.3 84.2 86.8 85.2 105.2 89.0 91.9 86.0 88.4 91.3 87.7 90.4 91.3 84.8 83.3 89.1 51.2 64.6 297.2 322.0 384.6 74.0 48.5 117.1 71.8 120.7 87.2 218.6 125.0 6.2 309.5 70.3 182.0 328.7 216.5 350.3 102.8 110.9 133.0 133.4 45.0 50.7 219.5 366.9 171.6 105.0 162.8 50.7 67.1 102.4 183.7 375.3 58.9 53.4 200.4 262.4 122.9 221.6 911.4 145.7 153.3 197.5 83.4 110.5 144.7 41.2 50.3 71.7 234.0 148.2 212.9 107.1 323.2 168.4 441.7 162.4 45.6 72.3 103.8 210.9 193.8 106.7 90.7 293.8 703.8 70.5 76.5 168.4 477.9 RARRES2 "HP10433, TIG2" ENSG00000106538 "Retinoic acid receptor responder 2" Q99969 7 150338317-150341662 "Plasma proteins, Predicted secreted proteins" "Chemotaxis, Differentiation, Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 2400.4;liver: 1994.6;pancreas: 1482.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 659.2;Hepatocytes: 2819.0;Muller glia cells: 785.1" "Cancer enhanced" "Detected in all" "liver cancer: 420.2" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "plasmacytoid DC: 5.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 5.4" "Group enriched" "Detected in many" 6 "AF22: 132.9;Hep G2: 213.8;HHSteC: 172.9;NTERA-2: 411.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 75000000 460000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (2.31e-1)" "unprognostic (4.81e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (2.72e-2)" "unprognostic (2.82e-3)" "unprognostic (1.50e-1)" "unprognostic (1.17e-1)" "unprognostic (5.29e-2)" "unprognostic (2.50e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (6.83e-4)" "unprognostic (2.94e-2)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.17e-2)" 525.6 2400.4 61.0 87.4 62.1 0.4 295.6 56.2 70.2 522.4 321.7 386.8 53.2 359.2 55.9 78.7 408.5 116.5 212.7 62.0 63.3 271.9 1994.6 466.8 109.8 65.9 73.6 626.3 1482.0 627.1 104.1 59.0 63.3 262.5 78.3 33.9 56.2 114.7 18.3 60.4 185.9 103.0 64.8 149.5 180.0 26.9 64.5 9.8 85.0 34.6 63.1 265.3 380.7 66.7 0.0 0.1 132.9 0.3 0.0 0.0 2.1 11.9 25.2 4.2 17.2 1.2 8.2 1.1 15.0 2.9 1.3 0.5 0.0 0.0 0.0 2.4 0.5 0.6 23.6 213.8 172.9 2.2 0.4 36.4 0.0 0.0 0.0 2.8 0.0 0.4 0.4 0.4 4.2 0.9 2.1 2.4 411.9 1.2 0.0 0.1 17.1 0.4 2.8 1.1 0.6 1.2 2.3 0.1 0.4 1.9 0.6 0.0 0.0 0.4 1.8 0.8 0.6 1.4 0.9 1.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 61.0 62.1 56.2 70.2 62.0 63.3 65.9 73.6 63.3 64.8 64.5 66.7 47.1 67.3 32.0 9.4 7.0 35.1 80.7 16.8 15.9 7.0 26.2 39.0 75.0 381.8 45.0 82.8 2.1 10.1 1.9 172.6 103.7 19.8 3.7 39.9 128.7 27.1 97.4 32.0 0.4 659.2 4.3 469.6 8.2 16.4 12.0 207.5 84.6 2819.0 11.6 10.1 0.4 233.9 541.2 53.8 42.4 19.3 454.2 8.9 44.4 7.5 1.0 785.1 0.0 9.0 0.3 209.1 107.4 194.9 1.2 82.0 1.2 269.1 29.8 25.4 13.1 302.5 181.1 4.9 5.2 4.4 28.8 14.6 12.3 307.5 418.7 31.9 RDH11 "ARSDR1, MDT1, SDR7C1" ENSG00000072042 "Retinol dehydrogenase 11" Q8TC12 14 67676800-67695793 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Cataract, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 582.0" "Cell type enhanced" "Detected in all" "Hepatocytes: 241.8;Muller glia cells: 299.7;Prostatic glandular cells: 285.7" "Cancer enriched" "Detected in all" 13 "prostate cancer: 286.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB046011 Enhanced "Intracellular and membrane" NA NA 340000 "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 5: Muller glia cells - Visual perception" "CAB046011: AB_11129613" "unprognostic (1.38e-1)" "unprognostic (6.86e-3)" "unprognostic (1.77e-1)" "prognostic favorable (2.62e-4)" "unprognostic (6.06e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (9.29e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.58e-2)" "unprognostic (2.91e-2)" "unprognostic (1.27e-1)" "prognostic favorable (1.30e-7)" "unprognostic (1.65e-1)" "unprognostic (1.68e-1)" "unprognostic (2.18e-1)" "unprognostic (4.74e-2)" 23.6 59.5 39.3 24.5 43.2 13.9 28.7 50.2 54.4 32.6 35.9 29.2 34.1 33.2 86.0 34.6 23.5 42.7 17.6 40.4 47.2 106.0 153.1 34.9 20.4 49.2 47.7 28.9 42.6 79.8 23.4 21.9 49.3 582.0 31.4 73.9 44.2 34.4 8.3 31.4 23.9 43.6 49.8 22.2 31.9 28.4 46.1 30.7 61.7 13.5 26.2 34.3 30.3 58.4 183.7 81.9 71.3 82.0 111.5 100.4 59.3 68.0 134.2 83.7 150.9 68.6 216.7 31.7 51.2 64.6 104.8 142.5 104.0 150.8 113.7 63.0 42.6 65.1 40.7 69.0 106.9 24.3 46.0 94.4 98.0 109.3 92.0 63.9 97.4 87.0 52.1 101.1 77.2 97.5 72.2 38.8 40.4 49.7 92.8 53.6 87.4 45.8 194.1 93.0 73.8 62.0 71.2 89.7 99.1 58.2 100.7 38.3 74.2 89.5 101.1 38.9 49.5 47.5 40.0 40.7 115.8 66.0 74.3 282.4 71.1 104.0 62.3 57.7 68.2 39.0 67.7 61.5 51.3 45.5 67.3 64.8 11.0 56.3 65.4 59.1 65.1 115.8 39.3 43.2 50.2 54.4 40.4 47.2 49.2 47.7 49.3 49.8 46.1 58.4 27.0 25.6 66.0 38.2 29.2 11.5 40.0 77.9 16.5 53.5 45.4 24.5 20.4 68.6 59.9 47.8 50.1 24.9 32.4 26.8 7.9 92.5 2.5 21.9 50.9 39.3 43.3 29.2 33.3 84.0 38.1 37.5 19.9 38.2 29.2 46.3 47.8 241.8 35.8 79.1 37.6 28.9 89.5 42.4 15.4 6.1 43.2 35.9 35.6 17.8 39.8 299.7 37.0 70.4 43.4 61.2 36.7 56.1 27.3 285.7 17.5 56.0 23.9 97.0 46.0 29.7 38.7 25.8 24.0 20.2 19.2 63.5 29.8 66.7 25.3 46.1 RFT1 CDG1N ENSG00000163933 "RFT1 homolog" Q96AA3 3 53088483-53130453 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 39.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060327, HPA069022" Approved Approved Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA060327: AB_2684253, HPA069022: AB_2732126" "unprognostic (5.74e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (5.16e-3)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.09e-1)" "unprognostic (1.22e-1)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.48e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (3.54e-2)" 11.8 12.5 5.7 14.5 6.2 8.3 12.5 5.5 6.6 9.0 4.9 11.8 10.3 9.1 13.0 12.1 12.4 10.5 9.0 6.1 5.3 8.7 14.0 9.2 16.7 5.6 5.2 12.5 22.3 15.6 6.2 13.8 5.9 9.3 13.2 4.3 18.0 10.4 5.1 9.9 10.5 11.2 5.5 9.9 10.4 13.5 5.4 14.2 14.6 6.7 15.8 12.6 8.8 8.0 39.1 36.3 24.3 39.0 27.9 29.5 50.6 34.8 32.3 59.2 53.7 35.9 74.6 51.0 21.3 33.5 55.6 40.7 55.4 56.8 51.9 48.4 24.5 50.6 24.8 36.0 48.8 46.7 28.4 31.4 46.8 79.6 57.1 26.2 37.9 52.7 27.1 45.2 39.4 39.6 44.2 27.3 48.8 67.5 47.3 18.1 23.5 77.5 32.8 26.1 13.8 18.7 43.0 30.9 31.2 26.2 23.3 65.5 25.5 54.3 35.2 37.7 69.1 28.6 37.1 38.4 38.9 58.8 58.3 50.2 40.2 18.4 22.2 40.5 22.5 21.2 20.6 22.9 42.9 35.5 23.7 23.7 13.4 23.1 29.4 48.9 20.1 25.7 5.7 6.2 5.5 6.6 6.1 5.3 5.6 5.2 5.9 5.5 5.4 8.0 6.0 3.2 3.7 8.8 8.7 5.0 10.8 18.3 5.2 4.6 7.6 5.5 7.4 11.5 12.6 9.2 4.2 39.4 6.0 5.1 1.9 17.4 1.9 5.6 9.5 8.1 2.4 17.7 9.4 21.1 33.1 9.2 4.1 5.7 2.5 17.8 10.4 10.7 22.0 5.0 8.9 6.4 10.2 9.9 5.0 2.3 8.7 9.8 7.2 9.4 11.7 5.8 3.1 7.5 11.3 12.2 8.8 6.0 19.3 9.1 5.7 5.6 8.3 6.4 0.0 7.0 8.7 10.1 8.9 8.0 4.3 24.2 7.7 22.0 11.7 8.1 RNF181 HSPC238 ENSG00000168894 "Ring finger protein 181" Q9P0P0 2 85595725-85597708 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 851.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046112, HPA062121" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA046112: AB_2679542, HPA062121: AB_2684687" "unprognostic (3.79e-1)" "unprognostic (8.31e-2)" "unprognostic (5.08e-2)" "unprognostic (2.05e-1)" "unprognostic (3.24e-1)" "unprognostic (1.67e-2)" "unprognostic (3.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.22e-2)" "unprognostic (5.85e-2)" "unprognostic (1.11e-1)" "unprognostic (4.96e-2)" "prognostic unfavorable (1.06e-6)" "unprognostic (3.24e-1)" "unprognostic (2.04e-1)" "prognostic favorable (4.59e-5)" "unprognostic (1.49e-2)" 110.4 135.0 87.6 60.2 92.4 76.7 109.8 93.3 101.9 105.5 85.7 101.3 75.1 85.2 85.0 118.0 87.4 50.2 141.1 88.9 93.2 174.3 169.5 114.0 69.1 92.8 91.5 90.7 168.5 80.1 61.9 82.9 91.8 111.0 69.0 36.0 110.0 73.0 172.1 102.6 91.4 65.2 93.7 101.2 121.8 107.6 94.5 59.5 93.8 105.1 89.6 107.5 98.7 97.7 125.7 120.4 96.3 103.8 94.3 113.4 152.2 104.7 195.4 207.7 199.7 185.2 132.2 118.8 196.8 150.6 206.2 117.5 83.5 164.8 223.8 133.9 104.0 91.6 58.5 224.7 168.0 104.8 122.1 122.0 208.5 144.5 237.1 166.2 175.4 110.8 109.1 119.7 282.7 193.0 97.8 235.6 68.6 164.9 180.2 105.1 202.5 171.7 200.8 109.3 57.2 74.5 88.4 126.2 171.7 114.8 125.4 136.2 160.1 104.9 77.2 218.4 149.6 170.3 143.5 143.1 166.4 144.9 95.5 213.9 418.5 339.7 176.1 326.0 164.6 251.9 181.4 169.2 321.4 214.8 156.4 153.0 356.6 195.5 254.9 360.4 262.0 439.0 87.6 92.4 93.3 101.9 88.9 93.2 92.8 91.5 91.8 93.7 94.5 97.7 89.3 147.4 104.8 7.8 89.3 116.9 102.5 343.7 75.7 27.1 92.8 95.4 122.8 124.4 200.2 150.8 2.1 237.1 104.2 148.1 416.7 236.5 365.7 70.5 63.6 102.8 70.2 85.2 2.2 290.4 260.2 113.7 55.0 93.2 102.7 59.0 99.6 214.4 263.4 18.5 2.2 138.4 185.1 154.0 182.3 250.6 88.3 147.6 170.7 3.7 188.7 80.4 94.7 2.0 6.9 304.0 201.5 78.2 113.8 123.8 271.9 851.7 141.7 29.1 59.2 66.3 108.8 121.3 33.1 97.9 118.6 221.2 86.7 62.6 102.0 115.6 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022260 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 130000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 21.9 27.6 15.9 20.1 20.0 19.4 25.4 18.3 21.7 19.7 11.9 24.0 21.8 22.6 22.3 29.1 21.0 19.8 14.5 16.2 14.7 30.0 27.4 17.9 25.1 11.0 13.3 25.4 15.1 21.0 17.2 29.4 12.8 22.5 31.8 17.8 20.6 31.1 11.0 19.7 19.8 29.3 14.6 19.2 24.2 15.3 16.5 22.9 29.5 27.4 29.4 27.4 17.4 23.1 62.4 81.0 47.5 47.9 71.3 68.0 85.4 80.2 60.9 67.9 93.1 118.7 92.1 39.9 50.6 58.8 104.1 59.9 69.7 81.9 103.3 49.7 47.8 78.2 112.3 112.3 98.8 80.7 56.1 51.7 75.4 83.2 107.5 60.2 94.8 39.1 79.7 57.2 55.5 106.7 43.5 63.5 68.2 121.4 59.8 52.4 58.4 56.7 78.6 94.7 56.6 31.4 70.2 63.7 52.3 85.6 54.4 85.2 80.0 96.7 66.9 47.5 73.8 31.9 49.5 88.6 69.6 76.0 62.5 20.2 40.2 19.1 23.1 51.0 19.8 20.2 17.7 21.7 69.5 21.6 23.4 21.0 3.7 77.2 34.8 25.4 26.7 28.8 15.9 20.0 18.3 21.7 16.2 14.7 11.0 13.3 12.8 14.6 16.5 23.1 14.9 6.4 7.5 14.4 13.1 16.6 15.2 21.6 13.1 13.2 13.2 10.3 6.2 10.0 20.1 18.4 20.9 35.4 18.1 14.0 31.3 24.5 10.7 13.5 17.4 14.3 10.2 17.2 61.9 17.5 42.8 17.4 14.3 11.2 6.3 18.1 18.2 17.5 37.0 10.1 44.7 14.6 14.2 19.4 45.8 11.8 11.1 17.2 14.2 15.0 19.7 8.9 26.8 27.2 39.2 19.4 11.6 14.7 12.2 19.9 14.2 48.6 15.9 12.7 6.6 11.1 16.1 14.7 17.4 20.1 20.3 25.6 10.5 24.8 21.3 14.8 RPH3AL Noc2 ENSG00000181031 "Rabphilin 3A like (without C2 domains)" Q9UNE2 17 212389-386254 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 52.5;pituitary gland: 44.4" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 35.2;Hepatocytes: 43.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 22.1;PC-3: 7.2;TIME: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024311 Approved NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 15: Hepatocytes - Hemostasis" "HPA024311: AB_1856429" "unprognostic (4.55e-2)" "unprognostic (1.66e-1)" "unprognostic (3.85e-2)" "unprognostic (9.43e-3)" "unprognostic (8.40e-2)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (6.71e-2)" "unprognostic (1.02e-1)" "unprognostic (2.24e-3)" "unprognostic (1.33e-2)" "prognostic favorable (1.03e-8)" "unprognostic (9.10e-2)" "unprognostic (1.63e-2)" "unprognostic (4.14e-1)" "unprognostic (3.59e-3)" 10.0 18.5 1.3 1.0 1.4 0.3 9.5 3.6 1.7 4.8 1.5 6.9 5.2 3.0 4.6 8.1 3.9 2.8 6.2 1.2 2.3 13.5 24.2 9.5 1.2 4.5 2.2 10.8 52.5 1.6 44.4 2.5 4.5 5.5 2.6 2.0 3.4 2.2 8.3 5.0 6.5 1.0 1.4 17.7 9.1 2.8 2.1 1.4 12.0 1.5 1.5 5.3 6.0 1.9 0.3 22.1 0.3 0.1 0.2 0.1 1.8 0.0 0.0 0.0 0.1 3.0 3.8 0.4 3.1 2.2 1.4 0.3 0.8 0.2 0.0 0.9 1.4 0.0 1.8 5.2 0.6 0.2 2.2 0.0 0.1 0.0 0.0 0.7 0.9 2.3 1.5 4.5 1.3 5.4 0.3 0.1 1.2 2.6 7.2 0.4 0.2 4.0 4.0 4.9 0.3 0.7 0.3 0.1 0.3 1.3 2.0 2.1 7.2 0.3 2.9 0.5 0.6 0.7 0.2 0.2 0.3 3.0 0.0 0.3 0.7 1.5 0.8 2.2 0.3 0.6 0.4 0.6 1.1 0.6 0.7 0.4 1.6 0.3 1.8 2.8 0.3 0.3 1.3 1.4 3.6 1.7 1.2 2.3 4.5 2.2 4.5 1.4 2.1 1.9 21.8 22.4 17.0 1.3 2.0 2.4 13.4 9.7 5.2 1.5 8.8 6.5 2.3 17.2 5.2 22.0 0.0 0.2 7.8 13.2 5.9 10.3 3.6 7.7 7.8 15.9 35.2 2.7 4.6 8.7 0.3 3.4 23.4 4.9 7.0 14.3 28.2 43.3 11.6 11.8 6.2 14.2 12.2 7.0 2.9 4.0 5.3 2.9 3.6 12.2 2.0 26.4 3.1 6.0 1.3 7.7 12.9 1.9 0.9 3.9 9.3 5.9 2.1 1.9 6.6 6.1 3.4 3.4 1.8 6.9 3.1 0.4 1.7 7.6 10.8 9.4 RPN1 OST1 ENSG00000163902 "Ribophorin I" P04843 3 128619969-128681075 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 424.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009748, HPA026828, HPA051520" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA 730000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" Cytosol "CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521" "unprognostic (4.83e-2)" "unprognostic (5.92e-2)" "unprognostic (1.10e-1)" "unprognostic (7.67e-2)" "unprognostic (2.36e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (4.80e-4)" "unprognostic (2.71e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" "unprognostic (4.58e-3)" "unprognostic (2.87e-1)" "unprognostic (7.68e-2)" "unprognostic (7.86e-2)" "unprognostic (1.52e-2)" "unprognostic (1.44e-1)" "unprognostic (9.74e-2)" 97.9 88.3 56.7 94.5 65.5 97.1 105.5 69.0 63.3 142.0 96.2 124.0 97.1 92.0 352.4 76.6 124.8 90.5 82.6 56.1 71.4 119.5 226.3 112.7 76.8 72.7 65.8 80.8 118.8 143.8 83.7 139.8 69.4 100.2 134.3 46.9 120.4 113.9 89.2 63.5 94.5 111.6 66.7 85.2 115.0 90.9 68.1 86.0 177.7 77.7 102.4 117.2 64.0 77.9 358.5 190.9 156.2 289.8 412.7 273.1 351.3 300.0 393.2 391.4 452.1 399.4 328.2 221.9 274.8 437.3 363.2 349.7 255.4 268.2 374.7 158.8 160.3 392.7 127.9 332.3 454.3 322.5 198.2 229.5 307.3 258.4 377.5 260.9 308.6 164.2 164.2 289.6 260.4 327.8 179.7 353.0 198.1 476.6 170.2 193.6 209.4 540.6 272.7 212.0 238.6 137.4 246.3 253.6 313.6 199.0 271.0 329.0 203.2 200.9 154.7 297.0 226.9 306.1 259.9 234.4 329.4 235.9 296.9 178.0 171.6 137.6 129.3 147.0 154.7 91.5 104.7 117.7 159.5 60.7 63.8 99.3 233.2 90.3 159.3 192.4 114.2 250.8 56.7 65.5 69.0 63.3 56.1 71.4 72.7 65.8 69.4 66.7 68.1 77.9 82.9 60.9 74.1 13.1 72.4 49.5 83.6 102.8 55.2 13.0 53.7 26.9 42.4 51.5 91.6 112.2 8.4 113.7 59.1 126.0 15.6 111.5 19.1 85.3 73.9 72.4 43.3 63.5 11.7 93.3 199.1 91.7 113.2 126.8 43.7 40.2 96.0 180.0 135.7 20.2 16.3 158.4 73.2 154.1 70.8 29.5 94.1 87.6 58.7 11.2 77.0 30.3 39.1 18.1 21.3 104.0 83.1 64.3 424.1 93.3 109.1 90.7 110.2 13.2 46.0 43.9 53.7 65.9 62.6 67.0 53.4 156.7 65.8 54.0 130.2 78.9 RPN2 "RIBIIR, RPN-II, RPNII, SWP1" ENSG00000118705 "Ribophorin II" P04844 20 37178410-37241619 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008297, CAB019277, HPA025922" Enhanced Supported "Endoplasmic reticulum" NA NA 1300000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458" "unprognostic (9.59e-3)" "unprognostic (5.22e-2)" "unprognostic (1.66e-2)" "unprognostic (1.06e-1)" "unprognostic (1.99e-1)" "unprognostic (1.20e-2)" "prognostic unfavorable (1.38e-4)" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.44e-10)" "unprognostic (2.83e-1)" "unprognostic (6.99e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (2.44e-4)" 112.6 132.5 48.2 131.9 50.4 180.8 146.1 49.9 55.9 161.8 98.0 156.9 125.5 108.7 344.1 106.8 122.9 119.8 107.3 49.5 56.5 145.1 212.1 129.7 109.2 54.0 50.6 94.8 159.6 180.9 79.1 257.9 53.9 164.4 175.2 117.0 158.2 157.5 110.4 91.5 110.9 156.6 53.8 118.1 145.1 144.2 55.4 108.5 232.5 75.1 143.3 165.4 87.9 61.9 328.2 290.6 302.7 401.2 413.1 308.2 586.7 426.7 516.8 544.8 459.2 939.2 564.8 255.3 501.6 572.3 506.4 468.4 318.8 516.4 492.0 121.2 196.5 295.3 308.4 634.1 398.9 468.4 467.0 294.6 505.1 432.3 447.5 519.8 530.4 239.2 458.7 805.1 389.1 300.9 270.6 451.0 240.4 839.3 415.7 242.3 549.1 852.7 371.6 304.3 246.4 261.0 517.9 1231.1 489.4 353.6 606.1 765.6 338.0 600.8 358.2 317.1 371.9 474.7 608.4 259.9 583.4 314.9 493.2 424.2 427.5 285.5 365.5 410.5 417.0 291.0 336.1 363.8 481.2 232.4 298.8 308.7 78.3 398.8 357.6 591.0 338.2 676.5 48.2 50.4 49.9 55.9 49.5 56.5 54.0 50.6 53.9 53.8 55.4 61.9 85.7 118.6 158.0 22.2 107.8 61.8 134.1 264.6 62.0 72.6 90.0 74.2 81.4 133.0 197.7 80.9 45.9 461.6 109.6 113.9 23.5 278.0 37.3 73.2 103.5 98.6 63.0 91.7 18.8 241.1 599.6 127.4 84.1 151.2 105.2 109.3 100.6 206.3 233.2 63.9 18.6 168.5 162.8 150.4 75.3 24.4 105.0 117.0 90.7 20.6 122.2 136.8 65.9 24.1 20.5 160.1 109.5 110.9 392.3 121.3 64.6 82.3 98.5 100.8 85.5 65.3 122.0 335.2 288.9 67.7 57.8 621.0 81.5 213.7 138.7 117.6 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 2535.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favorable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 142.2 242.4 78.6 71.3 80.6 73.2 127.1 81.5 113.1 124.7 102.5 190.8 157.4 108.4 157.9 70.8 117.9 94.8 181.0 78.1 84.2 194.5 266.0 109.4 83.5 82.9 81.7 95.9 247.4 94.0 88.6 69.3 84.5 156.2 178.0 31.8 164.7 106.7 190.1 75.9 161.4 80.7 86.0 103.2 174.7 38.1 81.4 86.3 106.5 97.7 68.2 149.2 94.1 90.0 140.4 383.0 340.4 92.9 486.4 571.3 341.3 432.1 306.0 93.8 225.3 71.1 190.0 130.8 150.9 415.9 166.0 52.9 116.5 212.9 155.7 97.8 157.5 108.3 329.1 512.7 558.7 86.8 287.0 452.1 279.0 211.2 158.4 701.2 535.2 81.2 101.6 127.7 785.1 194.1 112.4 134.9 101.0 178.0 112.6 86.9 163.1 149.5 266.7 278.8 49.2 74.7 157.6 65.8 326.2 677.8 145.4 199.1 571.1 490.6 463.8 106.7 195.3 142.3 132.3 117.5 518.5 235.6 453.8 263.8 132.5 164.6 99.4 145.2 125.2 132.0 149.9 118.1 122.0 105.2 116.9 119.4 44.3 110.9 198.2 121.3 305.2 166.0 78.6 80.6 81.5 113.1 78.1 84.2 82.9 81.7 84.5 86.0 81.4 90.0 210.9 96.1 198.6 9.4 255.9 255.4 262.6 424.8 230.5 33.4 361.3 429.1 349.0 511.9 424.6 410.1 47.9 300.1 144.9 694.7 903.9 802.7 60.9 202.3 185.3 245.8 285.4 184.5 12.6 782.4 1269.2 269.2 327.8 155.5 302.6 250.8 302.0 994.8 542.1 13.5 15.6 742.3 520.8 372.1 358.1 34.4 314.7 270.3 466.0 17.8 1049.6 184.8 221.4 16.1 18.5 1019.3 745.5 297.5 495.5 324.6 1513.1 2535.3 330.9 75.2 263.0 180.5 742.6 144.7 82.1 183.6 247.6 235.2 224.7 214.3 732.5 215.2 RPS4Y1 "MGC119100, MGC5070, RPS4Y, S4" ENSG00000129824 "Ribosomal protein S4 Y-linked 1" P22090 Y 2841602-2932000 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 1273.9" "Cancer enhanced" "Detected in many" "prostate cancer: 187.7" "Region enriched" "Detected in all" 28 "cerebral cortex: 427.8" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 1076.6;HSkMC: 1195.7;U-698: 1701.8" HPA000857 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 32: Non-specific - Translation" "HPA000857: AB_1079849" "unprognostic (7.04e-2)" "unprognostic (2.21e-2)" "unprognostic (1.32e-3)" "unprognostic (3.93e-2)" "unprognostic (6.31e-2)" "unprognostic (7.35e-2)" "unprognostic (1.26e-2)" "unprognostic (1.75e-1)" "unprognostic (8.11e-2)" "unprognostic (5.87e-3)" "unprognostic (1.81e-1)" "unprognostic (1.49e-2)" "unprognostic (4.55e-2)" 262.4 239.9 12.9 80.7 13.5 227.3 234.8 13.1 427.8 0.2 14.7 220.0 79.9 0.4 302.0 177.6 0.3 129.8 178.2 12.6 14.9 252.9 174.1 176.3 59.1 15.1 13.7 0.9 327.4 116.8 115.7 116.3 14.6 297.2 258.4 83.4 178.5 225.3 295.6 242.4 188.4 0.2 14.5 202.7 221.9 102.5 14.1 0.0 172.8 382.7 253.8 215.0 0.6 15.1 2.8 270.9 0.0 0.1 0.2 0.8 383.9 452.8 783.0 697.8 586.5 0.5 0.0 1076.6 1.4 645.0 0.0 0.6 0.0 0.3 849.8 317.4 0.1 683.8 0.1 829.0 953.5 1.4 0.7 1195.7 784.4 0.0 0.0 0.0 0.6 97.3 1.7 0.0 717.3 0.4 615.0 1.9 0.6 0.0 0.9 0.6 342.6 163.5 658.9 507.6 391.3 1.2 1.0 1.0 1.3 252.6 0.7 481.4 579.5 263.3 4.5 0.9 451.8 410.9 1.1 1701.8 0.0 1.1 0.1 42.4 97.3 21.2 112.8 84.1 168.6 156.3 187.2 116.0 159.3 142.4 227.6 213.3 21.8 125.1 56.8 65.4 170.1 252.1 12.9 13.5 13.1 427.8 12.6 14.9 15.1 13.7 14.6 14.5 14.1 15.1 0.0 201.9 459.1 9.8 493.4 849.9 981.5 1273.9 537.3 115.3 0.0 0.0 109.8 343.1 479.2 215.2 41.7 568.8 126.2 24.6 471.6 302.8 13.7 0.0 0.0 354.9 99.5 292.5 10.9 8.3 368.5 281.0 208.5 0.0 354.6 0.0 476.2 51.1 281.6 53.8 9.4 159.2 256.3 426.3 758.3 52.3 809.3 248.7 588.7 11.2 407.2 321.0 472.7 5.0 6.4 213.6 56.1 431.8 202.7 816.8 115.7 893.6 314.5 153.4 276.1 292.4 214.8 103.3 227.3 594.7 989.7 464.4 523.1 0.0 183.8 904.0 RUSF1 "C16orf58, FLJ13868" ENSG00000140688 "RUS family member 1" Q96GQ5 16 31489471-31509309 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 5.8;Cytotrophoblasts: 22.3;Extravillous trophoblasts: 21.0;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024406 Uncertain Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Golgi apparatus, Vesicles" "Nucleoplasm, Cytosol" "HPA024406: AB_1845580" "unprognostic (1.46e-2)" "unprognostic (2.52e-2)" "unprognostic (2.25e-2)" "unprognostic (4.22e-1)" "unprognostic (6.21e-2)" "unprognostic (3.05e-2)" "unprognostic (2.44e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (9.89e-2)" "unprognostic (3.20e-1)" "unprognostic (1.58e-1)" "unprognostic (6.34e-3)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "unprognostic (5.69e-2)" "unprognostic (2.24e-2)" 27.1 31.8 19.6 20.0 18.9 21.5 28.8 12.0 21.3 45.4 14.2 29.6 31.3 43.2 20.7 26.5 38.2 23.0 28.5 19.9 19.7 29.5 57.9 25.0 19.8 17.0 16.0 49.6 56.8 46.2 48.4 25.7 18.5 39.1 19.1 22.4 64.8 34.2 9.4 26.9 30.3 25.6 13.8 22.3 39.5 21.4 17.0 18.0 42.0 9.8 15.6 31.8 31.4 17.0 28.6 37.2 22.7 39.7 51.7 34.3 42.3 33.4 56.6 25.5 30.2 11.3 49.1 24.5 69.4 49.8 32.9 39.0 22.9 31.0 11.8 35.8 23.0 24.8 20.6 28.8 74.8 29.4 28.6 41.7 33.1 33.7 68.5 50.2 24.9 38.4 37.3 40.9 25.3 53.9 13.7 19.8 17.8 41.8 24.1 31.1 34.2 74.8 29.3 17.6 24.8 38.2 25.2 65.3 52.8 21.5 56.6 42.9 22.0 44.3 24.7 28.7 22.1 59.0 37.0 18.8 56.7 44.7 62.5 3.1 5.7 7.6 7.8 8.4 7.2 6.7 8.2 7.8 9.7 6.3 7.9 7.0 0.9 9.4 8.1 8.9 9.4 7.2 19.6 18.9 12.0 21.3 19.9 19.7 17.0 16.0 18.5 13.8 17.0 17.0 5.8 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 22.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 21.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 22.3 0.4 0.0 0.0 0.0 SAV1 "salvador, WW45, WWP4" ENSG00000151748 "Salvador family WW domain containing protein 1" Q9H4B6 14 50632058-50668306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001808 Approved Supported Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 50: Fibroblasts - ECM organization" Cytosol "HPA001808: AB_2666441" "prognostic favorable (2.92e-5)" "unprognostic (5.17e-2)" "unprognostic (1.24e-1)" "unprognostic (1.52e-2)" "unprognostic (4.38e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-3)" "unprognostic (3.00e-2)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-3)" "unprognostic (5.20e-2)" "prognostic favorable (3.83e-6)" "unprognostic (2.32e-1)" "unprognostic (2.05e-1)" "unprognostic (1.28e-2)" "unprognostic (1.90e-3)" 32.2 16.4 14.0 12.8 16.7 7.3 35.3 15.1 16.9 24.5 22.0 17.0 15.3 23.3 18.8 15.8 21.2 26.2 24.2 12.8 15.0 22.9 17.6 20.2 15.7 16.5 15.1 37.7 34.4 27.0 8.5 17.0 16.1 27.6 12.6 17.6 45.5 19.2 23.1 17.8 13.2 17.7 14.7 18.6 18.9 30.6 16.6 10.3 34.2 27.1 14.7 16.7 18.7 19.6 96.3 10.7 17.8 12.4 43.5 39.8 22.4 26.6 87.3 34.1 43.4 16.0 47.8 14.9 63.9 26.4 17.8 42.8 25.7 28.9 62.9 45.6 20.8 16.4 16.4 11.4 21.3 17.9 14.0 24.9 36.5 15.3 33.8 25.8 24.5 15.9 27.5 7.2 42.5 17.9 15.1 11.0 33.1 21.6 17.3 17.2 49.5 6.1 21.5 13.6 22.2 16.8 47.1 27.7 41.3 28.9 20.3 18.0 17.7 16.2 55.5 22.4 16.4 11.3 15.4 9.0 11.1 7.2 22.1 0.6 0.3 0.0 0.9 0.3 0.9 3.3 0.7 0.5 0.3 3.4 0.5 0.7 0.5 0.5 0.4 1.2 1.0 0.4 14.0 16.7 15.1 16.9 12.8 15.0 16.5 15.1 16.1 14.7 16.6 19.6 76.4 35.3 44.0 9.4 35.8 65.9 37.2 19.1 24.5 19.6 76.4 60.6 39.1 15.7 35.1 18.4 25.0 19.9 14.7 11.2 17.6 40.5 92.5 39.6 47.3 76.9 5.4 27.0 10.4 47.6 23.0 59.3 11.7 58.1 2.5 46.4 59.3 14.5 10.5 5.0 10.0 10.1 10.2 13.5 61.5 26.1 66.8 34.1 30.2 12.2 11.6 26.9 2.1 12.5 27.0 66.5 14.6 42.5 7.4 81.4 12.1 16.3 33.3 26.4 6.6 41.8 45.1 41.4 38.8 14.6 59.5 23.1 9.4 17.7 9.6 34.1 SCAMP1 SCAMP37 ENSG00000085365 "Secretory carrier membrane protein 1" O15126 5 78360611-78480739 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044753, CAB079009" Supported Uncertain "Nucleoplasm,Vesicles,Cell Junctions" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" "Cell Junctions" "Nucleoplasm, Vesicles" "CAB079009: , HPA044753: " "unprognostic (8.25e-2)" "unprognostic (3.65e-2)" "unprognostic (1.40e-3)" "unprognostic (5.34e-3)" "unprognostic (2.60e-1)" "unprognostic (2.57e-3)" "unprognostic (5.51e-2)" "unprognostic (3.43e-2)" "unprognostic (1.31e-1)" "unprognostic (8.23e-3)" "unprognostic (2.35e-2)" "unprognostic (2.56e-1)" "prognostic favorable (1.92e-4)" "unprognostic (8.44e-3)" "unprognostic (7.56e-2)" "unprognostic (3.12e-2)" "unprognostic (4.99e-2)" 17.9 22.4 18.4 12.7 20.5 8.5 28.2 24.5 29.1 23.9 23.9 19.6 16.0 25.0 23.2 24.7 29.6 20.2 24.7 20.4 22.4 28.6 17.8 17.8 12.1 18.4 21.5 22.8 25.2 47.1 15.7 23.4 21.4 34.3 22.3 40.2 31.5 29.8 10.6 17.7 15.6 26.6 20.0 13.6 27.9 14.1 23.3 14.6 39.8 16.3 13.4 25.0 11.4 19.0 32.7 23.9 23.4 76.1 35.5 45.5 40.8 30.0 46.1 26.5 56.1 9.3 61.1 48.1 31.4 45.5 65.7 26.2 34.9 57.0 45.9 17.4 32.5 20.5 17.8 20.1 22.7 13.6 16.5 28.6 54.5 27.3 41.2 62.5 41.3 25.0 8.4 33.6 50.9 39.2 25.2 26.7 19.9 14.3 26.0 29.5 38.3 55.3 43.5 38.6 70.9 40.6 27.6 38.5 26.7 24.9 52.5 26.1 36.6 26.3 19.3 30.0 24.2 20.9 29.4 27.6 50.1 50.4 22.6 20.3 11.4 13.2 7.5 12.7 9.3 7.6 8.7 9.2 14.8 6.5 7.1 6.3 6.8 10.3 16.6 4.5 9.1 8.0 18.4 20.5 24.5 29.1 20.4 22.4 18.4 21.5 21.4 20.0 23.3 19.0 59.5 25.6 22.4 45.7 20.3 39.1 31.5 33.6 38.7 72.1 33.4 22.7 36.1 21.5 30.4 40.5 70.9 13.8 21.7 19.1 13.7 24.2 42.2 34.9 30.2 31.4 35.4 12.0 80.0 30.5 24.8 34.3 36.7 34.1 12.0 41.7 27.1 15.7 19.2 32.0 100.1 34.2 20.3 33.7 33.1 15.3 20.2 25.1 30.2 45.0 19.1 47.4 19.6 76.4 60.3 29.8 14.9 28.6 23.9 44.6 14.2 24.7 65.4 68.2 13.1 33.5 25.4 25.6 23.1 30.8 45.3 10.5 21.2 30.8 18.8 33.7 SCFD1 "C14orf163, KIAA0917, RA410, SLY1, STXBP1L2" ENSG00000092108 "Sec1 family domain containing 1" Q8WVM8 14 30622291-30737694 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003579 Approved NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA003579: AB_1079872" "unprognostic (2.33e-1)" "unprognostic (1.04e-1)" "unprognostic (1.07e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (1.08e-2)" "unprognostic (1.24e-2)" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (3.07e-2)" "unprognostic (8.35e-2)" "unprognostic (2.65e-1)" "unprognostic (7.52e-3)" "unprognostic (1.05e-1)" "unprognostic (3.08e-1)" "unprognostic (3.05e-1)" "unprognostic (6.32e-2)" 23.2 29.3 11.8 22.3 12.4 9.9 29.2 12.3 12.6 34.0 13.0 27.6 22.2 21.8 40.8 29.7 21.7 19.6 29.6 11.9 12.4 32.5 35.1 22.5 26.2 11.8 12.1 23.6 46.4 41.8 29.3 27.8 11.8 27.7 29.8 14.9 52.3 24.0 24.6 19.5 23.8 22.9 11.5 19.0 28.0 26.6 11.6 25.6 44.3 29.3 29.1 30.0 20.8 12.0 71.7 26.0 37.8 22.9 64.1 67.0 53.4 57.0 68.4 69.5 83.5 42.2 58.9 36.9 24.2 79.7 38.8 44.5 41.3 46.5 80.0 53.2 22.2 30.7 28.6 149.5 77.9 50.2 32.4 49.1 39.1 48.9 78.1 58.5 45.5 26.5 42.6 68.0 74.7 66.8 30.7 27.8 40.7 83.9 45.1 30.2 42.1 42.2 70.7 45.6 35.9 33.0 58.7 54.4 53.6 42.9 70.5 35.3 48.1 41.9 44.0 43.0 45.3 45.3 40.8 49.4 26.9 36.7 52.9 26.8 17.2 20.2 14.0 23.2 17.8 20.1 16.2 17.3 23.7 14.7 15.2 14.1 3.0 23.1 27.8 16.9 24.4 16.1 11.8 12.4 12.3 12.6 11.9 12.4 11.8 12.1 11.8 11.5 11.6 12.0 33.0 51.3 31.3 67.9 47.7 25.0 55.2 55.1 18.2 35.0 26.9 27.1 35.3 18.6 50.8 25.8 43.8 61.9 51.3 31.8 64.6 49.2 29.3 34.9 51.6 32.3 47.2 24.2 123.0 50.6 61.0 47.9 20.9 34.2 53.7 32.1 24.3 20.6 44.9 30.3 112.8 44.9 36.7 27.7 33.4 16.6 38.5 35.5 37.4 90.9 66.9 31.1 62.8 112.6 106.6 41.2 23.5 40.3 70.9 42.3 28.8 40.9 52.1 39.9 13.1 53.7 49.0 71.8 53.5 20.5 24.4 83.0 41.4 47.8 30.0 43.5 SCLY SCL ENSG00000132330 "Selenocysteine lyase" Q96I15 2 238060924-238099413 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 39.1" "Group enriched" "Detected in many" 13 "Early spermatids: 90.6;Late spermatids: 156.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020190, HPA055760" Uncertain Enhanced "Golgi apparatus" NA NA 300000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA020190: , HPA055760: AB_2682910" "unprognostic (7.39e-3)" "unprognostic (1.43e-1)" "unprognostic (3.29e-2)" "unprognostic (8.65e-5)" "unprognostic (8.96e-2)" "unprognostic (9.85e-3)" "unprognostic (1.14e-3)" "unprognostic (4.24e-2)" "unprognostic (1.59e-2)" "unprognostic (8.38e-2)" "unprognostic (3.98e-3)" "unprognostic (1.03e-2)" "unprognostic (1.02e-3)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "unprognostic (2.50e-3)" "unprognostic (1.98e-1)" 5.1 4.3 7.2 5.3 9.4 5.0 4.9 9.4 9.3 6.8 6.4 7.3 8.5 8.1 5.6 5.9 6.3 3.8 8.1 6.8 8.2 12.9 39.1 4.7 5.7 9.2 8.8 6.3 22.8 6.1 5.0 2.0 9.4 5.9 3.2 4.6 4.4 4.1 6.4 3.5 8.6 3.9 7.3 7.2 5.8 16.8 8.3 5.9 7.2 3.5 4.3 7.8 5.1 10.4 11.1 19.1 11.9 31.1 9.0 6.4 23.2 11.2 5.6 11.3 14.3 11.6 8.0 18.9 3.3 5.9 35.4 16.4 44.1 21.5 10.9 21.2 41.8 21.1 24.0 37.6 16.7 17.6 18.2 7.1 11.6 21.3 22.0 5.1 21.0 26.1 38.0 5.1 11.7 16.9 17.9 33.0 36.4 16.0 15.6 22.0 23.3 18.2 11.3 3.6 13.1 28.9 12.0 19.4 20.6 8.2 6.3 26.5 8.5 16.3 11.8 24.2 23.7 14.2 13.3 9.3 11.3 37.0 14.4 1.1 3.2 4.0 2.6 2.3 2.0 2.6 3.1 4.4 3.3 1.6 2.3 2.6 0.5 2.9 3.5 0.6 3.2 2.8 7.2 9.4 9.4 9.3 6.8 8.2 9.2 8.8 9.4 7.3 8.3 10.4 2.2 0.0 0.0 0.0 4.6 1.7 2.4 1.9 5.7 5.4 1.7 1.9 2.6 1.5 1.2 0.0 8.4 1.4 3.4 1.9 3.9 5.3 90.6 1.7 3.4 2.4 2.4 9.4 0.0 3.7 2.1 1.9 5.1 2.6 0.0 3.5 1.8 3.3 4.0 6.7 0.0 3.3 8.2 0.9 3.2 156.3 3.1 2.1 1.8 0.0 2.7 2.6 2.1 0.0 0.0 3.0 5.0 0.0 4.9 1.9 3.9 2.7 1.9 6.9 0.0 1.9 3.2 6.2 5.6 3.4 1.6 0.7 4.4 2.2 4.8 1.8 SCYL2 "CVAK104, KIAA1360" ENSG00000136021 "SCY1 like pseudokinase 2" Q6P3W7 12 100267140-100341715 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021050 Approved NA NA "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" "HPA021050: AB_1846175" "unprognostic (7.01e-3)" "unprognostic (3.04e-2)" "unprognostic (4.34e-3)" "unprognostic (4.01e-2)" "unprognostic (3.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.27e-2)" "unprognostic (8.19e-2)" "unprognostic (5.32e-2)" "unprognostic (1.31e-1)" "unprognostic (1.34e-2)" "unprognostic (1.93e-2)" "unprognostic (4.44e-1)" "unprognostic (2.72e-1)" "unprognostic (3.46e-1)" "unprognostic (1.60e-1)" "unprognostic (2.18e-1)" 13.4 13.4 6.2 16.4 7.3 21.5 16.8 9.9 8.2 14.0 7.6 22.9 20.2 14.5 20.9 22.1 10.9 16.2 14.9 7.6 8.6 21.2 28.7 17.2 15.0 5.6 5.4 8.8 17.9 20.9 12.9 21.0 6.3 17.0 26.9 16.7 15.7 15.9 15.6 13.7 17.0 17.4 6.3 14.7 16.4 14.6 7.5 19.0 15.6 19.1 19.8 21.5 11.5 7.2 37.7 29.0 45.8 37.7 28.8 31.1 43.2 38.0 42.8 34.8 29.6 28.1 19.4 23.4 17.7 46.9 23.7 32.1 36.4 27.8 40.6 36.5 24.2 76.0 18.5 20.3 25.7 36.2 72.8 23.1 42.5 39.5 44.9 41.3 44.4 26.0 40.8 19.7 37.4 29.2 29.2 31.7 28.6 21.7 32.6 23.4 33.6 22.7 31.6 61.1 28.3 25.3 43.0 44.2 36.2 48.2 64.9 27.8 41.7 29.7 17.2 27.8 24.8 22.6 32.1 28.3 14.6 24.6 34.4 12.3 5.2 10.0 4.0 6.5 5.1 3.3 4.2 3.8 6.6 2.3 4.5 4.9 6.7 8.6 5.7 2.0 6.2 4.0 6.2 7.3 9.9 8.2 7.6 8.6 5.6 5.4 6.3 6.3 7.5 7.2 24.4 16.0 35.2 37.9 20.4 35.9 21.3 17.4 33.0 16.8 29.6 17.1 30.1 7.2 26.8 20.2 27.1 31.3 22.7 44.1 5.9 16.8 8.5 24.4 19.1 24.8 21.7 28.6 50.3 21.7 22.2 20.2 37.8 31.2 27.9 15.1 16.4 37.1 25.1 15.2 54.1 30.6 12.2 34.6 47.4 4.7 13.4 29.2 16.0 44.0 27.5 10.9 17.5 64.3 47.2 24.0 32.1 15.4 22.2 36.8 16.2 26.3 18.3 16.2 0.0 13.1 20.9 24.9 12.0 36.8 34.7 59.4 22.6 19.2 33.6 52.8 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 142.9 138.1 66.2 83.4 69.4 172.2 136.2 69.0 80.4 147.1 76.6 110.8 82.9 111.0 202.5 81.6 103.6 97.5 98.4 63.7 72.6 137.2 152.3 107.9 112.6 74.1 67.2 168.6 139.4 114.6 84.5 115.1 73.9 82.0 124.9 37.0 95.9 87.5 154.3 70.5 86.4 96.3 72.4 86.2 95.3 61.5 69.4 93.2 177.5 147.4 98.2 137.3 94.0 75.3 201.7 320.7 286.7 425.4 368.5 462.8 225.4 310.1 356.5 241.9 291.2 347.1 443.0 99.0 198.8 370.3 277.2 408.3 409.1 243.4 255.5 267.1 239.4 279.4 358.8 324.9 311.7 213.4 281.2 315.8 305.0 169.1 285.1 366.0 337.9 116.7 295.8 244.3 315.1 363.1 89.2 345.8 282.1 266.2 135.4 101.6 368.4 302.9 472.6 424.4 131.2 300.8 257.3 239.5 598.5 407.0 248.5 416.6 254.3 240.0 181.0 209.8 361.9 224.4 509.6 150.0 226.4 331.7 180.6 83.5 161.1 89.7 95.1 173.7 95.0 101.0 114.8 104.7 165.8 90.0 95.1 98.0 111.6 134.3 184.8 160.9 168.8 200.8 66.2 69.4 69.0 80.4 63.7 72.6 74.1 67.2 73.9 72.4 69.4 75.3 261.1 89.8 99.1 25.8 131.8 107.1 179.4 356.6 90.5 30.0 163.7 202.6 68.2 228.8 188.0 128.8 22.9 309.1 171.9 111.1 238.7 258.8 46.3 118.5 268.0 217.2 157.4 101.7 21.2 247.3 655.3 206.0 120.8 184.1 218.4 191.0 197.7 165.5 363.3 20.2 22.8 218.7 168.9 386.7 337.2 100.6 299.5 337.3 158.3 24.4 396.7 110.5 204.9 26.7 38.3 183.4 136.3 166.3 197.9 185.7 142.7 350.9 99.3 38.2 170.9 173.5 225.5 233.5 169.6 135.2 119.9 305.8 153.4 237.6 210.7 242.2 SEC16A "KIAA0310, p250, Sec16L" ENSG00000148396 "SEC16 homolog A, endoplasmic reticulum export factor" O15027 9 136440096-136483759 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005684 Supported Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 48000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Endoplasmic reticulum" "HPA005684: AB_1079189" "unprognostic (1.24e-3)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.84e-2)" "unprognostic (3.48e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-3)" "unprognostic (4.75e-1)" "prognostic favorable (4.47e-4)" "unprognostic (5.57e-3)" "unprognostic (2.64e-1)" "unprognostic (2.47e-2)" "unprognostic (1.41e-1)" 16.8 18.2 6.4 16.6 6.7 35.3 17.1 8.0 9.4 16.6 19.3 17.3 14.9 17.9 9.0 17.9 16.4 12.4 14.5 7.0 5.2 14.3 37.9 19.4 16.9 4.4 4.9 16.2 29.2 14.0 24.3 10.8 3.5 18.7 10.5 9.2 25.8 13.1 23.5 19.7 19.1 10.7 2.4 20.7 27.2 17.6 5.2 17.4 15.3 11.9 12.3 15.9 14.5 5.0 26.5 57.7 28.5 47.2 29.6 30.3 33.6 32.1 27.9 23.4 17.8 41.9 22.1 26.4 22.1 39.2 28.8 71.3 31.8 46.2 12.7 56.2 20.7 26.9 55.1 33.7 28.6 46.2 45.8 32.8 32.5 32.7 38.1 18.9 32.2 34.5 34.1 35.6 25.0 114.3 31.2 24.9 25.1 79.0 40.4 44.3 35.2 45.0 23.8 35.0 40.0 26.6 41.6 62.2 19.8 13.8 63.6 35.9 47.0 37.6 28.1 30.8 25.2 16.9 27.7 33.4 29.2 20.6 38.3 1.7 2.8 1.2 2.5 3.1 2.7 2.3 2.6 3.0 1.6 1.4 1.6 2.8 2.0 1.5 3.4 2.6 1.9 2.4 6.4 6.7 8.0 9.4 7.0 5.2 4.4 4.9 3.5 2.4 5.2 5.0 20.0 25.6 41.7 16.6 16.4 24.9 15.3 18.4 10.8 20.2 38.7 30.6 11.5 12.8 23.6 12.9 25.0 8.1 17.5 30.1 7.9 14.2 5.1 26.9 19.5 18.2 40.7 12.0 27.4 16.4 11.8 16.0 46.9 38.2 23.5 25.4 17.9 62.2 16.5 33.7 19.2 65.5 20.3 23.4 19.5 6.0 13.1 22.3 14.2 17.8 19.5 13.0 11.3 9.5 14.7 22.8 14.7 16.6 25.1 26.3 22.3 10.1 34.7 17.1 13.1 20.5 16.6 24.4 16.1 17.2 26.9 15.1 17.8 15.8 22.8 22.1 SEC23B "CDA-II, CDAII, CDAN2, HEMPAS" ENSG00000101310 "SEC23 homolog B, COPII coat complex component" Q15437 20 18507520-18561415 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008216, HPA069974" Uncertain Supported Vesicles NA Yes 16000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA008216: AB_1079895, HPA069974: AB_2686223" "unprognostic (4.47e-2)" "unprognostic (2.67e-2)" "unprognostic (3.52e-1)" "prognostic favorable (8.25e-4)" "unprognostic (1.24e-1)" "unprognostic (1.33e-1)" "unprognostic (5.44e-3)" "unprognostic (6.01e-2)" "unprognostic (1.39e-1)" "unprognostic (8.75e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-2)" "unprognostic (3.91e-2)" "unprognostic (1.72e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-2)" "unprognostic (8.21e-2)" 19.6 38.3 18.7 32.0 27.1 36.0 37.8 24.7 25.9 36.2 27.4 31.6 23.8 17.2 53.8 28.4 29.5 23.1 8.5 19.5 22.4 37.4 30.6 29.7 30.5 27.2 23.8 16.9 57.1 50.6 32.6 24.2 27.2 34.8 32.7 40.7 70.9 35.9 4.1 18.2 23.3 18.5 24.5 25.5 38.2 34.8 23.2 27.6 59.5 6.2 38.0 30.5 12.6 38.9 85.0 93.9 49.8 48.7 32.3 36.6 116.0 69.8 45.3 80.0 68.7 84.9 73.8 37.5 44.9 50.4 107.0 88.5 88.5 120.7 86.2 47.5 43.1 64.9 35.6 130.6 70.5 90.2 78.7 28.0 71.8 118.0 151.4 47.6 50.6 34.0 74.8 82.4 55.1 90.7 59.8 49.5 48.0 118.9 101.6 62.4 77.7 122.1 83.0 85.6 78.8 58.0 83.6 188.9 80.6 62.6 82.3 94.4 45.3 53.1 29.8 58.4 87.1 104.2 155.9 60.1 45.3 47.8 74.4 147.9 94.1 106.0 57.2 95.6 78.7 67.2 56.8 61.4 107.9 61.2 51.3 54.0 48.0 78.8 94.9 80.7 75.4 103.7 18.7 27.1 24.7 25.9 19.5 22.4 27.2 23.8 27.2 24.5 23.2 38.9 8.5 16.0 43.5 15.3 24.7 11.5 21.0 34.3 10.2 21.0 21.5 15.6 3.0 20.0 42.5 31.3 16.7 34.3 36.0 26.2 58.7 36.1 95.6 25.4 12.4 11.3 19.7 7.4 17.9 33.4 30.0 11.7 25.0 31.3 15.9 13.6 11.0 25.6 42.9 13.5 20.5 34.7 26.4 38.7 21.0 11.3 14.3 30.3 23.2 15.0 33.1 23.9 9.2 23.1 27.0 31.8 24.2 10.5 59.0 30.1 11.8 53.2 45.4 20.4 19.7 12.4 12.2 48.7 22.1 15.8 14.2 65.8 21.0 16.0 21.5 28.3 SEC23IP p125 ENSG00000107651 "SEC23 interacting protein" Q9Y6Y8 10 119892730-119944657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038403, HPA043305" Approved Enhanced Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Vesicles "HPA038403: AB_10675796, HPA043305: AB_2678416" "unprognostic (4.05e-2)" "unprognostic (5.01e-2)" "unprognostic (8.70e-2)" "unprognostic (1.35e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.78e-1)" "unprognostic (3.36e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (6.81e-3)" "unprognostic (3.43e-2)" 10.3 9.7 3.5 12.0 3.9 14.1 11.8 6.2 4.6 11.2 6.4 12.6 10.4 11.9 12.1 9.4 8.8 9.6 7.7 4.0 4.0 10.3 12.6 10.2 13.7 4.2 4.3 10.0 11.1 9.8 8.5 12.4 4.0 13.1 13.0 9.0 10.3 9.9 9.8 10.4 9.5 16.4 3.1 11.7 17.5 11.5 4.6 11.1 12.5 8.4 13.4 12.0 8.3 6.3 32.4 30.2 24.3 31.9 22.4 25.3 19.0 27.2 39.5 26.1 31.6 31.0 22.9 30.2 14.7 36.2 32.5 23.9 27.9 29.2 39.5 27.2 28.7 25.1 16.3 34.0 31.0 29.6 29.9 31.4 18.4 30.8 30.5 28.3 36.3 15.5 19.1 21.4 28.7 19.2 25.9 28.2 29.5 28.6 20.9 23.7 44.7 17.3 26.1 25.6 9.6 25.5 25.0 19.9 24.1 24.9 17.5 21.7 29.6 15.8 18.5 23.8 35.1 33.5 32.6 38.7 27.6 37.4 14.1 14.3 10.5 10.3 10.7 16.3 13.9 11.3 10.5 12.4 11.9 9.1 11.1 10.7 3.8 13.0 18.1 7.2 11.9 9.6 3.5 3.9 6.2 4.6 4.0 4.0 4.2 4.3 4.0 3.1 4.6 6.3 15.1 12.8 28.3 21.9 20.9 8.4 19.3 18.1 13.1 17.3 19.1 12.1 17.4 27.1 24.5 18.4 6.2 17.8 18.7 19.7 5.9 16.8 26.1 15.1 22.1 19.9 19.9 21.2 28.3 14.4 18.9 21.4 44.9 15.5 22.1 21.0 14.3 25.5 23.3 11.8 30.2 24.3 26.4 24.6 12.2 24.9 14.0 23.3 8.8 39.4 21.3 14.6 16.5 31.7 37.5 20.2 19.8 15.1 23.7 23.4 16.0 19.2 25.4 23.7 0.0 16.8 17.9 25.0 19.8 19.1 13.9 23.1 18.2 24.2 20.8 21.1 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818509-82901166 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol NA NA 40000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.69e-4)" 98.7 103.3 52.2 78.4 54.3 119.4 111.4 62.4 70.1 145.5 94.9 107.1 124.2 119.7 162.1 92.6 90.9 122.1 110.7 54.0 61.4 133.6 174.8 96.2 88.2 58.4 58.7 152.8 192.6 116.4 108.4 143.2 58.7 113.4 127.2 87.9 134.0 111.3 96.8 107.8 111.0 131.5 50.9 76.5 110.1 77.8 54.4 93.8 168.0 85.6 102.1 113.1 94.1 63.9 146.2 65.2 183.6 130.4 318.9 394.5 133.3 264.8 295.4 146.0 179.2 113.2 182.3 188.3 113.7 532.2 84.6 68.1 183.3 176.2 200.4 193.4 72.7 115.3 110.5 302.1 316.4 124.4 140.7 380.5 217.7 223.5 254.3 251.2 240.5 83.8 178.4 181.1 264.2 128.6 164.9 99.6 126.1 154.0 58.3 121.2 100.1 140.3 237.2 83.0 118.6 131.2 105.7 180.7 174.9 184.8 142.1 137.8 248.2 190.7 98.9 169.0 168.8 135.1 62.4 256.7 190.6 147.8 224.2 84.3 66.9 51.2 65.1 74.0 80.5 60.0 57.6 64.3 73.3 50.0 56.9 54.6 19.2 89.9 83.1 61.1 52.7 71.8 52.2 54.3 62.4 70.1 54.0 61.4 58.4 58.7 58.7 50.9 54.4 63.9 62.6 105.8 85.3 50.9 58.1 60.5 60.5 64.1 56.9 52.3 54.5 43.7 85.5 51.5 109.8 47.8 54.2 57.3 61.0 62.8 27.4 65.8 30.6 90.1 164.6 65.0 38.3 41.2 61.0 71.2 85.3 125.2 100.9 119.7 75.2 241.0 65.0 94.0 45.9 42.1 60.0 99.4 50.8 51.2 55.3 19.3 139.1 63.8 51.6 67.5 60.4 36.5 38.1 74.9 72.6 67.5 46.3 126.0 152.2 76.3 121.0 65.9 100.5 66.9 52.6 86.5 98.9 30.3 34.6 62.2 74.2 81.5 55.4 78.9 54.9 101.1 SEC61A1 ENSG00000058262 "SEC61 translocon subunit alpha 1" P61619 3 128051641-128071683 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022076 Supported "Endoplasmic reticulum" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "CAB022076: " "unprognostic (1.84e-1)" "unprognostic (8.00e-2)" "unprognostic (8.21e-2)" "prognostic favorable (7.82e-4)" "unprognostic (2.13e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.07e-6)" "unprognostic (2.84e-2)" "unprognostic (4.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.85e-2)" "unprognostic (1.43e-1)" "prognostic unfavorable (6.84e-9)" "unprognostic (2.73e-2)" "unprognostic (3.18e-2)" "unprognostic (8.33e-2)" "unprognostic (2.51e-2)" 82.1 100.7 31.3 88.3 33.4 79.5 75.3 33.5 34.7 144.5 52.4 90.7 81.9 88.9 128.9 88.7 78.1 81.7 74.2 32.3 39.6 64.6 134.8 93.3 60.2 40.9 37.6 67.3 272.1 111.7 93.5 112.8 36.0 90.0 90.0 37.0 176.3 97.0 70.5 66.9 75.8 110.7 36.6 73.7 105.5 38.8 46.6 61.4 104.8 59.3 80.6 97.0 68.7 35.8 272.8 136.5 132.0 240.3 367.9 317.3 256.9 426.9 470.8 349.0 371.2 259.1 186.9 184.7 259.5 534.8 266.2 232.6 209.0 291.3 334.2 168.1 126.2 213.5 143.5 273.6 542.9 264.1 225.9 348.1 345.4 329.3 422.4 265.0 314.3 122.2 136.9 415.3 412.8 237.7 135.1 87.5 184.6 231.6 202.8 144.2 125.5 349.8 181.4 229.3 155.8 162.4 216.0 193.5 270.7 152.0 184.2 215.1 327.3 278.3 164.7 333.7 201.4 386.6 210.6 265.8 456.3 166.2 369.1 160.3 88.6 67.0 89.0 79.6 120.0 43.8 62.9 78.2 82.6 26.1 38.8 46.2 22.5 65.0 84.2 114.0 45.1 116.9 31.3 33.4 33.5 34.7 32.3 39.6 40.9 37.6 36.0 36.6 46.6 35.8 31.9 32.1 33.1 18.6 46.6 37.0 25.7 44.4 30.7 17.0 63.5 41.3 15.0 37.1 43.3 49.7 35.5 64.3 59.2 107.2 3.9 81.0 42.2 28.2 72.9 45.9 73.6 19.5 12.6 154.5 136.3 57.4 77.5 68.6 26.0 55.6 49.6 118.2 75.9 26.9 18.5 150.8 38.7 34.8 32.1 25.7 41.0 38.2 33.8 26.2 32.1 22.4 28.8 19.1 17.2 104.9 50.2 43.6 192.8 69.6 63.5 26.8 31.0 15.5 32.9 25.6 47.2 12.3 18.4 42.5 29.5 127.9 32.4 52.6 100.4 44.6 SEC61B ENSG00000106803 "SEC61 translocon subunit beta" P60468 9 99222064-99230615 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 1573.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA049407 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 65: Plasmacytoid DCs - Unknown function" "Endoplasmic reticulum" "HPA049407: AB_2680750" "unprognostic (1.11e-1)" "unprognostic (5.99e-3)" "unprognostic (3.46e-1)" "prognostic favorable (1.26e-5)" "unprognostic (1.96e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.09e-1)" "unprognostic (6.67e-2)" "unprognostic (1.87e-2)" "unprognostic (2.90e-2)" "unprognostic (7.07e-2)" "unprognostic (1.22e-1)" "unprognostic (1.84e-1)" "unprognostic (1.57e-1)" "unprognostic (6.87e-2)" "unprognostic (2.75e-1)" 173.5 235.8 101.0 154.7 104.0 255.5 153.4 104.3 120.8 179.4 105.3 139.3 155.0 167.7 259.4 169.8 155.0 129.8 106.7 104.4 110.8 213.7 465.3 169.0 184.0 104.5 102.1 158.5 546.0 145.9 209.5 98.3 105.8 168.0 102.8 48.5 347.7 124.3 61.0 122.5 132.9 106.3 106.8 173.1 186.5 76.4 103.8 188.8 179.8 44.2 146.7 148.8 139.1 111.6 226.5 213.3 244.1 243.7 234.5 296.0 293.9 327.6 335.8 299.9 259.2 307.3 172.6 305.3 244.3 298.7 328.9 272.0 171.9 259.5 143.1 325.4 238.7 160.7 200.7 440.3 509.9 278.9 198.3 268.0 389.4 237.3 210.3 268.1 369.8 246.7 255.0 581.1 285.6 407.7 255.6 404.9 196.3 533.9 497.7 244.2 207.7 398.1 332.3 158.3 252.7 179.2 183.6 421.1 441.5 190.8 163.4 378.6 265.1 215.3 260.0 363.5 277.7 312.0 226.6 200.7 359.3 176.6 145.6 875.3 460.3 453.3 354.6 387.9 480.8 356.5 389.3 360.4 481.0 257.1 242.9 267.7 388.5 325.7 350.8 1661.8 388.0 525.0 101.0 104.0 104.3 120.8 104.4 110.8 104.5 102.1 105.8 106.8 103.8 111.6 255.6 102.5 206.1 18.3 370.9 395.8 308.3 712.8 213.9 59.3 499.1 530.7 55.5 271.7 416.8 200.5 31.3 336.6 605.9 239.9 633.9 498.6 184.2 274.7 410.2 286.1 302.0 226.8 16.2 792.5 577.9 343.2 214.1 391.3 214.8 258.8 213.8 822.0 509.8 53.8 15.5 534.0 406.9 295.3 553.2 51.8 328.0 316.3 496.2 17.8 1573.9 197.3 284.2 15.6 25.9 633.4 280.0 304.3 1190.6 654.2 290.3 767.6 331.4 81.5 138.1 237.1 404.7 218.4 171.0 337.5 443.4 553.8 270.1 333.0 334.0 501.5 SEC61G SSS1 ENSG00000132432 "SEC61 translocon subunit gamma" P60059 7 54752250-54759974 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enriched" "Detected in all" 5 "glioma: 333.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053196 Uncertain NA NA 37000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "HPA053196: AB_2682077" "unprognostic (1.39e-2)" "unprognostic (4.51e-3)" "unprognostic (5.26e-3)" "unprognostic (1.82e-2)" "unprognostic (2.46e-2)" "prognostic unfavorable (4.64e-7)" "prognostic unfavorable (3.85e-6)" "unprognostic (2.09e-2)" "unprognostic (2.17e-1)" "unprognostic (2.34e-2)" "unprognostic (1.75e-1)" "unprognostic (1.53e-1)" "prognostic unfavorable (6.60e-8)" "unprognostic (1.23e-1)" "unprognostic (1.12e-1)" "unprognostic (7.95e-3)" "unprognostic (8.43e-2)" 161.2 163.7 83.1 143.3 82.2 171.1 170.0 85.9 111.2 177.6 94.5 189.7 116.6 127.8 342.2 169.6 132.0 99.5 206.8 82.6 89.1 212.8 221.5 144.2 127.9 84.0 81.7 120.9 311.7 101.6 253.4 115.5 83.7 143.8 162.5 82.4 160.4 121.0 148.3 113.3 126.5 142.4 84.5 140.6 149.3 110.8 84.5 130.9 159.6 126.6 156.5 134.9 134.4 87.6 448.7 256.0 343.4 384.8 339.4 415.5 216.8 705.5 430.3 352.0 647.6 378.3 294.7 383.8 355.2 517.5 758.6 332.9 285.5 491.4 749.5 328.2 249.7 250.0 571.0 439.5 495.2 457.8 248.9 318.2 418.6 364.5 623.2 491.9 479.3 246.2 375.2 950.4 755.2 232.8 243.1 785.9 497.1 547.5 414.9 180.4 206.4 655.7 435.6 281.6 328.5 400.7 287.3 678.0 324.3 602.4 347.0 435.6 405.2 323.1 423.5 1273.5 526.0 385.8 392.5 737.5 672.8 256.9 639.4 294.5 135.4 119.7 145.8 141.0 201.1 144.6 166.5 156.3 154.9 105.5 116.8 140.5 45.1 124.5 156.1 696.8 168.7 136.4 83.1 82.2 85.9 111.2 82.6 89.1 84.0 81.7 83.7 84.5 84.5 87.6 258.9 99.3 139.0 10.4 318.3 378.8 264.8 1105.6 180.4 51.0 330.4 343.8 235.2 283.1 456.4 252.0 8.4 282.2 361.6 467.4 602.6 646.0 67.0 317.2 405.1 256.9 306.5 224.3 8.1 1006.7 775.2 325.7 311.4 524.7 147.2 190.2 267.0 706.0 472.5 23.5 13.1 735.0 506.6 333.3 450.8 46.8 251.0 258.2 498.0 13.1 537.4 166.1 292.5 6.6 12.5 814.2 476.0 222.7 962.7 544.6 544.6 652.0 343.1 45.4 111.7 229.4 500.1 287.6 233.4 290.4 463.9 507.3 257.1 192.2 423.4 362.5 SEC63 "DNAJC23, ERdj2, PRO2507, SEC63L" ENSG00000025796 "SEC63 homolog, protein translocation regulator" Q9UGP8 6 107867756-107958208 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Transport" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 354.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053295, HPA060535" Supported Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA053295: AB_2682105, HPA060535: AB_2684312" "prognostic unfavorable (3.32e-4)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.08e-1)" "unprognostic (1.56e-1)" "unprognostic (4.36e-3)" "unprognostic (1.51e-2)" "unprognostic (8.33e-3)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (6.16e-4)" "unprognostic (2.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.56e-1)" "unprognostic (4.41e-2)" 27.5 33.0 11.6 22.0 14.3 32.9 23.3 14.4 12.9 30.2 25.7 19.2 16.8 25.2 29.6 19.5 21.8 22.0 19.0 12.4 15.3 20.0 46.6 21.7 16.7 13.3 12.0 40.4 61.2 31.7 14.4 20.9 14.2 27.7 18.6 21.2 77.8 23.3 14.3 15.5 18.0 22.2 12.3 16.1 23.1 33.0 12.1 22.6 52.1 14.1 17.3 21.8 14.0 17.7 28.5 17.1 46.0 57.6 47.1 55.2 41.4 59.2 65.0 27.8 39.2 30.8 34.6 52.8 49.4 53.7 34.4 40.9 32.3 38.3 42.5 63.8 35.7 57.2 25.2 31.6 73.2 65.9 32.5 43.5 61.4 44.5 97.6 50.0 39.3 31.7 48.5 82.8 57.7 22.7 20.6 29.5 36.4 30.0 18.1 65.2 54.4 43.7 33.5 37.1 40.3 45.7 32.9 48.8 59.1 31.2 34.9 95.8 42.5 41.6 25.8 42.2 46.6 31.4 25.0 52.9 45.9 56.4 48.7 5.6 5.2 5.0 4.8 4.7 7.5 4.4 3.9 3.9 5.4 4.0 4.3 3.4 1.7 7.1 9.8 6.9 2.2 3.5 11.6 14.3 14.4 12.9 12.4 15.3 13.3 12.0 14.2 12.3 12.1 17.7 55.6 118.6 143.3 38.2 64.4 85.0 70.5 90.9 42.7 57.7 67.8 54.2 78.8 81.5 125.5 53.3 39.6 80.8 71.6 39.2 11.7 86.0 40.3 48.7 102.8 61.6 53.5 31.5 52.5 125.4 96.4 107.1 46.9 54.8 68.9 84.8 59.6 126.7 62.7 47.1 50.8 80.0 83.4 56.7 78.9 23.9 106.2 54.8 80.0 42.2 54.3 61.0 59.8 60.3 64.8 81.9 53.5 118.8 144.6 91.1 37.2 38.4 116.7 49.9 46.0 108.2 77.2 143.1 75.0 44.7 80.0 91.0 52.3 354.8 60.8 73.8 SELENOF SEP15 ENSG00000183291 "Selenoprotein F" O60613 1 86862445-86914424 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 248.6;Ductal cells: 235.9;Extravillous trophoblasts: 338.3;Hofbauer cells: 241.2;Syncytiotrophoblasts: 315.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054937 Approved Nucleoli,Cytosol "Intracellular and membrane" No No 420000 "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoli Cytosol "HPA054937: AB_2682642" "unprognostic (6.15e-2)" "unprognostic (6.98e-3)" "prognostic favorable (6.53e-4)" "unprognostic (6.20e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.65e-1)" "unprognostic (6.51e-3)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (2.39e-2)" "unprognostic (1.09e-1)" "unprognostic (8.24e-3)" "unprognostic (1.34e-2)" 118.1 137.9 77.6 118.8 80.0 107.9 147.4 80.9 106.1 156.6 97.9 127.8 113.5 117.4 211.4 83.6 130.1 123.3 84.6 75.2 84.3 160.3 173.9 114.9 140.6 82.6 79.8 124.6 93.4 115.7 88.4 155.8 84.0 121.1 134.2 90.7 104.1 116.4 45.6 66.3 111.3 107.1 86.4 107.2 116.8 66.7 79.0 135.5 234.0 64.7 126.9 146.6 72.6 92.5 203.1 133.3 118.0 129.1 383.0 396.4 178.3 249.1 317.3 251.4 254.8 176.8 261.8 245.2 309.7 248.9 195.7 131.8 135.2 150.7 296.0 222.1 180.2 252.4 108.5 178.2 245.2 336.8 166.1 272.3 233.0 152.8 253.0 180.2 220.2 207.8 241.4 262.3 253.3 90.2 254.4 227.3 170.7 211.2 197.9 207.7 205.1 251.9 355.5 198.5 149.5 122.6 241.6 235.6 349.2 104.7 104.0 298.5 205.3 180.0 122.9 347.6 277.0 155.1 158.7 251.9 107.7 268.4 216.7 170.9 111.3 113.4 89.7 115.9 116.1 161.4 98.7 97.2 107.1 194.2 98.8 102.3 109.3 82.3 132.4 166.3 115.2 171.3 77.6 80.0 80.9 106.1 75.2 84.3 82.6 79.8 84.0 86.4 79.0 92.5 131.6 118.6 155.2 0.0 52.4 0.0 0.0 0.0 0.0 0.0 142.1 107.7 0.0 0.0 74.9 108.5 0.0 248.6 89.3 0.0 74.3 235.9 0.0 102.2 119.1 73.2 0.0 0.0 0.0 193.5 338.3 85.2 0.0 98.1 64.3 68.8 0.0 0.0 241.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 64.1 0.0 0.0 0.0 0.0 197.8 0.0 0.0 19.1 0.0 0.0 151.5 70.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 315.2 53.9 122.2 0.0 0.0 SELENOS "AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP" ENSG00000131871 "Selenoprotein S" Q9BQE4 15 101270817-101277500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 229.2;Glandular and luminal cells: 211.7;Pancreatic endocrine cells: 226.1;Syncytiotrophoblasts: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 606.9" "Lineage enriched" "Detected in all" 5 "dendritic cells: 606.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010025 Approved Enhanced "Endoplasmic reticulum" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "HPA010025: AB_1079900" "unprognostic (1.90e-1)" "unprognostic (4.03e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.42e-2)" "unprognostic (3.74e-3)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (9.83e-2)" "prognostic favorable (5.19e-4)" "unprognostic (2.42e-3)" "unprognostic (4.42e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" "unprognostic (2.66e-2)" 65.6 75.4 30.6 48.4 32.8 50.6 55.0 33.8 39.8 50.1 39.7 82.4 80.0 41.9 75.5 55.6 44.6 45.5 66.3 29.8 32.7 48.7 84.7 59.6 49.2 35.2 33.2 41.6 103.7 51.1 44.5 57.6 35.3 53.6 87.2 28.7 73.8 49.1 71.0 48.4 82.2 42.9 33.7 58.7 67.2 92.7 32.4 24.1 55.8 48.7 53.1 60.7 45.3 36.3 45.3 68.8 61.2 54.5 129.8 91.1 52.4 136.4 100.2 89.8 90.2 82.3 105.0 33.6 49.6 117.5 150.8 125.1 66.6 59.7 58.6 63.5 91.8 57.2 62.5 86.8 206.5 43.5 63.9 80.2 166.3 60.3 177.7 70.7 68.1 44.3 58.3 369.0 97.4 71.7 31.7 67.6 46.8 169.9 45.7 41.6 50.1 74.7 90.7 104.2 34.5 88.5 93.0 85.7 193.8 79.9 64.0 96.2 73.6 84.0 57.1 116.4 103.3 272.5 246.3 49.9 92.2 50.8 104.2 134.4 66.4 81.2 94.1 84.0 91.1 62.2 71.4 101.1 58.6 51.4 53.7 79.6 23.1 95.6 100.1 606.9 71.4 63.7 30.6 32.8 33.8 39.8 29.8 32.7 35.2 33.2 35.3 33.7 32.4 36.3 164.0 118.6 108.6 0.0 47.8 0.0 0.0 0.0 0.0 0.0 172.5 129.4 0.0 0.0 64.4 154.5 0.0 125.9 87.7 0.0 31.3 183.9 0.0 127.0 165.2 53.3 0.0 0.0 0.0 189.3 229.2 91.6 0.0 211.7 30.3 53.5 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 92.0 0.0 0.0 0.0 0.0 226.1 0.0 0.0 101.0 0.0 0.0 73.0 56.9 0.0 0.0 0.0 78.5 0.0 0.0 0.0 0.0 303.7 40.4 100.9 0.0 0.0 SERP1 "FLJ43424, RAMP4" ENSG00000120742 "Stress associated endoplasmic reticulum protein 1" Q9Y6X1 3 150541998-150603228 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 542.5;U-266/70: 735.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038970 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA038970: AB_2676296" "unprognostic (8.81e-3)" "unprognostic (2.35e-3)" "unprognostic (1.91e-1)" "unprognostic (7.29e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.57e-2)" "unprognostic (2.35e-3)" "unprognostic (6.16e-2)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (1.12e-1)" "unprognostic (1.61e-3)" "unprognostic (2.55e-2)" "unprognostic (2.75e-2)" "unprognostic (4.75e-2)" "unprognostic (1.78e-1)" 74.6 94.0 52.9 64.4 56.5 86.8 103.9 51.5 67.7 104.3 55.1 78.5 63.4 51.0 158.0 80.6 80.2 48.2 39.0 54.2 56.1 73.9 157.7 82.3 66.1 54.3 51.2 80.7 255.6 57.2 84.6 60.2 53.2 92.4 67.8 26.1 185.5 69.8 16.9 52.8 64.2 45.0 56.1 87.8 114.8 37.5 56.0 66.4 113.3 17.0 74.5 64.6 64.2 58.8 216.1 46.3 68.9 52.5 99.7 116.0 152.9 150.4 98.7 82.2 96.5 121.6 93.7 175.8 274.8 111.7 67.7 102.2 113.6 79.5 108.6 104.7 93.3 187.1 38.4 123.9 193.9 170.8 117.4 69.6 139.4 47.7 236.7 89.2 97.7 118.1 92.7 241.0 70.8 95.3 144.5 143.3 128.1 138.5 115.1 181.2 52.5 542.5 100.4 69.7 116.8 99.3 57.8 128.4 244.5 83.2 112.8 165.0 93.8 38.9 69.6 84.4 117.0 735.1 230.5 236.0 70.9 165.2 36.8 347.2 410.6 375.2 237.4 399.6 304.5 239.7 250.3 238.5 317.6 222.1 244.0 227.3 299.9 188.5 456.8 321.1 268.0 508.0 52.9 56.5 51.5 67.7 54.2 56.1 54.3 51.2 53.2 56.1 56.0 58.8 168.0 67.3 162.7 66.0 468.4 538.0 677.4 277.8 363.7 74.5 500.8 451.2 44.5 158.7 246.5 172.9 58.4 284.6 337.7 351.1 365.9 231.3 361.1 246.5 198.9 189.5 254.0 157.5 51.6 304.3 553.8 213.0 218.2 359.7 219.7 135.4 249.5 480.7 373.5 42.1 48.0 563.2 168.9 662.6 477.8 627.0 219.6 512.6 348.6 25.3 558.1 174.5 279.1 63.3 60.6 349.0 564.2 190.3 923.0 744.8 326.1 293.7 218.5 69.6 111.7 98.1 192.4 208.0 91.3 347.4 592.7 944.7 335.5 94.2 404.3 1101.9 SH2D4A "FLJ20967, PPP1R38, SH2A" ENSG00000104611 "SH2 domain containing 4A" Q9H788 8 19313693-19396218 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 87.7;Pancreatic endocrine cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 181.7;OE19: 102.5;U-2197: 130.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001871, HPA001919" Enhanced Enhanced Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "HPA001871: AB_1079949, HPA001919: AB_1079947" "unprognostic (9.08e-2)" "unprognostic (8.40e-3)" "unprognostic (4.04e-3)" "unprognostic (2.72e-3)" "unprognostic (3.51e-2)" "unprognostic (4.07e-3)" "unprognostic (2.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.67e-1)" "unprognostic (2.70e-2)" "unprognostic (8.84e-3)" "unprognostic (2.81e-1)" "prognostic favorable (6.02e-8)" "unprognostic (1.67e-2)" "unprognostic (2.18e-1)" "unprognostic (3.51e-3)" "unprognostic (4.11e-2)" 5.0 8.8 1.6 4.1 1.4 0.1 6.2 1.2 2.0 13.6 1.9 13.6 12.7 4.0 1.7 20.4 9.1 11.1 3.1 1.6 1.5 12.6 39.1 15.8 1.0 1.6 1.6 36.9 13.1 18.2 1.4 17.7 1.9 7.4 10.8 9.6 24.0 10.1 0.6 7.2 12.6 2.0 1.3 3.3 29.9 2.2 1.5 1.3 16.8 1.6 7.4 18.3 10.5 2.0 60.5 67.3 0.2 0.1 6.5 8.0 44.9 73.9 36.6 70.7 68.3 55.7 53.4 0.0 17.4 181.7 11.2 30.5 2.7 20.0 73.6 0.2 1.0 0.0 40.7 8.6 38.3 1.6 0.3 7.8 24.5 48.4 8.8 42.5 0.3 0.0 0.1 0.1 12.0 27.2 0.1 0.7 15.8 102.5 25.4 0.1 0.0 19.5 19.5 62.6 4.1 0.1 66.0 70.6 0.2 10.4 13.3 5.3 1.2 22.9 0.1 130.8 22.4 0.0 0.7 0.2 23.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.2 0.0 1.8 0.1 0.0 0.0 0.1 0.0 1.6 1.4 1.2 2.0 1.6 1.5 1.6 1.6 1.9 1.3 1.5 2.0 8.5 64.1 33.9 6.5 0.9 1.5 15.0 22.2 5.2 2.2 9.4 5.6 2.0 34.3 26.2 46.0 27.1 87.7 0.3 20.1 43.0 50.3 25.3 30.9 6.0 5.4 3.0 0.0 1.5 67.0 69.4 11.7 67.8 34.4 1.3 43.3 2.5 45.5 37.7 1.7 1.0 24.8 54.9 8.5 1.6 53.5 6.2 6.3 0.0 1.9 0.6 3.5 0.0 11.1 0.3 99.1 8.3 11.3 0.4 14.6 20.5 10.9 46.9 36.2 19.7 3.0 6.5 0.5 2.8 31.9 2.6 30.6 1.0 52.0 26.3 31.2 SIL1 "BAP, MSS, ULG5" ENSG00000120725 "SIL1 nucleotide exchange factor" Q9H173 5 138946724-139293557 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 195.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011949 Enhanced "Intracellular and membrane" NA NA 710000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "HPA011949: AB_1856875" "unprognostic (1.06e-1)" "unprognostic (9.01e-2)" "unprognostic (2.04e-1)" "prognostic favorable (4.34e-4)" "prognostic unfavorable (4.27e-4)" "unprognostic (9.12e-3)" "unprognostic (3.60e-1)" "unprognostic (2.45e-1)" "unprognostic (1.33e-1)" "unprognostic (6.91e-2)" "unprognostic (2.31e-2)" "unprognostic (9.46e-2)" "unprognostic (3.21e-3)" "unprognostic (1.59e-1)" "unprognostic (1.65e-1)" "unprognostic (6.79e-2)" "unprognostic (1.22e-2)" 26.4 46.4 9.0 19.7 10.6 24.1 21.6 8.5 11.8 21.7 17.9 20.0 24.6 21.7 32.5 16.5 19.2 23.2 29.5 9.2 9.3 20.9 54.9 22.6 14.1 10.6 9.9 19.1 67.7 33.7 28.5 28.7 10.5 23.9 12.8 5.7 36.7 25.8 41.4 23.2 16.4 17.2 8.2 17.3 29.5 49.8 11.3 9.0 36.2 18.0 10.0 20.6 16.2 10.3 33.7 34.9 11.3 56.2 84.0 48.3 65.0 54.0 58.2 26.6 57.3 36.9 78.9 12.4 89.7 74.2 32.2 29.8 12.0 76.0 15.8 33.7 20.7 16.4 23.9 40.9 67.2 4.9 72.6 60.7 73.1 46.4 79.0 42.7 40.5 15.4 8.7 131.3 32.2 52.1 12.4 15.1 2.4 38.6 4.2 8.9 7.8 92.7 38.9 17.7 19.5 13.0 46.3 44.3 74.5 24.8 38.4 30.6 30.6 46.8 10.9 17.9 23.6 56.3 31.6 8.2 34.3 38.1 39.9 18.1 47.7 19.4 17.4 52.4 10.9 20.1 12.1 16.8 51.3 14.7 12.1 15.1 5.7 22.1 42.3 37.3 11.7 27.1 9.0 10.6 8.5 11.8 9.2 9.3 10.6 9.9 10.5 8.2 11.3 10.3 22.5 19.2 47.0 51.6 32.5 22.0 33.4 61.6 15.4 9.0 33.8 21.6 30.3 38.6 48.1 42.3 37.5 121.2 19.0 41.5 11.7 61.8 109.1 25.5 37.0 21.9 33.5 7.6 75.7 81.7 104.2 46.3 38.7 32.1 60.3 29.2 29.3 143.8 70.3 25.2 73.7 64.3 52.9 33.9 21.0 195.7 28.6 36.7 48.0 49.6 113.8 15.2 17.5 66.4 57.6 46.2 34.9 22.2 114.5 32.1 51.1 46.5 51.6 26.6 19.7 21.4 27.7 96.9 61.8 13.0 23.9 153.6 16.9 60.3 43.0 30.1 SLC10A7 "C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043" ENSG00000120519 "Solute carrier family 10 member 7" Q0GE19 4 146253975-146521964 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Amelogenesis imperfecta, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 44.4;Microglial cells: 50.6;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 82.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039996 Uncertain NA NA "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA039996: AB_10673266" "unprognostic (9.44e-2)" "unprognostic (4.03e-1)" "unprognostic (3.39e-3)" "unprognostic (5.07e-2)" "unprognostic (1.01e-1)" "unprognostic (9.02e-2)" "unprognostic (7.96e-2)" "unprognostic (2.54e-1)" "unprognostic (3.55e-1)" "unprognostic (8.53e-2)" "unprognostic (2.68e-3)" "unprognostic (1.24e-1)" "unprognostic (1.43e-2)" "unprognostic (8.99e-2)" "unprognostic (2.79e-1)" "unprognostic (6.69e-2)" "unprognostic (9.57e-2)" 5.4 4.6 2.6 4.9 4.0 6.0 6.0 3.2 2.6 7.2 1.7 7.0 4.6 4.9 12.0 5.8 4.4 5.6 2.9 2.9 3.6 3.8 7.2 5.9 5.6 4.6 3.8 5.6 6.5 3.7 3.6 8.9 4.9 6.3 9.2 3.9 6.9 3.3 2.2 3.7 5.4 5.9 3.8 5.3 9.7 3.4 3.5 6.5 7.0 3.2 5.9 4.7 4.8 5.1 5.2 1.7 12.2 5.0 8.6 10.3 5.8 6.3 8.2 5.7 5.8 4.7 21.6 9.6 4.4 6.9 3.6 5.2 7.2 8.6 6.8 11.1 3.5 11.8 4.2 8.5 5.5 20.5 18.3 4.9 6.8 6.9 8.7 3.1 10.2 10.2 13.2 25.6 4.3 3.6 15.6 5.2 2.2 11.4 8.6 8.6 8.9 13.7 4.0 3.8 3.7 3.1 4.3 12.8 5.3 6.4 7.5 8.1 5.8 5.1 5.4 7.8 4.4 20.7 24.9 13.4 7.0 8.2 7.4 10.9 3.0 4.5 3.7 4.8 3.8 3.9 3.7 3.3 4.0 2.8 3.5 3.4 0.3 5.1 3.9 2.7 4.9 2.2 2.6 4.0 3.2 2.6 2.9 3.6 4.6 3.8 4.9 3.8 3.5 5.1 10.8 3.2 3.9 44.4 7.9 3.3 4.2 2.0 2.8 6.8 5.2 3.7 2.1 8.6 3.2 1.8 4.2 6.4 8.2 6.2 1.9 4.0 2.3 4.8 6.2 5.4 4.8 9.9 34.3 5.1 13.2 6.1 11.2 6.0 22.9 5.8 8.9 10.3 5.8 8.4 37.1 14.7 2.0 7.3 3.1 1.2 7.5 6.1 0.0 50.6 4.9 3.4 6.2 62.4 82.0 3.6 3.4 4.9 15.8 3.3 4.2 1.9 7.3 11.8 0.0 4.0 5.5 7.0 4.5 5.2 4.8 6.2 8.6 2.3 7.6 4.1 SLC12A8 CCC9 ENSG00000221955 "Solute carrier family 12 member 8" A0AV02 3 125082636-125212864 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 22.9" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA031123 Uncertain Approved Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm "HPA031123: AB_2301872" "unprognostic (4.74e-2)" "unprognostic (1.46e-3)" "unprognostic (1.39e-1)" "unprognostic (5.91e-3)" "unprognostic (7.35e-3)" "unprognostic (1.79e-1)" "unprognostic (2.07e-1)" "unprognostic (3.76e-2)" "unprognostic (1.01e-1)" "unprognostic (7.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.56e-4)" "unprognostic (7.18e-2)" "unprognostic (3.47e-2)" "unprognostic (2.57e-2)" "unprognostic (1.78e-2)" 1.5 1.1 2.9 1.2 3.2 0.0 2.3 1.0 3.1 1.4 11.7 3.5 5.6 0.6 3.6 4.1 2.0 8.3 0.6 3.4 2.4 3.2 6.8 2.2 0.6 1.6 2.0 0.3 10.0 4.3 2.2 2.7 1.9 2.8 4.2 0.1 11.9 0.6 0.1 1.3 3.6 0.7 1.0 0.3 4.1 2.3 2.0 0.5 22.9 0.0 0.9 2.1 2.2 2.0 14.7 0.0 2.7 0.0 3.3 4.6 6.7 0.8 2.0 0.9 1.7 19.6 6.8 0.0 1.9 5.6 2.8 8.5 0.0 0.0 0.5 0.0 0.0 0.0 7.2 0.0 33.6 0.0 1.0 8.7 8.3 1.9 0.9 16.3 0.0 0.0 0.0 0.6 1.3 3.9 0.0 0.0 9.3 27.6 0.7 0.0 0.2 0.0 6.8 1.3 4.2 0.0 7.0 8.4 0.1 0.9 15.6 0.4 0.2 0.2 1.3 67.9 0.0 0.1 1.9 5.0 3.3 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.2 1.0 3.1 3.4 2.4 1.6 2.0 1.9 1.0 2.0 2.0 0.2 0.0 0.5 7.2 0.1 1.0 1.3 3.3 3.4 0.0 5.6 4.3 1.1 2.8 2.5 23.9 0.0 0.5 0.1 1.6 0.0 3.9 0.3 0.8 1.4 0.3 5.4 0.0 38.4 3.5 6.5 2.1 7.7 2.7 17.8 1.8 0.0 9.4 0.9 0.0 27.8 36.6 0.0 0.0 0.7 0.5 0.0 0.5 0.0 7.5 2.1 0.0 1.0 31.7 2.0 2.9 3.4 0.0 0.2 6.2 2.6 1.5 0.4 0.0 0.0 0.2 0.7 0.6 0.4 4.3 0.3 3.0 0.8 0.1 5.6 1.0 SLC25A15 "D13S327, HHH, ORC1, ORNT1" ENSG00000102743 "Solute carrier family 25 member 15" Q9Y619 13 40789412-40812460 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 37.6;liver: 88.3;pancreas: 52.1" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 44.5;Hepatocytes: 39.8;Proximal enterocytes: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042146 Approved NA NA "Cluster 32: T-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA042146: AB_2677874" "unprognostic (4.17e-1)" "unprognostic (4.50e-2)" "unprognostic (2.86e-2)" "unprognostic (5.19e-2)" "unprognostic (1.38e-1)" "unprognostic (3.85e-1)" "prognostic favorable (2.16e-4)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (2.37e-2)" "prognostic favorable (1.74e-4)" "unprognostic (4.04e-3)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (5.46e-4)" 2.3 1.4 2.0 4.1 2.2 5.6 4.6 2.3 2.5 2.1 2.3 5.9 37.6 3.1 1.1 3.2 2.6 5.0 2.8 1.9 2.6 5.6 88.3 2.3 4.8 2.6 2.3 2.9 52.1 3.4 1.3 2.8 2.5 2.8 6.5 2.8 3.4 1.8 5.9 3.7 26.7 3.4 2.1 2.5 5.5 9.4 2.4 5.3 17.3 6.0 5.3 2.6 1.6 2.9 7.4 14.7 16.5 21.3 6.5 8.2 17.3 5.6 2.9 6.8 3.9 17.6 15.2 48.0 6.4 10.3 12.7 12.6 26.6 15.5 7.0 11.9 12.4 37.0 8.6 26.6 12.7 15.0 5.3 9.0 8.6 9.6 21.9 4.6 11.2 23.8 18.1 7.8 11.8 28.2 10.2 9.9 33.2 32.7 7.9 25.5 12.0 10.6 11.7 7.0 7.7 20.1 10.2 18.4 10.1 11.5 13.6 23.2 8.4 8.4 12.1 12.7 17.0 8.9 9.6 27.9 8.4 11.4 16.4 1.3 0.5 0.1 1.6 0.9 1.0 0.6 1.0 1.1 1.1 0.7 1.0 2.0 0.7 1.4 0.5 0.5 0.9 0.5 2.0 2.2 2.3 2.5 1.9 2.6 2.6 2.3 2.5 2.1 2.4 2.9 0.3 3.2 0.5 3.9 1.3 0.3 1.0 0.8 2.2 1.4 2.1 1.4 1.1 1.5 0.2 0.0 0.0 2.2 1.3 0.6 7.9 2.1 4.6 1.2 2.1 0.9 1.2 9.0 2.4 4.3 44.5 1.0 1.5 2.1 0.0 1.5 0.7 39.8 1.7 0.0 4.3 0.6 2.0 1.6 0.3 6.8 0.6 1.0 1.8 1.0 0.0 0.4 2.1 5.0 1.4 1.7 2.7 0.0 6.2 1.6 19.0 4.3 0.1 1.9 0.0 1.0 1.1 5.4 9.3 2.1 0.1 1.5 3.2 4.3 3.5 0.8 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468422-119471396 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2533.6;Proximal enterocytes: 2785.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 640000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.25e-2)" "prognostic favorable (7.35e-4)" "prognostic favorable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 178.1 178.3 116.9 176.0 116.1 260.9 161.3 141.6 126.0 155.0 114.3 458.7 740.2 134.5 63.9 411.0 118.6 100.4 196.1 109.0 141.5 491.8 336.1 216.5 255.4 120.6 118.0 108.2 629.1 295.3 89.0 138.1 126.4 111.9 503.0 127.7 250.2 103.8 61.6 294.9 562.8 150.5 119.3 182.6 492.1 54.2 126.4 351.9 128.8 65.1 297.7 200.8 235.3 121.5 845.1 789.6 303.3 525.4 189.5 277.3 561.0 306.8 331.3 631.7 560.8 662.4 518.4 1059.3 400.9 296.1 456.1 576.9 752.1 640.5 572.5 281.1 711.2 357.5 418.7 477.0 239.8 984.0 566.1 303.7 705.2 652.2 412.6 240.1 660.4 535.0 292.5 425.9 350.1 1868.4 878.6 995.1 640.4 1147.6 1244.3 474.5 383.4 825.7 486.9 663.6 365.0 344.5 526.7 793.3 646.7 306.7 327.7 491.0 279.5 297.3 428.9 670.8 1122.2 494.6 656.3 847.4 329.5 987.7 492.2 113.4 603.4 170.2 170.7 1045.7 198.1 459.2 248.3 224.6 872.6 376.0 243.3 232.1 99.2 318.1 824.2 476.1 443.1 931.8 116.9 116.1 141.6 126.0 109.0 141.5 120.6 118.0 126.4 119.3 126.4 121.5 260.4 163.5 308.6 28.7 339.6 815.7 567.0 1615.3 398.9 109.8 406.2 413.5 131.2 301.7 609.2 187.6 60.5 1038.8 336.2 1379.0 2533.6 578.2 4.0 137.3 134.2 257.5 401.0 349.1 16.8 1056.4 463.1 214.4 543.3 157.6 192.9 306.0 146.7 333.6 881.7 26.9 25.5 856.4 1129.1 610.6 650.9 18.1 145.4 473.2 547.8 15.0 441.2 140.8 218.3 24.1 19.2 554.1 1061.8 110.6 419.9 522.3 2785.2 1622.3 239.5 199.0 131.5 163.9 506.7 11.5 119.2 1046.8 960.2 1589.1 291.2 626.6 1053.7 809.7 SLC27A3 "ACSVL3, FATP3, MGC4365" ENSG00000143554 "Solute carrier family 27 member 3" Q5K4L6 1 153774354-153780157 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "dendritic cells: 7.4;granulocytes: 12.6;monocytes: 11.1" "Cell line enhanced" "Detected in many" "ASC diff: 53.3;MCF7: 30.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA006935, HPA067508" Enhanced Enhanced "Endoplasmic reticulum" Yes No "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Endoplasmic reticulum" "HPA006935: AB_1080003, HPA067508: AB_2685857" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (1.34e-1)" "unprognostic (3.57e-2)" "unprognostic (2.70e-2)" "unprognostic (4.85e-2)" "unprognostic (6.08e-2)" "unprognostic (3.18e-2)" "unprognostic (4.22e-2)" "unprognostic (3.39e-2)" "prognostic favorable (5.23e-4)" "unprognostic (4.67e-2)" "prognostic unfavorable (6.33e-4)" "unprognostic (1.95e-1)" "unprognostic (4.41e-1)" "unprognostic (2.59e-1)" "unprognostic (2.08e-1)" 18.9 5.0 4.1 3.3 4.1 2.5 17.7 3.3 5.7 8.3 4.6 8.8 2.4 6.3 37.7 6.1 9.8 5.7 8.3 4.0 4.1 11.1 20.4 19.0 4.7 4.2 5.6 9.2 8.0 9.2 9.9 6.4 3.9 7.1 5.0 0.6 5.1 8.0 3.1 12.3 7.7 5.8 3.6 8.6 19.3 12.2 3.9 2.3 9.4 3.7 2.8 7.4 9.5 4.0 2.6 0.5 3.1 1.5 53.3 10.8 0.8 0.5 3.9 1.2 1.0 1.8 1.8 1.1 1.6 2.4 0.6 9.3 3.0 1.5 0.7 0.4 1.4 1.5 2.8 1.9 6.7 1.4 5.8 5.5 6.6 0.3 1.4 1.1 7.0 0.3 0.8 1.4 0.3 30.8 0.3 8.1 3.4 12.2 1.4 8.6 0.6 0.9 1.5 0.9 2.7 1.7 0.6 9.6 3.0 4.1 3.9 5.5 0.0 1.5 2.8 3.3 0.1 2.4 2.4 0.3 2.5 5.7 1.2 9.5 10.7 12.6 2.1 8.8 1.3 0.6 0.6 2.1 7.4 0.7 0.2 0.6 0.9 2.5 11.1 1.0 0.2 3.4 4.1 4.1 3.3 5.7 4.0 4.1 4.2 5.6 3.9 3.6 3.9 4.0 47.3 19.2 51.8 6.5 5.5 11.7 12.6 9.0 8.0 0.9 4.4 11.3 4.6 34.3 10.1 3.7 0.0 27.2 20.7 4.2 0.0 4.3 0.6 5.1 12.1 42.4 4.2 0.4 2.6 7.3 13.0 20.3 16.8 7.9 25.4 1.8 106.1 30.6 33.2 1.7 2.6 23.7 6.1 31.7 39.8 3.2 19.0 21.3 23.2 1.9 44.6 2.0 35.0 0.5 1.6 3.1 42.3 14.3 7.9 3.4 2.5 3.6 6.6 1.0 6.6 3.4 15.7 1.7 2.9 5.5 7.7 8.8 13.0 5.2 10.7 7.0 SLC2A10 GLUT10 ENSG00000197496 "Solute carrier family 2 member 10" O95528 20 46709649-46736347 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 43.6;Intestinal goblet cells: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 75 "basophil: 20.9" "Lineage enriched" "Detected in single" 75 "granulocytes: 20.9" "Cell line enhanced" "Detected in many" "ASC diff: 45.8;HSkMC: 56.6;OE19: 49.8;SK-MEL-30: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041015, HPA055673" Approved Supported Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol "HPA041015: AB_2677252, HPA055673: AB_2682879" "unprognostic (8.94e-3)" "unprognostic (2.62e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (6.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.68e-2)" "unprognostic (2.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.06e-2)" "unprognostic (4.94e-3)" "unprognostic (1.70e-1)" "unprognostic (3.63e-3)" "unprognostic (1.25e-2)" "unprognostic (1.05e-1)" "unprognostic (3.00e-1)" "unprognostic (5.96e-2)" 7.0 5.9 4.0 3.5 4.1 1.2 15.3 3.4 3.9 19.4 18.9 12.7 5.4 7.9 8.7 5.1 9.9 10.3 5.2 3.8 3.7 3.5 41.4 6.9 1.7 5.2 4.7 9.9 17.4 19.5 6.3 11.6 4.0 31.3 16.0 1.6 24.0 9.9 1.5 3.6 5.3 8.5 3.8 2.6 22.8 2.6 4.0 1.6 19.5 2.7 2.1 9.3 8.4 3.4 0.0 0.1 11.3 11.7 45.8 38.9 34.2 22.2 30.2 10.1 12.0 0.9 38.9 0.0 16.3 40.6 0.0 0.2 0.0 1.1 4.8 0.0 0.3 3.3 0.0 18.6 32.2 0.0 0.0 56.6 1.0 6.2 0.0 11.8 4.2 0.0 0.2 0.1 17.5 41.3 0.0 1.2 4.3 49.8 2.9 0.0 1.6 0.1 0.0 10.6 0.0 1.8 4.3 7.2 60.3 8.1 5.4 9.2 2.6 21.7 9.1 17.2 2.9 0.3 0.1 0.0 0.1 0.0 4.6 20.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 4.0 4.1 3.4 3.9 3.8 3.7 5.2 4.7 4.0 3.8 4.0 3.4 4.2 6.4 6.3 12.4 0.8 0.6 6.1 7.8 5.2 0.0 29.6 14.4 6.4 7.2 15.8 1.8 0.0 2.7 0.4 11.4 0.0 7.4 0.2 3.2 17.8 4.6 3.6 6.1 0.1 5.6 16.3 16.7 23.4 4.0 6.3 10.7 8.6 43.6 1.1 0.0 0.4 56.6 12.2 1.9 1.3 1.6 26.4 0.4 1.8 2.8 0.0 5.5 0.0 10.1 0.3 5.1 10.3 17.3 2.8 23.9 1.7 0.8 27.5 0.5 13.1 5.1 6.3 0.8 0.3 4.2 1.0 2.1 0.5 3.6 14.6 10.9 SLC30A5 "FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1" ENSG00000145740 "Solute carrier family 30 member 5" Q8TAD4 5 69093949-69131069 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035373 Approved Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "Golgi apparatus" Nucleoplasm "HPA035373: AB_10794630" "unprognostic (9.81e-3)" "unprognostic (3.33e-1)" "unprognostic (2.82e-2)" "unprognostic (8.16e-2)" "unprognostic (1.65e-1)" "unprognostic (3.88e-2)" "unprognostic (1.16e-3)" "unprognostic (2.47e-2)" "unprognostic (4.65e-2)" "unprognostic (5.41e-2)" "unprognostic (3.57e-2)" "unprognostic (2.92e-1)" "unprognostic (1.49e-1)" "unprognostic (2.53e-2)" "unprognostic (2.07e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" 25.8 25.6 9.8 21.0 10.3 19.6 30.3 11.7 15.9 29.7 17.4 26.9 24.7 25.6 38.2 19.3 24.3 24.0 24.1 9.7 10.6 29.1 29.0 21.1 24.7 10.1 11.4 22.3 33.0 35.9 24.0 27.4 10.2 29.4 24.7 18.5 30.8 24.0 16.4 27.1 23.6 22.8 9.7 21.9 26.3 16.4 10.9 20.8 37.5 16.5 23.7 23.6 19.7 12.1 37.4 29.9 26.3 46.2 69.1 53.2 82.5 58.8 53.6 36.4 55.1 26.0 45.7 50.2 70.6 41.4 63.7 38.8 38.6 46.1 61.5 60.2 43.5 55.7 35.0 43.2 55.0 34.8 58.3 35.7 57.1 38.3 46.5 50.1 36.6 34.2 34.9 57.0 46.1 46.9 46.4 71.6 29.4 25.3 33.3 35.5 33.2 89.9 53.6 34.5 46.0 36.8 47.4 45.0 84.5 36.0 43.7 76.2 33.3 23.2 29.5 58.7 58.2 49.5 67.5 37.9 46.6 62.3 58.9 11.9 5.1 8.5 4.1 5.3 4.4 6.9 6.4 6.2 6.3 4.3 5.9 4.8 4.1 4.0 5.5 9.6 4.9 2.8 9.8 10.3 11.7 15.9 9.7 10.6 10.1 11.4 10.2 9.7 10.9 12.1 17.3 19.2 21.5 14.7 26.9 18.7 27.9 27.5 19.9 15.3 28.5 20.6 29.2 18.6 23.2 25.8 22.9 42.0 35.3 19.9 29.4 22.0 6.9 28.8 35.8 19.3 13.2 29.9 29.6 27.1 80.4 24.8 34.7 23.7 41.3 15.4 21.8 19.8 22.3 8.4 30.6 27.9 32.6 17.2 18.4 9.9 24.2 16.8 14.2 19.7 21.2 14.9 15.5 22.1 23.3 19.0 16.7 22.2 51.8 34.7 16.9 21.3 27.7 24.7 26.3 17.5 21.4 11.0 14.9 26.6 21.5 51.6 23.4 20.9 23.2 28.6 SLC30A7 "ZNT7, ZnTL2" ENSG00000162695 "Solute carrier family 30 member 7" Q8NEW0 1 100896076-100981757 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018034 Uncertain Supported "Golgi apparatus" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA018034: AB_1857089" "unprognostic (1.94e-1)" "unprognostic (1.08e-1)" "unprognostic (8.05e-3)" "unprognostic (1.79e-1)" "unprognostic (2.50e-1)" "unprognostic (3.18e-1)" "unprognostic (2.89e-3)" "unprognostic (1.24e-1)" "unprognostic (1.61e-1)" "unprognostic (1.11e-3)" "unprognostic (2.78e-2)" "unprognostic (1.95e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (3.37e-1)" 6.8 6.8 2.5 7.2 3.0 6.7 6.5 3.7 3.5 7.2 6.6 5.9 6.6 4.7 7.8 5.0 4.6 6.7 4.2 2.5 3.0 5.3 10.2 9.3 7.5 2.9 3.1 4.5 8.0 6.8 5.7 8.7 3.0 5.9 7.1 4.7 8.6 3.6 2.6 6.1 6.1 4.4 2.7 7.1 7.6 3.0 3.2 7.0 6.9 2.1 7.0 7.8 5.3 3.9 11.3 5.2 6.1 12.5 16.5 14.9 16.2 8.5 17.0 7.3 9.4 5.3 7.7 5.0 17.2 14.1 4.9 10.7 6.5 11.1 12.7 6.4 4.7 8.5 8.4 11.4 19.5 11.7 7.6 17.3 8.4 12.9 18.9 10.9 15.3 8.4 4.9 15.9 12.5 4.4 9.4 8.1 7.7 5.6 5.5 4.2 10.8 5.8 10.6 10.0 3.3 7.4 11.4 15.8 12.2 5.3 6.7 8.1 17.9 18.2 6.3 19.9 13.7 14.0 5.7 4.6 23.1 11.1 5.7 8.3 5.8 4.2 5.2 6.6 4.9 2.7 5.3 4.8 3.9 2.5 5.5 5.7 2.7 3.5 8.7 3.9 4.3 3.1 2.5 3.0 3.7 3.5 2.5 3.0 2.9 3.1 3.0 2.7 3.2 3.9 28.3 32.1 21.6 32.3 26.3 57.4 19.7 22.8 21.1 10.1 25.8 13.2 6.1 20.0 22.1 23.9 6.2 32.6 24.5 24.1 1.9 24.1 0.9 14.9 27.0 34.5 22.8 11.6 44.8 26.4 24.3 29.1 29.0 29.4 37.4 16.3 33.5 44.6 22.1 5.0 39.6 38.3 14.2 37.0 39.1 1.1 17.1 28.5 32.0 34.7 29.6 6.5 28.8 52.8 59.2 36.0 27.9 16.6 48.1 46.0 20.7 15.7 23.5 13.7 6.6 30.2 20.9 11.4 9.2 19.3 63.9 41.7 28.8 34.8 24.3 32.7 SLC33A1 "ACATN, AT-1, AT1, SPG42" ENSG00000169359 "Solute carrier family 33 member 1" O00400 3 155821024-155854456 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042430 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Vesicles, Cytosol" "HPA042430: AB_10806238" "unprognostic (5.12e-3)" "unprognostic (7.78e-2)" "unprognostic (1.13e-2)" "unprognostic (7.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.73e-2)" "unprognostic (9.57e-2)" "unprognostic (5.65e-2)" "unprognostic (6.61e-2)" "unprognostic (4.36e-2)" "unprognostic (1.19e-1)" "unprognostic (1.93e-1)" "unprognostic (2.08e-2)" "unprognostic (2.92e-1)" "unprognostic (4.73e-2)" "unprognostic (5.74e-2)" 8.8 11.0 3.9 4.9 4.8 2.9 8.4 4.6 4.7 12.3 9.2 7.2 6.9 8.8 12.9 8.0 9.5 7.8 7.6 4.6 5.3 10.4 17.2 8.4 5.0 4.4 4.2 8.0 30.9 11.6 5.9 6.6 4.6 8.3 6.4 6.8 11.2 11.0 4.7 6.4 7.7 7.1 5.2 5.8 8.8 5.4 5.2 7.1 18.8 4.8 6.2 6.8 7.9 7.3 18.9 17.7 7.3 8.3 24.4 23.5 12.9 13.1 21.2 19.8 18.7 8.5 22.0 9.9 24.1 13.1 19.8 17.1 14.3 15.2 20.8 16.5 13.3 11.3 6.5 15.8 41.5 13.3 8.9 18.4 26.7 9.7 49.5 20.5 19.8 12.4 8.6 27.8 14.3 14.3 5.0 3.7 6.8 17.7 14.9 5.6 8.1 29.1 9.7 11.8 7.9 5.9 11.1 24.5 21.4 11.3 8.1 11.2 21.4 10.1 4.9 17.9 13.1 33.2 14.4 12.3 14.6 8.8 14.0 12.7 8.4 6.2 8.9 6.3 9.6 5.4 6.0 6.8 10.4 3.5 5.4 5.5 1.7 6.6 6.5 16.1 5.7 5.9 3.9 4.8 4.6 4.7 4.6 5.3 4.4 4.2 4.6 5.2 5.2 7.3 9.0 22.4 25.0 16.0 14.8 8.9 11.7 20.8 18.2 17.5 16.0 9.0 23.8 18.6 21.5 11.0 27.1 18.2 21.1 14.2 5.9 15.3 13.7 11.2 20.3 13.7 12.5 8.4 17.9 15.4 28.3 19.7 20.9 16.6 12.0 12.8 16.4 64.3 19.5 18.5 17.4 18.1 12.2 14.7 15.8 13.2 18.6 15.2 12.4 10.3 19.0 15.4 12.3 11.1 20.8 14.4 5.3 21.4 33.3 19.5 18.9 17.1 23.4 23.0 13.1 16.0 16.0 19.5 9.2 12.2 9.5 37.6 15.3 10.2 13.9 10.9 SLC35A2 "UGALT, UGAT, UGT, UGT1, UGT2, UGTL" ENSG00000102100 "Solute carrier family 35 member A2" P78381 X 48903180-48911958 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036087 Approved Supported "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 30: Mammary glandular cells - Lactation" "Golgi apparatus" "HPA036087: AB_10604093" "prognostic unfavorable (3.16e-4)" "unprognostic (3.34e-1)" "unprognostic (4.88e-3)" "unprognostic (1.11e-1)" "unprognostic (8.15e-3)" "unprognostic (4.25e-3)" "prognostic unfavorable (9.64e-5)" "unprognostic (3.47e-1)" "unprognostic (2.50e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-3)" "unprognostic (9.58e-2)" "unprognostic (3.16e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.38e-1)" "unprognostic (1.61e-1)" "unprognostic (5.13e-2)" 15.8 20.5 13.7 12.7 14.3 15.9 14.9 14.3 14.8 18.7 19.4 29.3 17.3 13.1 28.4 24.7 32.6 15.2 15.0 14.5 15.8 19.8 31.8 18.2 11.4 14.6 15.0 9.3 30.0 24.7 21.3 19.9 15.4 17.1 28.2 3.1 23.8 14.8 14.0 21.9 18.0 11.7 14.4 14.7 25.0 7.1 15.9 11.8 15.4 7.2 14.7 19.8 15.4 15.9 48.8 55.2 18.8 27.3 36.5 31.6 29.7 49.7 54.1 51.3 59.9 64.0 84.5 18.8 22.2 54.2 64.4 67.0 51.7 40.0 39.7 27.9 34.0 20.5 33.1 49.6 47.8 38.7 40.9 35.7 69.9 48.6 39.8 28.9 30.6 25.9 38.7 29.8 37.6 47.1 20.5 35.0 39.7 55.3 67.7 22.3 35.5 61.1 44.4 39.1 21.8 36.1 52.9 54.5 28.7 35.1 80.8 30.7 28.2 30.3 30.6 55.4 27.5 45.1 32.8 19.6 38.4 34.1 40.3 18.1 22.3 40.0 15.3 23.4 15.8 10.7 12.6 13.9 27.7 9.9 8.3 14.6 24.2 13.8 17.5 27.7 13.1 11.9 13.7 14.3 14.3 14.8 14.5 15.8 14.6 15.0 15.4 14.4 15.9 15.9 16.2 9.6 17.0 3.3 13.1 14.1 11.7 29.0 2.8 4.5 26.5 10.9 5.2 10.0 23.5 16.5 0.0 31.0 15.6 24.1 3.9 27.4 3.3 24.2 12.0 13.5 12.7 19.0 2.6 32.3 30.6 14.0 18.8 16.8 2.5 8.0 11.0 15.6 23.4 6.7 2.5 31.5 28.5 10.1 14.5 1.3 9.9 12.3 10.6 4.7 21.9 9.4 8.2 4.5 4.4 27.1 19.7 10.9 19.3 18.7 17.8 10.5 50.5 5.7 6.6 9.7 19.4 10.3 6.8 10.9 17.5 48.0 13.8 12.2 21.7 23.4 SLC35B2 UGTrel4 ENSG00000157593 "Solute carrier family 35 member B2" Q8TB61 6 44254096-44257890 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029638 Approved Approved Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA029638: AB_10602402" "prognostic unfavorable (7.90e-4)" "unprognostic (2.47e-3)" "unprognostic (2.30e-1)" "unprognostic (1.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (3.84e-1)" "unprognostic (2.51e-1)" "unprognostic (7.03e-3)" "unprognostic (4.27e-2)" "prognostic favorable (6.07e-4)" "unprognostic (3.60e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" 20.1 36.7 21.2 19.6 25.7 18.4 25.2 27.0 42.3 23.3 24.1 27.1 19.6 28.5 29.5 17.5 26.2 30.0 26.4 19.5 23.3 30.3 30.6 21.7 21.5 25.8 25.1 21.3 41.8 42.5 14.6 25.0 25.6 24.0 28.8 14.6 46.4 27.4 22.4 21.9 23.9 29.7 26.1 24.7 30.6 14.7 26.1 18.5 24.4 23.7 22.3 28.1 19.5 30.9 87.2 48.8 61.4 117.6 106.4 102.3 44.1 95.1 152.3 89.3 109.4 43.3 79.3 19.2 81.9 117.3 97.7 81.1 42.5 106.3 64.4 57.4 53.3 39.8 37.9 59.5 94.1 85.2 61.5 107.0 112.1 85.5 43.1 129.1 67.4 43.2 56.8 81.4 112.5 106.9 32.5 71.0 27.2 271.3 58.9 30.9 38.3 100.2 100.3 65.5 75.4 71.4 45.9 52.2 109.6 37.6 93.3 75.7 65.8 71.0 46.2 71.3 83.3 62.4 75.7 45.6 95.6 67.6 147.5 51.9 14.5 23.5 33.1 11.4 28.3 19.7 18.6 25.2 12.9 13.2 16.6 22.0 1.3 20.3 3.9 23.5 16.4 17.7 21.2 25.7 27.0 42.3 19.5 23.3 25.8 25.1 25.6 26.1 26.1 30.9 8.0 6.4 11.5 8.5 19.2 13.5 32.0 58.3 23.9 9.7 31.6 30.1 7.8 37.1 34.8 27.6 2.1 59.2 15.3 15.2 13.7 84.0 0.6 16.0 17.8 11.1 19.7 10.5 3.5 73.8 52.1 27.5 14.3 19.5 34.9 11.9 13.6 18.7 38.4 10.1 4.3 21.6 57.0 11.4 10.8 2.3 23.3 22.0 53.4 4.7 22.0 38.8 23.7 9.5 13.8 67.4 25.9 19.9 23.3 36.3 18.8 13.5 18.4 12.5 0.0 18.3 24.5 21.0 60.8 17.4 13.9 35.2 14.0 14.8 31.5 24.2 SLC35B3 "C6orf196, CGI-19, dJ453H5.1, PAPST2" ENSG00000124786 "Solute carrier family 35 member B3" Q9H1N7 6 8411435-8435561 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054661, HPA057801" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA054661: AB_2682561, HPA057801: AB_2683532" "unprognostic (2.84e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (4.93e-2)" "unprognostic (5.23e-3)" "unprognostic (5.00e-2)" "unprognostic (9.45e-2)" "unprognostic (9.27e-2)" "unprognostic (3.43e-1)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (3.08e-3)" "unprognostic (3.88e-3)" 11.3 9.7 6.0 10.2 7.6 4.6 12.9 6.3 10.6 12.2 7.2 24.2 14.8 9.4 43.0 10.3 9.6 15.1 10.3 6.3 6.2 16.4 23.4 10.6 12.2 7.2 6.6 8.1 18.4 14.6 12.0 14.7 7.1 12.1 24.9 5.2 15.0 17.4 5.7 10.7 16.9 9.4 6.4 13.4 17.9 8.8 6.6 9.9 18.2 4.5 11.8 12.3 10.9 9.4 14.8 7.7 10.4 14.1 23.4 35.7 8.5 37.9 31.4 13.5 17.3 24.7 13.9 12.5 20.9 27.7 19.5 10.6 11.5 10.3 22.6 18.0 8.4 6.1 6.1 15.0 24.5 9.1 13.2 24.4 14.3 14.3 15.5 17.5 18.5 7.4 13.2 5.1 30.5 10.2 6.9 13.7 8.2 20.6 9.2 6.2 9.7 12.6 36.7 13.2 9.9 8.4 9.8 8.6 17.9 29.6 6.5 18.4 15.9 22.3 6.4 15.9 17.2 12.8 23.9 6.3 12.8 10.0 29.6 5.4 4.5 4.8 6.2 3.5 6.9 4.2 6.2 6.6 4.0 5.8 7.0 5.5 5.2 10.8 5.8 2.7 7.0 4.3 6.0 7.6 6.3 10.6 6.3 6.2 7.2 6.6 7.1 6.4 6.6 9.4 13.3 6.4 10.6 21.9 14.9 13.5 13.0 29.4 10.8 5.7 20.9 10.3 9.1 20.0 27.5 29.5 4.2 21.1 18.5 42.8 7.9 20.5 9.9 28.6 19.4 15.1 14.9 5.5 19.5 24.3 29.1 21.8 28.1 15.5 6.3 11.5 18.5 23.6 19.9 10.1 17.7 47.3 36.7 15.1 10.4 7.6 15.5 11.3 21.4 24.4 16.7 7.1 13.4 30.7 65.7 15.4 33.4 12.0 22.2 22.6 31.1 27.5 46.8 3.7 13.1 9.9 15.7 32.1 14.2 13.7 17.6 16.4 13.1 10.7 33.5 22.9 SLC38A10 "MGC15523, PP1744" ENSG00000157637 "Solute carrier family 38 member 10" Q9HBR0 17 81244811-81295547 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021374, HPA023161, HPA024631" Enhanced Enhanced "Golgi apparatus" NA NA 70000000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860" "unprognostic (2.18e-2)" "unprognostic (1.54e-1)" "unprognostic (7.40e-2)" "unprognostic (3.00e-3)" "unprognostic (2.06e-2)" "unprognostic (1.69e-1)" "unprognostic (2.12e-1)" "unprognostic (2.63e-1)" "unprognostic (1.84e-1)" "unprognostic (1.92e-2)" "prognostic favorable (2.92e-4)" "unprognostic (8.39e-2)" "prognostic unfavorable (5.34e-7)" "unprognostic (6.55e-2)" "unprognostic (3.15e-1)" "unprognostic (1.31e-1)" "unprognostic (2.45e-1)" 37.6 37.0 12.7 23.4 14.0 30.8 31.2 12.7 16.1 33.0 14.7 31.7 31.8 35.3 17.3 24.0 31.7 25.8 36.8 10.5 13.8 31.6 75.2 31.4 21.4 21.5 14.9 37.7 91.4 15.6 62.1 24.6 15.7 34.2 9.5 4.4 51.1 20.8 20.0 25.2 34.7 15.4 13.3 43.8 38.8 30.5 16.6 12.9 41.3 6.3 10.6 37.6 26.8 19.4 45.2 77.5 13.3 70.2 49.8 23.3 77.6 53.7 48.2 32.5 38.2 36.1 73.0 34.4 59.2 37.3 36.0 53.0 13.5 27.1 12.0 34.7 40.0 34.6 28.5 61.2 44.4 34.1 78.4 40.7 19.7 29.2 18.9 26.2 62.2 24.5 26.3 51.3 24.6 56.5 21.0 59.4 12.9 41.3 37.6 33.8 27.8 34.8 22.2 42.3 25.7 65.7 43.2 26.9 59.2 18.3 38.1 70.0 61.9 52.2 29.9 38.9 29.4 44.6 21.4 20.0 30.9 51.8 54.5 12.7 10.6 18.6 7.4 11.9 8.7 6.2 7.1 9.1 6.2 7.0 4.8 5.4 8.0 4.6 15.9 9.8 5.6 9.5 12.7 14.0 12.7 16.1 10.5 13.8 21.5 14.9 15.7 13.3 16.6 19.4 24.4 25.6 35.6 25.8 28.6 8.3 12.3 21.9 13.6 10.9 25.3 18.0 19.3 31.5 24.6 11.0 18.8 61.0 29.8 66.4 5.9 31.9 25.4 17.3 13.7 22.4 45.0 22.3 12.3 26.9 62.4 35.9 44.9 32.8 15.2 64.6 27.5 79.2 49.3 25.2 14.3 58.8 12.2 40.6 15.1 75.6 32.9 35.7 14.2 28.1 29.1 27.7 23.7 9.0 20.5 25.1 53.1 27.4 96.5 16.0 59.1 23.9 21.4 9.1 32.9 17.0 21.2 19.7 22.8 11.8 7.2 62.5 25.0 39.9 48.2 11.4 SLC39A5 ENSG00000139540 "Solute carrier family 39 member 5" Q6ZMH5 12 56230049-56237846 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8" "Cell type enriched" "Detected in some" 4 "Proximal enterocytes: 798.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 30.6;liver cancer: 36.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 53 "CACO-2: 39.9;Hep G2: 58.5" "Region enhanced" "Detected in single" "basal ganglia: 1.1" "Not detected" "Not detected" HPA018423 Approved Nucleoplasm,Vesicles NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" Vesicles Nucleoplasm "HPA018423: AB_1857154" "unprognostic (5.94e-3)" "unprognostic (8.29e-2)" "unprognostic (1.82e-2)" "unprognostic (2.19e-7)" "unprognostic (1.73e-1)" "unprognostic (7.79e-2)" "unprognostic (1.56e-1)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "unprognostic (1.32e-1)" "unprognostic (7.33e-2)" "unprognostic (2.93e-3)" "prognostic favorable (5.05e-4)" "unprognostic (2.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (1.96e-4)" 0.3 0.1 0.2 5.5 0.2 0.1 0.3 0.5 0.4 0.3 0.2 73.7 237.4 0.4 0.0 0.1 0.3 6.5 0.2 0.1 0.1 110.0 171.1 0.2 0.4 0.2 0.1 0.4 306.8 0.0 0.2 0.1 0.1 0.3 45.9 6.4 0.1 0.3 0.1 0.3 219.0 2.6 0.1 0.3 1.4 0.2 0.1 0.0 0.3 0.2 0.0 0.2 0.2 0.1 0.0 0.3 0.1 0.2 0.2 0.3 0.5 0.0 0.0 0.1 0.0 39.9 0.4 0.1 0.1 0.1 0.0 0.2 0.0 0.3 0.0 0.6 0.1 0.2 0.2 58.5 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.0 0.8 0.0 0.9 0.1 0.2 0.2 0.3 0.5 0.1 0.3 0.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.5 0.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.6 0.1 0.0 0.0 0.9 0.1 0.3 0.2 15.7 0.0 3.7 116.7 0.0 0.0 171.9 19.6 0.3 0.6 0.0 0.1 0.2 25.3 2.7 0.2 20.6 0.0 0.1 0.0 0.0 0.0 0.0 2.2 138.9 0.1 0.0 0.2 112.7 0.0 1.6 1.2 1.4 0.0 1.3 0.0 0.0 0.6 0.6 0.0 0.0 0.1 7.4 192.8 0.0 0.0 0.1 798.4 169.9 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.8 0.0 168.7 0.0 SLC39A9 FLJ11274 ENSG00000029364 "Solute carrier family 39 member 9" Q9NUM3 14 69398015-69462390 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007921, HPA075390" Approved Approved "Endoplasmic reticulum" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 27: Mucus-secreting cells - Mucin production" "Endoplasmic reticulum" "HPA007921: AB_1080007, HPA075390: AB_2686748" "unprognostic (2.37e-1)" "unprognostic (9.29e-2)" "unprognostic (1.57e-1)" "unprognostic (2.53e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (5.50e-2)" "unprognostic (1.71e-1)" "unprognostic (2.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.57e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.20e-1)" "unprognostic (1.83e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" 15.2 21.6 17.3 12.1 17.5 10.7 24.4 17.7 24.6 18.2 20.9 20.3 21.5 14.8 25.6 23.1 15.6 14.3 12.2 17.4 18.9 29.8 43.0 15.6 12.7 17.0 17.3 13.7 28.5 26.4 22.8 17.7 17.0 19.0 21.5 12.7 33.8 15.1 7.9 18.3 19.4 15.5 18.7 16.0 21.8 8.9 18.3 18.0 22.2 11.6 17.8 15.3 15.3 20.1 55.0 46.3 26.9 28.7 46.2 34.6 25.1 31.9 40.2 30.7 34.8 35.4 49.7 49.3 23.8 39.8 14.2 45.3 30.9 30.5 37.4 31.9 17.0 28.9 23.0 24.8 36.0 20.9 38.1 30.3 50.3 27.1 40.5 30.6 30.8 38.1 22.2 44.2 32.5 33.6 33.0 26.1 20.9 47.7 31.2 32.8 37.6 30.3 40.9 56.1 28.3 46.1 32.2 55.1 22.2 20.2 76.9 37.8 30.4 50.8 36.2 22.1 24.6 48.8 27.4 36.6 47.1 25.4 42.0 11.2 10.3 9.4 7.9 9.7 8.1 6.9 6.8 7.7 11.3 4.8 6.7 7.0 8.7 6.8 9.4 5.9 5.5 6.8 17.3 17.5 17.7 24.6 17.4 18.9 17.0 17.3 17.0 18.7 18.3 20.1 13.3 19.2 12.6 37.9 13.4 12.1 8.0 19.2 17.1 8.4 27.7 14.1 7.9 18.6 18.0 16.5 6.2 14.1 7.3 42.8 5.9 15.0 16.2 16.0 16.1 17.0 29.4 15.4 31.0 25.1 17.3 14.3 22.4 17.8 12.0 13.8 22.1 67.7 15.9 10.1 30.9 30.3 14.2 24.5 8.7 22.4 13.1 13.8 7.2 24.4 16.4 9.5 12.3 30.2 37.0 28.6 22.4 12.8 18.6 18.7 34.6 15.8 24.6 11.2 6.6 12.6 12.0 13.9 9.2 18.3 12.5 17.8 9.2 14.2 25.7 20.2 SLC43A1 "PB39, POV1, R00504" ENSG00000149150 "Solute carrier family 43 member 1" O75387 11 57484534-57515780 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "liver: 128.6;pancreas: 233.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2" "Cancer enhanced" "Detected in all" "liver cancer: 45.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 62.7;NB-4: 74.3;U-937: 70.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018813, HPA018826" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 2: Hepatocytes - Metabolism" "Golgi apparatus, Vesicles, Plasma membrane" "HPA018813: AB_1857164, HPA018826: AB_1857165" "unprognostic (3.04e-1)" "unprognostic (1.15e-1)" "unprognostic (9.19e-2)" "prognostic favorable (3.19e-4)" "unprognostic (2.51e-2)" "unprognostic (5.48e-2)" "unprognostic (2.32e-1)" "unprognostic (6.71e-3)" "unprognostic (1.63e-1)" "unprognostic (3.12e-2)" "unprognostic (6.06e-2)" "unprognostic (2.72e-1)" "prognostic unfavorable (2.97e-5)" "unprognostic (1.39e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (5.27e-4)" "unprognostic (7.30e-2)" 13.9 10.7 3.6 4.7 4.2 35.7 11.1 2.7 5.0 13.1 2.7 15.7 8.7 12.6 10.3 4.4 13.5 18.2 8.6 3.6 2.8 7.3 128.6 9.9 7.4 3.8 3.2 20.3 233.2 1.8 4.4 6.3 3.5 12.8 9.4 1.3 13.8 6.2 17.1 18.8 9.2 8.7 2.7 8.5 30.4 3.4 3.4 2.1 12.7 9.1 6.6 16.2 9.9 3.9 1.1 1.7 1.8 20.3 25.7 18.8 0.2 10.4 13.8 3.0 7.6 6.5 2.8 59.5 2.7 7.9 3.9 1.0 18.1 1.2 3.7 2.8 4.6 30.9 0.5 62.7 33.7 54.3 7.2 23.8 4.4 5.2 23.2 7.3 13.4 34.7 43.9 10.7 3.8 2.3 0.5 74.3 6.6 27.0 13.6 51.0 9.8 27.2 0.5 0.1 23.5 3.6 1.9 0.3 23.8 0.5 1.6 27.3 5.5 3.1 7.1 26.2 1.7 12.1 4.3 35.3 1.5 70.6 4.2 11.1 6.2 0.7 10.9 2.4 9.2 2.9 4.9 7.7 8.4 1.5 4.9 6.9 0.5 7.5 0.2 1.9 9.5 5.5 3.6 4.2 2.7 5.0 3.6 2.8 3.8 3.2 3.5 2.7 3.4 3.9 4.4 0.0 7.3 1.6 3.3 7.0 1.6 0.0 3.4 5.7 1.8 2.4 6.8 47.1 0.6 0.0 0.0 0.2 3.6 3.1 3.9 3.4 21.5 5.3 6.0 4.7 6.0 82.9 3.5 35.4 0.4 10.9 4.6 13.4 3.8 1.3 15.4 138.2 7.4 0.0 1.4 8.8 0.0 8.1 2.9 14.8 15.5 3.2 5.4 5.6 1.3 0.2 5.2 4.0 0.6 11.1 2.9 7.9 6.2 3.2 0.3 0.1 0.7 0.4 6.6 6.4 7.7 0.7 1.5 0.3 3.7 0.1 6.4 2.9 9.0 0.9 SLC50A1 "HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1" ENSG00000169241 "Solute carrier family 50 member 1" Q9BRV3 1 155135344-155138857 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 130.7;Intestinal goblet cells: 195.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 166.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018095 Approved NA NA "Cluster 37: B-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 30: Mammary glandular cells - Lactation" "HPA018095: AB_1856048" "unprognostic (4.75e-2)" "unprognostic (1.21e-1)" "unprognostic (7.57e-2)" "unprognostic (2.24e-1)" "unprognostic (3.29e-1)" "unprognostic (9.30e-2)" "unprognostic (1.64e-3)" "unprognostic (1.95e-1)" "unprognostic (1.38e-1)" "unprognostic (5.51e-2)" "unprognostic (3.53e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.88e-7)" "unprognostic (4.36e-2)" "unprognostic (1.40e-1)" "unprognostic (3.50e-3)" "unprognostic (4.39e-2)" 23.0 42.3 9.3 17.0 9.4 14.2 22.5 10.2 11.0 28.2 11.9 45.4 40.4 16.0 101.5 34.3 21.3 13.9 13.3 9.6 11.3 44.4 48.1 26.3 21.4 10.7 9.8 13.2 57.8 34.3 18.1 18.2 12.6 29.9 53.7 2.6 28.9 15.3 6.5 32.3 36.1 15.7 9.6 35.4 47.3 11.9 11.1 17.1 27.6 6.6 26.9 20.3 19.7 10.7 48.0 15.0 13.5 16.9 42.9 42.4 31.2 19.1 28.9 24.6 31.7 28.7 166.5 34.1 58.8 27.3 34.6 62.6 16.3 52.5 14.7 72.7 8.4 29.2 17.9 18.3 72.0 18.2 35.1 44.0 144.2 41.3 98.0 43.1 25.7 20.5 32.2 53.1 23.6 56.0 15.0 21.6 18.7 99.7 59.1 26.3 9.5 117.8 53.0 16.9 23.5 19.2 31.2 63.7 50.6 21.0 140.3 19.3 13.3 18.0 17.9 25.6 9.8 68.5 45.1 32.0 30.1 42.0 19.4 22.9 24.1 24.5 20.0 36.2 24.3 54.5 25.2 24.0 29.7 60.6 27.0 23.8 10.3 51.7 34.6 30.3 28.8 30.8 9.3 9.4 10.2 11.0 9.6 11.3 10.7 9.8 12.6 9.6 11.1 10.7 33.0 22.4 33.6 2.6 40.4 16.2 21.1 43.5 18.8 7.4 78.8 22.5 5.3 12.8 41.3 23.9 12.5 37.0 26.3 66.5 13.7 43.7 0.6 28.7 20.7 33.2 23.4 20.4 4.3 48.8 130.7 21.4 60.6 42.2 24.1 17.7 24.7 22.1 45.2 6.7 4.8 195.0 71.2 32.2 33.4 1.5 13.4 35.8 28.4 5.6 33.8 5.3 16.5 4.0 1.8 42.1 54.3 5.7 47.0 40.8 69.8 23.8 38.6 7.2 6.6 11.1 20.4 8.2 5.2 27.9 18.5 62.8 23.2 28.5 52.5 39.3 SMIM22 CASIMO1 ENSG00000267795 "Small integral membrane protein 22" K7EJ46 16 4788397-4796491 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 193.6;pancreas: 154.3;salivary gland: 147.2;stomach 1: 201.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2005.0;Intestinal goblet cells: 1223.5;Paneth cells: 1462.9;Proximal enterocytes: 1685.8;Respiratory ciliated cells: 686.7;Undifferentiated cells: 775.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "CAPAN-2: 261.7;OE19: 247.3;RT4: 89.8;SCLC-21H: 70.7;SK-BR-3: 201.2" "Low region specificity" "Detected in many" HPA077331 Approved Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "HPA077331: AB_2686834" "unprognostic (6.55e-2)" "unprognostic (4.12e-2)" "unprognostic (4.84e-2)" "unprognostic (3.69e-3)" "unprognostic (7.82e-2)" "unprognostic (3.84e-2)" "unprognostic (4.63e-2)" "unprognostic (2.67e-2)" "unprognostic (6.20e-2)" "unprognostic (3.27e-1)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.59e-2)" "unprognostic (2.60e-1)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (1.73e-3)" 1.2 0.3 0.1 14.6 1.2 3.5 48.2 4.6 2.0 45.4 0.0 193.6 129.6 8.9 50.4 10.3 77.3 33.3 0.5 0.5 0.4 42.0 1.4 24.1 0.6 2.6 0.9 0.5 154.3 0.1 48.9 2.0 2.1 42.6 122.7 1.5 147.2 36.3 0.2 10.4 128.4 6.3 0.8 0.2 201.7 33.8 2.6 0.2 1.1 0.0 2.7 46.1 6.5 3.1 0.2 0.0 0.1 0.6 0.0 0.0 1.9 0.3 0.1 0.1 0.1 0.6 261.7 0.3 7.3 0.0 0.3 1.3 0.1 0.0 0.1 0.4 1.9 0.1 5.8 0.9 0.1 0.7 0.3 0.2 1.4 0.0 0.0 0.2 0.1 0.4 0.0 0.6 0.0 1.9 0.1 0.6 0.8 247.3 0.0 0.8 0.3 23.6 1.5 89.8 70.7 0.8 0.5 201.2 0.0 0.5 15.2 0.0 0.0 0.6 0.8 1.1 0.1 0.2 0.6 0.9 0.0 0.7 0.6 1.2 0.3 0.4 0.3 0.1 0.1 0.1 0.3 0.1 0.0 0.4 0.3 0.1 0.9 0.3 0.1 0.4 0.1 0.1 0.1 1.2 4.6 2.0 0.5 0.4 2.6 0.9 2.1 0.8 2.6 3.1 1.4 48.1 117.7 0.0 5.8 2.2 22.7 92.7 0.0 4.2 363.3 267.5 0.5 183.0 154.9 250.1 0.0 3.9 3.0 2005.0 25.4 259.8 40.1 430.4 26.5 4.4 470.3 0.0 0.5 381.9 0.4 4.7 438.8 258.3 18.4 0.1 0.4 0.2 0.4 1.7 0.3 1223.5 152.5 0.0 0.8 107.3 0.6 4.2 23.2 0.0 5.3 0.6 0.0 0.0 1.3 539.9 1462.9 1.2 1.0 29.5 1685.8 99.4 686.7 4.2 0.0 0.0 15.9 38.6 0.6 2.3 2.3 3.7 6.6 0.2 775.6 148.6 SMPDL3B ASML3B ENSG00000130768 "Sphingomyelin phosphodiesterase acid like 3B" Q92485 1 27935000-27959157 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 24.1;pancreas: 49.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 38.1;Ductal cells: 31.5;Paneth cells: 47.5;Proximal enterocytes: 37.4;Undifferentiated cells: 31.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 6 "eosinophil: 3.3;myeloid DC: 1.3;neutrophil: 1.8" "Group enriched" "Detected in many" 7 "dendritic cells: 1.3;granulocytes: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 46.0;CAPAN-2: 35.3;NTERA-2: 27.6;RPMI-8226: 30.1;SK-BR-3: 45.9;T-47d: 33.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA030561 Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 400000 "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "Golgi apparatus" "HPA030561: AB_10604095" "unprognostic (1.22e-2)" "unprognostic (4.45e-1)" "unprognostic (4.58e-3)" "unprognostic (3.83e-2)" "unprognostic (3.35e-3)" "unprognostic (2.96e-2)" "unprognostic (1.50e-1)" "unprognostic (2.68e-1)" "unprognostic (3.95e-1)" "unprognostic (6.02e-2)" "unprognostic (1.64e-1)" "unprognostic (3.02e-1)" "unprognostic (2.48e-2)" "unprognostic (2.40e-1)" "unprognostic (1.48e-1)" "unprognostic (4.40e-2)" "unprognostic (3.09e-3)" 1.5 0.3 0.5 2.2 0.6 2.0 5.7 2.5 0.6 2.8 2.0 22.2 24.1 1.9 15.8 1.1 7.0 2.2 0.3 1.1 0.7 5.2 0.4 6.6 1.2 0.4 0.4 0.2 49.4 7.9 1.0 0.3 0.5 3.6 23.6 0.1 12.5 0.5 0.0 0.9 14.2 1.0 0.6 1.7 16.5 0.7 0.8 0.5 13.9 0.0 3.1 2.2 0.4 0.6 5.4 2.5 0.0 0.3 0.0 0.0 46.0 0.0 1.1 0.6 3.4 12.1 35.3 1.7 8.3 0.0 0.7 5.9 3.8 3.2 0.5 0.0 23.6 7.9 0.5 3.0 0.0 2.6 0.0 0.2 2.9 7.0 0.4 1.0 1.0 0.3 1.0 0.4 0.0 19.5 0.1 0.8 27.6 4.1 4.3 0.5 0.2 30.1 24.6 9.5 23.4 0.5 0.0 45.9 1.3 4.7 33.3 1.4 0.0 0.0 7.6 0.1 0.0 0.3 12.9 0.6 0.8 0.0 0.1 0.1 0.1 3.3 0.0 0.1 0.0 0.2 0.0 0.0 1.3 0.2 0.1 0.0 1.8 0.3 0.0 0.0 0.0 0.1 0.5 0.6 2.5 0.6 1.1 0.7 0.4 0.4 0.5 0.6 0.8 0.6 0.1 9.6 17.9 0.0 2.3 0.1 2.7 4.0 0.0 0.0 15.0 6.5 0.4 1.5 13.8 9.2 0.0 2.5 0.5 38.1 0.0 31.5 0.4 2.2 0.3 1.1 20.4 1.3 0.8 23.3 0.2 0.2 18.3 5.6 0.0 2.0 0.4 0.0 0.3 0.0 0.1 21.6 10.2 0.0 0.4 0.2 0.0 0.9 0.0 1.0 0.0 0.0 0.0 1.0 0.0 21.7 47.5 0.0 16.6 3.7 37.4 8.7 2.7 0.0 0.0 0.0 0.8 0.0 0.2 0.6 0.1 7.7 0.8 0.1 31.2 3.0 SMUG1 "FDG, HMUDG, UNG3" ENSG00000123415 "Single-strand-selective monofunctional uracil-DNA glycosylase 1" Q53HV7 12 54121277-54189008 "Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 98.9;Syncytiotrophoblasts: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026804, HPA065892" Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nucleoli fibrillar center, Cytosol" "HPA026804: , HPA065892: " "unprognostic (2.68e-1)" "unprognostic (2.86e-1)" "unprognostic (8.58e-2)" "unprognostic (7.68e-2)" "unprognostic (1.40e-1)" "unprognostic (3.30e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.82e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.31e-4)" "unprognostic (1.67e-3)" "unprognostic (3.35e-1)" "unprognostic (2.41e-3)" "unprognostic (2.02e-1)" "unprognostic (1.60e-1)" "unprognostic (2.46e-1)" "unprognostic (1.73e-1)" 20.5 29.2 21.9 13.9 22.4 10.7 26.3 20.7 24.2 17.3 22.6 20.8 17.1 17.1 39.9 38.6 24.5 16.9 19.4 22.3 21.1 28.9 49.6 14.7 18.9 23.7 21.4 18.8 30.0 23.9 16.9 19.1 22.1 24.0 18.7 14.3 29.7 18.1 27.4 29.4 21.3 16.3 22.1 21.8 32.2 15.9 22.7 17.8 21.9 21.8 18.6 20.3 20.1 24.8 31.9 57.5 22.2 23.2 40.4 31.3 37.7 24.2 31.4 37.2 33.8 58.0 69.5 19.0 60.4 35.1 34.8 40.3 15.7 63.7 23.5 19.7 33.3 28.6 47.4 42.3 48.2 19.3 34.0 35.7 97.7 43.9 43.2 40.4 30.2 33.3 48.2 40.3 41.4 60.8 24.3 37.2 27.7 54.3 51.7 17.5 22.6 34.3 46.6 46.2 33.1 39.2 27.6 47.3 43.5 44.9 73.7 35.9 14.3 24.7 27.5 22.5 28.1 37.3 32.1 13.1 35.8 15.0 38.4 89.6 46.2 57.1 28.5 39.5 28.4 49.7 27.3 30.7 40.3 36.6 24.6 24.6 45.5 27.1 31.5 45.5 41.0 33.9 21.9 22.4 20.7 24.2 22.3 21.1 23.7 21.4 22.1 22.1 22.7 24.8 6.6 6.4 16.0 2.9 13.3 7.5 14.4 40.2 11.4 10.5 25.5 22.5 17.7 22.8 26.4 25.8 8.4 87.5 8.8 28.4 60.7 37.1 5.2 15.3 8.9 11.0 11.5 7.4 6.8 40.2 98.9 13.6 16.3 11.0 2.5 10.1 18.2 49.4 46.1 6.7 6.1 25.8 32.6 19.2 5.8 11.8 18.6 14.0 5.4 3.7 34.0 16.3 19.6 5.0 8.1 41.4 24.6 17.7 12.6 20.7 58.4 56.6 27.1 11.9 32.9 8.5 13.8 26.2 28.0 20.8 10.4 100.0 9.5 19.4 23.7 19.6 SND1 "p100, TDRD11" ENSG00000197157 "Staphylococcal nuclease and tudor domain containing 1" Q7KZF4 7 127652194-128092609 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Endonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002529, HPA002632, CAB019323" Enhanced Enhanced Cytosol NA NA 1800000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316" "unprognostic (2.06e-1)" "unprognostic (8.27e-3)" "unprognostic (2.21e-1)" "prognostic favorable (1.95e-4)" "unprognostic (5.10e-3)" "unprognostic (6.83e-2)" "unprognostic (1.17e-2)" "unprognostic (2.91e-2)" "unprognostic (4.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.30e-1)" "unprognostic (1.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.42e-2)" "unprognostic (2.26e-3)" 48.5 52.5 19.1 57.8 22.6 65.8 56.7 25.3 21.4 76.9 41.0 51.3 54.2 67.2 90.6 47.7 65.1 37.3 45.3 19.9 33.3 33.9 67.5 46.7 53.0 29.7 29.4 87.3 179.0 50.8 52.7 86.7 29.9 59.0 49.4 32.1 102.2 57.7 41.9 43.7 45.3 66.5 26.2 45.8 65.7 38.5 25.4 67.5 66.0 40.0 65.3 50.0 41.8 33.5 160.0 141.8 106.3 193.5 156.6 162.7 145.3 183.5 214.8 163.8 182.5 184.6 134.6 210.6 90.4 225.7 137.8 130.4 150.7 198.1 158.6 116.1 127.2 116.1 153.0 177.9 284.2 181.9 109.6 241.3 216.3 140.0 232.3 185.7 206.2 85.1 131.3 204.9 165.0 118.6 199.5 135.6 119.5 159.7 173.6 136.8 94.6 476.1 128.1 110.5 133.0 143.7 132.8 606.6 217.5 157.8 76.2 127.2 207.3 132.3 86.4 243.3 144.7 250.1 101.1 217.0 265.6 153.6 245.2 49.7 86.4 17.1 67.0 76.6 78.0 70.1 50.0 54.0 87.4 44.6 34.9 39.8 6.2 59.7 66.1 92.9 43.4 92.9 19.1 22.6 25.3 21.4 19.9 33.3 29.7 29.4 29.9 26.2 25.4 33.5 20.3 16.0 44.7 60.4 56.7 19.6 24.7 32.9 22.2 17.1 41.0 28.6 29.2 35.8 28.9 29.5 20.9 255.0 44.3 28.8 17.6 62.8 20.1 21.9 51.9 30.3 73.1 47.5 128.0 96.7 106.1 40.7 54.6 39.5 34.9 54.4 25.0 49.8 81.9 30.3 116.0 59.4 18.3 52.8 36.7 68.1 45.7 50.8 33.8 78.7 72.5 16.7 32.0 84.9 89.9 58.6 29.8 41.3 124.6 42.8 38.2 33.1 19.0 32.7 32.9 27.0 34.4 23.4 28.0 37.6 27.4 267.6 37.2 74.0 58.3 27.0 SNTB1 "59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43" ENSG00000172164 "Syntrophin beta 1" Q13884 8 120535745-120813273 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 89.3" "Cell type enhanced" "Detected in many" "Astrocytes: 70.2;Hepatocytes: 66.8;Microglial cells: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 84.9;OE19: 78.5;U-266/70: 77.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024659 Uncertain "Intracellular and membrane" NA NA 25000 "Cluster 2: Granulocytes - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 64: Astrocytes - Nervous system maintenance" "HPA024659: AB_1857713" "unprognostic (1.32e-1)" "unprognostic (2.77e-2)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (6.41e-3)" "unprognostic (2.07e-1)" "unprognostic (3.88e-1)" "unprognostic (1.31e-1)" "unprognostic (4.72e-1)" "unprognostic (2.00e-2)" "unprognostic (5.08e-2)" "unprognostic (5.88e-2)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" 7.9 66.4 7.5 5.5 6.5 18.9 8.0 5.8 5.9 5.6 42.9 6.2 5.7 4.4 2.7 8.4 6.0 4.3 4.9 6.1 11.8 12.6 89.3 15.4 7.3 7.2 11.4 2.5 45.0 1.4 2.6 8.6 7.8 4.8 6.4 4.8 34.8 3.4 28.2 9.8 6.3 3.1 6.0 11.9 24.1 9.8 9.1 3.4 61.4 32.4 3.5 3.9 3.6 6.5 0.1 1.8 0.7 0.0 11.3 22.9 0.1 6.0 36.7 1.8 2.7 12.0 1.6 0.0 10.7 6.8 0.0 0.1 2.0 0.0 1.3 5.6 6.5 0.0 0.3 84.9 1.2 16.9 0.0 11.4 0.0 10.1 0.0 14.9 0.4 10.4 0.0 32.3 5.9 3.3 0.0 13.7 2.1 78.5 8.7 0.0 43.8 0.1 34.4 2.0 0.1 0.4 2.4 12.5 30.2 0.7 1.5 30.5 0.0 23.7 1.4 0.0 2.0 77.2 33.0 34.8 18.4 49.0 26.7 1.8 0.8 2.7 2.2 0.4 0.5 0.5 0.4 1.1 0.6 0.2 1.1 1.1 0.1 1.6 0.3 0.0 0.0 0.6 7.5 6.5 5.8 5.9 6.1 11.8 7.2 11.4 7.8 6.0 9.1 6.5 1.9 12.8 27.2 70.2 4.7 0.4 0.7 0.9 1.8 2.4 8.5 6.0 2.0 2.8 9.0 5.5 2.1 0.8 8.4 1.3 9.8 1.5 9.3 2.4 5.8 4.2 0.0 14.1 2.4 10.9 2.2 9.8 11.2 6.2 1.3 8.8 13.2 66.8 11.3 0.0 3.1 3.9 16.2 29.9 4.3 4.2 4.7 18.1 1.8 45.9 12.1 16.0 18.6 2.5 12.2 4.3 1.9 13.2 2.8 1.1 0.1 3.3 13.8 0.7 13.1 3.9 14.3 1.1 0.2 10.1 1.0 0.3 12.0 11.0 4.1 0.6 SPCS1 "HSPC033, SPC1, SPC12, YJR010C-A" ENSG00000114902 "Signal peptidase complex subunit 1" Q9Y6A9 3 52704955-52711148 "Metabolic proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046091, HPA055273" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: U-266 - Nucleosome" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA046091: AB_10959614, HPA055273: AB_2682768" "unprognostic (5.47e-2)" "unprognostic (4.04e-1)" "prognostic favorable (9.28e-4)" "unprognostic (5.93e-2)" "unprognostic (6.88e-2)" "unprognostic (1.10e-2)" "unprognostic (3.22e-1)" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (5.56e-2)" "unprognostic (3.89e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.90e-4)" "unprognostic (5.96e-2)" "unprognostic (1.80e-1)" "unprognostic (3.58e-1)" "unprognostic (3.09e-2)" 95.3 154.7 75.1 64.1 76.6 61.3 100.5 80.7 101.1 97.4 88.7 110.1 94.8 101.0 110.8 117.0 92.1 48.4 119.7 75.4 83.9 137.3 172.8 87.8 71.2 82.3 80.5 91.1 231.2 89.5 141.1 59.4 82.1 96.3 84.7 124.6 145.2 79.1 142.2 109.0 103.9 53.0 81.7 105.6 151.1 153.2 81.4 66.6 113.2 49.7 87.1 103.0 94.7 84.9 114.6 102.2 113.4 139.3 164.9 134.4 157.2 157.6 144.5 139.4 128.4 108.1 171.0 114.6 65.7 145.4 142.5 110.2 109.9 142.5 149.1 154.3 115.8 138.6 169.2 164.6 175.1 213.3 229.1 104.7 190.5 148.5 174.4 130.5 117.4 147.5 118.8 418.0 151.8 105.5 168.8 207.2 195.8 317.2 203.9 67.9 95.7 608.6 232.7 148.3 73.6 157.4 148.7 178.1 224.2 102.4 188.1 248.1 106.2 127.3 119.1 226.3 192.1 406.2 654.1 169.8 196.5 209.4 169.8 292.7 129.9 258.2 131.1 137.0 155.1 202.0 158.5 144.2 143.9 149.3 146.8 152.1 100.1 119.6 152.5 620.5 177.1 253.8 75.1 76.6 80.7 101.1 75.4 83.9 82.3 80.5 82.1 81.7 81.4 84.9 172.5 64.1 104.2 23.8 282.3 156.5 227.9 470.7 136.1 465.4 289.0 351.0 148.7 221.6 283.6 310.8 118.9 373.5 488.1 195.2 361.9 353.8 597.8 286.4 180.8 157.6 167.7 143.9 27.1 339.4 399.8 181.9 119.8 181.5 211.6 138.7 131.4 301.8 311.0 102.6 34.4 291.3 325.5 202.9 189.9 1177.6 216.3 192.5 380.6 13.1 321.9 296.9 213.1 21.1 53.2 274.8 274.1 191.8 888.8 295.0 405.5 665.1 374.1 251.3 164.3 152.6 335.5 746.4 504.5 195.8 184.4 351.2 220.8 283.6 267.7 285.3 SPCS2 KIAA0102 ENSG00000118363 "Signal peptidase complex subunit 2" Q15005 11 74949247-74979033 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 933.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013386 Approved Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm "HPA013386: AB_1857426" "unprognostic (2.43e-1)" "unprognostic (7.01e-2)" "unprognostic (1.65e-2)" "unprognostic (7.09e-3)" "unprognostic (9.30e-2)" "unprognostic (2.31e-2)" "unprognostic (7.04e-3)" "unprognostic (9.61e-2)" "unprognostic (8.83e-2)" "unprognostic (2.02e-3)" "unprognostic (1.25e-2)" "unprognostic (1.74e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-2)" "unprognostic (5.70e-2)" "unprognostic (1.37e-1)" "unprognostic (8.62e-2)" 81.0 99.4 86.4 104.9 96.6 60.1 108.2 98.7 131.1 127.5 88.8 119.3 90.5 92.2 220.1 72.8 95.9 66.5 76.2 86.3 102.7 105.6 151.6 79.5 98.2 98.5 93.3 84.3 137.3 147.7 75.1 81.2 98.9 106.9 115.1 75.4 139.0 93.3 71.4 56.6 83.3 93.1 99.7 92.5 105.5 50.4 94.3 97.8 143.9 69.5 154.8 95.0 68.1 107.7 141.7 163.4 213.2 192.2 183.2 122.0 115.9 198.6 192.4 179.0 154.8 322.9 311.7 228.2 244.1 168.9 213.6 254.2 187.3 146.1 220.5 190.0 136.4 232.2 189.7 268.9 208.1 249.3 156.7 109.7 186.1 151.5 245.5 156.8 173.7 166.6 271.9 578.0 163.9 215.0 179.1 158.0 131.0 558.3 153.5 219.2 328.2 522.4 208.2 232.3 172.3 172.6 198.1 262.9 687.6 146.7 254.1 187.6 142.0 201.9 124.9 212.1 177.5 245.1 268.8 423.8 83.0 173.4 209.4 546.3 229.2 219.2 279.8 231.0 315.2 400.7 253.7 269.4 222.0 344.3 191.7 229.5 148.5 260.9 209.8 459.5 272.0 428.3 86.4 96.6 98.7 131.1 86.3 102.7 98.5 93.3 98.9 99.7 94.3 107.7 192.3 86.6 143.6 40.5 323.2 304.5 314.0 812.0 129.7 97.6 212.6 199.9 69.1 214.4 406.0 239.1 52.1 330.8 233.5 130.3 189.8 290.0 36.5 126.4 250.4 181.4 125.4 191.5 46.6 288.0 334.4 239.4 104.5 240.2 155.2 114.7 158.1 338.0 278.9 95.9 55.4 255.1 431.3 140.1 283.3 27.2 240.8 159.7 521.2 23.4 188.6 215.6 197.8 48.7 73.5 253.2 140.0 195.6 933.5 355.5 141.7 280.8 231.1 87.3 170.9 153.6 253.6 127.8 133.1 112.1 229.4 464.8 204.6 192.2 189.5 298.1 SPCS3 "FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W" ENSG00000129128 "Signal peptidase complex subunit 3" P61009 4 176319966-176332245 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 670.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 374.4" "Low region specificity" "Detected in all" HPA053180 Approved NA NA "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA053180: AB_2682071" "unprognostic (4.30e-2)" "unprognostic (1.38e-1)" "unprognostic (5.20e-3)" "prognostic favorable (8.89e-6)" "unprognostic (1.79e-1)" "unprognostic (2.98e-2)" "unprognostic (1.50e-3)" "unprognostic (1.79e-2)" "unprognostic (4.78e-3)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.87e-4)" "unprognostic (2.58e-2)" "unprognostic (2.85e-1)" "unprognostic (2.26e-1)" "unprognostic (4.92e-2)" "unprognostic (2.16e-2)" "unprognostic (1.44e-1)" 33.0 24.6 13.9 50.6 16.0 68.1 36.0 15.5 18.0 46.6 15.1 37.0 34.5 38.5 47.5 25.0 25.5 32.0 37.6 17.3 17.1 34.1 43.6 36.1 50.3 15.9 25.6 21.6 72.8 31.3 30.1 45.5 16.1 32.9 37.5 13.5 99.1 30.0 24.1 26.9 36.9 34.8 18.1 46.5 48.9 10.7 16.3 34.8 62.2 26.4 48.2 41.1 25.6 21.2 64.9 21.5 57.8 47.8 80.9 142.5 61.0 125.2 119.1 71.4 61.4 23.5 139.1 124.2 25.1 72.7 37.6 43.6 55.3 92.1 108.0 84.2 24.3 107.6 32.2 53.5 82.5 162.3 90.9 86.9 99.4 63.4 60.9 79.8 107.1 59.4 70.2 374.4 99.4 39.7 100.1 61.4 39.5 45.6 21.0 48.7 89.8 109.3 87.7 46.5 46.1 42.2 130.6 96.4 58.8 49.8 31.1 75.1 100.2 52.5 52.8 47.4 58.2 172.3 54.7 153.8 112.0 80.6 74.1 43.0 16.1 14.2 15.2 19.3 20.2 10.0 14.0 13.9 12.2 6.8 11.6 14.5 16.2 16.6 16.1 22.6 11.9 19.2 13.9 16.0 15.5 18.0 17.3 17.1 15.9 25.6 16.1 18.1 16.3 21.2 121.4 54.5 86.3 19.2 150.0 57.2 67.4 111.8 25.0 31.3 62.9 52.1 79.5 32.9 84.1 29.5 27.1 64.1 170.0 55.2 21.5 76.4 66.8 49.3 130.6 109.3 44.9 61.4 40.9 136.1 205.1 66.2 70.3 102.2 91.2 36.3 88.9 123.8 153.2 23.5 37.3 102.1 89.5 100.8 98.4 14.4 22.4 127.9 110.3 29.0 105.8 31.2 74.2 41.2 59.1 157.0 36.0 17.0 670.6 173.8 48.1 71.6 54.5 31.0 13.1 46.4 64.8 95.4 56.4 58.7 65.1 184.4 107.0 51.8 53.3 147.1 SPG21 "ABHD21, ACP33, BM-019, GL010, MAST" ENSG00000090487 "SPG21 abhydrolase domain containing, maspardin" Q9NZD8 15 64963022-64990310 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 181.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040407, HPA040436" Approved Supported Vesicles,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Cytosol" "HPA040407: AB_2676965, HPA040436: AB_10796454" "unprognostic (7.47e-2)" "unprognostic (2.94e-2)" "unprognostic (5.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.64e-1)" "unprognostic (5.40e-3)" "unprognostic (7.25e-2)" "unprognostic (1.43e-1)" "unprognostic (4.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.24e-3)" "unprognostic (1.15e-1)" "unprognostic (3.96e-1)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.57e-1)" "unprognostic (3.19e-1)" 56.6 61.7 48.4 50.8 54.1 69.4 68.8 51.5 52.9 60.4 66.0 61.6 52.1 60.2 150.1 46.1 73.4 54.7 54.4 47.8 50.3 85.3 113.1 61.9 56.9 52.1 50.2 55.3 54.7 72.1 47.1 66.3 52.7 49.8 59.3 38.6 45.7 59.0 74.3 58.5 46.6 64.5 51.1 52.6 60.1 35.0 52.6 57.7 83.1 42.4 58.8 61.2 47.8 59.4 87.0 127.0 62.8 119.5 158.7 155.7 78.0 52.8 179.7 103.2 119.8 57.4 131.1 99.1 80.6 124.8 153.1 113.3 182.1 124.5 97.8 41.0 58.5 85.7 81.7 104.0 200.7 82.2 72.7 107.0 139.3 82.1 154.2 100.7 125.6 112.2 72.7 78.3 127.8 124.1 75.8 71.5 69.6 193.9 66.3 78.2 67.3 174.6 107.1 103.6 76.7 68.6 62.7 131.4 124.9 123.3 89.9 140.9 61.5 87.1 90.6 125.4 80.6 55.6 101.8 58.2 112.8 215.1 75.1 9.9 138.2 15.5 14.1 84.2 13.1 39.0 13.8 14.7 76.9 37.6 19.9 10.9 181.4 15.7 69.8 25.1 17.5 52.3 48.4 54.1 51.5 52.9 47.8 50.3 52.1 50.2 52.7 51.1 52.6 59.4 29.4 9.6 56.3 11.1 67.7 74.9 81.8 70.6 66.6 16.2 62.7 39.4 32.1 61.5 51.5 71.7 37.5 202.9 33.6 42.7 137.0 97.1 6.0 32.9 36.9 56.9 64.8 54.3 13.1 74.1 92.2 67.5 46.9 34.3 28.5 37.5 38.2 121.6 153.9 20.2 13.7 58.2 61.1 158.7 145.4 13.2 86.6 128.5 80.0 16.9 123.2 24.8 64.9 5.5 19.6 62.3 93.5 89.9 66.2 145.2 121.1 202.3 57.9 18.9 39.5 93.4 39.5 35.4 51.3 75.4 82.8 186.5 46.5 35.5 69.5 123.5 SRP54 ENSG00000100883 "Signal recognition particle 54" P61011 14 34981957-35029686 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrolase, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 327.3;Late spermatids: 901.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048977, HPA062044" Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA048977: AB_2680583, HPA062044: AB_2684668" "unprognostic (1.22e-3)" "unprognostic (6.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.72e-2)" "unprognostic (3.88e-1)" "unprognostic (2.67e-3)" "unprognostic (2.06e-3)" "unprognostic (6.44e-2)" "unprognostic (2.53e-1)" "unprognostic (1.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.50e-3)" 22.8 33.1 17.1 30.2 18.1 17.4 28.7 19.3 22.5 32.5 20.9 28.1 25.8 23.3 35.8 28.5 22.0 23.2 32.1 17.6 21.3 35.3 61.9 25.0 34.6 19.8 19.2 22.7 55.0 39.7 36.2 29.5 20.5 31.2 29.5 24.2 60.3 28.7 39.8 26.1 26.8 23.5 20.0 28.4 30.4 44.0 18.1 35.5 30.9 33.7 42.6 34.8 23.1 21.4 59.3 66.9 56.7 54.9 62.8 61.3 67.8 83.2 78.3 87.3 107.0 71.3 62.8 75.8 77.5 81.4 75.8 56.1 79.0 66.7 125.6 87.5 37.8 70.9 54.6 184.6 92.7 70.5 65.4 51.5 64.8 63.5 102.3 66.1 88.8 64.9 61.7 82.7 93.1 98.8 81.9 42.4 45.0 96.1 61.3 58.5 72.2 67.4 104.9 89.3 48.9 59.4 59.3 76.7 74.6 71.4 99.4 49.7 66.6 48.7 51.0 62.8 57.1 73.2 108.3 101.1 36.8 45.9 63.5 23.8 27.4 39.2 31.0 35.0 39.6 25.6 31.4 34.0 32.8 25.8 28.7 28.3 27.1 42.1 47.0 21.9 48.2 30.5 17.1 18.1 19.3 22.5 17.6 21.3 19.8 19.2 20.5 20.0 18.1 21.4 40.8 12.8 49.3 25.5 63.2 40.0 56.0 74.6 37.5 37.5 40.7 29.0 41.0 34.3 81.2 40.5 58.4 67.3 59.6 39.4 64.6 73.2 327.3 53.1 43.9 40.7 44.9 36.2 25.4 79.8 75.6 45.8 38.7 64.3 47.5 37.3 36.4 110.0 49.7 26.9 26.8 48.7 87.5 39.0 43.6 901.8 38.5 47.4 28.4 24.4 56.1 44.3 41.2 27.6 54.6 55.1 34.0 37.6 133.1 60.7 39.0 79.2 93.0 50.1 26.3 38.3 46.1 95.4 76.0 36.0 50.3 94.0 64.7 43.0 31.6 64.5 SRPRA "SR-alpha, Sralpha, SRP-alpha, SRPR" ENSG00000182934 "SRP receptor subunit alpha" P08240 11 126262938-126269144 "Plasma proteins, Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 232.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 19000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.23e-3)" "unprognostic (6.87e-2)" "unprognostic (6.11e-2)" "prognostic favorable (8.56e-4)" "unprognostic (1.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.87e-1)" "unprognostic (3.64e-1)" "unprognostic (4.78e-1)" "unprognostic (3.96e-2)" "unprognostic (2.22e-2)" "unprognostic (2.73e-1)" "unprognostic (3.72e-1)" "unprognostic (1.33e-2)" "unprognostic (4.38e-2)" "unprognostic (1.93e-1)" "unprognostic (2.74e-2)" 64.4 78.9 24.9 71.4 25.9 82.5 58.0 27.2 32.5 85.6 51.7 54.7 53.1 64.8 144.2 55.7 57.4 64.7 62.9 26.7 29.2 54.1 164.0 65.5 67.4 28.9 26.9 55.8 254.8 71.5 88.9 49.9 28.9 81.8 61.9 36.3 236.8 87.7 91.1 53.8 52.2 68.8 25.6 66.7 96.3 32.7 30.6 61.8 90.2 69.3 86.4 82.0 48.6 27.6 65.5 63.5 59.5 90.9 160.1 124.0 79.5 183.8 168.5 87.4 102.9 117.5 163.4 122.2 186.4 182.3 109.2 126.4 91.1 105.8 87.2 134.9 71.9 223.8 49.1 117.9 223.7 198.7 139.9 106.4 132.5 134.6 245.0 105.5 120.9 47.7 76.2 284.3 124.1 87.6 95.9 78.5 39.7 193.1 135.5 62.8 82.3 128.4 86.8 132.2 85.5 80.3 125.6 150.9 95.7 48.0 198.7 117.5 115.5 153.2 68.2 88.0 132.8 123.3 85.0 73.9 85.3 177.5 202.5 72.1 61.8 95.9 91.3 67.4 79.7 48.7 62.6 74.0 59.4 41.1 56.3 65.2 64.3 62.3 82.8 78.1 53.5 94.7 24.9 25.9 27.2 32.5 26.7 29.2 28.9 26.9 28.9 25.6 30.6 27.6 52.9 44.8 69.3 0.0 69.1 0.0 53.5 0.0 44.9 30.4 37.6 24.9 0.0 32.9 46.4 22.0 8.4 38.0 81.7 12.1 1.9 64.3 9.8 33.5 53.2 36.5 12.2 24.6 0.0 90.9 42.4 42.9 35.2 67.9 49.2 25.9 32.9 77.9 25.7 60.6 0.0 14.2 0.0 27.0 0.0 8.4 36.4 43.4 0.0 0.0 56.6 28.0 52.5 0.0 0.0 67.6 9.5 46.6 232.5 60.6 25.1 19.2 21.1 28.8 46.0 42.3 30.7 18.5 34.3 36.3 0.0 81.0 64.3 38.4 9.5 66.3 SSR1 TRAPA ENSG00000124783 "Signal sequence receptor subunit 1" P43307 6 7268306-7347446 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011276, HPA017062" Enhanced Supported "Endoplasmic reticulum" NA NA 1600000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA011276: AB_1857503, HPA017062: AB_1857505" "unprognostic (2.27e-1)" "unprognostic (2.10e-1)" "unprognostic (5.98e-3)" "unprognostic (1.57e-2)" "unprognostic (3.10e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (7.83e-2)" "unprognostic (2.27e-2)" "unprognostic (4.72e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (5.79e-6)" "unprognostic (3.17e-1)" "unprognostic (2.56e-2)" "unprognostic (6.51e-3)" "unprognostic (2.19e-2)" 64.0 64.4 20.3 89.6 24.6 101.9 70.3 25.4 24.8 88.5 35.7 65.3 65.6 62.7 74.2 71.6 50.8 64.5 41.2 19.0 28.9 58.6 95.5 56.7 68.4 27.6 25.2 67.0 67.9 49.4 25.8 71.5 27.2 59.2 76.4 36.6 79.7 56.0 28.3 42.6 62.4 76.9 23.7 62.4 68.2 38.5 27.8 55.9 84.8 29.1 84.2 74.4 32.8 34.7 122.2 121.7 92.3 171.7 244.9 173.1 144.4 274.5 225.5 183.4 219.1 167.5 98.5 162.9 472.1 282.5 168.3 107.0 112.0 156.6 251.6 172.2 94.6 174.3 130.6 350.7 253.4 325.6 189.6 154.2 169.0 210.2 429.2 140.4 205.2 80.4 199.3 191.1 204.6 146.4 89.6 86.6 78.2 136.5 137.2 120.1 116.0 615.7 161.3 171.5 124.6 57.9 167.0 91.1 263.4 276.8 147.9 141.7 183.1 196.1 149.0 153.3 238.1 195.7 312.1 130.4 95.3 180.4 367.1 146.1 169.5 114.5 82.9 121.9 105.6 73.0 91.7 93.9 199.9 56.1 86.3 86.9 93.3 85.7 110.1 139.3 109.4 214.7 20.3 24.6 25.4 24.8 19.0 28.9 27.6 25.2 27.2 23.7 27.8 34.7 54.0 28.9 48.1 32.3 106.1 77.8 62.1 120.2 69.4 75.4 85.3 46.1 48.5 84.4 93.7 130.6 100.1 78.2 118.6 65.4 15.6 96.0 16.1 48.7 96.0 69.6 62.3 80.8 38.6 103.0 208.5 95.4 68.8 74.3 47.5 64.0 78.1 148.1 130.0 70.7 41.3 130.4 81.4 157.3 251.5 12.4 78.6 129.7 94.3 35.6 131.5 64.1 87.6 49.8 47.8 71.9 47.0 73.0 302.1 111.2 61.5 67.1 57.8 104.2 26.3 57.6 71.6 53.4 58.7 96.0 75.4 121.8 83.6 61.2 93.6 70.4 SSR2 "TLAP, TRAPB" ENSG00000163479 "Signal sequence receptor subunit 2" P43308 1 156009048-156020951 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 62000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (1.93e-1)" "unprognostic (3.86e-2)" "unprognostic (9.85e-2)" "unprognostic (2.77e-1)" "unprognostic (2.05e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (7.35e-2)" "unprognostic (4.55e-2)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (2.93e-2)" "prognostic unfavorable (1.00e-7)" "unprognostic (1.28e-1)" "unprognostic (4.64e-1)" "unprognostic (4.55e-2)" "unprognostic (1.30e-1)" 190.4 290.6 104.4 157.0 108.5 245.8 276.7 105.1 119.2 281.4 111.8 187.6 140.8 201.4 457.4 134.6 184.3 180.0 128.7 102.2 108.1 165.4 233.1 192.5 220.1 104.4 104.6 325.7 513.1 168.0 136.6 194.1 104.6 158.2 246.3 55.7 293.5 155.4 92.3 163.8 158.7 208.2 105.0 206.5 217.3 108.1 107.5 230.1 152.8 105.5 277.4 222.1 153.9 107.1 249.4 197.1 330.9 576.6 531.9 593.1 239.0 384.6 664.6 514.5 526.3 231.8 418.9 219.7 348.8 733.2 195.9 274.0 230.8 302.2 494.9 206.0 234.7 150.0 207.0 296.4 409.3 394.5 275.2 474.1 372.4 369.6 514.0 468.2 670.1 245.6 145.8 611.3 525.8 368.9 200.7 303.7 462.0 590.8 298.0 170.2 204.7 751.5 344.0 189.5 256.3 640.6 275.8 630.1 432.5 373.1 391.0 732.4 324.4 219.8 216.5 210.2 377.2 753.1 390.4 267.4 304.9 317.5 374.0 674.9 403.3 326.5 408.0 301.4 471.0 385.6 436.2 422.1 344.8 327.5 442.1 390.1 336.4 412.8 282.5 404.0 393.8 1070.9 104.4 108.5 105.1 119.2 102.2 108.1 104.4 104.6 104.6 105.0 107.5 107.1 187.3 169.9 151.3 10.1 324.0 241.9 222.9 453.4 140.0 43.2 296.0 368.4 41.1 235.9 243.5 119.5 33.3 435.5 340.7 178.6 140.8 497.9 56.4 95.7 298.6 189.1 229.4 117.1 10.8 571.6 761.6 272.3 154.9 186.5 187.1 292.1 192.4 132.2 349.8 18.5 13.6 392.7 233.9 258.1 348.4 79.6 284.3 223.0 298.8 15.0 315.8 125.2 385.2 10.1 14.7 410.7 273.0 212.1 520.7 221.9 292.9 255.7 76.7 46.0 164.3 167.6 244.3 268.6 81.7 140.1 238.0 570.3 333.2 268.1 292.9 259.5 SSR3 TRAPG ENSG00000114850 "Signal sequence receptor subunit 3" Q9UNL2 3 156539553-156555149 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 894.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014906 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "HPA014906: AB_2195736" "unprognostic (4.11e-1)" "unprognostic (3.50e-1)" "unprognostic (5.49e-2)" "unprognostic (5.46e-2)" "unprognostic (5.74e-2)" "prognostic unfavorable (3.43e-4)" "prognostic unfavorable (4.46e-7)" "unprognostic (1.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-3)" "unprognostic (6.68e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (3.23e-2)" "unprognostic (2.92e-2)" "unprognostic (1.39e-2)" "unprognostic (8.29e-2)" 84.9 72.0 36.2 74.2 39.3 52.9 106.2 40.2 44.8 144.4 35.5 84.8 61.7 84.5 173.0 51.8 106.8 59.0 116.0 34.9 44.0 75.3 100.9 60.3 64.0 45.5 39.9 93.8 195.3 72.1 58.7 60.4 46.0 73.9 91.1 29.0 181.2 137.1 61.6 34.2 56.5 113.6 44.9 61.9 82.6 57.9 46.4 48.7 113.9 45.0 87.9 73.5 53.0 51.0 449.0 92.9 113.3 143.4 377.4 354.9 118.1 641.9 363.2 320.6 444.6 184.9 209.1 148.4 277.3 432.9 290.1 203.4 192.5 760.2 762.3 178.7 91.9 264.4 58.5 185.9 402.2 279.9 122.0 318.1 278.3 545.3 1081.7 309.6 400.6 129.0 151.9 528.2 930.8 131.1 96.8 63.1 138.7 253.6 181.5 136.1 185.7 969.9 300.6 105.2 91.2 76.8 166.0 246.3 358.9 176.4 252.3 143.2 508.5 424.0 204.9 325.3 721.8 485.5 207.3 249.0 254.0 231.9 248.1 111.1 88.7 71.6 60.6 104.1 95.7 76.1 64.0 75.4 115.5 46.8 42.6 52.0 30.5 66.7 136.0 162.1 81.1 72.4 36.2 39.3 40.2 44.8 34.9 44.0 45.5 39.9 46.0 44.9 46.4 51.0 103.4 109.0 167.3 22.2 205.3 83.7 132.7 182.6 41.5 33.7 157.8 263.4 153.4 117.2 151.1 73.5 31.3 113.1 142.1 85.1 109.5 238.4 98.1 89.7 281.2 124.9 71.1 91.9 10.7 229.8 470.0 174.0 103.0 160.0 95.7 145.4 123.5 219.0 388.2 25.2 14.3 247.0 69.2 218.1 224.3 38.0 214.9 196.2 145.9 10.3 241.5 89.6 73.2 17.1 18.5 233.2 81.5 223.0 894.2 257.5 90.3 214.7 81.0 37.1 72.3 96.3 178.4 177.1 69.0 74.0 78.7 188.9 109.8 119.5 148.9 157.8 STX5 "SED5, STX5A" ENSG00000162236 "Syntaxin 5" Q13190 11 62806860-62832051 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 177.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001358 Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Golgi apparatus" Nucleoplasm "HPA001358: AB_1080119" "unprognostic (3.51e-2)" "unprognostic (4.23e-2)" "unprognostic (1.79e-1)" "unprognostic (1.91e-3)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (1.71e-2)" "unprognostic (3.30e-1)" "unprognostic (1.13e-1)" "unprognostic (3.34e-2)" "unprognostic (1.01e-1)" "unprognostic (2.19e-1)" "unprognostic (1.67e-2)" "unprognostic (3.42e-2)" "unprognostic (2.79e-1)" "unprognostic (2.86e-2)" "unprognostic (8.22e-3)" 34.2 31.8 31.2 22.2 32.1 41.9 34.4 35.3 39.0 42.0 34.6 27.5 22.7 30.6 42.6 34.9 33.1 25.0 27.2 31.3 32.1 38.3 51.0 32.7 25.1 34.2 31.8 42.2 51.1 27.0 29.6 27.4 31.7 43.6 22.4 18.8 51.8 26.9 27.7 41.4 28.4 23.9 31.3 35.5 36.0 29.0 32.9 30.4 37.9 20.2 31.6 28.4 34.2 33.5 40.9 25.4 34.5 29.9 44.6 50.2 31.0 39.2 54.9 64.7 52.0 18.8 39.0 26.0 35.9 55.9 37.8 41.7 29.7 37.2 47.8 60.4 28.3 23.0 33.0 39.2 55.3 26.9 33.5 40.7 41.6 58.6 70.3 50.5 31.9 37.0 21.0 71.7 34.5 48.4 36.5 43.8 11.3 36.2 36.8 37.1 32.3 70.2 28.8 20.7 26.3 21.6 31.4 49.4 63.6 25.7 54.4 35.9 36.8 46.8 24.6 54.6 25.1 64.2 38.1 27.4 38.0 18.7 29.6 11.7 11.4 36.2 10.4 14.1 9.3 11.0 8.1 10.1 10.4 11.3 7.5 7.6 17.8 13.1 12.7 12.9 13.0 6.6 31.2 32.1 35.3 39.0 31.3 32.1 34.2 31.8 31.7 31.3 32.9 33.5 30.3 22.4 29.3 12.7 64.1 67.2 79.5 37.9 13.6 21.0 38.0 27.9 5.6 20.0 27.6 11.0 27.1 55.3 57.6 29.8 29.4 45.7 113.1 28.2 28.6 33.1 32.9 23.5 16.0 59.6 75.1 39.5 23.9 34.0 52.7 25.2 30.0 24.4 46.5 18.5 15.4 54.8 22.4 39.5 53.5 143.7 39.1 33.2 46.2 12.2 51.6 30.3 44.3 10.1 16.6 44.1 36.0 25.2 47.2 61.2 44.8 32.6 20.7 18.6 32.9 34.1 33.6 32.2 30.1 19.8 64.2 177.6 40.4 28.0 26.2 75.5 SURF1 ENSG00000148290 "SURF1 cytochrome c oxidase assembly factor" Q15526 9 133351758-133356676 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Charcot-Marie-Tooth disease, Disease variant, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB033946 Uncertain NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" "CAB033946: AB_2302648" "unprognostic (1.87e-1)" "unprognostic (7.76e-3)" "unprognostic (1.34e-2)" "unprognostic (4.26e-3)" "unprognostic (3.43e-1)" "unprognostic (2.58e-1)" "unprognostic (1.35e-1)" "unprognostic (7.68e-2)" "unprognostic (3.00e-1)" "unprognostic (4.75e-2)" "unprognostic (1.11e-2)" "unprognostic (2.66e-1)" "prognostic favorable (6.92e-9)" "unprognostic (3.91e-2)" "unprognostic (2.13e-1)" "unprognostic (4.58e-2)" "unprognostic (1.98e-1)" 41.8 54.3 31.8 9.8 32.9 16.8 39.9 32.3 41.3 33.6 34.2 53.8 18.8 32.8 38.5 34.9 34.5 12.7 70.6 31.0 31.8 59.0 93.1 33.4 16.7 31.9 32.3 31.7 79.4 34.8 41.2 11.9 31.7 42.5 20.8 8.9 42.4 21.4 80.2 41.4 41.1 13.8 32.1 39.9 65.4 33.9 33.8 20.3 43.7 41.2 21.8 45.6 31.8 32.4 9.6 21.8 16.5 23.5 39.7 22.0 35.6 11.5 27.8 18.9 16.5 29.6 32.6 13.0 16.3 18.2 27.6 27.8 20.4 27.6 15.0 23.8 13.3 13.2 31.5 23.4 46.9 21.1 13.5 26.3 47.8 13.2 32.1 23.1 14.9 33.2 13.7 26.3 21.0 42.4 26.7 21.8 18.6 86.9 22.1 18.2 24.7 40.8 31.4 20.4 16.2 45.0 26.2 34.2 30.6 22.4 50.1 15.8 12.2 23.3 14.3 16.1 11.6 32.2 51.9 16.3 22.1 10.3 24.0 10.7 11.6 24.1 6.6 7.8 7.9 23.9 9.8 9.0 10.2 19.3 14.0 7.7 11.1 6.5 7.1 13.4 14.9 5.6 31.8 32.9 32.3 41.3 31.0 31.8 31.9 32.3 31.7 32.1 33.8 32.4 46.2 28.9 29.6 5.2 55.6 46.5 54.9 56.1 43.3 24.4 85.5 97.3 94.6 75.8 44.0 68.0 6.2 93.4 55.7 114.0 137.0 90.4 48.3 54.5 25.2 36.8 53.8 32.2 4.8 101.0 87.5 38.3 41.8 36.9 22.9 44.3 50.3 158.1 101.1 28.6 5.6 74.3 99.7 93.2 83.6 127.1 52.2 60.3 69.4 4.7 96.9 95.2 62.8 4.5 10.4 71.9 102.1 48.2 74.3 56.1 215.0 174.5 45.1 25.3 32.9 41.5 56.6 66.2 94.4 50.4 49.0 80.6 51.5 52.6 79.6 63.4 SURF4 "ERV29, FLJ22993, MGC102753" ENSG00000148248 "Surfeit 4" O15260 9 133361450-133376166 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 325.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064613 Approved Supported "Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol" NA Yes 65000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA064613: AB_2685299" "prognostic unfavorable (5.85e-4)" "unprognostic (1.38e-2)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (1.47e-5)" "prognostic unfavorable (8.11e-4)" "unprognostic (1.10e-3)" "unprognostic (3.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.30e-3)" "unprognostic (1.23e-1)" "unprognostic (9.76e-3)" "unprognostic (7.58e-3)" "unprognostic (1.25e-1)" "unprognostic (2.29e-1)" "unprognostic (4.29e-3)" 97.0 106.4 20.3 38.8 22.5 66.5 76.5 22.1 23.4 70.5 27.9 72.1 79.2 78.5 40.6 77.6 71.1 39.0 74.1 21.5 22.3 67.1 223.8 84.2 29.6 23.6 22.2 61.0 150.4 35.4 88.6 55.4 22.2 69.2 37.9 14.0 86.4 39.5 60.1 63.2 82.2 43.4 22.9 59.6 88.5 49.4 25.8 27.8 68.2 23.3 31.4 62.7 59.4 25.9 59.8 96.4 65.3 90.3 134.8 140.2 127.4 184.1 178.4 127.0 124.7 145.9 84.8 41.1 70.6 254.2 122.9 152.7 75.7 94.4 97.0 86.5 46.3 72.1 87.1 156.5 156.2 124.8 94.1 150.4 85.8 109.3 120.2 101.6 118.6 62.9 89.0 109.8 164.5 131.8 60.1 115.4 72.7 162.8 96.2 41.2 89.9 156.5 100.4 56.3 53.8 65.5 136.4 100.4 95.2 61.5 106.6 75.8 127.5 179.4 64.5 137.3 119.6 56.1 86.4 46.4 166.7 66.6 137.5 43.9 40.8 36.2 51.9 32.8 56.9 15.1 36.3 48.4 32.9 12.1 22.0 34.6 28.4 29.4 31.7 38.9 46.9 68.8 20.3 22.5 22.1 23.4 21.5 22.3 23.6 22.2 22.2 22.9 25.8 25.9 53.5 44.8 48.1 18.9 43.0 60.8 65.8 72.5 46.1 21.9 55.5 43.2 42.6 31.5 47.5 35.0 39.6 167.9 80.4 106.9 19.6 95.7 38.6 28.6 72.8 54.8 75.2 31.1 23.2 118.1 254.4 84.8 78.5 67.7 24.7 49.5 47.5 207.3 85.9 33.7 15.6 107.9 30.5 52.3 50.5 19.7 68.3 50.8 40.9 17.8 53.7 53.3 52.5 22.6 23.8 115.1 65.5 53.0 114.8 106.8 151.3 48.5 23.2 26.9 78.9 51.9 80.6 84.4 47.3 46.1 62.4 325.2 90.5 81.8 81.2 84.2 SYVN1 "DER3, HRD1" ENSG00000162298 "Synoviolin 1" Q86TM6 11 65121780-65134532 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Stress response, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 72.9;Plasma cells: 90.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 205.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005480, HPA024300, CAB037030" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum,Plasma membrane" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm "Endoplasmic reticulum, Plasma membrane" "CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073" "unprognostic (1.12e-1)" "unprognostic (3.10e-1)" "unprognostic (1.22e-1)" "unprognostic (2.17e-2)" "unprognostic (2.85e-2)" "prognostic favorable (6.88e-4)" "unprognostic (7.67e-2)" "unprognostic (2.50e-2)" "unprognostic (2.64e-2)" "unprognostic (1.30e-1)" "unprognostic (1.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.77e-2)" "unprognostic (1.56e-2)" "unprognostic (4.89e-1)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 29.2 40.3 19.3 37.1 25.6 31.0 27.6 23.2 21.4 30.7 26.7 29.2 26.1 29.1 38.8 28.4 30.6 19.7 25.3 18.6 21.2 24.5 117.5 27.0 60.9 27.9 25.6 30.9 90.9 35.0 38.2 26.2 24.6 28.5 29.0 18.7 55.9 30.3 34.2 29.3 39.4 25.9 22.8 51.2 39.4 24.3 23.4 18.3 43.4 19.0 81.1 25.8 24.8 25.9 32.4 40.6 24.0 32.5 59.8 33.8 23.8 32.8 33.5 40.9 28.8 22.2 55.0 181.0 43.8 42.4 53.8 48.8 26.4 33.3 33.6 28.4 20.0 28.6 46.8 50.2 72.3 43.3 49.6 43.3 59.0 36.1 81.0 36.4 27.0 19.0 36.4 90.1 24.3 47.9 19.1 31.2 26.1 33.6 28.0 31.9 20.3 74.0 25.7 31.5 15.6 32.0 30.4 74.1 53.3 21.0 55.4 28.2 25.9 28.3 18.6 51.2 22.4 178.1 134.2 205.9 38.1 21.8 32.3 16.8 7.4 14.0 7.4 4.7 6.5 21.9 5.2 6.9 4.4 22.6 3.7 3.9 7.0 3.5 4.7 18.4 5.3 6.6 19.3 25.6 23.2 21.4 18.6 21.2 27.9 25.6 24.6 22.8 23.4 25.9 11.5 16.0 21.4 11.1 43.5 17.6 6.9 13.8 12.0 10.7 21.0 15.5 4.0 22.8 20.8 11.0 33.3 14.5 16.4 23.1 1.9 13.6 6.6 14.2 16.2 11.3 8.4 13.2 9.6 18.9 16.5 14.2 17.9 22.1 1.3 10.1 15.0 72.9 15.1 13.5 9.5 33.6 16.2 15.3 13.2 4.1 20.5 10.8 12.4 9.4 10.5 11.0 13.4 13.0 15.8 18.2 11.7 13.2 90.5 14.9 14.0 7.7 15.1 18.7 13.1 11.9 10.7 19.3 13.2 9.7 16.1 42.8 11.7 13.6 18.6 13.8 TAB3 MAP3K7IP3 ENSG00000157625 "TGF-beta activated kinase 1 (MAP3K7) binding protein 3" Q8N5C8 X 30827442-30975084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034980, HPA034981" Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles, Cytosol" "HPA034980: AB_10602708, HPA034981: AB_2674394" "unprognostic (4.39e-1)" "unprognostic (2.22e-1)" "unprognostic (3.04e-2)" "unprognostic (1.73e-1)" "unprognostic (6.35e-2)" "unprognostic (2.95e-3)" "unprognostic (1.49e-2)" "unprognostic (1.73e-2)" "unprognostic (3.10e-1)" "unprognostic (2.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.51e-1)" "prognostic favorable (8.45e-4)" "unprognostic (5.91e-2)" "unprognostic (1.25e-1)" "unprognostic (9.12e-2)" "unprognostic (2.75e-1)" 8.1 7.6 3.6 8.0 4.5 16.8 8.9 3.9 6.7 8.5 20.6 9.6 7.7 18.0 8.9 16.6 9.7 8.1 8.6 5.3 4.0 14.3 27.1 9.0 8.9 5.2 6.5 12.2 24.9 31.8 6.5 11.6 4.7 14.6 9.5 23.9 9.7 12.6 10.7 9.7 7.9 13.3 3.1 8.5 12.5 15.3 4.4 9.7 10.0 8.9 12.6 7.2 8.3 5.7 40.2 9.5 9.6 9.8 7.3 11.0 10.1 12.2 15.3 8.0 9.1 10.8 33.5 18.1 7.3 14.2 15.5 20.4 14.8 31.0 11.6 31.2 14.2 16.9 10.9 26.4 6.3 18.0 12.7 8.0 18.2 13.8 35.0 13.9 13.5 13.5 19.7 14.4 10.6 19.4 14.4 9.1 11.5 7.2 15.9 9.1 16.8 13.5 13.3 11.6 8.0 11.3 13.6 20.3 26.0 17.8 17.5 7.1 13.0 8.9 13.0 44.8 11.3 18.6 15.3 17.8 13.9 8.3 12.7 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.3 0.2 0.2 0.1 0.9 0.2 0.0 0.1 0.1 3.6 4.5 3.9 6.7 5.3 4.0 5.2 6.5 4.7 3.1 4.4 5.7 9.6 12.8 13.2 14.0 10.2 9.1 7.9 7.2 6.8 7.4 10.0 5.3 11.4 20.0 10.5 11.0 12.5 15.1 11.0 12.3 3.9 8.4 1.5 13.0 23.0 8.8 7.2 39.2 23.2 6.9 4.9 5.6 12.8 11.9 14.5 28.6 10.0 26.0 7.7 11.8 22.3 10.8 6.1 16.0 13.7 3.4 10.8 12.6 5.4 20.6 11.5 6.7 3.1 21.6 21.2 9.9 11.2 16.1 7.3 12.6 7.3 11.2 19.6 20.4 0.0 6.3 6.7 3.3 2.2 9.6 10.1 22.4 10.9 24.4 9.8 13.2 TARBP2 Trbp ENSG00000139546 "TARBP2 subunit of RISC loading complex" Q15633 12 53500921-53506431 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051181, HPA061454, CAB069406" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nuclear bodies" "CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526" "unprognostic (1.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (6.61e-3)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.04e-1)" "unprognostic (4.72e-3)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (8.06e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (4.31e-1)" 9.2 13.1 9.8 9.2 10.0 6.8 8.9 13.4 11.3 8.9 9.5 9.5 9.0 8.5 7.9 13.1 11.7 6.7 9.7 9.6 10.1 18.6 20.6 10.1 10.5 10.0 10.0 8.0 18.7 8.5 8.5 13.8 9.9 11.3 5.5 6.7 11.0 5.1 9.8 9.8 9.5 6.1 9.9 15.2 12.4 13.1 10.8 10.3 12.0 7.1 9.0 10.4 8.9 10.5 25.5 69.1 26.8 29.6 15.3 20.8 35.0 22.6 19.2 34.1 20.3 61.2 33.5 24.5 44.6 24.9 22.2 20.0 32.8 34.1 19.9 30.5 54.1 28.6 26.6 43.9 33.3 48.0 31.9 24.3 21.0 35.2 16.5 23.2 41.2 36.6 37.1 38.3 24.9 102.9 32.5 62.9 53.0 19.7 37.1 23.9 14.4 31.6 22.6 26.4 34.8 24.8 11.8 28.7 58.9 19.1 40.4 63.7 22.1 31.2 29.8 11.9 27.4 19.7 39.6 26.1 34.8 24.2 35.6 2.1 11.5 5.7 13.9 11.9 13.3 10.9 13.3 12.8 14.9 15.3 13.7 13.6 0.7 13.1 7.7 13.3 11.7 12.5 9.8 10.0 13.4 11.3 9.6 10.1 10.0 10.0 9.9 9.9 10.8 10.5 5.2 0.0 8.2 4.6 10.7 6.4 10.5 15.3 17.1 9.3 12.0 10.0 6.0 15.7 11.2 9.2 10.4 46.5 7.2 9.8 21.5 20.7 10.7 7.9 8.8 11.6 5.4 9.4 2.3 26.2 48.9 9.3 13.7 7.2 10.8 10.5 12.1 18.4 25.6 1.7 3.1 10.8 18.3 9.3 4.7 23.8 5.6 7.9 14.2 1.0 12.2 10.2 10.3 4.5 6.2 16.8 9.9 4.1 15.6 11.2 11.3 28.6 7.1 14.2 0.0 4.0 10.0 11.6 13.0 14.4 4.7 32.2 9.0 9.9 14.8 10.1 TARS1 TARS ENSG00000113407 "Threonyl-tRNA synthetase 1" P26639 5 33440696-33468091 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 63.4;Cytotrophoblasts: 36.6;dendritic cells: 15.9;Extravillous trophoblasts: 42.1;Hofbauer cells: 32.1;Syncytiotrophoblasts: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037425 Approved Approved "Actin filaments,Cytosol" NA NA 580000 "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Actin filaments" "HPA037425: AB_10672279" "prognostic unfavorable (6.14e-5)" "unprognostic (5.13e-2)" "unprognostic (9.04e-2)" "prognostic unfavorable (5.17e-4)" "unprognostic (9.10e-2)" "unprognostic (1.07e-3)" "prognostic unfavorable (9.88e-7)" "unprognostic (1.43e-1)" "unprognostic (1.61e-1)" "unprognostic (2.65e-3)" "unprognostic (5.97e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (9.63e-4)" "unprognostic (1.37e-1)" "unprognostic (5.15e-2)" "unprognostic (1.18e-1)" "unprognostic (7.25e-2)" 29.0 32.2 13.7 33.8 16.2 45.0 26.8 20.0 20.1 24.0 17.1 42.6 30.7 24.7 35.8 40.9 17.4 19.9 38.7 13.8 17.9 32.4 68.6 24.1 29.9 22.4 18.5 17.9 68.1 33.8 9.9 37.1 18.3 27.6 42.8 40.7 36.8 26.4 38.4 19.1 29.8 37.2 18.4 21.7 40.0 18.7 18.3 31.7 37.6 28.4 40.1 42.9 10.8 22.6 253.0 136.1 132.7 189.5 80.2 129.9 230.1 237.5 172.9 152.5 163.7 176.6 128.7 96.0 84.8 176.5 271.8 151.1 261.1 207.1 267.4 158.9 140.5 151.1 332.9 108.5 256.7 225.6 141.0 133.7 287.7 217.5 273.9 102.4 144.3 191.8 236.3 204.6 191.5 105.7 166.3 104.7 159.2 181.5 168.4 137.1 237.9 123.4 170.8 119.8 81.0 102.7 245.6 175.8 195.5 103.8 85.9 236.3 123.0 132.8 211.9 102.5 196.3 135.4 258.4 132.6 156.2 302.6 148.3 34.2 22.0 22.6 27.4 24.5 27.6 28.7 25.2 26.6 32.6 23.9 21.5 27.5 2.6 46.2 18.3 18.3 24.2 20.6 13.7 16.2 20.0 20.1 13.8 17.9 22.4 18.5 18.3 18.4 18.3 22.6 12.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.4 0.0 0.0 0.0 0.0 36.6 15.9 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 42.1 11.7 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 52.1 2.6 0.0 0.0 0.0 TBCA ENSG00000171530 "Tubulin folding cofactor A" O75347 5 77691166-77868780 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 1298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036487 Approved Supported Nucleoli,Microtubules NA NA 1800000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Microtubules Nucleoli "HPA036487: AB_10669794" "unprognostic (2.03e-2)" "unprognostic (2.12e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (5.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" "unprognostic (7.63e-2)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" 152.9 255.7 134.2 112.1 136.7 156.5 146.4 137.9 177.2 149.1 137.7 152.0 105.3 131.3 246.2 170.6 142.3 89.0 153.9 134.8 152.7 189.9 286.7 114.4 146.2 144.7 151.8 194.1 131.7 162.1 150.7 122.9 150.4 127.7 106.2 108.8 124.4 100.0 147.1 98.1 104.6 104.7 138.3 108.7 153.0 79.3 145.4 155.0 130.2 108.1 140.7 133.1 136.9 140.9 427.1 286.2 526.4 515.1 227.5 322.7 285.1 352.9 303.2 377.9 432.6 389.5 456.0 654.1 627.0 200.5 562.2 258.0 328.1 453.9 372.7 306.6 524.8 310.9 286.4 426.5 331.7 271.8 248.1 326.4 350.4 270.0 401.0 372.1 329.6 532.2 331.9 396.4 346.7 367.4 575.7 650.3 320.5 122.1 265.0 383.6 434.5 703.6 373.7 358.0 501.1 324.3 339.3 236.6 668.0 455.3 337.2 679.0 307.2 192.2 214.2 341.5 563.3 323.0 339.3 580.9 438.0 463.3 391.1 73.3 138.4 77.5 135.4 153.6 153.5 218.6 160.9 162.4 172.5 196.0 150.8 194.9 82.2 132.7 168.3 253.7 241.6 156.8 134.2 136.7 137.9 177.2 134.8 152.7 144.7 151.8 150.4 138.3 145.4 140.9 177.5 153.8 141.9 53.2 234.6 210.9 264.5 447.5 140.0 167.4 310.9 371.0 88.5 275.9 217.0 303.5 58.4 453.9 195.5 231.4 718.1 377.4 46.5 458.4 263.1 185.2 253.5 189.1 71.2 388.5 374.1 216.1 151.4 238.8 159.0 394.1 297.0 1298.8 411.2 148.0 73.9 300.7 252.3 495.5 401.4 42.7 306.6 226.3 225.9 40.3 394.9 231.3 254.3 66.9 126.8 476.2 283.1 258.8 182.6 406.3 256.6 1037.0 360.8 133.3 236.7 214.8 223.0 236.5 119.0 261.6 226.0 563.8 203.7 505.0 303.6 303.3 TCIRG1 "a3, Atp6i, ATP6N1C, ATP6V0A3, OC-116, OC116, TIRC7" ENSG00000110719 "T cell immune regulator 1, ATPase H+ transporting V0 subunit a3" Q13488 11 68039025-68050895 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 289.2" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 135.5;Kupffer cells: 115.2;Macrophages: 132.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 131.9;RPMI-8226: 138.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038742 Approved Approved Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Mitochondria "HPA038742: AB_10795138" "unprognostic (5.35e-2)" "unprognostic (5.01e-2)" "unprognostic (1.81e-2)" "unprognostic (1.50e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (5.07e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "unprognostic (2.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.50e-11)" "unprognostic (2.48e-3)" "unprognostic (7.88e-3)" "unprognostic (2.50e-1)" "prognostic favorable (9.45e-6)" 56.8 112.5 7.1 46.1 7.1 97.7 47.2 9.2 14.5 85.1 11.4 66.6 44.2 58.0 18.6 45.3 61.4 11.7 27.9 6.6 7.2 35.5 61.7 113.9 30.9 10.9 9.3 49.1 289.2 4.4 20.3 14.1 12.0 72.2 8.0 0.3 57.9 16.1 10.5 25.9 87.0 12.1 9.1 194.8 59.2 6.7 18.1 12.1 52.5 3.9 13.4 56.1 60.7 10.8 31.8 57.2 0.8 0.2 25.1 19.7 39.0 61.5 29.4 17.2 16.3 1.3 92.0 2.7 32.9 21.9 26.2 39.0 3.7 23.5 3.6 82.1 1.9 22.0 80.6 18.9 23.4 16.3 131.9 22.8 13.5 21.2 1.4 0.0 11.8 1.2 11.6 8.4 5.7 10.7 0.8 97.8 3.5 44.6 14.4 26.8 0.9 138.6 16.2 17.6 3.0 0.7 26.0 33.4 16.8 6.1 36.3 41.1 42.3 33.2 25.9 93.3 11.4 1.3 1.2 4.8 74.0 26.7 16.2 21.7 65.5 72.8 15.7 109.0 12.7 11.3 11.7 16.9 49.0 7.5 6.6 7.2 150.0 32.1 144.3 33.8 12.1 47.8 7.1 7.1 9.2 14.5 6.6 7.2 10.9 9.3 12.0 9.1 18.1 10.8 40.6 28.9 59.8 0.3 37.1 6.2 13.2 36.2 7.4 0.7 14.9 8.9 1.6 18.6 57.1 7.3 0.0 21.7 60.6 74.2 0.0 30.4 0.4 13.3 16.7 22.1 23.9 15.2 0.3 67.0 54.1 24.9 135.5 21.5 50.0 29.5 21.0 17.8 105.1 0.0 0.6 32.4 18.3 115.2 22.8 0.6 5.9 132.3 5.4 8.4 74.9 0.7 45.3 0.5 0.1 51.8 85.4 13.2 59.1 10.6 45.5 2.0 47.9 1.0 39.5 7.7 26.0 0.1 2.9 10.4 5.3 26.5 46.5 9.0 36.2 19.0 TGDS "SDR2E1, TDPGD" ENSG00000088451 "TDP-glucose 4,6-dehydratase" O95455 13 94574054-94596242 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Lyase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 75.2;U-698: 97.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039927, HPA040857" Approved Approved Nucleoplasm,Nucleoli,Cytosol NA No "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 33: Fibroblasts - ECM organization" Nucleoplasm "Nucleoli, Cytosol" "HPA039927: AB_10795238, HPA040857: AB_10794867" "unprognostic (4.07e-2)" "unprognostic (3.56e-1)" "unprognostic (2.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.27e-1)" "unprognostic (2.25e-2)" "unprognostic (1.60e-1)" "unprognostic (2.87e-1)" "unprognostic (9.99e-2)" "unprognostic (1.96e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (5.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-2)" "unprognostic (1.09e-1)" 10.4 9.4 5.3 8.2 5.5 6.0 12.4 5.6 8.2 10.4 6.3 8.0 10.2 8.0 11.8 6.9 9.2 6.8 5.4 4.9 5.6 10.9 30.0 7.1 12.9 5.6 5.4 12.1 10.0 8.1 8.4 10.1 5.9 7.9 9.5 6.9 7.7 7.6 4.1 7.5 9.2 6.7 5.6 9.2 9.1 6.0 5.3 14.1 13.3 4.3 11.0 9.1 6.4 6.6 16.7 7.2 11.6 10.6 17.2 13.5 14.1 15.3 14.9 14.2 13.4 18.9 15.9 26.0 14.8 10.9 8.8 10.4 20.1 11.9 14.9 20.3 7.7 20.7 8.1 18.1 21.0 75.2 13.8 14.9 9.5 8.0 22.8 11.1 13.2 18.9 21.3 8.9 13.3 10.8 20.6 38.4 15.2 26.8 8.3 17.1 11.4 15.9 18.3 7.4 15.9 8.9 11.6 24.2 43.5 19.1 10.2 39.8 12.2 5.6 14.5 8.6 12.6 20.0 11.4 97.5 14.9 26.5 15.5 14.7 5.5 10.8 9.6 6.6 14.9 9.5 11.6 10.7 8.7 7.1 16.8 12.5 1.6 12.1 8.3 7.6 13.8 6.9 5.3 5.5 5.6 8.2 4.9 5.6 5.6 5.4 5.9 5.6 5.3 6.6 7.4 12.8 6.8 8.1 12.8 2.4 9.2 15.9 6.8 4.3 7.8 7.9 5.2 8.6 11.9 7.3 2.1 15.7 12.5 5.8 9.8 11.9 1.2 10.4 8.9 7.0 5.4 3.4 7.7 9.1 17.7 12.9 6.1 6.0 11.4 7.7 7.9 21.4 11.2 1.7 6.7 7.7 8.2 8.8 7.2 1.0 14.3 7.5 8.8 8.4 11.1 7.0 7.2 12.1 10.4 8.9 6.6 8.2 10.7 10.9 10.0 17.6 15.9 4.7 26.3 6.7 8.1 11.9 12.3 8.5 3.7 10.4 11.0 9.2 9.1 9.7 TM9SF1 "HMP70, MP70" ENSG00000100926 "Transmembrane 9 superfamily member 1" O15321 14 24189149-24195687 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Plasma cells: 54.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059249 Supported Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA059249: AB_2683959" "unprognostic (3.27e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (9.31e-2)" "unprognostic (1.48e-1)" "unprognostic (3.84e-2)" "unprognostic (1.19e-2)" "unprognostic (4.84e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.54e-1)" "unprognostic (1.37e-1)" "unprognostic (2.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.62e-3)" "unprognostic (2.44e-1)" "unprognostic (4.24e-1)" "unprognostic (2.20e-1)" "unprognostic (4.18e-3)" 28.0 35.2 7.5 10.5 7.6 3.7 25.6 7.9 7.9 29.2 18.2 23.9 12.7 31.1 31.3 25.4 27.9 17.5 21.7 7.4 7.7 25.1 34.6 26.7 7.7 8.8 9.4 24.8 46.8 36.6 20.0 18.1 8.4 23.4 15.5 5.9 35.6 21.3 19.5 24.2 21.4 18.1 8.5 19.4 29.4 20.2 8.3 8.3 30.7 11.1 12.4 23.8 23.6 8.4 22.0 45.1 17.7 18.0 59.4 40.4 22.4 37.6 55.4 53.7 60.5 19.1 49.0 12.5 25.2 50.3 30.7 50.5 14.9 29.7 39.3 18.4 15.4 9.4 21.3 56.2 41.8 18.5 22.8 41.3 56.1 36.9 50.5 42.3 32.3 7.9 11.2 30.7 43.6 51.2 12.1 15.7 8.4 62.1 39.2 15.6 22.1 24.7 42.5 37.9 16.3 18.6 39.0 44.3 24.5 16.8 28.8 14.1 26.0 47.5 21.2 23.1 28.1 31.0 25.5 7.4 18.1 11.5 39.5 33.4 20.5 25.0 14.1 18.1 15.3 15.0 14.6 12.6 23.4 16.3 13.0 12.9 28.3 23.1 18.5 39.2 17.2 13.5 7.5 7.6 7.9 7.9 7.4 7.7 8.8 9.4 8.4 8.5 8.3 8.4 5.5 16.0 5.3 8.8 11.2 3.3 6.1 7.3 18.8 4.4 6.1 5.0 1.5 7.2 7.6 1.8 14.6 9.8 5.0 4.0 0.0 8.2 13.9 5.2 7.4 8.7 1.8 5.5 6.6 4.9 10.4 14.9 13.7 6.3 2.5 5.3 5.0 4.8 4.1 0.0 7.1 3.5 6.1 2.5 4.5 6.2 5.3 5.6 1.8 4.7 5.3 5.4 4.1 9.0 7.3 5.3 6.1 4.5 54.3 7.7 3.5 3.0 30.0 7.6 6.6 10.1 7.4 7.0 5.4 19.5 4.7 11.9 9.1 5.7 4.1 3.8 TMBIM4 "CGI-119, GAAP, LFG4, S1R, ZPRO" ENSG00000155957 "Transmembrane BAX inhibitor motif containing 4" Q9HC24 12 66135846-66170072 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA077642 Supported "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA077642: AB_2686849" "unprognostic (5.41e-2)" "unprognostic (1.27e-1)" "unprognostic (3.19e-1)" "unprognostic (8.14e-2)" "unprognostic (2.69e-2)" "unprognostic (5.62e-2)" "unprognostic (7.18e-3)" "unprognostic (8.51e-2)" "unprognostic (2.49e-1)" "unprognostic (1.33e-2)" "unprognostic (3.36e-1)" "unprognostic (9.93e-2)" "unprognostic (2.49e-2)" "unprognostic (3.70e-1)" "unprognostic (3.68e-2)" "unprognostic (3.75e-2)" "unprognostic (2.20e-3)" 79.7 88.6 28.0 75.3 34.3 61.5 81.4 34.0 29.7 67.3 47.6 90.5 59.5 61.0 68.6 62.6 65.8 70.1 70.8 27.1 35.6 94.0 109.6 76.7 74.5 38.5 32.1 56.7 103.5 104.7 40.1 74.2 39.1 72.8 70.2 39.7 89.3 73.7 46.7 52.2 69.8 58.5 34.7 74.4 93.3 85.1 31.0 63.1 97.9 61.5 56.0 80.0 42.9 41.5 49.1 62.4 39.7 72.8 131.4 122.7 41.9 74.4 129.1 56.7 45.8 32.8 78.7 45.6 86.3 105.2 42.6 78.9 20.1 65.7 36.6 74.5 27.3 87.7 30.0 38.6 66.6 106.9 109.2 86.9 92.8 27.7 31.1 79.0 87.2 51.8 65.9 160.3 94.3 79.5 41.1 37.5 47.4 76.1 63.3 21.5 26.5 50.8 126.8 80.3 20.1 47.6 84.5 154.5 102.3 34.2 146.3 146.7 106.0 69.1 25.9 50.5 44.8 82.7 48.5 32.2 94.8 103.7 84.1 420.7 372.7 371.6 136.0 381.4 137.9 205.9 139.7 139.4 256.2 196.6 157.9 139.1 662.3 135.3 434.3 171.7 159.8 483.9 28.0 34.3 34.0 29.7 27.1 35.6 38.5 32.1 39.1 34.7 31.0 41.5 232.8 150.6 147.2 34.0 131.3 0.0 64.1 0.0 84.2 47.8 202.2 152.1 37.0 0.0 66.2 244.6 45.9 137.0 128.2 191.4 103.7 213.8 330.6 116.2 96.4 114.5 74.7 32.0 15.8 338.1 116.9 140.7 85.1 105.8 179.0 72.7 0.0 0.0 210.7 45.4 25.2 172.4 0.0 0.0 0.0 143.8 104.4 193.2 0.0 62.8 205.5 114.1 123.6 42.7 77.0 202.9 176.9 91.0 126.8 87.9 128.9 214.5 99.1 65.9 59.2 67.8 75.7 391.0 40.8 112.5 0.0 130.8 99.3 142.7 182.2 62.8 TMED10 "p23, P24(DELTA), p24d1, p24delta1, TMP21" ENSG00000170348 "Transmembrane p24 trafficking protein 10" P49755 14 75131469-75176612 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034442, CAB037251, HPA047139, HPA050539" Enhanced Supported "Golgi apparatus" NA NA 220000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163" "unprognostic (2.00e-1)" "unprognostic (1.73e-2)" "unprognostic (2.02e-1)" "unprognostic (2.51e-3)" "unprognostic (4.06e-1)" "unprognostic (1.17e-3)" "unprognostic (5.88e-2)" "unprognostic (1.21e-1)" "unprognostic (3.68e-2)" "unprognostic (6.46e-3)" "unprognostic (1.01e-2)" "unprognostic (1.27e-2)" "unprognostic (1.36e-2)" "unprognostic (1.43e-1)" "unprognostic (2.82e-1)" "prognostic unfavorable (8.67e-4)" "unprognostic (2.06e-2)" 68.0 70.3 51.8 55.2 55.8 18.0 93.2 52.6 60.7 137.9 61.2 77.0 62.3 92.6 133.1 59.9 100.6 69.2 82.3 49.5 66.1 62.7 126.9 68.0 61.0 65.8 54.3 99.7 131.9 91.4 53.6 76.3 63.2 91.0 82.3 48.8 130.7 85.9 73.7 56.0 58.8 78.9 57.5 54.6 78.3 40.0 58.2 73.7 146.0 61.0 65.9 66.9 59.7 69.6 93.3 52.2 85.5 142.5 197.5 183.7 110.9 96.5 159.5 99.5 111.2 51.8 161.2 82.5 80.6 167.5 56.8 90.8 80.4 140.6 160.5 43.7 36.2 50.5 31.1 79.2 167.1 101.7 50.2 135.1 221.5 77.0 220.1 196.0 176.9 91.7 44.6 177.8 145.0 104.6 71.0 80.7 51.9 145.2 55.8 70.6 55.3 116.6 119.7 94.8 82.9 87.1 89.0 147.0 175.9 81.0 138.3 163.3 122.3 97.0 62.9 65.9 50.7 98.9 99.3 91.3 177.0 88.3 95.8 107.4 46.4 28.9 60.8 39.4 93.8 39.7 58.7 59.3 62.9 30.3 51.9 55.9 20.4 101.8 42.6 70.9 38.2 91.4 51.8 55.8 52.6 60.7 49.5 66.1 65.8 54.3 63.2 57.5 58.2 69.6 80.8 64.1 106.3 32.0 141.8 114.2 180.4 488.1 107.0 55.6 182.5 130.6 155.3 187.3 279.9 200.5 27.1 181.0 186.7 186.2 62.6 319.1 14.5 147.7 177.5 107.3 140.7 75.5 26.9 385.7 609.9 164.4 145.8 172.0 100.1 170.9 123.1 339.7 255.0 77.4 30.0 276.2 272.6 159.4 166.3 31.5 179.3 151.6 297.1 38.4 129.5 137.9 130.7 50.8 84.2 225.8 148.9 209.9 538.8 218.7 120.3 138.9 304.8 63.1 78.9 112.7 132.2 317.7 116.5 151.7 135.1 309.2 122.1 145.8 161.9 207.7 TMED2 "P24A, p24b1, p24beta1, RNP24" ENSG00000086598 "Transmembrane p24 trafficking protein 2" Q15363 12 123584533-123598582 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014060 Approved Supported Vesicles NA NA 82000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA014060: AB_1856389" "unprognostic (6.36e-2)" "unprognostic (3.38e-3)" "unprognostic (5.41e-3)" "unprognostic (1.75e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (3.36e-6)" "unprognostic (3.57e-3)" "unprognostic (2.20e-2)" "unprognostic (4.31e-2)" "unprognostic (9.76e-3)" "unprognostic (1.03e-2)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.35e-7)" "unprognostic (2.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (9.87e-2)" 106.0 97.1 40.7 92.6 43.5 122.1 136.1 44.2 50.8 155.6 59.5 132.5 123.7 102.5 203.3 111.9 102.3 96.1 116.5 40.5 45.3 102.8 271.1 85.4 72.7 46.6 46.6 101.5 229.1 99.3 65.0 125.4 46.9 140.5 140.7 56.9 227.6 102.2 131.0 74.8 110.5 102.1 46.0 63.2 133.8 58.5 44.2 69.1 197.6 112.1 95.2 118.6 71.4 53.8 237.7 204.9 133.4 232.2 295.7 260.2 317.5 401.2 318.5 246.8 194.2 209.9 198.9 199.3 210.7 398.7 169.4 228.1 181.8 214.5 257.3 155.2 169.3 217.3 114.0 267.6 559.5 296.9 178.1 220.5 349.2 212.6 286.0 352.7 234.7 133.5 223.1 132.9 255.6 175.1 159.8 242.7 192.9 201.0 206.6 164.8 216.8 235.7 303.9 349.1 166.5 143.1 267.3 263.6 273.7 160.0 450.2 237.2 226.2 210.1 132.4 204.9 227.5 292.3 290.7 167.6 248.3 192.9 254.2 249.7 143.2 145.9 157.0 147.5 198.8 111.8 137.0 148.4 158.6 102.5 110.3 129.4 111.1 148.5 141.3 242.5 140.1 142.2 40.7 43.5 44.2 50.8 40.5 45.3 46.6 46.6 46.9 46.0 44.2 53.8 97.1 48.1 71.5 9.1 148.8 417.4 290.3 348.5 207.1 50.1 258.8 98.0 167.2 213.1 233.2 154.5 20.9 281.5 166.9 169.6 117.4 325.1 12.2 89.2 136.5 142.0 170.7 76.3 20.0 249.6 678.6 242.7 156.5 136.8 92.6 88.4 143.5 538.8 215.8 48.8 20.3 352.4 321.4 141.7 414.3 13.9 181.4 128.5 378.8 17.8 129.8 124.1 195.7 19.6 27.5 224.9 158.5 153.4 521.0 486.3 178.1 163.0 142.1 54.7 164.3 112.6 193.5 165.9 150.6 289.8 498.8 451.9 154.3 125.0 263.9 389.2 TMED7 "CGI-109, FLJ90481, p24g3, p24gamma3" ENSG00000134970 "Transmembrane p24 trafficking protein 7" Q9Y3B3 5 115613210-115632992 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008960, CAB025883" Supported NA NA 13000 "Cluster 34: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "CAB025883: , HPA008960: AB_1080280" "unprognostic (1.40e-1)" "unprognostic (8.42e-2)" "unprognostic (1.45e-2)" "unprognostic (1.22e-1)" "unprognostic (2.04e-1)" "unprognostic (4.35e-2)" "unprognostic (1.27e-1)" "unprognostic (2.26e-3)" "unprognostic (2.02e-1)" "unprognostic (2.11e-2)" "unprognostic (6.15e-3)" "unprognostic (4.10e-2)" "unprognostic (6.82e-2)" "unprognostic (4.95e-2)" "unprognostic (3.06e-1)" "unprognostic (4.79e-2)" "unprognostic (1.22e-1)" 35.0 41.2 23.1 29.5 31.9 31.8 37.8 31.2 32.7 50.5 37.8 42.1 36.9 41.2 70.2 32.4 38.6 33.5 43.5 21.9 24.6 54.2 80.2 30.5 23.4 39.8 27.2 31.0 35.2 53.6 28.0 43.8 28.1 48.7 42.3 19.2 43.4 44.3 22.0 18.9 38.3 45.0 33.3 25.9 41.5 18.9 28.5 19.5 79.8 24.9 24.1 37.6 22.6 44.8 63.6 42.4 43.8 54.7 112.3 84.4 68.1 109.8 116.4 79.7 129.8 36.3 110.1 33.1 105.7 115.1 99.5 49.6 41.3 128.0 125.7 76.0 34.4 30.5 39.2 76.8 119.8 31.9 59.0 78.2 60.5 76.1 95.8 100.4 78.5 22.3 29.6 44.5 87.1 30.1 24.0 28.5 30.8 37.7 35.5 25.9 65.1 63.8 98.6 44.6 33.3 39.8 90.0 52.3 68.1 41.7 63.0 41.8 80.1 109.0 46.3 79.2 66.3 29.3 24.0 33.5 88.7 52.2 61.8 25.5 23.8 20.2 14.9 23.1 15.3 10.4 11.5 13.3 19.3 9.1 11.1 12.0 16.3 14.2 18.5 13.3 11.5 20.7 23.1 31.9 31.2 32.7 21.9 24.6 39.8 27.2 28.1 33.3 28.5 44.8 37.8 38.5 29.8 0.0 26.9 45.6 30.1 35.3 15.4 31.5 47.4 21.5 42.4 61.5 29.3 46.0 10.4 44.2 30.6 63.8 13.7 37.4 28.7 34.5 48.9 30.6 87.3 9.1 0.0 28.3 103.6 51.8 34.1 45.6 10.1 20.4 44.3 114.2 50.1 30.3 0.0 85.8 24.4 51.6 55.5 20.1 46.9 38.4 51.6 0.0 36.8 52.6 19.6 0.0 0.0 37.4 39.9 53.4 13.9 60.5 50.0 42.2 36.9 25.8 39.5 42.9 43.1 39.2 18.0 25.3 44.0 82.8 23.6 33.9 46.9 55.6 TMED9 "HSGP25L2G, p24a2, p24alpha2" ENSG00000184840 "Transmembrane p24 trafficking protein 9" Q9BVK6 5 177592203-177597242 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 915.2;Syncytiotrophoblasts: 773.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved NA NA 36000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA014650: AB_1858066" "unprognostic (5.75e-3)" "unprognostic (4.35e-2)" "unprognostic (1.37e-1)" "unprognostic (3.82e-2)" "unprognostic (9.37e-3)" "unprognostic (5.14e-3)" "unprognostic (2.55e-2)" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (7.00e-2)" "unprognostic (4.01e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (5.88e-5)" "unprognostic (2.88e-1)" "unprognostic (4.71e-2)" "unprognostic (9.07e-2)" "unprognostic (3.65e-2)" 86.5 106.7 29.8 38.3 30.0 37.7 74.4 29.8 34.0 74.9 42.0 87.5 31.8 76.6 65.6 135.7 60.7 25.7 99.1 29.9 30.7 97.3 229.5 100.6 29.7 32.4 31.2 62.4 253.7 40.8 82.1 59.1 30.8 87.0 45.5 15.7 139.2 34.4 55.7 83.8 75.6 39.4 31.0 102.1 114.0 54.0 32.3 24.4 87.8 16.8 36.4 84.8 82.5 30.6 100.4 115.9 51.0 163.3 131.5 93.0 224.1 181.5 139.1 91.0 125.3 178.5 142.5 57.5 214.3 171.2 179.5 79.9 49.6 244.8 91.1 275.7 73.6 47.8 93.2 151.2 132.7 130.9 170.4 88.1 125.6 95.8 106.7 122.9 137.4 51.7 55.9 100.0 99.3 243.9 31.3 96.4 57.0 89.9 112.7 53.3 66.9 147.8 109.3 86.0 26.6 38.4 89.7 104.1 99.9 80.4 104.7 131.0 121.0 112.2 83.2 93.0 140.5 171.4 109.9 56.7 149.1 165.9 146.5 78.9 98.3 77.2 85.5 94.5 85.3 65.9 68.3 67.0 91.9 63.5 58.0 53.8 39.1 76.8 89.0 201.4 74.8 131.9 29.8 30.0 29.8 34.0 29.9 30.7 32.4 31.2 30.8 31.0 32.3 30.6 115.6 67.3 69.5 10.1 127.3 145.0 193.4 601.4 48.9 67.4 118.6 94.0 48.0 147.3 235.8 128.8 31.3 525.6 167.8 172.8 29.4 428.6 7.1 51.0 108.4 145.1 112.3 78.9 9.3 354.1 915.2 175.9 79.0 89.8 113.4 141.8 115.6 118.4 384.5 60.6 9.6 323.1 238.0 79.5 139.2 13.5 135.2 121.2 256.1 15.9 189.2 105.4 147.2 17.6 10.3 320.0 155.7 98.2 370.3 229.6 84.2 71.7 94.5 73.7 65.7 83.4 160.3 89.1 175.7 59.9 138.5 773.2 104.7 157.7 182.7 203.6 TMEM214 FLJ20254 ENSG00000119777 "Transmembrane protein 214" Q6NUQ4 2 27032910-27041694 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034551 Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum, Golgi apparatus, Cytosol" "HPA034551: AB_10602481" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (3.10e-1)" "unprognostic (4.12e-3)" "unprognostic (1.90e-2)" "unprognostic (2.42e-2)" "prognostic unfavorable (4.96e-4)" "unprognostic (1.96e-1)" "unprognostic (3.70e-1)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.74e-2)" "prognostic unfavorable (2.39e-10)" "unprognostic (1.54e-2)" "unprognostic (1.97e-2)" "unprognostic (2.04e-1)" "unprognostic (2.92e-2)" 45.8 39.0 14.7 30.8 15.8 23.1 43.2 15.3 17.3 45.0 28.7 38.3 30.5 43.7 66.2 31.5 37.5 30.7 36.7 14.8 17.0 30.0 46.5 37.7 25.1 19.1 18.7 41.4 79.9 56.0 60.4 45.8 18.3 37.9 41.7 8.8 83.6 44.4 35.7 37.8 33.6 45.1 15.6 37.4 40.8 19.5 17.8 21.7 42.3 21.3 34.4 36.7 33.9 14.9 82.4 53.5 32.2 68.2 102.8 103.7 69.4 105.9 142.4 76.0 85.2 53.0 67.3 37.6 52.4 156.6 59.7 57.6 39.3 74.9 61.0 36.3 44.1 49.9 41.4 109.8 128.1 45.7 82.5 90.4 52.7 66.8 112.0 58.6 83.5 24.3 46.0 75.3 85.9 59.6 23.3 34.1 23.1 110.0 42.8 31.3 58.5 91.0 57.1 57.0 27.8 32.3 49.4 83.3 38.2 31.0 45.9 27.0 72.4 55.2 52.8 57.0 60.4 100.9 73.3 59.2 71.1 56.8 77.9 5.7 3.5 2.8 3.9 3.8 5.0 2.5 3.0 2.8 2.8 2.8 1.5 2.1 0.6 5.6 2.2 5.0 2.6 2.5 14.7 15.8 15.3 17.3 14.8 17.0 19.1 18.7 18.3 15.6 17.8 14.9 15.8 3.2 20.1 3.9 18.5 7.6 9.6 10.4 3.4 9.3 19.8 11.0 8.2 21.5 15.0 14.7 10.4 43.6 15.0 37.5 1.9 24.7 6.4 11.3 25.4 17.5 17.9 18.5 4.8 34.6 62.9 26.9 33.1 23.8 14.5 17.0 32.5 28.9 27.3 6.7 4.4 37.6 10.2 18.9 12.8 7.8 32.6 11.7 5.4 6.5 14.6 6.9 14.4 4.0 3.8 21.7 22.3 20.3 63.0 20.8 25.4 10.4 11.0 8.4 26.3 11.6 19.6 24.4 12.7 8.4 9.2 71.7 12.0 17.6 27.6 15.8 TMEM238 ENSG00000233493 "Transmembrane protein 238" C9JI98 19 55379244-55384292 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.9;stomach 1: 16.5" "Group enriched" "Detected in many" 4 "Breast glandular cells: 102.2;Breast myoepithelial cells: 233.7;Endometrial ciliated cells: 80.6;Glandular and luminal cells: 104.2" "Cancer enhanced" "Detected in all" "ovarian cancer: 52.1;stomach cancer: 48.5" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 30.6;CAPAN-2: 18.3;HaCaT: 27.3;RPMI-8226: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 35: Glandular cells - Unknown function" "unprognostic (1.90e-2)" "unprognostic (7.93e-2)" "unprognostic (6.31e-2)" "unprognostic (4.69e-2)" "unprognostic (1.39e-2)" "unprognostic (2.61e-1)" "unprognostic (1.19e-1)" "unprognostic (7.35e-2)" "unprognostic (7.21e-2)" "unprognostic (2.25e-2)" "unprognostic (5.49e-2)" "unprognostic (5.33e-2)" "prognostic favorable (8.84e-6)" "unprognostic (1.78e-3)" "unprognostic (5.55e-2)" "unprognostic (7.91e-3)" "unprognostic (1.17e-3)" 1.1 1.0 0.7 2.5 0.8 1.1 2.4 2.6 1.2 1.7 3.2 15.9 13.9 0.5 0.2 8.8 1.5 0.1 0.3 0.9 0.7 6.7 8.9 3.1 0.8 1.2 1.2 0.4 13.4 1.1 3.1 0.1 1.0 4.4 2.0 0.1 9.2 0.4 1.0 7.2 14.4 0.1 0.7 1.6 16.5 0.3 0.9 0.3 6.2 0.0 0.6 1.9 3.3 0.9 30.6 2.1 0.1 1.7 0.0 0.0 1.7 1.3 0.1 0.0 0.0 1.3 18.3 13.8 5.5 0.1 0.0 27.3 0.5 0.7 0.1 4.0 0.8 0.4 2.6 0.0 0.1 2.9 0.5 0.0 3.7 0.1 0.6 0.2 0.0 2.5 1.8 11.3 0.0 6.8 3.7 1.6 0.8 7.6 9.5 6.8 0.2 19.0 1.2 9.6 9.1 2.9 1.2 14.2 2.1 0.1 10.8 1.7 0.0 0.3 2.4 0.1 0.3 7.5 5.1 3.5 0.1 1.6 0.2 0.0 0.0 0.1 0.4 0.0 1.0 0.6 1.0 0.7 0.0 0.4 0.7 0.6 0.0 0.2 0.0 0.2 1.3 0.1 0.7 0.8 2.6 1.2 0.9 0.7 1.2 1.2 1.0 0.7 0.9 0.9 13.0 0.0 2.4 0.0 20.2 8.5 3.7 0.5 1.2 0.3 102.2 233.7 1.1 27.1 0.5 7.3 0.0 0.0 21.4 29.1 1.9 1.9 0.0 80.6 8.2 2.4 13.8 0.4 0.4 4.3 0.1 2.0 4.1 104.2 0.0 4.5 1.4 13.6 0.3 3.3 0.4 22.8 0.0 2.8 4.9 0.0 0.0 4.3 1.8 0.0 0.7 8.6 2.1 0.0 0.4 3.9 12.9 0.0 16.5 2.3 12.3 1.8 0.5 1.5 0.0 6.3 2.6 0.0 0.0 3.1 26.0 0.0 19.9 2.7 20.3 3.8 TMEM248 "C7orf42, FLJ10099, FLJ13090" ENSG00000106609 "Transmembrane protein 248" Q9NWD8 7 66921225-66958551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016495 Uncertain Approved Vesicles NA NA 1600000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 4: Macrophages - Innate immune response" Vesicles "HPA016495: AB_1848643" "unprognostic (6.74e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (4.64e-2)" "unprognostic (6.67e-3)" "unprognostic (9.36e-2)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.54e-2)" "unprognostic (9.18e-2)" "unprognostic (2.80e-3)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.11e-2)" "unprognostic (8.28e-2)" "unprognostic (5.57e-2)" 31.8 39.7 29.2 27.5 30.8 17.8 34.8 25.3 29.0 46.6 57.5 40.8 42.4 44.3 40.6 26.6 45.0 38.6 32.4 32.2 36.1 36.3 49.4 38.7 36.5 27.3 31.0 50.0 40.3 50.0 31.7 34.5 31.0 43.1 41.1 39.0 39.6 40.9 23.1 29.5 37.4 39.2 26.3 34.2 43.6 32.6 40.1 29.5 46.1 21.4 35.0 34.0 32.4 28.0 46.4 53.3 44.2 63.4 98.2 75.0 38.7 55.7 95.1 51.8 55.9 38.9 59.2 46.7 66.3 75.5 70.8 40.8 38.3 45.9 64.0 43.1 28.2 34.2 36.9 45.4 63.5 57.6 45.5 68.0 52.4 43.6 36.1 75.4 68.5 36.1 66.6 30.6 83.4 28.1 54.3 70.5 65.9 47.5 36.1 39.3 51.4 79.3 70.3 35.1 30.7 65.6 49.1 89.0 50.6 65.6 44.8 52.1 63.9 72.4 35.4 48.0 61.9 37.2 45.4 52.1 60.6 62.9 70.5 2.3 4.0 7.7 6.0 4.3 7.2 8.3 6.5 6.4 3.2 8.1 6.3 6.8 5.8 7.3 2.7 8.3 4.7 1.9 29.2 30.8 25.3 29.0 32.2 36.1 27.3 31.0 31.0 26.3 40.1 28.0 55.1 51.3 42.7 14.7 66.2 64.5 53.5 23.6 46.7 18.5 60.6 44.2 25.0 51.5 25.2 53.3 6.2 48.3 75.2 100.8 11.7 37.0 106.2 37.8 34.5 51.7 27.6 45.9 25.8 47.2 81.2 60.9 55.5 35.0 28.5 44.8 58.2 109.9 52.7 18.5 26.4 82.6 16.2 65.7 76.5 172.3 63.6 53.0 49.8 20.6 46.2 96.7 62.8 24.1 27.7 60.2 62.3 65.8 76.5 108.8 64.4 34.3 36.9 12.7 32.9 40.3 47.7 111.5 57.9 42.2 73.9 88.1 64.4 46.4 60.3 98.7 TMEM263 "C12orf23, MGC17943" ENSG00000151135 "Transmembrane protein 263" Q8WUH6 12 106955719-106978778 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014453, HPA042339" Uncertain Approved Vesicles NA NA 14000 "Cluster 40: NK-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" Vesicles "HPA014453: , HPA042339: AB_10795503" "unprognostic (2.56e-2)" "unprognostic (1.41e-1)" "unprognostic (8.99e-2)" "unprognostic (5.65e-2)" "unprognostic (3.90e-1)" "unprognostic (3.46e-2)" "prognostic unfavorable (7.84e-4)" "unprognostic (4.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.11e-2)" "unprognostic (7.07e-2)" "unprognostic (1.19e-1)" "unprognostic (3.05e-3)" "unprognostic (3.49e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.53e-1)" 20.6 27.1 14.5 20.4 15.6 7.4 22.3 14.2 18.2 41.6 21.8 17.8 17.3 28.3 33.4 9.5 16.2 30.4 28.6 15.5 22.1 29.4 44.6 15.3 21.1 13.2 17.1 29.3 23.4 20.7 37.5 43.2 16.5 28.5 19.2 16.8 21.0 21.6 11.5 8.6 15.3 29.9 13.3 16.4 30.9 19.4 21.4 31.0 33.6 14.2 19.7 22.1 13.9 13.5 32.7 28.2 54.1 37.4 125.8 141.6 23.5 123.1 114.0 59.0 74.6 30.1 14.0 3.2 37.5 174.3 33.3 14.9 34.4 48.6 80.9 61.5 38.0 45.5 41.0 65.0 65.1 2.4 28.3 98.6 23.1 63.9 53.8 137.3 73.4 35.1 22.1 12.1 83.6 26.7 35.4 21.4 17.7 21.1 60.3 77.1 41.3 7.9 60.7 27.3 28.2 38.6 67.3 31.2 51.2 41.9 36.5 13.7 86.7 50.6 30.7 66.9 31.6 50.8 31.5 30.3 39.2 7.7 79.4 11.7 1.4 1.6 15.8 1.6 18.3 15.7 15.2 13.7 4.3 16.8 26.8 24.9 1.0 19.8 0.6 14.8 17.4 13.9 14.5 15.6 14.2 18.2 15.5 22.1 13.2 17.1 16.5 13.3 21.4 13.5 31.6 9.6 23.6 12.1 33.5 0.0 52.0 0.0 53.5 24.4 47.7 25.8 55.4 22.8 11.2 23.9 31.3 40.4 54.3 12.4 92.0 19.2 34.8 19.9 75.7 26.4 28.8 10.9 15.4 33.0 72.6 61.5 50.0 32.4 29.9 33.7 33.2 44.4 13.5 11.8 16.5 65.1 0.0 6.7 0.0 37.2 47.2 10.4 0.0 22.5 9.6 34.1 22.6 24.1 8.4 17.3 13.2 43.6 68.3 48.6 23.0 47.7 12.4 21.0 26.3 39.1 41.7 51.2 22.5 12.7 0.0 36.0 36.3 30.6 16.4 44.2 TMEM33 "FLJ10525, Pom33" ENSG00000109133 "Transmembrane protein 33" P57088 4 41935129-41960803 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075863 Approved NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "HPA075863: " "unprognostic (7.14e-2)" "unprognostic (9.25e-3)" "unprognostic (1.59e-2)" "unprognostic (1.58e-1)" "unprognostic (1.92e-1)" "unprognostic (2.49e-1)" "unprognostic (2.04e-1)" "unprognostic (3.94e-2)" "unprognostic (5.45e-2)" "unprognostic (2.09e-1)" "unprognostic (1.16e-2)" "unprognostic (3.75e-1)" "prognostic favorable (1.35e-5)" "unprognostic (7.70e-2)" "unprognostic (4.20e-1)" "unprognostic (9.35e-3)" "unprognostic (2.36e-2)" 12.4 16.1 8.0 19.4 10.5 14.9 16.0 13.1 11.4 11.4 16.0 18.7 21.1 11.1 25.5 21.2 12.3 17.2 10.5 9.6 12.8 24.2 39.9 15.1 17.0 15.5 13.5 10.5 18.2 30.1 11.0 20.0 14.7 17.2 21.3 13.0 17.9 11.8 8.4 11.9 16.9 11.3 14.1 13.9 19.1 9.9 12.1 14.9 23.8 12.4 20.1 21.8 10.8 18.8 36.9 42.4 36.7 51.3 46.7 31.8 44.9 49.5 53.9 41.5 47.5 52.4 123.4 64.8 74.7 41.5 85.5 57.4 124.4 65.0 56.1 17.1 26.2 80.7 49.7 45.9 54.4 108.7 67.6 33.4 69.0 52.5 78.3 26.5 32.7 37.3 86.8 24.7 57.4 32.6 96.5 67.9 67.2 58.1 50.0 42.7 57.8 51.6 58.2 53.5 40.8 58.4 40.5 38.0 62.4 35.3 42.9 37.4 53.0 48.3 65.0 48.9 89.5 44.5 76.9 77.4 51.7 88.4 71.2 41.2 32.1 21.7 14.9 31.0 17.6 13.0 15.3 14.2 22.9 12.0 13.6 15.0 43.2 16.5 35.2 17.9 19.0 16.4 8.0 10.5 13.1 11.4 9.6 12.8 15.5 13.5 14.7 14.1 12.1 18.8 25.1 60.9 34.3 20.9 25.0 73.3 35.7 42.4 24.5 19.2 36.9 16.4 18.0 27.1 40.5 55.2 16.7 56.3 35.2 58.9 23.5 44.6 2.9 26.9 31.2 25.9 35.0 25.0 33.6 38.1 49.3 30.5 36.2 33.4 38.7 23.1 24.7 84.4 57.3 28.6 32.8 40.4 34.6 67.5 51.0 4.7 20.2 55.7 56.9 11.2 55.9 33.9 16.5 32.6 40.3 54.1 47.4 23.3 32.5 73.7 41.6 41.1 29.7 20.4 26.3 26.5 55.6 31.0 28.7 47.5 66.9 133.1 28.3 39.7 43.0 64.5 TMEM39A "FLJ10902, SUSR2" ENSG00000176142 "Transmembrane protein 39A" Q9NV64 3 119428949-119468830 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039140 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Nucleoplasm Vesicles "HPA039140: AB_10673303" "unprognostic (2.16e-1)" "unprognostic (8.75e-2)" "unprognostic (4.25e-2)" "unprognostic (6.86e-2)" "unprognostic (1.56e-2)" "unprognostic (2.81e-1)" "prognostic unfavorable (3.26e-4)" "unprognostic (9.68e-2)" "unprognostic (6.35e-2)" "unprognostic (2.12e-1)" "unprognostic (1.32e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (4.07e-1)" "unprognostic (2.52e-2)" "unprognostic (1.88e-1)" "unprognostic (6.41e-2)" 12.4 10.5 2.2 14.4 4.3 12.9 10.2 4.1 3.5 19.5 10.9 9.0 10.0 13.2 10.9 9.0 11.7 12.6 11.1 2.2 3.1 6.4 13.0 12.4 10.0 4.0 3.4 13.1 28.4 12.8 15.4 18.1 4.3 9.1 9.3 5.0 13.3 14.3 7.2 8.8 8.0 9.7 3.1 9.2 9.8 7.8 4.7 12.1 16.6 11.9 13.6 14.4 10.5 6.2 28.3 15.1 24.1 17.4 56.1 54.2 24.1 26.4 54.3 37.2 50.0 26.1 21.2 12.0 27.4 28.7 37.9 28.7 29.3 12.1 38.0 12.6 11.2 15.5 13.5 25.4 37.9 27.1 23.4 29.7 20.5 25.9 61.5 37.5 23.6 18.5 16.1 35.5 19.6 14.1 13.7 7.0 20.5 29.8 31.5 16.5 11.3 25.7 9.2 10.7 10.7 15.8 26.6 15.2 33.4 17.3 14.8 23.8 18.5 20.2 17.2 13.8 17.3 39.5 12.5 28.5 27.6 18.2 26.8 12.7 10.9 7.3 11.7 5.8 11.9 7.7 7.1 9.6 12.3 9.0 5.6 6.1 3.8 11.9 4.6 17.3 8.9 9.4 2.2 4.3 4.1 3.5 2.2 3.1 4.0 3.4 4.3 3.1 4.7 6.2 8.5 9.6 15.8 9.8 14.3 22.8 16.0 21.8 8.6 4.7 14.6 10.8 10.8 7.2 16.2 7.3 6.2 26.5 24.7 7.4 5.9 11.6 22.8 8.2 26.3 10.8 10.8 9.0 12.4 14.2 57.6 28.9 13.3 17.9 1.3 13.5 7.9 12.0 13.3 1.7 14.0 18.3 6.1 15.0 54.9 6.8 17.1 17.8 10.6 12.2 31.0 3.9 9.2 25.1 21.8 10.2 6.6 13.2 57.8 20.6 8.0 3.0 14.9 6.4 6.6 15.9 25.2 26.1 18.5 9.6 21.7 59.8 17.4 9.4 11.1 20.4 TMEM59 "C1orf8, HSPC001" ENSG00000116209 "Transmembrane protein 59" Q9BXS4 1 54026681-54053504 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075447 Approved NA NA 27000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA075447: " "unprognostic (2.63e-1)" "unprognostic (9.88e-2)" "unprognostic (2.63e-2)" "unprognostic (2.86e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (1.63e-2)" "unprognostic (8.28e-2)" "unprognostic (4.10e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (4.49e-2)" "unprognostic (6.34e-3)" "unprognostic (9.84e-2)" "unprognostic (1.70e-1)" "unprognostic (6.83e-3)" "unprognostic (7.38e-2)" 257.6 359.7 181.9 164.6 220.8 259.7 341.4 240.3 253.8 343.6 379.5 488.3 364.1 208.7 415.5 241.8 403.2 299.3 275.7 178.4 202.0 473.7 505.7 264.0 162.6 240.6 205.0 225.4 586.1 532.5 170.2 325.8 239.1 350.2 485.3 254.2 550.3 279.9 194.5 194.7 369.1 219.8 235.7 188.7 433.0 174.9 204.6 186.9 341.3 247.6 189.2 289.2 202.6 286.8 188.9 122.3 142.8 185.2 844.1 371.1 182.8 347.9 499.1 211.5 276.0 99.1 391.9 96.7 322.6 595.6 257.7 281.1 166.2 237.5 221.9 237.7 177.4 133.5 266.6 166.1 317.8 165.7 268.7 408.3 411.2 207.5 219.2 566.9 246.6 127.8 158.9 326.3 245.1 91.6 97.9 137.3 201.0 528.3 226.3 94.0 251.6 403.2 257.6 248.0 208.2 173.3 381.5 386.0 398.3 266.2 184.9 348.4 259.3 259.8 90.7 193.3 187.8 289.0 338.7 114.5 349.4 275.4 222.3 1183.5 654.6 831.5 439.7 532.9 461.8 449.3 465.9 480.4 520.9 405.2 430.3 426.4 1196.5 430.4 595.9 527.1 576.1 1153.8 181.9 220.8 240.3 253.8 178.4 202.0 240.6 205.0 239.1 235.7 204.6 286.8 355.3 233.9 181.3 49.6 221.3 404.2 637.0 1214.2 237.3 150.2 409.0 325.1 155.1 479.0 991.8 437.7 118.9 477.7 244.5 905.2 160.4 527.8 357.1 348.5 201.9 279.5 408.2 277.0 44.3 352.5 528.7 410.6 226.8 217.2 155.2 89.5 334.4 413.2 320.2 132.9 42.1 672.8 1131.1 302.9 290.3 183.1 432.7 225.4 690.1 27.2 209.3 473.5 190.5 60.3 176.6 329.3 1064.8 354.0 692.8 583.2 1015.8 468.8 977.4 183.6 368.1 198.6 350.4 488.9 210.1 245.5 414.3 687.1 227.2 185.8 534.9 750.4 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257655 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 26000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 11.0 8.8 5.8 10.8 6.3 10.7 11.3 6.7 8.7 7.8 7.4 12.3 10.6 8.1 10.8 9.1 6.6 8.5 4.8 5.4 6.6 10.2 12.6 9.3 12.4 6.5 6.8 6.6 9.1 9.4 5.5 13.2 7.0 7.9 12.2 6.8 8.3 9.2 5.2 9.8 9.3 9.9 6.9 10.7 10.4 5.0 7.0 11.6 11.4 4.4 10.5 13.0 6.6 7.0 27.0 23.8 33.8 18.4 26.0 20.3 35.5 33.5 26.8 33.2 42.2 24.9 49.0 38.8 30.0 22.6 15.6 26.1 60.3 21.5 60.4 38.6 19.6 28.4 19.4 24.7 22.4 66.2 27.4 24.4 19.5 22.2 16.3 24.0 29.7 31.2 23.6 25.9 32.1 32.6 29.7 35.5 38.3 42.2 28.5 30.9 60.9 23.4 32.2 34.8 21.1 15.5 26.6 17.8 24.6 22.2 25.8 28.6 19.0 34.9 32.2 24.8 30.9 22.4 23.9 31.4 15.4 36.6 33.5 10.5 12.2 6.2 8.6 14.7 10.6 7.7 8.8 9.0 13.6 6.3 8.5 10.1 4.3 11.5 11.0 15.7 11.0 12.4 5.8 6.3 6.7 8.7 5.4 6.6 6.5 6.8 7.0 6.9 7.0 7.0 43.0 38.5 29.1 24.5 55.9 108.6 63.1 80.5 71.2 13.7 40.7 20.8 9.2 44.3 55.7 35.0 12.5 73.9 82.6 38.2 9.8 62.1 2.5 22.0 42.2 47.5 17.4 81.2 8.9 67.6 149.3 48.4 32.1 28.0 43.6 24.4 43.2 44.0 73.2 10.1 11.2 29.2 63.1 61.1 84.3 4.3 24.8 65.7 55.2 18.7 70.0 27.0 46.4 22.1 25.2 50.3 44.0 28.6 79.2 58.4 29.3 32.4 42.2 32.6 59.2 37.3 49.4 59.5 68.7 79.0 97.3 57.7 62.5 58.7 46.5 59.5 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 612.4;Basal prostatic cells: 1315.6;Basal respiratory cells: 622.2;Ductal cells: 938.2;Exocrine glandular cells: 698.4;Pancreatic endocrine cells: 1232.3;Prostatic glandular cells: 757.9;Urothelial cells: 695.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "eosinophil: 139.6;neutrophil: 102.9" "Lineage enriched" "Detected in many" 10 "granulocytes: 139.6" "Cell line enhanced" "Detected in many" "U-251 MG: 699.6" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 370000 "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 42.0 45.9 5.3 27.0 5.2 8.3 24.4 6.1 9.9 12.5 9.4 26.5 37.5 34.8 1.2 17.6 19.0 55.2 108.3 5.6 8.8 133.5 61.0 72.6 2.4 8.2 7.9 8.2 116.3 56.1 59.3 33.0 7.0 33.4 4.5 4.8 48.4 17.1 58.5 18.1 21.6 32.5 7.4 6.7 42.6 5.4 10.4 5.2 37.0 9.3 3.1 73.8 13.9 7.0 217.6 155.6 17.7 31.9 31.0 71.3 109.1 444.3 277.5 316.2 205.5 70.1 336.0 1.5 566.2 270.4 401.3 224.2 4.2 283.4 132.2 8.3 11.2 1.5 52.4 58.4 205.1 3.7 15.2 65.2 196.7 345.1 433.5 298.1 100.9 0.6 24.5 2.4 362.7 394.0 0.6 28.3 85.5 88.7 369.6 1.9 207.1 7.8 355.8 37.6 19.9 7.3 314.7 127.9 255.8 57.7 69.4 5.8 192.2 601.9 303.2 423.8 699.6 6.6 2.9 3.1 190.0 18.9 488.8 12.2 11.4 139.6 6.1 7.3 7.9 0.2 2.8 4.9 14.6 0.2 1.4 2.7 102.9 8.0 4.7 0.6 3.4 4.0 5.3 5.2 6.1 9.9 5.6 8.8 8.2 7.9 7.0 7.4 10.4 7.0 16.9 102.5 37.7 0.3 6.9 612.4 1315.6 622.2 113.3 1.5 139.0 46.7 63.9 195.9 238.7 182.1 2.1 134.6 10.0 74.2 64.6 938.2 1.3 170.5 29.4 47.5 27.3 1.3 0.2 698.4 169.5 155.1 33.1 173.1 59.1 3.0 24.3 20.7 39.7 0.0 0.5 19.9 152.5 5.6 121.4 0.8 6.2 23.0 112.1 1.9 10.8 23.3 4.1 0.0 0.1 1232.3 155.3 6.8 5.3 757.9 52.9 118.0 118.4 5.9 6.6 190.5 228.6 10.9 9.4 35.5 359.7 189.1 25.3 1.3 50.0 695.6 TOB1 "APRO5, TOB, TROB, TROB1" ENSG00000141232 "Transducer of ERBB2, 1" P50616 17 50862223-50867978 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 253.3" "Low region specificity" "Detected in all" HPA047839 Approved Approved Nucleoplasm,Vesicles NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "HPA047839: AB_2680175" "unprognostic (3.46e-1)" "unprognostic (1.09e-1)" "unprognostic (2.45e-1)" "unprognostic (6.78e-3)" "unprognostic (1.19e-1)" "unprognostic (8.27e-2)" "unprognostic (3.50e-3)" "unprognostic (1.53e-1)" "unprognostic (3.56e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (5.04e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.92e-3)" "unprognostic (9.44e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-2)" "unprognostic (6.97e-2)" 42.6 210.2 32.6 22.3 34.9 70.2 65.3 31.6 40.8 55.3 59.3 47.4 56.1 23.9 26.5 77.7 54.6 47.6 44.7 29.8 39.4 67.9 168.6 36.8 18.9 37.3 48.2 63.4 207.9 81.4 50.1 13.8 38.6 72.3 57.5 101.8 99.8 92.2 178.6 133.5 48.1 29.4 31.8 17.8 87.5 26.0 33.4 17.7 95.4 109.9 21.0 81.9 70.9 40.2 44.1 88.7 28.1 11.5 51.4 25.4 22.0 31.9 79.2 20.5 25.0 36.0 54.6 40.0 60.6 43.9 20.7 61.0 19.5 54.1 21.1 20.4 29.3 4.8 100.7 60.5 72.0 21.5 18.9 54.5 65.5 23.9 120.0 27.3 9.9 12.2 17.0 33.7 43.4 119.0 16.1 19.4 10.2 109.4 33.9 14.0 35.6 47.6 80.9 89.4 16.6 40.4 55.1 158.9 19.9 42.5 253.3 27.1 13.2 23.3 16.7 26.7 15.8 51.9 57.7 18.5 19.2 10.2 9.1 417.7 53.5 285.6 245.8 107.3 269.9 40.7 222.7 192.5 119.1 31.9 192.1 233.6 130.7 28.8 152.5 38.5 206.0 169.0 32.6 34.9 31.6 40.8 29.8 39.4 37.3 48.2 38.6 31.8 33.4 40.2 101.6 115.4 118.3 71.8 53.1 283.2 232.9 119.8 284.0 125.3 180.6 179.6 115.5 210.1 81.8 68.0 56.3 20.8 124.8 183.3 103.7 42.6 97.9 143.7 51.7 40.7 203.4 18.1 11.5 54.1 2.0 83.5 123.3 176.2 63.9 19.7 33.2 205.6 35.4 18.5 14.1 223.2 48.8 27.6 249.2 40.4 26.4 89.9 71.2 5.6 29.1 118.3 20.6 16.6 34.1 41.8 186.7 59.8 41.3 187.2 126.2 60.4 87.8 62.7 164.3 137.3 123.8 36.9 12.1 153.8 230.7 10.9 154.7 77.4 167.6 287.2 TOMM20 "KIAA0016, MAS20, MOM19, TOM20" ENSG00000173726 "Translocase of outer mitochondrial membrane 20" Q15388 1 235109341-235128837 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005585, HPA011562" Supported Enhanced Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" Mitochondria "CAB005585: AB_628381, HPA011562: AB_1080326" "unprognostic (1.30e-1)" "unprognostic (3.08e-3)" "unprognostic (1.66e-2)" "unprognostic (4.49e-2)" "unprognostic (8.65e-3)" "unprognostic (1.17e-2)" "unprognostic (7.09e-2)" "unprognostic (3.28e-1)" "unprognostic (3.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.16e-3)" "unprognostic (5.05e-2)" "unprognostic (7.08e-3)" "unprognostic (2.33e-2)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (3.97e-1)" 71.5 83.5 80.0 39.2 89.0 96.6 130.8 63.0 111.9 82.9 63.4 64.3 61.0 83.5 91.6 67.8 95.6 48.3 86.4 91.7 79.9 100.4 88.3 60.2 53.7 76.9 71.5 119.5 103.1 111.6 54.3 68.2 81.2 80.5 67.9 51.3 125.1 70.1 83.0 82.5 54.5 59.3 81.7 47.2 69.4 32.8 84.1 57.1 142.9 82.4 56.6 66.4 56.7 83.3 198.7 102.4 131.6 111.6 101.4 202.6 203.5 138.8 119.3 127.9 92.5 133.1 135.6 239.3 180.1 121.0 36.1 154.0 147.8 135.0 166.9 57.9 314.8 146.2 126.2 253.9 169.2 331.3 84.2 182.3 180.8 128.6 175.4 173.0 140.7 92.2 312.1 85.9 141.9 58.2 141.9 149.4 296.6 131.2 54.9 170.9 100.3 312.6 144.5 140.2 172.5 402.8 108.0 149.2 306.7 53.6 230.9 358.6 125.6 111.5 67.5 143.0 299.6 201.2 203.1 172.4 131.2 155.4 193.1 37.7 18.8 6.5 19.4 19.7 23.6 23.0 24.8 24.3 22.7 18.2 30.1 24.2 5.6 15.8 22.9 30.6 23.7 21.5 80.0 89.0 63.0 111.9 91.7 79.9 76.9 71.5 81.2 81.7 84.1 83.3 167.2 137.8 163.5 25.1 201.9 267.4 254.9 158.5 251.6 49.9 299.2 307.0 137.8 160.2 151.3 49.7 29.2 171.3 195.5 98.3 160.4 161.6 318.4 180.2 254.3 156.8 160.5 127.0 69.0 211.2 462.5 139.9 121.3 216.9 157.7 146.4 129.9 160.1 159.9 50.5 61.1 273.4 99.7 197.7 164.6 354.0 155.0 175.7 149.4 28.1 187.5 145.4 116.4 26.2 55.8 220.1 172.3 153.4 176.7 340.4 247.0 223.5 99.7 60.9 105.2 201.4 207.5 186.5 71.1 273.3 286.1 199.5 179.5 196.1 272.6 333.4 TOR1A "DQ2, DYT1" ENSG00000136827 "Torsin family 1 member A" O14656 9 129812942-129824244 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012473, HPA051195" Approved Supported "Nuclear membrane,Vesicles" "Intracellular and membrane" NA NA 20000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear membrane, Vesicles" "CAB012473: AB_2240792, HPA051195: AB_2681382" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.95e-1)" "unprognostic (1.86e-3)" "unprognostic (3.67e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (2.10e-2)" "unprognostic (1.41e-1)" "unprognostic (4.10e-2)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (3.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.77e-1)" "unprognostic (1.99e-1)" 21.2 24.2 14.3 20.7 14.8 34.5 19.6 14.7 17.7 18.6 14.2 20.7 16.6 20.3 19.9 14.3 17.2 20.6 16.8 15.7 15.9 20.5 35.9 19.4 22.9 13.6 14.0 17.2 19.5 19.4 14.3 23.5 14.0 21.3 22.3 9.8 17.0 23.1 16.4 17.8 18.8 25.4 14.1 18.8 18.1 9.2 15.4 26.3 23.8 14.9 19.0 28.6 15.6 14.8 33.7 49.5 35.9 41.5 53.1 51.3 47.4 76.7 94.5 67.0 57.2 32.3 48.2 41.0 44.0 99.7 46.0 77.2 34.7 50.8 54.7 65.7 32.9 36.9 49.8 32.3 66.9 82.1 65.5 69.8 50.7 63.5 45.6 61.5 73.2 65.3 66.5 32.3 74.6 84.3 58.9 79.3 53.8 39.2 55.6 30.5 56.5 41.9 54.9 42.4 27.0 47.6 79.3 30.7 43.3 40.1 61.6 63.4 65.1 66.1 37.7 49.6 59.6 36.6 87.0 37.7 49.0 46.9 54.3 95.5 72.8 141.3 57.4 68.5 48.1 45.5 48.4 52.1 61.4 33.5 40.9 42.4 72.7 68.6 58.3 56.5 59.1 78.9 14.3 14.8 14.7 17.7 15.7 15.9 13.6 14.0 14.0 14.1 15.4 14.8 25.0 9.6 11.8 5.5 17.5 17.6 16.6 39.5 12.0 11.2 16.5 15.9 9.9 18.6 24.4 14.7 2.1 47.9 39.3 18.7 15.6 42.1 0.7 12.5 18.8 24.2 19.2 30.5 6.3 49.9 65.7 25.0 13.7 15.0 22.2 23.4 16.1 22.7 45.2 21.9 6.4 17.8 26.4 19.1 22.4 1.3 12.8 27.9 14.2 3.7 47.6 18.5 35.0 9.5 6.6 40.1 18.9 15.4 23.7 24.7 21.0 17.0 14.9 9.2 32.9 15.2 24.3 7.3 10.1 9.3 18.5 53.4 25.5 23.4 15.4 19.6 TP53INP1 "DKFZp434M1317, FLJ22139, P53DINP1, SIP, Teap, TP53INP1A, TP53INP1B" ENSG00000164938 "Tumor protein p53 inducible nuclear protein 1" Q96A56 8 94925972-94949378 "Predicted intracellular proteins" "Apoptosis, Autophagy, Transcription, Transcription regulation" "Activator, Antioxidant" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 101.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 175.6;Plasma cells: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 54.6" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.6" "Cell line enhanced" "Detected in many" "Karpas-707: 79.7;U-266/70: 85.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005856 Uncertain Supported Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA005856: AB_10600832" "unprognostic (1.39e-2)" "unprognostic (4.47e-3)" "unprognostic (7.17e-2)" "unprognostic (2.70e-1)" "unprognostic (5.31e-2)" "prognostic favorable (1.11e-4)" "unprognostic (5.72e-2)" "unprognostic (1.16e-3)" "unprognostic (1.28e-1)" "unprognostic (7.54e-2)" "unprognostic (5.00e-3)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (9.83e-2)" "unprognostic (3.13e-1)" "unprognostic (1.18e-2)" "prognostic favorable (5.45e-5)" 11.2 10.6 6.4 23.1 7.9 42.1 12.7 6.0 7.6 11.8 9.7 16.5 17.2 12.7 12.6 10.9 14.7 10.9 10.9 5.5 6.5 11.5 101.9 25.3 36.0 8.5 6.8 9.0 60.4 10.1 7.1 14.4 7.0 22.5 20.2 17.6 17.9 9.2 9.2 13.1 35.5 12.2 7.0 40.6 25.6 28.6 8.0 29.3 10.2 8.6 41.1 13.3 8.7 8.8 0.5 2.5 24.1 9.3 29.4 27.6 24.8 5.8 13.5 2.6 6.2 2.2 0.6 5.3 12.4 11.2 2.3 4.2 0.0 9.5 5.8 0.3 3.0 3.4 5.3 14.8 19.7 0.0 16.8 45.4 22.2 6.9 2.8 22.4 39.8 2.6 1.8 79.7 12.4 1.7 4.0 1.5 2.3 0.1 0.7 3.4 1.9 29.4 6.3 26.5 3.3 19.5 3.6 2.0 5.2 38.5 11.8 3.3 27.6 4.8 5.8 0.0 0.9 85.4 18.9 2.3 8.4 0.0 0.0 54.6 3.7 11.7 1.4 3.6 1.3 11.5 4.0 2.7 1.4 9.7 0.8 0.6 16.9 5.2 2.3 1.4 6.6 2.5 6.4 7.9 6.0 7.6 5.5 6.5 8.5 6.8 7.0 7.0 8.0 8.8 18.5 35.3 35.7 10.7 70.0 4.6 3.0 17.9 8.0 5.2 27.4 11.6 13.2 75.8 27.9 11.0 27.1 6.1 10.1 27.5 3.9 9.3 17.3 39.9 18.1 14.2 83.9 6.7 0.9 21.3 1.5 11.4 11.2 35.9 4.5 18.8 29.3 175.6 12.5 1.7 2.9 20.9 20.3 44.2 5.6 43.3 7.2 12.6 16.0 16.9 17.7 5.3 3.1 12.1 11.0 18.0 32.2 10.1 233.2 18.1 21.6 9.6 66.4 19.8 6.6 11.0 12.7 18.9 5.6 10.8 6.5 5.7 17.9 26.8 4.8 8.7 TRABD PP2447 ENSG00000170638 "TraB domain containing" Q9H4I3 22 50185913-50199598 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000822 Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Mitochondria" "HPA000822: AB_10959384" "unprognostic (9.37e-2)" "unprognostic (1.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (1.19e-5)" "unprognostic (2.80e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-3)" "unprognostic (6.12e-2)" "unprognostic (2.40e-1)" "unprognostic (4.68e-3)" "unprognostic (1.65e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.08e-3)" "unprognostic (1.19e-1)" "unprognostic (2.87e-2)" "unprognostic (2.98e-3)" 19.8 20.7 7.1 27.7 6.9 60.9 18.5 10.1 10.6 23.0 5.9 24.1 18.3 16.8 3.8 40.4 18.8 11.0 21.8 7.0 6.2 26.8 40.8 26.0 32.8 8.5 6.7 18.8 72.7 7.6 21.9 8.4 6.6 29.1 6.3 3.2 29.0 9.6 29.3 23.6 30.7 5.3 6.7 36.9 27.5 20.8 7.2 16.6 24.8 5.0 15.7 22.6 27.0 6.8 62.8 40.9 14.5 24.7 7.8 9.0 35.9 21.4 14.0 17.6 14.9 26.2 29.6 38.3 20.5 10.1 13.7 38.6 18.8 38.1 3.5 27.1 87.1 22.5 71.2 46.0 30.5 45.4 42.7 14.6 22.9 12.9 17.7 10.3 17.9 37.3 27.8 61.7 7.6 70.5 32.5 51.2 21.3 21.3 38.0 87.6 19.7 83.0 13.4 61.5 16.8 28.0 18.4 66.2 31.3 6.1 28.0 47.0 19.4 14.6 36.2 19.2 24.4 73.9 14.1 46.7 18.0 31.5 23.5 16.9 30.5 51.4 21.2 26.5 20.3 13.6 19.1 19.5 32.5 6.7 12.6 15.3 40.6 32.1 16.7 68.7 29.5 22.4 7.1 6.9 10.1 10.6 7.0 6.2 8.5 6.7 6.6 6.7 7.2 6.8 22.2 9.6 19.3 12.1 80.3 42.1 57.4 48.9 33.6 32.6 38.8 30.1 12.0 17.2 31.8 33.1 18.8 25.5 151.7 66.2 27.4 52.3 20.7 17.1 25.1 27.2 18.0 17.4 11.6 62.9 54.5 27.2 77.5 32.4 27.3 31.6 12.8 24.0 46.4 43.7 12.9 55.3 46.8 46.9 59.4 8.8 32.3 69.6 42.7 9.4 111.4 22.5 117.4 14.1 15.3 80.6 67.7 32.4 133.1 125.9 55.0 28.9 19.7 32.8 19.7 20.5 23.7 49.9 31.5 34.3 45.6 30.6 84.3 31.2 71.0 92.5 TRAF4 "CART1, MLN62, RNF83" ENSG00000076604 "TNF receptor associated factor 4" Q9BUZ4 17 28744005-28750956 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Urothelial cells: 346.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "plasmacytoid DC: 54.0" "Lineage enriched" "Detected in all" 6 "dendritic cells: 54.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009055, HPA021904, HPA052377" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoli fibrillar center" "Nucleoplasm, Cytosol" "CAB009055: AB_2209701, HPA021904: , HPA052377: AB_2681804" "unprognostic (1.77e-1)" "unprognostic (9.05e-2)" "unprognostic (1.31e-2)" "unprognostic (2.51e-3)" "unprognostic (1.76e-1)" "unprognostic (7.38e-3)" "unprognostic (1.09e-2)" "unprognostic (1.24e-1)" "unprognostic (1.09e-2)" "unprognostic (2.33e-1)" "unprognostic (7.13e-2)" "unprognostic (7.55e-2)" "unprognostic (1.74e-3)" "unprognostic (6.98e-2)" "unprognostic (9.26e-2)" "unprognostic (2.77e-2)" "unprognostic (5.58e-3)" 10.7 19.4 16.1 11.2 17.8 31.2 19.3 15.6 19.1 10.9 18.4 28.4 47.1 9.1 4.1 28.6 14.4 20.3 5.2 15.5 15.5 45.0 60.1 22.7 18.8 18.6 17.7 12.2 32.1 4.0 14.5 16.4 17.0 31.4 22.2 3.6 46.8 6.9 1.8 15.4 38.7 5.1 15.6 19.0 35.9 15.1 16.3 13.6 29.1 0.8 20.1 36.7 11.8 23.9 41.2 62.7 85.3 41.6 12.0 13.9 131.2 27.3 22.8 28.2 37.2 50.2 50.0 62.5 38.8 29.9 19.0 61.0 39.1 61.5 11.6 20.3 58.5 22.5 111.7 58.3 45.9 10.9 25.0 26.5 59.2 33.2 39.7 25.5 22.2 29.1 60.1 5.4 26.1 67.3 34.6 22.7 65.9 80.2 14.4 52.1 38.8 30.6 80.8 115.7 53.2 61.3 42.0 181.7 84.3 73.4 69.5 17.2 15.0 17.8 37.4 20.3 39.2 8.2 21.3 80.1 14.0 17.8 81.9 5.7 0.5 1.9 1.0 1.1 2.6 9.7 1.8 1.9 2.9 9.3 1.3 1.3 0.2 1.8 0.9 54.0 1.0 1.8 16.1 17.8 15.6 19.1 15.5 15.5 18.6 17.7 17.0 15.6 16.3 23.9 9.3 22.4 28.3 28.4 59.2 137.5 185.0 58.2 122.3 3.4 134.8 100.1 0.4 44.3 66.7 20.2 6.2 107.9 88.3 121.3 43.0 78.5 53.4 102.8 22.8 20.7 84.1 4.8 0.9 109.2 136.8 20.4 83.1 133.7 7.0 10.1 8.9 38.1 13.9 8.4 1.6 81.6 61.1 2.2 71.9 12.1 3.7 16.0 39.2 3.7 7.3 23.0 5.2 37.7 19.8 128.0 125.7 1.5 36.6 219.0 155.7 33.8 68.7 2.3 0.0 9.8 34.9 5.8 22.6 57.7 78.6 124.4 31.5 14.5 93.5 346.4 TRAM1 "TRAM, TRAMP" ENSG00000067167 "Translocation associated membrane protein 1" Q15629 8 70573218-70608416 "Plasma proteins, Predicted membrane proteins, Transporters" "Host-virus interaction, Protein transport, Translocation, Transport, Unfolded protein response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 670.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023929 Approved NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA023929: AB_1858239" "unprognostic (3.85e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (8.34e-3)" "unprognostic (1.31e-1)" "unprognostic (3.52e-2)" "unprognostic (5.93e-2)" "unprognostic (8.94e-2)" "unprognostic (2.21e-2)" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (3.39e-3)" "unprognostic (3.61e-2)" "prognostic unfavorable (7.79e-4)" "unprognostic (7.45e-2)" "unprognostic (1.61e-1)" "unprognostic (2.31e-1)" "unprognostic (3.85e-2)" 93.2 82.8 26.6 95.9 28.9 102.3 115.8 27.6 42.1 139.2 47.7 85.4 91.7 93.4 148.5 65.2 78.5 117.7 59.8 24.8 31.1 120.7 190.2 146.3 103.5 32.5 27.9 73.4 175.5 117.3 38.8 146.8 32.4 87.2 79.7 33.3 193.9 86.0 26.7 49.2 93.6 96.7 29.1 90.0 94.7 61.0 29.1 98.6 170.7 54.9 114.3 120.2 47.7 34.5 171.1 172.5 73.6 45.2 352.6 367.8 105.2 302.9 301.7 231.7 279.1 109.9 275.8 169.1 58.5 259.6 91.3 219.3 67.6 262.1 221.8 112.2 76.1 118.5 54.6 125.7 515.4 91.3 66.3 441.5 249.6 114.2 410.8 238.5 196.7 85.0 77.8 430.3 288.6 47.2 210.4 65.7 48.3 132.3 81.0 100.9 55.3 113.8 610.5 160.4 53.4 54.2 195.0 389.0 180.5 103.1 144.1 102.0 195.3 141.0 117.5 162.4 102.0 338.7 140.1 85.5 160.3 92.9 105.0 150.1 97.3 64.9 120.8 107.7 153.5 107.9 132.1 137.6 114.3 87.9 119.6 125.2 28.2 130.7 113.7 190.4 146.8 232.7 26.6 28.9 27.6 42.1 24.8 31.1 32.5 27.9 32.4 29.1 29.1 34.5 138.3 275.7 132.0 19.6 166.4 85.5 85.2 214.0 69.4 23.7 114.2 62.4 43.0 131.5 209.3 178.4 14.6 154.3 200.5 69.3 68.4 174.5 142.8 77.9 140.7 134.3 44.2 59.7 27.4 247.7 236.7 177.0 70.8 186.6 72.4 59.0 137.8 202.9 182.7 23.5 26.1 95.5 156.6 134.9 251.0 222.2 127.4 123.7 202.7 29.0 132.1 65.6 128.8 34.2 40.3 290.5 51.0 94.4 670.6 199.6 78.0 147.0 110.2 32.9 124.9 76.4 99.5 134.8 56.8 72.3 88.5 194.3 154.2 78.2 65.5 130.6 TRIM5 "RNF88, TRIM5alpha" ENSG00000132256 "Tripartite motif containing 5" Q9C035 11 5663195-5938619 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "CAB013497, HPA023420, HPA023422" Approved Supported Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379" "unprognostic (2.60e-1)" "unprognostic (9.62e-2)" "unprognostic (2.04e-2)" "unprognostic (1.41e-2)" "unprognostic (6.88e-2)" "unprognostic (4.74e-3)" "unprognostic (5.48e-3)" "unprognostic (5.82e-2)" "unprognostic (1.49e-1)" "unprognostic (6.76e-3)" "unprognostic (8.54e-3)" "unprognostic (1.64e-1)" "unprognostic (2.20e-2)" "unprognostic (1.90e-1)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (6.12e-2)" 8.8 10.9 2.1 8.1 2.3 3.8 8.0 2.0 2.4 11.8 7.2 7.2 7.4 11.7 18.4 7.7 9.4 6.9 5.7 2.0 3.3 9.0 12.8 11.8 8.4 4.0 3.5 11.4 13.3 4.2 3.8 9.6 3.4 8.5 7.7 1.9 14.0 9.1 1.9 5.5 8.5 11.3 3.0 10.4 7.8 8.3 3.5 9.4 9.6 4.0 8.9 8.2 8.6 2.9 7.7 15.4 19.2 12.4 24.0 22.5 5.4 18.0 35.0 37.3 50.0 13.8 13.5 5.5 13.3 18.8 27.6 13.0 18.4 25.8 14.9 9.6 5.1 15.2 10.4 9.5 20.2 11.5 15.3 15.4 22.7 10.5 31.3 22.9 52.8 8.9 16.9 12.2 32.1 4.2 7.7 5.3 7.7 11.7 8.1 14.3 4.7 1.5 23.7 14.4 0.5 1.1 11.8 18.4 6.8 20.7 9.3 6.6 43.3 13.9 20.2 3.6 4.2 9.4 7.9 1.9 10.9 6.8 15.4 10.7 7.6 11.6 3.6 7.8 3.0 3.1 2.8 2.8 9.4 2.6 1.8 3.7 7.7 4.1 8.0 7.0 2.2 4.1 2.1 2.3 2.0 2.4 2.0 3.3 4.0 3.5 3.4 3.0 3.5 2.9 14.2 6.4 14.0 4.9 8.7 5.2 9.5 9.7 9.6 0.2 8.3 6.5 4.9 2.8 13.4 11.0 0.0 7.8 16.4 5.5 5.9 10.6 5.0 8.6 12.6 14.8 1.2 8.4 3.0 8.8 10.5 12.4 6.1 12.5 0.0 11.9 15.4 13.9 6.4 0.0 1.4 9.7 4.1 12.2 7.1 3.8 7.8 10.8 3.6 19.7 10.8 7.0 14.4 3.0 1.0 8.1 4.9 7.5 6.7 10.1 7.4 6.3 3.7 0.1 19.7 6.5 10.9 5.2 3.3 7.0 5.4 7.8 7.5 20.6 7.5 9.9 TRIM50 "FLJ32804, TRIM50A" ENSG00000146755 "Tripartite motif containing 50" Q86XT4 7 73312536-73328082 "Enzymes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "pancreas: 29.1;parathyroid gland: 33.3;stomach 1: 48.7" "Cell type enhanced" "Detected in some" "Early spermatids: 2.3;Gastric mucus-secreting cells: 17.9;Spermatocytes: 5.2;Spermatogonia: 4.2" "Group enriched" "Detected in some" 8 "liver cancer: 2.9;renal cancer: 6.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 32 "Hep G2: 6.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA019862, HPA047843" Uncertain Approved Cytosol NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Cytosol "HPA019862: AB_1858305, HPA047843: AB_2680176" "unprognostic (1.93e-1)" "unprognostic (3.93e-1)" "unprognostic (1.07e-2)" "unprognostic (5.96e-2)" "unprognostic (3.87e-1)" "unprognostic (2.66e-2)" "unprognostic (1.49e-1)" "unprognostic (3.04e-3)" "unprognostic (2.63e-2)" "unprognostic (2.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.33e-1)" "prognostic favorable (9.36e-7)" "unprognostic (3.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.20e-1)" "unprognostic (2.25e-1)" 0.5 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 1.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 6.8 0.3 0.1 0.0 0.1 0.1 0.2 29.1 33.3 0.0 0.3 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 0.1 0.4 48.7 8.7 0.1 0.0 0.3 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.1 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.1 0.0 17.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.2 4.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 TRIP11 "CEV14, GMAP-210, GMAP210, Trip230" ENSG00000100815 "Thyroid hormone receptor interactor 11" Q15643 14 91965991-92040896 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002570, HPA070684" Supported Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoplasm "HPA002570: AB_1078995, HPA070684: AB_2686295" "unprognostic (1.65e-1)" "unprognostic (2.81e-2)" "unprognostic (7.14e-2)" "unprognostic (1.12e-1)" "unprognostic (6.89e-2)" "unprognostic (1.39e-1)" "unprognostic (3.49e-3)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (7.33e-3)" "unprognostic (2.04e-1)" "unprognostic (1.21e-1)" "prognostic favorable (1.78e-6)" "unprognostic (1.78e-1)" "unprognostic (5.08e-1)" "unprognostic (7.74e-2)" "unprognostic (5.55e-2)" 10.4 10.5 4.7 8.6 8.8 7.6 10.5 10.8 7.4 11.6 13.5 10.1 10.4 9.7 6.7 12.1 7.7 10.1 10.6 3.5 5.4 13.5 12.9 8.0 9.4 6.2 7.3 11.0 25.5 19.2 4.8 11.6 6.8 9.6 9.8 10.6 11.0 8.5 11.8 8.9 7.9 10.2 6.2 8.6 15.3 13.6 6.5 11.2 16.7 15.6 11.4 10.4 5.8 10.7 22.8 22.5 14.4 15.2 24.8 38.1 21.8 35.3 27.0 17.1 19.5 13.8 36.0 15.8 25.3 31.3 13.3 29.1 19.1 17.1 37.0 24.1 5.8 17.9 20.4 13.1 18.9 21.2 17.1 14.7 20.4 30.3 25.8 18.9 27.8 8.7 11.9 17.8 27.0 31.7 12.2 5.2 6.6 22.1 16.0 14.8 27.5 8.0 15.3 36.5 10.5 9.5 28.5 16.6 11.0 14.5 36.2 10.5 36.9 19.8 13.8 20.8 16.1 15.7 25.9 14.2 23.2 11.7 25.3 9.3 9.7 20.2 13.9 9.0 13.6 13.0 14.7 13.1 7.9 23.7 14.2 14.9 9.6 14.8 16.1 14.3 14.5 4.3 4.7 8.8 10.8 7.4 3.5 5.4 6.2 7.3 6.8 6.2 6.5 10.7 66.8 54.5 79.8 57.5 32.5 16.6 30.7 31.7 21.6 61.1 39.9 40.0 115.7 34.3 54.0 38.6 73.0 44.2 41.4 29.8 17.6 72.5 13.6 58.2 81.2 53.9 32.2 30.7 58.1 46.2 32.0 51.7 39.8 56.5 37.9 68.7 32.9 37.5 24.4 43.7 74.7 40.4 32.6 25.7 11.2 14.7 62.1 30.4 7.2 51.5 41.6 56.5 47.4 66.9 92.4 44.7 29.5 54.2 26.3 39.0 31.6 23.4 56.4 70.4 59.2 76.6 50.4 105.0 65.8 19.5 17.0 72.5 30.2 79.8 32.9 35.1 TRPM5 "LTRPC5, MTR1" ENSG00000070985 "Transient receptor potential cation channel subfamily M member 5" Q9NZQ8 11 2404515-2423045 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 1.8;intestine: 3.3;pancreas: 2.4;seminal vesicle: 1.7" "Cell type enriched" "Detected in some" 4 "Gastric mucus-secreting cells: 9.7" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (6.47e-5)" "unprognostic (6.81e-4)" "unprognostic (7.90e-3)" "unprognostic (1.18e-1)" "unprognostic (1.13e-2)" "unprognostic (2.24e-2)" "unprognostic (4.75e-1)" "unprognostic (1.53e-1)" "unprognostic (2.36e-1)" "unprognostic (3.19e-1)" "unprognostic (5.07e-3)" "unprognostic (2.40e-1)" "unprognostic (5.21e-1)" "unprognostic (5.72e-2)" "unprognostic (4.91e-2)" 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 2.0 2.9 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 1.7 0.0 0.0 3.3 0.0 0.0 0.1 0.3 0.6 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.1 TSTD1 KAT ENSG00000215845 "Thiosulfate sulfurtransferase like domain containing 1" Q8NFU3 1 161037631-161038977 "Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 684.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 205.3;OE19: 215.1;SK-BR-3: 284.0;T-47d: 274.9;U-266/70: 315.4;U-266/84: 243.2" "Region enriched" "Detected in some" 4 "olfactory bulb: 6.6" "Low region specificity" "Detected in all" "HPA006518, HPA006655" Approved Approved "Cytosol,Cytoplasmic bodies" NA NA 57000 "Cluster 37: B-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Cytosol, Cytoplasmic bodies" "HPA006518: AB_2667608, HPA006655: AB_10600919" "unprognostic (6.10e-2)" "unprognostic (4.70e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" "unprognostic (5.77e-2)" "unprognostic (1.63e-1)" "unprognostic (6.56e-2)" "unprognostic (2.51e-3)" "unprognostic (2.60e-2)" "unprognostic (1.04e-1)" "unprognostic (1.51e-2)" "unprognostic (1.13e-1)" "unprognostic (4.64e-2)" "unprognostic (2.38e-2)" "unprognostic (2.83e-2)" "unprognostic (8.57e-3)" "unprognostic (8.88e-3)" 33.8 72.1 28.3 25.8 31.4 48.3 73.6 19.8 40.3 31.4 34.6 60.3 40.4 10.4 101.5 91.3 69.2 18.9 55.4 28.2 28.0 125.3 74.7 47.4 52.8 21.2 23.4 55.1 93.5 167.2 119.2 13.2 23.2 98.6 40.8 11.4 175.7 43.5 38.7 79.6 50.5 8.5 20.8 39.7 61.3 35.6 27.3 59.5 140.0 18.6 51.2 29.9 46.4 24.9 119.8 1.6 0.3 0.6 0.0 0.0 2.1 0.2 0.0 0.2 0.0 11.1 112.5 25.0 67.9 0.0 0.0 107.2 0.1 46.4 0.0 98.4 84.9 13.3 43.2 0.0 12.2 43.7 0.9 0.6 28.2 0.0 4.8 0.1 15.6 100.8 0.4 130.8 12.8 205.3 118.6 0.6 0.7 215.1 0.3 38.7 0.0 184.8 98.0 32.8 67.5 37.2 0.0 284.0 0.9 54.0 274.9 0.6 0.5 0.0 41.5 0.6 4.8 315.4 243.2 26.3 0.3 0.2 0.4 438.2 24.2 357.7 226.5 72.0 218.8 530.9 296.2 252.0 72.6 506.1 333.3 282.1 337.5 306.5 104.8 203.9 410.8 220.6 28.3 31.4 19.8 40.3 28.2 28.0 21.2 23.4 23.2 20.8 27.3 24.9 6.5 253.2 228.8 1.0 170.3 86.3 307.5 331.1 160.5 16.2 443.9 457.1 68.4 223.1 259.0 367.8 27.1 271.5 101.2 478.1 684.8 169.7 16.3 336.9 29.2 14.0 218.5 29.0 5.8 151.5 112.7 35.8 59.1 201.2 124.7 88.7 10.8 149.3 72.3 3.3 1.9 418.1 402.8 18.7 116.2 25.1 8.4 40.7 151.2 1.9 178.3 73.0 206.0 1.0 0.7 131.5 383.6 9.8 110.5 386.2 426.6 665.8 615.1 31.8 19.7 99.5 37.7 73.3 44.4 199.6 135.8 151.0 149.3 31.7 267.0 384.9 TTC17 FLJ10890 ENSG00000052841 "Tetratricopeptide repeat domain 17" Q96AE7 11 43358920-43494933 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038508 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" "Plasma membrane" Cytosol "HPA038508: AB_10671744" "unprognostic (2.71e-1)" "unprognostic (4.04e-3)" "unprognostic (6.48e-2)" "unprognostic (2.64e-1)" "unprognostic (1.17e-1)" "unprognostic (5.66e-2)" "unprognostic (1.74e-1)" "unprognostic (9.03e-2)" "unprognostic (5.01e-3)" "unprognostic (2.62e-1)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (1.04e-2)" "unprognostic (4.40e-1)" "unprognostic (1.18e-1)" "unprognostic (1.54e-2)" 20.7 18.7 11.0 16.1 11.3 15.5 28.6 16.7 12.2 22.0 22.0 21.2 21.6 26.9 25.0 14.2 28.4 22.3 13.5 11.1 12.2 19.4 38.6 24.2 20.2 11.9 12.5 40.9 49.5 27.7 12.3 29.2 11.7 25.4 22.9 25.1 40.7 21.4 16.4 19.5 25.5 23.0 11.0 23.4 27.4 24.8 12.4 24.6 36.9 20.0 22.4 18.8 15.6 13.0 15.0 30.4 31.3 49.3 77.2 63.6 22.1 35.6 47.6 29.3 35.1 21.1 21.7 31.6 34.9 35.9 33.7 31.1 22.3 23.5 35.2 24.5 29.0 24.2 19.5 20.8 95.3 36.6 29.9 59.5 69.8 21.3 68.4 66.2 29.5 22.7 35.5 26.2 29.8 18.1 27.1 20.3 46.8 58.0 25.0 25.1 33.3 36.9 37.2 21.4 16.7 39.7 27.7 73.1 44.6 31.4 68.6 40.8 39.6 41.7 18.4 47.1 52.1 51.1 44.5 29.8 26.9 21.6 45.3 20.0 21.7 19.0 14.9 22.4 15.9 16.4 16.2 14.5 16.9 14.8 16.3 15.1 18.5 16.5 20.8 17.6 16.1 18.0 11.0 11.3 16.7 12.2 11.1 12.2 11.9 12.5 11.7 11.0 12.4 13.0 43.0 64.1 62.7 159.6 53.3 42.1 35.0 36.4 30.7 44.1 40.3 35.7 20.5 31.5 51.9 22.0 60.5 32.6 43.8 30.7 3.9 23.1 52.6 35.8 44.5 40.9 22.3 44.0 204.6 43.4 28.8 44.4 40.2 48.6 36.6 56.2 40.0 57.5 26.2 47.1 203.2 42.1 34.6 48.0 32.3 18.4 57.2 37.1 28.4 181.8 47.8 24.8 37.0 192.0 200.6 29.7 31.5 36.5 48.9 50.1 47.7 15.5 54.3 47.3 52.6 45.5 36.2 51.8 35.0 34.6 43.2 30.8 45.6 33.5 35.8 42.7 TXNDC12 "AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19" ENSG00000117862 "Thioredoxin domain containing 12" O95881 1 52020131-52055191 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA 160000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (6.54e-2)" "unprognostic (5.46e-2)" "prognostic favorable (4.44e-4)" "unprognostic (2.33e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.61e-4)" "prognostic unfavorable (1.28e-5)" "unprognostic (1.25e-1)" "unprognostic (3.28e-2)" "unprognostic (1.17e-1)" "unprognostic (6.14e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.40e-12)" "unprognostic (2.13e-1)" "unprognostic (5.83e-2)" "unprognostic (1.73e-2)" "unprognostic (1.17e-1)" 49.6 47.7 39.7 45.7 40.7 51.3 50.8 41.2 48.0 49.2 44.2 60.8 47.0 40.8 62.9 31.2 56.8 46.5 36.6 40.1 47.0 54.0 74.1 46.9 50.1 42.5 41.6 47.8 56.5 46.7 21.9 54.5 43.1 40.8 66.1 28.6 57.6 36.5 18.2 29.9 48.4 40.8 44.1 46.4 56.4 38.9 42.8 52.3 52.6 30.2 54.4 57.5 18.0 46.1 97.1 88.9 96.0 135.4 160.1 83.9 76.4 143.5 143.8 132.7 150.7 99.8 78.2 73.0 93.8 118.1 141.1 127.3 134.5 112.9 178.2 94.1 124.2 93.1 73.3 163.2 165.7 176.8 181.8 120.5 132.0 134.0 203.3 99.0 135.4 89.1 87.1 48.2 111.9 91.4 89.3 233.6 208.0 138.8 85.9 94.2 143.3 207.1 178.6 85.3 68.3 97.3 143.9 123.5 138.7 187.7 69.6 228.1 86.5 93.9 100.1 106.7 166.1 107.2 183.6 84.2 131.0 164.9 108.2 355.3 224.0 356.5 135.3 215.0 170.8 160.1 164.3 145.3 169.2 146.0 156.7 151.1 393.2 150.0 234.2 180.6 220.0 273.3 39.7 40.7 41.2 48.0 40.1 47.0 42.5 41.6 43.1 44.1 42.8 46.1 89.8 9.6 12.3 9.4 50.4 44.1 63.1 78.9 35.3 18.3 53.6 57.0 13.6 62.9 30.4 44.1 14.6 115.5 58.9 35.3 17.6 75.4 13.3 42.5 54.7 62.3 48.5 25.7 15.0 89.4 170.9 52.1 23.4 49.2 33.0 106.3 55.6 31.0 120.8 21.9 14.7 70.5 50.8 59.1 55.7 7.2 55.9 66.0 51.6 19.7 66.6 39.2 50.4 10.1 15.9 73.0 57.0 30.9 68.7 68.7 65.4 36.1 32.3 17.0 32.9 40.7 47.1 60.4 9.7 36.0 45.5 118.5 52.3 75.4 71.2 60.4 TXNDC15 "2310047H23Rik, C5orf14, FLJ22625" ENSG00000113621 "Thioredoxin domain containing 15" Q96J42 5 134874371-134901635 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Meckel syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015483 Approved Approved "Golgi apparatus" NA NA 49000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA015483: AB_1845722" "unprognostic (1.56e-1)" "unprognostic (1.22e-2)" "unprognostic (2.29e-2)" "unprognostic (3.73e-2)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.86e-2)" "unprognostic (7.95e-2)" "unprognostic (6.68e-2)" "unprognostic (9.71e-3)" "unprognostic (3.88e-2)" "prognostic unfavorable (1.44e-4)" "unprognostic (2.36e-1)" "unprognostic (4.37e-1)" "unprognostic (1.41e-3)" "unprognostic (1.50e-1)" 34.1 44.7 20.3 34.9 23.2 8.9 33.9 22.8 23.2 42.5 39.1 37.3 23.7 35.0 56.1 22.3 29.5 32.5 35.8 20.8 24.2 29.0 33.7 30.5 25.4 25.9 21.6 31.4 49.7 43.7 42.9 37.1 21.6 38.2 26.2 36.5 46.8 44.0 41.9 19.1 21.7 43.7 21.5 35.9 32.3 18.8 21.8 20.3 59.9 30.4 31.1 35.9 24.7 23.8 28.8 77.8 47.8 76.9 75.8 102.7 5.5 117.7 135.1 42.3 93.7 56.8 38.5 38.1 64.3 108.6 78.8 21.0 33.0 48.6 38.6 81.5 36.6 20.0 46.7 46.1 58.7 13.6 51.2 61.7 39.6 56.0 35.2 70.6 65.8 18.0 10.1 106.8 65.6 36.5 20.8 30.7 21.4 31.3 31.7 30.0 58.1 117.7 35.5 29.4 27.7 35.6 70.3 19.4 63.9 22.7 27.3 19.8 83.0 62.5 35.3 62.0 42.7 70.7 120.3 31.8 93.0 28.5 41.3 32.7 34.3 19.8 31.0 33.7 32.7 32.3 25.2 32.8 31.0 23.8 20.8 24.5 9.3 29.5 33.8 30.1 29.8 32.7 20.3 23.2 22.8 23.2 20.8 24.2 25.9 21.6 21.6 21.5 21.8 23.8 47.8 60.9 31.9 11.8 49.9 25.4 30.5 41.5 22.8 37.6 25.1 29.0 36.4 27.1 36.3 23.9 20.9 32.4 31.9 10.0 13.7 33.5 4.2 12.1 49.4 38.7 12.6 6.7 13.7 33.1 54.3 65.7 12.8 19.2 30.4 33.1 45.3 29.7 33.9 63.9 19.7 17.0 44.7 31.3 32.3 6.7 63.3 27.3 69.4 19.7 39.2 43.0 29.9 19.6 20.1 19.2 14.0 45.5 203.2 25.1 17.4 28.3 26.7 36.6 46.0 45.2 44.1 36.5 61.6 17.4 23.4 30.0 36.3 45.1 13.3 21.5 UBA5 "FLJ23251, UBE1DC1" ENSG00000081307 "Ubiquitin like modifier activating enzyme 5" Q9GZZ9 3 132654446-132679794 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 418.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017235, HPA076042" Supported Enhanced Vesicles,Cytosol NA NA 43000 "Cluster 15: NK-cells - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Vesicles "HPA017235: AB_1858507, HPA076042: " "unprognostic (4.34e-3)" "unprognostic (6.44e-2)" "unprognostic (7.70e-2)" "unprognostic (3.49e-1)" "unprognostic (8.25e-2)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "unprognostic (3.06e-1)" "unprognostic (3.28e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-2)" "unprognostic (1.84e-2)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.08e-2)" "unprognostic (1.02e-2)" "unprognostic (2.40e-2)" 18.3 29.2 15.6 18.6 17.5 21.5 23.0 15.2 16.3 18.0 30.9 21.5 24.0 17.2 30.4 17.2 16.6 16.9 23.8 16.7 15.8 31.3 31.8 17.7 22.4 12.6 13.6 16.9 52.1 31.0 22.3 25.8 14.1 24.8 22.6 25.2 48.0 20.2 31.4 22.0 24.8 17.7 13.8 21.1 26.7 17.0 14.2 19.7 31.8 24.4 24.9 17.2 11.8 16.5 67.2 24.4 42.1 35.3 28.4 31.9 44.5 57.1 57.2 34.4 39.6 44.9 24.2 52.1 41.1 40.8 23.3 39.6 41.6 43.6 49.5 51.3 18.1 63.6 39.6 50.1 27.9 79.6 36.7 28.0 24.8 32.8 48.7 31.8 38.6 28.6 41.0 76.2 38.0 59.4 44.1 29.2 38.6 56.3 22.9 38.6 37.0 99.8 31.0 50.9 40.2 35.8 33.5 32.0 51.3 37.8 40.0 39.5 35.9 36.7 36.2 17.8 29.8 71.7 51.8 98.3 40.9 28.1 33.5 8.3 7.1 7.0 12.4 8.2 14.6 15.1 13.8 19.1 15.9 10.2 16.1 16.3 1.6 26.0 9.5 19.2 15.5 10.5 15.6 17.5 15.2 16.3 16.7 15.8 12.6 13.6 14.1 13.8 14.2 16.5 23.1 35.3 25.9 37.2 24.0 17.2 18.9 26.4 21.1 22.1 26.1 13.1 36.9 22.8 24.4 7.3 14.6 63.0 28.4 8.3 68.4 30.3 124.8 17.7 22.2 20.5 21.6 10.9 37.6 44.9 48.0 24.8 28.5 17.4 24.1 16.8 13.2 22.8 22.6 21.9 35.6 22.6 34.6 10.3 11.4 418.2 16.8 13.9 17.8 16.9 21.6 26.1 16.5 37.7 28.4 23.2 16.7 27.1 85.4 23.1 35.4 43.1 20.8 23.6 32.9 23.5 28.2 49.4 23.1 15.9 18.5 99.7 20.4 29.7 18.3 18.1 UBXN4 "KIAA0242, UBXD2, UBXDC1" ENSG00000144224 "UBX domain protein 4" Q92575 2 135741734-135785056 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 863.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036325 Approved Supported "Endoplasmic reticulum" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA036325: AB_10669788" "unprognostic (1.22e-2)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (1.47e-1)" "unprognostic (1.54e-1)" "unprognostic (1.90e-1)" "unprognostic (1.17e-1)" "unprognostic (2.91e-1)" "unprognostic (5.40e-2)" "unprognostic (2.94e-2)" "unprognostic (2.63e-2)" "unprognostic (1.93e-1)" "unprognostic (1.83e-2)" "unprognostic (4.44e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (5.14e-3)" 51.9 55.6 33.3 58.4 38.3 65.4 57.4 37.4 38.0 62.3 44.7 57.1 69.8 56.0 71.1 44.4 49.0 57.2 44.3 31.5 33.8 64.2 93.8 47.2 59.5 40.2 36.8 52.6 73.4 83.5 19.6 63.0 40.1 64.6 60.2 85.6 71.8 47.8 55.1 56.0 67.9 43.9 35.9 55.7 64.6 57.7 33.7 76.6 76.1 52.7 59.8 60.5 25.1 47.6 136.2 34.6 85.1 66.2 106.9 107.0 95.5 106.6 106.3 87.0 77.4 65.3 91.8 84.0 149.4 105.1 46.6 98.3 50.7 68.4 103.5 115.5 62.8 80.5 60.7 98.6 99.4 85.2 70.7 81.6 66.6 86.7 85.8 118.2 110.5 66.2 74.4 116.1 95.3 64.1 109.9 61.3 64.3 70.6 70.9 87.9 100.5 146.5 112.2 97.7 77.4 50.2 97.2 64.1 64.4 77.1 68.0 78.2 101.8 78.4 40.1 82.5 58.4 108.7 72.2 76.2 99.0 59.3 75.5 62.9 35.8 59.1 46.5 42.3 42.6 45.9 42.5 42.5 35.8 42.6 41.4 41.0 73.7 48.4 52.2 56.6 52.3 35.9 33.3 38.3 37.4 38.0 31.5 33.8 40.2 36.8 40.1 35.9 33.7 47.6 178.1 208.3 171.4 56.2 177.4 175.1 283.0 318.5 160.5 172.3 164.1 153.3 150.8 134.4 264.1 126.9 223.1 238.2 140.8 168.9 90.1 254.6 863.9 209.3 223.1 151.7 186.6 129.8 85.2 195.8 214.0 197.4 129.5 240.6 176.9 151.5 113.2 225.7 138.8 97.6 78.4 246.9 183.1 88.6 125.2 325.1 172.7 139.9 92.5 60.9 158.8 162.2 122.6 71.9 105.3 190.7 166.7 143.7 300.3 344.1 183.0 156.8 286.7 349.8 105.2 159.3 173.9 446.1 248.4 176.1 183.6 379.4 171.6 271.6 186.0 303.7 UCN3 "SPC, UCNIII" ENSG00000178473 "Urocortin 3" Q969E3 10 5364966-5374692 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 8.8;pancreas: 5.8;stomach 1: 3.4" "Cell type enriched" "Detected in some" 29 "Enteroendocrine cells: 242.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 15.4" "Region enhanced" "Detected in some" "medulla oblongata: 1.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "SCLC-21H: 1.2" "Region enhanced" "Detected in some" "hypothalamus: 5.1" HPA038281 Uncertain "Secreted to blood" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA038281: AB_10672408" "unprognostic (2.00e-2)" "unprognostic (2.31e-1)" "unprognostic (1.60e-1)" "unprognostic (2.10e-1)" "unprognostic (3.18e-3)" "unprognostic (8.42e-2)" "unprognostic (3.55e-2)" "unprognostic (2.91e-2)" 0.0 0.8 1.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 2.3 8.8 0.0 0.0 0.0 1.0 1.0 0.0 0.0 0.8 0.7 0.0 0.6 0.0 1.9 0.5 0.0 5.8 0.0 2.7 0.1 0.1 0.3 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.0 0.8 1.9 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.1 242.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.3 0.0 0.0 0.3 0.6 2.9 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 UFM1 "bA131P10.1, C13orf20" ENSG00000120686 "Ubiquitin fold modifier 1" P61960 13 38349849-38363619 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039758 Approved NA NA 240000 "Cluster 6: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" "HPA039758: AB_10697555" "unprognostic (8.08e-2)" "unprognostic (3.29e-2)" "unprognostic (1.49e-1)" "prognostic favorable (9.35e-4)" "unprognostic (3.33e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (9.67e-2)" "unprognostic (1.68e-1)" "unprognostic (3.92e-2)" "unprognostic (1.45e-1)" "unprognostic (8.11e-2)" "unprognostic (7.03e-2)" "unprognostic (4.90e-3)" "unprognostic (1.12e-2)" "unprognostic (3.99e-1)" "unprognostic (8.23e-2)" "unprognostic (1.90e-1)" 41.9 43.1 35.6 47.8 38.1 100.1 47.4 35.6 44.0 43.5 40.5 39.7 48.5 58.4 64.8 29.9 37.1 42.2 35.8 37.6 42.1 45.3 52.9 41.6 52.3 39.1 37.5 50.3 67.0 32.7 37.2 53.1 39.4 49.9 50.6 32.1 58.5 50.3 24.8 42.8 47.8 39.2 40.1 46.9 52.3 19.8 36.9 31.9 52.1 26.2 48.5 41.7 35.8 44.5 31.3 18.1 47.4 46.2 81.8 97.4 43.3 94.1 72.8 47.7 50.3 56.2 63.1 50.9 29.1 81.8 94.5 51.6 44.9 57.4 67.6 71.4 27.5 42.5 33.9 50.0 107.8 63.3 59.1 81.6 84.3 46.4 127.6 69.9 47.7 39.6 28.5 68.5 68.6 35.6 42.8 52.5 48.9 94.4 45.8 48.9 84.8 50.6 60.2 40.6 17.9 40.6 32.4 54.8 80.8 64.9 40.0 49.1 56.5 55.1 33.5 88.1 53.1 64.7 43.9 67.6 116.6 32.2 84.5 71.5 30.6 41.1 30.7 42.0 37.3 40.1 31.2 28.7 26.7 37.6 30.4 31.8 15.5 39.6 40.3 45.0 32.4 34.7 35.6 38.1 35.6 44.0 37.6 42.1 39.1 37.5 39.4 40.1 36.9 44.5 92.1 80.1 73.3 20.9 141.6 136.9 151.7 147.8 108.1 24.0 102.7 64.4 66.3 64.3 115.3 62.5 20.9 87.2 112.7 84.8 99.7 91.5 38.6 126.8 113.4 78.8 31.7 52.6 29.0 102.3 140.2 121.5 92.8 148.1 115.3 53.4 68.9 119.6 97.6 6.7 34.9 113.5 107.8 94.3 148.3 13.3 59.0 102.0 94.3 43.1 92.3 26.7 62.8 26.2 58.9 161.9 102.2 40.3 330.9 215.8 95.2 136.5 141.2 22.3 19.7 87.3 88.1 56.6 44.9 110.2 173.3 140.4 93.0 45.2 80.8 220.3 UMAD1 "RPA3-AS1, RPA3OS" ENSG00000219545 "UBAP1-MVB12-associated (UMA) domain containing 1" C9J7I0 7 7640711-7968020 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 96.7;Inhibitory neurons: 114.3;Microglial cells: 79.6;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 119.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044806 Approved Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA044806: AB_10961141" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.23e-1)" "unprognostic (9.08e-3)" "unprognostic (9.24e-2)" "unprognostic (6.86e-3)" "unprognostic (4.87e-1)" "unprognostic (2.56e-1)" "unprognostic (6.57e-2)" "unprognostic (1.19e-1)" "unprognostic (2.43e-1)" "prognostic favorable (1.73e-8)" "unprognostic (6.66e-3)" "unprognostic (8.34e-2)" "unprognostic (7.69e-2)" "unprognostic (3.58e-1)" 9.2 16.5 5.5 11.2 5.8 9.5 10.3 5.6 6.2 10.1 7.0 12.8 15.4 10.3 11.4 8.9 10.2 10.7 13.7 4.9 8.3 17.2 14.3 12.0 15.7 6.9 7.3 13.6 36.1 29.7 10.3 9.2 7.5 18.9 11.6 11.5 20.6 11.7 11.3 7.0 16.6 9.8 6.1 10.3 23.0 5.8 7.0 18.4 24.6 10.5 13.4 12.3 8.4 7.1 24.7 17.9 9.0 10.5 12.7 14.9 10.3 14.9 17.2 11.5 17.4 7.6 17.9 13.4 15.4 9.4 46.3 15.7 10.4 15.0 14.3 10.1 8.1 7.3 12.4 8.9 14.2 13.6 16.3 14.2 18.6 16.6 12.7 13.5 7.1 17.2 15.1 40.0 15.4 19.9 12.4 7.4 16.2 16.5 14.8 13.6 21.3 21.3 20.9 11.1 3.6 14.8 21.0 26.7 21.6 26.5 20.8 16.3 7.8 11.7 27.2 23.3 15.2 28.6 34.2 15.5 26.4 19.2 36.8 51.8 16.0 43.5 19.3 21.5 23.9 28.8 27.2 24.2 13.8 26.0 31.8 23.8 46.1 18.5 24.1 16.3 38.7 17.9 5.5 5.8 5.6 6.2 4.9 8.3 6.9 7.3 7.5 6.1 7.0 7.1 12.1 25.6 11.9 58.8 22.8 0.0 27.7 0.0 12.0 6.5 13.8 12.3 10.9 11.5 9.9 14.7 14.6 16.7 7.7 7.6 39.2 8.4 7.1 9.7 7.6 7.1 6.1 6.7 96.7 14.5 23.6 11.4 33.1 10.6 15.2 3.8 6.4 9.5 16.8 15.2 114.3 13.3 0.0 13.2 0.0 3.7 13.4 12.9 0.0 79.6 8.9 11.4 16.5 80.9 119.3 10.4 9.0 7.9 28.4 19.3 16.8 34.2 9.5 9.8 26.3 12.0 9.6 4.8 5.0 12.6 0.0 21.2 17.0 7.6 7.7 21.2 USP43 FLJ30626 ENSG00000154914 "Ubiquitin specific peptidase 43" Q70EL4 17 9644698-9729687 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 37.9;Excitatory neurons: 35.5;Glandular and luminal cells: 52.5;Oligodendrocyte precursor cells: 73.4;Syncytiotrophoblasts: 73.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 11.7;SK-BR-3: 8.1;T-47d: 9.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA023389, HPA027762, HPA027763" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nuclear speckles" "HPA023389: AB_1858691, HPA027762: AB_10603001, HPA027763: " "unprognostic (1.39e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-3)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (2.04e-1)" "unprognostic (6.40e-3)" "unprognostic (2.26e-1)" "unprognostic (3.05e-3)" "unprognostic (2.41e-2)" "unprognostic (7.49e-2)" "unprognostic (5.95e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.24e-1)" "unprognostic (2.06e-1)" "unprognostic (3.28e-1)" 0.3 0.2 2.6 0.6 3.4 0.7 1.9 0.8 4.1 2.9 2.9 3.5 4.2 1.9 1.0 6.5 4.2 1.2 0.0 3.3 1.4 4.0 9.1 3.2 0.1 2.5 4.6 0.1 5.0 1.1 3.5 8.3 2.5 9.8 3.2 1.4 4.3 2.2 0.0 2.2 3.5 0.2 2.1 0.3 2.1 3.2 2.3 0.3 1.7 0.0 0.7 1.1 2.4 2.5 5.6 1.4 0.0 0.5 0.0 0.0 11.7 0.1 0.2 0.6 1.6 2.8 4.5 0.0 1.8 0.2 2.5 6.8 0.6 5.3 0.6 3.6 1.8 0.3 3.0 1.0 0.1 0.5 0.0 0.0 6.8 0.3 2.8 0.3 0.0 0.8 0.0 0.0 0.0 2.6 0.9 4.6 0.7 4.8 0.3 3.6 0.0 0.8 4.1 3.0 0.7 0.0 2.4 8.1 1.0 3.7 9.9 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 3.4 0.8 4.1 3.3 1.4 2.5 4.6 2.5 2.1 2.3 2.5 0.0 3.2 3.1 1.6 0.3 4.7 7.8 4.6 5.2 0.5 7.0 2.4 0.6 4.3 7.4 11.0 6.2 26.2 0.6 14.3 1.9 4.4 1.1 37.9 4.2 0.5 2.4 3.2 35.5 4.7 23.7 0.8 7.7 52.5 0.0 0.9 0.4 15.6 2.7 0.0 4.0 8.3 2.0 0.9 0.3 1.1 0.0 0.6 5.4 0.0 0.3 8.4 0.0 73.4 1.2 11.3 3.5 0.0 0.2 10.6 8.7 1.8 30.2 1.5 0.0 0.0 1.0 1.5 0.3 12.3 3.3 73.2 0.7 0.0 9.7 11.8 UTY "KDM6AL, KDM6C" ENSG00000183878 "Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked" O14607 Y 13248379-13480673 "Enzymes, Predicted intracellular proteins" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Excitatory neurons: 66.7;Inhibitory neurons: 65.2;Oligodendrocytes: 65.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 20.6;SK-MEL-30: 14.9;U-266/84: 16.4;U-698: 20.2" "Low region specificity" "Detected in all" "HPA000568, HPA001165" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli rim" "Intracellular and membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nucleoli, Nucleoli rim" "HPA000568: AB_1858705, HPA001165: AB_1080541" "unprognostic (7.52e-2)" "unprognostic (6.60e-2)" "unprognostic (4.04e-6)" "unprognostic (6.47e-2)" "unprognostic (9.34e-2)" "unprognostic (2.00e-2)" "unprognostic (9.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (1.41e-2)" "unprognostic (2.82e-1)" "unprognostic (2.67e-2)" "unprognostic (1.46e-2)" 3.6 3.5 0.9 2.4 1.5 6.8 3.5 2.0 2.2 0.0 1.6 2.9 2.5 0.0 9.4 4.1 0.0 3.5 2.9 0.9 1.2 3.1 4.1 4.2 2.1 2.1 1.1 0.0 3.4 2.9 4.0 3.4 2.1 8.1 6.2 4.5 4.3 6.2 5.7 5.1 6.3 0.0 1.3 3.4 2.9 3.8 1.4 0.0 3.8 5.2 6.0 3.6 0.0 3.2 0.0 2.5 0.0 0.0 0.0 0.0 8.7 4.5 7.7 5.0 7.5 0.0 0.0 12.4 0.0 5.1 0.0 0.0 0.0 0.0 6.9 6.9 0.0 20.6 0.0 0.0 6.4 0.0 0.0 7.8 7.8 0.0 0.0 0.0 0.0 4.2 0.0 0.0 5.5 0.0 7.1 0.1 0.0 0.0 0.0 0.0 3.1 5.6 5.4 8.3 4.9 0.0 0.0 0.0 14.9 8.5 0.0 4.4 5.9 8.7 0.0 0.0 3.1 13.5 16.4 20.2 0.8 0.0 0.0 1.8 1.7 3.8 2.6 1.9 3.7 2.9 2.6 2.1 1.8 3.2 3.6 2.7 3.9 5.8 2.2 2.9 3.2 1.1 0.9 1.5 2.0 2.2 0.9 1.2 2.1 1.1 2.1 1.3 1.4 3.2 0.0 16.0 25.3 58.4 35.4 11.3 18.4 8.2 44.3 35.2 0.0 0.0 6.1 5.7 10.7 18.4 64.6 10.0 8.0 3.0 0.0 4.8 0.4 0.0 0.0 9.0 1.8 19.6 66.7 0.0 3.7 9.3 37.8 0.0 16.4 0.0 12.5 2.1 3.0 37.0 65.2 3.3 2.0 14.2 14.5 2.0 10.8 12.7 8.8 54.4 18.1 12.8 25.7 57.8 65.8 1.5 2.2 11.7 23.2 14.0 2.9 2.6 10.7 37.4 0.0 4.7 5.0 4.0 6.8 33.2 15.3 13.3 25.1 0.0 2.9 21.3 VAMP8 EDB ENSG00000118640 "Vesicle associated membrane protein 8" Q9BV40 2 85561562-85582031 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiviral defense, Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 873.4;NB-4: 1362.5;U-937: 912.8" "Low region specificity" "Detected in all" "HPA006882, HPA007215, CAB037132, CAB037147" Enhanced Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 220000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 24: NB-4 - Immune response" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Golgi apparatus, Plasma membrane" Nucleoplasm "CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: " "unprognostic (1.00e-1)" "unprognostic (1.16e-1)" "unprognostic (7.46e-3)" "unprognostic (1.13e-1)" "unprognostic (7.33e-2)" "unprognostic (1.31e-1)" "unprognostic (1.76e-2)" "unprognostic (3.79e-3)" "unprognostic (3.83e-2)" "unprognostic (4.15e-1)" "unprognostic (2.74e-2)" "unprognostic (8.62e-2)" "unprognostic (1.57e-3)" "unprognostic (1.92e-2)" "unprognostic (2.16e-1)" "prognostic favorable (8.07e-9)" "prognostic favorable (1.59e-6)" 74.0 34.7 26.9 148.4 28.2 299.7 225.1 28.7 53.8 121.8 51.6 250.6 229.9 30.6 144.5 303.1 166.1 119.2 24.6 26.5 29.9 280.1 247.4 266.5 212.4 35.6 31.6 10.4 182.5 270.3 33.7 265.7 34.3 107.7 300.9 4.4 322.5 90.4 24.3 210.2 252.1 71.4 31.9 175.9 228.4 23.4 35.5 173.5 126.0 27.3 311.7 198.0 150.0 36.5 255.0 33.2 2.6 2.3 2.4 1.4 241.6 0.7 0.3 0.2 0.3 191.2 225.2 56.8 174.4 1.2 17.9 175.2 2.4 451.6 0.6 232.3 173.7 290.3 104.4 220.7 3.3 873.4 287.1 2.3 317.5 0.3 72.3 1.2 58.2 1.2 214.9 11.6 103.8 363.9 0.8 1362.5 3.2 315.9 26.0 5.2 8.9 381.7 516.9 384.3 8.4 2.9 120.9 628.3 19.4 126.3 231.4 665.4 113.9 0.3 15.3 2.9 2.7 3.0 151.1 340.0 2.6 912.8 1.1 601.3 868.6 328.4 469.3 740.3 455.6 519.3 537.0 463.3 787.3 508.3 423.2 442.0 52.4 556.3 460.0 2135.6 665.3 1536.0 26.9 28.2 28.7 53.8 26.5 29.9 35.6 31.6 34.3 31.9 35.5 36.5 39.4 371.8 283.2 1.3 147.7 259.1 303.3 800.9 164.4 1.2 289.7 251.7 6.3 356.0 662.1 366.0 0.0 980.8 447.1 832.3 765.0 630.7 28.0 231.3 22.8 46.1 129.1 147.4 0.1 730.0 460.4 35.6 188.6 212.9 269.4 3.3 163.1 314.8 1191.1 0.0 0.1 391.8 545.3 1000.4 488.7 49.1 9.3 537.2 352.2 2.8 686.1 7.9 375.9 0.0 0.5 865.5 843.2 7.5 103.0 302.7 1184.0 1046.8 600.5 2.0 46.0 21.4 56.5 48.0 8.3 239.8 329.7 877.8 219.5 13.8 299.4 602.0 VAV2 ENSG00000160293 "Vav guanine nucleotide exchange factor 2" P52735 9 133761894-133992604 "Plasma proteins, Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 48.3;Inhibitory neurons: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 3.3" "Group enriched" "Detected in many" 22 "B-cells: 3.3;dendritic cells: 1.1;monocytes: 2.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003224 Uncertain Approved Vesicles NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA003224: AB_1080554" "unprognostic (1.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (6.57e-2)" "unprognostic (1.16e-3)" "unprognostic (1.83e-2)" "unprognostic (3.74e-3)" "unprognostic (4.73e-2)" "unprognostic (9.16e-2)" "prognostic favorable (7.39e-7)" "unprognostic (8.64e-3)" "unprognostic (3.00e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (3.97e-2)" 8.4 26.8 9.3 10.7 8.8 3.0 7.7 7.4 9.8 12.0 10.9 11.8 20.9 9.9 7.2 6.7 12.2 10.8 7.4 11.6 9.9 21.3 46.1 16.8 13.3 11.6 16.0 5.5 38.6 10.8 8.0 13.1 13.2 10.2 9.6 3.0 13.2 8.9 2.0 6.1 22.4 6.9 8.9 13.9 9.5 4.4 9.9 6.2 13.8 2.3 13.3 11.4 7.9 8.4 12.5 21.6 33.3 13.5 9.0 15.1 85.8 24.6 13.5 20.3 12.2 33.0 19.0 3.6 19.6 24.6 26.2 72.8 31.6 53.0 10.4 21.3 7.3 4.2 28.3 37.2 33.4 10.3 1.6 15.0 33.5 17.9 25.3 13.6 22.9 7.3 7.3 6.0 14.2 63.5 0.8 5.1 16.3 54.3 20.5 33.9 28.2 12.1 46.1 22.4 36.9 24.9 64.7 42.7 8.8 21.3 26.0 14.5 18.7 28.6 16.0 28.7 34.5 0.4 0.3 6.8 19.1 8.8 18.0 0.0 0.8 0.0 0.0 2.0 0.0 3.3 0.0 0.0 1.1 2.1 0.0 0.0 0.0 0.0 1.4 0.7 0.0 0.5 9.3 8.8 7.4 9.8 11.6 9.9 11.6 16.0 13.2 8.9 9.9 8.4 4.8 0.0 5.4 20.5 11.2 5.1 3.0 10.1 4.0 1.9 6.7 5.6 4.7 21.5 7.5 36.8 0.0 1.3 0.6 27.0 3.9 9.2 2.5 6.9 6.4 6.6 28.2 0.4 8.5 12.5 18.3 5.0 9.7 13.9 0.0 24.6 6.8 48.3 6.2 0.0 40.9 9.8 6.1 5.4 7.2 7.9 7.2 7.7 1.8 8.4 9.3 4.2 2.1 31.2 2.6 24.7 15.6 6.0 3.3 6.3 35.7 13.6 3.3 1.8 13.1 6.4 8.8 0.1 3.8 2.1 2.7 1.0 1.7 12.0 13.5 2.1 VPS54 "HCC8, PPP1R164" ENSG00000143952 "VPS54 subunit of GARP complex" Q9P1Q0 2 63892146-64019428 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 81.8;Microglial cells: 76.8;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 108.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055894, HPA067981, HPA070582" Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Nucleoplasm "HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282" "unprognostic (1.35e-1)" "unprognostic (3.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.46e-1)" "unprognostic (3.37e-1)" "unprognostic (9.47e-3)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.16e-1)" "unprognostic (4.62e-2)" "unprognostic (1.82e-1)" "prognostic favorable (2.03e-4)" "unprognostic (3.20e-1)" "unprognostic (8.38e-2)" "unprognostic (3.02e-2)" "unprognostic (1.36e-1)" "unprognostic (1.57e-1)" "unprognostic (4.91e-2)" 11.7 11.5 8.1 10.6 9.7 15.0 14.5 13.5 9.6 13.5 10.9 11.6 13.0 14.4 12.3 10.8 12.4 10.4 8.4 7.8 8.5 16.0 14.4 13.1 11.1 8.8 8.7 14.6 17.0 28.3 13.0 13.5 8.9 17.4 13.4 17.3 36.8 12.8 9.3 10.9 12.2 12.8 8.5 12.9 14.4 13.4 8.5 13.2 17.7 9.9 11.2 10.9 9.8 11.0 23.3 11.9 22.5 17.4 15.7 17.1 16.6 14.3 21.4 15.0 14.9 22.0 14.9 15.8 10.5 20.1 22.3 10.7 22.1 12.9 27.1 23.0 15.9 14.7 10.0 38.9 15.0 10.3 6.2 16.3 19.8 10.5 22.7 18.0 23.0 11.3 16.6 13.4 19.4 10.1 10.9 11.5 13.8 22.9 9.1 10.8 21.8 9.0 17.1 13.1 13.1 19.6 12.8 16.3 17.8 17.3 11.9 20.6 16.8 19.3 15.3 11.8 23.9 30.8 8.7 20.4 14.3 20.5 16.4 1.0 0.7 0.3 0.5 0.6 0.5 0.6 0.4 0.5 0.4 0.7 0.6 0.5 0.6 0.7 0.5 0.6 0.9 0.2 8.1 9.7 13.5 9.6 7.8 8.5 8.8 8.7 8.9 8.5 8.5 11.0 16.6 16.0 22.3 62.7 5.2 11.1 8.7 6.4 3.4 20.9 11.8 9.8 14.3 15.7 14.2 1.8 12.5 6.5 6.4 11.1 1.9 6.8 53.9 9.3 16.6 13.4 13.2 2.1 71.6 13.2 6.8 11.8 15.8 11.0 2.5 15.2 10.8 15.4 8.1 23.5 81.8 17.4 2.0 9.8 9.3 37.4 18.6 12.2 5.4 76.8 9.6 9.4 3.1 105.6 108.9 11.3 12.8 12.4 7.7 17.3 11.6 9.9 10.6 16.2 19.7 13.4 12.8 14.9 8.3 9.4 10.4 5.5 7.5 15.9 12.9 13.8 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: " "prognostic unfavorable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 9.9 9.2 5.2 9.5 5.4 12.9 9.2 6.2 5.6 7.6 6.8 10.6 9.3 7.8 4.3 13.4 7.4 6.1 7.7 5.4 5.8 9.4 12.3 8.8 10.1 6.4 5.6 7.5 11.1 6.1 9.0 7.6 6.0 8.8 10.3 4.0 10.5 5.4 9.1 11.0 11.0 6.4 5.4 12.6 10.5 4.9 5.7 7.8 7.4 6.0 10.6 8.9 7.9 5.9 13.2 18.0 8.5 34.4 12.8 10.1 23.7 12.9 15.5 13.3 15.2 31.1 17.7 12.3 16.8 16.6 24.3 16.1 11.5 22.4 10.2 11.6 9.6 14.1 15.9 12.7 12.2 14.8 25.5 12.2 12.7 18.3 9.6 9.2 14.4 13.7 9.9 9.3 14.9 19.2 14.0 13.3 8.9 18.9 15.2 11.6 12.2 11.6 15.9 19.7 8.3 11.1 17.7 51.3 20.2 10.4 36.3 15.8 13.0 17.5 9.0 20.3 17.6 15.6 12.9 9.6 22.7 19.5 10.6 6.4 10.2 7.8 11.3 16.6 11.7 8.5 10.5 9.8 9.9 7.3 8.3 8.5 9.0 10.3 14.2 7.2 12.6 10.0 5.2 5.4 6.2 5.6 5.4 5.8 6.4 5.6 6.0 5.4 5.7 5.9 17.1 9.6 16.7 5.9 16.9 14.5 10.9 9.1 9.6 13.5 15.5 10.3 5.3 5.7 16.2 18.4 12.5 21.6 28.9 31.9 21.5 20.2 29.3 20.6 13.1 12.9 14.9 13.9 7.2 28.2 42.8 12.6 25.0 13.9 19.7 16.4 12.5 14.9 20.8 23.5 7.0 22.6 8.2 16.1 13.9 9.7 9.6 18.3 8.8 1.0 20.5 5.7 23.7 4.5 6.5 27.2 39.3 7.5 23.0 15.6 24.9 20.8 17.2 8.3 13.1 13.0 14.1 7.9 9.8 15.1 13.4 23.3 21.0 14.2 26.0 16.4 XBP1 XBP2 ENSG00000100219 "X-box binding protein 1" P17861 22 28794555-28800597 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Angiogenesis, Apoptosis, Autophagy, Differentiation, Lipid biosynthesis, Lipid metabolism, Myogenesis, Protein transport, Stress response, Transcription, Transcription regulation, Transport, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 1159.0" "Cell type enhanced" "Detected in all" "Breast glandular cells: 1756.7;Plasma cells: 2344.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 960.5;SK-BR-3: 870.0;T-47d: 1012.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" 100.3 103.7 23.8 150.1 25.9 247.2 720.6 26.8 27.7 369.7 46.8 203.6 163.7 94.2 150.5 85.2 126.5 120.2 75.8 22.5 32.2 87.7 687.3 151.8 138.3 33.3 33.2 67.5 1159.0 195.1 87.7 107.9 29.0 228.8 196.5 21.1 849.4 152.1 90.1 72.2 140.3 105.5 30.8 213.2 259.9 22.2 33.0 148.2 168.9 48.7 307.8 250.4 52.2 30.8 77.1 50.8 71.4 111.0 132.2 144.2 181.1 130.9 223.2 128.4 168.8 82.5 104.4 290.2 63.0 121.8 75.3 104.5 134.2 64.4 110.4 130.0 84.9 88.3 42.6 356.2 285.9 166.1 80.8 90.7 378.2 85.2 363.7 115.9 104.1 35.0 79.5 355.0 78.6 960.5 23.3 157.0 49.7 594.6 79.0 168.6 78.5 401.5 118.4 105.4 94.7 90.7 79.0 870.0 358.6 94.8 1012.9 188.5 59.8 73.3 69.8 78.5 47.3 598.8 456.8 174.8 98.0 210.0 112.3 185.0 27.1 23.5 73.3 14.1 95.2 38.0 52.4 76.5 23.5 43.8 52.9 43.2 2.1 88.5 10.1 75.0 20.5 38.5 23.8 25.9 26.8 27.7 22.5 32.2 33.3 33.2 29.0 30.8 33.0 30.8 116.4 86.6 195.6 3.6 379.0 210.6 410.2 192.2 47.3 25.4 1756.7 829.4 46.2 205.9 390.1 138.0 131.3 112.8 298.6 171.2 80.3 240.6 30.2 160.1 147.8 107.0 189.7 68.6 8.5 633.3 335.4 220.0 208.0 293.6 99.7 55.1 93.1 654.5 267.9 15.2 11.4 633.0 225.9 130.0 281.5 22.7 95.7 172.3 355.8 18.7 95.0 18.6 385.2 8.0 7.3 328.4 190.5 64.7 2344.9 381.9 247.0 73.2 168.9 53.2 13.1 144.4 179.3 36.8 32.5 86.2 202.0 349.7 206.1 34.8 260.0 355.3 XPNPEP1 "XPNPEP, XPNPEPL, XPNPEPL1" ENSG00000108039 "X-prolyl aminopeptidase 1" Q9NQW7 10 109864766-109923553 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025196, HPA030419, HPA030420, HPA030422" Supported Enhanced Cytosol NA NA 810000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783" "unprognostic (3.17e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.46e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (2.12e-5)" "unprognostic (8.03e-2)" "unprognostic (2.10e-2)" "unprognostic (1.88e-1)" "unprognostic (4.89e-2)" "unprognostic (7.61e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (5.18e-2)" 19.7 19.4 13.2 22.9 13.6 23.3 20.1 13.1 14.8 19.7 17.2 32.2 51.7 19.4 22.7 25.1 22.3 27.5 27.9 15.3 13.4 21.4 18.9 19.2 25.4 13.2 12.7 19.8 62.0 24.5 19.2 26.6 13.1 21.7 40.4 18.7 30.4 15.7 28.4 29.5 61.8 28.2 13.2 19.3 24.4 18.1 13.3 19.5 23.6 22.1 28.4 24.6 19.3 13.7 78.1 33.6 52.3 72.1 83.6 77.4 40.2 42.4 85.5 61.8 66.5 65.4 65.2 110.3 35.9 65.0 31.3 40.5 41.7 52.2 60.4 33.0 40.3 74.0 20.5 27.6 58.2 58.3 59.0 76.9 31.8 67.8 60.1 94.6 103.1 70.0 24.3 34.3 80.1 26.3 41.7 36.0 20.6 58.7 35.7 46.1 105.3 19.8 78.5 24.3 15.9 60.5 36.9 23.1 70.6 56.9 28.3 53.6 53.9 25.3 32.9 40.4 38.1 58.4 30.4 92.8 59.4 80.0 20.3 25.7 26.8 11.3 19.5 42.2 13.4 10.6 12.6 17.5 46.4 8.9 8.7 11.7 2.2 30.5 36.8 36.4 15.5 29.6 13.2 13.6 13.1 14.8 15.3 13.4 13.2 12.7 13.1 13.2 13.3 13.7 13.4 6.4 14.4 24.5 14.6 8.9 13.2 32.9 11.4 20.5 12.1 9.7 17.0 18.6 26.3 3.7 6.2 38.2 33.1 34.5 17.6 37.4 6.4 12.3 16.5 18.2 16.8 14.7 18.9 72.9 29.6 22.7 24.5 13.6 11.4 17.0 15.7 12.1 30.9 26.9 25.3 37.1 18.3 20.5 9.6 5.1 18.3 37.5 8.8 15.9 33.5 27.1 24.7 21.6 27.0 54.4 35.1 29.7 18.1 22.5 63.5 31.1 22.8 19.5 13.1 9.8 14.2 17.5 35.9 18.6 8.7 25.2 19.4 30.0 36.5 27.1 YIF1A "54TM, FinGER7, YIF1, YIF1P" ENSG00000174851 "Yip1 interacting factor homolog A, membrane trafficking protein" O95070 11 66284580-66289145 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014840, HPA076194" Enhanced Supported "Golgi apparatus,Vesicles" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014840: AB_2217189, HPA076194: " "unprognostic (9.35e-2)" "unprognostic (7.86e-2)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "unprognostic (3.23e-1)" "unprognostic (4.38e-3)" "unprognostic (2.25e-3)" "unprognostic (2.51e-2)" "unprognostic (3.57e-2)" "unprognostic (2.13e-1)" "unprognostic (6.39e-3)" "unprognostic (1.35e-1)" "unprognostic (2.60e-2)" "unprognostic (2.03e-1)" "unprognostic (2.64e-1)" "unprognostic (6.53e-2)" "prognostic unfavorable (8.70e-4)" 49.2 54.7 33.4 28.4 36.0 16.7 47.5 38.5 41.4 42.7 42.4 50.8 56.5 53.5 34.5 50.9 45.7 25.5 57.8 33.5 35.6 50.9 149.5 44.9 22.9 38.9 36.1 42.1 86.0 40.6 74.1 34.5 38.2 47.3 37.7 12.3 51.1 29.6 96.2 43.0 47.4 41.1 38.5 35.9 56.1 36.4 35.6 21.6 49.9 59.3 24.7 45.4 40.6 41.9 80.7 131.3 39.4 72.6 130.0 138.7 73.8 114.4 122.3 95.5 94.3 126.0 95.5 67.9 111.5 161.4 107.8 119.9 60.7 107.9 75.6 77.7 72.0 42.5 93.3 158.7 147.4 59.3 61.5 97.4 144.4 98.6 158.9 76.6 91.3 67.0 80.7 114.8 84.3 199.3 71.3 64.4 40.3 147.4 136.6 54.9 61.2 203.9 81.9 70.9 58.5 57.9 62.5 106.7 103.4 49.6 155.5 43.5 81.0 80.8 69.0 165.3 54.1 78.1 86.0 63.0 125.4 56.2 90.2 19.4 95.6 20.6 71.3 141.4 78.4 95.9 60.6 67.2 116.4 82.4 48.0 55.3 9.4 51.2 140.0 141.6 54.9 99.8 33.4 36.0 38.5 41.4 33.5 35.6 38.9 36.1 38.2 38.5 35.6 41.9 63.4 38.5 48.0 6.2 52.2 36.1 88.1 170.4 38.1 27.1 84.4 92.7 34.5 82.9 115.5 46.0 22.9 114.3 42.6 66.8 64.6 137.9 28.1 42.1 84.8 53.6 87.4 21.0 1.9 149.4 248.5 90.4 55.0 42.8 29.9 38.8 49.2 172.0 105.4 26.9 3.9 140.9 116.0 38.4 44.9 48.6 75.5 45.0 72.9 8.4 40.8 73.7 28.8 10.1 10.4 132.1 93.3 82.4 92.4 195.2 202.2 135.2 101.4 34.0 39.5 60.8 150.0 61.0 56.8 63.3 46.3 154.3 36.5 88.1 107.2 112.1 YIPF5 "FinGER5, SMAP-5" ENSG00000145817 "Yip1 domain family member 5" Q969M3 5 144158162-144170714 "Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "TIME: 236.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042338, HPA073622" Supported Supported "Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles" NA NA "Cluster 13: T-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum, Golgi apparatus, Vesicles" Nucleoplasm "HPA042338: AB_2677953, HPA073622: AB_2686618" "prognostic unfavorable (7.83e-5)" "unprognostic (1.13e-3)" "unprognostic (1.95e-2)" "unprognostic (8.35e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.12e-5)" "prognostic unfavorable (3.26e-5)" "unprognostic (2.89e-2)" "unprognostic (1.99e-1)" "unprognostic (3.64e-2)" "unprognostic (1.20e-3)" "unprognostic (4.79e-2)" "unprognostic (8.79e-2)" "unprognostic (1.69e-1)" "unprognostic (1.24e-2)" "unprognostic (5.11e-2)" "unprognostic (6.49e-2)" 22.2 20.4 8.3 17.7 9.8 21.0 24.1 9.8 11.0 24.7 16.3 25.8 30.5 20.2 21.2 28.6 20.3 21.4 18.1 9.5 12.5 25.4 31.7 20.3 18.9 9.7 10.3 20.6 32.0 25.7 17.0 30.2 11.5 18.3 26.0 20.6 26.2 19.2 9.3 17.7 27.3 28.5 10.3 15.5 22.7 20.9 10.3 16.1 22.6 14.5 23.9 24.0 14.3 12.0 43.2 28.2 36.0 28.6 84.4 90.5 32.9 143.6 96.9 63.2 101.5 45.3 44.0 23.5 67.3 156.9 72.5 38.7 34.7 70.5 84.8 32.9 30.2 17.4 44.9 46.7 68.0 39.3 27.7 69.1 64.3 56.8 46.3 108.9 61.0 25.6 18.8 38.5 86.4 22.5 19.4 22.2 23.3 27.5 30.7 20.3 53.4 39.3 39.4 37.7 24.4 30.0 49.7 26.4 66.5 36.2 54.9 25.5 236.7 74.0 35.8 72.5 57.2 34.7 61.8 29.9 70.7 36.9 55.2 48.9 34.5 48.7 47.2 47.4 53.1 37.9 47.1 52.4 41.2 36.4 49.0 46.3 26.0 41.0 44.7 45.0 62.8 40.6 8.3 9.8 9.8 11.0 9.5 12.5 9.7 10.3 11.5 10.3 10.3 12.0 43.5 38.5 27.4 8.5 35.6 29.4 24.5 49.4 26.2 40.6 33.4 29.6 21.8 31.5 35.9 20.2 33.3 56.7 40.5 33.0 31.3 43.7 14.9 31.4 49.8 44.1 14.8 20.0 19.7 68.3 77.1 51.9 33.6 31.2 36.8 34.1 30.4 34.7 36.5 33.7 16.9 50.1 22.4 34.0 24.4 7.3 35.4 28.7 30.2 6.5 38.3 54.9 27.8 13.6 16.2 60.5 35.5 33.8 70.0 23.4 56.0 36.1 50.6 53.8 39.5 31.8 45.4 83.9 56.0 33.4 26.0 67.5 42.0 41.1 27.4 24.5 ZBTB42 ZNF925 ENSG00000179627 "Zinc finger and BTB domain containing 42" B2RXF5 14 104800596-104804712 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 11.7;Exocrine glandular cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 10 "eosinophil: 5.4" "Lineage enriched" "Detected in single" 10 "granulocytes: 5.4" "Cell line enhanced" "Detected in many" "HDLM-2: 19.3;MCF7: 33.7;T-47d: 26.9" "Not detected" "Not detected" HPA066961 Approved Supported Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA066961: AB_2685756" "unprognostic (1.23e-1)" "unprognostic (1.84e-1)" "unprognostic (8.68e-2)" "unprognostic (1.59e-1)" "unprognostic (6.99e-2)" "unprognostic (6.67e-2)" "unprognostic (6.17e-3)" "unprognostic (2.56e-1)" "unprognostic (4.35e-1)" "unprognostic (2.70e-2)" "unprognostic (1.63e-1)" "unprognostic (3.42e-1)" "prognostic favorable (2.30e-9)" "unprognostic (1.34e-1)" "unprognostic (2.75e-1)" "unprognostic (1.58e-3)" "unprognostic (5.45e-2)" 2.3 3.5 1.1 1.7 1.1 0.3 3.3 1.0 0.9 1.7 1.5 3.0 3.2 2.2 1.8 4.8 4.5 1.8 4.5 0.9 1.2 4.1 5.5 4.3 1.4 1.8 1.4 1.1 11.5 2.2 1.0 1.1 1.3 6.2 1.8 0.4 6.3 3.3 6.5 2.6 2.9 1.4 1.4 2.2 6.5 2.4 1.2 1.4 4.7 2.6 1.3 2.3 2.2 1.0 1.3 4.4 1.3 5.3 1.0 1.1 5.4 1.9 2.0 3.4 3.0 2.8 5.1 0.4 3.7 1.9 2.3 5.8 1.1 1.8 0.5 19.3 1.3 1.8 2.3 3.3 1.6 0.4 10.3 2.0 2.1 1.4 0.7 2.4 1.5 3.8 3.0 2.9 0.6 33.7 3.6 2.8 0.8 8.9 4.0 5.0 0.3 2.7 2.5 8.6 5.9 2.5 1.5 7.9 3.4 1.2 26.9 2.1 2.4 1.3 3.0 0.3 0.6 3.1 1.8 0.3 4.3 1.8 2.8 0.0 0.1 5.4 0.3 0.0 0.5 0.4 0.4 0.1 0.0 0.4 0.3 0.4 0.0 0.1 0.0 0.4 0.3 0.2 1.1 1.1 1.0 0.9 0.9 1.2 1.8 1.4 1.3 1.4 1.2 1.0 3.1 3.2 11.7 0.3 1.2 0.4 5.0 1.9 1.2 0.3 8.1 3.4 4.4 5.7 8.2 0.0 0.0 1.2 1.1 4.3 3.9 4.2 2.6 2.3 1.2 2.6 5.4 4.4 0.0 13.5 1.9 1.1 3.1 3.9 0.0 2.3 2.5 7.3 1.1 0.0 0.0 6.4 2.0 2.5 0.6 0.9 0.6 0.9 1.8 0.0 0.8 2.8 5.2 0.5 0.0 7.5 3.2 0.4 0.7 6.9 3.4 4.3 3.1 0.4 0.0 1.5 1.6 8.4 3.4 3.4 0.1 0.8 1.8 0.5 4.9 5.1 ZDHHC12 "FLJ14524, ZNF400" ENSG00000160446 "Zinc finger DHHC-type palmitoyltransferase 12" Q96GR4 9 128720870-128724127 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 224.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059339 Uncertain Approved "Nucleoplasm,Intermediate filaments" No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Intermediate filaments" "HPA059339: AB_2683985" "unprognostic (2.05e-1)" "unprognostic (5.81e-2)" "unprognostic (2.54e-1)" "unprognostic (1.53e-3)" "unprognostic (5.34e-3)" "unprognostic (3.11e-2)" "unprognostic (1.50e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-1)" "unprognostic (6.42e-2)" "unprognostic (9.97e-2)" "unprognostic (9.41e-2)" "unprognostic (1.09e-2)" "unprognostic (8.82e-3)" "unprognostic (2.18e-1)" "unprognostic (1.95e-2)" "unprognostic (3.23e-1)" 18.8 23.9 7.8 15.5 7.7 41.3 19.3 7.5 9.9 16.8 8.4 40.5 26.3 12.9 7.1 67.8 12.0 14.1 13.7 7.4 8.8 30.6 52.3 23.3 20.0 9.6 7.8 7.4 67.1 9.8 11.3 16.3 8.4 26.6 13.7 0.5 43.2 12.5 15.6 42.4 36.8 6.3 8.4 31.7 49.2 24.7 10.5 12.4 16.2 4.1 13.7 18.7 30.5 9.7 53.5 127.6 6.0 31.3 17.6 12.1 59.4 32.8 28.8 34.5 22.9 109.6 61.5 37.3 29.6 25.5 62.9 139.8 13.0 65.0 3.8 65.0 31.7 20.1 92.7 49.1 34.7 33.1 87.1 19.9 44.7 29.6 11.0 17.7 25.6 65.6 18.8 93.6 7.1 187.3 45.9 66.2 26.8 118.8 107.6 21.0 21.0 108.4 28.7 43.4 42.1 30.4 46.2 64.1 18.3 9.6 98.9 35.6 27.5 0.1 36.9 25.9 45.8 58.1 106.8 17.3 61.3 38.4 41.4 231.1 122.3 385.6 105.1 123.9 91.2 94.6 95.9 101.5 100.1 111.0 99.2 91.4 269.5 90.5 150.0 244.7 130.9 101.0 7.8 7.7 7.5 9.9 7.4 8.8 9.6 7.8 8.4 8.4 10.5 9.7 10.0 16.0 12.0 1.3 31.8 16.2 43.3 94.0 10.8 1.2 55.5 30.4 14.8 77.2 59.0 46.0 0.0 183.9 39.1 171.0 13.7 106.8 73.2 20.7 11.5 21.1 51.2 51.1 0.6 200.0 224.0 14.2 38.7 52.5 18.4 13.7 35.7 55.3 137.0 0.0 0.5 108.5 67.1 62.2 20.9 30.0 9.6 46.5 42.7 6.5 115.3 18.4 81.4 0.5 2.0 133.8 167.7 7.2 43.3 56.5 186.0 48.5 20.1 2.0 6.6 5.4 16.3 36.0 18.6 55.2 28.1 134.1 34.1 22.0 110.0 77.5 ZFAND1 FLJ14007 ENSG00000104231 "Zinc finger AN1-type containing 1" Q8TCF1 8 81701334-81732903 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 239.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023383 Approved Approved Centrosome,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Centrosome, Cytosol" "HPA023383: AB_1859008" "unprognostic (6.45e-2)" "unprognostic (1.48e-2)" "unprognostic (7.74e-2)" "unprognostic (8.90e-2)" "unprognostic (1.23e-1)" "unprognostic (8.04e-3)" "unprognostic (8.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-2)" "unprognostic (3.88e-2)" "unprognostic (1.30e-2)" "unprognostic (3.77e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "unprognostic (8.35e-2)" "unprognostic (2.36e-2)" 30.3 26.8 15.2 14.8 15.9 28.6 41.8 19.1 21.4 30.8 11.8 27.6 25.8 35.3 26.9 28.3 32.0 24.2 22.2 15.6 17.4 30.7 35.5 24.5 26.8 15.4 15.7 55.7 53.8 32.3 21.7 18.9 16.7 28.1 29.9 21.0 39.9 26.5 21.6 20.7 23.6 32.5 14.0 25.2 30.0 9.2 16.0 31.8 58.1 27.9 29.6 32.1 23.5 16.4 74.1 23.5 31.3 29.4 40.5 86.0 31.0 42.5 57.8 38.3 48.0 26.4 56.8 72.5 49.1 32.5 41.4 47.2 35.9 61.7 57.4 60.1 36.8 41.1 35.1 29.5 78.7 53.9 26.6 70.8 138.4 26.0 239.0 64.6 46.9 70.6 61.1 96.7 38.6 46.0 65.4 35.6 9.6 147.5 70.1 43.8 26.2 32.5 48.1 67.1 30.8 21.6 30.1 19.3 71.6 35.2 62.6 38.7 29.7 27.2 39.4 38.5 60.5 38.2 26.2 45.3 30.9 4.6 21.9 16.8 29.5 8.4 21.8 21.3 36.7 36.4 35.2 28.8 40.8 27.2 46.6 36.1 2.9 37.0 25.8 24.3 44.1 36.0 15.2 15.9 19.1 21.4 15.6 17.4 15.4 15.7 16.7 14.0 16.0 16.4 44.1 25.6 38.3 14.4 47.9 95.8 73.0 73.0 88.2 27.3 49.7 63.6 18.8 41.5 41.4 25.8 4.2 33.8 32.8 10.0 103.7 27.4 3.4 20.1 25.3 42.8 23.4 31.5 49.2 49.4 45.6 36.3 32.1 21.4 34.9 28.9 41.7 22.5 29.1 23.5 45.3 33.6 36.7 47.7 75.0 3.7 39.7 29.1 49.8 20.6 35.2 15.3 23.7 26.7 29.0 33.6 24.4 29.7 44.4 72.2 28.4 80.1 20.9 15.2 32.9 42.6 48.1 18.5 17.3 53.0 78.4 32.7 42.6 49.1 33.3 61.5 ZFPM1 "FOG, FOG1, ZC2HC11A, ZNF89A" ENSG00000179588 "Zinc finger protein, FOG family member 1" Q8IX07 16 88453280-88537031 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 35.3;Muller glia cells: 58.0;Theca cells: 37.4" "Cancer enhanced" "Detected in all" "stomach cancer: 12.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 19.3;K-562: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046603 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 1: K-562 - Erythropoiesis" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Vesicles, Cytosol" "HPA046603: AB_2679718" "unprognostic (1.29e-1)" "unprognostic (2.42e-1)" "unprognostic (3.08e-2)" "unprognostic (3.32e-2)" "unprognostic (1.13e-1)" "unprognostic (9.21e-2)" "unprognostic (1.24e-1)" "unprognostic (7.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (5.58e-2)" "unprognostic (3.05e-2)" "unprognostic (2.49e-4)" "unprognostic (1.99e-2)" "unprognostic (3.32e-1)" "unprognostic (4.89e-2)" "prognostic favorable (4.24e-4)" 2.1 2.5 4.8 1.9 2.4 9.2 1.9 5.7 5.8 2.3 4.2 1.7 12.4 2.2 1.0 1.8 4.0 1.5 4.8 5.8 2.1 3.7 8.6 2.1 2.7 3.5 3.2 2.2 10.4 1.4 5.6 0.8 2.6 3.2 0.8 0.7 2.8 1.3 1.6 3.7 6.8 0.2 1.6 4.9 13.7 5.7 3.3 1.5 4.0 0.3 1.2 2.3 2.0 1.6 1.4 3.8 2.8 5.9 0.5 0.1 11.9 4.0 0.5 1.3 0.4 12.1 1.5 5.9 3.0 0.6 1.4 9.5 0.1 3.3 0.3 4.6 2.5 19.3 8.1 10.7 2.1 1.1 6.2 1.3 2.1 1.4 0.5 1.4 1.3 1.6 29.2 0.4 1.0 7.3 6.9 7.0 1.9 9.3 3.2 2.0 1.3 2.9 1.3 4.8 7.7 12.8 4.9 0.3 3.9 1.4 3.1 3.1 4.8 4.9 3.1 2.2 0.8 1.4 1.0 0.5 1.4 2.3 4.9 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 2.4 5.7 5.8 5.8 2.1 3.5 3.2 2.6 1.6 3.3 1.6 16.7 3.2 2.2 12.4 4.8 0.9 6.1 0.7 0.0 20.7 13.5 25.8 17.2 5.7 0.4 1.8 29.2 0.4 27.5 10.8 1.9 1.3 0.7 24.1 23.7 6.3 6.0 4.8 6.8 5.1 0.2 10.9 14.3 20.1 0.0 16.0 5.0 8.8 0.9 35.3 8.0 6.7 0.0 5.3 1.2 1.1 0.9 7.5 1.8 8.4 1.6 58.0 2.1 5.5 13.4 2.9 6.2 1.5 9.5 1.4 1.3 1.3 0.4 23.9 0.0 16.1 12.4 0.7 1.0 1.9 1.4 0.3 9.6 37.4 5.2 2.1 ZNF277 "NRIF4, ZNF277P" ENSG00000198839 "Zinc finger protein 277" Q9NRM2 7 112206695-112343934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027307 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 32: Non-specific - Translation" Nucleoplasm "Plasma membrane" "HPA027307: AB_1859164" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (3.95e-2)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (1.43e-1)" "unprognostic (4.18e-2)" "unprognostic (4.60e-2)" "unprognostic (7.61e-2)" "unprognostic (1.88e-2)" "unprognostic (2.85e-1)" "prognostic favorable (9.47e-4)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 7.5 6.8 3.9 5.4 4.9 6.1 8.9 4.2 7.2 6.1 3.8 7.1 5.9 6.7 3.1 7.1 6.0 6.4 8.0 4.5 3.7 9.5 11.6 7.0 6.8 4.7 3.8 7.1 11.3 7.1 4.6 4.6 4.6 5.6 6.9 4.5 7.1 4.4 6.5 8.3 5.6 6.0 3.8 5.8 7.8 5.4 4.7 7.9 9.4 3.4 6.3 8.2 7.0 7.1 7.6 4.5 7.5 9.3 10.2 28.1 5.6 7.4 7.9 3.5 6.3 6.8 6.8 12.6 13.3 6.1 7.2 5.0 5.7 7.3 9.4 10.2 3.6 6.6 6.1 5.8 6.3 12.1 5.2 17.1 10.8 8.6 5.7 11.1 10.7 13.2 7.9 13.3 6.4 8.8 15.2 20.6 5.1 6.5 5.0 7.4 8.2 11.4 9.5 5.6 5.3 13.8 9.7 12.0 11.9 8.1 3.4 10.2 14.9 5.4 3.1 12.0 4.8 11.5 14.6 14.8 3.9 11.5 6.6 9.3 4.6 6.4 5.7 8.1 8.5 8.7 8.0 8.2 3.7 9.6 9.6 8.1 6.6 7.4 7.2 5.9 9.4 3.7 3.9 4.9 4.2 7.2 4.5 3.7 4.7 3.8 4.6 3.8 4.7 7.1 13.0 38.5 24.6 77.1 25.7 20.6 18.2 35.7 26.2 10.0 19.0 17.5 12.8 27.1 24.1 5.5 2.1 12.3 19.6 12.4 27.4 25.9 46.4 13.6 15.6 17.9 18.5 11.1 51.9 31.0 18.3 15.7 12.8 16.3 7.6 21.4 16.4 19.2 21.7 32.0 43.4 22.5 34.6 46.9 34.8 8.6 17.1 29.1 12.4 43.1 50.6 6.6 37.0 47.7 70.5 24.6 22.9 25.2 13.2 17.5 27.0 34.5 12.7 12.0 19.7 17.1 23.7 32.8 10.4 19.1 24.3 13.8 25.8 28.1 22.4 21.5 ZNF33B "KOX2, KOX31, ZNF11B" ENSG00000196693 "Zinc finger protein 33B" Q06732 10 42574185-42638570 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA005538, HPA056638" Approved Approved "Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli fibrillar center, Endoplasmic reticulum" Vesicles "HPA005538: , HPA056638: AB_2683199" "unprognostic (3.01e-3)" "unprognostic (2.20e-1)" "unprognostic (2.93e-2)" "unprognostic (8.34e-2)" "unprognostic (5.15e-2)" "unprognostic (1.16e-1)" "unprognostic (1.01e-2)" "unprognostic (2.19e-2)" "unprognostic (1.43e-2)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (3.79e-2)" "unprognostic (2.90e-3)" "unprognostic (3.71e-1)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (1.61e-2)" 4.7 9.8 3.9 5.9 4.9 3.1 20.6 9.8 5.1 9.5 9.5 9.1 8.9 11.7 7.6 7.4 18.6 8.6 5.3 4.8 6.6 18.5 10.3 8.9 9.4 4.9 4.0 23.5 34.1 15.2 10.0 7.2 5.1 12.6 10.4 10.4 18.6 10.4 3.9 12.2 9.7 5.2 2.5 10.3 14.3 4.7 5.3 8.0 18.3 4.9 8.9 9.0 9.0 3.7 13.2 3.3 8.5 8.8 3.1 0.4 10.6 8.1 6.2 5.1 7.1 7.3 14.9 19.9 4.8 3.1 7.7 10.9 16.5 5.6 5.7 11.8 12.4 7.9 12.7 11.9 3.6 18.8 6.2 5.1 20.1 3.1 17.0 13.4 4.4 10.8 10.9 14.7 3.1 5.7 7.5 4.5 9.3 6.5 7.7 8.0 8.5 8.5 13.4 17.2 15.3 14.9 5.1 10.5 5.1 7.7 13.4 5.7 5.3 2.6 12.3 4.5 8.6 9.5 15.5 6.1 1.8 13.9 2.4 19.4 7.5 7.1 10.7 6.7 15.1 20.1 15.4 10.8 6.7 15.4 19.5 13.7 2.4 8.3 5.5 11.1 13.4 9.0 3.9 4.9 9.8 5.1 4.8 6.6 4.9 4.0 5.1 2.5 5.3 3.7 10.0 80.1 37.8 14.0 17.7 4.8 18.0 5.5 18.2 15.4 26.0 27.8 31.5 34.3 30.0 20.2 10.4 18.6 13.4 9.7 21.5 27.0 2.4 37.2 6.0 14.1 25.3 17.1 25.6 36.1 16.8 10.0 14.8 14.5 8.2 23.8 16.4 10.8 8.4 10.1 48.2 17.6 4.1 13.6 3.6 3.8 20.5 9.3 7.2 36.5 17.9 10.2 21.6 30.7 14.1 25.8 21.4 11.7 15.2 13.0 21.2 27.0 47.6 9.6 0.0 9.0 8.5 9.0 11.3 11.8 4.0 11.5 17.0 22.6 18.5 12.8 ZNF449 "FLJ23614, ZSCAN19" ENSG00000173275 "Zinc finger protein 449" Q6P9G9 X 135344796-135363413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 15.8;Inhibitory neurons: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018079 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" "HPA018079: AB_1859277" "unprognostic (5.51e-3)" "unprognostic (1.64e-1)" "unprognostic (6.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-2)" "unprognostic (4.86e-2)" "unprognostic (2.69e-1)" "unprognostic (5.31e-2)" "unprognostic (1.34e-3)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (9.61e-2)" "unprognostic (4.22e-2)" 7.3 10.3 2.9 4.4 3.2 1.4 6.1 2.6 4.0 5.6 2.7 5.5 3.2 6.4 5.3 3.6 4.4 5.3 5.3 3.2 3.4 3.8 3.5 5.0 3.9 3.2 2.9 4.5 8.3 5.8 4.2 6.8 3.1 5.6 3.4 4.9 4.8 4.3 5.2 3.6 3.7 4.8 2.8 6.1 4.9 2.8 3.8 2.8 7.0 5.5 3.4 4.5 4.7 3.1 2.7 3.8 7.7 6.3 6.8 13.5 3.7 5.1 3.9 3.2 7.8 1.3 3.6 1.7 6.4 4.0 4.3 3.1 5.4 2.3 5.1 2.3 4.6 2.2 4.3 2.0 5.2 1.8 3.2 5.3 6.6 2.7 7.9 4.5 6.2 4.2 2.2 1.8 9.2 1.5 2.3 2.0 2.7 2.6 4.2 1.9 5.1 2.5 4.7 1.6 1.8 4.5 1.2 3.7 3.8 4.9 2.7 2.0 6.1 7.4 2.7 5.0 4.6 1.4 1.8 1.3 2.9 3.0 4.8 0.7 1.2 1.7 1.2 1.5 2.4 0.7 1.1 1.7 1.1 0.4 1.1 1.1 0.3 2.6 3.3 0.7 1.1 1.0 2.9 3.2 2.6 4.0 3.2 3.4 3.2 2.9 3.1 2.8 3.8 3.1 6.7 0.0 2.2 7.8 2.4 0.9 0.9 1.1 1.2 6.0 2.5 2.5 10.2 1.5 1.3 1.8 0.0 2.5 1.3 0.8 0.0 1.7 0.3 1.2 3.4 6.4 3.0 0.8 15.8 0.6 2.1 3.7 3.1 1.1 1.3 6.4 6.8 0.6 4.2 10.1 12.5 0.8 0.0 3.2 1.9 0.5 5.3 2.4 3.6 8.4 5.0 3.9 0.0 9.5 7.2 1.2 1.4 4.1 1.1 1.1 0.6 0.6 2.2 2.8 0.0 2.4 4.0 2.8 2.3 1.0 2.3 1.2 1.9 11.5 0.6 0.6